,genes,disease,drug_name,drug_id,ind_name,status,iso_smiles,phase,disease category,cell_id1,cell_id2,cell_id3,cell_id4,cell_id5,cell_id6,cell_id7,cell_id8,cell_id9,cell_id10,cell_id11,cell_id12,cell_id13,cell_id14,cell_id15,cell_id16,cell_id17,genes.1,GEO accession ,link ,Unnamed: 29,Unnamed: 30,Unnamed: 31,Unnamed: 32,Unnamed: 33,Unnamed: 34
31097,RELA,C0022661,Niacin,DB00627,"Kidney Failure, Chronic",Terminated,C1=CC(=CN=C1)C(=O)O},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27386,TFPI,C0852036,Magnesium Sulfate,DB00653,Pregnancy associated hypertension,Suspended,[O-]S(=O)(=O)[O-].[Mg+2]},Phase 2/Phase 3,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10546,GFAP,C0014544,Zonisamide,DB00909,Epilepsy,Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 3,Nervous system disease,FLJ45472,,,,,,,,,,,,,,,,,,,,,,,,,
12818,BCL10,C0024301,Vincristine,DB00541,"Lymphoma, Follicular",Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33892,LINC02211,C0041296,Moxifloxacin,DB00218,Tuberculosis,Withdrawn,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O},Phase 1,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7924,CTNNB1,C0029458,Zoledronic acid,DB00399,"Osteoporosis, Postmenopausal",Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,beta-catenin,armadillo,CTNNB,,,,,,,,,,,,,,,,,,,,,,,
148,Amcinonide,DB00288,Pruritus Ani,C0033775,Approved,CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3CCC5=CC(=O)C=C[C@@]54C)F)O)C)OC6(O2)CCCC6},,,,,,,,,,,,,,,,,,,,,HP,,,,,,,,
15163,CCL4L1,C0009088,Sumatriptan,DB00669,Cluster Headache,Approved,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
12272,APOB,C0020557,Topiramate,DB00273,Hypertriglyceridemia,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
33883,ASAP1,C0041296,Moxifloxacin,DB00218,Tuberculosis,Withdrawn,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O},Phase 1,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35459,ACTB,C0003129,Nitric Oxide,DB00435,Anoxemia,Terminated,[N]=O},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
14032,IL6,C2894027,Triamcinolone,DB00620,Post traumatic osteoarthritis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
30653,PTGS2,C0685938,Erythropoietin,DB00016,Malignant neoplasm of gastrointestinal tract,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
13085,FLI1,C0011644,Imatinib,DB00619,Scleroderma,Terminated,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 2,Skin disease,SIC-1,,,,,,,,,,,,,,,,,,,,,,,,,
27439,PAX2,C1332219,Vincristine,DB00541,Adult Kidney Wilms Tumor,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
12220,ABCG8,C0020474,Simvastatin,DB00641,"Hyperlipidemia, Familial Combined",Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Metabolic disease,GBD4,,,,,,,,,,,,,,,,,,,,,,,,,
4509,Norfloxacin,DB01059,Legionella pneumophila pneumonia,C0857846,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CBLN2,,,,,,,,
31758,ADNP,C0524528,Levoleucovorin,DB11596,Pervasive Development Disorder,Terminated,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
34788,DGAT1,C0023772,Ezetimibe,DB00973,"Lipid Metabolism, Inborn Errors",Terminated,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O},Phase 3,Congenital disorder of metabolism,ARGP1,DGAT,,,,,,,,,,,,,,,,,,,,,,,,
9743,TLR9,C0085437,Tobramycin,DB00684,"Meningitis, Bacterial",Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Infectious disease,CD289,,,,,,,,,,,,,,,,,,,,,,,,,
17971,TERT,C0027819,Topotecan,DB01030,Neuroblastoma,Withdrawn,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O},Phase 2,Cancer,TRT,TCS1,hEST2,EST2,,,,,,,,,,,,,,,,,,,,,,
18771,MYDGF,C0022548,Triamcinolone,DB00620,Keloid,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29756,CD34,C0265965,Danazol,DB01406,Dyskeratosis Congenita,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5},Phase 1/Phase 2,Ribosomopathy,,,,,,,,,,,,,,,,,,,,,,,,,,
3233,Gramicidin D,DB00027,Blepharoconjunctivitis,C0005743,Approved,C[C@@H](C(=O)N[C@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC7=CNC8=CC=CC=C87)C(=O)NCCO)NC(=O)[C@@H](CC(C)C)NC(=O)CNC(=O)[C@H](C(C)C)NC=O},,Infectious disease,,,,,,,,,,,,,,,,,,,MDM2,,,,,,,,
36388,F5,C0751956,Nimodipine,DB00393,Acute Cerebrovascular Accidents,Withdrawn,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC},Phase 2,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
35761,SELP,C0012359,Riboflavin,DB00140,Pathological Dilatation,Terminated,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)C[C@@H]([C@@H]([C@@H](CO)O)O)O},Phase 3,Congenital malformation,CD62,PSEL,PADGEM,GMP140,CD62P,GRMP,,,,,,,,,,,,,,,,,,,,
26715,LOC102723407,C0020981,Thalidomide,DB01041,Angioimmunoblastic Lymphadenopathy,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4076,Methylprednisolone,DB00959,Crohn Disease,C0010346,Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O},,Immune system disease,,,,,,,,,,,,,,,,,,,FBXO8,,,,,,,,
12137,AMELX,C0342882,Simvastatin,DB00641,Familial hypercholesterolemia - heterozygous,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Inherited metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16067,HLA-DRB1,C0025289,Gemcitabine,DB00441,Meningitis,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1,Infectious disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
21641,AAVS1,C0019880,Glycine betaine,DB06756,Homocystinuria,Approved,C[N+](C)(C)CC(=O)[O-]},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
2297,Diclofenac,DB00586,Ankylosing spondylitis,C0038013,Approved,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,BRAF,,,,,,,,
24146,ARNT2,C0005697,Oxybutynin,DB01062,Neurogenic Urinary Bladder,Approved,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
788,Bromocriptine,DB01200,Parkinson Disease,C0030567,Approved,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O},,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,Iloprost,,,,,,,,
24644,PPBP,C0004031,Prednisolone,DB00860,"Aspergillosis, Allergic Bronchopulmonary",Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Infectious disease,SCYB7,TGB,NAP-2-L1,LA-PF4,MDGF,LDGF,Beta-TG,CTAP3,CXCL7,b-TG1,TGB1,CTAPIII,NAP-2,THBGB1,,,,,,,,,,,,
20604,CBFB,C0029396,Etidronic acid,DB01077,Heterotopic Ossification,Approved,CC(O)(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24623,MBL2,C0004031,Prednisolone,DB00860,"Aspergillosis, Allergic Bronchopulmonary",Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Infectious disease,COLEC1,,,,,,,,,,,,,,,,,,,,,,,,,
5018,Piroxicam,DB00554,Rheumatoid Arthritis,C0003873,Approved,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3},,Immune system disease,,,,,,,,,,,,,,,,,,,RPTN,,,,,,,,
22025,ATM,C0855095,Idelalisib,DB09054,Small Lymphocytic Lymphoma,Approved,CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29091,ERBB2,C0280401,Sirolimus,DB00877,Laryngeal squamous cell carcinoma recurrent,Withdrawn,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 1,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
3286,Hexamethylenetetramine,DB06799,Urinary tract infection,C0042029,Approved,C1N2CN3CN1CN(C2)C3},,Infectious disease,,,,,,,,,,,,,,,,,,,CEBPD,,,,,,,,
32778,SEPTIN9,C0019045,Pegfilgrastim,DB00019,Hemoglobinopathies,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
1397,Ceftriaxone,DB01212,Haemophilus parainfluenzae pneumonia,C0877633,Approved,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Sodium phenylbutyrate,,,,,,,,
12406,FCN2,C0035243,Azidocillin,DB08795,Respiratory Tract Infections,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N=[N+]=[N-])C(=O)O)C},,Infectious disease,P35,FCNL,EBP-37,ficolin-2,,,,,,,,,,,,,,,,,,,,,,
36466,MMP2,C0862312,Pemetrexed,DB00642,"Epithelioid mesothelioma, malignant",Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,TBE-1,CLG4,CLG4A,,,,,,,,,,,,,,,,,,,,,,,
23825,MAPK14,C1262117,Natamycin,DB00826,Fungal keratitis,Approved,C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)O)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)N)O},,Infectious disease,PRKM14,Mxi2,PRKM15,CSPB1,CSBP1,CSBP2,,,,,,,,,,,,,,,,,,,,
34466,SETBP1,C0023470,Mycophenolic acid,DB01024,Myeloid Leukemia,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1996,Cycloserine,DB00260,Acute tuberculosis,C0275959,Approved,C1[C@H](C(=O)NO1)N},,Infectious disease,,,,,,,,,,,,,,,,,,,NECTIN2,,,,,,,,
2915,Fluorouracil,DB00544,Actinic keratosis,C0022602,Approved,C1=C(C(=O)NC(=O)N1)F},,Skin disease,,,,,,,,,,,,,,,,,,,ITGB6,,,,,,,,
13415,IL6,C0004364,Triamcinolone,DB00620,Autoimmune Diseases,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
33654,OPTN,C0206638,Zoledronic acid,DB00399,Giant Cell Tumor of Bone,Terminated,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},Phase 2,Cancer,FIP2,HYPL,FIP-2,TFIIIA-INTP,HIP7,GLC1E,,,,,,,,,,,,,,,,,,,,
173,Amikacin,DB00479,Osteomyelitis,C0029443,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},,Immune system disease,,,,,,,,,,,,,,,,,,,Bleomycin,,,,,,,,
11340,CLOCK,C0034362,Tetracycline,DB00759,Q Fever,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,,KIAA0334,KAT13D,bHLHe8,,,,,,,,,,,,,,,,,,,,,,,
36432,CTAA1,C0333875,Celecoxib,DB00482,High-Grade Squamous Intraepithelial Lesions,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15225,SIK1,C0026838,Tizanidine,DB00697,Muscle Spasticity,Approved,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl},,Nervous system disease,msk,SNF1LK,,,,,,,,,,,,,,,,,,,,,,,,
29318,CFTR,C0279628,Cisplatin,DB00515,Adenocarcinoma Of Esophagus,Terminated,N.N.Cl[Pt]Cl},Phase 2,Cancer,ABC35,TNR-CFTR,CFTR/MRP,CF,ABCC7,,,,,,,,,,,,,,,,,,,,,
23279,NSMF,C0232940,Progesterone,DB00396,Secondary physiologic amenorrhea,Approved,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15968,CCND1,C0153633,Carmustine,DB00262,Malignant neoplasm of brain,Approved,C(CCl)NC(=O)N(CCCl)N=O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36318,TSEN34,C0011168,Lansoprazole,DB00448,Deglutition Disorders,Withdrawn,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F},Phase 1/Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
35531,CPM,C0154830,Octreotide,DB00104,Proliferative diabetic retinopathy,Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 3,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
15322,HSD3B7,C0035579,Calcitriol,DB00136,Rickets,Terminated,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},Phase 2,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
13452,FOXP3,C0002880,Triamcinolone,DB00620,Autoimmune hemolytic anemia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,JM2,XPID,AIID,PIDX,DIETER,SCURFIN,IPEX,,,,,,,,,,,,,,,,,,,
702,Betamethasone,DB00443,"Lupus Erythematosus, Systemic",C0024141,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Immune system disease,,,,,,,,,,,,,,,,,,,Gentamicin,,,,,,,,
4747,CSF3R,C0857177,Salicylic acid,DB00936,Arthritic pains,Approved,C1=CC=C(C(=C1)C(=O)O)O},,,GCSFR,CD114,,,,,,,,,,,,,,,,PNKP,,,,,,,,
1058,Cefazolin,DB01327,Bacterial sepsis,C0684256,Approved,CC1=NN=C(S1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Moxisylyte,,,,,,,,
9689,ITGB2,C2242472,Vancomycin,DB00512,Infection of bone,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,CD18,MFI7,,,,,,,,,,,,,,,,,,,,,,,,
12936,IFNA13,C0011633,Benzoic Acid,DB03793,Dermatomyositis,Approved,C1=CC=C(C=C1)C(=O)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28928,FCGR3B,C0024143,Tacrolimus,DB00864,Lupus Nephritis,Withdrawn,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 3,Urinary system disease,CD16b,,,,,,,,,,,,,,,,,,,,,,,,,
7972,GATA3,C0020626,Ergocalciferol,DB00153,Hypoparathyroidism,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Endocrine and metabolic disease,HDR,,,,,,,,,,,,,,,,,,,,,,,,,
14782,GPR101,C0001206,Somatostatin,DB09099,Acromegaly,Terminated,C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=CC=C6)O},Phase 2,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5331,Promazine,DB00420,Intractable hiccups,C0744896,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,,,,,,,,,,,,,,,,,,,,SLC22A1,,,,,,,,
5107,Prednicarbate,DB01130,Exanthema,C0015230,Approved,CCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)OC(=O)OCC},,Infectious disease,,,,,,,,,,,,,,,,,,,SAA1,,,,,,,,
14456,FAS,C0079744,Vincristine,DB00541,Diffuse Large B-Cell Lymphoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,CD95,APO-1,FAS1,APT1,TNFRSF6,,,,,,,,,,,,,,,,,,,,,
13353,EPO,C1260899,Triamcinolone,DB00620,"Anemia, Diamond-Blackfan",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Hematologic disease,EP,,,,,,,,,,,,,,,,,,,,,,,,,
30123,CCK,C0235032,Methylphenidate,DB00422,Neurotoxicity Syndromes,Terminated,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},Phase 2,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
25073,MIR942,C2363973,Riociguat,DB08931,Chronic thromboembolic pulmonary hypertension,Approved,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21219,SRY,C0151721,Testosterone Propionate,DB01420,Testicular hypogonadism,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7385,Spironolactone,DB00421,Type 2 diabetes mellitus with established diabetic nephropathy,C0837031,Terminated,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C},Phase 1,Endocrine disease,,,,,,,,,,,,,,,,,,,PRDM2,,,,,,,,
31647,TP53,C0149978,Oxaliplatin,DB00526,Adenocarcinoma of rectum,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4339,Nafcillin,DB00607,Staphylococcus aureus infection,C1318973,Approved,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,MIR214,,,,,,,,
29608,PASK,C0278883,Paclitaxel,DB01229,Metastatic melanoma,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
5093,Pravastatin,DB00175,Cerebrovascular accident,C0038454,Approved,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,ZBTB46,,,,,,,,
36135,PDE2A,C0034544,Ganciclovir,DB01004,Radiculitis,Withdrawn,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N},Phase 1,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
2707,Erythromycin,DB00199,Inclusion conjunctivitis,C0009770,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,PLD1,,,,,,,,
32231,DISC1,C0236792,Memantine,DB01043,Asperger Syndrome,Terminated,CC12CC3CC(C1)(CC(C3)(C2)N)C},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
31363,ALK,C0220654,Erlotinib,DB00530,Meningeal Carcinomatosis,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
31248,MEN1,C0001624,Erlotinib,DB00530,Adrenal Gland Neoplasms,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,
3503,Incadronic acid,DB06255,Osteoporosis,C0029456,Approved,C1CCCC(CC1)NC(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,XIAP,,,,,,,,
29207,ERBB2,C0278878,Irinotecan,DB00762,adult glioblastoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
8646,DYNLL1,C0242350,Vardenafil,DB00862,Erectile dysfunction,Approved,CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2363,Diltiazem,DB00343,Atrial Fibrillation,C0004238,Approved,CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,RBM8A,,,,,,,,
27055,NF1,C0205824,Ifosfamide,DB01181,"Liposarcoma, Dedifferentiated",Suspended,C1CN(P(=O)(OC1)NCCCl)CCCl},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
3921,Medroxyprogesterone acetate,DB00603,Endometriosis,C0014175,Approved,C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C},,Reproductive system disease,,,,,,,,,,,,,,,,,,,CYP19A1,,,,,,,,
26015,JAK1,C0023646,Triamcinolone,DB00620,Lichen Planus,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17263,MME,C1303258,Clopidogrel,DB00758,Acute ST segment elevation myocardial infarction (disorder),Approved,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3},,Cardiovascular disease,CALLA,CD10,,,,,,,,,,,,,,,,,,,,,,,,
7181,IL6,C0024117,Salmeterol,DB00938,Chronic Obstructive Airway Disease,Withdrawn,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O},Phase 3,Lung disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,PSMD12,,,,,,,,
36493,BAP1,C0334513,Pemetrexed,DB00642,Sarcomatoid Mesothelioma,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,other disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7204,Fludarabine,DB01073,Systemic Scleroderma,C0036421,Terminated,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 1,Skin disease,,,,,,,,,,,,,,,,,,,CBR1,,,,,,,,
15353,GBA,C0018790,Metoprolol,DB00264,Cardiac Arrest,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28347,PCNA,C0023486,Thalidomide,DB01041,Prolymphocytic Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
13678,BEST1,C0015397,Triamcinolone,DB00620,Disorder of eye,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
15024,GABRA2,C0085159,Bupropion,DB01156,Seasonal Affective Disorder,Approved,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
190,Amikacin,DB00479,Staphylococcal Pneumonia,C0032308,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},,Infectious disease,,,,,,,,,,,,,,,,,,,Brompheniramine,,,,,,,,
6172,Triamcinolone,DB00620,Subacute bursitis,C1290159,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,,,,,,,,,,,,,,,,,,,,CLNK,,,,,,,,
21847,FOS,C0034013,Nafarelin,DB00666,Precocious Puberty,Approved,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CC3=CC=CC=C3C=C2)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8},,,c-fos,,,,,,,,,,,,,,,,,,,,,,,,,
14390,IL6,C0011991,Zidovudine,DB00495,Diarrhea,Terminated,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]},Phase 3,Digestive system disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
2623,Ephedrine,DB01364,Bronchitis,C0006277,Approved,C[C@@H]([C@@H](C1=CC=CC=C1)O)NC},,Lung disease,,,,,,,,,,,,,,,,,,,OSR1,,,,,,,,
27964,HDAC5,C0036421,Iloprost,DB01088,Systemic Scleroderma,Terminated,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17554,SPTAN1,C0037769,Vigabatrin,DB01080,West Syndrome,Approved,C=CC(CCC(=O)O)N},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15804,PROS1,C0033581,Ofloxacin,DB01165,prostatitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,PROS,,,,,,,,,,,,,,,,,,,,,,,,,
19201,CD52,C0751967,Mitoxantrone,DB01204,"Multiple Sclerosis, Relapsing-Remitting",Approved,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},,Nervous system disease,HE5,EDDM5,CDW52,,,,,,,,,,,,,,,,,,,,,,,
1690,Clarithromycin,DB01211,Haemophilus parainfluenzae pneumonia,C0877633,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,GCH1,,,,,,,,
14537,H3P10,C0080032,Thiotepa,DB04572,"Pleural Effusion, Malignant",Approved,C1CN1P(=S)(N2CC2)N3CC3},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29178,AURKB,C1541316,Irinotecan,DB00762,adult giant cell glioblastoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,Aik2,IPL1,AurB,ARK2,STK5,PPP1R48,STK12,,,,,,,,,,,,,,,,,,,
22145,GLI3,C0238198,Sunitinib,DB01268,Gastrointestinal Stromal Tumors,Approved,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},,Cancer,PAP-A,PAPA1,PAPB,ACLS,PPDIV,GCPS,PHS,,,,,,,,,,,,,,,,,,,
20766,G6PD,C0343386,Vancomycin,DB00512,Clostridium difficile infection,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,G6PD1,,,,,,,,,,,,,,,,,,,,,,,,,
24989,CD99,C0040558,Sulfamethoxazole,DB01015,Toxoplasmosis,Approved,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,MIC2,,,,,,,,,,,,,,,,,,,,,,,,,
17998,CTNNB1,C0035335,Melphalan,DB01042,Retinoblastoma,Terminated,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl},Phase 2,Cancer,beta-catenin,armadillo,CTNNB,,,,,,,,,,,,,,,,,,,,,,,
11496,P3H3,C0041471,Tetracycline,DB00759,TYPHUS,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,GRCB,HSU47926,LEPREL2,,,,,,,,,,,,,,,,,,,,,,,
15413,SST,C0020621,Potassium Citrate,DB09125,Hypokalemia,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Endocrine and metabolic disease,SMST,,,,,,,,,,,,,,,,,,,,,,,,,
26587,FOXA1,C0278838,Ketoconazole,DB01026,Prostate cancer recurrent,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,HNF3A,,,,,,,,,,,,,,,,,,,,,,,,,
32942,MIR6886,C0549399,Simvastatin,DB00641,Low density lipoprotein increased,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25567,NARS1,C0030201,Sufentanil,DB00708,"Pain, Postoperative",Approved,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
18621,NOS1,C0270327,Imipramine,DB00458,Bedwetting,Approved,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31},,,nNOS,,,,,,,,,,,,,,,,,,,,,,,,,
15601,CRHR2,C0003469,Paroxetine,DB00715,Anxiety Disorders,Terminated,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
4661,Orphenadrine,DB01173,Muscle Spasticity,C0026838,Approved,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C},,Nervous system disease,,,,,,,,,,,,,,,,,,,COL4A3,,,,,,,,
8112,IL17F,C0033774,Zinc oxide,DB09321,Pruritus,Approved,O=[Zn]},,,IL-17F,ML1,,,,,,,,,,,,,,,,,,,,,,,,
9875,Bupivacaine,DB00297,Shoulder Injuries,C0149776,Withdrawn,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C},Phase 3,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
34937,GCG,C0025517,Heparin,DB01109,Metabolic Diseases,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Endocrine and metabolic disease,GLP2,GRPP,,,,,,,,,,,,,,,,,,,,,,,,
7285,EEF1D,C0001144,Tretinoin,DB00755,Acne Vulgaris,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Infectious disease,0,,,,,,,,,,,,,,,,,AK7,,,,,,,,
26916,CD19,C0432487,Vidarabine,DB00194,Post-transplant lymphoproliferative disorder,Suspended,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
2353,Dihydroergotamine,DB00320,Vascular Headaches,C0042376,Approved,C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C},,,,,,,,,,,,,,,,,,,,,RREB1,,,,,,,,
36386,CDK6,C0751956,Nimodipine,DB00393,Acute Cerebrovascular Accidents,Withdrawn,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31788,CEACAM5,C0750952,Fluorouracil,DB00544,Biliary Tract Cancer,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 3,Cancer,CD66e,,,,,,,,,,,,,,,,,,,,,,,,,
26762,CD34,C1511566,Thalidomide,DB01041,Cutaneous B-Cell Non-Hodgkin Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
37174,HPGDS,C0023051,Omeprazole,DB00338,Laryngeal Diseases,Withdrawn,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 3,,GSTS,H-PGDS,PGD2,GSTS1-1,GSTS1,,,,,,,,,,,,,,,,,,,,,
24541,CASZ1,C0042345,Sodium Tetradecyl Sulfate,DB00464,Varicosity,Approved,CCCCCCCCCCCCCCOS(=O)(=O)[O-].[Na+]},,Vascular disease,FLJ20321,ZNF693,castor,cst,SRG,,,,,,,,,,,,,,,,,,,,,
13759,CD274,C0019829,Tacrolimus,DB00864,Hodgkin Disease,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2,Cancer,B7-H,B7H1,PD-L1,PDL1,B7-H1,PDCD1LG1,,,,,,,,,,,,,,,,,,,,
8780,PLG,C0013295,Sucralfate,DB00364,Duodenal Ulcer,Approved,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al]},,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
13325,CYP11B1,C0405580,Triamcinolone,DB00620,Adrenal cortical hypofunction,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18240,FOXO1,C0035412,Vincristine,DB00541,Rhabdomyosarcoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,FKH1,FKHR,FOXO1A,,,,,,,,,,,,,,,,,,,,,,,
14173,CRP,C0039520,Triamcinolone,DB00620,Tenosynovitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,,,,,,,,
518,Aztreonam,DB00355,Infection of skin AND/OR subcutaneous tissue,C0178299,Approved,C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\\OC(C)(C)C(=O)O)/C2=CSC(=N2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,APOE,,,,,,,,
14120,ALB,C0242459,Triamcinolone,DB00620,Simple Pulmonary Eosinophilia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
25731,FOXA2,C0020635,Testosterone,DB00624,Hypopituitarism,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,Endocrine disease,HNF3B,,,,,,,,,,,,,,,,,,,,,,,,,
8111,TRAF3IP2,C0033774,Zinc oxide,DB09321,Pruritus,Approved,O=[Zn]},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
4413,Nicotine,DB00184,Nicotine Dependence,C0028043,Approved,CN1CCC[C@H]1C2=CN=CC=C2},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,NPEPPS,,,,,,,,
13657,TNIK,C0037274,Triamcinolone,DB00620,Dermatologic disorders,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29004,IL17A,C0019187,Pentoxifylline,DB00806,"Hepatitis, Alcoholic",Terminated,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C},Phase 1,Digestive system disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
36598,IL2,C0278882,Sorafenib,DB00398,malignant melanoma of skin stage III,Withdrawn,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,IL-2,TCGF,,,,,,,,,,,,,,,,,,,,,,,,
33331,PTRH1,C0342341,Teriparatide,DB06285,Post-surgical hypoparathyroidism,Terminated,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N},Phase 2,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22767,WFS1,C0002888,Levoleucovorin,DB11596,"Anemia, Megaloblastic",Approved,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15529,OPRM1,C0027796,Pregabalin,DB00230,Neuralgia,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,Nervous system disease,MOR1,,,,,,,,,,,,,,,,,,,,,,,,,
28878,EDN1,C0278493,Tamoxifen,DB00675,Breast cancer recurrent,Withdrawn,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},Phase 3,Cancer,ET1,,,,,,,,,,,,,,,,,,,,,,,,,
18997,PF4,C0040053,Warfarin,DB00682,Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,SCYB4,CXCL4,,,,,,,,,,,,,,,,,,,,,,,,
5080,Pramocaine,DB09345,Otitis Externa,C0029878,Approved,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2},,Infectious disease,,,,,,,,,,,,,,,,,,,CKM,,,,,,,,
15706,KCNJ11,C0494475,Primidone,DB00794,Tonic - clonic seizures,Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,Kir6.2,BIR,,,,,,,,,,,,,,,,,,,,,,,,
12282,BCHE,C0020557,Topiramate,DB00273,Hypertriglyceridemia,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Metabolic disease,CHE2,,,,,,,,,,,,,,,,,,,,,,,,,
25495,KCNJ5,C0020428,Spironolactone,DB00421,Hyperaldosteronism,Approved,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16994,FCGR1A,C0343467,Thalidomide,DB01041,Erythema nodosum leprosum,Approved,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},,Infectious disease,CD64,CD64A,,,,,,,,,,,,,,,,,,,,,,,,
26894,JAK2,C1328061,Decitabine,DB01262,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable",Terminated,C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O},Phase 1,Cancer,JTK10,,,,,,,,,,,,,,,,,,,,,,,,,
18977,F2,C0040053,Warfarin,DB00682,Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1227,Cefpodoxime,DB01416,Acute exacerbation of chronic bronchitis,C0856695,Approved,COCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O},,Lung disease,,,,,,,,,,,,,,,,,,,Pioglitazone,,,,,,,,
29469,GPX1,C0005695,Mitomycin,DB00305,Bladder Neoplasm,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
1282,Ceftaroline fosamil,DB06590,Bacterial infection due to Klebsiella pneumoniae,C0343402,Approved,CCO/N=C(/C1=NSC(=N1)NP(=O)(O)O)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,SUFU,,,,,,,,
32087,IL2,C0023903,Sirolimus,DB00877,Liver neoplasms,Withdrawn,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,IL-2,TCGF,,,,,,,,,,,,,,,,,,,,,,,,
7541,H3P13,C0406317,Ulobetasol,DB00596,Chronic small plaque psoriasis,Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Skin disease,0,,,,,,,,,,,,,,,,,RGS14,,,,,,,,
2649,Eplerenone,DB00700,Hypertensive disease,C0020538,Approved,C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,CALCOCO1,,,,,,,,
35775,KCNJ11,C0730345,Rimonabant,DB06155,Microalbuminuria,Terminated,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl},Phase 3,Urinary system disease,Kir6.2,BIR,,,,,,,,,,,,,,,,,,,,,,,,
36519,JAG2,C0019621,Clofarabine,DB00631,"Histiocytosis, Langerhans-Cell",Withdrawn,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33095,IL6,C0041696,Scopolamine,DB00747,Unipolar Depression,Terminated,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},Phase 2,Mental and behavioural disorder,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
32522,LGALS3,C0278851,Sorafenib,DB00398,Metastatic papillary thyroid carcinoma,Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,MAC-2,GALIG,LGALS2,,,,,,,,,,,,,,,,,,,,,,,
18846,LEP,C0020459,Diazoxide,DB01119,Hyperinsulinism,Approved,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl},,Endocrine and metabolic disease,OBS,,,,,,,,,,,,,,,,,,,,,,,,,
189,Amikacin,DB00479,Staphylococcal meningitis,C0154640,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},,Infectious disease,,,,,,,,,,,,,,,,,,,Bromodiphenhydramine,,,,,,,,
24124,MTFMT,C0005697,Oxybutynin,DB01062,Neurogenic Urinary Bladder,Approved,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6969,CXCR1,C0392164,L-Cysteine,DB00151,Pulmonary Cystic Fibrosis,Approved,C([C@@H](C(=O)O)N)S},,Congenital disorder of metabolism,CDw128a,CD181,CMKAR1,IL8RA,,,,,,,,,,,,,,BARX1,,,,,,,,
29717,FN1,C0279627,Vorinostat,DB02546,adult acute myelomonocytic leukemia (M4),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,CIG,LETS,GFND2,FINC,,,,,,,,,,,,,,,,,,,,,,
13890,BRAF,C0024305,Vidarabine,DB00194,"Lymphoma, Non-Hodgkin",Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 3,Cancer,BRAF1,,,,,,,,,,,,,,,,,,,,,,,,,
2931,Fluoxymesterone,DB01185,Delayed Puberty,C0034012,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,COPS5,,,,,,,,
1469,Celiprolol,DB04846,Hypertensive disease,C0020538,Approved,CCN(CC)C(=O)NC1=CC(=C(C=C1)OCC(CNC(C)(C)C)O)C(=O)C},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,PTGS2,,,,,,,,
36378,AR,C0149654,Methylphenidate,DB00422,Conduct Disorder,Withdrawn,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},Phase 1/Phase 2,Mental and behavioural disorder,AIS,NR3C4,SMAX1,HUMARA,DHTR,SBMA,,,,,,,,,,,,,,,,,,,,
18518,DHODH,C0005283,Deferiprone,DB08826,beta Thalassemia,Approved,CC1=C(C(=O)C=CN1C)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18927,IL1A,C0409959,Diclofenac,DB00586,"Osteoarthritis, Knee",Approved,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl},,Musculoskeletal disease,IL1F1,IL-1A,IL1-ALPHA,IL1,,,,,,,,,,,,,,,,,,,,,,
28744,APC,C0009402,Levoleucovorin,DB11596,Colorectal Carcinoma,Withdrawn,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2/Phase 3,Cancer,DP2.5,PPP1R46,,,,,,,,,,,,,,,,,,,,,,,,
12777,CX3CL1,C0034065,Edoxaban,DB09075,Pulmonary Embolism,Approved,CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C},,Lung disease,C3Xkine,ABCD-3,CXC3C,CXC3,fractalkine,neurotactin,SCYD1,,,,,,,,,,,,,,,,,,,
33657,PWAR1,C0206638,Zoledronic acid,DB00399,Giant Cell Tumor of Bone,Terminated,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12596,NOS3,C0600142,Testosterone,DB00624,Hot flushes,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,,ECNOS,eNOS,,,,,,,,,,,,,,,,,,,,,,,,
5266,Primaquine,DB01087,"Malaria, Vivax",C0024537,Approved,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2},,Infectious disease,,,,,,,,,,,,,,,,,,,MGAT4A,,,,,,,,
903,Capsaicin,DB06774,Arthritic pains,C0857177,Approved,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},,,,,,,,,,,,,,,,,,,,,Lomefloxacin,,,,,,,,
7251,IL17A,C1260880,Xylometazoline,DB06694,Rhinorrhea,Approved,CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C},,Nervous system disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,RPS6KC1,,,,,,,,
35769,WWC1,C0730345,Rimonabant,DB06155,Microalbuminuria,Terminated,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12713,TNFRSF8,C0079774,Thalidomide,DB01041,Peripheral T-Cell Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,KI-1,CD30,D1S166E,,,,,,,,,,,,,,,,,,,,,,,
12978,ACAD9,C0220994,Phenylacetic acid,DB09269,Hyperammonemia,Approved,C1=CC=C(C=C1)CC(=O)O},,Inherited metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28590,IL15,C1262481,Sirolimus,DB00877,Eosinophilic gastroenteritis,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 1,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2103,Demeclocycline,DB00618,Yaws,C0043388,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3[C@@H](C4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O},,Infectious disease,,,,,,,,,,,,,,,,,,,ADORA2A-AS1,,,,,,,,
953,Cariprazine,DB06016,"Bipolar affective disorder, current episode manic",C0338873,Approved,CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,Medrysone,,,,,,,,
28030,GDNF,C0458247,Capsaicin,DB06774,Allodynia,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,,ATF1,ATF2,HFB1-GDNF,,,,,,,,,,,,,,,,,,,,,,,
26111,SCFD2,C0042133,Ulipristal,DB08867,Uterine Fibroids,Approved,CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19545,RASSF1,C0242379,Vinorelbine,DB00361,Malignant neoplasm of lung,Withdrawn,CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13501,CPT2,C0006114,Hydroxocobalamin,DB00200,Cerebral Edema,Terminated,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]\\4([C@H]([C@@H]5[C@]6([C@@]([C@@H](C(=N6)/C(=C\\7/[C@@]([C@@H](C(=N7)/C=C\\8/C([C@@H](C(=N8)/C(=C4\\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2]},Phase 2,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7671,Amifostine,DB01143,Radiation Sickness,C1510432,Terminated,C(CN)CNCCSP(=O)(O)O},Phase 2,,,,,,,,,,,,,,,,,,,,DPP10,,,,,,,,
27382,ACE,C0852036,Magnesium Sulfate,DB00653,Pregnancy associated hypertension,Suspended,[O-]S(=O)(=O)[O-].[Mg+2]},Phase 2/Phase 3,Cardiovascular disease,ACE1,CD143,DCP1,,,,,,,,,,,,,,,,,,,,,,,
10616,CD44,C0271429,Trimethoprim,DB00440,Acute otitis media,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,IN,MC56,Pgp1,CD44R,HCELL,CSPG8,MIC4,MDU2,MDU3,,,,,,,,,,,,,,,,,
20098,MRPL28,C0041228,Suramin,DB04786,African Trypanosomiasis,Approved,CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30999,POR,C0206726,Temozolomide,DB00853,gliosarcoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29971,DES,C0043116,Sodium phenylbutyrate,DB06819,HMN (Hereditary Motor Neuropathy) Proximal Type I,Terminated,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},Phase 1/Phase 2,Neurodegenerative disease,CMD1I,CSM1,CSM2,,,,,,,,,,,,,,,,,,,,,,,
21379,F5,C0524702,Fondaparinux sodium,DB00569,Pulmonary Thromboembolisms,Approved,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},,Hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
32825,TERT,C0040136,Ponatinib,DB08901,Thyroid Neoplasm,Terminated,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5},Phase 2,Cancer,TRT,TCS1,hEST2,EST2,,,,,,,,,,,,,,,,,,,,,,
2721,Erythromycin,DB00199,"Pneumonia, Bacterial",C0004626,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,MSH6,,,,,,,,
10987,S100A1,C0006840,Voriconazole,DB00582,Candidiasis,Terminated,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4306,Moxifloxacin,DB00218,Enterobacteriaceae Infections,C0014347,Approved,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,ACKR3,,,,,,,,
36174,ND1,C0155305,Timolol,DB00373,"Optic Neuropathy, Ischemic",Withdrawn,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O},Phase 1,,0,,,,,,,,,,,,,,,,,,,,,,,,,
25635,NUS1P3,C1134719,Tamoxifen,DB00675,Invasive Ductal Breast Carcinoma,Approved,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36814,JAZF1,C0600139,Simvastatin,DB00641,Prostate carcinoma,Withdrawn,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,TIP27,DKFZp761K2222,ZNF802,,,,,,,,,,,,,,,,,,,,,,,
6121,Triamcinolone,DB00620,Bursitis,C0006444,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,CLDN19,,,,,,,,
32683,KRAS,C2931822,Oxaliplatin,DB00526,Nasopharyngeal carcinoma,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11630,TLR2,C0152964,Piperacillin,DB00319,Streptococcal sepsis,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,TIL4,CD282,,,,,,,,,,,,,,,,,,,,,,,,
1916,Cortisone acetate,DB01380,Lichen Simplex Chronicus,C0149922,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,GYPE,,,,,,,,
9288,Tamsulosin,DB00706,Urinary Retention,C0080274,Terminated,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
21246,WFS1,C0151721,Testosterone Propionate,DB01420,Testicular hypogonadism,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18369,GLUD2,C0085606,Trospium,DB00209,Urgency of micturition,Approved,C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
31005,BRAF,C0206726,Temozolomide,DB00853,gliosarcoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,BRAF1,,,,,,,,,,,,,,,,,,,,,,,,,
12956,TLR5,C0220994,Phenylacetic acid,DB09269,Hyperammonemia,Approved,C1=CC=C(C=C1)CC(=O)O},,Inherited metabolic disease,TIL3,MGC126430,MGC126431,SLEB1,,,,,,,,,,,,,,,,,,,,,,
30014,HMGB1,C0024137,Tretinoin,DB00755,"Lupus Erythematosus, Cutaneous",Terminated,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18109,SMUG1,C1704231,Cytarabine,DB00987,Metastatic Malignant Neoplasm to the Leptomeninges,Approved,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
14555,SEPTIN9,C0080032,Thiotepa,DB04572,"Pleural Effusion, Malignant",Approved,C1CN1P(=S)(N2CC2)N3CC3},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33307,CD177,C0001815,Sunitinib,DB01268,Primary Myelofibrosis,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,PRV1,HNA2A,NB1,,,,,,,,,,,,,,,,,,,,,,,
17610,IL6,C0010043,Prednisolone,DB00860,Corneal Ulcer,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
16999,IL1B,C0343467,Thalidomide,DB01041,Erythema nodosum leprosum,Approved,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},,Infectious disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
10066,CD274,C0022602,Masoprocol,DB00179,Actinic keratosis,Approved,C[C@H](CC1=CC(=C(C=C1)O)O)[C@@H](C)CC2=CC(=C(C=C2)O)O},,Skin disease,B7-H,B7H1,PD-L1,PDL1,B7-H1,PDCD1LG1,,,,,,,,,,,,,,,,,,,,
4335,Nafcillin,DB00607,Staphylococcal endocarditis,C0520767,Approved,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,ADAMTS5,,,,,,,,
36719,DUSP6,C1153706,Norgestrel,DB09389,Endometrial adenocarcinoma,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
24241,SH2B3,C0085096,Treprostinil,DB00374,Peripheral Vascular Diseases,Terminated,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33744,CXCR3,C0006272,Cyclosporine,DB00091,Bronchiolitis Obliterans,Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 2/Phase 3,Respiratory disease,CKR-L2,CMKAR3,IP10-R,MigR,CD183,GPR9,,,,,,,,,,,,,,,,,,,,
31283,TP53,C0279607,Erlotinib,DB00530,adult primary hepatocellular carcinoma,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35691,ABCG2,C0747820,Sulfadoxine,DB01299,"Malaria, antepartum",Terminated,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N},Phase 3,Infectious disease,EST157481,MXR,BCRP,ABCP,CD338,,,,,,,,,,,,,,,,,,,,,
8461,Norepinephrine,DB00368,"orthostatic; hypotension, neurogenic",C1400301,Terminated,C1=CC(=C(C=C1[C@H](CN)O)O)O},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
7379,Sirolimus,DB00877,Eosinophilic gastroenteritis,C1262481,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 1,Digestive system disease,,,,,,,,,,,,,,,,,,,SERPINB6,,,,,,,,
24267,NOS3,C0085096,Treprostinil,DB00374,Peripheral Vascular Diseases,Terminated,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},Phase 3,Cancer,ECNOS,eNOS,,,,,,,,,,,,,,,,,,,,,,,,
3967,Mepyramine,DB06691,Pruritus,C0033774,Approved,CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2},,,,,,,,,,,,,,,,,,,,,FGB,,,,,,,,
2714,Erythromycin,DB00199,Meningitis,C0025289,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,RAD51C,,,,,,,,
21091,SRY,C0010417,Testosterone Propionate,DB01420,Cryptorchidism,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
29290,C8A,C0021051,Vidarabine,DB00194,Immunologic Deficiency Syndromes,Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 1/Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17378,MICA,C0031069,Colchicine,DB01394,Familial Mediterranean Fever,Approved,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19692,CCR5,C0008149,Fusidic Acid,DB02703,Chlamydia Infections,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,CKR-5,CC-CKR-5,CKR5,CD195,IDDM22,CMKBR5,,,,,,,,,,,,,,,,,,,,
26222,SERPINE1,C0271066,Imatinib,DB00619,Choroidal retinal neovascularization,Withdrawn,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 1,Congenital malformation,PAI,PLANH1,PAI1,,,,,,,,,,,,,,,,,,,,,,,
25454,NKX2-1,C3163939,Vandetanib,DB05294,Malignant epithelial neoplasm of thyroid,Approved,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC},,Cancer,TTF-1,TTF1,NKX2A,BCH,TITF1,,,,,,,,,,,,,,,,,,,,,
8306,PDZD2,C1262211,Ranolazine,DB00243,Diarrhoea predominant irritable bowel syndrome,Terminated,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O},Phase 2/Phase 3,Digestive system disease,KIAA0300,PDZK3,,,,,,,,,,,,,,,,,,,,,,,,
11669,AR,C0040028,Anagrelide,DB00261,"Thrombocythemia, Essential",Approved,C1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3},,Cancer,AIS,NR3C4,SMAX1,HUMARA,DHTR,SBMA,,,,,,,,,,,,,,,,,,,,
14814,SLC6A3,C0020514,Cabergoline,DB00248,Hyperprolactinemia,Approved,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C},,Endocrine disease,DAT,,,,,,,,,,,,,,,,,,,,,,,,,
33570,GSTP1,C0007273,Vitamin E,DB00163,Carotid Artery Diseases,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8606,NRAS,C0003492,Alprostadil,DB00770,Aortic coarctation,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7678,TNF,C0085074,Ulobetasol,DB00596,Granuloma Annulare,Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Skin disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,GLMN,,,,,,,,
10232,SNRPF,C0034067,Vilanterol,DB09082,Pulmonary Emphysema,Approved,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6549,CACNA1A,C0014553,Valproic Acid,DB00313,Absence Epilepsy,Approved,CCCC(CCC)C(=O)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,RAET1M,,,,,,,,
17294,DEFB103B,C0919659,Miconazole,DB01110,Oropharyngeal candidiasis,Approved,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29103,MDM2,C1334008,Valproic Acid,DB00313,High Grade Sarcoma,Terminated,CCCC(CCC)C(=O)O},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
24562,CNGB3,C0042345,Sodium Tetradecyl Sulfate,DB00464,Varicosity,Approved,CCCCCCCCCCCCCCOS(=O)(=O)[O-].[Na+]},,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26569,PLAG1,C0278838,Ketoconazole,DB01026,Prostate cancer recurrent,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19368,CRH,C0020649,Phentermine,DB00191,Hypotension,Approved,CC(C)(CC1=CC=CC=C1)N},,Cardiovascular disease,CRH1,,,,,,,,,,,,,,,,,,,,,,,,,
29243,CYP17A1,C1328504,Sirolimus,DB00877,Hormone refractory prostate cancer,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 1/Phase 2,Cancer,P450C17,CPT7,S17AH,CYP17,,,,,,,,,,,,,,,,,,,,,,
1969,Cyanocobalamin,DB00115,Iron deficiency anemia,C0162316,Approved,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]4([C@H]([C@@H]5[C@]6([C@@]([C@@H](/C(=C(/C7=N/C(=C\\C8=N/C(=C(\\C4=N5)/C)/[C@H](C8(C)C)CCC(=O)N)/[C@H]([C@]7(C)CC(=O)N)CCC(=O)N)\\C)/[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]},,Hematologic disease,,,,,,,,,,,,,,,,,,,CTSA,,,,,,,,
35881,ABO,C1112459,Sorafenib,DB00398,Liver cell carcinoma non-resectable,Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
6184,Trichlormethiazide,DB01021,Hypertensive disease,C0020538,Approved,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,PRDX5,,,,,,,,
28032,GRIN1,C0458247,Capsaicin,DB06774,Allodynia,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,,GluN1,NMDAR1,,,,,,,,,,,,,,,,,,,,,,,,
26441,EPCAM,C0278987,Pemetrexed,DB00642,Non-small cell lung cancer metastatic,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,Ly74,TROP1,GA733-2,EGP34,EGP40,EGP-2,KSA,CD326,Ep-CAM,HEA125,KS1/4,MK-1,MH99,MOC31,323/A3,17-1A,TACST-1,,,,,,,,,
35343,COMT,C0001723,Mifepristone,DB00834,"Affective Disorders, Psychotic",Terminated,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
19541,CDKN1A,C0242379,Vinorelbine,DB00361,Malignant neoplasm of lung,Withdrawn,CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
31728,PIH1D3,C0021359,Ganirelix,DB06785,Infertility,Withdrawn,CCNC(=NCCCC[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C)NCC},Phase 3,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25517,STXBP1,C0751122,Stiripentol,DB09118,Infantile Severe Myoclonic Epilepsy,Approved,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23955,IL13,C0085786,Warfarin,DB00682,Hamman-Rich syndrome,Terminated,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},Phase 3,Lung disease,P600,IL-13,ALRH,BHR1,MGC116786,MGC116788,MGC116789,,,,,,,,,,,,,,,,,,,
33418,ERBB2,C0687132,Topiramate,DB00273,heavy drinking,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 2,Mental and behavioural disorder,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
15238,VDR,C0020598,Teriparatide,DB06285,Hypocalcemia,Terminated,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N},Phase 2,Urinary system disease,NR1I1,PPP1R163,,,,,,,,,,,,,,,,,,,,,,,,
31073,ICOS,C0030809,Dapsone,DB00250,Pemphigus Vulgaris,Terminated,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N},Phase 2,Skin and connective tissue disease,AILIM,CD278,,,,,,,,,,,,,,,,,,,,,,,,
22479,SOD2,C0042373,Tolazoline,DB00797,Vascular Diseases,Approved,C1CN=C(N1)CC2=CC=CC=C2},,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6492,ASTN2,C0149931,Zolmitriptan,DB00315,Migraine Disorders,Approved,CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3},,Nervous system disease,0,,,,,,,,,,,,,,,,,ATP2B3,,,,,,,,
35740,REG1A,C0038868,Rasagiline,DB01367,Progressive supranuclear palsy,Terminated,C#CCN[C@@H]1CCC2=CC=CC=C12},Phase 3,Neurodegenerative disease,PSPS,PSPS1,REG,,,,,,,,,,,,,,,,,,,,,,,
5724,Sulfapyridine,DB00891,Dermatitis Herpetiformis,C0011608,Approved,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Immune system disease,,,,,,,,,,,,,,,,,,,SREBF1,,,,,,,,
14829,BRD2,C0020514,Cabergoline,DB00248,Hyperprolactinemia,Approved,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15719,CHRNA3,C0494475,Primidone,DB00794,Tonic - clonic seizures,Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
6801,RBM12,C0033975,Triflupromazine,DB00508,Psychotic Disorders,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,VAV1,,,,,,,,
23459,NFE2L2,C0023886,Tinidazole,DB00911,"Liver Abscess, Amebic",Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12612,ZMYND10,C0027430,Beclomethasone dipropionate,DB00394,Nasal Polyps,Approved,CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC},,Immune system disease,BLU,CILD22,DNAAF7,,,,,,,,,,,,,,,,,,,,,,,
24028,STAT3,C0031190,Sildenafil,DB00203,Persistent Fetal Circulation Syndrome,Withdrawn,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C},Phase 2,,APRF,,,,,,,,,,,,,,,,,,,,,,,,,
15958,EML4,C0153633,Carmustine,DB00262,Malignant neoplasm of brain,Approved,C(CCl)NC(=O)N(CCCl)N=O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
7368,Pioglitazone,DB01132,Opioid-Related Disorders,C0027412,Terminated,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3},Phase 1,,,,,,,,,,,,,,,,,,,,SPATA6,,,,,,,,
28631,MME,C1565489,Simeprevir,DB06290,Renal Insufficiency,Withdrawn,CC1=C(C=CC2=C1N=C(C=C2O[C@@H]3C[C@@H]4[C@@H](C3)C(=O)N(CCCC/C=C\\[C@@H]5C[C@]5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC},Phase 2,Endocrine disease,CALLA,CD10,,,,,,,,,,,,,,,,,,,,,,,,
11492,KLRC2,C0040592,Tetracycline,DB00759,Trachoma,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,NKG2-C,CD159c,,,,,,,,,,,,,,,,,,,,,,,,
35501,THBS1,C0011884,Octreotide,DB00104,Diabetic Retinopathy,Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 3,Nervous system disease,TSP1,THBS,TSP,THBS-1,TSP-1,,,,,,,,,,,,,,,,,,,,,
14709,ACVRL1,C0020542,Iloprost,DB01088,Pulmonary Hypertension,Withdrawn,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Lung disease,HHT2,HHT,ACVRLK1,ORW2,,,,,,,,,,,,,,,,,,,,,,
3428,Hydroxyzine,DB00557,Allergic rhinitis (disorder),C2607914,Approved,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl},,Immune system disease,,,,,,,,,,,,,,,,,,,FKBP1AP2,,,,,,,,
30699,PDGFRA,C0025149,Valproic Acid,DB00313,Medulloblastoma,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,CD140a,PDGFR2,GAS9,,,,,,,,,,,,,,,,,,,,,,,
20551,FGFR1,C0271578,Tranexamic Acid,DB00302,Female hypogonadism syndrome,Approved,C1CC(CCC1CN)C(=O)O},,Endocrine disease,CEK,FLG,BFGFR,N-SAM,CD331,FLT2,KAL2,,,,,,,,,,,,,,,,,,,
21850,SETBP1,C0023473,Vindesine,DB00309,"Myeloid Leukemia, Chronic",Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34643,PIK3CD,C0744619,Gefitinib,DB00317,Head and neck cancer metastatic,Terminated,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
20587,CDKN1B,C0033578,Flutamide,DB00499,Prostatic Neoplasms,Approved,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36703,TP53,C1153706,Norgestrel,DB09389,Endometrial adenocarcinoma,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
21105,IL6,C0342527,Testosterone Propionate,DB01420,Deficiency of testosterone biosynthesis,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Metabolic disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
37220,SLC9A6,C0015732,Phenylephrine,DB00388,Fecal Incontinence,Withdrawn,CNC[C@@H](C1=CC(=CC=C1)O)O},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
10011,MFGE8,C0456103,Vancomycin,DB00512,Sepsis of the newborn,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,,SED1,EDIL1,BA46,OAcGD3S,HsT19888,MFG-E8,hP47,SPAG10,,,,,,,,,,,,,,,,,,
12294,APOC2,C0020557,Topiramate,DB00273,Hypertriglyceridemia,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22354,HLA-DRB1,C0011854,Pentoxifylline,DB00806,"Diabetes Mellitus, Insulin-Dependent",Terminated,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C},Phase 1/Phase 2,Endocrine disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
14519,HIF1A,C0007847,Topotecan,DB01030,Malignant tumor of cervix,Approved,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O},,Cancer,MOP1,HIF-1alpha,PASD8,HIF1,bHLHe78,,,,,,,,,,,,,,,,,,,,,
16474,AVPR2,C0029442,Ergocalciferol,DB00153,Osteomalacia,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Urinary system disease,V2R,DIR3,DIR,,,,,,,,,,,,,,,,,,,,,,,
1921,PDYN,C0001973,Zonisamide,DB00909,"Alcoholic Intoxication, Chronic",Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 2,Other,0,,,,,,,,,,,,,,,,,TLE5,,,,,,,,
7710,ARHGEF1,C0149922,Ulobetasol,DB00596,Lichen Simplex Chronicus,Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Skin and connective tissue disease,P115-RHOGEF,SUB1.5,LBCL2,,,,,,,,,,,,,,,SMAD1,,,,,,,,
28756,TCF7L2,C0009402,Levoleucovorin,DB11596,Colorectal Carcinoma,Withdrawn,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2/Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
659,Bepridil,DB01244,Angina Pectoris,C0002962,Approved,CC(C)COCC(CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,TNNI3K,,,,,,,,
22448,RNF213,C0007820,Tolazoline,DB00797,Cerebrovascular Disorders,Approved,C1CN=C(N1)CC2=CC=CC=C2},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32877,TRPA1,C0178782,Pregabalin,DB00230,Orofacial Pain,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,,ANKTM1,,,,,,,,,,,,,,,,,,,,,,,,,
31930,ADORA2A,C0349231,Hydrocortisone,DB00741,Phobic anxiety disorder,Terminated,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},Phase 2,Mental and behavioural disorder,RDC8,ADORA2,,,,,,,,,,,,,,,,,,,,,,,,
23846,TAL1,C1961099,Nelarabine,DB01280,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,Approved,COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},,Cancer,bHLHa17,TCL5,,,,,,,,,,,,,,,,,,,,,,,,
8687,ZFPM2,C0243002,Alprostadil,DB00770,Tricuspid Atresia,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Congenital malformation,FOG2,hFOG-2,ZNF89B,ZC2HC11B,,,,,,,,,,,,,,,,,,,,,,
12457,LSAMP,C0032302,Trovafloxacin,DB00685,Mycoplasma pneumonia,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,IGLON3,,,,,,,,,,,,,,,,,,,,,,,,,
13773,NRSN1,C0019829,Tacrolimus,DB00864,Hodgkin Disease,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
14325,PSCA,C0936223,Nilutamide,DB00665,Metastatic Prostate Carcinoma,Approved,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
18875,GIP,C0020459,Diazoxide,DB01119,Hyperinsulinism,Approved,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
12009,DHFR,C0023449,Vindesine,DB00309,Acute lymphocytic leukemia,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
8865,Amitriptyline,DB00321,Transformed migraine,C1960870,Terminated,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31},Phase 3,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
22524,MIR29A,C0022354,Kappadione,DB09332,"Jaundice, Obstructive",Approved,CC1=C(C2=CC=CC=C2C(=C1)OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+]},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35829,CCND1,C0032927,Celecoxib,DB00482,Precancerous Conditions,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2/Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
30619,PDPN,C0346990,Cisplatin,DB00515,Carcinomatosis of peritoneal cavity,Terminated,N.N.Cl[Pt]Cl},Phase 2,Cancer,T1A-2,Gp38,aggrus,PA2.26,,,,,,,,,,,,,,,,,,,,,,
27161,CCN1,C0206728,Sunitinib,DB01268,Plexiform Neurofibroma,Suspended,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
19409,AGA,C0008325,Doripenem,DB06211,Cholecystitis,Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O},,Digestive system disease,ASRG,,,,,,,,,,,,,,,,,,,,,,,,,
26494,CLDN19,C1561643,Sevelamer,DB00658,Chronic Kidney Diseases,Terminated,C=CCN.C1C(O1)CCl},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
29912,MIR155,C0856825,Pentostatin,DB00552,Acute GVH disease,Terminated,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O},Phase 1/Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28526,SMARCB1,C0042076,Mitomycin,DB00305,Urologic Neoplasms,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2810,Fenofibrate,DB01039,Hyperlipidemia,C0020473,Approved,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},,Metabolic disease,,,,,,,,,,,,,,,,,,,CORO7,,,,,,,,
18969,MTHFR,C0040038,Warfarin,DB00682,Thromboembolism,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6943,MPO,C0392164,L-Cysteine,DB00151,Pulmonary Cystic Fibrosis,Approved,C([C@@H](C(=O)O)N)S},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,PLPP3,,,,,,,,
13393,ATG5,C0038013,Triamcinolone,DB00620,Ankylosing spondylitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33086,NUMA1,C2076600,Rosuvastatin,DB01098,Influenza due to Influenza A virus subtype H1N1,Terminated,CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7303,Mefloquine,DB00358,Malaria,C0024530,Terminated,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O},Phase 1,Infectious disease,,,,,,,,,,,,,,,,,,,SLC4A8,,,,,,,,
24255,F5,C0085096,Treprostinil,DB00374,Peripheral Vascular Diseases,Terminated,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
21349,ADH5,C0016412,Levoleucovorin,DB11596,Folic Acid Deficiency,Approved,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14078,IL18,C0036202,Triamcinolone,DB00620,Sarcoidosis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34355,MSLN,C0007860,Cefixime,DB00671,Uterine Cervicitis,Terminated,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O},Phase 3,Reproductive system disease,MPF,,,,,,,,,,,,,,,,,,,,,,,,,
34896,GLRA3,C0278704,Heparin,DB01109,Malignant Childhood Neoplasm,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27576,SERPINC1,C2937358,Fluoxetine,DB00472,Cerebral Hemorrhage,Terminated,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F},Phase 3,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5808,Telmisartan,DB00966,Hypertensive disease,C0020538,Approved,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,AMHR2,,,,,,,,
17356,HPRT1,C0268108,Sulfinpyrazone,DB01138,Chronic gouty arthritis,Approved,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27511,AKT2,C0332890,Vincristine,DB00541,Congenital hemihypertrophy,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
34529,IL1B,C0149778,Vancomycin,DB00512,Soft Tissue Infections,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
21916,GNA11,C0025202,Lovastatin,DB00227,melanoma,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
8165,Hydroxocobalamin,DB00200,Cerebral Edema,C0006114,Terminated,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]\\4([C@H]([C@@H]5[C@]6([C@@]([C@@H](C(=N6)/C(=C\\7/[C@@]([C@@H](C(=N7)/C=C\\8/C([C@@H](C(=N8)/C(=C4\\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2]},Phase 2,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
19304,BRCA2,C0678222,Paclitaxel,DB01229,Breast Carcinoma,Approved,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
6984,CTSK,C0029408,Salmon Calcitonin,DB00017,Degenerative polyarthritis,Terminated,CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CN=CN2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO},Phase 3,Immune system disease,PKND,CTSO2,CTSO,PYCD,,,,,,,,,,,,,,HLA-E,,,,,,,,
23009,OPRM1,C0029104,Methadone,DB00333,Opioid withdrawal,Approved,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2},,Mental and behavioural disorder,MOR1,,,,,,,,,,,,,,,,,,,,,,,,,
15251,CLCNKB,C0020598,Teriparatide,DB06285,Hypocalcemia,Terminated,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N},Phase 2,Urinary system disease,hClC-Kb,,,,,,,,,,,,,,,,,,,,,,,,,
7006,IFNL3,C0019342,Valaciclovir,DB00577,Genital Herpes,Approved,CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,ALPK2,,,,,,,,
5863,Tetracycline,DB00759,Acute gonococcal cervicitis,C0153195,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,FGF10,,,,,,,,
14569,ERCC3,C0007137,Cisplatin,DB00515,Squamous cell carcinoma,Terminated,N.N.Cl[Pt]Cl},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30922,GP1BA,C0279650,Idarubicin,DB01177,childhood acute megakaryocytic leukemia (M7),Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O},Phase 2,Cancer,CD42b,GPIbalpha,GP1B,,,,,,,,,,,,,,,,,,,,,,,
9936,Pentoxifylline,DB00806,Nonalcoholic Steatohepatitis,C3241937,Withdrawn,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C},Phase 3,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
17672,DEK,C0022073,Sulfacetamide,DB00634,Iridocyclitis,Approved,CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
5185,Prednisolone,DB00860,Pemphigus,C0030807,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,WIPF1,,,,,,,,
14187,ATN1,C0040147,Triamcinolone,DB00620,Thyroiditis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
667,Betamethasone,DB00443,Adrenogenital disorder,C0701163,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Congenital malformation,,,,,,,,,,,,,,,,,,,Flurazepam,,,,,,,,
32716,TMEM241,C0015944,Oxytocin,DB00107,"Fetal Membranes, Premature Rupture",Terminated,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
7754,Capsaicin,DB06774,Diabetic Neuropathies,C0011882,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 2,Endocrine disease,,,,,,,,,,,,,,,,,,,PDE2A,,,,,,,,
5938,Tiagabine,DB00906,Simple Partial Seizures,C0234974,Approved,CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(=O)O)C3=C(C=CS3)C},,Nervous system disease,,,,,,,,,,,,,,,,,,,ETNK1,,,,,,,,
33826,ADCY8,C0011875,Heparin,DB01109,Diabetic Angiopathies,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2/Phase 3,Vascular disease,HBAC1,AC8,ADCY3,,,,,,,,,,,,,,,,,,,,,,,
675,Betamethasone,DB00443,Asthma,C0004096,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Immune system disease,,,,,,,,,,,,,,,,,,,Fluvoxamine,,,,,,,,
23574,HEXB,C0020651,Midodrine,DB00211,"Hypotension, Orthostatic",Approved,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17468,CLCNKA,C0020625,Tolvaptan,DB06212,Hyponatremia,Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Urinary system disease,hClC-Ka,,,,,,,,,,,,,,,,,,,,,,,,,
36678,APC,C0349579,Norgestrel,DB09389,Atypical Endometrial Hyperplasia,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Reproductive system disease,DP2.5,PPP1R46,,,,,,,,,,,,,,,,,,,,,,,,
27251,STAT3,C0007097,Cisplatin,DB00515,Carcinoma,Withdrawn,N.N.Cl[Pt]Cl},Phase 3,Cancer,APRF,,,,,,,,,,,,,,,,,,,,,,,,,
19690,CGAS,C0008149,Fusidic Acid,DB02703,Chlamydia Infections,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2857,Fluconazole,DB00196,Mucocutaneous candidiasis,C0006848,Approved,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O},,Infectious disease,,,,,,,,,,,,,,,,,,,BPIFA2,,,,,,,,
17656,DLK1,C0019112,Zinc oxide,DB09321,Hemorrhoids,Approved,O=[Zn]},,,FA1,pG2,Pref-1,ZOG,Delta1,,,,,,,,,,,,,,,,,,,,,
36015,MMP2,C1135191,Udenafil,DB06267,"Heart Failure, Systolic",Terminated,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C},Phase 3,Cardiovascular disease,TBE-1,CLG4,CLG4A,,,,,,,,,,,,,,,,,,,,,,,
30994,CYP2C18,C0206726,Temozolomide,DB00853,gliosarcoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
18695,HLA-DRB1,C0042165,Tobramycin,DB00684,Anterior uveitis,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
20889,CYP2D6,C0184567,Floctafenine,DB08976,Acute onset pain,Approved,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC=C(C3=NC=C2)C(F)(F)F},,,CPD6,P450-DB1,P450C2D,CYP2DL1,CYP2D7P2,CYP2D7BP,CYP2D8P2,CYP2D7AP,,,,,,,,,,,,,,,,,,
2290,Diazepam,DB00829,Tetanus,C0039614,Approved,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3},,Infectious disease,,,,,,,,,,,,,,,,,,,KDSR,,,,,,,,
37114,MMP2,C0032460,Metformin,DB00331,Polycystic Ovary Syndrome,Withdrawn,CN(C)C(=N)N=C(N)N},Phase 3,Reproductive system disease,TBE-1,CLG4,CLG4A,,,,,,,,,,,,,,,,,,,,,,,
22910,ALAD,C0020676,Liothyronine,DB00279,Hypothyroidism,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Endocrine disease,ALADH,PBGS,,,,,,,,,,,,,,,,,,,,,,,,
21584,HNF1A,C0020615,Glucagon recombinant,DB00040,Hypoglycemia,Approved,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CNC=N7)N)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29521,PMP22,C0278502,Fluorouracil,DB00544,recurrent gastric cancer,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 1/Phase 2,Cancer,HNPP,GAS3,Sp110,,,,,,,,,,,,,,,,,,,,,,,
23454,SUMF2,C0023885,Metronidazole,DB00916,Liver Abscess,Approved,CC1=NC=C(N1CCO)[N+](=O)[O-]},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18470,BRCA1,C0023465,Daunorubicin,DB00694,Acute monocytic leukemia,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O},,Cancer,RNF53,PPP1R53,FANCS,,,,,,,,,,,,,,,,,,,,,,,
7600,STOML2,C0011616,Urea,DB03904,Contact Dermatitis,Approved,C(=O)(N)N},,Immune system disease,0,,,,,,,,,,,,,,,,,GLRA3,,,,,,,,
15022,A2M,C0085159,Bupropion,DB01156,Seasonal Affective Disorder,Approved,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C},,Mental and behavioural disorder,FWP007,S863-7,CPAMD5,,,,,,,,,,,,,,,,,,,,,,,
26815,IRF4,C0206180,Thalidomide,DB01041,Ki-1+ Anaplastic Large Cell Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,LSIRF,MUM1,,,,,,,,,,,,,,,,,,,,,,,,
27434,POMC,C0038506,Asenapine,DB06216,Stuttering,Suspended,CN1C[C@@H]2[C@@H](C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24},Phase 3,,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
30060,HEY2,C0004114,Temozolomide,DB00853,Astrocytoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,bHLHb32,HERP1,HESR2,,,,,,,,,,,,,,,,,,,,,,,
1294,Ceftazidime,DB00438,Bacterial urinary infection,C0729524,Approved,CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,Propranolol,,,,,,,,
37076,CCL18,C1168198,Propranolol,DB00571,Recurrent respiratory papillomatosis,Withdrawn,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},Phase 2/Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6376,CXCL1,C0392171,Salicylic acid,DB00936,Influenza-like symptoms,Approved,C1=CC=C(C(=C1)C(=O)O)O},,Infectious disease,SCYB1,GROa,MGSA-a,NAP-3,MGSA,GRO1,FSP,,,,,,,,,,,NUBPL,,,,,,,,
18884,CDKN1B,C0021670,Romidepsin,DB06176,insulinoma,Terminated,C/C=C\\1/C(=O)N[C@H](C(=O)O[C@H]\\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13816,ATG16L1,C0021390,Naltrexone,DB00704,Inflammatory Bowel Diseases,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,,WDR30,FLJ10035,ATG16A,APG16L,ATG16L,,,,,,,,,,,,,,,,,,,,,
13616,AGA,C0011608,Triamcinolone,DB00620,Dermatitis Herpetiformis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,ASRG,,,,,,,,,,,,,,,,,,,,,,,,,
27819,MAP6,C0085633,Atomoxetine,DB00289,Mood swings,Terminated,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2},Phase 1,Mental and behavioural disorder,KIAA1878,STOP,FLJ41346,MAP6-N,,,,,,,,,,,,,,,,,,,,,,
31813,TP63,C4048328,Gemcitabine,DB00441,cervical cancer,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 2,Cancer,SHFM4,EEC3,p63,p73L,OFC8,KET,p73H,p53CP,TP73L,TP53L,TP53CP,,,,,,,,,,,,,,,
35299,IL2,C0017658,Prednisolone,DB00860,Glomerulonephritis,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 3,Urinary system disease,IL-2,TCGF,,,,,,,,,,,,,,,,,,,,,,,,
27816,SLC6A4,C1456624,Methamphetamine,DB01577,Methamphetamine abuse,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 1,Mental and behavioural disorder,5-HTT,SERT1,HTT,OCD1,,,,,,,,,,,,,,,,,,,,,,
36580,MUC1,C0278506,Pemetrexed,DB00642,Non-small cell lung cancer stage III,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,CD227,PEM,ADMCKD,ADMCKD1,MCKD,MCKD1,,,,,,,,,,,,,,,,,,,,
5277,Probenecid,DB01032,Acute gonococcal urethritis,C0275652,Approved,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,REST,,,,,,,,
40,Acetylcysteine,DB06151,Pulmonary Cystic Fibrosis,C0392164,Approved,CC(=O)N[C@@H](CS)C(=O)O},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,Almotriptan,,,,,,,,
5802,Telithromycin,DB00976,Chlamydial pneumonia,C0339959,Approved,CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C},,Infectious disease,,,,,,,,,,,,,,,,,,,PUM1,,,,,,,,
26797,AUTS2,C1333984,Thalidomide,DB01041,Hepatosplenic T-cell lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26154,ABCC2,C0008312,Ursodeoxycholic acid,DB01586,Primary biliary cirrhosis,Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C},,Digestive system disease,DJS,cMRP,CMOAT,,,,,,,,,,,,,,,,,,,,,,,
3562,Isoxsuprine,DB08941,Vascular Diseases,C0042373,Approved,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O},,Vascular disease,,,,,,,,,,,,,,,,,,,TST1,,,,,,,,
19722,POMC,C0008354,Minocycline,DB01017,Cholera,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
18017,NLRP3,C0013238,Xanthophyll,DB00137,Dry Eye Syndromes,Approved,CC1=C(C(C[C@@H](C1)O)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(\\C)/C=C/C=C(\\C)/C=C/[C@H]2C(=C[C@@H](CC2(C)C)O)C)/C)/C},,,AGTAVPRL,AII,AVP,FCAS,FCU,NALP3,PYPAF1,MWS,CLR1.1,C1orf7,CIAS1,,,,,,,,,,,,,,,
26398,C11orf65,C0007124,Oxytocin,DB00107,Noninfiltrating Intraductal Carcinoma,Suspended,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N},Phase 0,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
20617,TESC,C0241961,Everolimus,DB01590,Angiomyolipoma of kidney,Approved,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC},,Cancer,FLJ20607,CHP3,,,,,,,,,,,,,,,,,,,,,,,,
12292,MTOR,C0020557,Topiramate,DB00273,Hypertriglyceridemia,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21431,BTNL2,C0010930,Tobramycin,DB00684,Dacryocystitis,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
22406,ALB,C0158996,Sodium ferric gluconate complex,DB09517,Anemia of prematurity,Approved,C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.[Na+].[Fe+3]},,Hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
25938,IGF1,C0162810,Tranilast,DB07615,"Cicatrix, Hypertrophic",Approved,COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC},,,IGF1A,IGFI,IGF-I,IGF,,,,,,,,,,,,,,,,,,,,,,
12819,IGH,C0024301,Vincristine,DB00541,"Lymphoma, Follicular",Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29530,CD44,C0278502,Fluorouracil,DB00544,recurrent gastric cancer,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 1/Phase 2,Cancer,IN,MC56,Pgp1,CD44R,HCELL,CSPG8,MIC4,MDU2,MDU3,,,,,,,,,,,,,,,,,
17187,NUS1,C0014550,Stiripentol,DB09118,"Epilepsies, Myoclonic",Approved,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19700,ERN1,C0008149,Fusidic Acid,DB02703,Chlamydia Infections,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,IRE1,IRE1P,,,,,,,,,,,,,,,,,,,,,,,,
26176,SLC51A,C0008312,Ursodeoxycholic acid,DB01586,Primary biliary cirrhosis,Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C},,Digestive system disease,OSTalpha,,,,,,,,,,,,,,,,,,,,,,,,,
10860,BBS1,C0028754,Fenofibrate,DB01039,Obesity,Withdrawn,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 1,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22156,SALL3,C0238198,Sunitinib,DB01268,Gastrointestinal Stromal Tumors,Approved,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},,Cancer,ZNF796,,,,,,,,,,,,,,,,,,,,,,,,,
22066,PIK3CD,C0019357,Vidarabine,DB00194,"Keratitis, Herpetic",Approved,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17382,FCGR1A,C0031069,Colchicine,DB01394,Familial Mediterranean Fever,Approved,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC},,Infectious disease,CD64,CD64A,,,,,,,,,,,,,,,,,,,,,,,,
491,Azithromycin,DB00207,Streptococcal pneumonia,C0155862,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Disopyramide,,,,,,,,
29692,HLA-A,C0280634,Vorinostat,DB02546,adult acute monocytic leukemia (M5b),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
29252,IL6,C1328504,Sirolimus,DB00877,Hormone refractory prostate cancer,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 1/Phase 2,Cancer,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
11523,TLR6,C0014121,Vancomycin,DB00512,Bacterial Endocarditis,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,CD286,,,,,,,,,,,,,,,,,,,,,,,,,
9957,Voriconazole,DB00582,Neuroaspergillosis,C0752342,Withdrawn,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
19077,AOPEP,C0004238,Verapamil,DB00661,Atrial Fibrillation,Approved,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5640,Spectinomycin,DB00919,Gonorrhea,C0018081,Approved,C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,MSR1,,,,,,,,
4317,Moxifloxacin,DB00218,Rhinoscleroma,C0035468,Approved,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,BANK1,,,,,,,,
3662,Leucovorin,DB00650,"Anemia, Megaloblastic",C0002888,Approved,C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Hematologic disease,,,,,,,,,,,,,,,,,,,GAS8,,,,,,,,
24421,LOXL2,C0019202,Triethylenetetramine,DB06824,Hepatolenticular Degeneration,Approved,C(CNCCNCCN)N},,Congenital disorder of metabolism,WS9-14,LOR,,,,,,,,,,,,,,,,,,,,,,,,
8937,PTGS1,C0038358,Roxatidine acetate,DB08806,Gastric ulcer,Approved,CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2},,Digestive system disease,PGHS-1,PTGHS,,,,,,,,,,,,,,,,,,,,,,,,
13508,ASS1,C0006114,Hydroxocobalamin,DB00200,Cerebral Edema,Terminated,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]\\4([C@H]([C@@H]5[C@]6([C@@]([C@@H](C(=N6)/C(=C\\7/[C@@]([C@@H](C(=N7)/C=C\\8/C([C@@H](C(=N8)/C(=C4\\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2]},Phase 2,Nervous system disease,CTLN1,ASS,,,,,,,,,,,,,,,,,,,,,,,,
24609,SCO2,C0001126,Potassium Citrate,DB09125,Renal tubular acidosis,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10485,ERLIN2,C0010200,Sodium Citrate,DB09154,Coughing,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
37006,GNA12,C0221002,Cholecalciferol,DB00169,"Hyperparathyroidism, Primary",Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 2/Phase 3,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32570,MMP3,C0745133,Nitrendipine,DB01054,Isolated systolic hypertension,Terminated,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C},Phase 2,Cardiovascular disease,STMY1,STMY,,,,,,,,,,,,,,,,,,,,,,,,
27782,NXT1,C0278519,Pegaspargase,DB00059,recurrent childhood acute lymphoblastic leukemia,Terminated,CC1=CC(=C(C=C1)C(=O)C(=C)CN(C)C)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10051,POMC,C0346993,Aminoglutethimide,DB00357,Secondary malignant neoplasm of female breast,Approved,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N},,Cancer,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
23749,MYD88,C0152936,Moxifloxacin,DB00218,"Plague, Septicemic",Approved,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
2092,Demeclocycline,DB00618,Psittacosis,C0029291,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3[C@@H](C4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O},,Infectious disease,,,,,,,,,,,,,,,,,,,MIR146A,,,,,,,,
17833,TPO,C0002892,Thiamine,DB00152,"Anemia, Pernicious",Approved,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},,Hematologic disease,TPX,,,,,,,,,,,,,,,,,,,,,,,,,
20428,SCN1A,C0019147,Paromomycin,DB01421,Hepatic Coma,Approved,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N},,Nervous system disease,Nav1.1,GEFSP2,SMEI,SCN1,FEB3,,,,,,,,,,,,,,,,,,,,,
9714,AMBP,C1112209,Trovafloxacin,DB00685,Intraabdominal Infections,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,UTI,EDC1,HI30,IATIL,ITILC,ITI,ITIL,,,,,,,,,,,,,,,,,,,
37131,TRIM13,C0280099,Docetaxel,DB01248,adult solid tumor,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3291,Homatropine Methylbromide,DB00725,Irritable Bowel Syndrome,C0022104,Approved,C[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C.[Br-]},,Digestive system disease,,,,,,,,,,,,,,,,,,,IL22RA2,,,,,,,,
23701,MET,C0031099,Lidocaine,DB00281,Periodontitis,Terminated,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},Phase 2,Infectious disease,HGFR,RCCP2,DFNB97,,,,,,,,,,,,,,,,,,,,,,,
20422,MAOB,C0019147,Paromomycin,DB01421,Hepatic Coma,Approved,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N},,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
5525,Salmon Calcitonin,DB00017,Osteitis Deformans,C0029401,Approved,CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CN=CN2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,MARCKSL1,,,,,,,,
1028,Cefamandole,DB01326,Staphylococcal Pneumonia,C0032308,Approved,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)[C@@H](C4=CC=CC=C4)O)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Midodrine,,,,,,,,
15673,CHD2,C0238111,Topiramate,DB00273,Lennox-Gastaut syndrome,Approved,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33638,SPP1,C0206638,Zoledronic acid,DB00399,Giant Cell Tumor of Bone,Terminated,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},Phase 2,Cancer,BSPI,ETA-1,BNSP,OPN,,,,,,,,,,,,,,,,,,,,,,
4253,Minocycline,DB01017,Syphilis,C0039128,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,SOX2,,,,,,,,
3100,Fusidic Acid,DB02703,Sepsis due to Pseudomonas,C2887096,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,CYP2A6,,,,,,,,
33727,NUCB2,C0027609,Clonidine,DB00575,Neonatal Abstinence Syndrome,Terminated,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl},Phase 2/Phase 3,Vascular disease,NEFA,,,,,,,,,,,,,,,,,,,,,,,,,
25735,HESX1,C0020635,Testosterone,DB00624,Hypopituitarism,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23387,ANO1,C0267176,Metoclopramide,DB01233,Gastroparesis due to diabetes mellitus,Approved,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl},,Digestive system disease,TAOS2,FLJ10261,DOG1,ORAOV2,TMEM16A,,,,,,,,,,,,,,,,,,,,,
35045,GNLY,C1609538,Ofloxacin,DB01165,Latent Tuberculosis,Terminated,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},Phase 3,Infectious disease,NKG5,LAG-2,D2S69E,TLA519,LAG2,,,,,,,,,,,,,,,,,,,,,
16110,UGT1A10,C0008350,Ursodeoxycholic acid,DB01586,Cholelithiasis,Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10760,CRP,C0155862,Troleandomycin,DB01361,Streptococcal pneumonia,Approved,C[C@@H]1C[C@@H]([C@H]([C@@H](O1)O[C@H]2[C@H](C[C@@]3(CO3)C(=O)[C@@H]([C@H]([C@H]([C@H](OC(=O)[C@@H]([C@H]([C@@H]2C)O[C@H]4C[C@@H]([C@H]([C@@H](O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
22337,NR1I3,C0011849,Pramlintide,DB01278,Diabetes Mellitus,Withdrawn,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N)NC(=O)[C@@H]4CCCN4C(=O)CNC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CNC=N6)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@@H]8CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N8)[C@@H](C)O)C)[C@@H](C)O)CC(=O)N)NC(=O)[C@H](CCCCN)N},Phase 1/Phase 2,Endocrine disease,MB67,CAR1,,,,,,,,,,,,,,,,,,,,,,,,
3314,Hydrocortisone,DB00741,Allergic Conjunctivitis,C0009766,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,Immune system disease,,,,,,,,,,,,,,,,,,,HCRTR2,,,,,,,,
30737,TBC1D9,C0206663,Vincristine,DB00541,"Neuroectodermal Tumor, Primitive",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
6835,MAPT,C0002726,L-Cysteine,DB00151,Amyloidosis,Approved,C([C@@H](C(=O)O)N)S},,Hematology,MTBT1,tau,PPND,FTDP-17,TAU,MSTD,MTBT2,FLJ31424,MGC138549,PPP1R103,DDPAC,MAPTL,,,,,,SERPINB3,,,,,,,,
11321,TNF,C0034362,Tetracycline,DB00759,Q Fever,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
11372,EHMT2,C0035793,Tetracycline,DB00759,Rocky Mountain Spotted Fever,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23499,TLR2,C0040921,Tinidazole,DB00911,Trichomonas Infections,Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Infectious disease,TIL4,CD282,,,,,,,,,,,,,,,,,,,,,,,,
35221,IBD2,C0012813,Mesalazine,DB00244,Diverticulitis,Terminated,C1=CC(=C(C=C1N)C(=O)O)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21591,SOD2,C0020615,Glucagon recombinant,DB00040,Hypoglycemia,Approved,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CNC=N7)N)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20386,HBEGF,C0012546,Erythromycin,DB00199,Diphtheria,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,HEGFL,DTS,DTR,,,,,,,,,,,,,,,,,,,,,,,
10577,CCL3,C0038220,Secobarbital,DB00418,Status Epilepticus,Approved,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C},,Nervous system disease,G0S19-1,LD78ALPHA,MIP-1-alpha,SCYA3,,,,,,,,,,,,,,,,,,,,,,
13267,THPO,C0154301,Triamcinolone,DB00620,Acquired thrombocytopenia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36779,HMGCR,C0175694,Lovastatin,DB00227,Smith-Lemli-Opitz Syndrome,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19752,NT5C2,C0023860,Minocycline,DB01017,Listeriosis,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35173,PCSK9,C0947751,Linagliptin,DB08882,Vascular inflammations,Terminated,CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C},Phase 3,Vascular disease,NARC-1,FH3,HCHOLA3,,,,,,,,,,,,,,,,,,,,,,,
23380,APRT,C0267176,Metoclopramide,DB01233,Gastroparesis due to diabetes mellitus,Approved,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26232,ERCC1,C0153594,Vinblastine,DB00570,Malignant neoplasm of testis,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,RAD10,,,,,,,,,,,,,,,,,,,,,,,,,
29420,IFNA1,C0004623,Triamcinolone,DB00620,Bacterial Infections,Terminated,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},Phase 1/Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17836,SLC11A2,C0162316,Succinic acid,DB00139,Iron deficiency anemia,Approved,C(CC(=O)O)C(=O)O},,Hematologic disease,DCT1,NRAMP2,,,,,,,,,,,,,,,,,,,,,,,,
8134,IL12A,C0343065,Triprolidine,DB00427,Symptomatic dermographism,Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22271,FOXC1,C0013274,Ibuprofen,DB01050,Patent ductus arteriosus,Withdrawn,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O},Phase 2,Congenital malformation,FREAC3,IGDA,IHG1,FKHL7,IRID1,,,,,,,,,,,,,,,,,,,,,
11720,CIZ1,C0428974,Aprindine,DB01429,Supraventricular arrhythmia,Approved,CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C3=CC=CC=C3},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32946,FHL1,C0549399,Simvastatin,DB00641,Low density lipoprotein increased,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Metabolic disease,SLIM1,KYO-T,bA535K18.1,FHL1B,XMPMA,FLH1A,MGC111107,,,,,,,,,,,,,,,,,,,
10705,NLRP12,C0031350,Tetracycline,DB00759,Pharyngitis,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36842,CFTR,C0038580,Methamphetamine,DB01577,Substance Dependence,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 2,Mental and behavioural disorder,ABC35,TNR-CFTR,CFTR/MRP,CF,ABCC7,,,,,,,,,,,,,,,,,,,,,
20964,CSF2,C0006848,Nystatin,DB00646,Mucocutaneous candidiasis,Approved,C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/C(CC2C(C(C[C@](O2)(CC(C(CCC(CC(CC(CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,GM-CSF,GMCSF,,,,,,,,,,,,,,,,,,,,,,,,
18303,HSD17B2,C0014175,Pioglitazone,DB01132,Endometriosis,Withdrawn,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3},Phase 2/Phase 3,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5763,Tacrolimus,DB00864,Transplanted organ rejection,C0345468,Approved,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},,Immune system disease,,,,,,,,,,,,,,,,,,,ARIH1,,,,,,,,
34480,TOP2B,C0023470,Mycophenolic acid,DB01024,Myeloid Leukemia,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19612,AHSA1,C0585442,Methotrexate,DB00563,Osteosarcoma of bone,Approved,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
28289,GSTT1,C0022665,Vincristine,DB00541,Kidney Neoplasm,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 1,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
6896,FLNA,C0006277,Theophylline,DB00277,Bronchitis,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Lung disease,FLN1,FLN,OPD2,OPD1,,,,,,,,,,,,,,IFFO2,,,,,,,,
2703,Erythromycin,DB00199,Erythrasma,C0014752,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,INVS,,,,,,,,
27194,HRAS,C1266050,Trametinib,DB08911,Poorly Differentiated Thyroid Carcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
7799,JUNB,C0406326,Ulobetasol,DB00596,Scalp psoriasis,Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Immune system disease,,,,,,,,,,,,,,,,,,TRIP6,,,,,,,,
32979,GAST,C0017150,Romidepsin,DB06176,Gastrinoma,Terminated,C/C=C\\1/C(=O)N[C@H](C(=O)O[C@H]\\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
20387,EGF,C0012546,Erythromycin,DB00199,Diphtheria,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
9142,Mycophenolate mofetil,DB00688,Painful Bladder Syndrome,C1720830,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)OCCN3CCOCC3)O},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34360,AQP8,C0007860,Cefixime,DB00671,Uterine Cervicitis,Terminated,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O},Phase 3,Reproductive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
17623,MUC5AC,C0010043,Prednisolone,DB00860,Corneal Ulcer,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,,,,,,,,,,,,,,,,,,,,,,,,,,,
18385,SPAST,C0085606,Trospium,DB00209,Urgency of micturition,Approved,C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
4634,COL2A1,C0003862,Salicylic acid,DB00936,Arthralgia,Approved,C1=CC=C(C(=C1)C(=O)O)O},,Immune system disease,STL1,SEDC,AOM,,,,,,,,,,,,,,,L1CAM,,,,,,,,
14816,HSD3B2,C0020514,Cabergoline,DB00248,Hyperprolactinemia,Approved,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8102,OPRM1,C0033774,Zinc oxide,DB09321,Pruritus,Approved,O=[Zn]},,,MOR1,,,,,,,,,,,,,,,,,,,,,,,,,
18908,RALBP1,C0021670,Romidepsin,DB06176,insulinoma,Terminated,C/C=C\\1/C(=O)N[C@H](C(=O)O[C@H]\\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9099,CDKN2B,C0030920,Sodium Citrate,DB09154,Peptic Ulcer,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19001,VHL,C0040053,Warfarin,DB00682,Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1614,Cimetidine,DB00501,Gastric ulcer,C0038358,Approved,CC1=C(N=CN1)CSCCNC(=NC)NC#N},,Digestive system disease,,,,,,,,,,,,,,,,,,,Vinblastine,,,,,,,,
22250,FCGRT,C0009663,Podofilox,DB01179,Condylomata Acuminata,Approved,COC1=CC(=CC(=C1OC)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](C4=CC5=C(C=C24)OCO5)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23044,SIRT1,C0006118,Lomustine,DB01206,Brain Neoplasms,Approved,C1CCC(CC1)NC(=O)N(CCCl)N=O},,Cancer,SIR2L1,,,,,,,,,,,,,,,,,,,,,,,,,
15882,CP,C0020550,Sodium Iodide I-131,DB09293,Hyperthyroidism,Approved,[Na+].[131I-]},,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,
14501,CDKN2A,C0007847,Topotecan,DB01030,Malignant tumor of cervix,Approved,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O},,Cancer,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
4340,Naftifine,DB00735,Tinea corporis (disorder),C0040252,Approved,CN(C/C=C/C1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32},,Infectious disease,,,,,,,,,,,,,,,,,,,TRAT1,,,,,,,,
1188,Cefotetan,DB01330,"Pneumonia, Bacterial",C0004626,Approved,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Pentamidine,,,,,,,,
5993,Tioconazole,DB01007,"Candidiasis, Vulvovaginal",C0700345,Approved,C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,HIPK1,,,,,,,,
8286,ZNF365,C0558595,Potassium Citrate,DB09125,Uric acid renal calculus,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8828,Isoniazid,DB00951,HIV Infections,C0019693,Terminated,C1=CN=CC=C1C(=O)NN},Phase 2/Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
30626,WT1,C0346990,Cisplatin,DB00515,Carcinomatosis of peritoneal cavity,Terminated,N.N.Cl[Pt]Cl},Phase 2,Cancer,WIT-2,AWT1,NPHS4,GUD,,,,,,,,,,,,,,,,,,,,,,
12027,MTCO2P12,C0578870,Loratadine,DB00455,Chronic idiopathic urticaria,Approved,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28354,IFNG,C0006111,Temozolomide,DB00853,Brain Diseases,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
1619,Cimetidine,DB00501,Upper gastrointestinal hemorrhage,C0041909,Approved,CC1=C(N=CN1)CSCCNC(=NC)NC#N},,,,,,,,,,,,,,,,,,,,,IFNL1,,,,,,,,
20995,WNT1,C0025218,Tretinoin,DB00755,Chloasma,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26204,CFH,C0600518,Imatinib,DB00619,Choroidal Neovascularization,Withdrawn,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 1,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
29239,NOS1,C3900099,Aminolevulinic acid,DB00855,Adult Mixed Glioma,Terminated,C(CC(=O)O)C(=O)CN},Phase 1/Phase 2,Cancer,nNOS,,,,,,,,,,,,,,,,,,,,,,,,,
36633,CTNNB1,C0079218,Hydroxyurea,DB01005,"Fibromatosis, Aggressive",Withdrawn,C(=O)(N)NO},Phase 2,Musculoskeletal disease,beta-catenin,armadillo,CTNNB,,,,,,,,,,,,,,,,,,,,,,,
33991,IL10,C0035222,Salbutamol,DB01001,"Respiratory Distress Syndrome, Adult",Terminated,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O},Phase 2/Phase 3,Lung disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
20523,IL5,C0014869,Omeprazole,DB00338,Peptic Esophagitis,Approved,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},,Digestive system disease,IL-5,EDF,,,,,,,,,,,,,,,,,,,,,,,,
4678,Oxacillin,DB00713,Staphylococcal Pneumonia,C0032308,Approved,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SLC30A9,,,,,,,,
33725,CYP2B6,C0027609,Clonidine,DB00575,Neonatal Abstinence Syndrome,Terminated,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl},Phase 2/Phase 3,Vascular disease,CPB6,CYPIIB6,,,,,,,,,,,,,,,,,,,,,,,,
10870,LPL,C0028754,Fenofibrate,DB01039,Obesity,Withdrawn,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 1,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2735,Esomeprazole,DB00736,Gastroesophageal reflux disease,C0017168,Approved,CC1=CN=C(C(=C1OC)C)C[S@](=O)C2=NC3=C(N2)C=C(C=C3)OC},,Digestive system disease,,,,,,,,,,,,,,,,,,,LY6D,,,,,,,,
24728,ICAM1,C0032533,Prednisone,DB00635,Polymyalgia Rheumatica,Terminated,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 3,Musculoskeletal disease,CD54,,,,,,,,,,,,,,,,,,,,,,,,,
11548,TNF,C0025295,Meropenem,DB00760,"Meningitis, Pneumococcal",Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O},,Infectious disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
30553,HGF,C0206698,Oxaliplatin,DB00526,Cholangiocarcinoma,Withdrawn,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,F-TCF,HGFB,HPTA,DFNB39,,,,,,,,,,,,,,,,,,,,,,
7548,IL17RA,C0406317,Ulobetasol,DB00596,Chronic small plaque psoriasis,Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Skin disease,hIL-17R,IL-17RA,CDw217,CD217,IL17R,,,,,,,,,,,,,CCN6,,,,,,,,
33924,LILRA1,C2347126,Prednisolone,DB00860,Microscopic Polyarteritis,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2/Phase 3,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23913,EDNRB,C0038525,Deferoxamine,DB00746,Subarachnoid Hemorrhage,Terminated,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O},Phase 0,,ETB,HSCR2,HSCR,,,,,,,,,,,,,,,,,,,,,,,
23827,RNF19A,C1262117,Natamycin,DB00826,Fungal keratitis,Approved,C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)O)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19941,ASIC3,C0016053,Pramipexole,DB00413,Fibromyalgia,Terminated,CCCN[C@H]1CCC2=C(C1)SC(=N2)N},Phase 2,Musculoskeletal disease,TNaC1,DRASIC,ACCN3,,,,,,,,,,,,,,,,,,,,,,,
18483,ADRA1A,C0036220,Vinblastine,DB00570,Kaposi Sarcoma,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29325,ASZ1,C0279628,Cisplatin,DB00515,Adenocarcinoma Of Esophagus,Terminated,N.N.Cl[Pt]Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
24505,IFNG,C0003615,Ropivacaine,DB00296,Appendicitis,Terminated,CCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C},Phase 2,Other disease,,,,,,,,,,,,,,,,,,,,,,,,,,
23302,ANO6,C0021603,Cyclobenzaprine,DB00924,Sleep Initiation and Maintenance Disorders,Terminated,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31},Phase 2,,DKFZp313M0720,TMEM16F,,,,,,,,,,,,,,,,,,,,,,,,
8337,SEMA6A,C0348898,Ranolazine,DB00243,Irritable bowel syndrome with diarrhea,Terminated,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O},Phase 2/Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31602,IFNA2,C0035309,Finasteride,DB01216,Retinal Diseases,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},Phase 2,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28143,PSG2,C0278505,Paclitaxel,DB01229,Non-small cell lung cancer stage II,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,PSGGB,PSG1,PSBG2,,,,,,,,,,,,,,,,,,,,,,,
7179,EPHX1,C0024117,Salmeterol,DB00938,Chronic Obstructive Airway Disease,Withdrawn,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O},Phase 3,Lung disease,EPHX,,,,,,,,,,,,,,,,,H3P44,,,,,,,,
19858,SBDS,C0002874,Heparin,DB01109,Aplastic Anemia,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16600,SLC9A6,C0744130,Tazobactam,DB01606,Diabetic foot infection,Approved,C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14883,SNCG,C0017601,Echothiophate,DB01057,Glaucoma,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Nervous system disease,BCSG1,SR,persyn,,,,,,,,,,,,,,,,,,,,,,,
8603,Simvastatin,DB00641,Low density lipoprotein increased,C0549399,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
37091,CXCL8,C0037011,Dexamethasone,DB01234,Shoulder Pain,Withdrawn,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,Musculoskeletal disease,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
37254,CYP2E1,C3241937,Vitamin E,DB00163,Nonalcoholic Steatohepatitis,Withdrawn,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 3,Endocrine disease,CYP2E,,,,,,,,,,,,,,,,,,,,,,,,,
18644,TNF,C0019069,Desmopressin,DB00035,Hemophilia A,Approved,C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N},,Hematologic disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
25392,SOX9,C0041408,Somatropin recombinant,DB00052,Turner Syndrome,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Congenital malformation,SRA1,CMD1,CMPD1,,,,,,,,,,,,,,,,,,,,,,,
33832,RELA,C0011875,Heparin,DB01109,Diabetic Angiopathies,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2/Phase 3,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7770,PLCG1,C0079773,Belinostat,DB05015,"Lymphoma, T-Cell, Cutaneous",Terminated,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)/C=C/C(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,OR51E1,,,,,,,,
37016,ADORA1,C0520679,Dexmedetomidine,DB00633,"Sleep Apnea, Obstructive",Withdrawn,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 2/Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
19622,ERCC1,C0585442,Methotrexate,DB00563,Osteosarcoma of bone,Approved,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,RAD10,,,,,,,,,,,,,,,,,,,,,,,,,
13588,PTPN2,C0010346,Naltrexone,DB00704,Crohn Disease,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22606,IL12RB1,C0030409,Ketoconazole,DB01026,Paracoccidioidomycosis,Approved,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},,Infectious disease,CD212,IL12RB,,,,,,,,,,,,,,,,,,,,,,,,
20653,PTEN,C0041341,Everolimus,DB01590,Tuberous Sclerosis,Approved,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7702,Atorvastatin,DB01076,Venous Thromboembolism,C1861172,Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 2,Vascular disease,,,,,,,,,,,,,,,,,,,LRMDA,,,,,,,,
7207,VAV3,C0018621,Triprolidine,DB00427,Hay fever,Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Infectious disease,0,,,,,,,,,,,,,,,,,CLEC4G,,,,,,,,
27271,PAX3,C0281508,Vitamin C,DB00126,Desmoplastic Small Round Cell Tumor,Suspended,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O},Phase 2,Cancer,HUP2,WS1,,,,,,,,,,,,,,,,,,,,,,,,
10800,CNR1,C1263846,Methylphenidate,DB00422,Attention deficit hyperactivity disorder,Approved,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},,Mental and behavioural disorder,CB1K5,CB-R,CB1,CANN6,CB1A,CNR,,,,,,,,,,,,,,,,,,,,
30431,IL6,C0494165,Oxaliplatin,DB00526,Secondary malignant neoplasm of liver,Withdrawn,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2/Phase 3,Cancer,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
24112,GAPDH,C0036323,Praziquantel,DB01058,Schistosomiasis,Approved,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2},,Mental and behavioural disorder,GAPD,,,,,,,,,,,,,,,,,,,,,,,,,
14611,GAB2,C1336708,Vinblastine,DB00570,Testicular Germ Cell Tumor,Terminated,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33766,JAK3,C0018133,Tacrolimus,DB00864,Graft-vs-Host Disease,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
752,Bisacodyl,DB09020,Constipation,C0009806,Approved,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3},,Digestive system disease,,,,,,,,,,,,,,,,,,,KCNE5,,,,,,,,
25289,IGHD,C0013338,Somatropin recombinant,DB00052,Pituitary dwarfism,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Endocrine and metabolic disease,FLJ00382,FLJ46727,MGC29633,,,,,,,,,,,,,,,,,,,,,,,
9805,CRP,C0949083,Vitamin E,DB00163,Nosocomial pneumonia,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
33286,MYB,C0001815,Sunitinib,DB01268,Primary Myelofibrosis,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,c-myb,,,,,,,,,,,,,,,,,,,,,,,,,
35687,ATP2B4,C0747820,Sulfadoxine,DB01299,"Malaria, antepartum",Terminated,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18097,FANCA,C0023467,Tretinoin,DB00755,"Leukemia, Myelocytic, Acute",Withdrawn,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33966,NFE2L2,C0006287,Nitric Oxide,DB00435,Bronchopulmonary Dysplasia,Terminated,[N]=O},Phase 2/Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
15737,POMC,C0014549,Topiramate,DB00273,Tonic-Clonic Epilepsy,Approved,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},,Nervous system disease,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
13274,GLI3,C0001403,Triamcinolone,DB00620,Addison Disease,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,PAP-A,PAPA1,PAPB,ACLS,PPDIV,GCPS,PHS,,,,,,,,,,,,,,,,,,,
7915,LRP5,C0029458,Zoledronic acid,DB00399,"Osteoporosis, Postmenopausal",Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,LR3,BMND1,HBM,OPS,OPTA1,VBCH2,EVR4,LRP7,OPPG,,,,,,,,,,,,,,,,,
21871,CRY1,C0023473,Vindesine,DB00309,"Myeloid Leukemia, Chronic",Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13915,TNFAIP3,C0026769,Zoledronic acid,DB00399,Multiple Sclerosis,Terminated,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},Phase 3,Nervous system disease,OTUD7C,,,,,,,,,,,,,,,,,,,,,,,,,
4065,Methylprednisolone,DB00959,Asthma,C0004096,Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O},,Immune system disease,,,,,,,,,,,,,,,,,,,RNPC3,,,,,,,,
9314,Tramadol,DB00193,Premature Ejaculation,C0033038,Terminated,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
694,Betamethasone,DB00443,Exfoliative dermatitis,C0011606,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Skin disease,,,,,,,,,,,,,,,,,,,Ganciclovir,,,,,,,,
15119,FLCN,C0238462,Sorafenib,DB00398,Medullary carcinoma of thyroid,Withdrawn,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33719,TH,C0040332,Nicotine,DB00184,Tobacco Dependence,Terminated,CN1CCC[C@H]1C2=CN=CC=C2},Phase 3,Mental and behavioural disorder,DYT5b,,,,,,,,,,,,,,,,,,,,,,,,,
31623,MSH6,C0338106,Oxaliplatin,DB00526,Adenocarcinoma of colon,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1126,Cefonicid,DB01328,Lower respiratory tract infection,C0149725,Approved,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)O)C(=O)O)CSC4=NN=NN4CS(=O)(=O)O},,,,,,,,,,,,,,,,,,,,,Ombitasvir,,,,,,,,
33362,KYNU,C0038362,Thalidomide,DB01041,Stomatitis,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
112,Alogliptin,DB06203,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,Approved,CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@H](C3)N},,Endocrine disease,,,,,,,,,,,,,,,,,,,Azathioprine,,,,,,,,
18235,ANGPT2,C0035412,Vincristine,DB00541,Rhabdomyosarcoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,Ang2,,,,,,,,,,,,,,,,,,,,,,,,,
11093,FBP1,C0010414,Amphotericin B,DB00681,Infection by Cryptococcus neoformans,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
3959,Meprobamate,DB00371,Anxiety,C0003467,Approved,CCCC(C)(COC(=O)N)COC(=O)N},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,PIGM,,,,,,,,
11257,MPO,C0242172,Ticarcillin,DB01607,Pelvic Inflammatory Disease,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
5264,Pregabalin,DB00230,Postherpetic neuralgia,C0032768,Approved,CC(C)C[C@@H](CC(=O)O)CN},,Infectious disease,,,,,,,,,,,,,,,,,,,PAK4,,,,,,,,
4702,Oxycodone,DB00497,Severe pain,C0278140,Approved,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O},,,,,,,,,,,,,,,,,,,,,GFRA1,,,,,,,,
2038,Dantrolene,DB01219,Malignant hyperpyrexia due to anesthesia,C0024591,Approved,C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-]},,,,,,,,,,,,,,,,,,,,,GJB2,,,,,,,,
4299,Morphine,DB00295,Severe pain,C0278140,Approved,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O},,,,,,,,,,,,,,,,,,,,,SOCS1,,,,,,,,
31890,NOS1,C1696708,Losartan,DB00678,Prehypertension,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl},Phase 2,Cardiovascular disease,nNOS,,,,,,,,,,,,,,,,,,,,,,,,,
28040,IL1RN,C0458247,Capsaicin,DB06774,Allodynia,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,,ICIL-1RA,IL1F3,IL-1RN,MGC10430,,,,,,,,,,,,,,,,,,,,,,
30740,TP53,C1514428,Paclitaxel,DB01229,Primary peritoneal carcinoma,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
21632,PRDX1,C0019880,Glycine betaine,DB06756,Homocystinuria,Approved,C[N+](C)(C)CC(=O)[O-]},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
889,Calcium Gluceptate,DB00326,Hypermagnesemia,C0151714,Approved,C([C@H]([C@H]([C@@H]([C@H](C(C(=O)[O-])O)O)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(C(=O)[O-])O)O)O)O)O)O.[Ca+2]},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,Lindane,,,,,,,,
10924,CTLA4,C0006309,Tetracycline,DB00759,Brucellosis,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,CD152,CELIAC3,IDDM12,,,,,,,,,,,,,,,,,,,,,,,
27012,IFNG,C1955861,Thalidomide,DB01041,T-Cell Large Granular Lymphocyte Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
35433,PON1,C0342879,Simvastatin,DB00641,Primary hypercholesterolemia,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Inherited metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22143,GLI1,C0238198,Sunitinib,DB01268,Gastrointestinal Stromal Tumors,Approved,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},,Cancer,GLI,,,,,,,,,,,,,,,,,,,,,,,,,
3220,Glycine betaine,DB06756,Homocystinuria,C0019880,Approved,C[N+](C)(C)CC(=O)[O-]},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,GRIA2,,,,,,,,
8758,Verapamil,DB00661,Classical phenylketonuria,C0751434,Terminated,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},Phase 2,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,,
30651,GDF15,C0685938,Erythropoietin,DB00016,Malignant neoplasm of gastrointestinal tract,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 3,Cancer,PLAB,MIC-1,PDF,NAG-1,PTGFB,,,,,,,,,,,,,,,,,,,,,
20457,FHL5,C0043167,Erythromycin,DB00199,Pertussis,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,FLJ33049,dJ393D12.2,,,,,,,,,,,,,,,,,,,,,,,,
15982,FANCD2,C0040425,Dirithromycin,DB00954,Tonsillitis,Approved,CC[C@@H]1[C@@]([C@H]2[C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)N(C)C)O)(C)O)C)N[C@H](O2)COCCOC)C)(C)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
31258,PRKAR1A,C0001624,Erlotinib,DB00530,Adrenal Gland Neoplasms,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32459,TP53,C0238461,Paclitaxel,DB01229,Anaplastic thyroid carcinoma,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10949,ABCB6,C0877445,Voriconazole,DB00582,Candidemia,Approved,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30841,TRBV20OR9-2,C1522378,Cyclosporine,DB00091,"Leukemia, Large Granular Lymphocytic",Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19293,DAXX,C0036980,Dobutamine,DB00841,"Shock, Cardiogenic",Approved,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
36107,B2M,C0279663,Paclitaxel,DB01229,Serous cystadenocarcinoma ovary,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4869,Phenobarbital,DB01174,Bipolar disorder in remission,C0270425,Approved,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,ALPP,,,,,,,,
27397,CCHCR1,C0852036,Magnesium Sulfate,DB00653,Pregnancy associated hypertension,Suspended,[O-]S(=O)(=O)[O-].[Mg+2]},Phase 2/Phase 3,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17862,CDK13,C0162316,Succinic acid,DB00139,Iron deficiency anemia,Approved,C(CC(=O)O)C(=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34999,OGG1,C0151526,Progesterone,DB00396,Premature Birth,Terminated,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
24549,EPHB4,C0042345,Sodium Tetradecyl Sulfate,DB00464,Varicosity,Approved,CCCCCCCCCCCCCCOS(=O)(=O)[O-].[Na+]},,Vascular disease,Tyro11,HTK,,,,,,,,,,,,,,,,,,,,,,,,
30909,NUP98,C0279650,Idarubicin,DB01177,childhood acute megakaryocytic leukemia (M7),Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
14997,HTR2A,C0085159,Bupropion,DB01156,Seasonal Affective Disorder,Approved,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
29189,CDKN1A,C0278878,Irinotecan,DB00762,adult glioblastoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29012,CCL4,C0019187,Pentoxifylline,DB00806,"Hepatitis, Alcoholic",Terminated,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C},Phase 1,Digestive system disease,MIP-1-beta,Act-2,AT744.1,SCYA4,,,,,,,,,,,,,,,,,,,,,,
9065,F2RL1,C0018834,Sodium Citrate,DB09154,Heartburn,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Cardiovascular disease,GPR11,,,,,,,,,,,,,,,,,,,,,,,,,
21357,ESR1,C0016412,Levoleucovorin,DB11596,Folic Acid Deficiency,Approved,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Endocrine and metabolic disease,NR3A1,Era,ER-alpha,ESR,,,,,,,,,,,,,,,,,,,,,,
5049,Posaconazole,DB01263,Mycetoma,C0024449,Approved,CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F},,Infectious disease,,,,,,,,,,,,,,,,,,,HUWE1,,,,,,,,
19498,IL1A,C0276535,Doxorubicin,DB00997,AIDS with Kaposi's sarcoma,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},,Cancer,IL1F1,IL-1A,IL1-ALPHA,IL1,,,,,,,,,,,,,,,,,,,,,,
24712,CRYAB,C0029077,Triamcinolone,DB00620,"Ophthalmia, Sympathetic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,HSPB5,CRYA2,,,,,,,,,,,,,,,,,,,,,,,,
11528,DCR,C0014121,Vancomycin,DB00512,Bacterial Endocarditis,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8737,MSH6,C1140680,Fondaparinux sodium,DB00569,Malignant neoplasm of ovary,Withdrawn,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25644,HIF1A,C0334579,Valproic Acid,DB00313,Anaplastic astrocytoma,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,MOP1,HIF-1alpha,PASD8,HIF1,bHLHe78,,,,,,,,,,,,,,,,,,,,,
6944,FAM13A,C0392164,L-Cysteine,DB00151,Pulmonary Cystic Fibrosis,Approved,C([C@@H](C(=O)O)N)S},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,JCAD,,,,,,,,
317,Amphotericin B,DB00681,Urinary tract infection,C0042029,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Cisapride,,,,,,,,
8279,FBP1,C0740394,Sulfinpyrazone,DB01138,Hyperuricemia,Approved,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4},,,,,,,,,,,,,,,,,,,,,,,,,,,,
37230,DSTYK,C0015732,Phenylephrine,DB00388,Fecal Incontinence,Withdrawn,CNC[C@@H](C1=CC(=CC=C1)O)O},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
16507,SOD2,C0029456,Calcium carbonate,DB06724,Osteoporosis,Withdrawn,C(=O)([O-])[O-].[Ca+2]},Phase 3,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13084,FBN1,C0011644,Imatinib,DB00619,Scleroderma,Terminated,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 2,Skin disease,MASS,OCTD,SGS,FBN,MFS1,WMS,,,,,,,,,,,,,,,,,,,,
24665,MMRN1,C0002390,Prednisolone,DB00860,Extrinsic allergic alveolitis,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Immune system disease,ECM,EMILIN4,GPIa*,MMRN,,,,,,,,,,,,,,,,,,,,,,
24746,HLA-DQB1,C0032533,Prednisone,DB00635,Polymyalgia Rheumatica,Terminated,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 3,Musculoskeletal disease,HLA-DQB,,,,,,,,,,,,,,,,,,,,,,,,,
1588,Ciclopirox,DB01188,Tinea corporis (disorder),C0040252,Approved,CC1=CC(=O)N(C(=C1)C2CCCCC2)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Ursodeoxycholic acid,,,,,,,,
16545,IL6,C0238052,Cholic Acid,DB02659,"Xanthomatosis, Cerebrotendinous",Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C},,Congenital disorder of metabolism,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
4582,Ofloxacin,DB01165,Enteric campylobacteriosis,C0275982,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,LYSMD3,,,,,,,,
34621,IL6,C0020450,Thiamine,DB00152,Hyperemesis Gravidarum,Terminated,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},Phase 3,Endocrine and metabolic disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
32328,NOD1,C0238013,Voriconazole,DB00582,Invasive aspergillosis,Terminated,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,NLRC1,CLR7.1,CARD4,,,,,,,,,,,,,,,,,,,,,,,
6888,ELANE,C0006277,Theophylline,DB00277,Bronchitis,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Lung disease,NE,HNE,HLE,ELA2,,,,,,,,,,,,,,LECT2,,,,,,,,
35685,IL10,C0747820,Sulfadoxine,DB01299,"Malaria, antepartum",Terminated,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N},Phase 3,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
18996,GP1BA,C0040053,Warfarin,DB00682,Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,CD42b,GPIbalpha,GP1B,,,,,,,,,,,,,,,,,,,,,,,
32193,TP53,C1370419,Ketoconazole,DB01026,Granulosa cell tumor of the ovary,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26688,IDH2,C0020981,Thalidomide,DB01041,Angioimmunoblastic Lymphadenopathy,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28723,FOXC1,C0339573,Latanoprost,DB00654,"Glaucoma, Primary Open Angle",Terminated,CC(C)OC(=O)CCC/C=C\\C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O},Phase 1,Nervous system disease,FREAC3,IGDA,IHG1,FKHL7,IRID1,,,,,,,,,,,,,,,,,,,,,
6626,TGFB2,C0017605,Methazolamide,DB00703,Angle Closure Glaucoma,Approved,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C},,Nervous system disease,,,,,,,,,,,,,,,,,,COMMD1,,,,,,,,
11024,MRC1,C0009186,Posaconazole,DB01263,Coccidioidomycosis,Approved,CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F},,Infectious disease,CLEC13D,CD206,bA541I19.1,CLEC13DL,MRC1L1,,,,,,,,,,,,,,,,,,,,,
28671,VEGFA,C0153690,Ketoconazole,DB01026,Secondary malignant neoplasm of bone,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
11296,TGFB1,C0032285,Simvastatin,DB00641,Pneumonia,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Infectious disease,CED,TGFbeta,TGFB,DPD1,,,,,,,,,,,,,,,,,,,,,,
16023,MAS1,C1692886,Ceftriaxone,DB01212,"Arthritis, Bacterial",Approved,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12814,RPS15,C0023434,Venetoclax,DB11581,Chronic Lymphocytic Leukemia,Approved,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35171,ESR1,C0947751,Linagliptin,DB08882,Vascular inflammations,Terminated,CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C},Phase 3,Vascular disease,NR3A1,Era,ER-alpha,ESR,,,,,,,,,,,,,,,,,,,,,,
20167,FBLN5,C0018802,Levosimendan,DB00922,Congestive heart failure,Approved,C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N},,Congenital malformation,EVEC,UP50,DANCE,ARMD3,,,,,,,,,,,,,,,,,,,,,,
14339,CXCL8,C0936223,Nilutamide,DB00665,Metastatic Prostate Carcinoma,Approved,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C},,Cancer,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
36862,IFNG,C0867389,Prednisolone,DB00860,Chronic graft-versus-host disease,Withdrawn,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
20694,LCAT,C0473527,Simvastatin,DB00641,Hypoalphalipoproteinemias,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
26513,PIK3CG,C0235782,Oxaliplatin,DB00526,Gallbladder Carcinoma,Suspended,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25274,GNRHR,C0013338,Somatropin recombinant,DB00052,Pituitary dwarfism,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Endocrine and metabolic disease,LHRHR,GRHR,,,,,,,,,,,,,,,,,,,,,,,,
16414,S100B,C0012734,Promazine,DB00420,Disruptive Behavior Disorder,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Mental and behavioural disorder,S100beta,,,,,,,,,,,,,,,,,,,,,,,,,
21245,TACR3,C0151721,Testosterone Propionate,DB01420,Testicular hypogonadism,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19782,GPR182,C0036472,Fusidic Acid,DB02703,Scrub Typhus,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,hrhAMR,G10D,AM-R,ADMR,,,,,,,,,,,,,,,,,,,,,,
24385,AQP1,C0812413,Pemetrexed,DB00642,Malignant Pleural Mesothelioma,Approved,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,CHIP28,CO,,,,,,,,,,,,,,,,,,,,,,,,
31311,PCBP2-OT1,C0279607,Erlotinib,DB00530,adult primary hepatocellular carcinoma,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29181,BAG3,C0278878,Irinotecan,DB00762,adult glioblastoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
6264,Trovafloxacin,DB00685,Infection of skin AND/OR subcutaneous tissue,C0178299,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,,,,,,,,,,,,,,,,,,,TMED10,,,,,,,,
25161,VPS45,C0026987,Teriparatide,DB06285,Myelofibrosis,Terminated,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
8897,SEMA4D,C0013395,Omeprazole,DB00338,Dyspepsia,Suspended,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 2,Digestive system disease,CD100,coll-4,FLJ39737,SEMAJ,C9orf164,,,,,,,,,,,,,,,,,,,,,
29818,ACADVL,C0700292,Nitric Oxide,DB00435,Hypoxemia,Terminated,[N]=O},Phase 1/Phase 2,Hematologic disease,VLCAD,LCACD,ACAD6,,,,,,,,,,,,,,,,,,,,,,,
1633,Ciprofloxacin,DB00537,Anthrax disease,C0003175,Approved,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Vortioxetine,,,,,,,,
5773,Tamsulosin,DB00706,Prostatic Hypertrophy,C1739363,Approved,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N},,,,,,,,,,,,,,,,,,,,,GRIA3,,,,,,,,
8787,Vitamin C,DB00126,Shock,C0036974,Terminated,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
88,Alendronic acid,DB00630,Osteitis Deformans,C0029401,Approved,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,Aprobarbital,,,,,,,,
5834,Terbutaline,DB00871,Pulmonary Emphysema,C0034067,Approved,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O},,Lung disease,,,,,,,,,,,,,,,,,,,SEPHS1,,,,,,,,
20297,PTH,C3536984,Ergocalciferol,DB00153,"Vitamin D-Resistant Rickets, X-Linked",Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
17832,TG,C0002892,Thiamine,DB00152,"Anemia, Pernicious",Approved,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},,Hematologic disease,TGN,AITD3,,,,,,,,,,,,,,,,,,,,,,,,
29242,CTNNB1,C1328504,Sirolimus,DB00877,Hormone refractory prostate cancer,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 1/Phase 2,Cancer,beta-catenin,armadillo,CTNNB,,,,,,,,,,,,,,,,,,,,,,,
20662,TYMS,C0041341,Everolimus,DB01590,Tuberous Sclerosis,Approved,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC},,Nervous system disease,Tsase,TMS,HsT422,,,,,,,,,,,,,,,,,,,,,,,
6517,DRD2,C0030193,Oxycodone,DB00497,Pain,Withdrawn,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O},Phase 3,,,,,,,,,,,,,,,,,,,SOHLH1,,,,,,,,
23953,IL4,C0085786,Warfarin,DB00682,Hamman-Rich syndrome,Terminated,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},Phase 3,Lung disease,BSF1,IL-4,BCGF1,BCGF-1,MGC79402,,,,,,,,,,,,,,,,,,,,,
12681,POLDIP2,C0206525,Bedaquiline,DB08903,"Tuberculosis, Drug-Resistant",Approved,CN(C)CC[C@@](C1=CC=CC2=CC=CC=C21)([C@H](C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29949,PRKCQ,C0007112,Prednisone,DB00635,Adenocarcinoma of prostate,Withdrawn,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
30522,ERCC6,C0152025,Capsaicin,DB06774,Polyneuropathy,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1140,Cefotaxime,DB00493,Escherichia coli septicemia,C0276088,Approved,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Oxamniquine,,,,,,,,
20169,EDNRA,C0018802,Levosimendan,DB00922,Congestive heart failure,Approved,C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N},,Congenital malformation,ET-A,ETA-R,hET-AR,,,,,,,,,,,,,,,,,,,,,,,
22890,SLC12A3,C0677607,Levothyroxine,DB00451,Hashimoto Disease,Approved,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N},,Immune system disease,NCCT,,,,,,,,,,,,,,,,,,,,,,,,,
6671,ATXN2,C0017612,Unoprostone,DB06826,"Glaucoma, Open-Angle",Approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,DERL2,,,,,,,,
7191,Everolimus,DB01590,Eosinophilic esophagitis,C0341106,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC},Phase 1,Immune system disease,,,,,,,,,,,,,,,,,,,COMMD3-BMI1,,,,,,,,
5448,Rimexolone,DB00896,Uveitis,C0042164,Approved,CCC(=O)[C@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C)C},,Immune system disease,,,,,,,,,,,,,,,,,,,CNNM2,,,,,,,,
2709,Erythromycin,DB00199,Infection of skin AND/OR subcutaneous tissue,C0178299,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,NFATC1,,,,,,,,
14544,KRT19,C0080032,Thiotepa,DB04572,"Pleural Effusion, Malignant",Approved,C1CN1P(=S)(N2CC2)N3CC3},,Lung disease,K19,CK19,K1CS,MGC15366,,,,,,,,,,,,,,,,,,,,,,
26543,MLANA,C0278884,Sorafenib,DB00398,Melanoma recurrent,Withdrawn,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
15269,FGF23,C0085682,"Sodium phosphate, monobasic, monohydrate",DB09525,Hypophosphatemia,Approved,OP(=O)(O)[O-].[Na+]},,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
33344,ITK,C0038362,Thalidomide,DB01041,Stomatitis,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Infectious disease,PSCTK2,LYK,,,,,,,,,,,,,,,,,,,,,,,,
37205,GHRL,C0221406,Mifepristone,DB00834,Pituitary-dependent Cushing's disease,Withdrawn,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O},Phase 3,Endocrine and metabolic disease,MTLRP,ghrelin,obestatin,,,,,,,,,,,,,,,,,,,,,,,
20133,TNF,C0017205,Voglibose,DB04878,Gaucher Disease,Approved,C1[C@@H]([C@@H]([C@H]([C@@H]([C@]1(CO)O)O)O)O)NC(CO)CO},,Lysosomal storage disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
36911,PTPN11,C0206733,Timolol,DB00373,Strawberry nevus of skin,Withdrawn,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O},Phase 2,Vascular disease,BPTP3,SH-PTP2,SHP-2,PTP2C,SHP2,NS1,,,,,,,,,,,,,,,,,,,,
24687,GCA,C0039483,Triamcinolone,DB00620,Giant Cell Arteritis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11315,FLOT1,C0034362,Tetracycline,DB00759,Q Fever,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
611,Benzylpenicillin,DB01053,Gingivostomatitis,C0149704,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,,,,,,,,,,,,,,,,,,,,LEP,,,,,,,,
2105,Deoxycholic Acid,DB03619,Excess subcutaneous fat,C0424620,Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C},,Metabolic disease,,,,,,,,,,,,,,,,,,,C11orf49,,,,,,,,
24956,ACKR1,C0024530,Prednisone,DB00635,Malaria,Withdrawn,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 3,Infectious disease,CCBP1,GPD,Dfy,CD234,FY,DARC,,,,,,,,,,,,,,,,,,,,
29583,MMP9,C0007114,Fludarabine,DB01073,Malignant neoplasm of skin,Terminated,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 1/Phase 2,Cancer,CLG4B,,,,,,,,,,,,,,,,,,,,,,,,,
25602,ERAP1,C0040560,Sulfadiazine,DB00359,"Toxoplasmosis, Congenital",Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14893,CYP1B1,C0017601,Echothiophate,DB01057,Glaucoma,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Nervous system disease,CP1B,GLC3A,,,,,,,,,,,,,,,,,,,,,,,,
13000,VIM,C1527383,Imiquimod,DB00724,Morphea,Withdrawn,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N},Phase 3,Skin disease,,,,,,,,,,,,,,,,,,,,,,,,,,
13001,C3,C0030807,Sirolimus,DB00877,Pemphigus,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 0,Skin and connective tissue disease,CPAMD1,ARMD9,C3a,C3b,,,,,,,,,,,,,,,,,,,,,,
8956,Dextroamphetamine,DB01576,Schizophrenia,C0036341,Terminated,C[C@@H](CC1=CC=CC=C1)N},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,
9857,Pioglitazone,DB01132,Endometriosis,C0014175,Withdrawn,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3},Phase 2/Phase 3,Reproductive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
11398,IKBKB,C0037199,Pseudoephedrine,DB00852,Sinusitis,Withdrawn,C[C@@H]([C@H](C1=CC=CC=C1)O)NC},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8990,Fenofibrate,DB01039,Coronary Arteriosclerosis,C0010054,Terminated,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 3,Vascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
1033,Cefamandole,DB01326,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,Approved,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)[C@@H](C4=CC=CC=C4)O)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Milrinone,,,,,,,,
13403,MECP2,C1761609,Triamcinolone,DB00620,Aspiration pneumonitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,RTT,MRX16,MRX79,,,,,,,,,,,,,,,,,,,,,,,
28407,CSF2,C0007682,Temozolomide,DB00853,CNS disorder,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Nervous system disease,GM-CSF,GMCSF,,,,,,,,,,,,,,,,,,,,,,,,
17335,FOLH1,C0860594,Trametinib,DB08911,"Malignant melanoma, metastatic",Approved,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15642,SCN3A,C0014547,Primidone,DB00794,"Epilepsies, Partial",Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,Nav1.3,,,,,,,,,,,,,,,,,,,,,,,,,
960,KLF6,C0376358,Sirolimus,DB00877,Malignant neoplasm of prostate,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,CPBP,GBF,Zf9,ST12,COPEB,,,,,,,,,,,,,Meloxicam,,,,,,,,
23172,IL13,C0040954,Thiabendazole,DB00730,Infection by Trichuris trichiura,Approved,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3},,Infectious disease,P600,IL-13,ALRH,BHR1,MGC116786,MGC116788,MGC116789,,,,,,,,,,,,,,,,,,,
30491,HSPB1,C0031117,Capsaicin,DB06774,Peripheral Neuropathy,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 3,Nervous system disease,HSP27,HSP28,Hs.76067,Hsp25,CMT2F,,,,,,,,,,,,,,,,,,,,,
5643,Spirapril,DB01348,Hypertensive disease,C0020538,Approved,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3(C[C@H]2C(=O)O)SCCS3},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,NXF1,,,,,,,,
30482,SPTLC3,C0031117,Capsaicin,DB06774,Peripheral Neuropathy,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 3,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29903,PECAM1,C0856825,Pentostatin,DB00552,Acute GVH disease,Terminated,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O},Phase 1/Phase 2,Immune system disease,CD31,,,,,,,,,,,,,,,,,,,,,,,,,
14098,SLC27A5,C0036202,Triamcinolone,DB00620,Sarcoidosis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16179,TLR4,C0036117,Chloramphenicol,DB00446,Salmonella infections,Approved,C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]},,Infectious disease,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,,,,,,,,,
14986,COMT,C0028043,Varenicline,DB01273,Nicotine Dependence,Terminated,C1C2CNCC1C3=CC4=NC=CN=C4C=C23},Phase 2/Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
1720,Clavulanate,DB00766,Sepsis due to Pseudomonas,C2887096,Approved,C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,NIPA2,,,,,,,,
23363,CCL11,C0035457,Methylprednisolone,DB00959,"Rhinitis, Allergic, Perennial",Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O},,Immune system disease,eotaxin,MGC22554,SCYA11,,,,,,,,,,,,,,,,,,,,,,,
22969,GUCY2C,C1868889,Lubiprostone,DB01046,Irritable bowel syndrome characterized by constipation,Approved,CCCCC([C@]1(CC[C@H]2[C@H](O1)CC(=O)[C@@H]2CCCCCCC(=O)O)O)(F)F},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23663,CCR5,C1328252,Miltefosine,DB09031,Mucocutaneous leishmaniasis,Approved,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},,Infectious disease,CKR-5,CC-CKR-5,CKR5,CD195,IDDM22,CMKBR5,,,,,,,,,,,,,,,,,,,,
25411,LINC00513,C0007117,Vismodegib,DB08828,Basal cell carcinoma,Approved,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2084,Demeclocycline,DB00618,Granuloma Inguinale,C0018190,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3[C@@H](C4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O},,Skin disease,,,,,,,,,,,,,,,,,,,CCDC114,,,,,,,,
467,Azelnidipine,DB09230,Hypertensive disease,C0020538,Approved,CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC(C)C},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,Diflorasone,,,,,,,,
12414,DEFB1,C0035243,Azidocillin,DB08795,Respiratory Tract Infections,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N=[N+]=[N-])C(=O)O)C},,Infectious disease,HBD-1,DEFB-1,DEFB101,HBD1,BD1,MGC51822,,,,,,,,,,,,,,,,,,,,
30852,IL2RB,C1522378,Cyclosporine,DB00091,"Leukemia, Large Granular Lymphocytic",Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 2,Cancer,CD122,IL15RB,,,,,,,,,,,,,,,,,,,,,,,,
5354,Propranolol,DB00571,Atrial Fibrillation,C0004238,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,MLYCD,,,,,,,,
35378,PTGER3,C0005686,Mitomycin,DB00305,Urinary Bladder Diseases,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Urinary system disease,EP3,,,,,,,,,,,,,,,,,,,,,,,,,
28615,BRCA3,C0238033,Goserelin,DB00014,Carcinoma of Male Breast,Terminated,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10523,SDR9C7,C0151908,Pramocaine,DB09345,Dry skin,Approved,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6422,Zinc oxide,DB09321,Burn injury,C0006434,Approved,O=[Zn]},,,,,,,,,,,,,,,,,,,,,SETX,,,,,,,,
29691,ERVW-1,C0280634,Vorinostat,DB02546,adult acute monocytic leukemia (M5b),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
5177,KRAS,C0004604,Hydromorphone,DB00327,Back Pain,Terminated,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4},Phase 3,,0,,,,,,,,,,,,,,,,,AP5M1,,,,,,,,
3724,ABO,C2607914,Triprolidine,DB00427,Allergic rhinitis (disorder),Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Immune system disease,0,,,,,,,,,,,,,,,,,ENOSF1,,,,,,,,
22633,GLP1R,C0036992,Glucagon recombinant,DB00040,Short Bowel Syndrome,Terminated,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CNC=N7)N)O},Phase 1/Phase 2,,GLP-1R,,,,,,,,,,,,,,,,,,,,,,,,,
23452,EDNRB,C0023885,Metronidazole,DB00916,Liver Abscess,Approved,CC1=NC=C(N1CCO)[N+](=O)[O-]},,Liver disease,ETB,HSCR2,HSCR,,,,,,,,,,,,,,,,,,,,,,,
25397,DDB2,C0007117,Vismodegib,DB08828,Basal cell carcinoma,Approved,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15569,AGT,C0032768,Pregabalin,DB00230,Postherpetic neuralgia,Approved,CC(C)C[C@@H](CC(=O)O)CN},,Infectious disease,SERPINA8,,,,,,,,,,,,,,,,,,,,,,,,,
28908,AKT1,C0279680,Metronidazole,DB00916,Transitional cell carcinoma of bladder,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,RAC,PKB,PRKBA,AKT,,,,,,,,,,,,,,,,,,,,,,
15310,CTNS,C0035579,Calcitriol,DB00136,Rickets,Terminated,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},Phase 2,Congenital disorder of metabolism,CTNS-LSB,PQLC4,,,,,,,,,,,,,,,,,,,,,,,,
19775,IFNG,C0036472,Fusidic Acid,DB02703,Scrub Typhus,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
21053,CNR1,C2267227,Acetylcysteine,DB06151,Bulimia Nervosa,Terminated,CC(=O)N[C@@H](CS)C(=O)O},Phase 3,Mental and behavioural disorder,CB1K5,CB-R,CB1,CANN6,CB1A,CNR,,,,,,,,,,,,,,,,,,,,
31368,CD274,C0220654,Erlotinib,DB00530,Meningeal Carcinomatosis,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,B7-H,B7H1,PD-L1,PDL1,B7-H1,PDCD1LG1,,,,,,,,,,,,,,,,,,,,
36191,ALK,C0220603,Valproic Acid,DB00313,childhood brain tumor,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
22400,GEM,C0346976,Gemcitabine,DB00441,Secondary malignant neoplasm of pancreas,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
33098,SLC6A4,C0041696,Scopolamine,DB00747,Unipolar Depression,Terminated,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},Phase 2,Mental and behavioural disorder,5-HTT,SERT1,HTT,OCD1,,,,,,,,,,,,,,,,,,,,,,
14141,ICAM1,C0039103,Triamcinolone,DB00620,Synovitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,CD54,,,,,,,,,,,,,,,,,,,,,,,,,
16410,LILRB1,C0162565,Promazine,DB00420,Acute intermittent porphyria,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Congenital disorder of metabolism,LIR-1,ILT2,MIR-7,LIR1,CD85j,,,,,,,,,,,,,,,,,,,,,
28246,FN1,C0017636,Temozolomide,DB00853,Glioblastoma,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,CIG,LETS,GFND2,FINC,,,,,,,,,,,,,,,,,,,,,,
9803,GADL1,C0339968,Vancomycin,DB00512,Neonatal pneumonia,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
26941,ABL1,C0280449,Cyclophosphamide,DB00531,secondary acute myeloid leukemia,Terminated,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17612,DEFB1,C0010043,Prednisolone,DB00860,Corneal Ulcer,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,,HBD-1,DEFB-1,DEFB101,HBD1,BD1,MGC51822,,,,,,,,,,,,,,,,,,,,
6304,Uridine triacetate,DB09144,Hereditary orotic aciduria,C0220987,Approved,CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=O)NC2=O)OC(=O)C)OC(=O)C},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,PCDH11Y,,,,,,,,
3458,PARK7,C0917801,Citalopram,DB00215,Sleeplessness,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,,0,,,,,,,,,,,,,,,,,ERVK-10,,,,,,,,
5831,Terbutaline,DB00871,Bronchitis,C0006277,Approved,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O},,Lung disease,,,,,,,,,,,,,,,,,,,ARNTL2,,,,,,,,
18394,TBC1D9,C0023474,Nilotinib,DB04868,"Leukemia, Myeloid, Chronic-Phase",Approved,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36627,TOP2A,C0016048,Hydroxyurea,DB01005,Fibromatosis,Withdrawn,C(=O)(N)NO},Phase 2,Musculoskeletal disease,TOP2,,,,,,,,,,,,,,,,,,,,,,,,,
27988,LZTS1,C0014859,Fluorouracil,DB00544,Esophageal Neoplasms,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30383,QRSL1,C0018939,Melphalan,DB01042,Hematological Disease,Terminated,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8377,Meropenem,DB00760,"Pneumonia, Bacterial",C0004626,Terminated,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
32142,PON1,C0376545,Isotretinoin,DB00982,Hematologic Neoplasms,Terminated,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\\C(=O)O)/C)/C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1449,Cefuroxime,DB01112,Lower respiratory tract infection,C0149725,Approved,CO/N=C(/C1=CC=CO1)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O},,,,,,,,,,,,,,,,,,,,,Talbutal,,,,,,,,
28872,ZNF35,C0278493,Tamoxifen,DB00675,Breast cancer recurrent,Withdrawn,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29806,ADK,C0700292,Nitric Oxide,DB00435,Hypoxemia,Terminated,[N]=O},Phase 1/Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6190,Trifluoperazine,DB00831,Schizophrenia,C0036341,Approved,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,MAK16,,,,,,,,
27960,HLA-DQB1,C0036421,Iloprost,DB01088,Systemic Scleroderma,Terminated,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Skin disease,HLA-DQB,,,,,,,,,,,,,,,,,,,,,,,,,
25881,HBA2,C0085413,Tolvaptan,DB06212,"Polycystic Kidney, Autosomal Dominant",Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Congenital malformation,HBA-T2,,,,,,,,,,,,,,,,,,,,,,,,,
9029,Haloperidol,DB00502,Delirium,C0011206,Terminated,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,
18960,GAS6,C0040038,Warfarin,DB00682,Thromboembolism,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,AXSF,FLJ34709,DKFZp666G247,AXLLG,,,,,,,,,,,,,,,,,,,,,,
13870,FCGR2A,C0024141,Mycophenolic acid,DB01024,"Lupus Erythematosus, Systemic",Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 2/Phase 3,Immune system disease,CD32A,IGFR2,CDw32,FCGR2A1,,,,,,,,,,,,,,,,,,,,,,
5269,Primidone,DB00794,Epilepsy,C0014544,Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,,,,,,,,,,,,,,,,,,,NLRP7,,,,,,,,
20444,POMC,C0023241,Erythromycin,DB00199,Legionnaires' Disease,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
1379,Ceftriaxone,DB01212,Bacterial sepsis,C0684256,Approved,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Sibutramine,,,,,,,,
12610,RSPH9,C0027430,Beclomethasone dipropionate,DB00394,Nasal Polyps,Approved,CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14999,DRD4,C0085159,Bupropion,DB01156,Seasonal Affective Disorder,Approved,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
26188,ITGAV,C0600518,Imatinib,DB00619,Choroidal Neovascularization,Withdrawn,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 1,Congenital malformation,CD51,VNRA,MSK8,VTNR,,,,,,,,,,,,,,,,,,,,,,
30379,ABL1,C0018939,Melphalan,DB01042,Hematological Disease,Terminated,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17823,GAD2,C0002892,Thiamine,DB00152,"Anemia, Pernicious",Approved,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},,Hematologic disease,GAD65,,,,,,,,,,,,,,,,,,,,,,,,,
29648,KMT2A,C0279632,Vorinostat,DB02546,adult acute megakaryoblastic leukemia (M7),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3876,Magnesium salicylate,DB01397,Shoulder tendinitis,C0262633,Approved,C1=CC=C(C(=C1)C(=O)O)[O-].C1=CC=C(C(=C1)C(=O)O)[O-].[Mg+2]},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,PYROXD1,,,,,,,,
17632,TIMP3,C0017563,Triamcinolone,DB00620,Gingival Diseases,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,,,,,,,,,,,,,,,,,,,,,,,,,,,
17569,HSD17B4,C0037769,Vigabatrin,DB01080,West Syndrome,Approved,C=CC(CCC(=O)O)N},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28684,MMP2,C0009404,Sorafenib,DB00398,Colorectal Neoplasms,Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,TBE-1,CLG4,CLG4A,,,,,,,,,,,,,,,,,,,,,,,
9211,Parecoxib,DB08439,Pain,C0030193,Terminated,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1212,Cefoxitin,DB01331,Lung Abscess,C0024110,Approved,CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3},,,,,,,,,,,,,,,,,,,,,Phenprocoumon,,,,,,,,
32776,PRMT5,C0019045,Pegfilgrastim,DB00019,Hemoglobinopathies,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
9948,SLCO2A1,C0029443,Amikacin,DB00479,Osteomyelitis,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31978,FGF2,C1368898,Ifosfamide,DB01181,Adult teratoma,Terminated,C1CN(P(=O)(OC1)NCCCl)CCCl},Phase 2,Cancer,FGFB,,,,,,,,,,,,,,,,,,,,,,,,,
17218,DRD3,C0270846,Lorazepam,DB00186,Epileptic drop attack,Approved,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl},,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
13455,RAG1,C0002880,Triamcinolone,DB00620,Autoimmune hemolytic anemia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20798,LINC02210-CRHR1,C4083212,Finasteride,DB01216,"Alopecia, Male Pattern",Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32668,KIT,C0206695,Octreotide,DB00104,"Carcinoma, Neuroendocrine",Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 2,Cancer,CD117,SCFR,C-Kit,PBT,,,,,,,,,,,,,,,,,,,,,,
2571,Echothiophate,DB01057,Glaucoma,C0017601,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Nervous system disease,,,,,,,,,,,,,,,,,,,KLB,,,,,,,,
36651,TRIM13,C0079218,Hydroxyurea,DB01005,"Fibromatosis, Aggressive",Withdrawn,C(=O)(N)NO},Phase 2,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11793,NPY,C0008677,Vilanterol,DB09082,"Bronchitis, Chronic",Approved,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl},,Lung disease,PYY4,,,,,,,,,,,,,,,,,,,,,,,,,
5100,Prazepam,DB01588,Sleeplessness,C0917801,Approved,C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4},,,,,,,,,,,,,,,,,,,,,PRS,,,,,,,,
34790,INSRR,C1135120,Fentanyl,DB00813,Breakthrough Pain,Terminated,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3},Phase 3,,IRR,,,,,,,,,,,,,,,,,,,,,,,,,
20007,LGI4,C0014877,Echothiophate,DB01057,Esotropia,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
22679,INSR,C0019151,Phenylacetic acid,DB09269,Hepatic Encephalopathy,Terminated,C1=CC=C(C=C1)CC(=O)O},Phase 2,Liver disease,CD220,,,,,,,,,,,,,,,,,,,,,,,,,
34523,GAPDH,C0037278,Vancomycin,DB00512,"Skin Diseases, Infectious",Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,GAPD,,,,,,,,,,,,,,,,,,,,,,,,,
22216,FCN3,C0043037,Imiquimod,DB00724,Common wart,Approved,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N},,Skin disease,FCNH,HAKA1,,,,,,,,,,,,,,,,,,,,,,,,
9738,LAMC2,C0085437,Tobramycin,DB00684,"Meningitis, Bacterial",Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Infectious disease,nicein-100kDa,kalinin-105kDa,BM600-100kDa,EBR2,LAMB2T,LAMNB2,EBR2A,,,,,,,,,,,,,,,,,,,
20865,PRL,C0020594,Flibanserin,DB04908,Hypoactive Sexual Desire Disorder,Approved,C1CN(CCN1CCN2C3=CC=CC=C3NC2=O)C4=CC=CC(=C4)C(F)(F)F},,,,,,,,,,,,,,,,,,,,,,,,,,,,
2888,Fluocinolone Acetonide,DB00591,Pruritus Ani,C0033775,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@@]53C)F)F)O},,,,,,,,,,,,,,,,,,,,,VHL,,,,,,,,
20252,GSTK1,C0043144,Epinephrine,DB00668,Wheezing,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
5868,Tetracycline,DB00759,Bacterial keratitis,C0854211,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,PAK3,,,,,,,,
8617,Sirolimus,DB00877,Rheumatoid Arthritis,C0003873,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
18148,NUTM1,C0553580,Vincristine,DB00541,Ewings sarcoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25131,NFE2L2,C0730607,Roflumilast,DB01656,Severe chronic obstructive pulmonary disease,Approved,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14273,BNC2,C0080274,Tamsulosin,DB00706,Urinary Retention,Terminated,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N},Phase 3,,BSN2,FLJ20043,,,,,,,,,,,,,,,,,,,,,,,,
26196,FBLN5,C0600518,Imatinib,DB00619,Choroidal Neovascularization,Withdrawn,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 1,Congenital malformation,EVEC,UP50,DANCE,ARMD3,,,,,,,,,,,,,,,,,,,,,,
2633,Ephedrine,DB01364,Sinus headache,C0037195,Approved,C[C@@H]([C@@H](C1=CC=CC=C1)O)NC},,Nervous system disease,,,,,,,,,,,,,,,,,,,COPE,,,,,,,,
27762,TNFSF10,C0023418,Vincristine,DB00541,leukemia,Withdrawn,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,TRAIL,Apo-2L,TL2,CD253,,,,,,,,,,,,,,,,,,,,,,
20171,GCG,C0018802,Levosimendan,DB00922,Congestive heart failure,Approved,C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N},,Congenital malformation,GLP2,GRPP,,,,,,,,,,,,,,,,,,,,,,,,
8444,CRHR1,C0270549,Quetiapine,DB01224,Generalized Anxiety Disorder,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,CRF-R,CRF1,CRHR,,,,,,,,,,,,,,,,,,,,,,,
17112,AR,C0021361,Clomifene,DB00882,Female infertility,Approved,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\Cl)/C3=CC=CC=C3},,Reproductive system disease,AIS,NR3C4,SMAX1,HUMARA,DHTR,SBMA,,,,,,,,,,,,,,,,,,,,
21185,CFTR,C0022735,Testosterone Propionate,DB01420,Klinefelter Syndrome,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Congenital malformation,ABC35,TNR-CFTR,CFTR/MRP,CF,ABCC7,,,,,,,,,,,,,,,,,,,,,
19041,FCGR2A,C0029001,Ivermectin,DB00602,Onchocerciasis,Approved,CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C},,Infectious disease,CD32A,IGFR2,CDw32,FCGR2A1,,,,,,,,,,,,,,,,,,,,,,
33844,ADM,C0011875,Heparin,DB01109,Diabetic Angiopathies,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2/Phase 3,Vascular disease,AM,,,,,,,,,,,,,,,,,,,,,,,,,
17599,NGF,C0010043,Prednisolone,DB00860,Corneal Ulcer,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,,NGFB,,,,,,,,,,,,,,,,,,,,,,,,,
19236,TNF,C0282488,Mycophenolic acid,DB01024,Interstitial Cystitis,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,Urinary system disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
13999,NPHS1,C0027726,Triamcinolone,DB00620,Nephrotic Syndrome,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Urinary system disease,CNF,NPHN,,,,,,,,,,,,,,,,,,,,,,,,
12417,IL1B,C0035243,Azidocillin,DB08795,Respiratory Tract Infections,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N=[N+]=[N-])C(=O)O)C},,Infectious disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
35904,SOD2,C0235974,Sunitinib,DB01268,Pancreatic carcinoma,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32998,GH1,C0017150,Romidepsin,DB06176,Gastrinoma,Terminated,C/C=C\\1/C(=O)N[C@H](C(=O)O[C@H]\\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C},Phase 2,Cancer,GH-N,GHN,GH,hGH-N,,,,,,,,,,,,,,,,,,,,,,
27068,MIR4668,C0205824,Ifosfamide,DB01181,"Liposarcoma, Dedifferentiated",Suspended,C1CN(P(=O)(OC1)NCCCl)CCCl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26778,FANCB,C0280451,Allopurinol,DB00437,de novo myelodysplastic syndromes,Terminated,C1=NNC2=C1C(=O)NC=N2},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15456,PENK,C0264716,Amlodipine,DB00381,Chronic heart failure,Suspended,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN},Phase 2,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
6298,Urea,DB03904,Exanthema,C0015230,Approved,C(=O)(N)N},,Infectious disease,,,,,,,,,,,,,,,,,,,ARNT2,,,,,,,,
12125,CDKN2B-AS1,C0003850,Simvastatin,DB00641,Arteriosclerosis,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13582,TYK2,C0010346,Naltrexone,DB00704,Crohn Disease,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19689,NLRP3,C0008149,Fusidic Acid,DB02703,Chlamydia Infections,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,AGTAVPRL,AII,AVP,FCAS,FCU,NALP3,PYPAF1,MWS,CLR1.1,C1orf7,CIAS1,,,,,,,,,,,,,,,
20884,CNR1,C0184567,Floctafenine,DB08976,Acute onset pain,Approved,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC=C(C3=NC=C2)C(F)(F)F},,,CB1K5,CB-R,CB1,CANN6,CB1A,CNR,,,,,,,,,,,,,,,,,,,,
34393,ALB,C0451641,Ciprofloxacin,DB00537,Urolithiasis,Terminated,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
2765,Ethionamide,DB00609,"Tuberculosis, Pulmonary",C0041327,Approved,CCC1=NC=CC(=C1)C(=S)N},,Infectious disease,,,,,,,,,,,,,,,,,,,HRH3,,,,,,,,
3946,FLG,C2607914,Triprolidine,DB00427,Allergic rhinitis (disorder),Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Immune system disease,,,,,,,,,,,,,,,,,,NCAM1,,,,,,,,
31956,KLF4,C1368898,Ifosfamide,DB01181,Adult teratoma,Terminated,C1CN(P(=O)(OC1)NCCCl)CCCl},Phase 2,Cancer,EZF,GKLF,,,,,,,,,,,,,,,,,,,,,,,,
25147,THPO,C0026987,Teriparatide,DB06285,Myelofibrosis,Terminated,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23378,FOS,C0267176,Metoclopramide,DB01233,Gastroparesis due to diabetes mellitus,Approved,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl},,Digestive system disease,c-fos,,,,,,,,,,,,,,,,,,,,,,,,,
25729,POLR3B,C0271623,Methyltestosterone,DB06710,Hypogonadotropic hypogonadism,Terminated,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C},Phase 2,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26500,SLC22A2,C1561643,Sevelamer,DB00658,Chronic Kidney Diseases,Terminated,C=CCN.C1C(O1)CCl},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23584,ELP1,C0020651,Midodrine,DB00211,"Hypotension, Orthostatic",Approved,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24134,ACER3,C0005697,Oxybutynin,DB01062,Neurogenic Urinary Bladder,Approved,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O},,Urinary system disease,FLJ11238,APHC,PHCA,,,,,,,,,,,,,,,,,,,,,,,
31146,CDKN1B,C1292753,Doxorubicin,DB00997,Primary Effusion Lymphoma,Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4464,Norethisterone,DB00717,Secondary physiologic amenorrhea,C0232940,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},,Reproductive system disease,,,,,,,,,,,,,,,,,,,DDR2,,,,,,,,
14129,CRP,C0039103,Triamcinolone,DB00620,Synovitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
36816,PRNCR1,C0600139,Simvastatin,DB00641,Prostate carcinoma,Withdrawn,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17260,EPO,C1303258,Clopidogrel,DB00758,Acute ST segment elevation myocardial infarction (disorder),Approved,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3},,Cardiovascular disease,EP,,,,,,,,,,,,,,,,,,,,,,,,,
13883,NBN,C0024305,Vidarabine,DB00194,"Lymphoma, Non-Hodgkin",Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36906,ATP6V1A,C0206733,Timolol,DB00373,Strawberry nevus of skin,Withdrawn,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O},Phase 2,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7430,CACNA1C,C1269683,Quetiapine,DB01224,Major Depressive Disorder,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,ADGRE2,,,,,,,,
24143,VANGL1,C0005697,Oxybutynin,DB01062,Neurogenic Urinary Bladder,Approved,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35397,CXCL10,C1720830,Mycophenolic acid,DB01024,Painful Bladder Syndrome,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,,IFI10,IP-10,crg-2,mob-1,C7,gIP-10,INP10,SCYB10,,,,,,,,,,,,,,,,,,
26991,STAT3,C1955861,Thalidomide,DB01041,T-Cell Large Granular Lymphocyte Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,APRF,,,,,,,,,,,,,,,,,,,,,,,,,
25738,CSHL1,C0020635,Testosterone,DB00624,Hypopituitarism,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5,Acamprosate,DB00659,"Alcoholic Intoxication, Chronic",C0001973,Approved,CC(=O)NCCCS(=O)(=O)O},,Other,RALDH2,,,,,,,,,,,,,,,,,,Acebutolol,,,,,,,,aldehyde dehydrogenase 1 family member A2
29331,ERBB2,C1332166,Paclitaxel,DB01229,Adenocarcinoma of the gastroesophageal junction,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1/Phase 2,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
9987,IL10,C0004626,Tobramycin,DB00684,"Pneumonia, Bacterial",Terminated,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},Phase 2,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
22783,NBEAL2,C0025323,Tranexamic Acid,DB00302,Menorrhagia,Approved,C1CC(CCC1CN)C(=O)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
8299,MYLK,C1262211,Ranolazine,DB00243,Diarrhoea predominant irritable bowel syndrome,Terminated,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O},Phase 2/Phase 3,Digestive system disease,smMLCK,MYLK1,MLCK1,,,,,,,,,,,,,,,,,,,,,,,
31644,PIK3CA,C0338106,Oxaliplatin,DB00526,Adenocarcinoma of colon,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 3,Cancer,PI3K,,,,,,,,,,,,,,,,,,,,,,,,,
3507,Indomethacin,DB00328,Ankylosing spondylitis,C0038013,Approved,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,SLC29A3,,,,,,,,
4540,Norfloxacin,DB01059,URINARY TRACT INFECTION CITROBACTER,C0749955,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,LINC01241,,,,,,,,
28959,ANXA1,C0027627,Sirolimus,DB00877,Neoplasm Metastasis,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 3,Cancer,ANX1,LPC1,,,,,,,,,,,,,,,,,,,,,,,,
17567,WDR45,C0037769,Vigabatrin,DB01080,West Syndrome,Approved,C=CC(CCC(=O)O)N},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27726,ACD,C0023532,Aminolevulinic acid,DB00855,"Leukoplakia, Oral",Terminated,C(CC(=O)O)C(=O)CN},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11555,ADAM17,C0025295,Meropenem,DB00760,"Meningitis, Pneumococcal",Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10069,TNC,C0022602,Masoprocol,DB00179,Actinic keratosis,Approved,C[C@H](CC1=CC(=C(C=C1)O)O)[C@@H](C)CC2=CC(=C(C=C2)O)O},,Skin disease,MGC167029,HXB,DFNA56,,,,,,,,,,,,,,,,,,,,,,,
27613,CAV1,C0010073,Sildenafil,DB00203,Coronary Artery Vasospasm,Suspended,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C},Phase 3,Vascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
32097,SLC2A1,C0031149,Oxaliplatin,DB00526,Peritoneal Neoplasms,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,DYT18,DYT9,GLUT1,GLUT,HTLVR,CSE,,,,,,,,,,,,,,,,,,,,
13646,KL,C0037274,Triamcinolone,DB00620,Dermatologic disorders,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,,,,,,,,
8052,IL5,C1739363,Terazosin,DB01162,Prostatic Hypertrophy,Approved,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC},,,IL-5,EDF,,,,,,,,,,,,,,,,,,,,,,,,
119,Alprostadil,DB00770,Aortic coarctation,C0003492,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,Azlocillin,,,,,,,,
25148,CD34,C0026987,Teriparatide,DB06285,Myelofibrosis,Terminated,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
31054,STK19,C0030809,Dapsone,DB00250,Pemphigus Vulgaris,Terminated,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N},Phase 2,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2325,Diflorasone,DB00223,Chronic small plaque psoriasis,C0406317,Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C)F},,Skin disease,,,,,,,,,,,,,,,,,,,STAT5B,,,,,,,,
16055,CSF2,C0025289,Gemcitabine,DB00441,Meningitis,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1,Infectious disease,GM-CSF,GMCSF,,,,,,,,,,,,,,,,,,,,,,,,
10052,SOX10,C0346993,Aminoglutethimide,DB00357,Secondary malignant neoplasm of female breast,Approved,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N},,Cancer,DOM,WS4,WS2E,,,,,,,,,,,,,,,,,,,,,,,
26340,ORM1,C1275684,Xanthophyll,DB00137,Meibomian gland dysfunction,Approved,CC1=C(C(C[C@@H](C1)O)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(\\C)/C=C/C=C(\\C)/C=C/[C@H]2C(=C[C@@H](CC2(C)C)O)C)/C)/C},,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
15019,COMT,C0085159,Bupropion,DB01156,Seasonal Affective Disorder,Approved,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
31273,CELSR2,C0220624,Erlotinib,DB00530,adult brain tumor,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,KIAA0279,MEGF3,Flamingo1,CDHF10,ADGRC2,EGFL2,,,,,,,,,,,,,,,,,,,,
2524,Doxylamine,DB00366,Influenza-like symptoms,C0392171,Approved,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,LINC01405,,,,,,,,
8194,SLC17A4,C0003868,Triamcinolone,DB00620,"Arthritis, Gouty",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7833,EGFR,C0007131,Carboplatin,DB00958,Non-Small Cell Lung Carcinoma,Withdrawn,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2]},Phase 2,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,LDAH,,,,,,,,
31163,CALCR,C0877438,Doxycycline,DB00254,Non-ischemic cardiomyopathy,Terminated,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},Phase 2,Cardiovascular disease,CTR,,,,,,,,,,,,,,,,,,,,,,,,,
12494,ESD,C0032290,Ticarcillin,DB01607,Aspiration Pneumonia,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26489,FLT1,C1561643,Sevelamer,DB00658,Chronic Kidney Diseases,Terminated,C=CCN.C1C(O1)CCl},Phase 3,Urinary system disease,VEGFR1,FLT,,,,,,,,,,,,,,,,,,,,,,,,
33981,ALAD,C0035222,Salbutamol,DB01001,"Respiratory Distress Syndrome, Adult",Terminated,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O},Phase 2/Phase 3,Lung disease,ALADH,PBGS,,,,,,,,,,,,,,,,,,,,,,,,
35109,BARD1,C1333990,Norgestrel,DB09389,Hereditary Nonpolyposis Colorectal Cancer,Terminated,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9792,MFT2,C0339968,Vancomycin,DB00512,Neonatal pneumonia,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29470,GSTM1,C0005695,Mitomycin,DB00305,Bladder Neoplasm,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26302,CFHR1,C0242383,Xanthophyll,DB00137,Age related macular degeneration,Approved,CC1=C(C(C[C@@H](C1)O)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(\\C)/C=C/C=C(\\C)/C=C/[C@H]2C(=C[C@@H](CC2(C)C)O)C)/C)/C},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12169,APOA1,C0342881,Simvastatin,DB00641,Familial hypercholesterolemia - homozygous,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Inherited metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
9487,JAK2,C2973725,Treprostinil,DB00374,Pulmonary arterial hypertension,Approved,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},,Infectious disease,JTK10,,,,,,,,,,,,,,,,,,,,,,,,,
32343,TBX1,C0018798,Milrinone,DB00235,Congenital Heart Defects,Terminated,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2},Phase 2,Congenital malformation,VCF,,,,,,,,,,,,,,,,,,,,,,,,,
28730,MYOCOS,C0339573,Latanoprost,DB00654,"Glaucoma, Primary Open Angle",Terminated,CC(C)OC(=O)CCC/C=C\\C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O},Phase 1,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9603,Cyclophosphamide,DB00531,"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",C0393819,Withdrawn,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 2,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
31561,LEP,C0400966,Ezetimibe,DB00973,Non-alcoholic Fatty Liver Disease,Terminated,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O},Phase 2,Endocrine disease,OBS,,,,,,,,,,,,,,,,,,,,,,,,,
16280,C1D,C0236663,Diazepam,DB00829,Alcohol withdrawal syndrome,Approved,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
23397,GADL1,C0006105,Metronidazole,DB00916,Brain Abscess,Approved,CC1=NC=C(N1CCO)[N+](=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
34489,TERC,C0023470,Mycophenolic acid,DB01024,Myeloid Leukemia,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33247,SYNCRIP,C0280141,Sunitinib,DB01268,Acute Undifferentiated Leukemia,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1559,Chlortetracycline,DB09093,Trachoma,C0040592,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Triflupromazine,,,,,,,,
14657,EIF4E,C0334634,Thalidomide,DB01041,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35846,CDX2,C0032927,Celecoxib,DB00482,Precancerous Conditions,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2/Phase 3,,CDX3,,,,,,,,,,,,,,,,,,,,,,,,,
2654,Epoprostenol,DB01240,Pulmonary arterial hypertension,C2973725,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/O2)O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,PTK7,,,,,,,,
12437,HDAC5,C0032302,Trovafloxacin,DB00685,Mycoplasma pneumonia,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23142,LOC102723407,C0033845,Thiopental,DB00599,Pseudotumor Cerebri,Approved,CCCC(C)C1(C(=O)NC(=S)NC1=O)CC},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32032,CDX2,C0009375,Oxaliplatin,DB00526,Colonic Neoplasms,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,CDX3,,,,,,,,,,,,,,,,,,,,,,,,,
29705,KMT2A,C0279627,Vorinostat,DB02546,adult acute myelomonocytic leukemia (M4),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4246,Minocycline,DB01017,Pneumonia,C0032285,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,OR5J2,,,,,,,,
35386,NLRP4,C0042075,Mitomycin,DB00305,Urologic Diseases,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8632,VIP,C0242350,Vardenafil,DB00862,Erectile dysfunction,Approved,CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C},,Reproductive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
23915,ADORA1,C0038525,Deferoxamine,DB00746,Subarachnoid Hemorrhage,Terminated,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O},Phase 0,,0,,,,,,,,,,,,,,,,,,,,,,,,,
2789,Ezetimibe,DB00973,Hyperlipidemia,C0020473,Approved,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O},,Metabolic disease,,,,,,,,,,,,,,,,,,,SYT2,,,,,,,,
8442,OSR1,C0270549,Quetiapine,DB01224,Generalized Anxiety Disorder,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
19554,CD274,C0278498,Panobinostat,DB06603,Malignant neoplasm of stomach stage IV,Terminated,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)/C=C/C(=O)NO},Phase 2,Cancer,B7-H,B7H1,PD-L1,PDL1,B7-H1,PDCD1LG1,,,,,,,,,,,,,,,,,,,,
26089,FDPS,C0349506,Trioxsalen,DB04571,Photosensitivity of skin,Approved,CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28422,CEBPA,C1292772,Sunitinib,DB01268,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,C/EBP-alpha,CEBP,,,,,,,,,,,,,,,,,,,,,,,,
25896,RAPGEF5,C0085413,Tolvaptan,DB06212,"Polycystic Kidney, Autosomal Dominant",Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
10714,IL17A,C0519030,Norfloxacin,DB01059,Pneumonia due to Klebsiella pneumoniae,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
21479,CRP,C0032269,Lincomycin,DB01627,Pneumococcal Infections,Approved,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
34146,ARR3,C1960870,Cyclobenzaprine,DB00924,Transformed migraine,Terminated,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31},Phase 3,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30528,IDH2,C0206698,Oxaliplatin,DB00526,Cholangiocarcinoma,Withdrawn,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26393,LDHB,C0007124,Oxytocin,DB00107,Noninfiltrating Intraductal Carcinoma,Suspended,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N},Phase 0,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13789,EGFR,C0149911,Zoledronic acid,DB00399,Humoral hypercalcemia of malignancy (disorder),Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Urinary system disease,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
11631,LGALS3,C0581377,Torasemide,DB00214,Decompensated cardiac failure,Approved,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C},,Cardiovascular disease,MAC-2,GALIG,LGALS2,,,,,,,,,,,,,,,,,,,,,,,
17314,DISC1,C3544321,Thioridazine,DB00679,Treatment-resistant schizophrenia,Approved,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
32811,LNPEP,C0039730,Pegfilgrastim,DB00019,Thalassemia,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25049,NEK1,C0002736,Pioglitazone,DB01132,Amyotrophic Lateral Sclerosis,Terminated,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3},Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8844,Sulfamethoxazole,DB01015,HIV Infections,C0019693,Terminated,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N},Phase 2/Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
32411,ABCA1,C0007282,Minocycline,DB01017,Carotid Stenosis,Terminated,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},Phase 2,Cardiovascular disease,TGD,HDLDT1,,,,,,,,,,,,,,,,,,,,,,,,
13362,RPS27A,C1260899,Triamcinolone,DB00620,"Anemia, Diamond-Blackfan",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17699,PLEC,C0022568,Loteprednol,DB00873,Keratitis,Withdrawn,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)OCCl)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 3,Skin disease,PLTN,EBS1,PLEC1,,,,,,,,,,,,,,,,,,,,,,,
34192,HTR2A,C0853193,Risperidone,DB00734,Bipolar I disorder,Terminated,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
43,Aciclovir,DB00787,Chickenpox,C0008049,Approved,C1=NC2=C(N1COCCO)N=C(NC2=O)N},,Infectious disease,,,,,,,,,,,,,,,,,,,Alprazolam,,,,,,,,
20608,NT5E,C0029396,Etidronic acid,DB01077,Heterotopic Ossification,Approved,CC(O)(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,CD73,eN,eNT,CALJA,NT5,,,,,,,,,,,,,,,,,,,,,
34401,LOC110283621,C0451641,Ciprofloxacin,DB00537,Urolithiasis,Terminated,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3025,Fusidic Acid,DB02703,Bacterial peritonitis,C0341503,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,CR1,,,,,,,,
16453,DCTN1,C0027498,Ondansetron,DB00904,Nausea and vomiting,Withdrawn,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C},Phase 3,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
25404,TP53,C0007117,Vismodegib,DB08828,Basal cell carcinoma,Approved,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11618,UBE2N,C0013371,Trimethoprim,DB00440,Shigella Infections,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21265,IL25,C0155877,Zileuton,DB00744,Allergic asthma,Approved,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O},,Immune system disease,IL-17E,IL17E,,,,,,,,,,,,,,,,,,,,,,,,
3800,Loratadine,DB00455,Rhinorrhea,C1260880,Approved,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1},,Nervous system disease,,,,,,,,,,,,,,,,,,,STAP1,,,,,,,,
25752,MAGEL2,C0020635,Testosterone,DB00624,Hypopituitarism,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2814,Fenoldopam,DB00800,Hypertensive urgency,C0745138,Approved,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,MICU1,,,,,,,,
11430,AHR,C0039128,Tetracycline,DB00759,Syphilis,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,bHLHe76,,,,,,,,,,,,,,,,,,,,,,,,,
13329,HLA-DOA,C0405580,Triamcinolone,DB00620,Adrenal cortical hypofunction,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19373,DRD2,C0020649,Phentermine,DB00191,Hypotension,Approved,CC(C)(CC1=CC=CC=C1)N},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
35975,MIR378I,C0019163,Tenofovir,DB00300,Hepatitis B,Terminated,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2981,Fluvoxamine,DB00176,"Phobia, Social",C0031572,Approved,COCCCC/C(=N\\OCCN)/C1=CC=C(C=C1)C(F)(F)F},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,ACACA,,,,,,,,
6362,CCL4L2,C0393735,Salicylic acid,DB00936,Headache Disorders,Approved,C1=CC=C(C(=C1)C(=O)O)O},,Nervous system disease,,,,,,,,,,,,,,,,,,CDS1,,,,,,,,
3500,Imiquimod,DB00724,Common wart,C0043037,Approved,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N},,Skin disease,,,,,,,,,,,,,,,,,,,IBA57,,,,,,,,
32512,TFE3,C0279702,Sorafenib,DB00398,Conventional (Clear Cell) Renal Cell Carcinoma,Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,TFEA,bHLHe33,,,,,,,,,,,,,,,,,,,,,,,,
20100,H3P9,C0041228,Suramin,DB04786,African Trypanosomiasis,Approved,CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10476,TRPA1,C0010200,Sodium Citrate,DB09154,Coughing,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,,ANKTM1,,,,,,,,,,,,,,,,,,,,,,,,,
33443,CYP2E1,C0013221,Triptorelin,DB06825,Drug toxicity,Terminated,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8},Phase 2,,CYP2E,,,,,,,,,,,,,,,,,,,,,,,,,
8217,IL1B,C0018099,Naproxen,DB00788,Gout,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,Musculoskeletal disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
33317,ADRA1A,C0033117,Tadalafil,DB00820,Priapism,Terminated,CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
18859,GPX1,C0020459,Diazoxide,DB01119,Hyperinsulinism,Approved,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
33636,RUNX2,C0206638,Zoledronic acid,DB00399,Giant Cell Tumor of Bone,Terminated,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},Phase 2,Cancer,AML3,PEBP2A1,PEBP2aA1,CCD,CBFA1,CCD1,,,,,,,,,,,,,,,,,,,,
24186,UBR1,C0267963,Pancrelipase,DB00085,Exocrine pancreatic insufficiency,Approved,C1CC2C(C(C1O2)C(=O)[O-])C(=O)[O-].[Na+].[Na+]},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10501,ABCA3,C0010200,Sodium Citrate,DB09154,Coughing,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,,ABC-C,EST111653,LBM180,ABC3,,,,,,,,,,,,,,,,,,,,,,
36876,IL22,C0867389,Prednisolone,DB00860,Chronic graft-versus-host disease,Withdrawn,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Immune system disease,ILTIF,zcyto18,IL-TIF,IL-D110,TIFa,TIFIL-23,MGC79382,MGC79384,,,,,,,,,,,,,,,,,,
20148,AGT,C0018802,Levosimendan,DB00922,Congestive heart failure,Approved,C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N},,Congenital malformation,SERPINA8,,,,,,,,,,,,,,,,,,,,,,,,,
23914,NOS2,C0038525,Deferoxamine,DB00746,Subarachnoid Hemorrhage,Terminated,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O},Phase 0,,iNOS,HEP-NOS,NOS2A,,,,,,,,,,,,,,,,,,,,,,,
23847,IL7R,C1961099,Nelarabine,DB01280,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,Approved,COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},,Cancer,CD127,IL7RA,,,,,,,,,,,,,,,,,,,,,,,,
8783,S100A8,C0013295,Sucralfate,DB00364,Duodenal Ulcer,Approved,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al]},,Digestive system disease,P8,CGLA,CAGA,,,,,,,,,,,,,,,,,,,,,,,
20586,KRAS,C0033578,Flutamide,DB00499,Prostatic Neoplasms,Approved,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16752,NOP56,C0042571,Meclizine,DB00737,Vertigo,Approved,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
35974,MIR1468,C0019163,Tenofovir,DB00300,Hepatitis B,Terminated,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26287,RDH11,C0042842,Vitamin A,DB00162,Vitamin A Deficiency,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23371,AKT1,C0267176,Metoclopramide,DB01233,Gastroparesis due to diabetes mellitus,Approved,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl},,Digestive system disease,RAC,PKB,PRKBA,AKT,,,,,,,,,,,,,,,,,,,,,,
6541,MAOB,C0033893,Codeine,DB00318,Tension Headache,Approved,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O},,Nervous system disease,,,,,,,,,,,,,,,,,,STX17,,,,,,,,
36793,SHH,C0175694,Lovastatin,DB00227,Smith-Lemli-Opitz Syndrome,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,HHG1,SMMCI,TPTPS,MCOPCB5,HPE3,,,,,,,,,,,,,,,,,,,,,
28687,TYMS,C0009404,Sorafenib,DB00398,Colorectal Neoplasms,Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,Tsase,TMS,HsT422,,,,,,,,,,,,,,,,,,,,,,,
24601,RMND1,C0001126,Potassium Citrate,DB09125,Renal tubular acidosis,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11421,PHB2,C0039128,Tetracycline,DB00759,Syphilis,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21457,FOXC1,C0022573,Tobramycin,DB00684,Keratoconjunctivitis,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Infectious disease,FREAC3,IGDA,IHG1,FKHL7,IRID1,,,,,,,,,,,,,,,,,,,,,
3798,Loratadine,DB00455,Nasal congestion (finding),C0027424,Approved,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1},,,,,,,,,,,,,,,,,,,,,SERPINA7,,,,,,,,
27666,CSNK1A1,C0023493,Thalidomide,DB01041,Adult T-Cell Lymphoma/Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 0,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25688,PRG4,C0003864,Tenoxicam,DB00469,Arthritis,Approved,CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3},,Immune system disease,JCAP,SZP,HAPO,bG174L6.2,FLJ32635,CACP,,,,,,,,,,,,,,,,,,,,
34413,EGF,C0278601,Tamoxifen,DB00675,Inflammatory Breast Carcinoma,Terminated,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
31089,CCL2,C0022661,Niacin,DB00627,"Kidney Failure, Chronic",Terminated,C1=CC(=CN=C1)C(=O)O},Phase 3,Urinary system disease,MCP1,MCP-1,MCAF,SMC-CF,GDCF-2,HC11,MGC9434,SCYA2,,,,,,,,,,,,,,,,,,
35902,BRCA2,C0235974,Sunitinib,DB01268,Pancreatic carcinoma,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30745,NBN,C1514428,Paclitaxel,DB01229,Primary peritoneal carcinoma,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
22067,PIK3CG,C0019357,Vidarabine,DB00194,"Keratitis, Herpetic",Approved,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11909,CEBPA,C0023479,Arsenic trioxide,DB01169,Acute myelomonocytic leukemia,Approved,[O-2].[O-2].[O-2].[As+3].[As+3]},,Cancer,C/EBP-alpha,CEBP,,,,,,,,,,,,,,,,,,,,,,,,
18370,HSPD1,C0085606,Trospium,DB00209,Urgency of micturition,Approved,C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
8868,Anastrozole,DB01217,Obesity,C0028754,Terminated,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N},Phase 3,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
6763,TNF,C0042029,Trovafloxacin,DB00685,Urinary tract infection,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,FOXP2,,,,,,,,
27519,AFP,C0332890,Vincristine,DB00541,Congenital hemihypertrophy,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Congenital malformation,FETA,HPAFP,,,,,,,,,,,,,,,,,,,,,,,,
13626,IFNG,C0011608,Triamcinolone,DB00620,Dermatitis Herpetiformis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
11493,MIR155,C0040592,Tetracycline,DB00759,Trachoma,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31784,IDH2,C0750952,Fluorouracil,DB00544,Biliary Tract Cancer,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1789,Clofedanol,DB04837,Rhinorrhea,C1260880,Approved,CN(C)CCC(C1=CC=CC=C1)(C2=CC=CC=C2Cl)O},,Nervous system disease,,,,,,,,,,,,,,,,,,,CDKN2B,,,,,,,,
5617,Sofosbuvir,DB08934,"Hepatitis C, Chronic",C0524910,Approved,C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3},,Infectious disease,,,,,,,,,,,,,,,,,,,COL12A1,,,,,,,,
24783,GTF2I,C1527336,Prednisolone,DB00860,Sjogren's Syndrome,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35416,BCL2L11,C1720830,Mycophenolic acid,DB01024,Painful Bladder Syndrome,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
31095,CYBB,C0022661,Niacin,DB00627,"Kidney Failure, Chronic",Terminated,C1=CC(=CN=C1)C(=O)O},Phase 3,Urinary system disease,GP91-PHOX,NOX2,CGD,,,,,,,,,,,,,,,,,,,,,,,
16229,TLR5,C0041466,Ofloxacin,DB01165,Typhoid Fever,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,TIL3,MGC126430,MGC126431,SLEB1,,,,,,,,,,,,,,,,,,,,,,
32713,PLOD1,C0015944,Oxytocin,DB00107,"Fetal Membranes, Premature Rupture",Terminated,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
35319,SCT,C1262313,Micafungin,DB01141,Invasive Fungal Infections,Terminated,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)[C@@H](CC(=O)N)O)C)O)O)O},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
36654,CCN2,C0079218,Hydroxyurea,DB01005,"Fibromatosis, Aggressive",Withdrawn,C(=O)(N)NO},Phase 2,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12516,TXNIP,C0014179,Ertapenem,DB00303,Endometritis,Terminated,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)[C@@H](C)O},Phase 1,Reproductive system disease,VDUP1,EST01027,HHCPA78,THIF,ARRDC6,,,,,,,,,,,,,,,,,,,,,
23138,PRH1,C0033845,Thiopental,DB00599,Pseudotumor Cerebri,Approved,CCCC(C)C1(C(=O)NC(=S)NC1=O)CC},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15992,IL6,C0040425,Dirithromycin,DB00954,Tonsillitis,Approved,CC[C@@H]1[C@@]([C@H]2[C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)N(C)C)O)(C)O)C)N[C@H](O2)COCCOC)C)(C)O},,,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
26878,TNFAIP3,C0242647,Vincristine,DB00541,Mucosa-Associated Lymphoid Tissue Lymphoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,OTUD7C,,,,,,,,,,,,,,,,,,,,,,,,,
3561,Isoxsuprine,DB08941,Raynaud Disease,C0034734,Approved,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,ARSD,,,,,,,,
30595,MSH3,C0032580,Eflornithine,DB06243,Adenomatous Polyposis Coli,Terminated,C(CC(C(F)F)(C(=O)O)N)CN},Phase 2,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10779,DOCK3,C0155862,Troleandomycin,DB01361,Streptococcal pneumonia,Approved,C[C@@H]1C[C@@H]([C@H]([C@@H](O1)O[C@H]2[C@H](C[C@@]3(CO3)C(=O)[C@@H]([C@H]([C@H]([C@H](OC(=O)[C@@H]([C@H]([C@@H]2C)O[C@H]4C[C@@H]([C@H]([C@@H](O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15017,SPIN1,C0085159,Bupropion,DB01156,Seasonal Affective Disorder,Approved,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
34836,PTEN,C0030297,Gemcitabine,DB00441,Pancreatic Neoplasm,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1786,Clofedanol,DB04837,Nasal congestion (finding),C0027424,Approved,CN(C)CCC(C1=CC=CC=C1)(C2=CC=CC=C2Cl)O},,,,,,,,,,,,,,,,,,,,,CAV1,,,,,,,,
2339,Diflunisal,DB00861,Pain,C0030193,Approved,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O},,,,,,,,,,,,,,,,,,,,,TNFRSF1B,,,,,,,,
36427,HLA-DRB1,C0333875,Celecoxib,DB00482,High-Grade Squamous Intraepithelial Lesions,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2,Immune system disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
21697,LIG4,C0002453,Lisuride,DB00589,Amenorrhea,Approved,CCN(CC)C(=O)N[C@@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11963,CRP,C0024535,Sulfisoxazole,DB00263,"Malaria, Falciparum",Approved,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
27125,OPRM1,C0019196,Paroxetine,DB00715,Hepatitis C,Terminated,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4},Phase 2,Infectious disease,MOR1,,,,,,,,,,,,,,,,,,,,,,,,,
20903,TGFA,C0345904,Floxuridine,DB00322,Malignant neoplasm of liver,Approved,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)F)CO)O},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
35787,FTO,C0730345,Rimonabant,DB06155,Microalbuminuria,Terminated,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24872,MYH7,C0700053,Propranolol,DB00571,Idiopathic hypertrophic subaortic stenosis,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Vascular disease,CMD1S,CMH1,MPD1,,,,,,,,,,,,,,,,,,,,,,,
33160,MGME1,C1145670,Dexmedetomidine,DB00633,Respiratory Failure,Terminated,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 3,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14068,FCN2,C0035439,Triamcinolone,DB00620,Rheumatic Heart Disease,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Cardiovascular disease,P35,FCNL,EBP-37,ficolin-2,,,,,,,,,,,,,,,,,,,,,,
13275,HLA-DRB1,C0001403,Triamcinolone,DB00620,Addison Disease,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
23987,LSAMP,C0010418,Nitazoxanide,DB00507,Cryptosporidiosis,Approved,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]},,Infectious disease,IGLON3,,,,,,,,,,,,,,,,,,,,,,,,,
16007,ACLY,C1692886,Ceftriaxone,DB01212,"Arthritis, Bacterial",Approved,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O},,Infectious disease,ATPCL,CLATP,ACL,,,,,,,,,,,,,,,,,,,,,,,
1767,Clocortolone,DB00838,Contact Dermatitis,C0011616,Approved,C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)CO)C)O)Cl)C)F},,Immune system disease,,,,,,,,,,,,,,,,,,,SLC9A2,,,,,,,,
16736,ALDOB,C0027497,Haloperidol,DB00502,Nausea,Withdrawn,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F},Phase 0,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
24749,IL2RA,C0032533,Prednisone,DB00635,Polymyalgia Rheumatica,Terminated,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 3,Musculoskeletal disease,IL2R,IDDM10,,,,,,,,,,,,,,,,,,,,,,,,
15302,DMP1,C0035579,Calcitriol,DB00136,Rickets,Terminated,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},Phase 2,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
4033,Methoxsalen,DB00553,Vitiligo,C0042900,Approved,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2},,Skin disease,,,,,,,,,,,,,,,,,,,ASL,,,,,,,,
24816,VHL,C0018916,Propranolol,DB00571,Hemangioma,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20548,PROKR2,C0271578,Tranexamic Acid,DB00302,Female hypogonadism syndrome,Approved,C1CC(CCC1CN)C(=O)O},,Endocrine disease,GPR73b,PKR2,GPRg2,dJ680N4.3,GPR73L1,KAL3,,,,,,,,,,,,,,,,,,,,
34071,CYP27A1,C0029453,Cholecalciferol,DB00169,Osteopenia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 2/Phase 3,Musculoskeletal disease,CTX,CYP27,,,,,,,,,,,,,,,,,,,,,,,,
5066,Potassium Iodide,DB06715,Rhinorrhea,C1260880,Approved,[K+].[I-]},,Nervous system disease,,,,,,,,,,,,,,,,,,,SCARB2,,,,,,,,
36395,TSPAN2,C0751956,Nimodipine,DB00393,Acute Cerebrovascular Accidents,Withdrawn,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
591,Benzoyl peroxide,DB09096,Seborrheic dermatitis,C0036508,Approved,C1=CC=C(C=C1)C(=O)OOC(=O)C2=CC=CC=C2},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,Estradiol,,,,,,,,
7667,ERCC3,C0015230,Zinc oxide,DB09321,Exanthema,Approved,O=[Zn]},,Infectious disease,0,,,,,,,,,,,,,,,,,WDR72,,,,,,,,
35220,FOLR2,C0012813,Mesalazine,DB00244,Diverticulitis,Terminated,C1=CC(=C(C=C1N)C(=O)O)O},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
29354,PTGS2,C1332166,Paclitaxel,DB01229,Adenocarcinoma of the gastroesophageal junction,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1/Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
9307,Topiramate,DB00273,Hyperlipidemia,C0020473,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
13763,CFLAR,C0019829,Tacrolimus,DB00864,Hodgkin Disease,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10579,SLC8A3,C0038220,Secobarbital,DB00418,Status Epilepticus,Approved,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20734,SLC34A2,C0085681,Sevelamer,DB00658,Hyperphosphatemia (disorder),Terminated,C=CCN.C1C(O1)CCl},Phase 3,Endocrine and metabolic disease,NAPI-3B,,,,,,,,,,,,,,,,,,,,,,,,,
10562,GNAO1,C0014544,Zonisamide,DB00909,Epilepsy,Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 3,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
55,Acrivastine,DB09488,Nasal congestion (finding),C0027424,Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC(=N3)/C=C/C(=O)O},,,,,,,,,,,,,,,,,,,,,Amiloride,,,,,,,,
23325,TNF,C0042900,Tacrolimus,DB00864,Vitiligo,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Skin disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
6673,FOXC1,C0017612,Unoprostone,DB06826,"Glaucoma, Open-Angle",Approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},,Nervous system disease,FREAC3,IGDA,IHG1,FKHL7,IRID1,,,,,,,,,,,,,CHN2,,,,,,,,
175,Amikacin,DB00479,Pneumonia due to Gram negative bacteria,C0854248,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},,Infectious disease,,,,,,,,,,,,,,,,,,,BRCA2,,,,,,,,
9280,CP,C0015371,Trihexyphenidyl,DB00376,Extrapyramidal Disorders,Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
23326,CASP7,C0042900,Tacrolimus,DB00864,Vitiligo,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31277,GSTP1,C0220624,Erlotinib,DB00530,adult brain tumor,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13998,ALB,C0027726,Triamcinolone,DB00620,Nephrotic Syndrome,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
21047,NR3C1,C2267227,Acetylcysteine,DB06151,Bulimia Nervosa,Terminated,CC(=O)N[C@@H](CS)C(=O)O},Phase 3,Mental and behavioural disorder,GR,GRL,,,,,,,,,,,,,,,,,,,,,,,,
17505,ANOS1,C1384606,Ospemifene,DB04938,Dyspareunia,Approved,C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\C3=CC=C(C=C3)OCCO)/CCCl},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4056,Methylprednisolone,DB00959,Adrenal cortical hypofunction,C0405580,Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O},,Endocrine disease,,,,,,,,,,,,,,,,,,,SMAD2,,,,,,,,
14156,CCN2,C0039503,Ketoprofen,DB01009,Tendinitis,Terminated,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O},Phase 3,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23482,SCO1,C0023886,Tinidazole,DB00911,"Liver Abscess, Amebic",Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28645,AQP2,C1565489,Simeprevir,DB06290,Renal Insufficiency,Withdrawn,CC1=C(C=CC2=C1N=C(C=C2O[C@@H]3C[C@@H]4[C@@H](C3)C(=O)N(CCCC/C=C\\[C@@H]5C[C@]5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC},Phase 2,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,
16367,FYB1,C0024537,Primaquine,DB01087,"Malaria, Vivax",Approved,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18147,FUS,C0553580,Vincristine,DB00541,Ewings sarcoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36566,IREB2,C0012715,Deferasirox,DB01609,Iron Metabolism Disorders,Withdrawn,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1203,Cefoxitin,DB01331,Escherichia coli urinary tract infection,C0577708,Approved,CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3},,Infectious disease,,,,,,,,,,,,,,,,,,,Phendimetrazine,,,,,,,,
12651,MFN1,C0035455,Sodium Citrate,DB09154,Rhinitis,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4322,Moxisylyte,DB09205,Erectile dysfunction,C0242350,Approved,CC1=CC(=C(C=C1OC(=O)C)C(C)C)OCCN(C)C},,Reproductive system disease,,,,,,,,,,,,,,,,,,,DEF6,,,,,,,,
24198,CLCA4,C0267963,Pancrelipase,DB00085,Exocrine pancreatic insufficiency,Approved,C1CC2C(C(C1O2)C(=O)[O-])C(=O)[O-].[Na+].[Na+]},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33640,CEBPB,C0206638,Zoledronic acid,DB00399,Giant Cell Tumor of Bone,Terminated,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},Phase 2,Cancer,NFIL6,IL6DBP,C/EBP-beta,TCF5,,,,,,,,,,,,,,,,,,,,,,
29080,MIA3,C1956346,Heparin,DB01109,Coronary Artery Disease,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11932,CEBPA,C0023487,Tretinoin,DB00755,Acute Promyelocytic Leukemia,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Cancer,C/EBP-alpha,CEBP,,,,,,,,,,,,,,,,,,,,,,,,
14644,PNPLA3,C0524910,Cyclosporine,DB00091,"Hepatitis C, Chronic",Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 3,Infectious disease,dJ796I17.1,FLJ22012,adiponutrin,iPLA2epsilon,C22orf20,ADPN,,,,,,,,,,,,,,,,,,,,
10698,PDR,C0031350,Tetracycline,DB00759,Pharyngitis,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3754,Liothyronine,DB00279,Hypothyroidism,C0020676,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Endocrine disease,,,,,,,,,,,,,,,,,,,DAG1,,,,,,,,
12888,MEFV,C0038395,Procaine benzylpenicillin,DB09320,Streptococcal Infections,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,FMF,TRIM20,,,,,,,,,,,,,,,,,,,,,,,,
5820,Terazosin,DB01162,Prostatic Hypertrophy,C1739363,Approved,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC},,,,,,,,,,,,,,,,,,,,,KAT6B,,,,,,,,
7887,GTF2H1,C0029401,Zoledronic acid,DB00399,Osteitis Deformans,Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19224,TLR7,C0751967,Mitoxantrone,DB01204,"Multiple Sclerosis, Relapsing-Remitting",Approved,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
13399,ESD,C1761609,Triamcinolone,DB00620,Aspiration pneumonitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3173,Gentamicin,DB00798,Folliculitis,C0016436,Approved,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC},,Skin disease,,,,,,,,,,,,,,,,,,,ITGA2B,,,,,,,,
20184,F9,C0002792,Epinephrine,DB00668,anaphylaxis,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27092,LDB3,C2921627,Prednisolone,DB00860,Clinically isolated syndrome,Suspended,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Congenital malformation,PDLIM6,KIAA0613,ZASP,CMD1C,,,,,,,,,,,,,,,,,,,,,,
14414,XRCC3,C0278996,Methotrexate,DB00563,Cancer of Head and Neck,Approved,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17951,ALK,C0027819,Topotecan,DB01030,Neuroblastoma,Withdrawn,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17422,IL1B,C0022729,Colistin,DB00803,Klebsiella Infections,Approved,CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)[C@@H](C)O},,Infectious disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
2790,Ezetimibe,DB00973,"Hyperlipidemia, Familial Combined",C0020474,Approved,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O},,Metabolic disease,,,,,,,,,,,,,,,,,,,CA9,,,,,,,,
32865,IL37,C1290884,Prednisone,DB00635,Inflammatory disorder,Terminated,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18184,ETFA,C1135868,Vinblastine,DB00570,Gestational Trophoblastic Neoplasms,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34990,MOK,C0085278,Hydroxychloroquine,DB01611,Antiphospholipid Syndrome,Terminated,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO},Phase 3,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28432,HBG2,C1292772,Sunitinib,DB01268,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,HBG-T1,,,,,,,,,,,,,,,,,,,,,,,,,
5291,Procaine benzylpenicillin,DB09320,Infection of skin AND/OR subcutaneous tissue,C0178299,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,TIMM10,,,,,,,,
9183,SERPINE1,C0030920,Sodium Citrate,DB09154,Peptic Ulcer,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Digestive system disease,PAI,PLANH1,PAI1,,,,,,,,,,,,,,,,,,,,,,,
16431,CDKN2A,C0027498,Ondansetron,DB00904,Nausea and vomiting,Withdrawn,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C},Phase 3,Digestive system disease,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
20180,BTK,C0002792,Epinephrine,DB00668,anaphylaxis,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Immune system disease,ATK,XLA,PSCTK1,AGMX1,IMD1,,,,,,,,,,,,,,,,,,,,,
8291,TNF,C1262211,Ranolazine,DB00243,Diarrhoea predominant irritable bowel syndrome,Terminated,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O},Phase 2/Phase 3,Digestive system disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
23029,PTEN,C0006118,Lomustine,DB01206,Brain Neoplasms,Approved,C1CCC(CC1)NC(=O)N(CCCl)N=O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2719,Erythromycin,DB00199,Pertussis,C0043167,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,RAD51D,,,,,,,,
20892,DUSP1,C0184567,Floctafenine,DB08976,Acute onset pain,Approved,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC=C(C3=NC=C2)C(F)(F)F},,,HVH1,CL100,MKP-1,PTPN10,,,,,,,,,,,,,,,,,,,,,,
24397,SLC7A13,C0010691,Tiopronin,DB06823,Cystinuria,Approved,CC(C(=O)NCC(=O)O)S},,Congenital disorder of metabolism,AGT-1,XAT2,,,,,,,,,,,,,,,,,,,,,,,,
24643,TLR9,C0004031,Prednisolone,DB00860,"Aspergillosis, Allergic Bronchopulmonary",Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Infectious disease,CD289,,,,,,,,,,,,,,,,,,,,,,,,,
23569,SNCA,C0020651,Midodrine,DB00211,"Hypotension, Orthostatic",Approved,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O},,Cardiovascular disease,NACP,PARK1,PARK4,,,,,,,,,,,,,,,,,,,,,,,
14043,RUNX2,C2894027,Triamcinolone,DB00620,Post traumatic osteoarthritis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,AML3,PEBP2A1,PEBP2aA1,CCD,CBFA1,CCD1,,,,,,,,,,,,,,,,,,,,
7543,IL22,C0406317,Ulobetasol,DB00596,Chronic small plaque psoriasis,Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Skin disease,ILTIF,zcyto18,IL-TIF,IL-D110,TIFa,TIFIL-23,MGC79382,MGC79384,,,,,,,,,,EPB41L2,,,,,,,,
18060,LMNA,C0022575,Cyclosporine,DB00091,Keratoconjunctivitis Sicca,Approved,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},,Infectious disease,LMN1,CMD1A,LGMD1B,,,,,,,,,,,,,,,,,,,,,,,
5020,Pitavastatin,DB08860,"Hyperlipidemia, Familial Combined",C0020474,Approved,C1CC1C2=NC3=CC=CC=C3C(=C2/C=C/[C@H](C[C@H](CC(=O)O)O)O)C4=CC=C(C=C4)F},,Metabolic disease,,,,,,,,,,,,,,,,,,,BCL11B,,,,,,,,
31384,SSTR3,C0206754,Sunitinib,DB01268,Neuroendocrine Tumors,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11351,RNF168,C0035021,Tetracycline,DB00759,Relapsing Fever,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29925,AR,C0007112,Prednisone,DB00635,Adenocarcinoma of prostate,Withdrawn,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 2,Cancer,AIS,NR3C4,SMAX1,HUMARA,DHTR,SBMA,,,,,,,,,,,,,,,,,,,,
8527,Pegfilgrastim,DB00019,Thalassemia,C0039730,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
35258,KCNJ10,C0018784,Methotrexate,DB00563,Sensorineural Hearing Loss (disorder),Terminated,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 3,Cardiovascular disease,Kir4.1,Kir1.2,,,,,,,,,,,,,,,,,,,,,,,,
36002,TGFB3,C0085119,Treprostinil,DB00374,Foot Ulcer,Terminated,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
4807,Penicillamine,DB00859,Hepatolenticular Degeneration,C0019202,Approved,CC(C)([C@H](C(=O)O)N)S},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,ACP1,,,,,,,,
10099,HLA-DQB1,C0004096,Zafirlukast,DB00549,Asthma,Approved,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC},,Immune system disease,HLA-DQB,,,,,,,,,,,,,,,,,,,,,,,,,
11236,SCLT1,C0006849,Nystatin,DB00646,Oral candidiasis,Approved,C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/C(CC2C(C(C[C@](O2)(CC(C(CCC(CC(CC(CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29122,HMGA2,C0280483,Irinotecan,DB00762,adult anaplastic astrocytoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,BABL,LIPO,HMGIC,,,,,,,,,,,,,,,,,,,,,,,
14146,IL1RN,C0039103,Triamcinolone,DB00620,Synovitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,ICIL-1RA,IL1F3,IL-1RN,MGC10430,,,,,,,,,,,,,,,,,,,,,,
29043,HTR1B,C0600427,Vigabatrin,DB01080,Cocaine Dependence,Terminated,C=CC(CCC(=O)O)N},Phase 2,Mental and behavioural disorder,5-HT1B,HTR1D2,5-HT1DB,,,,,,,,,,,,,,,,,,,,,,,
34060,APC,C0850572,Salicylic acid,DB00936,Adenomatous polyp of colon,Terminated,C1=CC=C(C(=C1)C(=O)O)O},Phase 3,Digestive system disease,DP2.5,PPP1R46,,,,,,,,,,,,,,,,,,,,,,,,
36634,TNF,C0079218,Hydroxyurea,DB01005,"Fibromatosis, Aggressive",Withdrawn,C(=O)(N)NO},Phase 2,Musculoskeletal disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
14777,MBD2,C0023472,Nilotinib,DB04868,"Leukemia, Myeloid, Accelerated Phase",Approved,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
27989,DCC,C0014859,Fluorouracil,DB00544,Esophageal Neoplasms,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36528,LAMC2,C0393819,Cyclophosphamide,DB00531,"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",Withdrawn,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 2,Nervous system disease,nicein-100kDa,kalinin-105kDa,BM600-100kDa,EBR2,LAMB2T,LAMNB2,EBR2A,,,,,,,,,,,,,,,,,,,
31533,PIK3CD,C3495917,Exemestane,DB00990,Advanced breast cancer,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
21441,EGFR,C0016436,Gentamicin,DB00798,Folliculitis,Approved,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC},,Skin disease,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
35305,NGF,C0017658,Prednisolone,DB00860,Glomerulonephritis,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 3,Urinary system disease,NGFB,,,,,,,,,,,,,,,,,,,,,,,,,
18273,MMP1,C0016034,Danazol,DB01406,Breast Fibrocystic Disease,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5},,Other disease,,,,,,,,,,,,,,,,,,,,,,,,,,
5747,Sulfur,DB09353,Seborrheic dermatitis,C0036508,Approved,[S]},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,SYNM,,,,,,,,
24227,IL1RN,C0917798,Phentolamine,DB00692,Cerebral Ischemia,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cardiovascular disease,ICIL-1RA,IL1F3,IL-1RN,MGC10430,,,,,,,,,,,,,,,,,,,,,,
33070,SLITRK4,C2076600,Rosuvastatin,DB01098,Influenza due to Influenza A virus subtype H1N1,Terminated,CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32077,STAT3,C0023903,Sirolimus,DB00877,Liver neoplasms,Withdrawn,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,APRF,,,,,,,,,,,,,,,,,,,,,,,,,
6589,Fludarabine,DB01073,Mycosis fungoides/Sezary syndrome recurrent,C0862200,Suspended,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,RBP4,,,,,,,,
11382,DNAAF1,C0037199,Pseudoephedrine,DB00852,Sinusitis,Withdrawn,C[C@@H]([C@H](C1=CC=CC=C1)O)NC},Phase 2,Infectious disease,FLJ25330,ODA7,CILD13,swt,LRRC50,,,,,,,,,,,,,,,,,,,,,
26982,MS4A1,C0349632,Vincristine,DB00541,Splenic Marginal Zone B-Cell Lymphoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,Bp35,MS4A2,CD20,,,,,,,,,,,,,,,,,,,,,,,
9956,Voriconazole,DB00582,Aspergillosis,C0004030,Withdrawn,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
15434,KCNJ5,C0020621,Potassium Citrate,DB09125,Hypokalemia,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6862,SCNN1A,C0006267,Pirbuterol,DB01291,Bronchiectasis,Approved,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O},,Respiratory disease,ENaCalpha,SCNN1,,,,,,,,,,,,,,,,DUSP5,,,,,,,,
24995,IL18R1,C0040558,Sulfamethoxazole,DB01015,Toxoplasmosis,Approved,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,IL1RRP,IL-1Rrp,CD218a,,,,,,,,,,,,,,,,,,,,,,,
34993,IL4,C0151526,Progesterone,DB00396,Premature Birth,Terminated,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},Phase 3,,BSF1,IL-4,BCGF1,BCGF-1,MGC79402,,,,,,,,,,,,,,,,,,,,,
34453,VSX1,C0010034,Cyclosporine,DB00091,Corneal Diseases,Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
3434,Hyoscyamine,DB00424,Dysuria,C0013428,Approved,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3},,Urinary system disease,,,,,,,,,,,,,,,,,,,CDK8,,,,,,,,
13482,IL1B,C0006444,Ketoprofen,DB01009,Bursitis,Terminated,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O},Phase 3,Musculoskeletal disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
15171,PRL,C0009088,Sumatriptan,DB00669,Cluster Headache,Approved,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C},,,,,,,,,,,,,,,,,,,,,,,,,,,,
27645,PPARG,C0524620,Topiramate,DB00273,Metabolic Syndrome X,Suspended,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Endocrine and metabolic disease,PPARG1,PPARG2,NR1C3,PPARgamma,,,,,,,,,,,,,,,,,,,,,,
36440,NOS2,C0333875,Celecoxib,DB00482,High-Grade Squamous Intraepithelial Lesions,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2,Immune system disease,iNOS,HEP-NOS,NOS2A,,,,,,,,,,,,,,,,,,,,,,,
16448,CTLA4,C0027498,Ondansetron,DB00904,Nausea and vomiting,Withdrawn,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C},Phase 3,Digestive system disease,CD152,CELIAC3,IDDM12,,,,,,,,,,,,,,,,,,,,,,,
21892,HBE1,C0002895,Hydroxyurea,DB01005,"Anemia, Sickle Cell",Approved,C(=O)(N)NO},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27263,FLI1,C0281508,Vitamin C,DB00126,Desmoplastic Small Round Cell Tumor,Suspended,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O},Phase 2,Cancer,SIC-1,,,,,,,,,,,,,,,,,,,,,,,,,
16163,SLC2A4RG,C0035585,Fusidic Acid,DB02703,Rickettsia Infections,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
254,Amoxicillin,DB01060,Staphylococcal pharyngitis,C0275794,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Cefamandole,,,,,,,,
13722,IL17A,C0014742,Triamcinolone,DB00620,Erythema Multiforme,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
4601,Ofloxacin,DB01165,Malignant otitis externa due to Pseudomonas aeruginosa,C0395818,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,HOGA1,,,,,,,,
24049,IGF1,C0024586,Somatostatin,DB09099,Malignant Carcinoid Syndrome,Terminated,C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=CC=C6)O},Phase 2,Cancer,IGF1A,IGFI,IGF-I,IGF,,,,,,,,,,,,,,,,,,,,,,
32654,VHL,C0206695,Octreotide,DB00104,"Carcinoma, Neuroendocrine",Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15106,RNF19A,C0474368,Prednisolone,DB00860,Labor Pain,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 0,,0,,,,,,,,,,,,,,,,,,,,,,,,,
8304,CNR1,C1262211,Ranolazine,DB00243,Diarrhoea predominant irritable bowel syndrome,Terminated,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O},Phase 2/Phase 3,Digestive system disease,CB1K5,CB-R,CB1,CANN6,CB1A,CNR,,,,,,,,,,,,,,,,,,,,
668,Betamethasone,DB00443,Allergic rhinitis (disorder),C2607914,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Immune system disease,,,,,,,,,,,,,,,,,,,Flurbiprofen,,,,,,,,
27579,POMC,C2937358,Fluoxetine,DB00472,Cerebral Hemorrhage,Terminated,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F},Phase 3,Cardiovascular disease,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
1878,Cortisone acetate,DB01380,Autoimmune hemolytic anemia,C0002880,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Hematologic disease,,,,,,,,,,,,,,,,,,,SCNN1G,,,,,,,,
18593,FCN2,C0019156,Defibrotide,DB04932,Hepatic Veno-Occlusive Disease,Approved,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O},,Liver disease,P35,FCNL,EBP-37,ficolin-2,,,,,,,,,,,,,,,,,,,,,,
31473,PTEN,C0349604,Sirolimus,DB00877,Intracranial Meningioma,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
18536,SEA,C0005283,Deferiprone,DB08826,beta Thalassemia,Approved,CC1=C(C(=O)C=CN1C)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18462,UBE2T,C0023465,Daunorubicin,DB00694,Acute monocytic leukemia,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30495,DNM2,C0031117,Capsaicin,DB06774,Peripheral Neuropathy,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 3,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22450,COL4A1,C0007820,Tolazoline,DB00797,Cerebrovascular Disorders,Approved,C1CN=C(N1)CC2=CC=CC=C2},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
7676,PTPN22,C0015230,Zinc oxide,DB09321,Exanthema,Approved,O=[Zn]},,Infectious disease,Lyp,Lyp1,Lyp2,PTPN8,,,,,,,,,,,,,,BCAR3,,,,,,,,
31678,CXCL8,C0006271,Fluticasone Propionate,DB00588,Bronchiolitis,Terminated,CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF},Phase 2,Lung disease,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
14964,DTNBP1,C0524662,Naloxone,DB01183,Opiate Addiction,Approved,C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
8584,SMAD6,C0003492,Alprostadil,DB00770,Aortic coarctation,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Cardiovascular disease,HsT17432,,,,,,,,,,,,,,,,,,,,,,,,,
5584,Sitagliptin,DB01261,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,Approved,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N},,Endocrine disease,,,,,,,,,,,,,,,,,,,LINC00477,,,,,,,,
34501,GALNS,C0037278,Vancomycin,DB00512,"Skin Diseases, Infectious",Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7239,LRRC56,C1260880,Xylometazoline,DB06694,Rhinorrhea,Approved,CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C},,Nervous system disease,0,,,,,,,,,,,,,,,,,C11orf95,,,,,,,,
18384,SNCA,C0085606,Trospium,DB00209,Urgency of micturition,Approved,C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O},,,NACP,PARK1,PARK4,,,,,,,,,,,,,,,,,,,,,,,
18496,LPAR2,C0036220,Vinblastine,DB00570,Kaposi Sarcoma,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29947,CLU,C0007112,Prednisone,DB00635,Adenocarcinoma of prostate,Withdrawn,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 2,Cancer,SGP-2,SP-40,TRPM-2,KUB1,CLU2,CLI,APOJ,,,,,,,,,,,,,,,,,,,
14357,LRRK2,C0009806,Oxycodone,DB00497,Constipation,Terminated,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O},Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10396,PTPN22,C0002962,Verapamil,DB00661,Angina Pectoris,Approved,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},,Cardiovascular disease,Lyp,Lyp1,Lyp2,PTPN8,,,,,,,,,,,,,,,,,,,,,,
32734,RSPO1,C0553723,Paclitaxel,DB01229,Squamous cell carcinoma of skin,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,FLJ40906,RSPONDIN,,,,,,,,,,,,,,,,,,,,,,,,
21155,SLC2A1,C2936781,Fluoxymesterone,DB01185,Generalized Myotonia of Thomsen,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F},,Musculoskeletal disease,DYT18,DYT9,GLUT1,GLUT,HTLVR,CSE,,,,,,,,,,,,,,,,,,,,
12167,MTTP,C0342881,Simvastatin,DB00641,Familial hypercholesterolemia - homozygous,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Inherited metabolic disease,MTP,,,,,,,,,,,,,,,,,,,,,,,,,
29564,PTGS2,C0007114,Fludarabine,DB01073,Malignant neoplasm of skin,Terminated,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 1/Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
5580,Simvastatin,DB00641,Hypoalphalipoproteinemias,C0473527,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,COG5,,,,,,,,
16373,ANGPT2,C0024537,Primaquine,DB01087,"Malaria, Vivax",Approved,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2},,Infectious disease,Ang2,,,,,,,,,,,,,,,,,,,,,,,,,
4622,Ofloxacin,DB01165,Streptococcus pyogenes infection,C0554628,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,MUC16,,,,,,,,
36961,IFNA2,C0279084,Sunitinib,DB01268,Kaposi's sarcoma classical type,Withdrawn,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3068,Fusidic Acid,DB02703,Lymphogranuloma Venereum,C0024286,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,SCYL1,,,,,,,,
8652,Sunitinib,DB01268,cognitive/functional effects,C0935657,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
23938,SFTPC,C0085786,Warfarin,DB00682,Hamman-Rich syndrome,Terminated,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},Phase 3,Lung disease,SP-C,PSP-C,SMDP2,BRICD6,SFTP2,,,,,,,,,,,,,,,,,,,,,
31119,CEACAM5,C0742558,Doxorubicin,DB00997,colon cancer liver metastasis,Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},Phase 2,Cancer,CD66e,,,,,,,,,,,,,,,,,,,,,,,,,
36508,SMUG1,C0019621,Clofarabine,DB00631,"Histiocytosis, Langerhans-Cell",Withdrawn,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32621,CSTA,C0042344,Nitric Oxide,DB00435,Varicose Ulcer,Terminated,[N]=O},Phase 2,Reproductive system disease,STF1,STFA,,,,,,,,,,,,,,,,,,,,,,,,
34853,CD44,C0030297,Gemcitabine,DB00441,Pancreatic Neoplasm,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 3,Cancer,IN,MC56,Pgp1,CD44R,HCELL,CSPG8,MIC4,MDU2,MDU3,,,,,,,,,,,,,,,,,
3627,L-Serine,DB00133,"Tuberculosis, Pulmonary",C0041327,Approved,C([C@@H](C(=O)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,BMP4,,,,,,,,
32078,TNF,C0023903,Sirolimus,DB00877,Liver neoplasms,Withdrawn,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
22312,SEMA3A,C0035435,Indomethacin,DB00328,Rheumatism,Approved,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
940,Carbinoxamine,DB00748,Allergic Conjunctivitis,C0009766,Approved,CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2},,Immune system disease,,,,,,,,,,,,,,,,,,,ACTR1A,,,,,,,,
21252,IL13,C0155877,Zileuton,DB00744,Allergic asthma,Approved,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O},,Immune system disease,P600,IL-13,ALRH,BHR1,MGC116786,MGC116788,MGC116789,,,,,,,,,,,,,,,,,,,
10645,CAV1,C0343378,Clarithromycin,DB01211,Helicobacter-associated gastritis,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O},,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
22639,SLC26A3,C0036992,Glucagon recombinant,DB00040,Short Bowel Syndrome,Terminated,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CNC=N7)N)O},Phase 1/Phase 2,,DRA,CLD,,,,,,,,,,,,,,,,,,,,,,,,
35749,NEFL,C0038868,Rasagiline,DB01367,Progressive supranuclear palsy,Terminated,C#CCN[C@@H]1CCC2=CC=CC=C12},Phase 3,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10941,SPTBN5,C0877445,Voriconazole,DB00582,Candidemia,Approved,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8351,Lidocaine,DB00281,Chronic pain,C0150055,Terminated,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
25037,SOD1,C0002736,Pioglitazone,DB01132,Amyotrophic Lateral Sclerosis,Terminated,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3},Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19828,MIR6500,C0235480,Propafenone,DB01182,Paroxysmal atrial fibrillation,Approved,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
23164,SMC4,C0040954,Thiabendazole,DB00730,Infection by Trichuris trichiura,Approved,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3978,Meropenem,DB00760,Infection due to Pseudomonas aeruginosa,C0276075,Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,PRKD2,,,,,,,,
35633,SERPINA5,C1536220,Ticagrelor,DB08816,ST segment elevation myocardial infarction,Terminated,CCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)OCCO)N[C@@H]4C[C@H]4C5=CC(=C(C=C5)F)F},Phase 3,Cardiovascular disease,PAI3,PROCI,PLANH3,PCI,,,,,,,,,,,,,,,,,,,,,,
24108,CTLA4,C0036323,Praziquantel,DB01058,Schistosomiasis,Approved,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2},,Mental and behavioural disorder,CD152,CELIAC3,IDDM12,,,,,,,,,,,,,,,,,,,,,,,
25186,GATA2,C0027022,Vidarabine,DB00194,Myeloproliferative disease,Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 2,Cancer,NFE1B,,,,,,,,,,,,,,,,,,,,,,,,,
30881,MSX1,C0162429,Nandrolone phenpropionate,DB00984,Malnutrition,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CC[C@H]35},Phase 2,Cancer,HYD1,OFC5,HOX7,,,,,,,,,,,,,,,,,,,,,,,
33651,VDR,C0206638,Zoledronic acid,DB00399,Giant Cell Tumor of Bone,Terminated,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},Phase 2,Cancer,NR1I1,PPP1R163,,,,,,,,,,,,,,,,,,,,,,,,
9964,IL36G,C0854248,Amikacin,DB00479,Pneumonia due to Gram negative bacteria,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9118,Methylphenidate,DB00422,Asthenia,C0004093,Terminated,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},Phase 3,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
25845,PTGS2,C0005684,Mitomycin,DB00305,Malignant neoplasm of urinary bladder,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
2628,Ephedrine,DB01364,Influenza-like symptoms,C0392171,Approved,C[C@@H]([C@@H](C1=CC=CC=C1)O)NC},,Infectious disease,,,,,,,,,,,,,,,,,,,Nitrendipine,,,,,,,,
1253,Cefprozil,DB01150,Infection of skin AND/OR subcutaneous tissue,C0178299,Approved,C/C=C/C1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Pralidoxime,,,,,,,,
7613,IL5,C0011615,Triamcinolone,DB00620,"Dermatitis, Atopic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,IL-5,EDF,,,,,,,,,,,,,,,,PGPEP1,,,,,,,,
9318,Trimethoprim,DB00440,Pneumocystis jiroveci pneumonia,C1535939,Terminated,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
15418,CLCN2,C0020621,Potassium Citrate,DB09125,Hypokalemia,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24742,PTPN22,C0032533,Prednisone,DB00635,Polymyalgia Rheumatica,Terminated,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 3,Musculoskeletal disease,Lyp,Lyp1,Lyp2,PTPN8,,,,,,,,,,,,,,,,,,,,,,
22078,IL5,C0346421,Imatinib,DB00619,Chronic eosinophilic leukemia,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,IL-5,EDF,,,,,,,,,,,,,,,,,,,,,,,,
13886,CBS,C0024305,Vidarabine,DB00194,"Lymphoma, Non-Hodgkin",Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 3,Cancer,HIP4,,,,,,,,,,,,,,,,,,,,,,,,,
34634,PDCD1,C0744619,Gefitinib,DB00317,Head and neck cancer metastatic,Terminated,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4},Phase 3,Cancer,CD279,hSLE1,PD-1,SLEB2,,,,,,,,,,,,,,,,,,,,,,
12693,ABCB1,C0206525,Bedaquiline,DB08903,"Tuberculosis, Drug-Resistant",Approved,CN(C)CC[C@@](C1=CC=CC2=CC=CC=C21)([C@H](C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O},,Infectious disease,P-gp,CD243,GP170,ABC20,PGY1,CLCS,,,,,,,,,,,,,,,,,,,,
32208,INTS13,C1370419,Ketoconazole,DB01026,Granulosa cell tumor of the ovary,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4368,Naproxen,DB00788,Pain,C0030193,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,,,,,,,,,,,,,,,,,,,,HLA-DMB,,,,,,,,
34923,ESRRA,C0025517,Heparin,DB01109,Metabolic Diseases,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18664,F9,C0042974,Desmopressin,DB00035,von Willebrand Disease,Approved,C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11619,EZR,C0013371,Trimethoprim,DB00440,Shigella Infections,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,VIL2,,,,,,,,,,,,,,,,,,,,,,,,,
18983,F3,C0040053,Warfarin,DB00682,Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16421,MAOA,C0012734,Promazine,DB00420,Disruptive Behavior Disorder,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
26462,DYRK2,C0278517,Pemetrexed,DB00642,Non-small cell lung cancer recurrent,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
7085,CEACAM5,C0019348,Aciclovir,DB00787,Herpes Simplex Infections,Approved,C1=NC2=C(N1COCCO)N=C(NC2=O)N},,Infectious disease,CD66e,,,,,,,,,,,,,,,,,RPP21,,,,,,,,
9234,Quetiapine,DB01224,Delirium,C0011206,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,
3382,Hydrocortisone,DB00741,Rosacea,C0035854,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,Skin disease,,,,,,,,,,,,,,,,,,,MIR211,,,,,,,,
14335,COL11A2,C0936223,Nilutamide,DB00665,Metastatic Prostate Carcinoma,Approved,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C},,Cancer,HKE5,DFNA13,DFNB53,,,,,,,,,,,,,,,,,,,,,,,
33563,PTGS2,C0004153,Simvastatin,DB00641,Atherosclerosis,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
23114,SLC9A3,C0010674,Amikacin,DB00479,Cystic Fibrosis,Withdrawn,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},Phase 3,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
21074,PUM1,C0010417,Testosterone Propionate,DB01420,Cryptorchidism,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
35786,PRCD,C0730345,Rimonabant,DB06155,Microalbuminuria,Terminated,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28105,STK33,C0345958,Paclitaxel,DB01229,Large cell carcinoma of lung,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33409,DRD2,C0687132,Topiramate,DB00273,heavy drinking,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 2,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
6110,Triamcinolone,DB00620,Angioedema,C0002994,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,NPR3,,,,,,,,
24962,GYPC,C0024530,Prednisone,DB00635,Malaria,Withdrawn,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 3,Infectious disease,GPC,GYPD,Ge,CD236,CD236R,,,,,,,,,,,,,,,,,,,,,
22828,NEFH,C0010308,Liothyronine,DB00279,Congenital Hypothyroidism,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
22029,IGHG1,C0855095,Idelalisib,DB09054,Small Lymphocytic Lymphoma,Approved,CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
14240,CRYAA,C0028840,Unoprostone,DB06826,Ocular Hypertension,Approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20559,MEN1,C0271578,Tranexamic Acid,DB00302,Female hypogonadism syndrome,Approved,C1CC(CCC1CN)C(=O)O},,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,
25357,SLC25A13,C0175683,Sodium phenylbutyrate,DB06819,Citrullinemia,Approved,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
1724,Clavulanate,DB00766,Streptococcal pneumonia,C0155862,Approved,C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,GABRA5,,,,,,,,
15954,AMOT,C0153633,Carmustine,DB00262,Malignant neoplasm of brain,Approved,C(CCl)NC(=O)N(CCCl)N=O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11845,PTCHD1,C0004352,Risperidone,DB00734,Autistic Disorder,Approved,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
20023,ITIH2,C0271093,Echothiophate,DB01057,Stargardt's disease,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1312,Ceftazidime,DB00438,Neonatal meningitis,C0456107,Approved,CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,Rabeprazole,,,,,,,,
21,Acetaminophen,DB00316,Pain,C0030193,Approved,CC(=O)NC1=CC=C(C=C1)O},,,,,,,,,,,,,,,,,,,,,Adenosine monophosphate,,,,,,,,
5836,Terconazole,DB00251,"Candidiasis, Vulvovaginal",C0700345,Approved,CC(C)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,FRAXA,,,,,,,,
7377,HMOX1,C0162568,Afamelanotide,DB04931,Erythropoietic Protoporphyria,Approved,CCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N5CCC[C@H]5C(=O)N[C@@H](C(C)C)C(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CC=C(C=C6)O)NC(=O)[C@H](CO)NC(=O)C},,Congenital disorder of metabolism,bK286B10,HO-1,,,,,,,,,,,,,,,,HBZ,,,,,,,,
12763,TBXA2R,C0034065,Edoxaban,DB09075,Pulmonary Embolism,Approved,CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27838,C9orf72,C0085633,Atomoxetine,DB00289,Mood swings,Terminated,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
8123,Galantamine,DB00674,Traumatic Brain Injury,C0876926,Terminated,CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26850,IGHV3OR16-7,C0855139,Vincristine,DB00541,Monocytoid B-cell lymphoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
6088,Tranilast,DB07615,Asthma,C0004096,Approved,COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC},,Immune system disease,,,,,,,,,,,,,,,,,,,TSHB,,,,,,,,
656,Benzylpenicillin,DB01053,Upper Respiratory Infections,C0041912,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,DSP,,,,,,,,
4074,Methylprednisolone,DB00959,Contact Dermatitis,C0011616,Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O},,Immune system disease,,,,,,,,,,,,,,,,,,,NR5A1,,,,,,,,
11239,HTN3,C0006849,Nystatin,DB00646,Oral candidiasis,Approved,C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/C(CC2C(C(C[C@](O2)(CC(C(CCC(CC(CC(CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12303,TNF,C0003873,Thalidomide,DB01041,Rheumatoid Arthritis,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Immune system disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
21221,PROKR2,C0151721,Testosterone Propionate,DB01420,Testicular hypogonadism,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Reproductive system disease,GPR73b,PKR2,GPRg2,dJ680N4.3,GPR73L1,KAL3,,,,,,,,,,,,,,,,,,,,
19199,APOE,C0751967,Mitoxantrone,DB01204,"Multiple Sclerosis, Relapsing-Remitting",Approved,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},,Nervous system disease,AD2,,,,,,,,,,,,,,,,,,,,,,,,,
5606,Sodium phosphate,DB09449,Constipation,C0009806,Approved,[O-]P(=O)([O-])[O-].[Na+].[Na+].[Na+]},,Digestive system disease,,,,,,,,,,,,,,,,,,,SPINK6,,,,,,,,
8808,TRPV1,C0013395,Omeprazole,DB00338,Dyspepsia,Suspended,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 2,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
12077,TGFB1,C0027051,Fondaparinux sodium,DB00569,Myocardial Infarction,Withdrawn,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},Phase 2,Cardiovascular disease,CED,TGFbeta,TGFB,DPD1,,,,,,,,,,,,,,,,,,,,,,
5744,Sulfur,DB09353,Greasy skin,C0234925,Approved,[S]},,,,,,,,,,,,,,,,,,,,,ANKRD27,,,,,,,,
15164,LRP2,C0009088,Sumatriptan,DB00669,Cluster Headache,Approved,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C},,,gp330,,,,,,,,,,,,,,,,,,,,,,,,,
10384,SLC6A4,C0038363,Triamcinolone,DB00620,Aphthous Stomatitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,5-HTT,SERT1,HTT,OCD1,,,,,,,,,,,,,,,,,,,,,,
28145,TP53,C0278505,Paclitaxel,DB01229,Non-small cell lung cancer stage II,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9348,Zoledronic acid,DB00399,Multiple Sclerosis,C0026769,Terminated,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},Phase 3,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
12032,NLRP3,C0578870,Loratadine,DB00455,Chronic idiopathic urticaria,Approved,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1},,Immune system disease,AGTAVPRL,AII,AVP,FCAS,FCU,NALP3,PYPAF1,MWS,CLR1.1,C1orf7,CIAS1,,,,,,,,,,,,,,,
20492,SCN10A,C0039240,Propranolol,DB00571,Supraventricular tachycardia,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,Nav1.8,hPN3,SNS,PN3,,,,,,,,,,,,,,,,,,,,,,
20482,KCNJ2,C0039240,Propranolol,DB00571,Supraventricular tachycardia,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,Kir2.1,IRK1,LQT7,,,,,,,,,,,,,,,,,,,,,,,
4032,SLC40A1,C0003862,Salicylic acid,DB00936,Arthralgia,Approved,C1=CC=C(C(=C1)C(=O)O)O},,Immune system disease,MTP1,IREG1,FPN1,HFE4,SLC11A3,,,,,,,,,,,,,SLC25A15,,,,,,,,
3589,Kanamycin,DB01172,"Pneumonia, Bacterial",C0004626,Approved,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N},,Infectious disease,,,,,,,,,,,,,,,,,,,SETD1A,,,,,,,,
3254,Guanadrel,DB00226,Hypertensive disease,C0020538,Approved,C1CCC2(CC1)OCC(O2)CN=C(N)N},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,IGHG1,,,,,,,,
25114,PDE4A,C0730607,Roflumilast,DB01656,Severe chronic obstructive pulmonary disease,Approved,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F},,Lung disease,DPDE2,,,,,,,,,,,,,,,,,,,,,,,,,
36212,OPRD1,C1510472,Varenicline,DB01273,Drug Dependence,Withdrawn,C1C2CNCC1C3=CC4=NC=CN=C4C=C23},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
6834,LYZ,C0002726,L-Cysteine,DB00151,Amyloidosis,Approved,C([C@@H](C(=O)O)N)S},,Hematology,,,,,,,,,,,,,,,,,,RNF6,,,,,,,,
19255,ADCYAP1R1,C0282488,Mycophenolic acid,DB01024,Interstitial Cystitis,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8206,Iloprost,DB01088,Systemic Scleroderma,C0036421,Terminated,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Skin disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
33756,LINC01672,C0006272,Cyclosporine,DB00091,Bronchiolitis Obliterans,Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 2/Phase 3,Respiratory disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3156,Gemifloxacin,DB01155,Mycoplasma pneumonia,C0032302,Approved,CO/N=C/1\\CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F},,Infectious disease,,,,,,,,,,,,,,,,,,,APOB,,,,,,,,
18333,GCDH,C0024591,Dantrolene,DB01219,Malignant hyperpyrexia due to anesthesia,Approved,C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-]},,,ACAD5,,,,,,,,,,,,,,,,,,,,,,,,,
5841,Tesamorelin,DB08869,Lipodystrophy due to Human immunodeficiency virus infection and antiretroviral therapy,C3854116,Approved,CC/C=C/CC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N},,Primary immunodeficiency,,,,,,,,,,,,,,,,,,,MARK2,,,,,,,,
18548,BMP6,C0282193,Deferasirox,DB01609,Iron Overload,Withdrawn,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O},Phase 2,Mitochondrial disease,VGR1,VGR,,,,,,,,,,,,,,,,,,,,,,,,
33692,CHRNA5,C0040332,Nicotine,DB00184,Tobacco Dependence,Terminated,CN1CCC[C@H]1C2=CN=CC=C2},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
5833,Terbutaline,DB00871,Pruritus,C0033774,Approved,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O},,,,,,,,,,,,,,,,,,,,,DYNLL2,,,,,,,,
24670,TNC,C0002390,Prednisolone,DB00860,Extrinsic allergic alveolitis,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Immune system disease,MGC167029,HXB,DFNA56,,,,,,,,,,,,,,,,,,,,,,,
24118,IL9,C0036323,Praziquantel,DB01058,Schistosomiasis,Approved,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2},,Mental and behavioural disorder,IL-9,HP40,,,,,,,,,,,,,,,,,,,,,,,,
12206,STAP1,C0020443,Vitamin E,DB00163,Hypercholesterolemia,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 3,Metabolic disease,STAP-1,BRDG1,,,,,,,,,,,,,,,,,,,,,,,,
5111,FLI1,C0004604,Hydromorphone,DB00327,Back Pain,Terminated,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4},Phase 3,,SIC-1,,,,,,,,,,,,,,,,,SLC27A4,,,,,,,,
7252,LAMC2,C1260880,Xylometazoline,DB06694,Rhinorrhea,Approved,CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C},,Nervous system disease,nicein-100kDa,kalinin-105kDa,BM600-100kDa,EBR2,LAMB2T,LAMNB2,EBR2A,,,,,,,,,,,DLL4,,,,,,,,
8714,BRCA2,C1140680,Fondaparinux sodium,DB00569,Malignant neoplasm of ovary,Withdrawn,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2439,Dorzolamide,DB00869,"Glaucoma, Open-Angle",C0017612,Approved,CCN[C@H]1C[C@@H](S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C},,Nervous system disease,,,,,,,,,,,,,,,,,,,AIRE,,,,,,,,
33438,COMMD1,C0013221,Triptorelin,DB06825,Drug toxicity,Terminated,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
15785,SMAD4,C0033581,Ofloxacin,DB01165,prostatitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,DPC4,MADH4,,,,,,,,,,,,,,,,,,,,,,,,
7411,TBC1D9,C0002986,Agalsidase beta,DB00103,Fabry Disease,Approved,CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O.CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,PNLIPRP3,,,,,,,,
16436,MALT1,C0027498,Ondansetron,DB00904,Nausea and vomiting,Withdrawn,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C},Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26908,PIK3CA,C0432487,Vidarabine,DB00194,Post-transplant lymphoproliferative disorder,Suspended,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 2,Immune system disease,PI3K,,,,,,,,,,,,,,,,,,,,,,,,,
2951,Flurandrenolide,DB00846,Scalp psoriasis,C0406326,Approved,C[C@]12CCC(=O)C=C1[C@H](C[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3C[C@@H]5[C@]4(OC(O5)(C)C)C(=O)CO)C)O)F},,Immune system disease,,,,,,,,,,,,,,,,,,,CNPY2,,,,,,,,
8552,Pregabalin,DB00230,Neuralgia,C0027796,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
14402,NBN,C0011991,Zidovudine,DB00495,Diarrhea,Terminated,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]},Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6277,Udenafil,DB06267,Erectile dysfunction,C0242350,Approved,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C},,Reproductive system disease,,,,,,,,,,,,,,,,,,,LINC01081,,,,,,,,
13733,EBP,C0011606,Triamcinolone,DB00620,Exfoliative dermatitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25775,LHCGR,C0948896,Testosterone,DB00624,Primary hypogonadism,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,Endocrine disease,LHR,LCGR,LGR2,HHG,,,,,,,,,,,,,,,,,,,,,,
1010,Cefamandole,DB01326,Enterobacteriaceae Infections,C0014347,Approved,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)[C@@H](C4=CC=CC=C4)O)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Methylscopolamine bromide,,,,,,,,
23232,ZEB1,C0476089,Arsenic trioxide,DB01169,Endometrial Carcinoma,Terminated,[O-2].[O-2].[O-2].[As+3].[As+3]},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
18597,HFE,C0019156,Defibrotide,DB04932,Hepatic Veno-Occlusive Disease,Approved,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O},,Liver disease,HLA-H,,,,,,,,,,,,,,,,,,,,,,,,,
24776,MTOR,C0034069,Azathioprine,DB00993,Pulmonary Fibrosis,Terminated,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]},Phase 3,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2990,Fondaparinux sodium,DB00569,Deep Vein Thrombosis,C0149871,Approved,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},,Hematologic disease,,,,,,,,,,,,,,,,,,,Bexarotene,,,,,,,,
2452,LIPC,C0011860,Atorvastatin,DB01076,"Diabetes Mellitus, Non-Insulin-Dependent",Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Endocrine disease,HTGL,,,,,,,,,,,,,,,,,ND6,,,,,,,,
32235,CTSL,C0236792,Memantine,DB01043,Asperger Syndrome,Terminated,CC12CC3CC(C1)(CC(C3)(C2)N)C},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
27720,MEFV,C0023532,Aminolevulinic acid,DB00855,"Leukoplakia, Oral",Terminated,C(CC(=O)O)C(=O)CN},Phase 1,Cancer,FMF,TRIM20,,,,,,,,,,,,,,,,,,,,,,,,
5089,Pranlukast,DB01411,Allergic rhinitis (disorder),C2607914,Approved,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5},,Immune system disease,,,,,,,,,,,,,,,,,,,CSE1L,,,,,,,,
12449,LAMP3,C0032302,Trovafloxacin,DB00685,Mycoplasma pneumonia,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,TSC403,DC-LAMP,DCLAMP,CD208,,,,,,,,,,,,,,,,,,,,,,
28942,CCL2,C0024143,Tacrolimus,DB00864,Lupus Nephritis,Withdrawn,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 3,Urinary system disease,MCP1,MCP-1,MCAF,SMC-CF,GDCF-2,HC11,MGC9434,SCYA2,,,,,,,,,,,,,,,,,,
27384,ACE2,C0852036,Magnesium Sulfate,DB00653,Pregnancy associated hypertension,Suspended,[O-]S(=O)(=O)[O-].[Mg+2]},Phase 2/Phase 3,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20291,TGFB1,C0042870,Ergocalciferol,DB00153,Vitamin D Deficiency,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,CED,TGFbeta,TGFB,DPD1,,,,,,,,,,,,,,,,,,,,,,
20276,PTH,C0042870,Ergocalciferol,DB00153,Vitamin D Deficiency,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
21587,TNF,C0020615,Glucagon recombinant,DB00040,Hypoglycemia,Approved,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CNC=N7)N)O},,Endocrine disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
30447,MME,C0011882,Reboxetine,DB00234,Diabetic Neuropathies,Terminated,CCOC1=CC=CC=C1O[C@@H]([C@H]2CNCCO2)C3=CC=CC=C3},Phase 2,Urinary system disease,CALLA,CD10,,,,,,,,,,,,,,,,,,,,,,,,
16409,PDPN,C0162565,Promazine,DB00420,Acute intermittent porphyria,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Congenital disorder of metabolism,T1A-2,Gp38,aggrus,PA2.26,,,,,,,,,,,,,,,,,,,,,,
23590,ACE,C0020651,Midodrine,DB00211,"Hypotension, Orthostatic",Approved,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O},,Cardiovascular disease,ACE1,CD143,DCP1,,,,,,,,,,,,,,,,,,,,,,,
33105,COMT,C0041696,Scopolamine,DB00747,Unipolar Depression,Terminated,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
16926,CXCL8,C0085166,Tinidazole,DB00911,Bacterial Vaginosis,Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Infectious disease,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
37015,IL10,C0520679,Dexmedetomidine,DB00633,"Sleep Apnea, Obstructive",Withdrawn,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 2/Phase 3,,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
3721,Levothyroxine,DB00451,Hashimoto Disease,C0677607,Approved,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N},,Immune system disease,,,,,,,,,,,,,,,,,,,CLEC11A,,,,,,,,
30890,COX4I2,C0162429,Nandrolone phenpropionate,DB00984,Malnutrition,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CC[C@H]35},Phase 2,Cancer,COXIV-2,COX4B,dJ857M17.2,COX4-2,COX4L2,,,,,,,,,,,,,,,,,,,,,
28879,ERBB3,C0278493,Tamoxifen,DB00675,Breast cancer recurrent,Withdrawn,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30247,BCR,C1292778,Prednisolone,DB00860,Chronic myeloproliferative disorder,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23176,PRDX2,C0040954,Thiabendazole,DB00730,Infection by Trichuris trichiura,Approved,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11238,ELK4,C0006849,Nystatin,DB00646,Oral candidiasis,Approved,C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/C(CC2C(C(C[C@](O2)(CC(C(CCC(CC(CC(CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10748,HLA-DRB1,C1318973,Vancomycin,DB00512,Staphylococcus aureus infection,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
21773,NECTIN1,C0040517,Pimozide,DB01100,Gilles de la Tourette syndrome,Approved,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
17368,IL6,C0031069,Colchicine,DB01394,Familial Mediterranean Fever,Approved,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC},,Infectious disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
16187,HDAC11,C0036117,Chloramphenicol,DB00446,Salmonella infections,Approved,C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
31387,CHEK2,C0206754,Sunitinib,DB01268,Neuroendocrine Tumors,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,CDS1,CHK2,HuCds1,PP1425,bA444G7,RAD53,,,,,,,,,,,,,,,,,,,,
34814,TRBV20OR9-2,C0010823,Cidofovir,DB00369,Cytomegalovirus Infections,Withdrawn,C1=CN(C(=O)N=C1N)C[C@@H](CO)OCP(=O)(O)O},Phase 1,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28906,CDKN2A,C0279680,Metronidazole,DB00916,Transitional cell carcinoma of bladder,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
16076,PLG,C0021099,Retapamulin,DB01256,Impetigo,Approved,C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC4C[C@H]5CC[C@@H](C4)N5C)C},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,,,,,,,,
37083,CD46,C0037011,Dexamethasone,DB01234,Shoulder Pain,Withdrawn,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,Musculoskeletal disease,TRA2.10,MGC26544,MIC10,,,,,,,,,,,,,,,,,,,,,,,
28431,HBD,C1292772,Sunitinib,DB01268,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
7016,ITIH4,C0019342,Valaciclovir,DB00577,Genital Herpes,Approved,CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,PRKCI,,,,,,,,
8563,NKX2-5,C0003492,Alprostadil,DB00770,Aortic coarctation,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Cardiovascular disease,CSX1,NKX2.5,NKX4-1,CSX,NKX2E,,,,,,,,,,,,,,,,,,,,,
34769,TCTN2,C0030283,Ethanol,DB00898,Pancreatic Cyst,Terminated,CCO},Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
32297,DEGS2,C0085298,Metoprolol,DB00264,Sudden Cardiac Death,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,Cardiovascular disease,DES2,FADS8,C14orf66,,,,,,,,,,,,,,,,,,,,,,,
36797,TRPA1,C0175694,Lovastatin,DB00227,Smith-Lemli-Opitz Syndrome,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,ANKTM1,,,,,,,,,,,,,,,,,,,,,,,,,
18835,TRNW,C0152020,Domperidone,DB01184,Gastroparesis,Withdrawn,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O},Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9904,Erythromycin,DB00199,Preterm premature rupture of membranes (disorder),C0729264,Withdrawn,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5668,Succimer,DB00566,Accidental poisoning by lead and its compounds and fumes,C0261486,Approved,[C@@H]([C@@H](C(=O)O)S)(C(=O)O)S},,,,,,,,,,,,,,,,,,,,,IGHMBP2,,,,,,,,
8116,CYP4F22,C0033774,Zinc oxide,DB09321,Pruritus,Approved,O=[Zn]},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
34037,KRIT1,C0018681,Naratriptan,DB00952,Headache,Withdrawn,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
14724,ABCA3,C0020542,Iloprost,DB01088,Pulmonary Hypertension,Withdrawn,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Lung disease,ABC-C,EST111653,LBM180,ABC3,,,,,,,,,,,,,,,,,,,,,,
8376,PDE10A,C0003467,Citalopram,DB00215,Anxiety,Withdrawn,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
20050,SLC34A1,C0020437,Cholecalciferol,DB00169,Hypercalcemia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 2/Phase 3,Urinary system disease,NAPI-3,NPTIIa,SLC11,NPT2,SLC17A2,,,,,,,,,,,,,,,,,,,,,
5441,Rifapentine,DB01201,"Tuberculosis, Pulmonary",C0041327,Approved,C[C@H]1/C=C/C=C(\\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C6CCCC6)/C},,Infectious disease,,,,,,,,,,,,,,,,,,,KCNN3,,,,,,,,
36496,CD207,C0019621,Clofarabine,DB00631,"Histiocytosis, Langerhans-Cell",Withdrawn,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl)N},Phase 2,Cancer,Langerin,CLEC4K,,,,,,,,,,,,,,,,,,,,,,,,
14965,PPP1R1B,C0524662,Naloxone,DB01183,Opiate Addiction,Approved,C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O},,Mental and behavioural disorder,DARPP-32,FLJ20940,,,,,,,,,,,,,,,,,,,,,,,,
32680,PTEN,C2931822,Oxaliplatin,DB00526,Nasopharyngeal carcinoma,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4274,Moexipril,DB00691,Hypertensive disease,C0020538,Approved,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC(=C(C=C3C[C@H]2C(=O)O)OC)OC},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,ARC,,,,,,,,
14340,MIR141,C0936223,Nilutamide,DB00665,Metastatic Prostate Carcinoma,Approved,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33759,IFNG,C0018133,Tacrolimus,DB00864,Graft-vs-Host Disease,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
1439,Cefuroxime,DB01112,Gonorrhea,C0018081,Approved,CO/N=C(/C1=CC=CO1)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Sulindac,,,,,,,,
22558,LOC110673972,C0001622,Trilostane,DB01108,Adrenal Gland Hyperfunction,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(CC(=C([C@H]4O5)O)C#N)C},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30583,CNR1,C0151779,Temozolomide,DB00853,Cutaneous Melanoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,CB1K5,CB-R,CB1,CANN6,CB1A,CNR,,,,,,,,,,,,,,,,,,,,
31255,CYP19A1,C0001624,Erlotinib,DB00530,Adrenal Gland Neoplasms,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Endocrine disease,ARO,P-450AROM,CPV1,ARO1,CYAR,aromatase,CYP19,,,,,,,,,,,,,,,,,,,
28454,CHRM5,C0236736,Dextroamphetamine,DB01576,Cocaine-Related Disorders,Terminated,C[C@@H](CC1=CC=CC=C1)N},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
126,Aluminum hydroxide,DB06723,Dyspepsia,C0013395,Approved,[OH-].[OH-].[OH-].[Al+3]},,Digestive system disease,,,,,,,,,,,,,,,,,,,Bedaquiline,,,,,,,,
21666,MRPL28,C0037036,Hyoscyamine,DB00424,Sialorrhea,Approved,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
3645,Lansoprazole,DB00448,Erosive esophagitis,C0267055,Approved,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F},,Digestive system disease,,,,,,,,,,,,,,,,,,,KCNE1,,,,,,,,
36942,MS4A1,C0280803,Pemetrexed,DB00642,Primary central nervous system lymphoma,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,Bp35,MS4A2,CD20,,,,,,,,,,,,,,,,,,,,,,,
34752,VHL,C0030283,Ethanol,DB00898,Pancreatic Cyst,Terminated,CCO},Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
16248,OPRM1,C0001957,Oxazepam,DB00842,Alcohol Withdrawal Delirium,Approved,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O},,Mental and behavioural disorder,MOR1,,,,,,,,,,,,,,,,,,,,,,,,,
30934,PRG4,C0279644,Idarubicin,DB01177,childhood acute myelomonocytic leukemia (M4),Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O},Phase 2,Cancer,JCAP,SZP,HAPO,bG174L6.2,FLJ32635,CACP,,,,,,,,,,,,,,,,,,,,
8806,GNB3,C0013395,Omeprazole,DB00338,Dyspepsia,Suspended,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 2,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
19604,TP53,C0007115,Liothyronine,DB00279,Malignant neoplasm of thyroid,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27789,MGMT,C0278519,Pegaspargase,DB00059,recurrent childhood acute lymphoblastic leukemia,Terminated,CC1=CC(=C(C=C1)C(=O)C(=C)CN(C)C)C},Phase 1,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
4550,Nystatin,DB00646,Cutaneous Candidiasis,C0006846,Approved,C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/C(CC2C(C(C[C@](O2)(CC(C(CCC(CC(CC(CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Immune system disease,,,,,,,,,,,,,,,,,,,AUTS2,,,,,,,,
34151,OPRM1,C1960870,Cyclobenzaprine,DB00924,Transformed migraine,Terminated,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31},Phase 3,Nervous system disease,MOR1,,,,,,,,,,,,,,,,,,,,,,,,,
20340,EWSR1,C0023827,Trabectedin,DB05109,liposarcoma,Approved,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1856,Conjugated Estrogens,DB00286,Hot flushes,C0600142,Approved,C[C@]12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[Na+]},,,,,,,,,,,,,,,,,,,,,GSN,,,,,,,,
35379,BDNF,C0005686,Mitomycin,DB00305,Urinary Bladder Diseases,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
29663,SRSF2,C0279629,Vorinostat,DB02546,adult acute monoblastic leukemia (M5a),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35871,HSPA4,C0861876,Sorafenib,DB00398,Hepatoma recurrent,Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
35212,CRP,C0012813,Mesalazine,DB00244,Diverticulitis,Terminated,C1=CC(=C(C=C1N)C(=O)O)O},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
34056,CLCN2,C0018681,Naratriptan,DB00952,Headache,Withdrawn,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
9432,POMC,C0026896,Pyridostigmine,DB00545,Myasthenia Gravis,Approved,C[N+]1=CC=CC(=C1)OC(=O)N(C)C},,Immune system disease,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
7052,TNC,C0276226,Aciclovir,DB00787,Herpes encephalitis,Approved,C1=NC2=C(N1COCCO)N=C(NC2=O)N},,Infectious disease,MGC167029,HXB,DFNA56,,,,,,,,,,,,,,,ALDH1L1,,,,,,,,
9600,CIITA,C0008311,Sulbactam,DB09324,Cholangitis,Approved,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34323,MBL2,C0004610,Vancomycin,DB00512,Bacteremia,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,COLEC1,,,,,,,,,,,,,,,,,,,,,,,,,
19926,ABCB6,C0740447,Pregabalin,DB00230,Diabetic peripheral neuropathy,Approved,CC(C)C[C@@H](CC(=O)O)CN},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25541,CPLX1,C0751122,Stiripentol,DB09118,Infantile Severe Myoclonic Epilepsy,Approved,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O},,Nervous system disease,CPX-I,,,,,,,,,,,,,,,,,,,,,,,,,
28939,NIN,C0024143,Tacrolimus,DB00864,Lupus Nephritis,Withdrawn,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31490,CEBPZ,C0349604,Sirolimus,DB00877,Intracranial Meningioma,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34592,NTN1,C0751530,Dexmedetomidine,DB00633,"Subarachnoid Hemorrhage, Aneurysmal",Terminated,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 3,,NTN1L,,,,,,,,,,,,,,,,,,,,,,,,,
25657,HGF,C0334579,Valproic Acid,DB00313,Anaplastic astrocytoma,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,F-TCF,HGFB,HPTA,DFNB39,,,,,,,,,,,,,,,,,,,,,,
23479,ERVK-7,C0023886,Tinidazole,DB00911,"Liver Abscess, Amebic",Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28680,CD44,C0153690,Ketoconazole,DB01026,Secondary malignant neoplasm of bone,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,IN,MC56,Pgp1,CD44R,HCELL,CSPG8,MIC4,MDU2,MDU3,,,,,,,,,,,,,,,,,
3510,Indomethacin,DB00328,Gout,C0018099,Approved,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,PSMB9,,,,,,,,
34623,GFRAL,C0020450,Thiamine,DB00152,Hyperemesis Gravidarum,Terminated,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},Phase 3,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8305,OR2AG1,C1262211,Ranolazine,DB00243,Diarrhoea predominant irritable bowel syndrome,Terminated,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O},Phase 2/Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14740,EVPL,C0005699,Imatinib,DB00619,Blast Phase,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12881,IFNB1,C0038395,Procaine benzylpenicillin,DB09320,Streptococcal Infections,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22912,NCAM1,C0020676,Liothyronine,DB00279,Hypothyroidism,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Endocrine disease,NCAM,CD56,,,,,,,,,,,,,,,,,,,,,,,,
21205,RRAS,C0028326,Fluoxymesterone,DB01185,Noonan Syndrome,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
27317,S100A9,C0008495,Sulbactam,DB09324,Chorioamnionitis,Suspended,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C},Phase 2/Phase 3,Infectious disease,MIF,NIF,LIAG,MRP14,MAC387,CGLB,CAGB,,,,,,,,,,,,,,,,,,,
8854,Zinc sulfate,DB09322,Acute gastroenteritis,C0267446,Terminated,[O-]S(=O)(=O)[O-].[Zn+2]},Phase 2/Phase 3,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
31221,TRAV30,C2363741,Tenofovir,DB00300,HIV-1 infection,Withdrawn,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8422,GAD2,C0270549,Quetiapine,DB01224,Generalized Anxiety Disorder,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,GAD65,,,,,,,,,,,,,,,,,,,,,,,,,
34515,ADSS2,C0037278,Vancomycin,DB00512,"Skin Diseases, Infectious",Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25328,EGFR,C0349649,Sirolimus,DB00877,Pulmonary lymphangioleiomyomatosis,Approved,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},,Immune system disease,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
6495,TAC1,C0030193,Oxycodone,DB00497,Pain,Withdrawn,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O},Phase 3,,NPK,TAC2,NKNA,,,,,,,,,,,,,,,ZIC3,,,,,,,,
1213,Cefoxitin,DB01331,Osteomyelitis due to Staphylococcus aureus,C1997728,Approved,CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3},,Immune system disease,,,,,,,,,,,,,,,,,,,Phensuximide,,,,,,,,
2575,Econazole,DB01127,Tinea corporis (disorder),C0040252,Approved,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,FGF19,,,,,,,,
3646,Lansoprazole,DB00448,Gastric ulcer,C0038358,Approved,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F},,Digestive system disease,,,,,,,,,,,,,,,,,,,HRC,,,,,,,,
5267,Primidone,DB00794,Bipolar disorder in remission,C0270425,Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,KHDC3L,,,,,,,,
20642,TSC1,C0041341,Everolimus,DB01590,Tuberous Sclerosis,Approved,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1176,Cefotetan,DB01330,Endometritis,C0014179,Approved,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O},,Reproductive system disease,,,,,,,,,,,,,,,,,,,Paromomycin,,,,,,,,
2220,Dexamethasone,DB01234,Psoriasis,C0033860,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Skin disease,,,,,,,,,,,,,,,,,,,SERPINB2,,,,,,,,
15122,TP53,C0238462,Sorafenib,DB00398,Medullary carcinoma of thyroid,Withdrawn,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25212,TRAF3IP2,C0870082,Tretinoin,DB00755,Hyperkeratosis,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13252,CLDN4,C0025281,Penciclovir,DB00299,Meniere Disease,Terminated,C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N},Phase 3,Nervous system disease,CPE-R,WBSCR8,hCPE-R,CPETR,CPETR1,,,,,,,,,,,,,,,,,,,,,
20709,BMP1,C0473527,Simvastatin,DB00641,Hypoalphalipoproteinemias,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Endocrine and metabolic disease,PCOLC,,,,,,,,,,,,,,,,,,,,,,,,,
11509,FN1,C0014121,Vancomycin,DB00512,Bacterial Endocarditis,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,CIG,LETS,GFND2,FINC,,,,,,,,,,,,,,,,,,,,,,
19271,CYBB,C1961112,Dobutamine,DB00841,Heart Decompensation,Approved,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O},,Cardiovascular disease,GP91-PHOX,NOX2,CGD,,,,,,,,,,,,,,,,,,,,,,,
19422,FBLN5,C0235063,Doxapram,DB00561,Respiratory Depression,Approved,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4},,Lung disease,EVEC,UP50,DANCE,ARMD3,,,,,,,,,,,,,,,,,,,,,,
16330,OCRL,C0017574,Chlorhexidine,DB00878,Gingivitis,Approved,C1=CC(=CC=C1N/C(=N/C(=NCCCCCCN=C(/N=C(/NC2=CC=C(C=C2)Cl)\\N)N)N)/N)Cl},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
36922,BCL6,C0280803,Pemetrexed,DB00642,Primary central nervous system lymphoma,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,ZBTB27,LAZ3,BCL5,BCL6A,ZNF51,,,,,,,,,,,,,,,,,,,,,
28280,IL2,C0022665,Vincristine,DB00541,Kidney Neoplasm,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 1,Cancer,IL-2,TCGF,,,,,,,,,,,,,,,,,,,,,,,,
24853,TNNC1,C0007194,Propranolol,DB00571,Hypertrophic Cardiomyopathy,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,TNNC,,,,,,,,,,,,,,,,,,,,,,,,,
16611,BAK1,C0021775,Cilostazol,DB01166,Intermittent Claudication,Approved,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
4759,Paliperidone,DB01267,Schizophrenia,C0036341,Approved,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,CDK5,,,,,,,,
28099,EML4,C0152013,Paclitaxel,DB01229,Adenocarcinoma of lung (disorder),Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
20161,ADRB3,C0018802,Levosimendan,DB00922,Congestive heart failure,Approved,C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N},,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
15425,CYP17A1,C0020621,Potassium Citrate,DB09125,Hypokalemia,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Endocrine and metabolic disease,P450C17,CPT7,S17AH,CYP17,,,,,,,,,,,,,,,,,,,,,,
11711,CRP,C0003872,Triamcinolone,DB00620,"Arthritis, Psoriatic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
27560,CASP8,C2937358,Fluoxetine,DB00472,Cerebral Hemorrhage,Terminated,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F},Phase 3,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33959,IL6,C0006287,Nitric Oxide,DB00435,Bronchopulmonary Dysplasia,Terminated,[N]=O},Phase 2/Phase 3,Congenital malformation,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
23332,TOB2,C0042900,Tacrolimus,DB00864,Vitiligo,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
468,Azidocillin,DB08795,Respiratory Tract Infections,C0035243,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N=[N+]=[N-])C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,CDKAL1,,,,,,,,
14283,APOE,C0020473,Cholecalciferol,DB00169,Hyperlipidemia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 1,Metabolic disease,AD2,,,,,,,,,,,,,,,,,,,,,,,,,
23606,H3P10,C0220756,Miglustat,DB00419,"Niemann-Pick Disease, Type C",Approved,CCCCN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
37050,CD274,C1168198,Propranolol,DB00571,Recurrent respiratory papillomatosis,Withdrawn,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},Phase 2/Phase 3,Infectious disease,B7-H,B7H1,PD-L1,PDL1,B7-H1,PDCD1LG1,,,,,,,,,,,,,,,,,,,,
17282,TRAF3IP2,C0919659,Miconazole,DB01110,Oropharyngeal candidiasis,Approved,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2816,Fenoprofen,DB00573,Degenerative polyarthritis,C0029408,Approved,CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,Rivaroxaban,,,,,,,,
8038,PRL,C1739363,Terazosin,DB01162,Prostatic Hypertrophy,Approved,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC},,,,,,,,,,,,,,,,,,,,,,,,,,,,
35185,DNM2,C0442874,Magnesium Sulfate,DB00653,Neuropathy,Terminated,[O-]S(=O)(=O)[O-].[Mg+2]},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36555,FTL,C0012715,Deferasirox,DB01609,Iron Metabolism Disorders,Withdrawn,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O},Phase 2,Hematologic disease,MGC71996,NBIA3,,,,,,,,,,,,,,,,,,,,,,,,
19341,NPY,C0002395,Rivastigmine,DB00989,Alzheimer's Disease,Approved,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C},,Neurodegenerative disease,PYY4,,,,,,,,,,,,,,,,,,,,,,,,,
27338,TEK,C1335177,Trametinib,DB08911,Ovarian Serous Adenocarcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2/Phase 3,Cancer,TIE2,TIE-2,VMCM1,CD202b,VMCM,,,,,,,,,,,,,,,,,,,,,
13693,MFRP,C0015397,Triamcinolone,DB00620,Disorder of eye,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
26590,IL6,C0278838,Ketoconazole,DB01026,Prostate cancer recurrent,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
8883,Atorvastatin,DB01076,Dyslipidemias,C0242339,Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
19512,MARCKSL1,C0276535,Doxorubicin,DB00997,AIDS with Kaposi's sarcoma,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},,Cancer,F52,MacMARCKS,,,,,,,,,,,,,,,,,,,,,,,,
17198,PIGM,C0270846,Lorazepam,DB00186,Epileptic drop attack,Approved,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23630,CXCL8,C0023283,Fluconazole,DB00196,"Leishmaniasis, Cutaneous",Terminated,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O},Phase 3,Infectious disease,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
75,Alclometasone,DB00240,Chronic small plaque psoriasis,C0406317,Approved,C[C@@H]1C[C@H]2[C@@H]3[C@@H](CC4=CC(=O)C=C[C@@]4([C@H]3[C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)C)Cl},,Skin disease,,,,,,,,,,,,,,,,,,,Amyl Nitrite,,,,,,,,
21294,IFNA13,C0155880,Zileuton,DB00744,Intrinsic asthma,Approved,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34117,BET1L,C1704272,Finasteride,DB01216,Benign Prostatic Hyperplasia,Withdrawn,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},Phase 3,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27622,HTR2C,C0524620,Topiramate,DB00273,Metabolic Syndrome X,Suspended,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Endocrine and metabolic disease,5-HT2C,5HTR2C,HTR1C,,,,,,,,,,,,,,,,,,,,,,,
3830,Lovastatin,DB00227,"Hyperlipidemia, Familial Combined",C0020474,Approved,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Metabolic disease,,,,,,,,,,,,,,,,,,,ANGPTL4,,,,,,,,
5418,Ranitidine,DB00863,Gastric ulcer,C0038358,Approved,CN/C(=C\\[N+](=O)[O-])/NCCSCC1=CC=C(O1)CN(C)C},,Digestive system disease,,,,,,,,,,,,,,,,,,,GLP1R,,,,,,,,
29794,ALB,C0001127,Nitric Oxide,DB00435,"Acidosis, Respiratory",Terminated,[N]=O},Phase 1/Phase 2,Respiratory diseases,,,,,,,,,,,,,,,,,,,,,,,,,,
2817,Fenoprofen,DB00573,Pain,C0030193,Approved,CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)O},,,,,,,,,,,,,,,,,,,,,Rosiglitazone,,,,,,,,
8761,EGFR,C1140680,Fondaparinux sodium,DB00569,Malignant neoplasm of ovary,Withdrawn,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},Phase 1,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
15341,TGFBR2,C0018790,Metoprolol,DB00264,Cardiac Arrest,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,Cardiovascular disease,TBRII,TBR-ii,MFS2,,,,,,,,,,,,,,,,,,,,,,,
14849,AUTS2,C0026603,Scopolamine,DB00747,Motion Sickness,Approved,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13071,SMAD3,C0011644,Imatinib,DB00619,Scleroderma,Terminated,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 2,Skin disease,JV15-2,HsT17436,MADH3,,,,,,,,,,,,,,,,,,,,,,,
28074,ALK,C0152013,Paclitaxel,DB01229,Adenocarcinoma of lung (disorder),Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
22998,CLOCK,C0005586,Ziprasidone,DB00246,Bipolar Disorder,Terminated,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54},Phase 3,Mental and behavioural disorder,KIAA0334,KAT13D,bHLHe8,,,,,,,,,,,,,,,,,,,,,,,
5319,Progesterone,DB00396,Endometriosis,C0014175,Approved,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Reproductive system disease,,,,,,,,,,,,,,,,,,,ZNF521,,,,,,,,
31513,CTLA4,C3898222,Sirolimus,DB00877,Mucosal Melanoma,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,CD152,CELIAC3,IDDM12,,,,,,,,,,,,,,,,,,,,,,,
30249,PTGS2,C0079731,Dexamethasone,DB01234,B-Cell Lymphomas,Terminated,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
25889,MTOR,C0085413,Tolvaptan,DB06212,"Polycystic Kidney, Autosomal Dominant",Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
25948,FN1,C0162810,Tranilast,DB07615,"Cicatrix, Hypertrophic",Approved,COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC},,,CIG,LETS,GFND2,FINC,,,,,,,,,,,,,,,,,,,,,,
15533,CXCR4,C0027796,Pregabalin,DB00230,Neuralgia,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,Nervous system disease,LESTR,NPY3R,HM89,NPYY3R,D2S201E,fusin,HSY3RR,CD184,,,,,,,,,,,,,,,,,,
34807,SCT,C0010823,Cidofovir,DB00369,Cytomegalovirus Infections,Withdrawn,C1=CN(C(=O)N=C1N)C[C@@H](CO)OCP(=O)(O)O},Phase 1,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
31307,MIR1307,C0279607,Erlotinib,DB00530,adult primary hepatocellular carcinoma,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34677,PIK3CG,C0220650,Temozolomide,DB00853,Metastatic malignant neoplasm to brain,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1529,Chloroquine,DB00608,Rheumatoid Arthritis,C0003873,Approved,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl},,Immune system disease,,,,,,,,,,,,,,,,,,,Tolvaptan,,,,,,,,
16435,PPARGC1A,C0027498,Ondansetron,DB00904,Nausea and vomiting,Withdrawn,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C},Phase 3,Digestive system disease,PGC1,PGC1A,PGC-1alpha,PPARGC1,,,,,,,,,,,,,,,,,,,,,,
33523,FUS,C0036974,Vitamin C,DB00126,Shock,Terminated,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5143,Prednisolone,DB00860,Contact Dermatitis,C0011616,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Immune system disease,,,,,,,,,,,,,,,,,,,MIR320A,,,,,,,,
8616,GDF1,C0242855,Alprostadil,DB00770,Congenital atresia of pulmonary valve,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
15468,CYP19A1,C0278488,Vinblastine,DB00570,Carcinoma breast stage IV,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,ARO,P-450AROM,CPV1,ARO1,CYAR,aromatase,CYP19,,,,,,,,,,,,,,,,,,,
20776,PARP1,C4083212,Finasteride,DB01216,"Alopecia, Male Pattern",Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},,Skin disease,PARP,PPOL,ADPRT,,,,,,,,,,,,,,,,,,,,,,,
26101,BET1L,C0042133,Ulipristal,DB08867,Uterine Fibroids,Approved,CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32710,LMNA,C0015944,Oxytocin,DB00107,"Fetal Membranes, Premature Rupture",Terminated,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N},Phase 2,,LMN1,CMD1A,LGMD1B,,,,,,,,,,,,,,,,,,,,,,,
22191,IL2,C0206141,Imatinib,DB00619,Idiopathic Hypereosinophilic Syndrome,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,IL-2,TCGF,,,,,,,,,,,,,,,,,,,,,,,,
34517,EGFR,C0037278,Vancomycin,DB00512,"Skin Diseases, Infectious",Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
22421,SYNE2,C0004245,Isoprenaline,DB01064,Atrioventricular Block,Approved,CC(C)NCC(C1=CC(=C(C=C1)O)O)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36238,CYP2D6,C1510472,Varenicline,DB01273,Drug Dependence,Withdrawn,C1C2CNCC1C3=CC4=NC=CN=C4C=C23},Phase 1,Mental and behavioural disorder,CPD6,P450-DB1,P450C2D,CYP2DL1,CYP2D7P2,CYP2D7BP,CYP2D8P2,CYP2D7AP,,,,,,,,,,,,,,,,,,
19315,FGFR1,C0678222,Paclitaxel,DB01229,Breast Carcinoma,Approved,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},,Cancer,CEK,FLG,BFGFR,N-SAM,CD331,FLT2,KAL2,,,,,,,,,,,,,,,,,,,
15813,NPAP1,C0032897,Somatropin recombinant,DB00052,Prader-Willi Syndrome,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Chromosomal abnormality,0,,,,,,,,,,,,,,,,,,,,,,,,,
9156,Nicotinamide,DB02701,Dyslipidemias,C0242339,Terminated,C1=CC(=CN=C1)C(=O)N},Phase 3,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
687,Betamethasone,DB00443,Dermatitis Herpetiformis,C0011608,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Immune system disease,,,,,,,,,,,,,,,,,,,Frovatriptan,,,,,,,,
11378,PIP,C0037199,Pseudoephedrine,DB00852,Sinusitis,Withdrawn,C[C@@H]([C@H](C1=CC=CC=C1)O)NC},Phase 2,Infectious disease,GCDFP-15,GCDFP15,GPIP4,,,,,,,,,,,,,,,,,,,,,,,
29700,MIRLET7B,C0280634,Vorinostat,DB02546,adult acute monocytic leukemia (M5b),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2558,Dutasteride,DB01126,Prostatic Hypertrophy,C1739363,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CC[C@@H]5[C@@]3(C=CC(=O)N5)C},,,,,,,,,,,,,,,,,,,,,REN,,,,,,,,
24120,NGF,C0005697,Oxybutynin,DB01062,Neurogenic Urinary Bladder,Approved,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O},,Urinary system disease,NGFB,,,,,,,,,,,,,,,,,,,,,,,,,
26295,ABCA4,C0242383,Xanthophyll,DB00137,Age related macular degeneration,Approved,CC1=C(C(C[C@@H](C1)O)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(\\C)/C=C/C=C(\\C)/C=C/[C@H]2C(=C[C@@H](CC2(C)C)O)C)/C)/C},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18964,EPOR,C0040038,Warfarin,DB00682,Thromboembolism,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
5384,Pyrimethamine,DB00205,Toxoplasmosis,C0040558,Approved,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,STXBP5,,,,,,,,
23157,GOT2,C0003950,Thiabendazole,DB00730,Ascariasis,Approved,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21376,THBD,C0524702,Fondaparinux sodium,DB00569,Pulmonary Thromboembolisms,Approved,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},,Hematologic disease,CD141,,,,,,,,,,,,,,,,,,,,,,,,,
23417,AHSA1,C0017536,Tinidazole,DB00911,Giardiasis,Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1181,Cefotetan,DB01330,Infection of skin AND/OR subcutaneous tissue,C0178299,Approved,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Pegfilgrastim,,,,,,,,
5601,Sodium oxybate,DB09072,Narcolepsy,C0027404,Approved,C(CC(=O)[O-])CO.[Na+]},,Nervous system disease,,,,,,,,,,,,,,,,,,,AKR1B1,,,,,,,,
16300,IL6,C0022104,Milnacipran,DB04896,Irritable Bowel Syndrome,Terminated,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2},Phase 2,Digestive system disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
20676,HMGCR,C0342907,Ezetimibe,DB00973,Sitosterolemia,Approved,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
26026,CHI3L1,C0023646,Triamcinolone,DB00620,Lichen Planus,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19240,IL4,C0282488,Mycophenolic acid,DB01024,Interstitial Cystitis,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,Urinary system disease,BSF1,IL-4,BCGF1,BCGF-1,MGC79402,,,,,,,,,,,,,,,,,,,,,
20545,AHSA1,C0014869,Omeprazole,DB00338,Peptic Esophagitis,Approved,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4896,Phenprocoumon,DB00946,Thrombosis,C0040053,Approved,CCC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,,,,,,,,,,,,,,,,,,,SPATA5,,,,,,,,
1065,Cefazolin,DB01327,Staphylococcal Pneumonia,C0032308,Approved,CC1=NN=C(S1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Nalbuphine,,,,,,,,
17239,GSN,C0948089,Citalopram,DB00215,Acute Coronary Syndrome,Withdrawn,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 1/Phase 2,Cardiovascular disease,DKFZp313L0718,,,,,,,,,,,,,,,,,,,,,,,,,
7959,Dexamethasone,DB01234,Nausea,C0027497,Terminated,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 2,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
25276,TACR3,C0013338,Somatropin recombinant,DB00052,Pituitary dwarfism,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
664,Betamethasone,DB00443,Addison Disease,C0001403,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Endocrine disease,,,,,,,,,,,,,,,,,,,Fluphenazine,,,,,,,,
24672,IL1RN,C0002390,Prednisolone,DB00860,Extrinsic allergic alveolitis,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Immune system disease,ICIL-1RA,IL1F3,IL-1RN,MGC10430,,,,,,,,,,,,,,,,,,,,,,
12578,TAC3,C0600142,Testosterone,DB00624,Hot flushes,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
12880,STING1,C0038395,Procaine benzylpenicillin,DB09320,Streptococcal Infections,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5249,Prednisone,DB00635,Mycosis Fungoides,C0026948,Approved,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},,Infectious disease,,,,,,,,,,,,,,,,,,,ETV1,,,,,,,,
28309,APEX1,C0242006,Azacitidine,DB00928,Myelofibrosis due to another disorder,Terminated,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27738,FANCD2,C0023418,Vincristine,DB00541,leukemia,Withdrawn,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30698,ERBB2,C0025149,Valproic Acid,DB00313,Medulloblastoma,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
12128,KLF2,C0003850,Simvastatin,DB00641,Arteriosclerosis,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Vascular disease,LKLF,,,,,,,,,,,,,,,,,,,,,,,,,
26120,SULT1B1,C0042133,Ulipristal,DB08867,Uterine Fibroids,Approved,CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33560,SERPINE1,C0004153,Simvastatin,DB00641,Atherosclerosis,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Cardiovascular disease,PAI,PLANH1,PAI1,,,,,,,,,,,,,,,,,,,,,,,
36708,BCL2,C1153706,Norgestrel,DB09389,Endometrial adenocarcinoma,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Cancer,Bcl-2,PPP1R50,,,,,,,,,,,,,,,,,,,,,,,,
28300,JAK1,C0242006,Azacitidine,DB00928,Myelofibrosis due to another disorder,Terminated,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36067,ARL6,C0035334,Unoprostone,DB06826,Retinitis Pigmentosa,Terminated,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},Phase 3,Nervous system disease,RP55,BBS3,,,,,,,,,,,,,,,,,,,,,,,,
22585,HSPD1,C0030409,Ketoconazole,DB01026,Paracoccidioidomycosis,Approved,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5214,Prednisone,DB00635,Addison Disease,C0001403,Approved,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},,Endocrine disease,,,,,,,,,,,,,,,,,,,HCFC1,,,,,,,,
1216,Cefoxitin,DB01331,Pneumonia due to Escherichia coli,C0276089,Approved,CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3},,Infectious disease,,,,,,,,,,,,,,,,,,,CLCN7,,,,,,,,
12197,ABCG5,C0020443,Vitamin E,DB00163,Hypercholesterolemia,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 3,Metabolic disease,STSL,,,,,,,,,,,,,,,,,,,,,,,,,
32404,VCAM1,C0007282,Minocycline,DB01017,Carotid Stenosis,Terminated,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},Phase 2,Cardiovascular disease,CD106,,,,,,,,,,,,,,,,,,,,,,,,,
2383,Diphenhydramine,DB01075,"Rhinitis, Vasomotor",C0035460,Approved,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2},,Immune system disease,,,,,,,,,,,,,,,,,,,EML4,,,,,,,,
31179,RNASEL,C0015674,Lipoic Acid,DB00166,Chronic Fatigue Syndrome,Withdrawn,C1CSS[C@@H]1CCCCC(=O)O},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
24955,HP,C0024530,Prednisone,DB00635,Malaria,Withdrawn,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
2055,KIAA0040,C0001973,Zonisamide,DB00909,"Alcoholic Intoxication, Chronic",Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 2,Other,0,,,,,,,,,,,,,,,,,FOXO3,,,,,,,,
23388,PRKCA,C0267176,Metoclopramide,DB01233,Gastroparesis due to diabetes mellitus,Approved,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl},,Digestive system disease,PKCA,,,,,,,,,,,,,,,,,,,,,,,,,
22499,SIRT1,C0042373,Tolazoline,DB00797,Vascular Diseases,Approved,C1CN=C(N1)CC2=CC=CC=C2},,Vascular disease,SIR2L1,,,,,,,,,,,,,,,,,,,,,,,,,
15848,HLA-A,C0018213,Carbimazole,DB00389,Graves Disease,Approved,CCOC(=O)N1C=CN(C1=S)C},,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
14119,CCR3,C0242459,Triamcinolone,DB00620,Simple Pulmonary Eosinophilia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,CC-CKR-3,CKR3,CD193,CMKBR3,,,,,,,,,,,,,,,,,,,,,,
6159,Triamcinolone,DB00620,Pemphigus,C0030807,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,BPTF,,,,,,,,
27581,BCL2,C2937358,Fluoxetine,DB00472,Cerebral Hemorrhage,Terminated,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F},Phase 3,Cardiovascular disease,Bcl-2,PPP1R50,,,,,,,,,,,,,,,,,,,,,,,,
15625,VEGFA,C0011881,Losartan,DB00678,Diabetic Nephropathy,Approved,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl},,Urinary system disease,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
21787,TDO2,C0040517,Pimozide,DB01100,Gilles de la Tourette syndrome,Approved,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
15774,MS,C0040997,Carbamazepine,DB00564,Trigeminal Neuralgia,Approved,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
14308,CYP2E1,C0020473,Cholecalciferol,DB00169,Hyperlipidemia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 1,Metabolic disease,CYP2E,,,,,,,,,,,,,,,,,,,,,,,,,
16444,CPOX,C0027498,Ondansetron,DB00904,Nausea and vomiting,Withdrawn,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C},Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23860,BCL11B,C1961099,Nelarabine,DB01280,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,Approved,COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},,Cancer,CTIP-2,CTIP2,hRIT1-alpha,ZNF856B,,,,,,,,,,,,,,,,,,,,,,
16954,CRHR1,C0085166,Tinidazole,DB00911,Bacterial Vaginosis,Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Infectious disease,CRF-R,CRF1,CRHR,,,,,,,,,,,,,,,,,,,,,,,
2027,TACR3,C0001973,Zonisamide,DB00909,"Alcoholic Intoxication, Chronic",Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 2,Other,0,,,,,,,,,,,,,,,,,Dasatinib,,,,,,,,
21569,SOCS3,C0206178,Foscarnet,DB00529,Cytomegalovirus Retinitis,Withdrawn,C(=O)(O)P(=O)(O)O},Phase 2,Infectious disease,SSI-3,CIS3,SOCS-3,Cish3,,,,,,,,,,,,,,,,,,,,,,
23478,MPO,C0023886,Tinidazole,DB00911,"Liver Abscess, Amebic",Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Liver disease,,,,,,,,,,,,,,,,,,,,,,,,,,
3102,Fusidic Acid,DB02703,Serratia Infections,C0085394,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,TGFBR1,,,,,,,,
21950,TNNI3K,C0085610,Hyoscyamine,DB00424,Sinus bradycardia,Approved,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9420,LYST,C0242422,Trihexyphenidyl,DB00376,Parkinsonian Disorders,Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Neurodegenerative disease,CHS,,,,,,,,,,,,,,,,,,,,,,,,,
9840,IFNGR1,C0029443,Amikacin,DB00479,Osteomyelitis,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12730,F13A1,C0149871,Warfarin,DB00682,Deep Vein Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,F13A,,,,,,,,,,,,,,,,,,,,,,,,,
5299,Procaine benzylpenicillin,DB09320,Streptococcal endocarditis,C3665800,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,KLF9,,,,,,,,
36485,CALB2,C0334513,Pemetrexed,DB00642,Sarcomatoid Mesothelioma,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,other disease,CAL2,,,,,,,,,,,,,,,,,,,,,,,,,
24983,EBI3,C0040558,Sulfamethoxazole,DB01015,Toxoplasmosis,Approved,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14876,TDRD7,C0017601,Echothiophate,DB01057,Glaucoma,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17063,LTB,C1562585,Clofazimine,DB00845,"Leprosy, Multibacillary",Approved,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl},,Infectious disease,TNFSF3,TNFC,,,,,,,,,,,,,,,,,,,,,,,,
7933,MEN1,C0020502,Alfacalcidol,DB01436,Hyperparathyroidism,Approved,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
24531,EDN1,C0003615,Ropivacaine,DB00296,Appendicitis,Terminated,CCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C},Phase 2,Other disease,ET1,,,,,,,,,,,,,,,,,,,,,,,,,
22681,SLC25A13,C0019151,Phenylacetic acid,DB09269,Hepatic Encephalopathy,Terminated,C1=CC=C(C=C1)CC(=O)O},Phase 2,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
37058,GEM,C1168198,Propranolol,DB00571,Recurrent respiratory papillomatosis,Withdrawn,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},Phase 2/Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
6814,Vidarabine,DB00194,Post-transplant lymphoproliferative disorder,C0432487,Suspended,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,TOP2A,,,,,,,,
2685,Ertapenem,DB00303,Moraxella catarrhalis pneumonia,C0857831,Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)[C@@H](C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Somatostatin,,,,,,,,
12020,IL10,C0578870,Loratadine,DB00455,Chronic idiopathic urticaria,Approved,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1},,Immune system disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
16892,LOC102724971,C0023443,Pentostatin,DB00552,Hairy Cell Leukemia,Approved,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36265,WNK1,C0022658,Valsartan,DB00177,Kidney Diseases,Withdrawn,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Urinary system disease,HSAN2,PPP1R167,PRKWNK1,HSN2,,,,,,,,,,,,,,,,,,,,,,
20472,CACNA1D,C0039240,Propranolol,DB00571,Supraventricular tachycardia,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,Cav1.3,CACH3,CACN4,CCHL1A2,CACNL1A2,,,,,,,,,,,,,,,,,,,,,
13599,CRP,C0010346,Naltrexone,DB00704,Crohn Disease,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
723,Betamethasone,DB00443,Status Asthmaticus,C0038218,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Immune system disease,,,,,,,,,,,,,,,,,,,Gramicidin D,,,,,,,,
10301,CACNA1C,C0042510,Metoprolol,DB00264,Ventricular Fibrillation,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
18684,EPHA3,C0042974,Desmopressin,DB00035,von Willebrand Disease,Approved,C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N},,Hematologic disease,HEK,HEK4,ETK1,,,,,,,,,,,,,,,,,,,,,,,
25287,GHR,C0013338,Somatropin recombinant,DB00052,Pituitary dwarfism,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Endocrine and metabolic disease,GHBP,,,,,,,,,,,,,,,,,,,,,,,,,
30105,GABRR2,C0235032,Methylphenidate,DB00422,Neurotoxicity Syndromes,Terminated,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},Phase 2,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8062,EGR1,C1739363,Terazosin,DB01162,Prostatic Hypertrophy,Approved,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC},,,TIS8,G0S30,NGFI-A,KROX-24,ZIF-268,AT225,ZNF225,,,,,,,,,,,,,,,,,,,
32834,IL6,C0040136,Ponatinib,DB08901,Thyroid Neoplasm,Terminated,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5},Phase 2,Cancer,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
1774,Clocortolone,DB00838,Pruritus of genital organs,C0033777,Approved,C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)CO)C)O)Cl)C)F},,,,,,,,,,,,,,,,,,,,,CAT,,,,,,,,
24082,TEK,C0153467,Olaparib,DB09074,Malignant tumor of peritoneum,Approved,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F},,Cancer,TIE2,TIE-2,VMCM1,CD202b,VMCM,,,,,,,,,,,,,,,,,,,,,
26981,TCL1A,C0349632,Vincristine,DB00541,Splenic Marginal Zone B-Cell Lymphoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,TCL1,,,,,,,,,,,,,,,,,,,,,,,,,
360,Ampicillin,DB00415,Shigella Infections,C0013371,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,NPY,,,,,,,,
13714,PLA2G15,C0014742,Triamcinolone,DB00620,Erythema Multiforme,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10402,APOB,C0002962,Verapamil,DB00661,Angina Pectoris,Approved,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
14925,SERPINA3,C0150055,Pregabalin,DB00230,Chronic pain,Withdrawn,CC(C)C[C@@H](CC(=O)O)CN},Phase 3,,AACT,,,,,,,,,,,,,,,,,,,,,,,,,
30842,PSIP1,C1522378,Cyclosporine,DB00091,"Leukemia, Large Granular Lymphocytic",Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12973,CPT1A,C0220994,Phenylacetic acid,DB09269,Hyperammonemia,Approved,C1=CC=C(C=C1)CC(=O)O},,Inherited metabolic disease,CPT1-L,L-CPT1,,,,,,,,,,,,,,,,,,,,,,,,
8760,MSLN,C1140680,Fondaparinux sodium,DB00569,Malignant neoplasm of ovary,Withdrawn,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},Phase 1,Cancer,MPF,,,,,,,,,,,,,,,,,,,,,,,,,
36071,PTCH1,C0004779,Verteporfin,DB00460,Basal Cell Nevus Syndrome,Terminated,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C.CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)O)C(=C3C)CCC(=O)OC)C=C},Phase 3,Skin and connective tissue disease,BCNS,NBCCS,PTCH,,,,,,,,,,,,,,,,,,,,,,,
14705,HLA-A,C0026764,Vorinostat,DB02546,Multiple Myeloma,Withdrawn,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
34411,PGR,C0278601,Tamoxifen,DB00675,Inflammatory Breast Carcinoma,Terminated,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},Phase 3,Cancer,NR3C3,,,,,,,,,,,,,,,,,,,,,,,,,
16857,POTEM,C0277528,Ofloxacin,DB01165,Traveler's diarrhea,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30729,NGFR,C0206663,Vincristine,DB00541,"Neuroectodermal Tumor, Primitive",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,TNFRSF16,CD271,p75NTR,,,,,,,,,,,,,,,,,,,,,,,
12934,IFIH1,C0011633,Benzoic Acid,DB03793,Dermatomyositis,Approved,C1=CC=C(C=C1)C(=O)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
181,Amikacin,DB00479,Pseudomonas aeruginosa meningitis,C3665869,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},,Infectious disease,,,,,,,,,,,,,,,,,,,MSMB,,,,,,,,
4972,Piperacillin,DB00319,Escherichia coli septicemia,C0276088,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SCTR,,,,,,,,
5321,Progesterone,DB00396,Metrorrhagia,C0025874,Approved,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,,,,,,,,,,,,,,,,,,,,CPT1C,,,,,,,,
5059,Potassium Citrate,DB09125,RENAL CALCULUS CALCIUM OXALATE,C0748267,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Urinary system disease,,,,,,,,,,,,,,,,,,,DLGAP3,,,,,,,,
5276,Probenecid,DB01032,Acute gonococcal endometritis,C0153196,Approved,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,TRIP13,,,,,,,,
20186,HP,C0002792,Epinephrine,DB00668,anaphylaxis,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
20511,EIF6,C0267055,Ranitidine,DB00863,Erosive esophagitis,Approved,CN/C(=C\\[N+](=O)[O-])/NCCSCC1=CC=C(O1)CN(C)C},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36423,PMEL,C0333875,Celecoxib,DB00482,High-Grade Squamous Intraepithelial Lesions,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2,Immune system disease,D12S53E,SI,Pmel17,gp100,SILV,,,,,,,,,,,,,,,,,,,,,
35500,CASP3,C0011884,Octreotide,DB00104,Diabetic Retinopathy,Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 3,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34818,HLA-C,C0010823,Cidofovir,DB00369,Cytomegalovirus Infections,Withdrawn,C1=CN(C(=O)N=C1N)C[C@@H](CO)OCP(=O)(O)O},Phase 1,Infectious disease,HLA-JY3,D6S204,PSORS1,,,,,,,,,,,,,,,,,,,,,,,
28995,ALB,C0019187,Pentoxifylline,DB00806,"Hepatitis, Alcoholic",Terminated,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C},Phase 1,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
22184,OCLN,C0206141,Imatinib,DB00619,Idiopathic Hypereosinophilic Syndrome,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,PPP1R115,,,,,,,,,,,,,,,,,,,,,,,,,
31859,GSTM1,C3495949,Valproic Acid,DB00313,Locally advanced breast cancer,Terminated,CCCC(CCC)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
18360,NIPA1,C0085606,Trospium,DB00209,Urgency of micturition,Approved,C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
4657,Oritavancin,DB04911,"Skin Diseases, Bacterial",C0162627,Approved,C[C@H]1[C@@H]([C@@](C[C@@H](O1)O[C@H]2[C@H]3C(=O)N[C@@H](C4=C(C(=CC(=C4)O)O)C5=C(C=CC(=C5)[C@H](C(=O)N3)NC(=O)[C@H]6C7=CC(=C(C(=C7)OC8=C(C=C2C=C8)Cl)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O[C@H]1C[C@]([C@H]([C@@H](O1)C)O)(C)NCC1=CC=C(C=C1)C1=CC=C(C=C1)Cl)OC1=C(C=C(C=C1)[C@H]([C@H](C(=O)N[C@H](C(=O)N6)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)O)C(=O)O)(C)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,FAM20C,,,,,,,,
2239,Dexbrompheniramine,DB00405,Hay fever,C0018621,Approved,CN(C)CC[C@@H](C1=CC=C(C=C1)Br)C2=CC=CC=N2},,Infectious disease,,,,,,,,,,,,,,,,,,,JAK1,,,,,,,,
1877,Cortisone acetate,DB01380,Autoimmune Diseases,C0004364,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Immune system disease,,,,,,,,,,,,,,,,,,,Ketamine,,,,,,,,
7138,IL12B,C0033860,Atorvastatin,DB01076,Psoriasis,Withdrawn,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Skin disease,0,,,,,,,,,,,,,,,,,DNAJB5,,,,,,,,
17004,MIF,C0343467,Thalidomide,DB01041,Erythema nodosum leprosum,Approved,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14121,CCL13,C0242459,Triamcinolone,DB00620,Simple Pulmonary Eosinophilia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2288,Diazepam,DB00829,Muscle Spasticity,C0026838,Approved,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3},,Nervous system disease,,,,,,,,,,,,,,,,,,,Amifostine,,,,,,,,
16120,SEC23B,C0008350,Ursodeoxycholic acid,DB01586,Cholelithiasis,Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C},,Digestive system disease,CDA-II,CDAII,HEMPAS,CDAN2,,,,,,,,,,,,,,,,,,,,,,
33379,CRP,C0878773,Lidocaine,DB00281,Overactive Bladder,Terminated,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
23591,ADRB2,C0020651,Midodrine,DB00211,"Hypotension, Orthostatic",Approved,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O},,Cardiovascular disease,ADRBR,B2AR,ADRB2R,,,,,,,,,,,,,,,,,,,,,,,
3703,Levofloxacin,DB01137,Staphylococcus aureus infection,C1318973,Approved,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,OPN1LW,,,,,,,,
14433,FANCC,C0278996,Methotrexate,DB00563,Cancer of Head and Neck,Approved,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27804,BDNF,C1456624,Methamphetamine,DB01577,Methamphetamine abuse,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 1,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
36825,LDAH,C0600139,Simvastatin,DB00641,Prostate carcinoma,Withdrawn,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
7901,ESR1,C0029401,Zoledronic acid,DB00399,Osteitis Deformans,Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,NR3A1,Era,ER-alpha,ESR,,,,,,,,,,,,,,,,,,,,,,
23635,TLR2,C0023283,Fluconazole,DB00196,"Leishmaniasis, Cutaneous",Terminated,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O},Phase 3,Infectious disease,TIL4,CD282,,,,,,,,,,,,,,,,,,,,,,,,
32276,HJV,C0020619,Testosterone,DB00624,Hypogonadism,Withdrawn,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},Phase 1,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6281,Ulobetasol,DB00596,Exanthema,C0015230,Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Infectious disease,,,,,,,,,,,,,,,,,,,OLA1,,,,,,,,
26993,NCAM1,C1955861,Thalidomide,DB01041,T-Cell Large Granular Lymphocyte Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,NCAM,CD56,,,,,,,,,,,,,,,,,,,,,,,,
34093,SBDS,C0029453,Cholecalciferol,DB00169,Osteopenia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 2/Phase 3,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9441,HCG9,C0026896,Pyridostigmine,DB00545,Myasthenia Gravis,Approved,C[N+]1=CC=CC(=C1)OC(=O)N(C)C},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13293,PEX1,C0001403,Triamcinolone,DB00620,Addison Disease,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16831,IGF2BP1,C0600041,Ofloxacin,DB01165,Infective cystitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15905,EGFR,C0349543,Temozolomide,DB00853,Glioblastoma multiforme of brain,Approved,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
16694,TRIM13,C0027662,Erlotinib,DB00530,Multiple Endocrine Neoplasia,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23036,CCND1,C0006118,Lomustine,DB01206,Brain Neoplasms,Approved,C1CCC(CC1)NC(=O)N(CCCl)N=O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2327,Diflorasone,DB00223,"Dermatitis, Atopic",C0011615,Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C)F},,Immune system disease,,,,,,,,,,,,,,,,,,,MIR22,,,,,,,,
31566,PPARD,C0400966,Ezetimibe,DB00973,Non-alcoholic Fatty Liver Disease,Terminated,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O},Phase 2,Endocrine disease,NUC1,NUCII,FAAR,NR1C2,,,,,,,,,,,,,,,,,,,,,,
31263,AGTR2,C0001624,Erlotinib,DB00530,Adrenal Gland Neoplasms,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15922,BRAF,C0555198,Ondansetron,DB00904,Malignant Glioma,Withdrawn,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C},Phase 2,Cancer,BRAF1,,,,,,,,,,,,,,,,,,,,,,,,,
24258,SERPINA5,C0085096,Treprostinil,DB00374,Peripheral Vascular Diseases,Terminated,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},Phase 3,Cancer,PAI3,PROCI,PLANH3,PCI,,,,,,,,,,,,,,,,,,,,,,
24718,PDCD1,C0029077,Triamcinolone,DB00620,"Ophthalmia, Sympathetic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,CD279,hSLE1,PD-1,SLEB2,,,,,,,,,,,,,,,,,,,,,,
20862,GRIA1,C0020594,Flibanserin,DB04908,Hypoactive Sexual Desire Disorder,Approved,C1CN(CCN1CCN2C3=CC=CC=C3NC2=O)C4=CC=CC(=C4)C(F)(F)F},,,GluA1,GLURA,GLUR1,,,,,,,,,,,,,,,,,,,,,,,
2300,Diclofenac,DB00586,"Osteoarthritis, Knee",C0409959,Approved,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,LINC02210-CRHR1,,,,,,,,
18461,FANCG,C0023465,Daunorubicin,DB00694,Acute monocytic leukemia,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11317,HMGCR,C0034362,Tetracycline,DB00759,Q Fever,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
6989,TGM2,C0029408,Salmon Calcitonin,DB00017,Degenerative polyarthritis,Terminated,CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CN=CN2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO},Phase 3,Immune system disease,0,,,,,,,,,,,,,,,,,COL15A1,,,,,,,,
16321,COL3A1,C0017574,Chlorhexidine,DB00878,Gingivitis,Approved,C1=CC(=CC=C1N/C(=N/C(=NCCCCCCN=C(/N=C(/NC2=CC=C(C=C2)Cl)\\N)N)N)/N)Cl},,,EDS4A,,,,,,,,,,,,,,,,,,,,,,,,,
16463,RAPGEF5,C0029442,Ergocalciferol,DB00153,Osteomalacia,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8931,Cyclophosphamide,DB00531,Cardiotoxicity,C0876994,Terminated,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 3,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
17497,FGFR1,C1384606,Ospemifene,DB04938,Dyspareunia,Approved,C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\C3=CC=C(C=C3)OCCO)/CCCl},,Reproductive system disease,CEK,FLG,BFGFR,N-SAM,CD331,FLT2,KAL2,,,,,,,,,,,,,,,,,,,
22039,TSBP1-AS1,C0855095,Idelalisib,DB09054,Small Lymphocytic Lymphoma,Approved,CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
270,Amphotericin B,DB00681,Brucellosis,C0006309,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Ceftazidime,,,,,,,,
36747,ASPA,C0206307,Lithium,DB01356,Canavan Disease,Withdrawn,[Li]},Phase 2,Neurodegenerative disease,ACY2,,,,,,,,,,,,,,,,,,,,,,,,,
30069,H3P10,C0206708,Aminolevulinic acid,DB00855,Cervical Intraepithelial Neoplasia,Terminated,C(CC(=O)O)C(=O)CN},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2126,Desonide,DB01260,Exanthema,C0015230,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)CCC5=CC(=O)C=C[C@]35C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CYP21A2,,,,,,,,
8452,CAT,C0270549,Quetiapine,DB01224,Generalized Anxiety Disorder,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
5285,Procaine benzylpenicillin,DB09320,Acute otitis media,C0271429,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,GLIPR1,,,,,,,,
34101,STARD4-AS1,C1704272,Finasteride,DB01216,Benign Prostatic Hyperplasia,Withdrawn,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},Phase 3,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11888,PPP1R1B,C0036341,Glycine,DB00145,Schizophrenia,Withdrawn,C(C(=O)O)N},Phase 3,Mental and behavioural disorder,DARPP-32,FLJ20940,,,,,,,,,,,,,,,,,,,,,,,,
8259,HNF1B,C0740394,Sulfinpyrazone,DB01138,Hyperuricemia,Approved,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4},,,LFB3,VHNF1,HNF1beta,MODY5,TCF2,,,,,,,,,,,,,,,,,,,,,
5073,Pramocaine,DB09345,Burn injury,C0006434,Approved,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2},,,,,,,,,,,,,,,,,,,,,DIRAS1,,,,,,,,
16406,LOC102723407,C0162565,Promazine,DB00420,Acute intermittent porphyria,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
19167,CYP24A1,C0042963,Haloperidol,DB00502,Vomiting,Withdrawn,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F},Phase 0,,CP24,P450-CC24,CYP24,,,,,,,,,,,,,,,,,,,,,,,
25384,DMRT1,C0041408,Somatropin recombinant,DB00052,Turner Syndrome,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Congenital malformation,CT154,,,,,,,,,,,,,,,,,,,,,,,,,
8401,Methyltestosterone,DB06710,hormone deficiency,C0599750,Terminated,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C},Phase 2,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
8781,LY6K,C0013295,Sucralfate,DB00364,Duodenal Ulcer,Approved,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al]},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28404,MMP9,C0007682,Temozolomide,DB00853,CNS disorder,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Nervous system disease,CLG4B,,,,,,,,,,,,,,,,,,,,,,,,,
12059,RGS6,C0013264,Ataluren,DB05016,"Muscular Dystrophy, Duchenne",Approved,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15107,POLDIP2,C0474368,Prednisolone,DB00860,Labor Pain,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 0,,0,,,,,,,,,,,,,,,,,,,,,,,,,
1516,Chlordiazepoxide,DB00475,Anxiety,C0003467,Approved,CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,Tirofiban,,,,,,,,
9894,Dexamethasone,DB01234,Disorder of shoulder,C1290859,Withdrawn,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
36630,CD34,C0016048,Hydroxyurea,DB01005,Fibromatosis,Withdrawn,C(=O)(N)NO},Phase 2,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,,,,,,,,
32364,FOLR1,C0018798,Milrinone,DB00235,Congenital Heart Defects,Terminated,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2},Phase 2,Congenital malformation,FOLR,,,,,,,,,,,,,,,,,,,,,,,,,
8644,CASP3,C0242350,Vardenafil,DB00862,Erectile dysfunction,Approved,CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26650,BRCA1,C0278486,Exemestane,DB00990,Breast cancer stage II,Withdrawn,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C},Phase 2,Cancer,RNF53,PPP1R53,FANCS,,,,,,,,,,,,,,,,,,,,,,,
29909,NOD2,C0856825,Pentostatin,DB00552,Acute GVH disease,Terminated,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O},Phase 1/Phase 2,Immune system disease,BLAU,PSORAS1,CLR16.3,NLRC2,IBD1,CARD15,,,,,,,,,,,,,,,,,,,,
12691,FOXP3,C0206525,Bedaquiline,DB08903,"Tuberculosis, Drug-Resistant",Approved,CN(C)CC[C@@](C1=CC=CC2=CC=CC=C21)([C@H](C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O},,Infectious disease,JM2,XPID,AIID,PIDX,DIETER,SCURFIN,IPEX,,,,,,,,,,,,,,,,,,,
5933,Thiotepa,DB04572,Malignant pericardial effusion,C0220655,Approved,C1CN1P(=S)(N2CC2)N3CC3},,,,,,,,,,,,,,,,,,,,,NABP1,,,,,,,,
24263,HIF1A,C0085096,Treprostinil,DB00374,Peripheral Vascular Diseases,Terminated,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},Phase 3,Cancer,MOP1,HIF-1alpha,PASD8,HIF1,bHLHe78,,,,,,,,,,,,,,,,,,,,,
36049,CRB1,C0035334,Unoprostone,DB06826,Retinitis Pigmentosa,Terminated,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},Phase 3,Nervous system disease,LCA8,RP12,,,,,,,,,,,,,,,,,,,,,,,,
34679,SMS,C0220650,Temozolomide,DB00853,Metastatic malignant neoplasm to brain,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34731,ADH1B,C0549393,Ethanol,DB00898,Alcohol problem,Terminated,CCO},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
15747,SYN1,C0014549,Topiramate,DB00273,Tonic-Clonic Epilepsy,Approved,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
5341,Promazine,DB00420,Urticaria,C0042109,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,UBE2T,,,,,,,,
11995,ALL1,C0023449,Vindesine,DB00309,Acute lymphocytic leukemia,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
5152,Prednisolone,DB00860,Dermatologic disorders,C0037274,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,CUL1,,,,,,,,
14482,FAT1,C0153601,Bleomycin,DB00290,Malignant neoplasm of penis,Approved,CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O},,Cancer,CDHF7,CDHR8,,,,,,,,,,,,,,,,,,,,,,,,
1941,Cortisone acetate,DB01380,Seborrheic dermatitis,C0036508,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,SMAD3,,,,,,,,
20811,CLOCK,C0028734,Flavoxate,DB01148,Nocturia,Approved,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4},,Urinary system disease,KIAA0334,KAT13D,bHLHe8,,,,,,,,,,,,,,,,,,,,,,,
21390,PEAR1,C0524702,Fondaparinux sodium,DB00569,Pulmonary Thromboembolisms,Approved,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21353,CYP2J2,C0016412,Levoleucovorin,DB11596,Folic Acid Deficiency,Approved,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14064,IL4,C0035439,Triamcinolone,DB00620,Rheumatic Heart Disease,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Cardiovascular disease,BSF1,IL-4,BCGF1,BCGF-1,MGC79402,,,,,,,,,,,,,,,,,,,,,
9025,CHAT,C0017168,Sodium Citrate,DB09154,Gastroesophageal reflux disease,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
18068,B2M,C0022575,Cyclosporine,DB00091,Keratoconjunctivitis Sicca,Approved,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11755,TGFB3,C0085612,Tocainide,DB01056,Ventricular arrhythmia,Approved,CC1=C(C(=CC=C1)C)NC(=O)C(C)N},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32530,HTR3A,C0520909,Nicotine,DB00184,Postoperative Nausea and Vomiting,Terminated,CN1CCC[C@H]1C2=CN=CC=C2},Phase 2,,5-HT3R,5-HT3A,,,,,,,,,,,,,,,,,,,,,,,,
19595,PIK3CG,C0007115,Liothyronine,DB00279,Malignant neoplasm of thyroid,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3990,Mesoridazine,DB00933,Schizophrenia,C0036341,Approved,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)C},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,KMT2D,,,,,,,,
2281,Dextromethorphan,DB00514,Sore Throat,C0242429,Approved,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC},,Infectious disease,,,,,,,,,,,,,,,,,,,LACC1,,,,,,,,
11897,SAMD9L,C0023479,Arsenic trioxide,DB01169,Acute myelomonocytic leukemia,Approved,[O-2].[O-2].[O-2].[As+3].[As+3]},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32215,BTG3,C0034931,Thalidomide,DB01041,Reflex Sympathetic Dystrophy,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9440,TSBP1-AS1,C0026896,Pyridostigmine,DB00545,Myasthenia Gravis,Approved,C[N+]1=CC=CC(=C1)OC(=O)N(C)C},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15662,MTOR,C0014547,Primidone,DB00794,"Epilepsies, Partial",Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33141,DDAH2,C0032914,Sildenafil,DB00203,Pre-Eclampsia,Terminated,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4440,Nitroglycerin,DB00727,Perioperative hypertension,C3661921,Approved,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]},,,,,,,,,,,,,,,,,,,,,DPYD,,,,,,,,
34956,GRP,C0032310,Hydrocortisone,DB00741,"Pneumonia, Viral",Terminated,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
17475,NR0B1,C0020625,Tolvaptan,DB06212,Hyponatremia,Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30855,PSMD12,C1522378,Cyclosporine,DB00091,"Leukemia, Large Granular Lymphocytic",Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2570,Echothiophate,DB01057,Esotropia,C0014877,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Congenital malformation,,,,,,,,,,,,,,,,,,,HTR3A,,,,,,,,
27990,ADH1B,C0014859,Fluorouracil,DB00544,Esophageal Neoplasms,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34365,MKI67,C0007860,Cefixime,DB00671,Uterine Cervicitis,Terminated,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O},Phase 3,Reproductive system disease,MIB-,PPP1R105,,,,,,,,,,,,,,,,,,,,,,,,
24224,ICAM1,C0917798,Phentolamine,DB00692,Cerebral Ischemia,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cardiovascular disease,CD54,,,,,,,,,,,,,,,,,,,,,,,,,
26233,ERCC4,C0153594,Vinblastine,DB00570,Malignant neoplasm of testis,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25475,VPS13A,C0003962,Eplerenone,DB00700,Ascites,Withdrawn,C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
22832,RUNX2,C0010308,Liothyronine,DB00279,Congenital Hypothyroidism,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Congenital malformation,AML3,PEBP2A1,PEBP2aA1,CCD,CBFA1,CCD1,,,,,,,,,,,,,,,,,,,,
5544,Scopolamine,DB00747,Rhinorrhea,C1260880,Approved,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},,Nervous system disease,,,,,,,,,,,,,,,,,,,MYO18B,,,,,,,,
31648,KRAS,C0149978,Oxaliplatin,DB00526,Adenocarcinoma of rectum,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34279,GCG,C0242339,Simvastatin,DB00641,Dyslipidemias,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Metabolic disease,GLP2,GRPP,,,,,,,,,,,,,,,,,,,,,,,,
14716,CCL2,C0020542,Iloprost,DB01088,Pulmonary Hypertension,Withdrawn,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Lung disease,MCP1,MCP-1,MCAF,SMC-CF,GDCF-2,HC11,MGC9434,SCYA2,,,,,,,,,,,,,,,,,,
33649,CCND1,C0206638,Zoledronic acid,DB00399,Giant Cell Tumor of Bone,Terminated,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
7096,HCP5,C0019360,Pregabalin,DB00230,Herpes zoster disease,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,LINC02521,,,,,,,,
26940,MECOM,C0280449,Cyclophosphamide,DB00531,secondary acute myeloid leukemia,Terminated,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 3,Cancer,MDS1-EVI1,PRDM3,KMT8E,MDS1,EVI1,,,,,,,,,,,,,,,,,,,,,
2503,Doxycycline,DB00254,Pharyngitis,C0031350,Approved,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,IL12A,,,,,,,,
24187,SBDS,C0267963,Pancrelipase,DB00085,Exocrine pancreatic insufficiency,Approved,C1CC2C(C(C1O2)C(=O)[O-])C(=O)[O-].[Na+].[Na+]},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16830,FST,C0600041,Ofloxacin,DB01165,Infective cystitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
33400,ALDH2,C0687132,Topiramate,DB00273,heavy drinking,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 2,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
8032,KLK3,C1739363,Terazosin,DB01162,Prostatic Hypertrophy,Approved,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC},,,,,,,,,,,,,,,,,,,,,,,,,,,,
12543,TNF,C0031154,Tazobactam,DB01606,Peritonitis,Approved,C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3},,Infectious disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
29788,HDAC1,C0023524,Mefloquine,DB00358,"Leukoencephalopathy, Progressive Multifocal",Terminated,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32866,HMGB1,C1290884,Prednisone,DB00635,Inflammatory disorder,Terminated,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16674,ZNRD2,C0027662,Erlotinib,DB00530,Multiple Endocrine Neoplasia,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
8053,IL13,C1739363,Terazosin,DB01162,Prostatic Hypertrophy,Approved,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC},,,P600,IL-13,ALRH,BHR1,MGC116786,MGC116788,MGC116789,,,,,,,,,,,,,,,,,,,
16869,ITGAX,C0023443,Pentostatin,DB00552,Hairy Cell Leukemia,Approved,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O},,Cancer,CD11c,CD11C,,,,,,,,,,,,,,,,,,,,,,,,
19609,CDKN1A,C0585442,Methotrexate,DB00563,Osteosarcoma of bone,Approved,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
18210,DGCR8,C0027708,Vincristine,DB00541,Nephroblastoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26291,ALB,C0042875,Vitamin E,DB00163,Vitamin E Deficiency,Approved,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
30865,ACTG2,C0162429,Nandrolone phenpropionate,DB00984,Malnutrition,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CC[C@H]35},Phase 2,Cancer,ACTSG,ACTL3,ACTA3,,,,,,,,,,,,,,,,,,,,,,,
22204,KRT1,C0043037,Imiquimod,DB00724,Common wart,Approved,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N},,Skin disease,KRT1A,,,,,,,,,,,,,,,,,,,,,,,,,
13864,JAZF1,C0024141,Mycophenolic acid,DB01024,"Lupus Erythematosus, Systemic",Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 2/Phase 3,Immune system disease,TIP27,DKFZp761K2222,ZNF802,,,,,,,,,,,,,,,,,,,,,,,
16890,ADA,C0023443,Pentostatin,DB00552,Hairy Cell Leukemia,Approved,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
6078,Tramadol,DB00193,Chronic pain,C0150055,Approved,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O},,,,,,,,,,,,,,,,,,,,,HPS5,,,,,,,,
25039,UNC13A,C0002736,Pioglitazone,DB01132,Amyotrophic Lateral Sclerosis,Terminated,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3},Phase 2,Neurodegenerative disease,KIAA1032,Munc13-1,,,,,,,,,,,,,,,,,,,,,,,,
17374,IL4,C0031069,Colchicine,DB01394,Familial Mediterranean Fever,Approved,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC},,Infectious disease,BSF1,IL-4,BCGF1,BCGF-1,MGC79402,,,,,,,,,,,,,,,,,,,,,
5389,Quetiapine,DB01224,Bipolar disorder in remission,C0270425,Approved,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,C4B_2,,,,,,,,
1961,Cromoglicic acid,DB01003,Asthma,C0004096,Approved,C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)O)O)C(=O)C=C(O2)C(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,IFNL3,,,,,,,,
10747,HIF1A,C1318973,Vancomycin,DB00512,Staphylococcus aureus infection,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,MOP1,HIF-1alpha,PASD8,HIF1,bHLHe78,,,,,,,,,,,,,,,,,,,,,
34764,CC2D2A,C0030283,Ethanol,DB00898,Pancreatic Cyst,Terminated,CCO},Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
35309,CXCR3,C0017658,Prednisolone,DB00860,Glomerulonephritis,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 3,Urinary system disease,CKR-L2,CMKAR3,IP10-R,MigR,CD183,GPR9,,,,,,,,,,,,,,,,,,,,
14524,MALAT1,C0007847,Topotecan,DB01030,Malignant tumor of cervix,Approved,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3352,Hydrocortisone,DB00741,Infective blepharitis,C0729587,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,DAPK1,,,,,,,,
1762,Clobetasol propionate,DB01013,Nummular eczema,C0085656,Approved,CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CCl},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,GSR,,,,,,,,
27802,TAC1,C0556385,Atomoxetine,DB00289,Alcohol dependence,Terminated,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2},Phase 1,Mental and behavioural disorder,NPK,TAC2,NKNA,,,,,,,,,,,,,,,,,,,,,,,
32478,PAX8,C0238461,Paclitaxel,DB01229,Anaplastic thyroid carcinoma,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
8589,Salicylic acid,DB00936,Hypertensive disease,C0020538,Terminated,C1=CC=C(C(=C1)C(=O)O)O},Phase 2,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
15471,AKT1,C0278488,Vinblastine,DB00570,Carcinoma breast stage IV,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,RAC,PKB,PRKBA,AKT,,,,,,,,,,,,,,,,,,,,,,
35985,RAB7A,C0085119,Treprostinil,DB00374,Foot Ulcer,Terminated,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
21552,TNFSF4,C0751362,Viloxazine,DB09185,Narcolepsy-Cataplexy Syndrome,Approved,CCOC1=CC=CC=C1OCC2CNCCO2},,Nervous system disease,OX-40L,gp34,CD252,TXGP1,,,,,,,,,,,,,,,,,,,,,,
25378,BRD2,C0041408,Somatropin recombinant,DB00052,Turner Syndrome,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
33341,HLA-DQB1,C0038362,Thalidomide,DB01041,Stomatitis,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Infectious disease,HLA-DQB,,,,,,,,,,,,,,,,,,,,,,,,,
29368,IGF1R,C1699634,Letrozole,DB01006,HER-2 positive breast cancer,Withdrawn,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3},Phase 1/Phase 2,Cancer,JTK13,CD221,IGFIR,MGC18216,IGFR,,,,,,,,,,,,,,,,,,,,,
20800,FAF1,C4083212,Finasteride,DB01216,"Alopecia, Male Pattern",Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13562,HFE,C0002875,Triamcinolone,DB00620,Cooley's anemia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Hematologic disease,HLA-H,,,,,,,,,,,,,,,,,,,,,,,,,
37145,EGF,C0280099,Docetaxel,DB01248,adult solid tumor,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
736,Betaxolol,DB00195,Ocular Hypertension,C0028840,Approved,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O},,Nervous system disease,,,,,,,,,,,,,,,,,,,Halofantrine,,,,,,,,
34376,CLDN14,C0451641,Ciprofloxacin,DB00537,Urolithiasis,Terminated,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},Phase 3,Urinary system disease,DFNB29,,,,,,,,,,,,,,,,,,,,,,,,,
18083,IDH1,C0023467,Tretinoin,DB00755,"Leukemia, Myelocytic, Acute",Withdrawn,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3284,Heparin,DB01109,Peripheral arterial embolism,C0564750,Approved,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},,Vascular disease,,,,,,,,,,,,,,,,,,,CDKN3,,,,,,,,
16974,IL33,C3875321,Pramocaine,DB09345,Inflammatory dermatosis,Approved,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2},,Skin and connective tissue disease,DVS27,DKFZp586H0523,NF-HEV,IL1F11,C9orf26,,,,,,,,,,,,,,,,,,,,,
9335,PARK7,C0030567,Trihexyphenidyl,DB00376,Parkinson Disease,Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24429,ANKS1B,C0019202,Triethylenetetramine,DB06824,Hepatolenticular Degeneration,Approved,C(CNCCNCCN)N},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
21921,STK11,C0025202,Lovastatin,DB00227,melanoma,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27177,RET,C1266050,Trametinib,DB08911,Poorly Differentiated Thyroid Carcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2,Cancer,CDHF12,RET51,CDHR16,HSCR1,MEN2A,MTC1,MEN2B,,,,,,,,,,,,,,,,,,,
33429,CLU,C0013221,Triptorelin,DB06825,Drug toxicity,Terminated,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8},Phase 2,,SGP-2,SP-40,TRPM-2,KUB1,CLU2,CLI,APOJ,,,,,,,,,,,,,,,,,,,
35602,NOTCH3,C0024121,Pemetrexed,DB00642,Lung Neoplasms,Terminated,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 3,Cancer,CASIL,CADASIL,,,,,,,,,,,,,,,,,,,,,,,,
3456,Icosapent,DB00159,Hypertriglyceridemia,C0020557,Approved,CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCC(=O)O},,Metabolic disease,,,,,,,,,,,,,,,,,,,WG,,,,,,,,
17325,BMS1,C3544321,Thioridazine,DB00679,Treatment-resistant schizophrenia,Approved,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
33301,THPO,C0001815,Sunitinib,DB01268,Primary Myelofibrosis,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36104,NRAS,C0279663,Paclitaxel,DB01229,Serous cystadenocarcinoma ovary,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
20391,ITGAM,C0012546,Erythromycin,DB00199,Diphtheria,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,CD11b,CR3A,CD11B,,,,,,,,,,,,,,,,,,,,,,,
12725,F2,C0149871,Warfarin,DB00682,Deep Vein Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13309,GH1,C0405580,Triamcinolone,DB00620,Adrenal cortical hypofunction,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,GH-N,GHN,GH,hGH-N,,,,,,,,,,,,,,,,,,,,,,
16571,SLC10A1,C0238052,Cholic Acid,DB02659,"Xanthomatosis, Cerebrotendinous",Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C},,Congenital disorder of metabolism,NTCP,,,,,,,,,,,,,,,,,,,,,,,,,
29138,IDH2,C0280790,Irinotecan,DB00762,adult anaplastic oligodendroglioma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9223,Prednisolone,DB00860,Lupus Nephritis,C0024143,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
10801,GIT1,C1263846,Methylphenidate,DB00422,Attention deficit hyperactivity disorder,Approved,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
16151,MTCO2P12,C0035585,Fusidic Acid,DB02703,Rickettsia Infections,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23298,LINC00989,C0021603,Cyclobenzaprine,DB00924,Sleep Initiation and Maintenance Disorders,Terminated,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
6930,TLE5,C0392164,L-Cysteine,DB00151,Pulmonary Cystic Fibrosis,Approved,C([C@@H](C(=O)O)N)S},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,MIR451A,,,,,,,,
16142,NOS2,C0006060,Fusidic Acid,DB02703,Boutonneuse Fever,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,iNOS,HEP-NOS,NOS2A,,,,,,,,,,,,,,,,,,,,,,,
12917,SQLE,C0040252,Zinc oxide,DB09321,Tinea corporis (disorder),Approved,O=[Zn]},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14372,SEMA3C,C0009806,Oxycodone,DB00497,Constipation,Terminated,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O},Phase 3,Digestive system disease,SemE,SEMAE,,,,,,,,,,,,,,,,,,,,,,,,
2145,Desoximetasone,DB00547,Pruritus of genital organs,C0033777,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)CO)C)O)F)C},,,,,,,,,,,,,,,,,,,,,HAMP,,,,,,,,
22879,IFNG,C0677607,Levothyroxine,DB00451,Hashimoto Disease,Approved,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N},,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
1477,Cephalexin,DB00567,Osteomyelitis due to Staphylococcus aureus,C1997728,Approved,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)SC1)C(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,Teriflunomide,,,,,,,,
25402,STAT5B,C0007117,Vismodegib,DB08828,Basal cell carcinoma,Approved,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15398,SLC12A3,C0151714,Calcium Gluceptate,DB00326,Hypermagnesemia,Approved,C([C@H]([C@H]([C@@H]([C@H](C(C(=O)[O-])O)O)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(C(=O)[O-])O)O)O)O)O)O.[Ca+2]},,Endocrine and metabolic disease,NCCT,,,,,,,,,,,,,,,,,,,,,,,,,
21564,SLC5A7,C0751362,Viloxazine,DB09185,Narcolepsy-Cataplexy Syndrome,Approved,CCOC1=CC=CC=C1OCC2CNCCO2},,Nervous system disease,hCHT,CHT1,,,,,,,,,,,,,,,,,,,,,,,,
15584,CNR1,C0003469,Paroxetine,DB00715,Anxiety Disorders,Terminated,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4},Phase 3,Mental and behavioural disorder,CB1K5,CB-R,CB1,CANN6,CB1A,CNR,,,,,,,,,,,,,,,,,,,,
28697,SMAD7,C0009404,Sorafenib,DB00398,Colorectal Neoplasms,Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30066,MTHFR,C0206708,Aminolevulinic acid,DB00855,Cervical Intraepithelial Neoplasia,Terminated,C(CC(=O)O)C(=O)CN},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19260,FBLN5,C1961112,Dobutamine,DB00841,Heart Decompensation,Approved,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O},,Cardiovascular disease,EVEC,UP50,DANCE,ARMD3,,,,,,,,,,,,,,,,,,,,,,
24889,MT1JP,C0041318,Pyrazinamide,DB00339,"Tuberculosis, Meningeal",Approved,C1=CN=C(C=N1)C(=O)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31164,CALR,C0877438,Doxycycline,DB00254,Non-ischemic cardiomyopathy,Terminated,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
832,Butenafine,DB01091,Tinea Versicolor,C0040262,Approved,CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32},,Infectious disease,,,,,,,,,,,,,,,,,,,Ivabradine,,,,,,,,
1487,Cetirizine,DB00341,Hay fever,C0018621,Approved,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,Thalidomide,,,,,,,,
9360,PINK1,C0030567,Trihexyphenidyl,DB00376,Parkinson Disease,Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
786,Bromocriptine,DB01200,Acromegaly,C0001206,Approved,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O},,Immune system disease,,,,,,,,,,,,,,,,,,,NAGS,,,,,,,,
36343,KLHL41,C0011168,Lansoprazole,DB00448,Deglutition Disorders,Withdrawn,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F},Phase 1/Phase 2,,SARCOSIN,Krp1,KBTBD10,,,,,,,,,,,,,,,,,,,,,,,
10643,TP53,C0343378,Clarithromycin,DB01211,Helicobacter-associated gastritis,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3442,FARS2,C0917801,Citalopram,DB00215,Sleeplessness,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,,0,,,,,,,,,,,,,,,,,ARG1,,,,,,,,
13904,HLA-DRB1,C0026769,Zoledronic acid,DB00399,Multiple Sclerosis,Terminated,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},Phase 3,Nervous system disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
24600,NOTCH2,C0001126,Potassium Citrate,DB09125,Renal tubular acidosis,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
8181,ERCC4,C0042109,Methotrexate,DB00563,Urticaria,Terminated,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3460,Idebenone,DB09081,"Optic Atrophy, Hereditary, Leber",C0917796,Approved,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,ERVK-21,,,,,,,,
26843,LOC102723407,C0855139,Vincristine,DB00541,Monocytoid B-cell lymphoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30899,GATA1,C0279650,Idarubicin,DB01177,childhood acute megakaryocytic leukemia (M7),Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O},Phase 2,Cancer,ERYF1,NFE1,GATA-1,,,,,,,,,,,,,,,,,,,,,,,
1014,Cefamandole,DB01326,Haemophilus influenzae pneumonia,C0276026,Approved,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)[C@@H](C4=CC=CC=C4)O)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Meticillin,,,,,,,,
34077,KCNMA1,C0029453,Cholecalciferol,DB00169,Osteopenia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 2/Phase 3,Musculoskeletal disease,KCa1.1,mSLO1,SLO,,,,,,,,,,,,,,,,,,,,,,,
32186,KRT20,C0079772,Isotretinoin,DB00982,T-Cell Lymphoma,Terminated,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\\C(=O)O)/C)/C},Phase 2,Cancer,CK20,K20,MGC35423,,,,,,,,,,,,,,,,,,,,,,,
23682,IL17A,C1328252,Miltefosine,DB09031,Mucocutaneous leishmaniasis,Approved,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},,Infectious disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
4233,Minocycline,DB01017,Gonorrhea,C0018081,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,MMP26,,,,,,,,
29044,FAM53B,C0600427,Vigabatrin,DB01080,Cocaine Dependence,Terminated,C=CC(CCC(=O)O)N},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
19241,TAC1,C0282488,Mycophenolic acid,DB01024,Interstitial Cystitis,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,Urinary system disease,NPK,TAC2,NKNA,,,,,,,,,,,,,,,,,,,,,,,
21729,PREPL,C0022972,Guanidine,DB00536,Lambert-Eaton Myasthenic Syndrome,Approved,C(=N)(N)N},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2584,Efinaconazole,DB09040,Onychomycosis,C0040261,Approved,C[C@H]([C@](CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3CCC(=C)CC3},,Infectious disease,,,,,,,,,,,,,,,,,,,HLA-DQA1,,,,,,,,
34803,IFNG,C0010823,Cidofovir,DB00369,Cytomegalovirus Infections,Withdrawn,C1=CN(C(=O)N=C1N)C[C@@H](CO)OCP(=O)(O)O},Phase 1,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
30400,ELK3,C0220647,Gemcitabine,DB00441,Carcinoma of unknown primary,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 2,Cancer,ERP,SAP2,,,,,,,,,,,,,,,,,,,,,,,,
20286,IL6,C0042870,Ergocalciferol,DB00153,Vitamin D Deficiency,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
6540,MAOA,C0033893,Codeine,DB00318,Tension Headache,Approved,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O},,Nervous system disease,,,,,,,,,,,,,,,,,,TRP-AGG2-5,,,,,,,,
8344,SLC6A4,C0003467,Citalopram,DB00215,Anxiety,Withdrawn,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Mental and behavioural disorder,5-HTT,SERT1,HTT,OCD1,,,,,,,,,,,,,,,,,,,,,,
23798,ENO3,C0231528,Naproxen,DB00788,Myalgia,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,,,,,,,,,,,,,,,,,,,,,,,,,,,
3180,Gentamicin,DB00798,Klebsiella sepsis,C0745528,Approved,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC},,Infectious disease,,,,,,,,,,,,,,,,,,,RSPH1,,,,,,,,
33836,FN1,C0011875,Heparin,DB01109,Diabetic Angiopathies,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2/Phase 3,Vascular disease,CIG,LETS,GFND2,FINC,,,,,,,,,,,,,,,,,,,,,,
19205,NEFL,C0751967,Mitoxantrone,DB01204,"Multiple Sclerosis, Relapsing-Remitting",Approved,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11788,AVPR1A,C0019080,Aprotinin,DB06692,Hemorrhage,Approved,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](CSSC[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N4CCC[C@@H]4C(=O)N5CCC[C@@H]5C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N6CCC[C@H]6C(=O)N[C@H](CSSC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CCC(=O)N)[C@@H](C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCNC(=N)N)C)CCCCN)[C@H](C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)[C@@H](C)CC},,,AVPR1,,,,,,,,,,,,,,,,,,,,,,,,,
17305,COMT,C3544321,Thioridazine,DB00679,Treatment-resistant schizophrenia,Approved,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
4752,OPRL1,C0857177,Salicylic acid,DB00936,Arthritic pains,Approved,C1=CC=C(C(=C1)C(=O)O)O},,,0,,,,,,,,,,,,,,,,,NES,,,,,,,,
30036,NF1,C0004114,Temozolomide,DB00853,Astrocytoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
36506,IL1B,C0019621,Clofarabine,DB00631,"Histiocytosis, Langerhans-Cell",Withdrawn,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl)N},Phase 2,Cancer,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
13552,DHODH,C0002875,Triamcinolone,DB00620,Cooley's anemia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14291,ALB,C0020473,Cholecalciferol,DB00169,Hyperlipidemia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 1,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
2359,Diiodohydroxyquinoline,DB09115,Amebiasis,C0002438,Approved,C1=CC2=C(C(=C(C=C2I)I)O)N=C1},,Infectious disease,,,,,,,,,,,,,,,,,,,UFD1,,,,,,,,
837,Butorphanol,DB00611,Pain,C0030193,Approved,C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O},,,,,,,,,,,,,,,,,,,,,IL13,,,,,,,,
36129,PDGFRA,C0677866,Sirolimus,DB00877,Brain Stem Neoplasms,Withdrawn,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 1,Cancer,CD140a,PDGFR2,GAS9,,,,,,,,,,,,,,,,,,,,,,,
4428,Nitisinone,DB00348,"Tyrosinemia, Type I",C0268490,Approved,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-]},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,GUCY2C,,,,,,,,
5991,Tinidazole,DB00911,"Liver Abscess, Amebic",C0023886,Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Liver disease,,,,,,,,,,,,,,,,,,,CTNNA1,,,,,,,,
26210,KLF5,C0600518,Imatinib,DB00619,Choroidal Neovascularization,Withdrawn,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 1,Congenital malformation,IKLF,CKLF,BTEB2,,,,,,,,,,,,,,,,,,,,,,,
34595,SOAT1,C0751965,Dimethyl fumarate,DB08908,"Multiple Sclerosis, Secondary Progressive",Terminated,COC(=O)/C=C/C(=O)OC},Phase 3,Nervous system disease,STAT,,,,,,,,,,,,,,,,,,,,,,,,,
27093,IL17F,C2921627,Prednisolone,DB00860,Clinically isolated syndrome,Suspended,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Congenital malformation,IL-17F,ML1,,,,,,,,,,,,,,,,,,,,,,,,
37090,IL1A,C0037011,Dexamethasone,DB01234,Shoulder Pain,Withdrawn,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,Musculoskeletal disease,IL1F1,IL-1A,IL1-ALPHA,IL1,,,,,,,,,,,,,,,,,,,,,,
26627,THAS,C0854750,Trametinib,DB08911,Colorectal cancer recurrent,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10087,CCL11,C0004096,Zafirlukast,DB00549,Asthma,Approved,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC},,Immune system disease,eotaxin,MGC22554,SCYA11,,,,,,,,,,,,,,,,,,,,,,,
821,Bupropion,DB01156,Obesity,C0028754,Approved,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C},,Metabolic disease,,,,,,,,,,,,,,,,,,,Isavuconazonium,,,,,,,,
18636,VWF,C0019069,Desmopressin,DB00035,Hemophilia A,Approved,C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N},,Hematologic disease,F8VWF,,,,,,,,,,,,,,,,,,,,,,,,,
11824,NRXN1,C0004352,Risperidone,DB00734,Autistic Disorder,Approved,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
9133,Mometasone,DB00764,Sinusitis,C0037199,Terminated,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)Cl)C},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
33963,AGBL1-AS1,C0006287,Nitric Oxide,DB00435,Bronchopulmonary Dysplasia,Terminated,[N]=O},Phase 2/Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
14590,PITX1,C1336708,Vinblastine,DB00570,Testicular Germ Cell Tumor,Terminated,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,POTX,BFT,,,,,,,,,,,,,,,,,,,,,,,,
36577,ALK,C0278506,Pemetrexed,DB00642,Non-small cell lung cancer stage III,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27979,HLA-DPB1,C0036421,Iloprost,DB01088,Systemic Scleroderma,Terminated,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Skin disease,HLA-DP1B,,,,,,,,,,,,,,,,,,,,,,,,,
1452,Cefuroxime,DB01112,Osteomyelitis due to Staphylococcus aureus,C1997728,Approved,CO/N=C(/C1=CC=CO1)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,Tapentadol,,,,,,,,
27971,SIRT7,C0036421,Iloprost,DB01088,Systemic Scleroderma,Terminated,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Skin disease,,,,,,,,,,,,,,,,,,,,,,,,,,
24777,CXCL8,C0034069,Azathioprine,DB00993,Pulmonary Fibrosis,Terminated,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]},Phase 3,Lung disease,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
15483,BRCA1,C0278488,Vinblastine,DB00570,Carcinoma breast stage IV,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,RNF53,PPP1R53,FANCS,,,,,,,,,,,,,,,,,,,,,,,
4618,Ofloxacin,DB01165,Shigella Infections,C0013371,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,RBM3,,,,,,,,
3346,Hydrocortisone,DB00741,Gingival Diseases,C0017563,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,,,,,,,,,,,,,,,,,,,,LBP,,,,,,,,
5349,Propafenone,DB01182,Paroxysmal atrial flutter,C0741292,Approved,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O},,,,,,,,,,,,,,,,,,,,,MRGPRF,,,,,,,,
8895,Cangrelor,DB06441,Atherosclerosis,C0004153,Terminated,CSCCNC1=C2C(=NC(=N1)SCCC(F)(F)F)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O},Phase 3,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
17242,RAB7B,C0948089,Citalopram,DB00215,Acute Coronary Syndrome,Withdrawn,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 1/Phase 2,Cardiovascular disease,MGC9726,MGC16212,,,,,,,,,,,,,,,,,,,,,,,,
260,Amphetamine,DB00182,Attention deficit hyperactivity disorder,C1263846,Approved,CC(CC1=CC=CC=C1)N},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,Cefixime,,,,,,,,
37097,TNF,C0037011,Dexamethasone,DB01234,Shoulder Pain,Withdrawn,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,Musculoskeletal disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
17471,CTNS,C0020625,Tolvaptan,DB06212,Hyponatremia,Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Urinary system disease,CTNS-LSB,PQLC4,,,,,,,,,,,,,,,,,,,,,,,,
35313,CARD9,C1262313,Micafungin,DB01141,Invasive Fungal Infections,Terminated,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)[C@@H](CC(=O)N)O)C)O)O)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29999,SMN1,C0393538,Sodium phenylbutyrate,DB06819,"Muscular Atrophy, Spinal, Type II",Terminated,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},Phase 1/Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30744,MRE11,C1514428,Paclitaxel,DB01229,Primary peritoneal carcinoma,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13755,SULT2B1,C0011606,Triamcinolone,DB00620,Exfoliative dermatitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29134,CRYAB,C0280483,Irinotecan,DB00762,adult anaplastic astrocytoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,HSPB5,CRYA2,,,,,,,,,,,,,,,,,,,,,,,,
9249,HTR2A,C0015371,Trihexyphenidyl,DB00376,Extrapyramidal Disorders,Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25885,REN,C0085413,Tolvaptan,DB06212,"Polycystic Kidney, Autosomal Dominant",Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
8119,COL7A1,C0033774,Zinc oxide,DB09321,Pruritus,Approved,O=[Zn]},,,EBDCT,EBD1,EBR1,,,,,,,,,,,,,,,,,,,,,,,
16784,TNF,C0010692,Ofloxacin,DB01165,Cystitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
14382,LTF,C0011991,Zidovudine,DB00495,Diarrhea,Terminated,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]},Phase 3,Digestive system disease,HLF2,,,,,,,,,,,,,,,,,,,,,,,,,
32943,TMEM199,C0549399,Simvastatin,DB00641,Low density lipoprotein increased,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24794,PTTG1,C1527336,Prednisolone,DB00860,Sjogren's Syndrome,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
37087,IL1RN,C0037011,Dexamethasone,DB01234,Shoulder Pain,Withdrawn,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,Musculoskeletal disease,ICIL-1RA,IL1F3,IL-1RN,MGC10430,,,,,,,,,,,,,,,,,,,,,,
6880,COPD,C0006277,Theophylline,DB00277,Bronchitis,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Lung disease,0,,,,,,,,,,,,,,,,,RPS20,,,,,,,,
33971,RAMP2,C0035222,Salbutamol,DB01001,"Respiratory Distress Syndrome, Adult",Terminated,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O},Phase 2/Phase 3,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3725,Levothyroxine,DB00451,Myxedema,C0027145,Approved,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,RECQL4,,,,,,,,
12045,CD4,C0013264,Ataluren,DB05016,"Muscular Dystrophy, Duchenne",Approved,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F},,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
15288,SNX10,C0085682,"Sodium phosphate, monobasic, monohydrate",DB09525,Hypophosphatemia,Approved,OP(=O)(O)[O-].[Na+]},,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
1914,Cortisone acetate,DB01380,Keratitis,C0022568,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Skin disease,,,,,,,,,,,,,,,,,,,GYPA,,,,,,,,
35949,UQCRFS1,C1328479,Sunitinib,DB01268,Pancreatic Endocrine Carcinoma,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25733,CYP17A1,C0020635,Testosterone,DB00624,Hypopituitarism,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,Endocrine disease,P450C17,CPT7,S17AH,CYP17,,,,,,,,,,,,,,,,,,,,,,
6642,MAP2K6,C0013604,Triamterene,DB00384,Edema,Approved,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N},,,0,,,,,,,,,,,,,,,,,MAGEA11,,,,,,,,
19197,PNP,C0311375,Dimercaprol,DB06782,Arsenic Poisoning,Approved,C(C(CS)S)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
649,Benzylpenicillin,DB01053,Syphilis,C0039128,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,TMEM43,,,,,,,,
34765,WDR19,C0030283,Ethanol,DB00898,Pancreatic Cyst,Terminated,CCO},Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
28503,OGG1,C0042076,Mitomycin,DB00305,Urologic Neoplasms,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32312,SLC27A5,C0238013,Voriconazole,DB00582,Invasive aspergillosis,Terminated,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2597,Emedastine,DB01084,Pruritus,C0033774,Approved,CCOCCN1C2=CC=CC=C2N=C1N3CCCN(CC3)C},,,,,,,,,,,,,,,,,,,,,SEMA6A,,,,,,,,
6586,EGLN3,C0002351,Acetazolamide,DB00819,Altitude Sickness,Approved,CC(=O)NC1=NN=C(S1)S(=O)(=O)N},,,PHD3,HIFPH3,,,,,,,,,,,,,,,,CCDC54,,,,,,,,
2379,Dinoprostone,DB00917,Incomplete spontaneous abortion,C0000810,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\\CCCC(=O)O)O)O},,,,,,,,,,,,,,,,,,,,,FGFR1,,,,,,,,
29301,BARX1,C0279628,Cisplatin,DB00515,Adenocarcinoma Of Esophagus,Terminated,N.N.Cl[Pt]Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
6148,Triamcinolone,DB00620,"Lupus Erythematosus, Discoid",C0024138,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,,,,,,,,,,,,,,,,,,,AIMP1,,,,,,,,
5106,Prednicarbate,DB01130,"Dermatitis, Atopic",C0011615,Approved,CCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)OC(=O)OCC},,Immune system disease,,,,,,,,,,,,,,,,,,,THBS2,,,,,,,,
35406,IL24,C1720830,Mycophenolic acid,DB01024,Painful Bladder Syndrome,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,,mda-7,IL10B,Mob-5,C49A,FISP,IL-24,ST16,,,,,,,,,,,,,,,,,,,
31337,VEGFA,C0014474,Erlotinib,DB00530,Ependymoma,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
7991,LIG4,C0020626,Ergocalciferol,DB00153,Hypoparathyroidism,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15867,MIR3681HG,C0018213,Carbimazole,DB00389,Graves Disease,Approved,CCOC(=O)N1C=CN(C1=S)C},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25540,B3GNT2,C0751122,Stiripentol,DB09118,Infantile Severe Myoclonic Epilepsy,Approved,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31145,TRIM28,C1292753,Doxorubicin,DB00997,Primary Effusion Lymphoma,Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},Phase 2,Cancer,TIF1B,KAP1,TF1B,RNF96,PPP1R157,,,,,,,,,,,,,,,,,,,,,
1239,Cefpodoxime,DB01416,Klebsiella cystitis,C0520775,Approved,COCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O},,Urinary system disease,,,,,,,,,,,,,,,,,,,Polaprezinc,,,,,,,,
34219,VEGFA,C0349217,Aripiprazole,DB01238,"Depressive episode, unspecified",Terminated,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl},Phase 3,Mental and behavioural disorder,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
9355,Hydroxyurea,DB01005,Pulmonary Hypertension,C0020542,Withdrawn,C(=O)(N)NO},Phase 0,Lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
8924,NOS3,C0038358,Roxatidine acetate,DB08806,Gastric ulcer,Approved,CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2},,Digestive system disease,ECNOS,eNOS,,,,,,,,,,,,,,,,,,,,,,,,
15274,SLC2A2,C0085682,"Sodium phosphate, monobasic, monohydrate",DB09525,Hypophosphatemia,Approved,OP(=O)(O)[O-].[Na+]},,Urinary system disease,GLUT2,,,,,,,,,,,,,,,,,,,,,,,,,
14243,APOA1,C0028840,Unoprostone,DB06826,Ocular Hypertension,Approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
503,Azlocillin,DB01061,Pneumonia due to Pseudomonas,C0155860,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Domperidone,,,,,,,,
24266,MMP9,C0085096,Treprostinil,DB00374,Peripheral Vascular Diseases,Terminated,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},Phase 3,Cancer,CLG4B,,,,,,,,,,,,,,,,,,,,,,,,,
8661,GDF1,C0039685,Alprostadil,DB00770,Tetralogy of Fallot,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
16987,CCL2,C3875321,Pramocaine,DB09345,Inflammatory dermatosis,Approved,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2},,Skin and connective tissue disease,MCP1,MCP-1,MCAF,SMC-CF,GDCF-2,HC11,MGC9434,SCYA2,,,,,,,,,,,,,,,,,,
27056,YEATS4,C0205824,Ifosfamide,DB01181,"Liposarcoma, Dedifferentiated",Suspended,C1CN(P(=O)(OC1)NCCCl)CCCl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35622,GLMN,C1136321,Pioglitazone,DB01132,HIV-Associated Lipodystrophy Syndrome,Terminated,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3},Phase 3,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10393,CYP27A1,C0002962,Verapamil,DB00661,Angina Pectoris,Approved,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},,Cardiovascular disease,CTX,CYP27,,,,,,,,,,,,,,,,,,,,,,,,
35891,F7,C0027660,Sorafenib,DB00398,"Neoplasms, Glandular and Epithelial",Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
33572,TP53,C0007273,Vitamin E,DB00163,Carotid Artery Diseases,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29985,SMN1,C0152109,Sodium phenylbutyrate,DB06819,Juvenile Spinal Muscular Atrophy,Terminated,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},Phase 1/Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17367,TNFRSF1A,C0031069,Colchicine,DB01394,Familial Mediterranean Fever,Approved,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC},,Infectious disease,TNF-R,TNFAR,TNFR60,TNF-R-I,CD120a,TNF-R55,TNFR1,,,,,,,,,,,,,,,,,,,
7962,Dexrazoxane,DB00380,Cardiotoxicity,C0876994,Terminated,C[C@@H](CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2},Phase 2,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
26932,NPM1,C0280449,Cyclophosphamide,DB00531,secondary acute myeloid leukemia,Terminated,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10364,HTR2A,C0011581,Norepinephrine,DB00368,Depressive disorder,Terminated,C1=CC(=C(C=C1[C@H](CN)O)O)O},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
10450,COL4A1,C0038454,Vorapaxar,DB09030,Cerebrovascular accident,Approved,CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@H]([C@H]2/C=C/C4=NC=C(C=C4)C5=CC(=CC=C5)F)[C@H](OC3=O)C},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
12845,CCBE1,C0014733,Procaine benzylpenicillin,DB09320,Erysipelas,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3109,Fusidic Acid,DB02703,Trachoma,C0040592,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,P2RX7,,,,,,,,
31488,SUFU,C0349604,Sirolimus,DB00877,Intracranial Meningioma,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9753,Methamphetamine,DB01577,Substance Dependence,C0038580,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 2,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,
15084,NLRP3,C0700345,Tioconazole,DB01007,"Candidiasis, Vulvovaginal",Approved,C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl},,Infectious disease,AGTAVPRL,AII,AVP,FCAS,FCU,NALP3,PYPAF1,MWS,CLR1.1,C1orf7,CIAS1,,,,,,,,,,,,,,,
16270,DRD2,C0236663,Diazepam,DB00829,Alcohol withdrawal syndrome,Approved,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
11762,F2,C0019080,Aprotinin,DB06692,Hemorrhage,Approved,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](CSSC[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N4CCC[C@@H]4C(=O)N5CCC[C@@H]5C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N6CCC[C@H]6C(=O)N[C@H](CSSC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CCC(=O)N)[C@@H](C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCNC(=N)N)C)CCCCN)[C@H](C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)[C@@H](C)CC},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
4992,Piperacillin,DB00319,Rhinoscleroma,C0035468,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,OGA,,,,,,,,
33982,FGFR4,C0035222,Salbutamol,DB01001,"Respiratory Distress Syndrome, Adult",Terminated,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O},Phase 2/Phase 3,Lung disease,JTK2,CD334,,,,,,,,,,,,,,,,,,,,,,,,
27772,MRPL28,C0278519,Pegaspargase,DB00059,recurrent childhood acute lymphoblastic leukemia,Terminated,CC1=CC(=C(C=C1)C(=O)C(=C)CN(C)C)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10819,HCRTR2,C0027404,Sodium oxybate,DB09072,Narcolepsy,Approved,C(CC(=O)[O-])CO.[Na+]},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6537,Cyclophosphamide,DB00531,Post-transplant lymphoproliferative disorder,C0432487,Suspended,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,NREP,,,,,,,,
31794,SEPTIN6,C0750952,Fluorouracil,DB00544,Biliary Tract Cancer,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
6666,OPTN,C0017612,Unoprostone,DB06826,"Glaucoma, Open-Angle",Approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},,Nervous system disease,FIP2,HYPL,FIP-2,TFIIIA-INTP,HIP7,GLC1E,,,,,,,,,,,,IGHV3-52,,,,,,,,
30954,DERL1,C0279644,Idarubicin,DB01177,childhood acute myelomonocytic leukemia (M4),Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
7437,FREM3,C1269683,Quetiapine,DB01224,Major Depressive Disorder,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,RHOH,,,,,,,,
9497,ABCA3,C2973725,Treprostinil,DB00374,Pulmonary arterial hypertension,Approved,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},,Infectious disease,ABC-C,EST111653,LBM180,ABC3,,,,,,,,,,,,,,,,,,,,,,
20142,TP53,C0272293,Eltrombopag,DB06210,Chronic idiopathic thrombocytopenic purpura,Approved,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4054,Methylprednisolone,DB00959,Addison Disease,C0001403,Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O},,Endocrine disease,,,,,,,,,,,,,,,,,,,KLRG1,,,,,,,,
6665,MYOC,C0017612,Unoprostone,DB06826,"Glaucoma, Open-Angle",Approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},,Nervous system disease,TIGR,JOAG1,GLC1A,,,,,,,,,,,,,,,EXOSC5,,,,,,,,
24132,ATXN3,C0005697,Oxybutynin,DB01062,Neurogenic Urinary Bladder,Approved,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32950,LDLRAP1,C0549399,Simvastatin,DB00641,Low density lipoprotein increased,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22665,GC,C0019151,Phenylacetic acid,DB09269,Hepatic Encephalopathy,Terminated,C1=CC=C(C=C1)CC(=O)O},Phase 2,Liver disease,VDBP,hDBP,,,,,,,,,,,,,,,,,,,,,,,,
4721,Oxytetracycline,DB00595,Bronchitis,C0006277,Approved,C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O},,Lung disease,,,,,,,,,,,,,,,,,,,SCN1A-AS1,,,,,,,,
5892,Tetracycline,DB00759,TYPHUS,C0041471,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SLC18A3,,,,,,,,
12945,ROBO3,C0011633,Benzoic Acid,DB03793,Dermatomyositis,Approved,C1=CC=C(C=C1)C(=O)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1301,Ceftazidime,DB00438,Escherichia coli urinary tract infection,C0577708,Approved,CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,Pyridostigmine,,,,,,,,
29395,CRP,C0004623,Triamcinolone,DB00620,Bacterial Infections,Terminated,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},Phase 1/Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
9823,Tiotropium,DB01409,Chronic Obstructive Airway Disease,C0024117,Withdrawn,C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C},Phase 2,Lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
27975,TGFBR1,C0036421,Iloprost,DB01088,Systemic Scleroderma,Terminated,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Skin disease,ALK-5,ALK5,TBRI,TBR-i,MSSE,ESS1,,,,,,,,,,,,,,,,,,,,
11361,PMP22,C0035021,Tetracycline,DB00759,Relapsing Fever,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,HNPP,GAS3,Sp110,,,,,,,,,,,,,,,,,,,,,,,
29589,CSF3,C0007114,Fludarabine,DB01073,Malignant neoplasm of skin,Terminated,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 1/Phase 2,Cancer,MGC45931,GCSF,G-CSF,C17orf33,,,,,,,,,,,,,,,,,,,,,,
20591,EGR1,C0033578,Flutamide,DB00499,Prostatic Neoplasms,Approved,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F},,Cancer,TIS8,G0S30,NGFI-A,KROX-24,ZIF-268,AT225,ZNF225,,,,,,,,,,,,,,,,,,,
33979,CYB5A,C0035222,Salbutamol,DB01001,"Respiratory Distress Syndrome, Adult",Terminated,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O},Phase 2/Phase 3,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27330,MARK1,C1335177,Trametinib,DB08911,Ovarian Serous Adenocarcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2/Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
5344,Promethazine,DB01069,Hay fever,C0018621,Approved,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,FANCM,,,,,,,,
1842,Colchicine,DB01394,Gout,C0018099,Approved,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,SERPINA3,,,,,,,,
3357,Hydrocortisone,DB00741,Iritis,C0022081,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,,,,,,,,,,,,,,,,,,,,GC,,,,,,,,
28128,CAMK4,C0345958,Paclitaxel,DB01229,Large cell carcinoma of lung,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,CaMK-GR,,,,,,,,,,,,,,,,,,,,,,,,,
7932,CASR,C0020502,Alfacalcidol,DB01436,Hyperparathyroidism,Approved,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},,Endocrine and metabolic disease,FHH,NSHPT,GPRC2A,HHC,HHC1,,,,,,,,,,,,,,,,,,,,,
16814,AMBP,C0600041,Ofloxacin,DB01165,Infective cystitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,UTI,EDC1,HI30,IATIL,ITILC,ITI,ITIL,,,,,,,,,,,,,,,,,,,
15710,SLC2A1,C0494475,Primidone,DB00794,Tonic - clonic seizures,Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,DYT18,DYT9,GLUT1,GLUT,HTLVR,CSE,,,,,,,,,,,,,,,,,,,,
36282,CTNNA3,C0003811,Phenylephrine,DB00388,Cardiac Arrhythmia,Withdrawn,CNC[C@@H](C1=CC(=CC=C1)O)O},Phase 1/Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17501,CCDC141,C1384606,Ospemifene,DB04938,Dyspareunia,Approved,C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\C3=CC=C(C=C3)OCCO)/CCCl},,Reproductive system disease,FLJ39502,CAMDI,,,,,,,,,,,,,,,,,,,,,,,,
34841,TSC2,C0030297,Gemcitabine,DB00441,Pancreatic Neoplasm,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11592,CASP1,C0025294,Sulfisoxazole,DB00263,Meningococcal meningitis,Approved,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7236,MUC1,C0035460,Triprolidine,DB00427,"Rhinitis, Vasomotor",Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Immune system disease,CD227,PEM,ADMCKD,ADMCKD1,MCKD,MCKD1,,,,,,,,,,,,HOTTIP,,,,,,,,
34932,CNR1,C0025517,Heparin,DB01109,Metabolic Diseases,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Endocrine and metabolic disease,CB1K5,CB-R,CB1,CANN6,CB1A,CNR,,,,,,,,,,,,,,,,,,,,
35882,APEX1,C1112459,Sorafenib,DB00398,Liver cell carcinoma non-resectable,Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16793,CX3CR1,C0010692,Ofloxacin,DB01165,Cystitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,CMKDR1,V28,GPR13,CMKBRL1,,,,,,,,,,,,,,,,,,,,,,
18798,TP63,C0013595,Dexpanthenol,DB09357,Eczema,Approved,CC(C)(CO)[C@H](C(=O)NCCCO)O},,Skin disease,SHFM4,EEC3,p63,p73L,OFC8,KET,p73H,p53CP,TP73L,TP53L,TP53CP,,,,,,,,,,,,,,,
23271,DUSP6,C0232940,Progesterone,DB00396,Secondary physiologic amenorrhea,Approved,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29744,GAR1,C0265965,Danazol,DB01406,Dyskeratosis Congenita,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5},Phase 1/Phase 2,Ribosomopathy,0,,,,,,,,,,,,,,,,,,,,,,,,,
23826,OR2AG1,C1262117,Natamycin,DB00826,Fungal keratitis,Approved,C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)O)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3055,Fusidic Acid,DB02703,Gonorrhea of rectum,C0275665,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,TBX21,,,,,,,,
4784,Paroxetine,DB00715,Major Depressive Disorder,C1269683,Approved,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,RIT1,,,,,,,,
3396,Hydrocortisone,DB00741,Transplanted organ rejection,C0345468,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,Immune system disease,,,,,,,,,,,,,,,,,,,HLA-DMA,,,,,,,,
1261,Cefradine,DB01333,Arthropathy associated with infection,C0157749,Approved,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CCC=CC3)N)SC1)C(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,Prazosin,,,,,,,,
12971,NR1H4,C0220994,Phenylacetic acid,DB09269,Hyperammonemia,Approved,C1=CC=C(C=C1)CC(=O)O},,Inherited metabolic disease,FXR,RIP14,HRR1,HRR-1,,,,,,,,,,,,,,,,,,,,,,
4964,Piperacillin,DB00319,Appendicitis,C0003615,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Other disease,,,,,,,,,,,,,,,,,,,H3P23,,,,,,,,
35730,TRIM11,C0038868,Rasagiline,DB01367,Progressive supranuclear palsy,Terminated,C#CCN[C@@H]1CCC2=CC=CC=C12},Phase 3,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16458,FGF23,C0029442,Ergocalciferol,DB00153,Osteomalacia,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
24404,CCL21,C0010691,Tiopronin,DB06823,Cystinuria,Approved,CC(C(=O)NCC(=O)O)S},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
11946,CD44,C0023487,Tretinoin,DB00755,Acute Promyelocytic Leukemia,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Cancer,IN,MC56,Pgp1,CD44R,HCELL,CSPG8,MIC4,MDU2,MDU3,,,,,,,,,,,,,,,,,
35467,TTR,C0021296,Nitric Oxide,DB00435,"Infant, Small for Gestational Age",Terminated,[N]=O},Phase 3,,HsT2651,CTS,PALB,CTS1,,,,,,,,,,,,,,,,,,,,,,
930,Carbenicillin,DB00578,Proteus urinary tract infection,C0577709,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)O)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Magnesium Sulfate,,,,,,,,
17508,IL17RD,C1384606,Ospemifene,DB04938,Dyspareunia,Approved,C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\C3=CC=C(C=C3)OCCO)/CCCl},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23929,TRPM4,C0038525,Deferoxamine,DB00746,Subarachnoid Hemorrhage,Terminated,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O},Phase 0,,0,,,,,,,,,,,,,,,,,,,,,,,,,
18155,CXCR4,C0553580,Vincristine,DB00541,Ewings sarcoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,LESTR,NPY3R,HM89,NPYY3R,D2S201E,fusin,HSY3RR,CD184,,,,,,,,,,,,,,,,,,
24290,DRD2,C0038436,Sertraline,DB01104,Post-Traumatic Stress Disorder,Approved,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
7029,TLR4,C0276226,Aciclovir,DB00787,Herpes encephalitis,Approved,C1=NC2=C(N1COCCO)N=C(NC2=O)N},,Infectious disease,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,JARID2,,,,,,,,
14415,ERBB2,C0278996,Methotrexate,DB00563,Cancer of Head and Neck,Approved,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
23686,FPR1,C0031099,Lidocaine,DB00281,Periodontitis,Terminated,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},Phase 2,Infectious disease,FPR,FMLP,,,,,,,,,,,,,,,,,,,,,,,,
33847,AKR1B1,C0011875,Heparin,DB01109,Diabetic Angiopathies,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2/Phase 3,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6224,Tripelennamine,DB00792,Allergic Conjunctivitis,C0009766,Approved,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2},,Immune system disease,,,,,,,,,,,,,,,,,,,RICTOR,,,,,,,,
8485,COPD,C0338908,Perphenazine,DB00850,Mixed anxiety and depressive disorder,Approved,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
21214,CENPJ,C0028326,Fluoxymesterone,DB01185,Noonan Syndrome,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
16301,POMC,C0022104,Milnacipran,DB04896,Irritable Bowel Syndrome,Terminated,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2},Phase 2,Digestive system disease,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
29813,ESD,C0700292,Nitric Oxide,DB00435,Hypoxemia,Terminated,[N]=O},Phase 1/Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20853,CNKSR2,C0042024,Tolterodine,DB01036,Urinary Incontinence,Terminated,CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
30786,CDR3,C0242596,Methotrexate,DB00563,"Neoplasm, Residual",Terminated,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
8605,MMP14,C0003492,Alprostadil,DB00770,Aortic coarctation,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Cardiovascular disease,MT1-MMP,,,,,,,,,,,,,,,,,,,,,,,,,
12304,CRP,C0003873,Thalidomide,DB01041,Rheumatoid Arthritis,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
13658,ALOX12,C0037274,Triamcinolone,DB00620,Dermatologic disorders,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,12S-LOX,,,,,,,,,,,,,,,,,,,,,,,,,
17131,STAG3,C0021361,Clomifene,DB00882,Female infertility,Approved,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\Cl)/C3=CC=CC=C3},,Reproductive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
4977,Piperacillin,DB00319,Infection due to Pseudomonas aeruginosa,C0276075,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,STRC,,,,,,,,
266,Amphotericin B,DB00681,Acute gonococcal urethritis,C0275652,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Cefpodoxime,,,,,,,,
264,Amphotericin B,DB00681,Actinomycosis,C0001261,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Cefotetan,,,,,,,,
36559,MON1A,C0012715,Deferasirox,DB01609,Iron Metabolism Disorders,Withdrawn,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1498,Chloramphenicol,DB00446,Meningococcal meningitis,C0025294,Approved,C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,Thiothixene,,,,,,,,
36663,CDKN1C,C0349579,Norgestrel,DB09389,Atypical Endometrial Hyperplasia,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Reproductive system disease,P57,BWCR,BWS,,,,,,,,,,,,,,,,,,,,,,,
3615,L-Aspartic Acid,DB00128,Hypokalemia,C0020621,Approved,C([C@@H](C(=O)O)N)C(=O)O},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,BCR,,,,,,,,
6568,SLC2A1,C0014553,Valproic Acid,DB00313,Absence Epilepsy,Approved,CCCC(CCC)C(=O)O},,Nervous system disease,DYT18,DYT9,GLUT1,GLUT,HTLVR,CSE,,,,,,,,,,,,DNM3,,,,,,,,
28853,VEGFA,C0278827,Metronidazole,DB00916,Bladder cancer recurrent,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
12618,CCDC151,C0027430,Beclomethasone dipropionate,DB00394,Nasal Polyps,Approved,CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33856,TP53,C0751690,Imatinib,DB00619,Malignant Peripheral Nerve Sheath Tumor,Terminated,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 2/Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
24472,SMUG1,C0221154,Phentolamine,DB00692,Paroxysmal hypertension,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21622,PPARA,C0154246,Sodium phenylbutyrate,DB06819,"Urea Cycle Disorders, Inborn",Approved,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},,,hPPAR,NR1C1,PPAR,,,,,,,,,,,,,,,,,,,,,,,
5844,Testosterone,DB00624,Deficiency of testosterone biosynthesis,C0342527,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,Metabolic disease,,,,,,,,,,,,,,,,,,,PEAR1,,,,,,,,
7928,PIK3CD,C0029458,Zoledronic acid,DB00399,"Osteoporosis, Postmenopausal",Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31840,PTEN,C3495949,Valproic Acid,DB00313,Locally advanced breast cancer,Terminated,CCCC(CCC)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19874,DIPK1A,C0002874,Heparin,DB01109,Aplastic Anemia,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3880,Magnesium Sulfate,DB00653,Hypomagnesemia,C0151723,Approved,[O-]S(=O)(=O)[O-].[Mg+2]},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,HDAC5,,,,,,,,
7648,Acetylsalicylic acid,DB00945,Hypertensive disease,C0020538,Terminated,CC(=O)OC1=CC=CC=C1C(=O)O},Phase 2,Cardiovascular disease,,,,,,,,,,,,,,,,,,,CCL1,,,,,,,,
8871,Aripiprazole,DB01238,Bipolar Disorder,C0005586,Terminated,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,
6993,CXCL2,C0029408,Salmon Calcitonin,DB00017,Degenerative polyarthritis,Terminated,CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CN=CN2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO},Phase 3,Immune system disease,SCYB2,GROb,MIP-2a,MGSA-b,CINC-2a,GRO2,,,,,,,,,,,,TIPARP,,,,,,,,
23460,ERVK-10,C0023886,Tinidazole,DB00911,"Liver Abscess, Amebic",Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18976,ENTPD1,C0040038,Warfarin,DB00682,Thromboembolism,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,NTPDase-1,ATPDase,SPG64,CD39,,,,,,,,,,,,,,,,,,,,,,
3895,Maprotiline,DB00934,Mixed anxiety and depressive disorder,C0338908,Approved,CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,LZTR1,,,,,,,,
34617,BET1,C0020450,Thiamine,DB00152,Hyperemesis Gravidarum,Terminated,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},Phase 3,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7569,LCN2,C0011616,Urea,DB03904,Contact Dermatitis,Approved,C(=O)(N)N},,Immune system disease,NGAL,24p3,,,,,,,,,,,,,,,,RGMA,,,,,,,,
9872,Bupivacaine,DB00297,Disorder of shoulder,C1290859,Withdrawn,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C},Phase 3,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
634,Benzylpenicillin,DB01053,"Pneumonia, Necrotizing",C0264515,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Finafloxacin,,,,,,,,
1149,Cefotaxime,DB00493,Klebsiella cystitis,C0520775,Approved,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O},,Urinary system disease,,,,,,,,,,,,,,,,,,,Oxymetholone,,,,,,,,
33650,TP53,C0206638,Zoledronic acid,DB00399,Giant Cell Tumor of Bone,Terminated,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15741,LGI1,C0014549,Topiramate,DB00273,Tonic-Clonic Epilepsy,Approved,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35395,CD44,C0042075,Mitomycin,DB00305,Urologic Diseases,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Urinary system disease,IN,MC56,Pgp1,CD44R,HCELL,CSPG8,MIC4,MDU2,MDU3,,,,,,,,,,,,,,,,,
32044,ALOX5,C0009375,Oxaliplatin,DB00526,Colonic Neoplasms,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,5-LOX,,,,,,,,,,,,,,,,,,,,,,,,,
35148,APOE,C0947751,Linagliptin,DB08882,Vascular inflammations,Terminated,CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C},Phase 3,Vascular disease,AD2,,,,,,,,,,,,,,,,,,,,,,,,,
31052,DSG1,C0030809,Dapsone,DB00250,Pemphigus Vulgaris,Terminated,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N},Phase 2,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4758,Paliperidone,DB01267,Schizoaffective Disorder,C0036337,Approved,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,MAPK9,,,,,,,,
20584,RXRA,C0033578,Flutamide,DB00499,Prostatic Neoplasms,Approved,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29240,NOS2,C3900099,Aminolevulinic acid,DB00855,Adult Mixed Glioma,Terminated,C(CC(=O)O)C(=O)CN},Phase 1/Phase 2,Cancer,iNOS,HEP-NOS,NOS2A,,,,,,,,,,,,,,,,,,,,,,,
21327,HTR1A,C0031572,Venlafaxine,DB00285,"Phobia, Social",Approved,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
36699,RRM2,C1153706,Norgestrel,DB09389,Endometrial adenocarcinoma,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19306,BRIP1,C0678222,Paclitaxel,DB01229,Breast Carcinoma,Approved,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32110,MLH1,C0034885,Oxaliplatin,DB00526,Rectal Neoplasms,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10272,TLR2,C0041327,Streptomycin,DB01082,"Tuberculosis, Pulmonary",Approved,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O},,Infectious disease,TIL4,CD282,,,,,,,,,,,,,,,,,,,,,,,,
27309,HPGD,C0008495,Sulbactam,DB09324,Chorioamnionitis,Suspended,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C},Phase 2/Phase 3,Infectious disease,SDR36C1,,,,,,,,,,,,,,,,,,,,,,,,,
7070,GLB1,C0019348,Aciclovir,DB00787,Herpes Simplex Infections,Approved,C1=NC2=C(N1COCCO)N=C(NC2=O)N},,Infectious disease,0,,,,,,,,,,,,,,,,,C2orf80,,,,,,,,
226,Ammonium lactate,DB06768,Pruritus of genital organs,C0033777,Approved,CC(C(=O)[O-])O.[NH4+]},,,,,,,,,,,,,,,,,,,,,Capsaicin,,,,,,,,
10982,DEFB103A,C0006840,Voriconazole,DB00582,Candidiasis,Terminated,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13758,KLHDC8B,C0019829,Tacrolimus,DB00864,Hodgkin Disease,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4028,NLRP3,C0003862,Salicylic acid,DB00936,Arthralgia,Approved,C1=CC=C(C(=C1)C(=O)O)O},,Immune system disease,AGTAVPRL,AII,AVP,FCAS,FCU,NALP3,PYPAF1,MWS,CLR1.1,C1orf7,CIAS1,,,,,,,MORC3,,,,,,,,
27463,GTF2I,C0004903,Vincristine,DB00541,Beckwith-Wiedemann Syndrome,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
2252,Dexfenfluramine,DB01191,Obesity,C0028754,Approved,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F},,Metabolic disease,,,,,,,,,,,,,,,,,,,DDIT3,,,,,,,,
31696,IL17A,C0006271,Fluticasone Propionate,DB00588,Bronchiolitis,Terminated,CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF},Phase 2,Lung disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
10182,TRIM26,C0006266,Theophylline,DB00277,Bronchial Spasm,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30688,PMS2,C0025149,Valproic Acid,DB00313,Medulloblastoma,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
20176,LTB4R,C0002792,Epinephrine,DB00668,anaphylaxis,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Immune system disease,BLTR,P2Y7,LTB4R1,P2RY7,GPR16,CMKRL1,,,,,,,,,,,,,,,,,,,,
7983,COL4A5,C0020626,Ergocalciferol,DB00153,Hypoparathyroidism,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Endocrine and metabolic disease,ASLN,ATS,,,,,,,,,,,,,,,,,,,,,,,,
9552,Phenylephrine,DB00388,Cardiac Arrhythmia,C0003811,Withdrawn,CNC[C@@H](C1=CC(=CC=C1)O)O},Phase 1/Phase 2,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
12708,NCAM1,C0079774,Thalidomide,DB01041,Peripheral T-Cell Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,NCAM,CD56,,,,,,,,,,,,,,,,,,,,,,,,
28067,NOS1,C0020429,Capsaicin,DB06774,Hyperalgesia,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,Nervous system,nNOS,,,,,,,,,,,,,,,,,,,,,,,,,
29875,CDKN2B-AS1,C0085136,Vincristine,DB00541,Central Nervous System Neoplasms,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23480,RPL23A,C0023886,Tinidazole,DB00911,"Liver Abscess, Amebic",Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Liver disease,L23A,,,,,,,,,,,,,,,,,,,,,,,,,
31917,PECAM1,C1696708,Losartan,DB00678,Prehypertension,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl},Phase 2,Cardiovascular disease,CD31,,,,,,,,,,,,,,,,,,,,,,,,,
10638,PTGS1,C0343378,Clarithromycin,DB01211,Helicobacter-associated gastritis,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O},,Digestive system disease,PGHS-1,PTGHS,,,,,,,,,,,,,,,,,,,,,,,,
32773,CD19,C0019045,Pegfilgrastim,DB00019,Hemoglobinopathies,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
1987,Cyclizine,DB01176,Sneezing,C0037383,Approved,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3},,,,,,,,,,,,,,,,,,,,,Busulfan,,,,,,,,
31324,TSC2,C0014474,Erlotinib,DB00530,Ependymoma,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34499,TNF,C0037278,Vancomycin,DB00512,"Skin Diseases, Infectious",Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
2018,TAS2R38,C0001973,Zonisamide,DB00909,"Alcoholic Intoxication, Chronic",Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 2,Other,0,,,,,,,,,,,,,,,,,CXCL13,,,,,,,,
8100,F2RL1,C0033774,Zinc oxide,DB09321,Pruritus,Approved,O=[Zn]},,,GPR11,,,,,,,,,,,,,,,,,,,,,,,,,
34955,CR2,C0032310,Hydrocortisone,DB00741,"Pneumonia, Viral",Terminated,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},Phase 3,Infectious disease,CD21,C3DR,,,,,,,,,,,,,,,,,,,,,,,,
28471,GABRA2,C0236736,Dextroamphetamine,DB01576,Cocaine-Related Disorders,Terminated,C[C@@H](CC1=CC=CC=C1)N},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
21830,CDKL5,C0034013,Nafarelin,DB00666,Precocious Puberty,Approved,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CC3=CC=CC=C3C=C2)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8},,,EIEE2,CFAP247,STK9,,,,,,,,,,,,,,,,,,,,,,,
10481,CCNO,C0010200,Sodium Citrate,DB09154,Coughing,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
26200,ABCC6,C0600518,Imatinib,DB00619,Choroidal Neovascularization,Withdrawn,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 1,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
22900,KDM5C,C0020676,Liothyronine,DB00279,Hypothyroidism,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22333,AOC3,C0011849,Pramlintide,DB01278,Diabetes Mellitus,Withdrawn,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N)NC(=O)[C@@H]4CCCN4C(=O)CNC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CNC=N6)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@@H]8CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N8)[C@@H](C)O)C)[C@@H](C)O)CC(=O)N)NC(=O)[C@H](CCCCN)N},Phase 1/Phase 2,Endocrine disease,VAP1,HPAO,VAP-1,,,,,,,,,,,,,,,,,,,,,,,
29338,MTCO2P12,C1332166,Paclitaxel,DB01229,Adenocarcinoma of the gastroesophageal junction,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
28416,ABL1,C1292772,Sunitinib,DB01268,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27158,GLI1,C0206728,Sunitinib,DB01268,Plexiform Neurofibroma,Suspended,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Congenital malformation,GLI,,,,,,,,,,,,,,,,,,,,,,,,,
15372,CYP11B1,C0020461,Polystyrene sulfonate,DB01344,Hyperkalemia,Approved,C=CC1=CC=C(C=C1)S(=O)(=O)O},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
37260,FAS,C3241937,Vitamin E,DB00163,Nonalcoholic Steatohepatitis,Withdrawn,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 3,Endocrine disease,CD95,APO-1,FAS1,APT1,TNFRSF6,,,,,,,,,,,,,,,,,,,,,
4877,Phenobarbital,DB01174,Tonic-Clonic Epilepsy,C0014549,Approved,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2},,Nervous system disease,,,,,,,,,,,,,,,,,,,NLRC4,,,,,,,,
19789,EMD,C0036472,Fusidic Acid,DB02703,Scrub Typhus,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12705,RC3H1,C0079774,Thalidomide,DB01041,Peripheral T-Cell Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
8623,NOS3,C0242350,Vardenafil,DB00862,Erectile dysfunction,Approved,CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C},,Reproductive system disease,ECNOS,eNOS,,,,,,,,,,,,,,,,,,,,,,,,
12364,VHL,C0007134,Thalidomide,DB01041,Renal Cell Carcinoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35183,NDUFAF6,C0442874,Magnesium Sulfate,DB00653,Neuropathy,Terminated,[O-]S(=O)(=O)[O-].[Mg+2]},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20989,PGR,C0025218,Tretinoin,DB00755,Chloasma,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Skin disease,NR3C3,,,,,,,,,,,,,,,,,,,,,,,,,
3915,Meclofenamic acid,DB00939,Dysmenorrhea,C0013390,Approved,CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)O)Cl},,Reproductive system disease,,,,,,,,,,,,,,,,,,,ADCY7,,,,,,,,
3837,Lubiprostone,DB01046,Irritable bowel syndrome characterized by constipation,C1868889,Approved,CCCCC([C@]1(CC[C@H]2[C@H](O1)CC(=O)[C@@H]2CCCCCCC(=O)O)O)(F)F},,Digestive system disease,,,,,,,,,,,,,,,,,,,ACOT1,,,,,,,,
16592,MFT2,C0040261,Terbinafine,DB00857,Onychomycosis,Approved,CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11427,DYNC1H1,C0039128,Tetracycline,DB00759,Syphilis,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22568,GIP,C0001622,Trilostane,DB01108,Adrenal Gland Hyperfunction,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(CC(=C([C@H]4O5)O)C#N)C},,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,
11327,IL10,C0034362,Tetracycline,DB00759,Q Fever,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
24895,IL13,C0041318,Pyrazinamide,DB00339,"Tuberculosis, Meningeal",Approved,C1=CN=C(C=N1)C(=O)N},,Infectious disease,P600,IL-13,ALRH,BHR1,MGC116786,MGC116788,MGC116789,,,,,,,,,,,,,,,,,,,
6278,Ulipristal,DB08867,Uterine Fibroids,C0042133,Approved,CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O},,Reproductive system disease,,,,,,,,,,,,,,,,,,,LINC01082,,,,,,,,
120,Alprostadil,DB00770,Congenital atresia of pulmonary valve,C0242855,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Congenital malformation,,,,,,,,,,,,,,,,,,,Aztreonam,,,,,,,,
29351,ABCB1,C1332166,Paclitaxel,DB01229,Adenocarcinoma of the gastroesophageal junction,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1/Phase 2,Cancer,P-gp,CD243,GP170,ABC20,PGY1,CLCS,,,,,,,,,,,,,,,,,,,,
34266,NR5A2,C0242339,Simvastatin,DB00641,Dyslipidemias,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Metabolic disease,FTZ-F1beta,hB1F,FTZ-F1,hB1F-2,B1F2,LRH1,FTF,,,,,,,,,,,,,,,,,,,
2568,Ecabet,DB05265,Peptic Ulcer,C0030920,Approved,CC(C)C1=C(C=C2C(=C1)CC[C@@H]3[C@@]2(CCC[C@@]3(C)C(=O)O)C)S(=O)(=O)O},,Digestive system disease,,,,,,,,,,,,,,,,,,,ALDOB,,,,,,,,
8947,NRG1,C0038358,Roxatidine acetate,DB08806,Gastric ulcer,Approved,CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2},,Digestive system disease,HRG,NDF,GGF,NRG1-IT2,,,,,,,,,,,,,,,,,,,,,,
27658,TERF2,C0023493,Thalidomide,DB01041,Adult T-Cell Lymphoma/Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 0,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13506,LAMA2,C0006114,Hydroxocobalamin,DB00200,Cerebral Edema,Terminated,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]\\4([C@H]([C@@H]5[C@]6([C@@]([C@@H](C(=N6)/C(=C\\7/[C@@]([C@@H](C(=N7)/C=C\\8/C([C@@H](C(=N8)/C(=C4\\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2]},Phase 2,Nervous system disease,LAMM,,,,,,,,,,,,,,,,,,,,,,,,,
11164,IL32,C0023281,Sodium stibogluconate,DB05630,Leishmaniasis,Approved,C([C@H]([C@@H]1[C@@H]([C@@H](O[Sb](=O)(O1)O[Sb]2(=O)O[C@@H]([C@@H]([C@@H](O2)C(=O)[O-])O)[C@@H](CO)O)C(=O)[O-])O)O)O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+]},,Infectious disease,NK4,TAIF,TAIFb,TAIFd,,,,,,,,,,,,,,,,,,,,,,
28004,RUNX3,C0014859,Fluorouracil,DB00544,Esophageal Neoplasms,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 3,Cancer,AML2,PEBP2A3,CBFA3,,,,,,,,,,,,,,,,,,,,,,,
12921,TNF,C0011633,Benzoic Acid,DB03793,Dermatomyositis,Approved,C1=CC=C(C=C1)C(=O)O},,Musculoskeletal disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
36571,SMUG1,C0278506,Pemetrexed,DB00642,Non-small cell lung cancer stage III,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30168,PTPN11,C3463824,Azacitidine,DB00928,MYELODYSPLASTIC SYNDROME,Terminated,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N},Phase 2,Hematologic disease,BPTP3,SH-PTP2,SHP-2,PTP2C,SHP2,NS1,,,,,,,,,,,,,,,,,,,,
31008,PDGFRA,C0206726,Temozolomide,DB00853,gliosarcoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,CD140a,PDGFR2,GAS9,,,,,,,,,,,,,,,,,,,,,,,
18670,ANGPT2,C0042974,Desmopressin,DB00035,von Willebrand Disease,Approved,C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N},,Hematologic disease,Ang2,,,,,,,,,,,,,,,,,,,,,,,,,
33671,CHRNA5,C0001956,Zonisamide,DB00909,alcohol use disorder,Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
9975,CYP2J2,C0004626,Tobramycin,DB00684,"Pneumonia, Bacterial",Terminated,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15050,YY1,C0279543,Nilotinib,DB04868,Philadelphia chromosome positive chronic myelogenous leukemia,Approved,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19162,CTNS,C0042963,Haloperidol,DB00502,Vomiting,Withdrawn,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F},Phase 0,,CTNS-LSB,PQLC4,,,,,,,,,,,,,,,,,,,,,,,,
18843,HMBS,C0030446,Dexpanthenol,DB09357,Paralytic Ileus,Approved,CC(C)(CO)[C@H](C(=O)NCCCO)O},,,PBGD,UPS,,,,,,,,,,,,,,,,,,,,,,,,
26215,CCN2,C0271066,Imatinib,DB00619,Choroidal retinal neovascularization,Withdrawn,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 1,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
10057,BCL2,C0022602,Masoprocol,DB00179,Actinic keratosis,Approved,C[C@H](CC1=CC(=C(C=C1)O)O)[C@@H](C)CC2=CC(=C(C=C2)O)O},,Skin disease,Bcl-2,PPP1R50,,,,,,,,,,,,,,,,,,,,,,,,
977,Cefaclor,DB00833,Lower respiratory tract infection,C0149725,Approved,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)Cl},,,,,,,,,,,,,,,,,,,,,Methacycline,,,,,,,,
6038,Tocainide,DB01056,Ventricular arrhythmia,C0085612,Approved,CC1=C(C(=CC=C1)C)NC(=O)C(C)N},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,LOC110673972,,,,,,,,
15102,ADRB2,C0474368,Prednisolone,DB00860,Labor Pain,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 0,,ADRBR,B2AR,ADRB2R,,,,,,,,,,,,,,,,,,,,,,,
28140,ENO2,C0278505,Paclitaxel,DB01229,Non-small cell lung cancer stage II,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
5865,Tetracycline,DB00759,Acute gonococcal epididymo-orchitis,C0153193,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CD69,,,,,,,,
6435,Zinc oxide,DB09321,Tinea Versicolor,C0040262,Approved,O=[Zn]},,Infectious disease,,,,,,,,,,,,,,,,,,,HHIP,,,,,,,,
9078,NR1I2,C0018834,Sodium Citrate,DB09154,Heartburn,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14685,CBX7,C0026764,Vorinostat,DB02546,Multiple Myeloma,Withdrawn,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
31952,NANOG,C1368898,Ifosfamide,DB01181,Adult teratoma,Terminated,C1CN(P(=O)(OC1)NCCCl)CCCl},Phase 2,Cancer,FLJ12581,FLJ40451,,,,,,,,,,,,,,,,,,,,,,,,
18241,GLI1,C0035412,Vincristine,DB00541,Rhabdomyosarcoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,GLI,,,,,,,,,,,,,,,,,,,,,,,,,
28002,MET,C0014859,Fluorouracil,DB00544,Esophageal Neoplasms,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 3,Cancer,HGFR,RCCP2,DFNB97,,,,,,,,,,,,,,,,,,,,,,,
15240,GNAS,C0020598,Teriparatide,DB06285,Hypocalcemia,Terminated,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N},Phase 2,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20526,PSMB9,C0014869,Omeprazole,DB00338,Peptic Esophagitis,Approved,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23109,CLCN2,C0010674,Amikacin,DB00479,Cystic Fibrosis,Withdrawn,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},Phase 3,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
12281,ANGPTL4,C0020557,Topiramate,DB00273,Hypertriglyceridemia,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Metabolic disease,pp1158,PGAR,ARP4,HFARP,FIAF,,,,,,,,,,,,,,,,,,,,,
15637,CDKN1A,C0011881,Losartan,DB00678,Diabetic Nephropathy,Approved,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24467,TMEM127,C0221154,Phentolamine,DB00692,Paroxysmal hypertension,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28000,XIAP,C0014859,Fluorouracil,DB00544,Esophageal Neoplasms,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
21758,SLITRK1,C0040517,Pimozide,DB01100,Gilles de la Tourette syndrome,Approved,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
34633,TTR,C0020450,Thiamine,DB00152,Hyperemesis Gravidarum,Terminated,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},Phase 3,Endocrine and metabolic disease,HsT2651,CTS,PALB,CTS1,,,,,,,,,,,,,,,,,,,,,,
17999,E2F1,C0035335,Melphalan,DB01042,Retinoblastoma,Terminated,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
22440,PLAU,C0007820,Tolazoline,DB00797,Cerebrovascular Disorders,Approved,C1CN=C(N1)CC2=CC=CC=C2},,Cardiovascular disease,URK,,,,,,,,,,,,,,,,,,,,,,,,,
24232,IL18,C0917798,Phentolamine,DB00692,Cerebral Ischemia,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5006,Piperonyl butoxide,DB09350,Infestation by Phthirus pubis,C0030759,Approved,CCCCOCCOCCOCC1=CC2=C(C=C1CCC)OCO2},,Infectious disease,,,,,,,,,,,,,,,,,,,ITGAX,,,,,,,,
7230,TLR4,C0018621,Triprolidine,DB00427,Hay fever,Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Infectious disease,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,WNT5A,,,,,,,,
14791,PRL,C0001206,Somatostatin,DB09099,Acromegaly,Terminated,C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=CC=C6)O},Phase 2,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,
25927,SERPINE1,C0023269,Gemcitabine,DB00441,leiomyosarcoma,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1/Phase 2,Cancer,PAI,PLANH1,PAI1,,,,,,,,,,,,,,,,,,,,,,,
32961,TMEM43,C0549399,Simvastatin,DB00641,Low density lipoprotein increased,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21464,PHF11,C0022573,Tobramycin,DB00684,Keratoconjunctivitis,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36572,KRAS,C0278506,Pemetrexed,DB00642,Non-small cell lung cancer stage III,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19040,GPT2,C0029001,Ivermectin,DB00602,Onchocerciasis,Approved,CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17980,MDM4,C0035335,Melphalan,DB01042,Retinoblastoma,Terminated,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30648,ERBB2,C0685938,Erythropoietin,DB00016,Malignant neoplasm of gastrointestinal tract,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 3,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
34746,TRA,C0549393,Ethanol,DB00898,Alcohol problem,Terminated,CCO},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
6879,Dactinomycin,DB00970,Beckwith-Wiedemann Syndrome,C0004903,Suspended,C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C},Phase 3,Congenital malformation,,,,,,,,,,,,,,,,,,,DNER,,,,,,,,
28274,BRAF,C0022665,Vincristine,DB00541,Kidney Neoplasm,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 1,Cancer,BRAF1,,,,,,,,,,,,,,,,,,,,,,,,,
17167,PMP22,C0014550,Stiripentol,DB09118,"Epilepsies, Myoclonic",Approved,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O},,Nervous system disease,HNPP,GAS3,Sp110,,,,,,,,,,,,,,,,,,,,,,,
25086,F2R,C2363973,Riociguat,DB08931,Chronic thromboembolic pulmonary hypertension,Approved,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC},,Cardiovascular disease,CF2R,,,,,,,,,,,,,,,,,,,,,,,,,
28589,IL4,C1262481,Sirolimus,DB00877,Eosinophilic gastroenteritis,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 1,Digestive system disease,BSF1,IL-4,BCGF1,BCGF-1,MGC79402,,,,,,,,,,,,,,,,,,,,,
4016,Methdilazine,DB00902,Urticaria,C0042109,Approved,CN1CCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,RNF5,,,,,,,,
20846,DLG3,C0042024,Tolterodine,DB01036,Urinary Incontinence,Terminated,CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
18272,IGFBP3,C0016034,Danazol,DB01406,Breast Fibrocystic Disease,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5},,Other disease,IBP3,BP-53,,,,,,,,,,,,,,,,,,,,,,,,
10609,MBL3P,C0271429,Trimethoprim,DB00440,Acute otitis media,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8747,SMARCA4,C1140680,Fondaparinux sodium,DB00569,Malignant neoplasm of ovary,Withdrawn,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
37147,MIR21,C0280099,Docetaxel,DB01248,adult solid tumor,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
24561,PIK3CA,C0042345,Sodium Tetradecyl Sulfate,DB00464,Varicosity,Approved,CCCCCCCCCCCCCCOS(=O)(=O)[O-].[Na+]},,Vascular disease,PI3K,,,,,,,,,,,,,,,,,,,,,,,,,
11933,DNMT3A,C0023487,Tretinoin,DB00755,Acute Promyelocytic Leukemia,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
24034,SDHD,C0024586,Somatostatin,DB09099,Malignant Carcinoid Syndrome,Terminated,C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=CC=C6)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30216,OSMR-AS1,C1861172,Atorvastatin,DB01076,Venous Thromboembolism,Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 2,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29144,COX8A,C0280790,Irinotecan,DB00762,adult anaplastic oligodendroglioma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25421,GPR183,C0007117,Vismodegib,DB08828,Basal cell carcinoma,Approved,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl},,Cancer,EBI2,,,,,,,,,,,,,,,,,,,,,,,,,
9418,DDC,C0242422,Trihexyphenidyl,DB00376,Parkinsonian Disorders,Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Neurodegenerative disease,AADC,,,,,,,,,,,,,,,,,,,,,,,,,
17487,IKZF1,C1384606,Ospemifene,DB04938,Dyspareunia,Approved,C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\C3=CC=C(C=C3)OCCO)/CCCl},,Reproductive system disease,hIk-1,LyF-1,Hs.54452,IKAROS,PPP1R92,ZNFN1A1,,,,,,,,,,,,,,,,,,,,
14748,ABCB1,C0005699,Imatinib,DB00619,Blast Phase,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,P-gp,CD243,GP170,ABC20,PGY1,CLCS,,,,,,,,,,,,,,,,,,,,
36294,TRH,C0003811,Phenylephrine,DB00388,Cardiac Arrhythmia,Withdrawn,CNC[C@@H](C1=CC(=CC=C1)O)O},Phase 1/Phase 2,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
5019,Pitavastatin,DB08860,Hypercholesterolemia,C0020443,Approved,C1CC1C2=NC3=CC=CC=C3C(=C2/C=C/[C@H](C[C@H](CC(=O)O)O)O)C4=CC=C(C=C4)F},,Metabolic disease,,,,,,,,,,,,,,,,,,,SMC4,,,,,,,,
12961,ARG1,C0220994,Phenylacetic acid,DB09269,Hyperammonemia,Approved,C1=CC=C(C=C1)CC(=O)O},,Inherited metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
37239,PLP1,C0015732,Phenylephrine,DB00388,Fecal Incontinence,Withdrawn,CNC[C@@H](C1=CC(=CC=C1)O)O},Phase 3,,GPM6C,SPG2,,,,,,,,,,,,,,,,,,,,,,,,
32977,NR4A3,C0280089,Romidepsin,DB06176,Carcinoid tumor of lung,Terminated,C/C=C\\1/C(=O)N[C@H](C(=O)O[C@H]\\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C},Phase 2,Cancer,CSMF,MINOR,,,,,,,,,,,,,,,,,,,,,,,,
34029,IL6,C0018681,Naratriptan,DB00952,Headache,Withdrawn,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C},Phase 3,,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
35363,TIMP3,C0005686,Mitomycin,DB00305,Urinary Bladder Diseases,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
25864,POMC,C0021141,Tolvaptan,DB06212,Inappropriate ADH Syndrome,Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Endocrine and metabolic disease,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
6033,Tobramycin,DB00684,Sepsis due to Pseudomonas,C2887096,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Infectious disease,,,,,,,,,,,,,,,,,,,RORC,,,,,,,,
14576,MIR205,C0007137,Cisplatin,DB00515,Squamous cell carcinoma,Terminated,N.N.Cl[Pt]Cl},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19771,IL1B,C0340354,Fusidic Acid,DB02703,Q fever endocarditis,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
24899,C1QTNF4,C0041318,Pyrazinamide,DB00339,"Tuberculosis, Meningeal",Approved,C1=CN=C(C=N1)C(=O)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30241,FLT3,C1292778,Prednisolone,DB00860,Chronic myeloproliferative disorder,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Cancer,FLK2,CD135,,,,,,,,,,,,,,,,,,,,,,,,
18916,IGFBP1,C0027773,Diazoxide,DB01119,Nesidioblastosis,Approved,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl},,Metabolic disease,IGF-BP25,AFBP,hIGFBP-1,PP12,,,,,,,,,,,,,,,,,,,,,,
24406,SLC3A2,C0010691,Tiopronin,DB06823,Cystinuria,Approved,CC(C(=O)NCC(=O)O)S},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
13791,ADRA1A,C0149911,Zoledronic acid,DB00399,Humoral hypercalcemia of malignancy (disorder),Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22466,GLA,C0007820,Tolazoline,DB00797,Cerebrovascular Disorders,Approved,C1CN=C(N1)CC2=CC=CC=C2},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32108,KRAS,C0034885,Oxaliplatin,DB00526,Rectal Neoplasms,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10937,CD14,C0006309,Tetracycline,DB00759,Brucellosis,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
9261,Simvastatin,DB00641,Dyslipidemias,C0242339,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
29229,MDM2,C1541317,Irinotecan,DB00762,adult gliosarcoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27482,TP53,C1333015,Vincristine,DB00541,Childhood Kidney Wilms Tumor,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12487,LZTR1,C0032290,Ticarcillin,DB01607,Aspiration Pneumonia,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8608,Sirolimus,DB00877,Hepatitis C recurrent,C2938989,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
35922,CLPTM1L,C0235974,Sunitinib,DB01268,Pancreatic carcinoma,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15680,CYP46A1,C0238111,Topiramate,DB00273,Lennox-Gastaut syndrome,Approved,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35793,FCGR2A,C0272285,Rivaroxaban,DB06228,Heparin-induced thrombocytopenia,Terminated,C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl},Phase 3,Hematologic disease,CD32A,IGFR2,CDw32,FCGR2A1,,,,,,,,,,,,,,,,,,,,,,
2269,Dextromethorphan,DB00514,Common Cold,C0009443,Approved,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC},,Infectious disease,,,,,,,,,,,,,,,,,,,CCL22,,,,,,,,
17510,WDR11,C1384606,Ospemifene,DB04938,Dyspareunia,Approved,C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\C3=CC=C(C=C3)OCCO)/CCCl},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21493,IL17A,C0032269,Lincomycin,DB01627,Pneumococcal Infections,Approved,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O},,Infectious disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
25886,TSC2,C0085413,Tolvaptan,DB06212,"Polycystic Kidney, Autosomal Dominant",Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
14356,SLC6A3,C0009806,Oxycodone,DB00497,Constipation,Terminated,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O},Phase 3,Digestive system disease,DAT,,,,,,,,,,,,,,,,,,,,,,,,,
8789,Vitamin E,DB00163,Blood Coagulation Disorders,C0005779,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
17286,AHR,C0919659,Miconazole,DB01110,Oropharyngeal candidiasis,Approved,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl},,Infectious disease,bHLHe76,,,,,,,,,,,,,,,,,,,,,,,,,
24796,IL2RA,C1527336,Prednisolone,DB00860,Sjogren's Syndrome,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Cardiovascular disease,IL2R,IDDM10,,,,,,,,,,,,,,,,,,,,,,,,
9159,BAZ1B,C0030920,Sodium Citrate,DB09154,Peptic Ulcer,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16060,TNFRSF13B,C0025289,Gemcitabine,DB00441,Meningitis,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1,Infectious disease,TACI,CD267,IGAD2,,,,,,,,,,,,,,,,,,,,,,,
9984,CAT,C0004626,Tobramycin,DB00684,"Pneumonia, Bacterial",Terminated,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5569,Silodosin,DB06207,Prostatic Hypertrophy,C1739363,Approved,C[C@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F},,,,,,,,,,,,,,,,,,,,,GPR182,,,,,,,,
10767,CAP1,C0155862,Troleandomycin,DB01361,Streptococcal pneumonia,Approved,C[C@@H]1C[C@@H]([C@H]([C@@H](O1)O[C@H]2[C@H](C[C@@]3(CO3)C(=O)[C@@H]([C@H]([C@H]([C@H](OC(=O)[C@@H]([C@H]([C@@H]2C)O[C@H]4C[C@@H]([C@H]([C@@H](O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14561,TP53,C0007137,Cisplatin,DB00515,Squamous cell carcinoma,Terminated,N.N.Cl[Pt]Cl},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36220,FARP1,C1510472,Varenicline,DB01273,Drug Dependence,Withdrawn,C1C2CNCC1C3=CC4=NC=CN=C4C=C23},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
16542,CYP27A1,C0238052,Cholic Acid,DB02659,"Xanthomatosis, Cerebrotendinous",Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C},,Congenital disorder of metabolism,CTX,CYP27,,,,,,,,,,,,,,,,,,,,,,,,
17760,ALB,C0042164,Triamcinolone,DB00620,Uveitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
25116,ADCY2,C0730607,Roflumilast,DB01656,Severe chronic obstructive pulmonary disease,Approved,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11401,CIITA,C0037199,Pseudoephedrine,DB00852,Sinusitis,Withdrawn,C[C@@H]([C@H](C1=CC=CC=C1)O)NC},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36031,ESR1,C1135191,Udenafil,DB06267,"Heart Failure, Systolic",Terminated,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C},Phase 3,Cardiovascular disease,NR3A1,Era,ER-alpha,ESR,,,,,,,,,,,,,,,,,,,,,,
10891,CYBB,C0004030,Voriconazole,DB00582,Aspergillosis,Withdrawn,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,GP91-PHOX,NOX2,CGD,,,,,,,,,,,,,,,,,,,,,,,
12042,LTBP4,C0013264,Ataluren,DB05016,"Muscular Dystrophy, Duchenne",Approved,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18766,MIF,C0022548,Triamcinolone,DB00620,Keloid,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19998,COL6A1,C0014877,Echothiophate,DB01057,Esotropia,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
22366,IGF1,C0011854,Pentoxifylline,DB00806,"Diabetes Mellitus, Insulin-Dependent",Terminated,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C},Phase 1/Phase 2,Endocrine disease,IGF1A,IGFI,IGF-I,IGF,,,,,,,,,,,,,,,,,,,,,,
17321,BLVRB,C3544321,Thioridazine,DB00679,Treatment-resistant schizophrenia,Approved,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
26479,AOC3,C1561643,Sevelamer,DB00658,Chronic Kidney Diseases,Terminated,C=CCN.C1C(O1)CCl},Phase 3,Urinary system disease,VAP1,HPAO,VAP-1,,,,,,,,,,,,,,,,,,,,,,,
27696,NPY1R,C1533217,Methamphetamine,DB01577,Methamphetamine dependence,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 1,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
33480,FLVCR1,C1701940,Vancomycin,DB00512,"Pneumonia, Ventilator-Associated",Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23391,REG1A,C0152499,Tinidazole,DB00911,Acute amebiasis,Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Infectious disease,PSPS,PSPS1,REG,,,,,,,,,,,,,,,,,,,,,,,
1416,Ceftriaxone,DB01212,Salmonella sepsis,C0152486,Approved,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Stanozolol,,,,,,,,
24488,FGFR2,C0043352,Cisplatin,DB00515,Xerostomia,Terminated,N.N.Cl[Pt]Cl},Phase 2,,CEK3,TK14,TK25,ECT1,K-SAM,CD332,KGFR,BEK,JWS,,,,,,,,,,,,,,,,,
22637,CYLD,C0036992,Glucagon recombinant,DB00040,Short Bowel Syndrome,Terminated,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CNC=N7)N)O},Phase 1/Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
13752,RMRP,C0011606,Triamcinolone,DB00620,Exfoliative dermatitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36511,LHCGR,C0019621,Clofarabine,DB00631,"Histiocytosis, Langerhans-Cell",Withdrawn,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl)N},Phase 2,Cancer,LHR,LCGR,LGR2,HHG,,,,,,,,,,,,,,,,,,,,,,
8413,Midazolam,DB00683,Pain,C0030193,Terminated,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
33864,CCND1,C0751690,Imatinib,DB00619,Malignant Peripheral Nerve Sheath Tumor,Terminated,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 2/Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29857,MTCO2P12,C0850666,Omeprazole,DB00338,Infection caused by Helicobacter pylori,Terminated,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 1/Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9077,CA1,C0018834,Sodium Citrate,DB09154,Heartburn,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Cardiovascular disease,Car1,,,,,,,,,,,,,,,,,,,,,,,,,
23217,ESR1,C0476089,Arsenic trioxide,DB01169,Endometrial Carcinoma,Terminated,[O-2].[O-2].[O-2].[As+3].[As+3]},Phase 2,Cancer,NR3A1,Era,ER-alpha,ESR,,,,,,,,,,,,,,,,,,,,,,
29289,C5,C0021051,Vidarabine,DB00194,Immunologic Deficiency Syndromes,Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 1/Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30461,MAPK14,C0011882,Reboxetine,DB00234,Diabetic Neuropathies,Terminated,CCOC1=CC=CC=C1O[C@@H]([C@H]2CNCCO2)C3=CC=CC=C3},Phase 2,Urinary system disease,PRKM14,Mxi2,PRKM15,CSPB1,CSBP1,CSBP2,,,,,,,,,,,,,,,,,,,,
5011,Pirbuterol,DB01291,Bronchiectasis,C0006267,Approved,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O},,Respiratory disease,,,,,,,,,,,,,,,,,,,RACK1,,,,,,,,
18399,IKZF1,C0023474,Nilotinib,DB04868,"Leukemia, Myeloid, Chronic-Phase",Approved,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,hIk-1,LyF-1,Hs.54452,IKAROS,PPP1R92,ZNFN1A1,,,,,,,,,,,,,,,,,,,,
7310,IL17A,C0001144,Tretinoin,DB00755,Acne Vulgaris,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Infectious disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,NANOG,,,,,,,,
12013,IL6,C0578870,Loratadine,DB00455,Chronic idiopathic urticaria,Approved,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1},,Immune system disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
1679,Citalopram,DB00215,Generalized Anxiety Disorder,C0270549,Approved,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,SLC1A3,,,,,,,,
20777,BRD4,C4083212,Finasteride,DB01216,"Alopecia, Male Pattern",Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29807,CPA2,C0700292,Nitric Oxide,DB00435,Hypoxemia,Terminated,[N]=O},Phase 1/Phase 2,Hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
11180,HLA-DRB1,C0023290,Miltefosine,DB09031,"Leishmaniasis, Visceral",Approved,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},,Infectious disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
1671,Ciprofloxacin,DB00537,Traveler's diarrhea,C0277528,Approved,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},,Digestive system disease,,,,,,,,,,,,,,,,,,,GABRQ,,,,,,,,
19751,SIRT2,C0023860,Minocycline,DB01017,Listeriosis,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10313,PDLIM5,C0221765,Memantine,DB01043,Chronic schizophrenia,Terminated,CC12CC3CC(C1)(CC(C3)(C2)N)C},Phase 3,Mental and behavioural disorder,LIM,Enh,,,,,,,,,,,,,,,,,,,,,,,,
33853,CDKN2A,C0751690,Imatinib,DB00619,Malignant Peripheral Nerve Sheath Tumor,Terminated,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 2/Phase 3,Cancer,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
31416,TLR4,C3873567,Erythropoietin,DB00016,Chemotherapy-induced peripheral neuropathy,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 2,,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,,,,,,,,,
34218,TLR4,C0349217,Aripiprazole,DB01238,"Depressive episode, unspecified",Terminated,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl},Phase 3,Mental and behavioural disorder,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,,,,,,,,,
20770,GLUD1,C0343386,Vancomycin,DB00512,Clostridium difficile infection,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10566,BDNF,C0038220,Secobarbital,DB00418,Status Epilepticus,Approved,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C},,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
16476,BGLAP,C0029442,Ergocalciferol,DB00153,Osteomalacia,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Urinary system disease,OCN,,,,,,,,,,,,,,,,,,,,,,,,,
26737,SYK,C0278791,Thalidomide,DB01041,Chronic lymphocytic leukaemia refractory,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
13200,ZAP70,C0149985,Procaine benzylpenicillin,DB09320,"Syphilis, secondary",Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18058,IL12A,C0022575,Cyclosporine,DB00091,Keratoconjunctivitis Sicca,Approved,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33058,ERCC5,C0278689,Paclitaxel,DB01229,Ovarian epithelial cancer recurrent,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12091,HSD11B2,C0027051,Fondaparinux sodium,DB00569,Myocardial Infarction,Withdrawn,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},Phase 2,Cardiovascular disease,SDR9C3,,,,,,,,,,,,,,,,,,,,,,,,,
19663,COL4A2,C0149925,Cisplatin,DB00515,Small cell carcinoma of lung,Terminated,N.N.Cl[Pt]Cl},Phase 2,Cancer,FLJ22259,DKFZp686I14213,,,,,,,,,,,,,,,,,,,,,,,,
13082,MMP1,C0011644,Imatinib,DB00619,Scleroderma,Terminated,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 2,Skin disease,,,,,,,,,,,,,,,,,,,,,,,,,,
35246,SOX2,C0018784,Methotrexate,DB00563,Sensorineural Hearing Loss (disorder),Terminated,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 3,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
4612,Ofloxacin,DB01165,prostatitis,C0033581,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,,,,,,,,,,,,,,,,,,,SLC5A5,,,,,,,,
8856,Acetylcysteine,DB06151,Acetaminophen overdose,C0572025,Terminated,CC(=O)N[C@@H](CS)C(=O)O},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
16573,TRAF3IP2,C0040261,Terbinafine,DB00857,Onychomycosis,Approved,CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
772,Bosentan,DB00559,Pulmonary arterial hypertension,C2973725,Approved,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC},,Infectious disease,,,,,,,,,,,,,,,,,,,TUBB3,,,,,,,,
20094,SERPINA1,C0041228,Suramin,DB04786,African Trypanosomiasis,Approved,CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C},,Infectious disease,AAT,A1A,PI1,alpha-1-antitrypsin,A1AT,alpha1AT,PI,,,,,,,,,,,,,,,,,,,
37056,RBM45,C1168198,Propranolol,DB00571,Recurrent respiratory papillomatosis,Withdrawn,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},Phase 2/Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14352,MED13,C0009806,Oxycodone,DB00497,Constipation,Terminated,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O},Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34310,BTBD8,C0004610,Vancomycin,DB00512,Bacteremia,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18542,REN,C1739382,Deferoxamine,DB00746,Chronic iron overload,Approved,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O},,,,,,,,,,,,,,,,,,,,,,,,,,,,
34129,PTX3,C1960870,Cyclobenzaprine,DB00924,Transformed migraine,Terminated,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31},Phase 3,Nervous system disease,TSG-14,TNFAIP5,,,,,,,,,,,,,,,,,,,,,,,,
458,Azatadine,DB00719,Sneezing,C0037383,Approved,CN1CCC(=C2C3=CC=CC=C3CCC4=C2N=CC=C4)CC1},,,,,,,,,,,,,,,,,,,,,Diclofenamide,,,,,,,,
462,Azelaic Acid,DB00548,Acne Vulgaris,C0001144,Approved,C(CCCC(=O)O)CCCC(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Didanosine,,,,,,,,
8954,Dextroamphetamine,DB01576,Depressive disorder,C0011581,Terminated,C[C@@H](CC1=CC=CC=C1)N},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,
28221,STAT3,C0153676,Ifosfamide,DB01181,Secondary malignant neoplasm of lung,Terminated,C1CN(P(=O)(OC1)NCCCl)CCCl},Phase 1,Cancer,APRF,,,,,,,,,,,,,,,,,,,,,,,,,
17460,OXT,C0020625,Tolvaptan,DB06212,Hyponatremia,Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26281,APP,C0042842,Vitamin A,DB00162,Vitamin A Deficiency,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18858,NOS3,C0020459,Diazoxide,DB01119,Hyperinsulinism,Approved,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl},,Endocrine and metabolic disease,ECNOS,eNOS,,,,,,,,,,,,,,,,,,,,,,,,
16413,DRD4,C0012734,Promazine,DB00420,Disruptive Behavior Disorder,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
20368,MYCNOS,C0281361,Mitomycin,DB00305,Adenocarcinoma of pancreas,Approved,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
21705,SLC29A3,C0002453,Lisuride,DB00589,Amenorrhea,Approved,CCN(CC)C(=O)N[C@@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28830,NT5C2,C0023452,Vincristine,DB00541,"Leukemia, Lymphocytic, Acute, L1",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
20042,AMD1,C0271093,Echothiophate,DB01057,Stargardt's disease,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3879,Magnesium Sulfate,DB00653,Eclampsia in pregnancy,C0156677,Approved,[O-]S(=O)(=O)[O-].[Mg+2]},,Nervous system disease,,,,,,,,,,,,,,,,,,,TOLLIP,,,,,,,,
21186,PNPLA6,C0022735,Testosterone Propionate,DB01420,Klinefelter Syndrome,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
25999,PADI3,C0002171,Triamcinolone,DB00620,Alopecia Areata,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18532,HFE,C0005283,Deferiprone,DB08826,beta Thalassemia,Approved,CC1=C(C(=O)C=CN1C)O},,Hematologic disease,HLA-H,,,,,,,,,,,,,,,,,,,,,,,,,
13381,HLA-A,C0038013,Triamcinolone,DB00620,Ankylosing spondylitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,,,,,,,,
4014,Methdilazine,DB00902,Sneezing,C0037383,Approved,CN1CCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42},,,,,,,,,,,,,,,,,,,,,TMEM8B,,,,,,,,
23466,LOC102724197,C0023886,Tinidazole,DB00911,"Liver Abscess, Amebic",Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33698,CXCL8,C0040332,Nicotine,DB00184,Tobacco Dependence,Terminated,CN1CCC[C@H]1C2=CN=CC=C2},Phase 3,Mental and behavioural disorder,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
15335,DYNLL1,C0018790,Metoprolol,DB00264,Cardiac Arrest,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20366,STK11,C0281361,Mitomycin,DB00305,Adenocarcinoma of pancreas,Approved,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1855,Conjugated Estrogens,DB00286,Dyspareunia,C1384606,Approved,C[C@]12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[Na+]},,Reproductive system disease,,,,,,,,,,,,,,,,,,,OLIG2,,,,,,,,
32926,SLC6A4,C0003125,Quetiapine,DB01224,Anorexia Nervosa,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 2,Mental and behavioural disorder,5-HTT,SERT1,HTT,OCD1,,,,,,,,,,,,,,,,,,,,,,
16798,MIF,C0010692,Ofloxacin,DB01165,Cystitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18277,BRCA1,C0016034,Danazol,DB01406,Breast Fibrocystic Disease,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5},,Other disease,RNF53,PPP1R53,FANCS,,,,,,,,,,,,,,,,,,,,,,,
18731,RHOA,C0006413,Vincristine,DB00541,Burkitt Lymphoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12110,CCL5,C0003850,Simvastatin,DB00641,Arteriosclerosis,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Vascular disease,RANTES,SISd,TCP228,MGC17164,D17S136E,SCYA5,,,,,,,,,,,,,,,,,,,,
18940,CD36,C0409959,Diclofenac,DB00586,"Osteoarthritis, Knee",Approved,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl},,Musculoskeletal disease,SCARB3,GPIV,GP4,GP3B,,,,,,,,,,,,,,,,,,,,,,
1450,Cefuroxime,DB01112,Lyme Disease,C0024198,Approved,CO/N=C(/C1=CC=CO1)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SLC26A4,,,,,,,,
12623,LRRC6,C0027430,Beclomethasone dipropionate,DB00394,Nasal Polyps,Approved,CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36146,AGTPBP1,C0264303,Omeprazole,DB00338,Laryngomalacia,Withdrawn,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 1,,0,,,,,,,,,,,,,,,,,,,,,,,,,
5785,Tazobactam,DB01606,Diabetic foot infection,C0744130,Approved,C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3},,Infectious disease,,,,,,,,,,,,,,,,,,,TNFSF13,,,,,,,,
29598,STK38,C0278883,Paclitaxel,DB01229,Metastatic melanoma,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11740,TTN-AS1,C0085612,Tocainide,DB01056,Ventricular arrhythmia,Approved,CC1=C(C(=CC=C1)C)NC(=O)C(C)N},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7845,BRAF,C0007131,Carboplatin,DB00958,Non-Small Cell Lung Carcinoma,Withdrawn,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2]},Phase 2,Cancer,BRAF1,,,,,,,,,,,,,,,,,LINC02770,,,,,,,,
8267,Ketamine,DB01221,Depressive disorder,C0011581,Terminated,CNC1(CCCCC1=O)C2=CC=CC=C2Cl},Phase 2,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,
26452,KRAS,C0278517,Pemetrexed,DB00642,Non-small cell lung cancer recurrent,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9371,Carvedilol,DB01136,Pulmonary Hypertension,C0020542,Withdrawn,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O},Phase 1,Lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
23778,FN1,C0038160,Vancomycin,DB00512,Staphylococcal Infections,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,CIG,LETS,GFND2,FINC,,,,,,,,,,,,,,,,,,,,,,
7725,NCF2,C0024138,Ulobetasol,DB00596,"Lupus Erythematosus, Discoid",Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Immune system disease,0,,,,,,,,,,,,,,,,,MIR378I,,,,,,,,
14295,ADRB2,C0020473,Cholecalciferol,DB00169,Hyperlipidemia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 1,Metabolic disease,ADRBR,B2AR,ADRB2R,,,,,,,,,,,,,,,,,,,,,,,
36734,EGFR,C0278802,Norgestrel,DB09389,Recurrent Endometrial Cancer,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
5012,Pirbuterol,DB01291,Bronchitis,C0006277,Approved,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O},,Lung disease,,,,,,,,,,,,,,,,,,,CDX1,,,,,,,,
7341,Mycophenolic acid,DB01024,Lupus Nephritis,C0024143,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 1,Urinary system disease,,,,,,,,,,,,,,,,,,,CREST2,,,,,,,,
20952,ACTB,C0085436,Flucytosine,DB01099,"Meningitis, Cryptococcal",Terminated,C1=NC(=O)NC(=C1F)N},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21633,LMBRD1,C0019880,Glycine betaine,DB06756,Homocystinuria,Approved,C[N+](C)(C)CC(=O)[O-]},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
4865,Pheniramine,DB01620,Sore Throat,C0242429,Approved,CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2},,Infectious disease,,,,,,,,,,,,,,,,,,,CCL19,,,,,,,,
29141,TP53,C0280790,Irinotecan,DB00762,adult anaplastic oligodendroglioma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4405,Niacin,DB00627,"Hyperlipidemia, Familial Combined",C0020474,Approved,C1=CC(=CN=C1)C(=O)O},,Metabolic disease,,,,,,,,,,,,,,,,,,,TMEM94,,,,,,,,
36554,CP,C0012715,Deferasirox,DB01609,Iron Metabolism Disorders,Withdrawn,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O},Phase 2,Hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
33016,FFAR1,C0017689,Romidepsin,DB06176,Glucagonoma,Terminated,C/C=C\\1/C(=O)N[C@H](C(=O)O[C@H]\\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C},Phase 2,Cancer,FFA1R,GPR40,,,,,,,,,,,,,,,,,,,,,,,,
18939,BGLAP,C0409959,Diclofenac,DB00586,"Osteoarthritis, Knee",Approved,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl},,Musculoskeletal disease,OCN,,,,,,,,,,,,,,,,,,,,,,,,,
24376,CALB2,C0812413,Pemetrexed,DB00642,Malignant Pleural Mesothelioma,Approved,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,CAL2,,,,,,,,,,,,,,,,,,,,,,,,,
26224,BEST1,C0271066,Imatinib,DB00619,Choroidal retinal neovascularization,Withdrawn,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 1,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
25879,ACE,C0085413,Tolvaptan,DB06212,"Polycystic Kidney, Autosomal Dominant",Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Congenital malformation,ACE1,CD143,DCP1,,,,,,,,,,,,,,,,,,,,,,,
18528,PMCH,C0005283,Deferiprone,DB08826,beta Thalassemia,Approved,CC1=C(C(=O)C=CN1C)O},,Hematologic disease,MCH,,,,,,,,,,,,,,,,,,,,,,,,,
36361,SLC6A3,C0149654,Methylphenidate,DB00422,Conduct Disorder,Withdrawn,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},Phase 1/Phase 2,Mental and behavioural disorder,DAT,,,,,,,,,,,,,,,,,,,,,,,,,
16141,IDO1,C0006060,Fusidic Acid,DB02703,Boutonneuse Fever,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,IDO,INDO,,,,,,,,,,,,,,,,,,,,,,,,
33197,ANP32B,C0948780,Simvastatin,DB00641,Rhinosinusitis,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8863,Alfuzosin,DB00346,Urinary Retention,C0080274,Terminated,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
15718,CHRM1,C0494475,Primidone,DB00794,Tonic - clonic seizures,Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5688,Sulfacetamide,DB00634,Amebiasis,C0002438,Approved,CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N},,Infectious disease,,,,,,,,,,,,,,,,,,,POLE,,,,,,,,
21627,CBSL,C0019880,Glycine betaine,DB06756,Homocystinuria,Approved,C[N+](C)(C)CC(=O)[O-]},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
30758,SCO2,C1514428,Paclitaxel,DB01229,Primary peritoneal carcinoma,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25739,NR5A1,C0020635,Testosterone,DB00624,Hypopituitarism,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25179,SH2B3,C0027022,Vidarabine,DB00194,Myeloproliferative disease,Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35584,SH2D3C,C0017160,Ondansetron,DB00904,Gastroenteritis,Terminated,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C},Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3873,Magnesium salicylate,DB01397,Headache Disorders,C0393735,Approved,C1=CC=C(C(=C1)C(=O)O)[O-].C1=CC=C(C(=C1)C(=O)O)[O-].[Mg+2]},,Nervous system disease,,,,,,,,,,,,,,,,,,,PEX13,,,,,,,,
35018,COL1A2,C0151526,Progesterone,DB00396,Premature Birth,Terminated,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,
18081,PTPN11,C0023467,Tretinoin,DB00755,"Leukemia, Myelocytic, Acute",Withdrawn,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},Phase 3,Cancer,BPTP3,SH-PTP2,SHP-2,PTP2C,SHP2,NS1,,,,,,,,,,,,,,,,,,,,
27719,KRT17,C0023532,Aminolevulinic acid,DB00855,"Leukoplakia, Oral",Terminated,C(CC(=O)O)C(=O)CN},Phase 1,Cancer,PCHC1,,,,,,,,,,,,,,,,,,,,,,,,,
16191,RABEPK,C0036117,Chloramphenicol,DB00446,Salmonella infections,Approved,C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30051,NCOA3,C0004114,Temozolomide,DB00853,Astrocytoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
5014,Pirbuterol,DB01291,Pulmonary Emphysema,C0034067,Approved,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O},,Lung disease,,,,,,,,,,,,,,,,,,,CST4,,,,,,,,
31133,MYC,C1292753,Doxorubicin,DB00997,Primary Effusion Lymphoma,Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},Phase 2,Cancer,c-Myc,bHLHe39,MYCC,,,,,,,,,,,,,,,,,,,,,,,
7084,ERVK-20,C0019348,Aciclovir,DB00787,Herpes Simplex Infections,Approved,C1=NC2=C(N1COCCO)N=C(NC2=O)N},,Infectious disease,0,,,,,,,,,,,,,,,,,TRIM39,,,,,,,,
2473,Doxycycline,DB00254,Acne Vulgaris,C0001144,Approved,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Flucytosine,,,,,,,,
27514,KCNQ1,C0332890,Vincristine,DB00541,Congenital hemihypertrophy,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Congenital malformation,Kv7.1,KCNA8,KVLQT1,JLNS1,LQT1,LQT,KCNA9,,,,,,,,,,,,,,,,,,,
14615,CENPE,C1336708,Vinblastine,DB00570,Testicular Germ Cell Tumor,Terminated,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35439,SARDH,C0003129,Nitric Oxide,DB00435,Anoxemia,Terminated,[N]=O},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
12366,PTGS2,C0007134,Thalidomide,DB01041,Renal Cell Carcinoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 1/Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
864,Calcipotriol,DB02300,Chronic small plaque psoriasis,C0406317,Approved,C[C@H](/C=C/[C@H](C1CC1)O)[C@H]2CC[C@@H]\\3[C@@]2(CCC/C3=C\\C=C/4\\C[C@H](C[C@@H](C4=C)O)O)C},,Skin disease,,,,,,,,,,,,,,,,,,,Lepirudin,,,,,,,,
29939,MAP2K1,C0007112,Prednisone,DB00635,Adenocarcinoma of prostate,Withdrawn,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11459,ERN1,C0153252,Voriconazole,DB00582,Systemic candidiasis,Approved,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},,Infectious disease,IRE1,IRE1P,,,,,,,,,,,,,,,,,,,,,,,,
22610,NOS2,C0030409,Ketoconazole,DB01026,Paracoccidioidomycosis,Approved,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},,Infectious disease,iNOS,HEP-NOS,NOS2A,,,,,,,,,,,,,,,,,,,,,,,
24811,IDH1,C0018916,Propranolol,DB00571,Hemangioma,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26191,MMP2,C0600518,Imatinib,DB00619,Choroidal Neovascularization,Withdrawn,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 1,Congenital malformation,TBE-1,CLG4,CLG4A,,,,,,,,,,,,,,,,,,,,,,,
27045,HSPD1,C0036983,Norepinephrine,DB00368,Septic Shock,Withdrawn,C1=CC(=C(C=C1[C@H](CN)O)O)O},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
6048,Tolnaftate,DB00525,Tinea barbae,C2349994,Approved,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2},,Infectious disease,,,,,,,,,,,,,,,,,,,SLFN12,,,,,,,,
35898,TP53,C0235974,Sunitinib,DB01268,Pancreatic carcinoma,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4278,Mometasone,DB00764,Asthma,C0004096,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)Cl)C},,Immune system disease,,,,,,,,,,,,,,,,,,,ACADS,,,,,,,,
25461,USP18,C0003962,Eplerenone,DB00700,Ascites,Withdrawn,C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,
6674,PTGS2,C0017612,Unoprostone,DB06826,"Glaucoma, Open-Angle",Approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},,Nervous system disease,,,,,,,,,,,,,,,,,,PPP1R9A,,,,,,,,
13377,ERAP2,C0038013,Triamcinolone,DB00620,Ankylosing spondylitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20448,TLR1,C0023241,Erythromycin,DB00199,Legionnaires' Disease,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,rsc786,KIAA0012,CD281,,,,,,,,,,,,,,,,,,,,,,,
12709,NOS1,C0079774,Thalidomide,DB01041,Peripheral T-Cell Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,nNOS,,,,,,,,,,,,,,,,,,,,,,,,,
1526,Chloroquine,DB00608,"Malaria, Vivax",C0024537,Approved,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,Tolnaftate,,,,,,,,
29143,CCNO,C0280790,Irinotecan,DB00762,adult anaplastic oligodendroglioma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15351,GPD1L,C0018790,Metoprolol,DB00264,Cardiac Arrest,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27853,ETV6,C0279630,Idarubicin,DB01177,adult acute eosinophilic leukemia,Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O},Phase 2,Cancer,TEL,,,,,,,,,,,,,,,,,,,,,,,,,
6562,Eptifibatide,DB00063,Pneumonia,C0032285,Suspended,C1C[C@H]2C(=O)N[C@@H](CSSCCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,SLC66A3,,,,,,,,
3636,Lamotrigine,DB00555,Bipolar disorder in remission,C0270425,Approved,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,CDH23,,,,,,,,
33192,CFTR,C0948780,Simvastatin,DB00641,Rhinosinusitis,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Immune system disease,ABC35,TNR-CFTR,CFTR/MRP,CF,ABCC7,,,,,,,,,,,,,,,,,,,,,
30814,PTPRU,C1321872,Fludarabine,DB01073,Stage IV Skin Melanoma,Terminated,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
20831,MAPK1,C0042024,Tolterodine,DB01036,Urinary Incontinence,Terminated,CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2},Phase 2,,ERK2,p41mapk,MAPK2,PRKM2,PRKM1,,,,,,,,,,,,,,,,,,,,,
32373,PTGDR2,C0263338,Miltefosine,DB09031,Chronic urticaria,Terminated,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},Phase 2,Skin and connective tissue disease,CRTH2,CD294,GPR44,,,,,,,,,,,,,,,,,,,,,,,
4528,Norfloxacin,DB01059,Proteus urinary tract infection,C0577709,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,PTPRF,,,,,,,,
34792,TRPV1,C1135120,Fentanyl,DB00813,Breakthrough Pain,Terminated,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,
27484,CAT,C1333015,Vincristine,DB00541,Childhood Kidney Wilms Tumor,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13189,LAP,C0343532,Benzylpenicillin,DB01053,Streptococcal toxic shock syndrome,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20598,AMACR,C0033578,Flutamide,DB00499,Prostatic Neoplasms,Approved,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
22584,CTLA4,C0030409,Ketoconazole,DB01026,Paracoccidioidomycosis,Approved,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},,Infectious disease,CD152,CELIAC3,IDDM12,,,,,,,,,,,,,,,,,,,,,,,
35830,IL6,C0032927,Celecoxib,DB00482,Precancerous Conditions,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2/Phase 3,,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
24877,CDH23,C0040127,Propylthiouracil,DB00550,Thyroid Crisis,Approved,CCCC1=CC(=O)NC(=S)N1},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20354,KRAS,C0281361,Mitomycin,DB00305,Adenocarcinoma of pancreas,Approved,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34371,MINDY4,C0007860,Cefixime,DB00671,Uterine Cervicitis,Terminated,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O},Phase 3,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33583,LPA,C0007273,Vitamin E,DB00163,Carotid Artery Diseases,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27856,EPO,C2347748,Mitoxantrone,DB01204,Adult Erythroleukemia,Terminated,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},Phase 1,Cancer,EP,,,,,,,,,,,,,,,,,,,,,,,,,
18552,IREB2,C0282193,Deferasirox,DB01609,Iron Overload,Withdrawn,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O},Phase 2,Mitochondrial disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6302,Urea,DB03904,Tinea Versicolor,C0040262,Approved,C(=O)(N)N},,Infectious disease,,,,,,,,,,,,,,,,,,,NEUROG1,,,,,,,,
11784,CXCL1,C0019080,Aprotinin,DB06692,Hemorrhage,Approved,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](CSSC[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N4CCC[C@@H]4C(=O)N5CCC[C@@H]5C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N6CCC[C@H]6C(=O)N[C@H](CSSC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CCC(=O)N)[C@@H](C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCNC(=N)N)C)CCCCN)[C@H](C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)[C@@H](C)CC},,,SCYB1,GROa,MGSA-a,NAP-3,MGSA,GRO1,FSP,,,,,,,,,,,,,,,,,,,
2230,Dexamethasone,DB01234,Simple Pulmonary Eosinophilia,C0242459,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Immune system disease,,,,,,,,,,,,,,,,,,,CDKN2D,,,,,,,,
14010,IL2,C0027726,Triamcinolone,DB00620,Nephrotic Syndrome,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Urinary system disease,IL-2,TCGF,,,,,,,,,,,,,,,,,,,,,,,,
3910,CARMIL2,C2607914,Triprolidine,DB00427,Allergic rhinitis (disorder),Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Immune system disease,0,,,,,,,,,,,,,,,,,TMEM67,,,,,,,,
6949,Sirolimus,DB00877,Pemphigus,C0030807,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 0,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,ADAMTS7,,,,,,,,
17478,HMBS,C0020625,Tolvaptan,DB06212,Hyponatremia,Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Urinary system disease,PBGD,UPS,,,,,,,,,,,,,,,,,,,,,,,,
767,BRCA2,C0376358,Sirolimus,DB00877,Malignant neoplasm of prostate,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,PRNP,,,,,,,,
7237,MUC7,C0035460,Triprolidine,DB00427,"Rhinitis, Vasomotor",Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Immune system disease,0,,,,,,,,,,,,,,,,,LINC-ROR,,,,,,,,
26772,CDKN2B,C0280451,Allopurinol,DB00437,de novo myelodysplastic syndromes,Terminated,C1=NNC2=C1C(=O)NC=N2},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12135,MTTP,C0342882,Simvastatin,DB00641,Familial hypercholesterolemia - heterozygous,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Inherited metabolic disease,MTP,,,,,,,,,,,,,,,,,,,,,,,,,
17489,TRAF3IP2,C1384606,Ospemifene,DB04938,Dyspareunia,Approved,C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\C3=CC=C(C=C3)OCCO)/CCCl},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34727,CYP19A1,C0241616,Estradiol,DB00783,Atrophy of vagina,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O},Phase 3,Reproductive system disease,ARO,P-450AROM,CPV1,ARO1,CYAR,aromatase,CYP19,,,,,,,,,,,,,,,,,,,
30160,GATA2,C3463824,Azacitidine,DB00928,MYELODYSPLASTIC SYNDROME,Terminated,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N},Phase 2,Hematologic disease,NFE1B,,,,,,,,,,,,,,,,,,,,,,,,,
1083,Cefepime,DB01413,Bacterial infection due to Klebsiella pneumoniae,C0343402,Approved,C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,Nesiritide,,,,,,,,
7322,HLA-C,C0524909,Tenofovir,DB00300,"Hepatitis B, Chronic",Approved,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},,Infectious disease,HLA-JY3,D6S204,PSORS1,,,,,,,,,,,,,,,MGA,,,,,,,,
14990,NRXN1,C0028043,Varenicline,DB01273,Nicotine Dependence,Terminated,C1C2CNCC1C3=CC4=NC=CN=C4C=C23},Phase 2/Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
25403,XPC,C0007117,Vismodegib,DB08828,Basal cell carcinoma,Approved,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19631,FN1,C0585442,Methotrexate,DB00563,Osteosarcoma of bone,Approved,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,CIG,LETS,GFND2,FINC,,,,,,,,,,,,,,,,,,,,,,
30152,NCOA3,C2938924,Letrozole,DB01006,Oestrogen receptor positive breast cancer,Terminated,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33320,G6PD,C0033117,Tadalafil,DB00820,Priapism,Terminated,CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36},Phase 2,,G6PD1,,,,,,,,,,,,,,,,,,,,,,,,,
31161,MDM2,C1292753,Doxorubicin,DB00997,Primary Effusion Lymphoma,Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27242,EPCAM,C0007097,Cisplatin,DB00515,Carcinoma,Withdrawn,N.N.Cl[Pt]Cl},Phase 3,Cancer,Ly74,TROP1,GA733-2,EGP34,EGP40,EGP-2,KSA,CD326,Ep-CAM,HEA125,KS1/4,MK-1,MH99,MOC31,323/A3,17-1A,TACST-1,,,,,,,,,
3719,Levothyroxine,DB00451,Congenital Hypothyroidism,C0010308,Approved,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N},,Congenital malformation,,,,,,,,,,,,,,,,,,,CEBPE,,,,,,,,
5117,SYNE2,C0004604,Hydromorphone,DB00327,Back Pain,Terminated,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4},Phase 3,,0,,,,,,,,,,,,,,,,,TRNT,,,,,,,,
23343,HLA-DRB1,C0042900,Tacrolimus,DB00864,Vitiligo,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Skin disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
6503,Amphotericin B,DB00681,Lung transplant recipient,C2063401,Suspended,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},Phase 2,,,,,,,,,,,,,,,,,,,,PTGER1,,,,,,,,
33933,FCGR2A,C2347126,Prednisolone,DB00860,Microscopic Polyarteritis,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2/Phase 3,Vascular disease,CD32A,IGFR2,CDw32,FCGR2A1,,,,,,,,,,,,,,,,,,,,,,
24455,PECAM1,C0232849,Pentosan Polysulfate,DB00686,Bladder pain,Approved,C1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2CO[C@H]([C@@H]([C@H]2OS(=O)(=O)O)OS(=O)(=O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)O},,,CD31,,,,,,,,,,,,,,,,,,,,,,,,,
31734,DNAAF4,C0021359,Ganirelix,DB06785,Infertility,Withdrawn,CCNC(=NCCCC[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C)NCC},Phase 3,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4753,OPRM1,C0857177,Salicylic acid,DB00936,Arthritic pains,Approved,C1=CC=C(C(=C1)C(=O)O)O},,,MOR1,,,,,,,,,,,,,,,,,CSTB,,,,,,,,
7827,SEC24C,C0036508,Urea,DB03904,Seborrheic dermatitis,Approved,C(=O)(N)N},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,SC5D,,,,,,,,
3381,Hydrocortisone,DB00741,Rheumatoid Arthritis,C0003873,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,Immune system disease,,,,,,,,,,,,,,,,,,,MIR204,,,,,,,,
11702,MICC,C0003872,Triamcinolone,DB00620,"Arthritis, Psoriatic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18936,EEF1A1,C0409959,Diclofenac,DB00586,"Osteoarthritis, Knee",Approved,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17864,IGF1,C0151482,Iron,DB01592,Megaloblastic anemia due to folate deficiency,Approved,[Fe]},,Inherited metabolic disease,IGF1A,IGFI,IGF-I,IGF,,,,,,,,,,,,,,,,,,,,,,
18498,SHISA8,C0036220,Vinblastine,DB00570,Kaposi Sarcoma,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,Orf26,C22orf17,,,,,,,,,,,,,,,,,,,,,,,,
32850,IL6,C1290884,Prednisone,DB00635,Inflammatory disorder,Terminated,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 2,Immune system disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
11645,SH2B3,C0040028,Anagrelide,DB00261,"Thrombocythemia, Essential",Approved,C1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33079,SPINK4,C2076600,Rosuvastatin,DB01098,Influenza due to Influenza A virus subtype H1N1,Terminated,CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C},Phase 2,Infectious disease,PEC-60,MGC133107,,,,,,,,,,,,,,,,,,,,,,,,
18247,MSH2,C0035412,Vincristine,DB00541,Rhabdomyosarcoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,HNPCC1,COCA1,,,,,,,,,,,,,,,,,,,,,,,,
23013,MTMR11,C0029104,Methadone,DB00333,Opioid withdrawal,Approved,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
9970,CASP1,C0155860,Trovafloxacin,DB00685,Pneumonia due to Pseudomonas,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4043,Methylergometrine,DB00353,Postpartum Hemorrhage,C0032797,Approved,CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C},,,,,,,,,,,,,,,,,,,,,CYC1,,,,,,,,
26283,LYZ,C0042842,Vitamin A,DB00162,Vitamin A Deficiency,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C},,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
15250,CLCN7,C0020598,Teriparatide,DB06285,Hypocalcemia,Terminated,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N},Phase 2,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16366,MLC1,C0024537,Primaquine,DB01087,"Malaria, Vivax",Approved,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9760,TACR1,C0085437,Tobramycin,DB00684,"Meningitis, Bacterial",Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Infectious disease,SPR,NK1R,TAC1R,,,,,,,,,,,,,,,,,,,,,,,
35511,NOS3,C0011884,Octreotide,DB00104,Diabetic Retinopathy,Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 3,Nervous system disease,ECNOS,eNOS,,,,,,,,,,,,,,,,,,,,,,,,
18562,SLC11A2,C0282193,Deferasirox,DB01609,Iron Overload,Withdrawn,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O},Phase 2,Mitochondrial disease,DCT1,NRAMP2,,,,,,,,,,,,,,,,,,,,,,,,
5074,Pramocaine,DB09345,Dry skin,C0151908,Approved,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,KCTD7,,,,,,,,
6639,INS,C0013604,Triamterene,DB00384,Edema,Approved,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N},,,IDDM2,,,,,,,,,,,,,,,,,FSD1L,,,,,,,,
31270,CYP2E1,C0220624,Erlotinib,DB00530,adult brain tumor,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,CYP2E,,,,,,,,,,,,,,,,,,,,,,,,,
24721,RBM45,C0032533,Prednisone,DB00635,Polymyalgia Rheumatica,Terminated,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 3,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5708,Sulfamethizole,DB00576,Klebsiella cystitis,C0520775,Approved,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N},,Urinary system disease,,,,,,,,,,,,,,,,,,,KISS1,,,,,,,,
33513,AVP,C0036974,Vitamin C,DB00126,Shock,Terminated,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O},Phase 2,Infectious disease,ADH,ARVP,,,,,,,,,,,,,,,,,,,,,,,,
2967,Fluticasone Propionate,DB00588,Intrinsic asthma,C0155880,Approved,CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF},,Immune system disease,,,,,,,,,,,,,,,,,,,LRG1,,,,,,,,
11543,TNF,C0013369,Ampicillin,DB00415,Dysentery,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C},,Infectious disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
2006,Cyproheptadine,DB00434,Nasal congestion (finding),C0027424,Approved,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1},,,,,,,,,,,,,,,,,,,,,ERVW-1,,,,,,,,
14653,UBR5,C0334634,Thalidomide,DB01041,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4376,Natamycin,DB00826,Fungal keratitis,C1262117,Approved,C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)O)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,THY1,,,,,,,,
37267,AHR,C3241937,Vitamin E,DB00163,Nonalcoholic Steatohepatitis,Withdrawn,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 3,Endocrine disease,bHLHe76,,,,,,,,,,,,,,,,,,,,,,,,,
17176,PRICKLE1,C0014550,Stiripentol,DB09118,"Epilepsies, Myoclonic",Approved,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17805,SMAD2,C0022577,Lodoxamide,DB06794,"Keratoconjunctivitis, Vernal",Approved,C1=C(C=C(C(=C1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N},,Infectious disease,MADR2,JV18-1,MADH2,,,,,,,,,,,,,,,,,,,,,,,
35162,MIR126,C0947751,Linagliptin,DB08882,Vascular inflammations,Terminated,CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C},Phase 3,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24247,DHX40,C0085096,Treprostinil,DB00374,Peripheral Vascular Diseases,Terminated,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19158,NDUFA11,C0042963,Haloperidol,DB00502,Vomiting,Withdrawn,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F},Phase 0,,0,,,,,,,,,,,,,,,,,,,,,,,,,
15605,GRM8,C0003469,Paroxetine,DB00715,Anxiety Disorders,Terminated,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4},Phase 3,Mental and behavioural disorder,GLUR8,GPRC1H,mGlu8,MGLUR8,,,,,,,,,,,,,,,,,,,,,,
32730,COL7A1,C0553723,Paclitaxel,DB01229,Squamous cell carcinoma of skin,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,EBDCT,EBD1,EBR1,,,,,,,,,,,,,,,,,,,,,,,
22384,MIR1271,C0346976,Gemcitabine,DB00441,Secondary malignant neoplasm of pancreas,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26423,PDCD1,C0278987,Pemetrexed,DB00642,Non-small cell lung cancer metastatic,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,CD279,hSLE1,PD-1,SLEB2,,,,,,,,,,,,,,,,,,,,,,
11362,SLC29A3,C0035021,Tetracycline,DB00759,Relapsing Fever,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28326,ABCC1,C0023486,Thalidomide,DB01041,Prolymphocytic Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
6610,MTHFR,C0017605,Methazolamide,DB00703,Angle Closure Glaucoma,Approved,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C},,Nervous system disease,0,,,,,,,,,,,,,,,,,SMYD5,,,,,,,,
20265,RETN,C0042870,Ergocalciferol,DB00153,Vitamin D Deficiency,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,FIZZ3,ADSF,RETN1,,,,,,,,,,,,,,,,,,,,,,,
13026,CHRNA7,C0030807,Sirolimus,DB00877,Pemphigus,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 0,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30711,HEY1,C0206663,Vincristine,DB00541,"Neuroectodermal Tumor, Primitive",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,HESR-1,CHF2,HESR1,HRT-1,CHF-2,HERP2,bHLHb31,,,,,,,,,,,,,,,,,,,
36258,IGF1,C0022658,Valsartan,DB00177,Kidney Diseases,Withdrawn,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Urinary system disease,IGF1A,IGFI,IGF-I,IGF,,,,,,,,,,,,,,,,,,,,,,
30375,XK,C0018939,Melphalan,DB01042,Hematological Disease,Terminated,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23285,PSMC3IP,C0232940,Progesterone,DB00396,Secondary physiologic amenorrhea,Approved,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4334,Nafcillin,DB00607,Sepsis due to Staphylococcus aureus,C2887088,Approved,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,ADAMTSL2,,,,,,,,
32649,RET,C0206695,Octreotide,DB00104,"Carcinoma, Neuroendocrine",Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 2,Cancer,CDHF12,RET51,CDHR16,HSCR1,MEN2A,MTC1,MEN2B,,,,,,,,,,,,,,,,,,,
1635,Ciprofloxacin,DB00537,Bacterial conjunctivitis,C0009768,Approved,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Xanthophyll,,,,,,,,
30429,HGF,C0494165,Oxaliplatin,DB00526,Secondary malignant neoplasm of liver,Withdrawn,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2/Phase 3,Cancer,F-TCF,HGFB,HPTA,DFNB39,,,,,,,,,,,,,,,,,,,,,,
23202,EGFR,C0220656,Thiotepa,DB04572,Malignant ascites,Approved,C1CN1P(=S)(N2CC2)N3CC3},,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
30710,EWSR1,C0206663,Vincristine,DB00541,"Neuroectodermal Tumor, Primitive",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35604,RASSF1,C0024121,Pemetrexed,DB00642,Lung Neoplasms,Terminated,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35936,CIB1,C1328479,Sunitinib,DB01268,Pancreatic Endocrine Carcinoma,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 3,Cancer,SIP2-28,KIP,,,,,,,,,,,,,,,,,,,,,,,,
5210,Prednisolone,DB00860,Ulcerative Colitis,C0009324,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Immune system disease,,,,,,,,,,,,,,,,,,,MMD,,,,,,,,
29158,APTX,C0280790,Irinotecan,DB00762,adult anaplastic oligodendroglioma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3818,Loteprednol,DB00873,Corneal Perforation,C0339293,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)OCCl)O)CCC4=CC(=O)C=C[C@]34C)O},,,,,,,,,,,,,,,,,,,,,FABP2,,,,,,,,
33047,MSLN,C0278689,Paclitaxel,DB01229,Ovarian epithelial cancer recurrent,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,MPF,,,,,,,,,,,,,,,,,,,,,,,,,
16881,BTK,C0023443,Pentostatin,DB00552,Hairy Cell Leukemia,Approved,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O},,Cancer,ATK,XLA,PSCTK1,AGMX1,IMD1,,,,,,,,,,,,,,,,,,,,,
36010,ACE,C1135191,Udenafil,DB06267,"Heart Failure, Systolic",Terminated,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C},Phase 3,Cardiovascular disease,ACE1,CD143,DCP1,,,,,,,,,,,,,,,,,,,,,,,
12424,CUL9,C1278807,Sulfisoxazole,DB00263,Chlamydial urethritis,Approved,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27653,IL4,C0023493,Thalidomide,DB01041,Adult T-Cell Lymphoma/Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 0,Cancer,BSF1,IL-4,BCGF1,BCGF-1,MGC79402,,,,,,,,,,,,,,,,,,,,,
21175,NR5A1,C0022735,Testosterone Propionate,DB01420,Klinefelter Syndrome,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
15444,ST2,C0264716,Amlodipine,DB00381,Chronic heart failure,Suspended,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1683,Clarithromycin,DB01211,Acute bacterial sinusitis,C0275556,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,ASTN2,,,,,,,,
17117,ARNTL,C0021361,Clomifene,DB00882,Female infertility,Approved,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\Cl)/C3=CC=CC=C3},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21494,IL22,C0032269,Lincomycin,DB01627,Pneumococcal Infections,Approved,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O},,Infectious disease,ILTIF,zcyto18,IL-TIF,IL-D110,TIFa,TIFIL-23,MGC79382,MGC79384,,,,,,,,,,,,,,,,,,
15105,MAPK14,C0474368,Prednisolone,DB00860,Labor Pain,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 0,,PRKM14,Mxi2,PRKM15,CSPB1,CSBP1,CSBP2,,,,,,,,,,,,,,,,,,,,
5320,Progesterone,DB00396,Hot flushes,C0600142,Approved,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,,,,,,,,,,,,,,,,,,,,NIPA1,,,,,,,,
28380,APOE,C0006111,Temozolomide,DB00853,Brain Diseases,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Nervous system disease,AD2,,,,,,,,,,,,,,,,,,,,,,,,,
2904,Fluocinonide,DB01047,Seborrheic dermatitis,C0036508,Approved,CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3C[C@@H](C5=CC(=O)C=C[C@@]54C)F)F)O)C)OC(O2)(C)C},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,MYD88,,,,,,,,
23367,VEGFA,C0035457,Methylprednisolone,DB00959,"Rhinitis, Allergic, Perennial",Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O},,Immune system disease,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
5230,Prednisone,DB00635,Cooley's anemia,C0002875,Approved,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},,Hematologic disease,,,,,,,,,,,,,,,,,,,RAB3GAP1,,,,,,,,
8538,ACE,C0003492,Alprostadil,DB00770,Aortic coarctation,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Cardiovascular disease,ACE1,CD143,DCP1,,,,,,,,,,,,,,,,,,,,,,,
35682,IFNG,C0747820,Sulfadoxine,DB01299,"Malaria, antepartum",Terminated,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
15945,SOX2,C0153633,Carmustine,DB00262,Malignant neoplasm of brain,Approved,C(CCl)NC(=O)N(CCCl)N=O},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
22771,PPBP,C0002888,Levoleucovorin,DB11596,"Anemia, Megaloblastic",Approved,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Hematologic disease,SCYB7,TGB,NAP-2-L1,LA-PF4,MDGF,LDGF,Beta-TG,CTAP3,CXCL7,b-TG1,TGB1,CTAPIII,NAP-2,THBGB1,,,,,,,,,,,,
19885,CSF2,C0178416,Oxymetholone,DB06412,Hypoplastic anemia,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(C/C(=C/O)/C(=O)C4)C},,Hematologic disease,GM-CSF,GMCSF,,,,,,,,,,,,,,,,,,,,,,,,
255,Amoxicillin,DB01060,Staphylococcal tonsillitis,C0275793,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Cefapirin,,,,,,,,
35603,IL24,C0024121,Pemetrexed,DB00642,Lung Neoplasms,Terminated,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 3,Cancer,mda-7,IL10B,Mob-5,C49A,FISP,IL-24,ST16,,,,,,,,,,,,,,,,,,,
1839,Codeine,DB00318,Tension Headache,C0033893,Approved,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O},,Nervous system disease,,,,,,,,,,,,,,,,,,,BDNF,,,,,,,,
24058,NLRP12,C0024586,Somatostatin,DB09099,Malignant Carcinoid Syndrome,Terminated,C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=CC=C6)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27760,STAT3,C0023418,Vincristine,DB00541,leukemia,Withdrawn,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,APRF,,,,,,,,,,,,,,,,,,,,,,,,,
30882,MYO5B,C0162429,Nandrolone phenpropionate,DB00984,Malnutrition,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CC[C@H]35},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33030,EHMT1,C0017689,Romidepsin,DB06176,Glucagonoma,Terminated,C/C=C\\1/C(=O)N[C@H](C(=O)O[C@H]\\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3236,Grazoprevir,DB11575,"Hepatitis C, Chronic",C0524910,Approved,CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCC[C@@H]7C[C@H]7OC(=O)N1},,Infectious disease,,,,,,,,,,,,,,,,,,,CTSZ,,,,,,,,
21369,MERTK,C0524702,Fondaparinux sodium,DB00569,Pulmonary Thromboembolisms,Approved,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},,Hematologic disease,mer,RP38,c-Eyk,Tyro12,,,,,,,,,,,,,,,,,,,,,,
145,Amcinonide,DB00288,Lichen Simplex Chronicus,C0149922,Approved,CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3CCC5=CC(=O)C=C[C@@]54C)F)O)C)OC6(O2)CCCC6},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,Besifloxacin,,,,,,,,
3779,Lodoxamide,DB06794,"Conjunctivitis, Vernal",C0009773,Approved,C1=C(C=C(C(=C1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N},,Infectious disease,,,,,,,,,,,,,,,,,,,SMARCAL1,,,,,,,,
25282,LHX4,C0013338,Somatropin recombinant,DB00052,Pituitary dwarfism,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8773,ACO1,C0013295,Sucralfate,DB00364,Duodenal Ulcer,Approved,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al]},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36292,PTGS2,C0003811,Phenylephrine,DB00388,Cardiac Arrhythmia,Withdrawn,CNC[C@@H](C1=CC(=CC=C1)O)O},Phase 1/Phase 2,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
11191,MBL2,C0023290,Miltefosine,DB09031,"Leishmaniasis, Visceral",Approved,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},,Infectious disease,COLEC1,,,,,,,,,,,,,,,,,,,,,,,,,
9967,PYCARD,C0155860,Trovafloxacin,DB00685,Pneumonia due to Pseudomonas,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,CARD5,ASC,,,,,,,,,,,,,,,,,,,,,,,,
20883,BET1,C0184567,Floctafenine,DB08976,Acute onset pain,Approved,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC=C(C3=NC=C2)C(F)(F)F},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
17005,FOXP3,C0343467,Thalidomide,DB01041,Erythema nodosum leprosum,Approved,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},,Infectious disease,JM2,XPID,AIID,PIDX,DIETER,SCURFIN,IPEX,,,,,,,,,,,,,,,,,,,
11367,QDPR,C0035021,Tetracycline,DB00759,Relapsing Fever,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8494,CNTN3,C0338908,Perphenazine,DB00850,Mixed anxiety and depressive disorder,Approved,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
30944,ABL1,C0279644,Idarubicin,DB01177,childhood acute myelomonocytic leukemia (M4),Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3791,Loperamide,DB00836,Traveler's diarrhea,C0277528,Approved,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4},,Digestive system disease,,,,,,,,,,,,,,,,,,,FLNB,,,,,,,,
21516,LRRK2,C0035258,Rotigotine,DB05271,Restless Legs Syndrome,Approved,CCCN(CCC1=CC=CS1)[C@H]2CCC3=C(C2)C=CC=C3O},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33667,GHSR,C0001956,Zonisamide,DB00909,alcohol use disorder,Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 2,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
3693,Levofloxacin,DB01137,Infection of skin AND/OR subcutaneous tissue,C0178299,Approved,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,MLLT11,,,,,,,,
28172,MIR27A,C0029928,Gemcitabine,DB00441,Ovarian Diseases,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9569,IL1B,C0684256,Vancomycin,DB00512,Bacterial sepsis,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
12271,APOA5,C0020557,Topiramate,DB00273,Hypertriglyceridemia,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Metabolic disease,RAP3,APOA-V,,,,,,,,,,,,,,,,,,,,,,,,
12833,IFNA2,C0024301,Vincristine,DB00541,"Lymphoma, Follicular",Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3707,Levoleucovorin,DB11596,"Anemia, Megaloblastic",C0002888,Approved,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Hematologic disease,,,,,,,,,,,,,,,,,,,NUP98,,,,,,,,
18476,RUNX1,C0023465,Daunorubicin,DB00694,Acute monocytic leukemia,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O},,Cancer,PEBP2A2,AMLCR1,AML1,CBFA2,,,,,,,,,,,,,,,,,,,,,,
14735,LOX,C0020542,Iloprost,DB01088,Pulmonary Hypertension,Withdrawn,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,
20659,OGG1,C0041341,Everolimus,DB01590,Tuberous Sclerosis,Approved,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10864,SIRT3,C0028754,Fenofibrate,DB01039,Obesity,Withdrawn,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 1,Metabolic disease,SIR2L3,,,,,,,,,,,,,,,,,,,,,,,,,
25318,TINF2,C0037299,Sulfadiazine,DB00359,Skin Ulcer,Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
324,Ampicillin,DB00415,Acute gonococcal cervicitis,C0153195,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Clemastine,,,,,,,,
16377,ACE2,C0745138,Losartan,DB00678,Hypertensive urgency,Approved,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24361,EGFR,C0812413,Pemetrexed,DB00642,Malignant Pleural Mesothelioma,Approved,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
31748,SHANK2,C0524528,Levoleucovorin,DB11596,Pervasive Development Disorder,Terminated,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Mental and behavioural disorder,CTTNBP1,ProSAP1,SHANK,SPANK-3,CORTBP1,,,,,,,,,,,,,,,,,,,,,
4670,Oxacillin,DB00713,Osteomyelitis due to Staphylococcus aureus,C1997728,Approved,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,TJP2,,,,,,,,
7185,NOS3,C0024117,Salmeterol,DB00938,Chronic Obstructive Airway Disease,Withdrawn,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O},Phase 3,Lung disease,ECNOS,eNOS,,,,,,,,,,,,,,,,DLX4,,,,,,,,
28042,CXCL8,C0458247,Capsaicin,DB06774,Allodynia,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
32581,TNF,C0263560,Nitric Oxide,DB00435,Chronic ulcer of lower extremity,Terminated,[N]=O},Phase 2,Vascular disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
23159,STAT6,C0003950,Thiabendazole,DB00730,Ascariasis,Approved,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3},,Infectious disease,D12S1644,IL-4-STAT,,,,,,,,,,,,,,,,,,,,,,,,
23453,ALDOA,C0023885,Metronidazole,DB00916,Liver Abscess,Approved,CC1=NC=C(N1CCO)[N+](=O)[O-]},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2955,Flurbiprofen,DB00712,Rheumatoid Arthritis,C0003873,Approved,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,NT5E,,,,,,,,
15368,SLC30A9,C0020461,Polystyrene sulfonate,DB01344,Hyperkalemia,Approved,C=CC1=CC=C(C=C1)S(=O)(=O)O},,Urinary system disease,HUEL,ZNT9,GAC63,C4orf1,,,,,,,,,,,,,,,,,,,,,,
2075,Demeclocycline,DB00618,Acute gonococcal endometritis,C0153196,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3[C@@H](C4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O},,Infectious disease,,,,,,,,,,,,,,,,,,,IL17A,,,,,,,,
29986,SMN2,C0152109,Sodium phenylbutyrate,DB06819,Juvenile Spinal Muscular Atrophy,Terminated,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},Phase 1/Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24121,GJA1,C0005697,Oxybutynin,DB01062,Neurogenic Urinary Bladder,Approved,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O},,Urinary system disease,CX43,ODOD,SDTY3,ODDD,GJAL,,,,,,,,,,,,,,,,,,,,,
34451,GFAP,C0010034,Cyclosporine,DB00091,Corneal Diseases,Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 3,,FLJ45472,,,,,,,,,,,,,,,,,,,,,,,,,
26749,LOC102723407,C1511566,Thalidomide,DB01041,Cutaneous B-Cell Non-Hodgkin Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1628,Ciprofloxacin,DB00537,Acute gonococcal cervicitis,C0153195,Approved,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Vitamin C,,,,,,,,
24098,IL4,C0036323,Praziquantel,DB01058,Schistosomiasis,Approved,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2},,Mental and behavioural disorder,BSF1,IL-4,BCGF1,BCGF-1,MGC79402,,,,,,,,,,,,,,,,,,,,,
20681,ABCG2,C0342907,Ezetimibe,DB00973,Sitosterolemia,Approved,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O},,Congenital disorder of metabolism,EST157481,MXR,BCRP,ABCP,CD338,,,,,,,,,,,,,,,,,,,,,
10385,TNF,C0038363,Triamcinolone,DB00620,Aphthous Stomatitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
19913,HSPA5,C0740447,Pregabalin,DB00230,Diabetic peripheral neuropathy,Approved,CC(C)C[C@@H](CC(=O)O)CN},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27298,TLR4,C0008495,Sulbactam,DB09324,Chorioamnionitis,Suspended,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C},Phase 2/Phase 3,Infectious disease,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,,,,,,,,,
35049,GEM,C1609538,Ofloxacin,DB01165,Latent Tuberculosis,Terminated,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
17474,SLC26A3,C0020625,Tolvaptan,DB06212,Hyponatremia,Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Urinary system disease,DRA,CLD,,,,,,,,,,,,,,,,,,,,,,,,
15783,DNMT3B,C0033581,Ofloxacin,DB01165,prostatitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
5655,Streptomycin,DB01082,Brucellosis,C0006309,Approved,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,TFEB,,,,,,,,
25676,CNR2,C0003864,Tenoxicam,DB00469,Arthritis,Approved,CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3},,Immune system disease,CB2,,,,,,,,,,,,,,,,,,,,,,,,,
18456,ERCC4,C0023465,Daunorubicin,DB00694,Acute monocytic leukemia,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30880,MMP1,C0162429,Nandrolone phenpropionate,DB00984,Malnutrition,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CC[C@H]35},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
35268,DGUOK,C0004093,Methylphenidate,DB00422,Asthenia,Terminated,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},Phase 3,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6050,Tolnaftate,DB00525,Tinea corporis (disorder),C0040252,Approved,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2},,Infectious disease,,,,,,,,,,,,,,,,,,,PTPN5,,,,,,,,
18124,CXCL12,C1704231,Cytarabine,DB00987,Metastatic Malignant Neoplasm to the Leptomeninges,Approved,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O},,Cancer,SCYB12,SDF-1a,SDF-1b,PBSF,TLSF-a,TLSF-b,TPAR1,SDF1A,SDF1B,SDF1,,,,,,,,,,,,,,,,
4276,Mometasone,DB00764,Allergic asthma,C0155877,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)Cl)C},,Immune system disease,,,,,,,,,,,,,,,,,,,FOLR2,,,,,,,,
34963,PPARG,C0085278,Hydroxychloroquine,DB01611,Antiphospholipid Syndrome,Terminated,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO},Phase 3,Hematologic disease,PPARG1,PPARG2,NR1C3,PPARgamma,,,,,,,,,,,,,,,,,,,,,,
20689,RRM2,C1274323,Valaciclovir,DB00577,Recurrent genital herpes simplex,Approved,CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15436,KCNQ1,C0020621,Potassium Citrate,DB09125,Hypokalemia,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Endocrine and metabolic disease,Kv7.1,KCNA8,KVLQT1,JLNS1,LQT1,LQT,KCNA9,,,,,,,,,,,,,,,,,,,
6164,Triamcinolone,DB00620,Rheumatic Heart Disease,C0035439,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,WDR17,,,,,,,,
1645,Ciprofloxacin,DB00537,Escherichia coli Infections,C0014836,Approved,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Zinc sulfate,,,,,,,,
19860,CSF3,C0002874,Heparin,DB01109,Aplastic Anemia,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Hematologic disease,MGC45931,GCSF,G-CSF,C17orf33,,,,,,,,,,,,,,,,,,,,,,
24537,DPT,C0042345,Sodium Tetradecyl Sulfate,DB00464,Varicosity,Approved,CCCCCCCCCCCCCCOS(=O)(=O)[O-].[Na+]},,Vascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
1545,Chlorphenamine,DB01114,Sneezing,C0037383,Approved,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2},,,,,,,,,,,,,,,,,,,,,Trazodone,,,,,,,,
5000,Piperacillin,DB00319,Streptococcal sepsis,C0152964,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,ACTBL2,,,,,,,,
6985,SOD2,C0029408,Salmon Calcitonin,DB00017,Degenerative polyarthritis,Terminated,CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CN=CN2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO},Phase 3,Immune system disease,0,,,,,,,,,,,,,,,,,GDE1,,,,,,,,
31056,HLA-DQA1,C0030809,Dapsone,DB00250,Pemphigus Vulgaris,Terminated,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N},Phase 2,Skin and connective tissue disease,HLA-DQA,,,,,,,,,,,,,,,,,,,,,,,,,
28169,HSPB1,C0029928,Gemcitabine,DB00441,Ovarian Diseases,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1,Reproductive system disease,HSP27,HSP28,Hs.76067,Hsp25,CMT2F,,,,,,,,,,,,,,,,,,,,,
36021,NOS3,C1135191,Udenafil,DB06267,"Heart Failure, Systolic",Terminated,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C},Phase 3,Cardiovascular disease,ECNOS,eNOS,,,,,,,,,,,,,,,,,,,,,,,,
20688,RPS23,C1274323,Valaciclovir,DB00577,Recurrent genital herpes simplex,Approved,CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9457,Imatinib,DB00619,Choroidal Neovascularization,C0600518,Withdrawn,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 1,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,,
26106,POGLUT3,C0042133,Ulipristal,DB08867,Uterine Fibroids,Approved,CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
37243,GATAD2B,C0015732,Phenylephrine,DB00388,Fecal Incontinence,Withdrawn,CNC[C@@H](C1=CC(=CC=C1)O)O},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
2834,Fidaxomicin,DB08874,Clostridium Infections,C0009062,Approved,CC[C@H]1/C=C(/[C@H](C/C=C/C=C(/C(=O)O[C@@H](C/C=C(/C=C(/[C@@H]1O[C@H]2[C@H]([C@H]([C@@H](C(O2)(C)C)OC(=O)C(C)C)O)O)\\C)\\C)[C@@H](C)O)\\CO[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)\\C},,Infectious disease,,,,,,,,,,,,,,,,,,,RGS2,,,,,,,,
6073,Torasemide,DB00214,Renal disease with edema NOS,C0866125,Approved,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C},,Urinary system disease,,,,,,,,,,,,,,,,,,,MIR136,,,,,,,,
6140,Triamcinolone,DB00620,Hay fever,C0018621,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,,,,,,,,,,,,,,,,,,,IGHV3OR16-7,,,,,,,,
17221,FAAH,C0270846,Lorazepam,DB00186,Epileptic drop attack,Approved,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10118,CRHR1,C0347950,Theophylline,DB00277,Asthma attack,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Immune system disease,CRF-R,CRF1,CRHR,,,,,,,,,,,,,,,,,,,,,,,
21711,SMARCB1,C0002453,Lisuride,DB00589,Amenorrhea,Approved,CCN(CC)C(=O)N[C@@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21754,CEACAM6,C0022972,Guanidine,DB00536,Lambert-Eaton Myasthenic Syndrome,Approved,C(=N)(N)N},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34232,APOA1,C0010054,Fenofibrate,DB01039,Coronary Arteriosclerosis,Terminated,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 3,Vascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
18719,TCF3,C0006413,Vincristine,DB00541,Burkitt Lymphoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17984,CHEK2,C0035335,Melphalan,DB01042,Retinoblastoma,Terminated,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl},Phase 2,Cancer,CDS1,CHK2,HuCds1,PP1425,bA444G7,RAD53,,,,,,,,,,,,,,,,,,,,
15752,AIF1,C0040997,Carbamazepine,DB00564,Trigeminal Neuralgia,Approved,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N},,,IRT-1,AIF-1,Em:AF129756.17,IBA1,,,,,,,,,,,,,,,,,,,,,,
28474,CEACAM7,C0278554,Levoleucovorin,DB11596,Recurrent Rectal Cancer,Withdrawn,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3722,Levothyroxine,DB00451,Hyperlipidemia,C0020473,Approved,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N},,Metabolic disease,,,,,,,,,,,,,,,,,,,HDGFL2,,,,,,,,
21592,CACNA1C,C0020615,Glucagon recombinant,DB00040,Hypoglycemia,Approved,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CNC=N7)N)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36667,MLH1,C0349579,Norgestrel,DB09389,Atypical Endometrial Hyperplasia,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29719,ABL1,C0279627,Vorinostat,DB02546,adult acute myelomonocytic leukemia (M4),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10042,ELAVL2,C0346993,Aminoglutethimide,DB00357,Secondary malignant neoplasm of female breast,Approved,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
5223,Prednisone,DB00635,Asthma,C0004096,Approved,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},,Immune system disease,,,,,,,,,,,,,,,,,,,LIN28B,,,,,,,,
11906,PAG1,C0023479,Arsenic trioxide,DB01169,Acute myelomonocytic leukemia,Approved,[O-2].[O-2].[O-2].[As+3].[As+3]},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11685,IL12B,C0003872,Triamcinolone,DB00620,"Arthritis, Psoriatic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27165,NTRK1,C0206728,Sunitinib,DB01268,Plexiform Neurofibroma,Suspended,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Congenital malformation,TRKA,MTC,,,,,,,,,,,,,,,,,,,,,,,,
34877,CAMKMT,C0011206,Quetiapine,DB01224,Delirium,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
36839,PATJ,C0038580,Methamphetamine,DB01577,Substance Dependence,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
3159,Gemifloxacin,DB01155,Streptococcal pneumonia,C0155862,Approved,CO/N=C/1\\CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F},,Infectious disease,,,,,,,,,,,,,,,,,,,PIGA,,,,,,,,
25874,BRD4,C0085413,Tolvaptan,DB06212,"Polycystic Kidney, Autosomal Dominant",Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
6256,Trovafloxacin,DB00685,Chlamydial pelvic inflammatory disease,C0520777,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,,,,,,,,,,,,,,,,,,,RTEL1,,,,,,,,
15869,CAT,C0020550,Sodium Iodide I-131,DB09293,Hyperthyroidism,Approved,[Na+].[131I-]},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28864,PCNA,C0279681,Metronidazole,DB00916,Bladder Squamous Cell Carcinoma,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
8136,IRF5,C0343065,Triprolidine,DB00427,Symptomatic dermographism,Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,,,,,,,,
26835,IGH,C0206180,Thalidomide,DB01041,Ki-1+ Anaplastic Large Cell Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36870,HLA-C,C0867389,Prednisolone,DB00860,Chronic graft-versus-host disease,Withdrawn,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Immune system disease,HLA-JY3,D6S204,PSORS1,,,,,,,,,,,,,,,,,,,,,,,
8711,TBX5,C0243002,Alprostadil,DB00770,Tricuspid Atresia,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
32688,AKT2,C2931822,Oxaliplatin,DB00526,Nasopharyngeal carcinoma,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
19413,OPN1MW,C0008325,Doripenem,DB06211,Cholecystitis,Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36183,HPSE,C0220603,Valproic Acid,DB00313,childhood brain tumor,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30961,KRAS,C0206704,Temozolomide,DB00853,"Carcinoma, Large Cell",Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15807,TRPV1,C0033581,Ofloxacin,DB01165,prostatitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
7485,GSTM3,C0338437,Albendazole,DB00518,Neurocysticercosis,Approved,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC},,Infectious disease,GST5,,,,,,,,,,,,,,,,,NBL1,,,,,,,,
34815,MBL2,C0010823,Cidofovir,DB00369,Cytomegalovirus Infections,Withdrawn,C1=CN(C(=O)N=C1N)C[C@@H](CO)OCP(=O)(O)O},Phase 1,Infectious disease,COLEC1,,,,,,,,,,,,,,,,,,,,,,,,,
8750,Tretinoin,DB00755,"Lupus Erythematosus, Cutaneous",C0024137,Terminated,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
25154,SRSF2,C0026987,Teriparatide,DB06285,Myelofibrosis,Terminated,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30789,RUNX1T1,C0242596,Methotrexate,DB00563,"Neoplasm, Residual",Terminated,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32504,GSTM1,C0279702,Sorafenib,DB00398,Conventional (Clear Cell) Renal Cell Carcinoma,Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19639,TP53,C0149925,Cisplatin,DB00515,Small cell carcinoma of lung,Terminated,N.N.Cl[Pt]Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2494,Doxycycline,DB00254,Gonorrhea of pharynx,C0149966,Approved,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CYP4F22,,,,,,,,
7041,CSF2,C0276226,Aciclovir,DB00787,Herpes encephalitis,Approved,C1=NC2=C(N1COCCO)N=C(NC2=O)N},,Infectious disease,GM-CSF,GMCSF,,,,,,,,,,,,,,,,SP100,,,,,,,,
33926,CSF2,C2347126,Prednisolone,DB00860,Microscopic Polyarteritis,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2/Phase 3,Vascular disease,GM-CSF,GMCSF,,,,,,,,,,,,,,,,,,,,,,,,
9054,CA9,C0018834,Sodium Citrate,DB09154,Heartburn,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8251,APLN,C0740394,Sulfinpyrazone,DB01138,Hyperuricemia,Approved,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4},,,apelin,XNPEP2,,,,,,,,,,,,,,,,,,,,,,,,
6603,TFAP2B,C0017605,Methazolamide,DB00703,Angle Closure Glaucoma,Approved,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C},,Nervous system disease,0,,,,,,,,,,,,,,,,,RLBP1,,,,,,,,
22006,LRAT,C0917796,Idebenone,DB09081,"Optic Atrophy, Hereditary, Leber",Approved,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
4520,Norfloxacin,DB01059,Pneumonia due to Escherichia coli,C0276089,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,BMI1,,,,,,,,
33779,IL6,C0018133,Tacrolimus,DB00864,Graft-vs-Host Disease,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Immune system disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
20561,CHD7,C0271578,Tranexamic Acid,DB00302,Female hypogonadism syndrome,Approved,C1CC(CCC1CN)C(=O)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15154,TRAF3IP2,C0009088,Sumatriptan,DB00669,Cluster Headache,Approved,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
26083,ERCC4,C0349506,Trioxsalen,DB04571,Photosensitivity of skin,Approved,CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9646,Erlotinib,DB00530,Psoriasis,C0033860,Withdrawn,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Skin disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
13757,GATA3,C0019829,Tacrolimus,DB00864,Hodgkin Disease,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2,Cancer,HDR,,,,,,,,,,,,,,,,,,,,,,,,,
11037,IL22,C0151874,Amphotericin B,DB00681,Fungal infection of lung,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,ILTIF,zcyto18,IL-TIF,IL-D110,TIFa,TIFIL-23,MGC79382,MGC79384,,,,,,,,,,,,,,,,,,
10000,CSF2,C0004626,Tobramycin,DB00684,"Pneumonia, Bacterial",Terminated,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},Phase 2,Infectious disease,GM-CSF,GMCSF,,,,,,,,,,,,,,,,,,,,,,,,
1950,Cortisone acetate,DB01380,Tinea cruris,C1384589,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CLU,,,,,,,,
13837,DEFA5,C0021390,Naltrexone,DB00704,Inflammatory Bowel Diseases,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,,HD-5,DEF5,,,,,,,,,,,,,,,,,,,,,,,,
3850,Magnesium carbonate,DB09481,Heartburn,C0018834,Approved,C(=O)([O-])[O-].[Mg+2]},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,BMP7,,,,,,,,
9854,CYBB,C0029443,Amikacin,DB00479,Osteomyelitis,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},,Immune system disease,GP91-PHOX,NOX2,CGD,,,,,,,,,,,,,,,,,,,,,,,
31328,IFNG,C0014474,Erlotinib,DB00530,Ependymoma,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
35612,MET,C0024121,Pemetrexed,DB00642,Lung Neoplasms,Terminated,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 3,Cancer,HGFR,RCCP2,DFNB97,,,,,,,,,,,,,,,,,,,,,,,
36418,TP53,C0333875,Celecoxib,DB00482,High-Grade Squamous Intraepithelial Lesions,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24907,AGO2,C0041318,Pyrazinamide,DB00339,"Tuberculosis, Meningeal",Approved,C1=CN=C(C=N1)C(=O)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33789,PKD1,C0022680,Sirolimus,DB00877,Polycystic Kidney Diseases,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2/Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
34338,IQSEC2,C0085426,Vancomycin,DB00512,Gram-Positive Bacterial Infections,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20356,BRCA1,C0281361,Mitomycin,DB00305,Adenocarcinoma of pancreas,Approved,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},,Cancer,RNF53,PPP1R53,FANCS,,,,,,,,,,,,,,,,,,,,,,,
14837,IL6,C0020514,Cabergoline,DB00248,Hyperprolactinemia,Approved,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C},,Endocrine disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
23443,STAT1,C0023885,Metronidazole,DB00916,Liver Abscess,Approved,CC1=NC=C(N1CCO)[N+](=O)[O-]},,Liver disease,STAT91,ISGF-3,,,,,,,,,,,,,,,,,,,,,,,,
17804,IL13,C0022577,Lodoxamide,DB06794,"Keratoconjunctivitis, Vernal",Approved,C1=C(C=C(C(=C1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N},,Infectious disease,P600,IL-13,ALRH,BHR1,MGC116786,MGC116788,MGC116789,,,,,,,,,,,,,,,,,,,
11189,IL4,C0023290,Miltefosine,DB09031,"Leishmaniasis, Visceral",Approved,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},,Infectious disease,BSF1,IL-4,BCGF1,BCGF-1,MGC79402,,,,,,,,,,,,,,,,,,,,,
3277,Haloprogin,DB00793,Tinea corporis (disorder),C0040252,Approved,C1=C(C(=CC(=C1Cl)Cl)Cl)OCC#CI},,Infectious disease,,,,,,,,,,,,,,,,,,,SETD2,,,,,,,,
26003,MIR924HG,C0002171,Triamcinolone,DB00620,Alopecia Areata,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28481,CISH,C0278726,Metronidazole,DB00916,Small cell lung cancer extensive stage,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9472,SMAD4,C2973725,Treprostinil,DB00374,Pulmonary arterial hypertension,Approved,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},,Infectious disease,DPC4,MADH4,,,,,,,,,,,,,,,,,,,,,,,,
8080,ALB,C0002994,Triamcinolone,DB00620,Angioedema,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,,,,,,,,
35701,ICAM1,C0856169,Valsartan,DB00177,Endothelial dysfunction,Terminated,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Endocrine and metabolic disease,CD54,,,,,,,,,,,,,,,,,,,,,,,,,
17640,ALDH2,C0019112,Zinc oxide,DB09321,Hemorrhoids,Approved,O=[Zn]},,,,,,,,,,,,,,,,,,,,,,,,,,,,
8680,Tadalafil,DB00820,Priapism,C0033117,Terminated,CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
4728,Oxytetracycline,DB00595,Infection of skin AND/OR subcutaneous tissue,C0178299,Approved,C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,ELP4,,,,,,,,
2500,Doxycycline,DB00254,Lymphogranuloma Venereum,C0024286,Approved,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,EPOR,,,,,,,,
30979,UBE2C,C0206704,Temozolomide,DB00853,"Carcinoma, Large Cell",Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,UBCH10,,,,,,,,,,,,,,,,,,,,,,,,,
11104,IL18,C0010414,Amphotericin B,DB00681,Infection by Cryptococcus neoformans,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29467,EGFR,C0005695,Mitomycin,DB00305,Bladder Neoplasm,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
33110,HTR1A,C0041696,Scopolamine,DB00747,Unipolar Depression,Terminated,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
3246,Guaifenesin,DB00874,Fever,C0015967,Approved,COC1=CC=CC=C1OCC(CO)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CD160,,,,,,,,
13260,FCGR3B,C0025281,Penciclovir,DB00299,Meniere Disease,Terminated,C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N},Phase 3,Nervous system disease,CD16b,,,,,,,,,,,,,,,,,,,,,,,,,
24517,PTX3,C0003615,Ropivacaine,DB00296,Appendicitis,Terminated,CCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C},Phase 2,Other disease,TSG-14,TNFAIP5,,,,,,,,,,,,,,,,,,,,,,,,
35770,GCK,C0730345,Rimonabant,DB06155,Microalbuminuria,Terminated,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl},Phase 3,Urinary system disease,MODY2,,,,,,,,,,,,,,,,,,,,,,,,,
35004,MICOS10-NBL1,C0151526,Progesterone,DB00396,Premature Birth,Terminated,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
5432,Retapamulin,DB01256,Superficial bacterial infection of skin,C0342985,Approved,C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC4C[C@H]5CC[C@@H](C4)N5C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,AGAP1,,,,,,,,
19933,CRP,C0016053,Pramipexole,DB00413,Fibromyalgia,Terminated,CCCN[C@H]1CCC2=C(C1)SC(=N2)N},Phase 2,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,,,,,,,,
35899,CDKN2A,C0235974,Sunitinib,DB01268,Pancreatic carcinoma,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 3,Cancer,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
30031,TNFRSF12A,C0024137,Tretinoin,DB00755,"Lupus Erythematosus, Cutaneous",Terminated,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},Phase 2,Immune system disease,FN14,TweakR,CD266,,,,,,,,,,,,,,,,,,,,,,,
16783,IL1B,C0010692,Ofloxacin,DB01165,Cystitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
16823,IL10,C0600041,Ofloxacin,DB01165,Infective cystitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
12803,C11orf21,C0023434,Venetoclax,DB11581,Chronic Lymphocytic Leukemia,Approved,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29176,SOD1,C1541316,Irinotecan,DB00762,adult giant cell glioblastoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
14110,KRT20,C0036830,Triamcinolone,DB00620,Serum Sickness,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,CK20,K20,MGC35423,,,,,,,,,,,,,,,,,,,,,,,
4497,Norfloxacin,DB01059,Female genital tract infection,C1263758,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,EIF4EBP1,,,,,,,,
9001,ANGPT2,C0038358,Roxatidine acetate,DB08806,Gastric ulcer,Approved,CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2},,Digestive system disease,Ang2,,,,,,,,,,,,,,,,,,,,,,,,,
35684,IL6,C0747820,Sulfadoxine,DB01299,"Malaria, antepartum",Terminated,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N},Phase 3,Infectious disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
34359,HLA-DQB1,C0007860,Cefixime,DB00671,Uterine Cervicitis,Terminated,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O},Phase 3,Reproductive system disease,HLA-DQB,,,,,,,,,,,,,,,,,,,,,,,,,
5268,Primidone,DB00794,"Epilepsies, Partial",C0014547,Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,,,,,,,,,,,,,,,,,,,DAB2,,,,,,,,
4148,Metolazone,DB00524,Renal disease with edema NOS,C0866125,Approved,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl},,Urinary system disease,,,,,,,,,,,,,,,,,,,RPL35,,,,,,,,
1555,Chlorpromazine,DB00477,Schizophrenia,C0036341,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,Trichlormethiazide,,,,,,,,
33240,ADGRE5,C0280141,Sunitinib,DB01268,Acute Undifferentiated Leukemia,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,TM7LN1,CD97,,,,,,,,,,,,,,,,,,,,,,,,
31500,MSH2,C0349604,Sirolimus,DB00877,Intracranial Meningioma,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,HNPCC1,COCA1,,,,,,,,,,,,,,,,,,,,,,,,
14172,CAPG,C0039503,Ketoprofen,DB01009,Tendinitis,Terminated,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O},Phase 3,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2242,Dexbrompheniramine,DB00405,"Rhinitis, Vasomotor",C0035460,Approved,CN(C)CC[C@@H](C1=CC=C(C=C1)Br)C2=CC=CC=N2},,Immune system disease,,,,,,,,,,,,,,,,,,,AZU1,,,,,,,,
16240,DBH,C0001957,Oxazepam,DB00842,Alcohol Withdrawal Delirium,Approved,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O},,Mental and behavioural disorder,DBM,,,,,,,,,,,,,,,,,,,,,,,,,
24972,ATP2B4,C0024530,Prednisone,DB00635,Malaria,Withdrawn,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13688,RDH5,C0015397,Triamcinolone,DB00620,Disorder of eye,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
6877,HDAC2,C0006277,Theophylline,DB00277,Bronchitis,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Lung disease,0,,,,,,,,,,,,,,,,,LCN1,,,,,,,,
7906,IL1B,C0029458,Zoledronic acid,DB00399,"Osteoporosis, Postmenopausal",Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
22000,ND2,C0917796,Idebenone,DB09081,"Optic Atrophy, Hereditary, Leber",Approved,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
5342,Promazine,DB00420,Vomiting,C0042963,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,,,,,,,,,,,,,,,,,,,,FANCL,,,,,,,,
16394,CFTR,C0162565,Promazine,DB00420,Acute intermittent porphyria,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Congenital disorder of metabolism,ABC35,TNR-CFTR,CFTR/MRP,CF,ABCC7,,,,,,,,,,,,,,,,,,,,,
5703,Sulfadiazine,DB00359,Ulcerative Colitis,C0009324,Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Immune system disease,,,,,,,,,,,,,,,,,,,SCN2B,,,,,,,,
33947,BAX,C0006287,Nitric Oxide,DB00435,Bronchopulmonary Dysplasia,Terminated,[N]=O},Phase 2/Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
36328,ATXN2,C0011168,Lansoprazole,DB00448,Deglutition Disorders,Withdrawn,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F},Phase 1/Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
372,Amrinone,DB01427,Decompensated cardiac failure,C0581377,Approved,C1=CN=CC=C1C2=CNC(=O)C(=C2)N},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,SNCA,,,,,,,,
10308,TANGO2,C0042510,Metoprolol,DB00264,Ventricular Fibrillation,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
9504,CNOT1,C0242429,Pheniramine,DB01620,Sore Throat,Approved,CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8384,LRRK2,C0003467,Citalopram,DB00215,Anxiety,Withdrawn,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
27977,COL3A1,C0036421,Iloprost,DB01088,Systemic Scleroderma,Terminated,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Skin disease,EDS4A,,,,,,,,,,,,,,,,,,,,,,,,,
12941,IL17A,C0011633,Benzoic Acid,DB03793,Dermatomyositis,Approved,C1=CC=C(C=C1)C(=O)O},,Musculoskeletal disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
34181,COL2A1,C0853193,Risperidone,DB00734,Bipolar I disorder,Terminated,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F},Phase 3,Mental and behavioural disorder,STL1,SEDC,AOM,,,,,,,,,,,,,,,,,,,,,,,
22405,EPO,C0158996,Sodium ferric gluconate complex,DB09517,Anemia of prematurity,Approved,C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.[Na+].[Fe+3]},,Hematologic disease,EP,,,,,,,,,,,,,,,,,,,,,,,,,
16098,AK6,C0024198,Cefuroxime,DB01112,Lyme Disease,Approved,CO/N=C(/C1=CC=CO1)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36819,CTBP2,C0600139,Simvastatin,DB00641,Prostate carcinoma,Withdrawn,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29378,MTDH,C1699634,Letrozole,DB01006,HER-2 positive breast cancer,Withdrawn,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12354,ADM,C0034186,Ofloxacin,DB01165,Pyelonephritis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,AM,,,,,,,,,,,,,,,,,,,,,,,,,
34195,BDNF,C0349217,Aripiprazole,DB01238,"Depressive episode, unspecified",Terminated,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
11157,SLC11A1,C0023281,Sodium stibogluconate,DB05630,Leishmaniasis,Approved,C([C@H]([C@@H]1[C@@H]([C@@H](O[Sb](=O)(O1)O[Sb]2(=O)O[C@@H]([C@@H]([C@@H](O2)C(=O)[O-])O)[C@@H](CO)O)C(=O)[O-])O)O)O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+]},,Infectious disease,NRAMP,NRAMP1,,,,,,,,,,,,,,,,,,,,,,,,
4561,Ofloxacin,DB01165,Acute gonococcal cervicitis,C0153195,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SH3PXD2B,,,,,,,,
17515,TACR3,C1384606,Ospemifene,DB04938,Dyspareunia,Approved,C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\C3=CC=C(C=C3)OCCO)/CCCl},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25559,SCN11A,C0030201,Sufentanil,DB00708,"Pain, Postoperative",Approved,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
25416,FLACC1,C0007117,Vismodegib,DB08828,Basal cell carcinoma,Approved,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19300,KRAS,C0678222,Paclitaxel,DB01229,Breast Carcinoma,Approved,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25976,STX17,C0002171,Triamcinolone,DB00620,Alopecia Areata,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4177,Mexiletine,DB00379,Ventricular arrhythmia,C0085612,Approved,CC1=C(C(=CC=C1)C)OCC(C)N},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,C4B,,,,,,,,
790,Bromodiphenhydramine,DB01237,Common Cold,C0009443,Approved,CN(C)CCOC(C1=CC=CC=C1)C2=CC=C(C=C2)Br},,Infectious disease,,,,,,,,,,,,,,,,,,,ELN,,,,,,,,
8663,CITED2,C0039685,Alprostadil,DB00770,Tetralogy of Fallot,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
28933,TNFSF13B,C0024143,Tacrolimus,DB00864,Lupus Nephritis,Withdrawn,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 3,Urinary system disease,BAFF,THANK,BLYS,TALL-1,TALL1,CD257,TNFSF20,,,,,,,,,,,,,,,,,,,
22533,SLC25A13,C0022354,Kappadione,DB09332,"Jaundice, Obstructive",Approved,CC1=C(C2=CC=CC=C2C(=C1)OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+]},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13830,STAT3,C0021390,Naltrexone,DB00704,Inflammatory Bowel Diseases,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,,APRF,,,,,,,,,,,,,,,,,,,,,,,,,
8455,Nicotine,DB00184,Postoperative Nausea and Vomiting,C0520909,Terminated,CN1CCC[C@H]1C2=CN=CC=C2},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
17372,S100A12,C0031069,Colchicine,DB01394,Familial Mediterranean Fever,Approved,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC},,Infectious disease,CGRP,CAAF1,CAGC,ENRAGE,,,,,,,,,,,,,,,,,,,,,,
2533,Drospirenone,DB01395,Acne Vulgaris,C0001144,Approved,C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7)C},,Infectious disease,,,,,,,,,,,,,,,,,,,LINC01229,,,,,,,,
36337,DNM1L,C0011168,Lansoprazole,DB00448,Deglutition Disorders,Withdrawn,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F},Phase 1/Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
627,Benzylpenicillin,DB01053,Meningococcemia,C0025306,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Fentanyl,,,,,,,,
23463,ERVK-18,C0023886,Tinidazole,DB00911,"Liver Abscess, Amebic",Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1782,Clofazimine,DB00845,Pyoderma Gangrenosum,C0085652,Approved,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl},,Immune system disease,,,,,,,,,,,,,,,,,,,CAV2,,,,,,,,
25101,DIAPH1,C0022876,Ritodrine,DB00867,Premature Obstetric Labor,Approved,C[C@@H]([C@@H](C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
12719,MME,C0079774,Thalidomide,DB01041,Peripheral T-Cell Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,CALLA,CD10,,,,,,,,,,,,,,,,,,,,,,,,
8857,Acetylcysteine,DB06151,Bulimia Nervosa,C2267227,Terminated,CC(=O)N[C@@H](CS)C(=O)O},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,
27325,NEK7,C1335177,Trametinib,DB08911,Ovarian Serous Adenocarcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2/Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3106,Fusidic Acid,DB02703,Staphylococcus aureus infection,C1318973,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,PPT2-EGFL8,,,,,,,,
34085,NOTCH2,C0029453,Cholecalciferol,DB00169,Osteopenia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 2/Phase 3,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,,,,,,,,
6333,Vancomycin,DB00512,Streptococcal endocarditis,C3665800,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,PPM1B,,,,,,,,
31402,PIK3CD,C0206754,Sunitinib,DB01268,Neuroendocrine Tumors,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36286,KCNE1,C0003811,Phenylephrine,DB00388,Cardiac Arrhythmia,Withdrawn,CNC[C@@H](C1=CC(=CC=C1)O)O},Phase 1/Phase 2,Cardiovascular disease,minK,ISK,JLNS2,LQT5,,,,,,,,,,,,,,,,,,,,,,
2370,Dimenhydrinate,DB00985,Vomiting,C0042963,Approved,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2},,,,,,,,,,,,,,,,,,,,,Cocaine,,,,,,,,
26350,NCS1,C0423673,Ziconotide,DB06283,Pain in spine,Approved,C[C@H]1C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N3)CO)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCN},,,NCS-1,FREQ,,,,,,,,,,,,,,,,,,,,,,,,
30004,CST7,C0393538,Sodium phenylbutyrate,DB06819,"Muscular Atrophy, Spinal, Type II",Terminated,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},Phase 1/Phase 2,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,,,,,,,,
27860,HBG1,C2347748,Mitoxantrone,DB01204,Adult Erythroleukemia,Terminated,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},Phase 1,Cancer,HBG-T2,,,,,,,,,,,,,,,,,,,,,,,,,
19810,IL11,C0041351,Streptomycin,DB01082,Tularemia,Approved,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1980,Cyclizine,DB01176,Common Cold,C0009443,Approved,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3},,Infectious disease,,,,,,,,,,,,,,,,,,,TRIM69,,,,,,,,
36203,ATOH1,C0220603,Valproic Acid,DB00313,childhood brain tumor,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,HATH1,MATH-1,Math1,bHLHa14,,,,,,,,,,,,,,,,,,,,,,
36360,OSR1,C0149654,Methylphenidate,DB00422,Conduct Disorder,Withdrawn,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},Phase 1/Phase 2,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
20740,CYP24A1,C0085681,Sevelamer,DB00658,Hyperphosphatemia (disorder),Terminated,C=CCN.C1C(O1)CCl},Phase 3,Endocrine and metabolic disease,CP24,P450-CC24,CYP24,,,,,,,,,,,,,,,,,,,,,,,
33145,ENG,C0032914,Sildenafil,DB00203,Pre-Eclampsia,Terminated,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C},Phase 2,Hematologic disease,END,HHT1,CD105,ORW1,ORW,,,,,,,,,,,,,,,,,,,,,
18477,ELANE,C0023465,Daunorubicin,DB00694,Acute monocytic leukemia,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O},,Cancer,NE,HNE,HLE,ELA2,,,,,,,,,,,,,,,,,,,,,,
5372,Pseudoephedrine,DB00852,Rhinitis,C0035455,Approved,C[C@@H]([C@H](C1=CC=CC=C1)O)NC},,Immune system disease,,,,,,,,,,,,,,,,,,,IGAN1,,,,,,,,
6618,ACD,C0017605,Methazolamide,DB00703,Angle Closure Glaucoma,Approved,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C},,Nervous system disease,0,,,,,,,,,,,,,,,,,SLC39A13,,,,,,,,
18231,TIMM10,C0035412,Vincristine,DB00541,Rhabdomyosarcoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11216,WG,C0026718,Isavuconazonium,DB06636,Mucormycosis,Approved,C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=[N+](C=N3)C(C)OC(=O)N(C)C4=C(C=CC=N4)COC(=O)CNC)(C5=C(C=CC(=C5)F)F)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24564,MMP9,C0024449,Posaconazole,DB01263,Mycetoma,Approved,CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F},,Infectious disease,CLG4B,,,,,,,,,,,,,,,,,,,,,,,,,
3188,Gentamicin,DB00798,Pneumonia due to Pseudomonas,C0155860,Approved,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC},,Infectious disease,,,,,,,,,,,,,,,,,,,CSF2RA,,,,,,,,
36849,BPIFA2,C0038580,Methamphetamine,DB01577,Substance Dependence,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
31046,DSG3,C0030809,Dapsone,DB00250,Pemphigus Vulgaris,Terminated,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N},Phase 2,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19287,GCG,C1961112,Dobutamine,DB00841,Heart Decompensation,Approved,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O},,Cardiovascular disease,GLP2,GRPP,,,,,,,,,,,,,,,,,,,,,,,,
25699,WAS,C0003864,Tenoxicam,DB00469,Arthritis,Approved,CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30001,DYNC1H1,C0393538,Sodium phenylbutyrate,DB06819,"Muscular Atrophy, Spinal, Type II",Terminated,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},Phase 1/Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21965,PAX5,C0024419,Thalidomide,DB01041,Waldenstrom Macroglobulinemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,BSAP,,,,,,,,,,,,,,,,,,,,,,,,,
5821,Terbinafine,DB00857,Onychomycosis,C0040261,Approved,CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21},,Infectious disease,,,,,,,,,,,,,,,,,,,APAF1,,,,,,,,
24468,RET,C0221154,Phentolamine,DB00692,Paroxysmal hypertension,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cardiovascular disease,CDHF12,RET51,CDHR16,HSCR1,MEN2A,MTC1,MEN2B,,,,,,,,,,,,,,,,,,,
19829,CDKN1A,C0235480,Propafenone,DB01182,Paroxysmal atrial fibrillation,Approved,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
22239,SULT2A1,C0009663,Podofilox,DB01179,Condylomata Acuminata,Approved,COC1=CC(=CC(=C1OC)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](C4=CC5=C(C=C24)OCO5)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
37086,COMT,C0037011,Dexamethasone,DB01234,Shoulder Pain,Withdrawn,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28506,CCND1,C0042076,Mitomycin,DB00305,Urologic Neoplasms,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29414,ITGB2,C0004623,Triamcinolone,DB00620,Bacterial Infections,Terminated,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},Phase 1/Phase 2,Infectious disease,CD18,MFI7,,,,,,,,,,,,,,,,,,,,,,,,
15649,SCN1A-AS1,C0014547,Primidone,DB00794,"Epilepsies, Partial",Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16821,CTH,C0600041,Ofloxacin,DB01165,Infective cystitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
36187,EPHX1,C0220603,Valproic Acid,DB00313,childhood brain tumor,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,EPHX,,,,,,,,,,,,,,,,,,,,,,,,,
4828,Perospirone,DB08922,Schizophrenia,C0036341,Approved,C1CC[C@H]2[C@@H](C1)C(=O)N(C2=O)CCCCN3CCN(CC3)C4=NSC5=CC=CC=C54},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,PPP3CA,,,,,,,,
36033,TAB2,C1135191,Udenafil,DB06267,"Heart Failure, Systolic",Terminated,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C},Phase 3,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8190,ALG1L3P,C0003868,Triamcinolone,DB00620,"Arthritis, Gouty",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19376,FGF1,C0020649,Phentermine,DB00191,Hypotension,Approved,CC(C)(CC1=CC=CC=C1)N},,Cardiovascular disease,AFGF,ECGF,ECGFA,ECGFB,HBGF1,ECGF-beta,FGF-alpha,GLIO703,FGFA,,,,,,,,,,,,,,,,,
22513,TGFB1,C0038463,Thiabendazole,DB00730,Strongyloidiasis,Approved,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3},,Infectious disease,CED,TGFbeta,TGFB,DPD1,,,,,,,,,,,,,,,,,,,,,,
4542,Norgestimate,DB00957,Acne Vulgaris,C0001144,Approved,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)OC(=O)C)CCC4=C/C(=N/O)/CC[C@H]34},,Infectious disease,,,,,,,,,,,,,,,,,,,LINC01440,,,,,,,,
2136,Desoximetasone,DB00547,Chronic small plaque psoriasis,C0406317,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)CO)C)O)F)C},,Skin disease,,,,,,,,,,,,,,,,,,,AREG,,,,,,,,
28356,TGFB1,C0006111,Temozolomide,DB00853,Brain Diseases,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Nervous system disease,CED,TGFbeta,TGFB,DPD1,,,,,,,,,,,,,,,,,,,,,,
28047,TNF,C0020429,Capsaicin,DB06774,Hyperalgesia,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,Nervous system,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
14535,CXCL8,C0080032,Thiotepa,DB04572,"Pleural Effusion, Malignant",Approved,C1CN1P(=S)(N2CC2)N3CC3},,Lung disease,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
12688,LPA,C0206525,Bedaquiline,DB08903,"Tuberculosis, Drug-Resistant",Approved,CN(C)CC[C@@](C1=CC=CC2=CC=CC=C21)([C@H](C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3425,HCRT,C0917801,Citalopram,DB00215,Sleeplessness,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,,0,,,,,,,,,,,,,,,,,LYPLA1,,,,,,,,
28755,BRAF,C0009402,Levoleucovorin,DB11596,Colorectal Carcinoma,Withdrawn,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2/Phase 3,Cancer,BRAF1,,,,,,,,,,,,,,,,,,,,,,,,,
6842,SCNN1B,C0006267,Pirbuterol,DB01291,Bronchiectasis,Approved,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O},,Respiratory disease,ENaCbeta,,,,,,,,,,,,,,,,,MAP3K2,,,,,,,,
10150,IL10,C4038730,Theophylline,DB00277,Asthma-chronic obstructive pulmonary disease overlap syndrome,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Immune system disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
10096,SCGB3A2,C0004096,Zafirlukast,DB00549,Asthma,Approved,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC},,Immune system disease,UGRP1,LU103,PNSP1,,,,,,,,,,,,,,,,,,,,,,,
397,Apremilast,DB05676,"Arthritis, Psoriatic",C0003872,Approved,CCOC1=C(C=CC(=C1)[C@@H](CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC},,Immune system disease,,,,,,,,,,,,,,,,,,,Dalfampridine,,,,,,,,
32329,LINC02210-CRHR1,C0238013,Voriconazole,DB00582,Invasive aspergillosis,Terminated,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18263,FHIT,C0016034,Danazol,DB01406,Breast Fibrocystic Disease,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5},,Other disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7952,HPT,C0020502,Alfacalcidol,DB01436,Hyperparathyroidism,Approved,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1142,Cefotaxime,DB00493,Female genital tract infection,C1263758,Approved,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Oxazepam,,,,,,,,
32375,CCR5,C0263338,Miltefosine,DB09031,Chronic urticaria,Terminated,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},Phase 2,Skin and connective tissue disease,CKR-5,CC-CKR-5,CKR5,CD195,IDDM22,CMKBR5,,,,,,,,,,,,,,,,,,,,
15559,SCN9A,C0032768,Pregabalin,DB00230,Postherpetic neuralgia,Approved,CC(C)C[C@@H](CC(=O)O)CN},,Infectious disease,Nav1.7,NE-NA,NENA,ETHA,,,,,,,,,,,,,,,,,,,,,,
25719,FGFR1,C0271623,Methyltestosterone,DB06710,Hypogonadotropic hypogonadism,Terminated,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C},Phase 2,Endocrine disease,CEK,FLG,BFGFR,N-SAM,CD331,FLT2,KAL2,,,,,,,,,,,,,,,,,,,
13229,DPP4,C0041912,Phenoxymethylpenicillin,DB00417,Upper Respiratory Infections,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C},,Infectious disease,CD26,ADCP2,,,,,,,,,,,,,,,,,,,,,,,,
25275,KISS1,C0013338,Somatropin recombinant,DB00052,Pituitary dwarfism,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
1758,Clobazam,DB00349,Lennox-Gastaut syndrome,C0238111,Approved,CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3},,Nervous system disease,,,,,,,,,,,,,,,,,,,LGTN,,,,,,,,
5782,Tazarotene,DB00799,Psoriasis,C0033860,Approved,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C},,Skin disease,,,,,,,,,,,,,,,,,,,NR1I3,,,,,,,,
922,Carbamazepine,DB00564,mixed; epileptic,C1398376,Approved,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,Lumiracoxib,,,,,,,,
17761,HSPA9,C0042164,Triamcinolone,DB00620,Uveitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3730,Lidocaine,DB00281,Pediculus capitis infestation,C0030757,Approved,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,LMO2,,,,,,,,
33033,COL11A2,C0278689,Paclitaxel,DB01229,Ovarian epithelial cancer recurrent,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,HKE5,DFNA13,DFNB53,,,,,,,,,,,,,,,,,,,,,,,
34979,HT,C0085278,Hydroxychloroquine,DB01611,Antiphospholipid Syndrome,Terminated,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO},Phase 3,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
423,Astemizole,DB00637,Allergic Conjunctivitis,C0009766,Approved,COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F},,Immune system disease,,,,,,,,,,,,,,,,,,,Delavirdine,,,,,,,,
21146,PRRT2,C2936781,Fluoxymesterone,DB01185,Generalized Myotonia of Thomsen,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25121,MSTN,C0730607,Roflumilast,DB01656,Severe chronic obstructive pulmonary disease,Approved,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F},,Lung disease,GDF8,,,,,,,,,,,,,,,,,,,,,,,,,
6508,OPRK1,C0030193,Oxycodone,DB00497,Pain,Withdrawn,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O},Phase 3,,KOR,OPRK,,,,,,,,,,,,,,,,KIAA1549,,,,,,,,
19371,ADRA2A,C0020649,Phentermine,DB00191,Hypotension,Approved,CC(C)(CC1=CC=CC=C1)N},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4248,Minocycline,DB01017,Q Fever,C0034362,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,,,,,,,,,,,,,,,,,,,,TRA2A,,,,,,,,
12451,HMGB1,C0032302,Trovafloxacin,DB00685,Mycoplasma pneumonia,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4703,Oxymetazoline,DB00935,Nasal congestion (finding),C0027424,Approved,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C},,,,,,,,,,,,,,,,,,,,,CACNA2D1,,,,,,,,
24969,ANK1,C0024530,Prednisone,DB00635,Malaria,Withdrawn,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22578,IL1B,C0008582,Posaconazole,DB01263,Chromoblastomycosis,Approved,CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F},,Infectious disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
26476,LCN2,C1561643,Sevelamer,DB00658,Chronic Kidney Diseases,Terminated,C=CCN.C1C(O1)CCl},Phase 3,Urinary system disease,NGAL,24p3,,,,,,,,,,,,,,,,,,,,,,,,
28391,GRM5,C0007682,Temozolomide,DB00853,CNS disorder,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Nervous system disease,MGLUR5,GPRC1E,mGlu5,PPP1R86,,,,,,,,,,,,,,,,,,,,,,
30446,LEPR,C0011882,Reboxetine,DB00234,Diabetic Neuropathies,Terminated,CCOC1=CC=CC=C1O[C@@H]([C@H]2CNCCO2)C3=CC=CC=C3},Phase 2,Urinary system disease,OBR,CD295,,,,,,,,,,,,,,,,,,,,,,,,
23193,DCTN6,C0220656,Thiotepa,DB04572,Malignant ascites,Approved,C1CN1P(=S)(N2CC2)N3CC3},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25277,TG,C0013338,Somatropin recombinant,DB00052,Pituitary dwarfism,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Endocrine and metabolic disease,TGN,AITD3,,,,,,,,,,,,,,,,,,,,,,,,
10155,MPLKIP,C0006266,Theophylline,DB00277,Bronchial Spasm,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
648,Benzylpenicillin,DB01053,Streptococcus pyogenes infection,C0554628,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Fluocinolone Acetonide,,,,,,,,
11596,ABCB1,C0030528,Chloramphenicol,DB00446,Paratyphoid Fever,Approved,C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]},,Infectious disease,P-gp,CD243,GP170,ABC20,PGY1,CLCS,,,,,,,,,,,,,,,,,,,,
29529,MUC16,C0278502,Fluorouracil,DB00544,recurrent gastric cancer,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 1/Phase 2,Cancer,FLJ14303,,,,,,,,,,,,,,,,,,,,,,,,,
1171,Cefotaxime,DB00493,URINARY TRACT INFECTION CITROBACTER,C0749955,Approved,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,PLAT,,,,,,,,
33167,PLAT,C1145670,Dexmedetomidine,DB00633,Respiratory Failure,Terminated,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 3,Lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,
215,Ammonium chloride,DB06767,Common Cold,C0009443,Approved,[NH4+].[Cl-]},,Infectious disease,,,,,,,,,,,,,,,,,,,Calcium Acetate,,,,,,,,
10847,POMC,C0028754,Fenofibrate,DB01039,Obesity,Withdrawn,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 1,Metabolic disease,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
22108,PDGFRB,C0392784,Imatinib,DB00619,Dermatofibrosarcoma Protuberans,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,JTK12,CD140b,PDGFR1,PDGFR,,,,,,,,,,,,,,,,,,,,,,
30771,ETV6,C0242596,Methotrexate,DB00563,"Neoplasm, Residual",Terminated,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,TEL,,,,,,,,,,,,,,,,,,,,,,,,,
19285,BAMBI,C1961112,Dobutamine,DB00841,Heart Decompensation,Approved,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29539,CDKN2A,C0279626,Fluorouracil,DB00544,Squamous cell carcinoma of esophagus,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 1/Phase 2,Cancer,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
33116,TPH1,C0041696,Scopolamine,DB00747,Unipolar Depression,Terminated,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},Phase 2,Mental and behavioural disorder,TPRH,TPH,,,,,,,,,,,,,,,,,,,,,,,,
7050,Capsaicin,DB06774,Hyperalgesia,C0020429,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,Nervous system,,,,,,,,,,,,,,,,,,,XRCC6P5,,,,,,,,
31212,ERVK-32,C2363741,Tenofovir,DB00300,HIV-1 infection,Withdrawn,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7318,HLA-DPB1,C0524909,Tenofovir,DB00300,"Hepatitis B, Chronic",Approved,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},,Infectious disease,HLA-DP1B,,,,,,,,,,,,,,,,,C17orf97,,,,,,,,
1022,Cefamandole,DB01326,Peritonitis,C0031154,Approved,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)[C@@H](C4=CC=CC=C4)O)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Mexiletine,,,,,,,,
9620,OPN1MW3,C0008311,Sulbactam,DB09324,Cholangitis,Approved,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3918,Meclofenamic acid,DB00939,Rheumatoid Arthritis,C0003873,Approved,CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)O)Cl},,Immune system disease,,,,,,,,,,,,,,,,,,,NKX2-3,,,,,,,,
18850,LEPR,C0020459,Diazoxide,DB01119,Hyperinsulinism,Approved,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl},,Endocrine and metabolic disease,OBR,CD295,,,,,,,,,,,,,,,,,,,,,,,,
135,Amantadine,DB00915,"Parkinson Disease, Postencephalitic",C0030568,Approved,C1C2CC3CC1CC(C2)(C3)N},,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,Benzocaine,,,,,,,,
37022,SLC18A3,C0520679,Dexmedetomidine,DB00633,"Sleep Apnea, Obstructive",Withdrawn,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 2/Phase 3,,VACHT,,,,,,,,,,,,,,,,,,,,,,,,,
12006,CSF3,C0023449,Vindesine,DB00309,Acute lymphocytic leukemia,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O},,Cancer,MGC45931,GCSF,G-CSF,C17orf33,,,,,,,,,,,,,,,,,,,,,,
7003,APOE,C0019342,Valaciclovir,DB00577,Genital Herpes,Approved,CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N},,Infectious disease,AD2,,,,,,,,,,,,,,,,,MAP3K9,,,,,,,,
19432,CACNA1S,C0235063,Doxapram,DB00561,Respiratory Depression,Approved,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30122,CRISPLD2,C0235032,Methylphenidate,DB00422,Neurotoxicity Syndromes,Terminated,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},Phase 2,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14115,CEL,C0242459,Triamcinolone,DB00620,Simple Pulmonary Eosinophilia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,BSSL,MODY8,,,,,,,,,,,,,,,,,,,,,,,,
3049,Fusidic Acid,DB02703,Furunculosis,C0016867,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,AK4,,,,,,,,
15474,AR,C0278488,Vinblastine,DB00570,Carcinoma breast stage IV,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,AIS,NR3C4,SMAX1,HUMARA,DHTR,SBMA,,,,,,,,,,,,,,,,,,,,
27832,NAGS,C0085633,Atomoxetine,DB00289,Mood swings,Terminated,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
20569,KISS1R,C0271578,Tranexamic Acid,DB00302,Female hypogonadism syndrome,Approved,C1CC(CCC1CN)C(=O)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12479,AFF4,C0032290,Ticarcillin,DB01607,Aspiration Pneumonia,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24430,HAMP,C0019202,Triethylenetetramine,DB06824,Hepatolenticular Degeneration,Approved,C(CNCCNCCN)N},,Congenital disorder of metabolism,LEAP-1,HEPC,HFE2B,LEAP1,,,,,,,,,,,,,,,,,,,,,,
11214,EGFR,C0026718,Isavuconazonium,DB06636,Mucormycosis,Approved,C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=[N+](C=N3)C(C)OC(=O)N(C)C4=C(C=CC=N4)COC(=O)CNC)(C5=C(C=CC(=C5)F)F)O},,Infectious disease,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
33031,PARP1,C0278689,Paclitaxel,DB01229,Ovarian epithelial cancer recurrent,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,PARP,PPOL,ADPRT,,,,,,,,,,,,,,,,,,,,,,,
4390,Neomycin,DB00994,Hepatic Encephalopathy,C0019151,Approved,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N},,Liver disease,,,,,,,,,,,,,,,,,,,PDCD1LG2,,,,,,,,
28750,DCC,C0009402,Levoleucovorin,DB11596,Colorectal Carcinoma,Withdrawn,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2/Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34837,TERT,C0030297,Gemcitabine,DB00441,Pancreatic Neoplasm,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 3,Cancer,TRT,TCS1,hEST2,EST2,,,,,,,,,,,,,,,,,,,,,,
14557,ERCC2,C0007137,Cisplatin,DB00515,Squamous cell carcinoma,Terminated,N.N.Cl[Pt]Cl},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3575,Ivabradine,DB09083,Chronic heart failure,C0264716,Approved,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)C[C@H]3CC4=CC(=C(C=C34)OC)OC},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,STK32C,,,,,,,,
31281,DNER,C0220624,Erlotinib,DB00530,adult brain tumor,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,UNQ26,bet,,,,,,,,,,,,,,,,,,,,,,,,
37201,GH1,C0221406,Mifepristone,DB00834,Pituitary-dependent Cushing's disease,Withdrawn,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O},Phase 3,Endocrine and metabolic disease,GH-N,GHN,GH,hGH-N,,,,,,,,,,,,,,,,,,,,,,
12627,DNAI1,C0027430,Beclomethasone dipropionate,DB00394,Nasal Polyps,Approved,CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33214,NFE2L2,C0948780,Simvastatin,DB00641,Rhinosinusitis,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21254,TNF,C0155877,Zileuton,DB00744,Allergic asthma,Approved,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O},,Immune system disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
24006,IDUA,C0268490,Nitisinone,DB00348,"Tyrosinemia, Type I",Approved,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-]},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
28727,GUCY1A1,C0339573,Latanoprost,DB00654,"Glaucoma, Primary Open Angle",Terminated,CC(C)OC(=O)CCC/C=C\\C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O},Phase 1,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19922,TMSB4X,C0740447,Pregabalin,DB00230,Diabetic peripheral neuropathy,Approved,CC(C)C[C@@H](CC(=O)O)CN},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20486,TRPM4,C0039240,Propranolol,DB00571,Supraventricular tachycardia,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6270,Trovafloxacin,DB00685,Pneumonia due to Escherichia coli,C0276089,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,,,,,,,,,,,,,,,,,,,RARG,,,,,,,,
15872,SOD1,C0020550,Sodium Iodide I-131,DB09293,Hyperthyroidism,Approved,[Na+].[131I-]},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31374,NR0B2,C0220654,Erlotinib,DB00530,Meningeal Carcinomatosis,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30676,PLCE1,C0685938,Erythropoietin,DB00016,Malignant neoplasm of gastrointestinal tract,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 3,Cancer,KIAA1516,NPHS3,,,,,,,,,,,,,,,,,,,,,,,,
10670,B3GAT1,C0149725,Piperacillin,DB00319,Lower respiratory tract infection,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,,GlcAT-P,HNK-1,NK-1,CD57,LEU7,,,,,,,,,,,,,,,,,,,,,
8274,SLC25A26,C0740394,Sulfinpyrazone,DB01138,Hyperuricemia,Approved,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
17153,TPH2,C0028768,Sertraline,DB01104,Obsessive-Compulsive Disorder,Approved,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl},,Mental and behavioural disorder,NTPH,FLJ37295,,,,,,,,,,,,,,,,,,,,,,,,
22597,IL37,C0030409,Ketoconazole,DB01026,Paracoccidioidomycosis,Approved,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20877,TICAM2,C0184567,Floctafenine,DB08976,Acute onset pain,Approved,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC=C(C3=NC=C2)C(F)(F)F},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
15172,RBM3,C0009088,Sumatriptan,DB00669,Cluster Headache,Approved,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C},,,IS1-RNPL,,,,,,,,,,,,,,,,,,,,,,,,,
1342,Ceftizoxime,DB01332,Enterobacteriaceae Infections,C0014347,Approved,CO/N=C(/C1=CSC(=N1)N)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Risedronate,,,,,,,,
15329,INS,C0018790,Metoprolol,DB00264,Cardiac Arrest,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,Cardiovascular disease,IDDM2,,,,,,,,,,,,,,,,,,,,,,,,,
4343,Nalbuphine,DB00844,Labor Pain,C0474368,Approved,C1CC(C1)CN2CC[C@]34[C@@H]5[C@H](CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O)O},,,,,,,,,,,,,,,,,,,,,TRBC1,,,,,,,,
7616,IL31,C0011615,Triamcinolone,DB00620,"Dermatitis, Atopic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,ROR2,,,,,,,,
34589,NOS2,C0751530,Dexmedetomidine,DB00633,"Subarachnoid Hemorrhage, Aneurysmal",Terminated,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 3,,iNOS,HEP-NOS,NOS2A,,,,,,,,,,,,,,,,,,,,,,,
23215,CDH1,C0476089,Arsenic trioxide,DB01169,Endometrial Carcinoma,Terminated,[O-2].[O-2].[O-2].[As+3].[As+3]},Phase 2,Cancer,uvomorulin,CD324,UVO,,,,,,,,,,,,,,,,,,,,,,,
30373,GAR1,C0018939,Melphalan,DB01042,Hematological Disease,Terminated,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26957,RARS1,C0280745,Decitabine,DB01262,secondary myelodysplastic syndromes,Terminated,C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2272,Dextromethorphan,DB00514,Headache Disorders,C0393735,Approved,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC},,Nervous system disease,,,,,,,,,,,,,,,,,,,EMSY,,,,,,,,
13834,IL2RA,C0021390,Naltrexone,DB00704,Inflammatory Bowel Diseases,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,,IL2R,IDDM10,,,,,,,,,,,,,,,,,,,,,,,,
3991,Mestranol,DB01357,Endometriosis,C0014175,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)OC},,Reproductive system disease,,,,,,,,,,,,,,,,,,,MTR,,,,,,,,
19239,EGF,C0282488,Mycophenolic acid,DB01024,Interstitial Cystitis,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
16468,MCAT,C0029442,Ergocalciferol,DB00153,Osteomalacia,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8404,Methyltestosterone,DB06710,Multiple Sclerosis,C0026769,Terminated,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C},Phase 2,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
30114,BCHE,C0235032,Methylphenidate,DB00422,Neurotoxicity Syndromes,Terminated,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},Phase 2,Nervous system disease,CHE2,,,,,,,,,,,,,,,,,,,,,,,,,
31129,CCL5,C0742558,Doxorubicin,DB00997,colon cancer liver metastasis,Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},Phase 2,Cancer,RANTES,SISd,TCP228,MGC17164,D17S136E,SCYA5,,,,,,,,,,,,,,,,,,,,
34349,HAVCR2,C0085426,Vancomycin,DB00512,Gram-Positive Bacterial Infections,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,Tim-3,TIM3,FLJ14428,TIMD3,CD366,,,,,,,,,,,,,,,,,,,,,
24900,CSF3,C0041318,Pyrazinamide,DB00339,"Tuberculosis, Meningeal",Approved,C1=CN=C(C=N1)C(=O)N},,Infectious disease,MGC45931,GCSF,G-CSF,C17orf33,,,,,,,,,,,,,,,,,,,,,,
26244,BCL10,C0153594,Vinblastine,DB00570,Malignant neoplasm of testis,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25893,FGF23,C0085413,Tolvaptan,DB06212,"Polycystic Kidney, Autosomal Dominant",Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
1418,Ceftriaxone,DB01212,Serratia Infections,C0085394,Approved,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Stiripentol,,,,,,,,
737,Bethanechol,DB01019,Urinary Retention,C0080274,Approved,CC(C[N+](C)(C)C)OC(=O)N},,,,,,,,,,,,,,,,,,,,,Haloperidol,,,,,,,,
33327,SSTR4,C0033117,Tadalafil,DB00820,Priapism,Terminated,CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
31386,CHGA,C0206754,Sunitinib,DB01268,Neuroendocrine Tumors,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
14647,CCND1,C0334634,Thalidomide,DB01041,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33233,ABL1,C0280141,Sunitinib,DB01268,Acute Undifferentiated Leukemia,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30133,FOXA1,C2938924,Letrozole,DB01006,Oestrogen receptor positive breast cancer,Terminated,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3},Phase 2,Cancer,HNF3A,,,,,,,,,,,,,,,,,,,,,,,,,
16469,GNAS,C0029442,Ergocalciferol,DB00153,Osteomalacia,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21033,BCL2,C0862889,Imiquimod,DB00724,Superficial basal cell carcinoma,Approved,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N},,Cancer,Bcl-2,PPP1R50,,,,,,,,,,,,,,,,,,,,,,,,
12379,KEAP1,C0007134,Thalidomide,DB01041,Renal Cell Carcinoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
14431,CYLD,C0278996,Methotrexate,DB00563,Cancer of Head and Neck,Approved,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
22589,CD40LG,C0030409,Ketoconazole,DB01026,Paracoccidioidomycosis,Approved,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},,Infectious disease,CD40L,gp39,hCD40L,CD154,HIGM1,IMD3,TNFSF5,,,,,,,,,,,,,,,,,,,
19219,LEP,C0751967,Mitoxantrone,DB01204,"Multiple Sclerosis, Relapsing-Remitting",Approved,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},,Nervous system disease,OBS,,,,,,,,,,,,,,,,,,,,,,,,,
4884,Phenoxymethylpenicillin,DB00417,Erysipelas,C0014733,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,CCR9,,,,,,,,
17477,NNT,C0020625,Tolvaptan,DB06212,Hyponatremia,Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
16381,POMC,C0423775,Urea,DB03904,Scurfiness of scalp,Approved,C(=O)(N)N},,Skin disease,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
33827,CREM,C0011875,Heparin,DB01109,Diabetic Angiopathies,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2/Phase 3,Vascular disease,hCREM-2,,,,,,,,,,,,,,,,,,,,,,,,,
2525,Doxylamine,DB00366,Nasal congestion (finding),C0027424,Approved,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C},,,,,,,,,,,,,,,,,,,,,ALG1L3P,,,,,,,,
33792,SEC63,C0022680,Sirolimus,DB00877,Polycystic Kidney Diseases,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2/Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
19186,IL1RN,C0311375,Dimercaprol,DB06782,Arsenic Poisoning,Approved,C(C(CS)S)O},,,ICIL-1RA,IL1F3,IL-1RN,MGC10430,,,,,,,,,,,,,,,,,,,,,,
15117,CEACAM5,C0238462,Sorafenib,DB00398,Medullary carcinoma of thyroid,Withdrawn,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,CD66e,,,,,,,,,,,,,,,,,,,,,,,,,
6447,Zolmitriptan,DB00315,Migraine Disorders,C0149931,Approved,CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3},,Nervous system disease,,,,,,,,,,,,,,,,,,,PAM,,,,,,,,
6062,Tolvaptan,DB06212,"Polycystic Kidney, Autosomal Dominant",C0085413,Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Congenital malformation,,,,,,,,,,,,,,,,,,,DIRC3,,,,,,,,
3030,Fusidic Acid,DB02703,Brill-Zinsser Disease,C0006181,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,MFGE8,,,,,,,,
10490,COPA,C0010200,Sodium Citrate,DB09154,Coughing,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
34223,ABCG8,C0010054,Fenofibrate,DB01039,Coronary Arteriosclerosis,Terminated,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 3,Vascular disease,GBD4,,,,,,,,,,,,,,,,,,,,,,,,,
7684,Amphetamine,DB00182,Neurotoxicity Syndromes,C0235032,Terminated,CC(CC1=CC=CC=C1)N},Phase 2,Nervous system disease,,,,,,,,,,,,,,,,,,,ABCB9,,,,,,,,
30968,CD274,C0206704,Temozolomide,DB00853,"Carcinoma, Large Cell",Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,B7-H,B7H1,PD-L1,PDL1,B7-H1,PDCD1LG1,,,,,,,,,,,,,,,,,,,,
33024,HMGN2,C0017689,Romidepsin,DB06176,Glucagonoma,Terminated,C/C=C\\1/C(=O)N[C@H](C(=O)O[C@H]\\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34091,GTF2I,C0029453,Cholecalciferol,DB00169,Osteopenia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 2/Phase 3,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10452,F2,C0038454,Vorapaxar,DB09030,Cerebrovascular accident,Approved,CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@H]([C@H]2/C=C/C4=NC=C(C=C4)C5=CC(=CC=C5)F)[C@H](OC3=O)C},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10279,TLR8,C0041327,Streptomycin,DB01082,"Tuberculosis, Pulmonary",Approved,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6510,POMC,C0030193,Oxycodone,DB00497,Pain,Withdrawn,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O},Phase 3,,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,ACVR1,,,,,,,,
27409,CNTNAP2,C0038506,Asenapine,DB06216,Stuttering,Suspended,CN1C[C@@H]2[C@@H](C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24},Phase 3,,Caspr2,KIAA0868,,,,,,,,,,,,,,,,,,,,,,,,
24954,CD36,C0024530,Prednisone,DB00635,Malaria,Withdrawn,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 3,Infectious disease,SCARB3,GPIV,GP4,GP3B,,,,,,,,,,,,,,,,,,,,,,
36035,COPD,C1135191,Udenafil,DB06267,"Heart Failure, Systolic",Terminated,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C},Phase 3,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17196,SLC6A1,C0270846,Lorazepam,DB00186,Epileptic drop attack,Approved,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl},,Nervous system disease,GAT1,GABATR,GABATHG,,,,,,,,,,,,,,,,,,,,,,,
22793,MYH9,C0025323,Tranexamic Acid,DB00302,Menorrhagia,Approved,C1CC(CCC1CN)C(=O)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
31026,MKI67,C0280793,Temozolomide,DB00853,Mixed Oligodendroglioma-Astrocytoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,MIB-,PPP1R105,,,,,,,,,,,,,,,,,,,,,,,,
35486,PLAU,C0035126,Nitric Oxide,DB00435,Reperfusion Injury,Terminated,[N]=O},Phase 3,,URK,,,,,,,,,,,,,,,,,,,,,,,,,
6347,Verteporfin,DB00460,Choroidal retinal neovascularization,C0271066,Approved,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C.CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)O)C(=C3C)CCC(=O)OC)C=C},,Congenital malformation,,,,,,,,,,,,,,,,,,,LOXL2,,,,,,,,
7352,LGALS3BP,C0524909,Tenofovir,DB00300,"Hepatitis B, Chronic",Approved,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},,Infectious disease,0,,,,,,,,,,,,,,,,,LYPD4,,,,,,,,
22936,PRL,C0033038,Tramadol,DB00193,Premature Ejaculation,Terminated,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,
14153,CMC1,C0039103,Triamcinolone,DB00620,Synovitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11975,ADAMTS13,C0024535,Sulfisoxazole,DB00263,"Malaria, Falciparum",Approved,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,VWFCP,vWF-CP,FLJ42993,MGC118899,MGC118900,DKFZp434C2322,C9orf8,,,,,,,,,,,,,,,,,,,
31294,LDHA,C0279607,Erlotinib,DB00530,adult primary hepatocellular carcinoma,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3650,Latanoprost,DB00654,"Glaucoma, Open-Angle",C0017612,Approved,CC(C)OC(=O)CCC/C=C\\C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O},,Nervous system disease,,,,,,,,,,,,,,,,,,,EPHA7,,,,,,,,
9529,Acetaminophen,DB00316,Cardiac Arrhythmia,C0003811,Withdrawn,CC(=O)NC1=CC=C(C=C1)O},Phase 1/Phase 2,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
7395,ERBB2,C1960925,Osimertinib,DB09330,Epidermal growth factor receptor positive non-small cell lung cancer,Approved,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC},,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,PYGM,,,,,,,,
31763,IL1RAPL1,C0524528,Levoleucovorin,DB11596,Pervasive Development Disorder,Terminated,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
7258,VEGFA,C1260880,Xylometazoline,DB06694,Rhinorrhea,Approved,CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C},,Nervous system disease,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,TBCK,,,,,,,,
6884,ERVK-32,C0006277,Theophylline,DB00277,Bronchitis,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Lung disease,0,,,,,,,,,,,,,,,,,IGKV1D-8,,,,,,,,
1503,Chloramphenicol,DB00446,Streptococcal meningitis,C0154639,Approved,C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,HMGB1,,,,,,,,
19061,TBX5,C0004238,Verapamil,DB00661,Atrial Fibrillation,Approved,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32533,IL6,C0520909,Nicotine,DB00184,Postoperative Nausea and Vomiting,Terminated,CN1CCC[C@H]1C2=CN=CC=C2},Phase 2,,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
14424,MAL,C0278996,Methotrexate,DB00563,Cancer of Head and Neck,Approved,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23273,ERCC6,C0232940,Progesterone,DB00396,Secondary physiologic amenorrhea,Approved,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35269,MTHFD1,C0004093,Methylphenidate,DB00422,Asthenia,Terminated,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},Phase 3,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14587,FGFR3,C1336708,Vinblastine,DB00570,Testicular Germ Cell Tumor,Terminated,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,CEK2,JTK4,CD333,ACH,,,,,,,,,,,,,,,,,,,,,,
5619,Solifenacin,DB01591,Increased frequency of micturition,C0042023,Approved,C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5},,,,,,,,,,,,,,,,,,,,,LGI4,,,,,,,,
1908,Cortisone acetate,DB01380,Infective otitis externa,C0021355,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,ERN1,,,,,,,,
21900,UGT1A3,C0002895,Hydroxyurea,DB01005,"Anemia, Sickle Cell",Approved,C(=O)(N)NO},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1219,Cefoxitin,DB01331,Proteus urinary tract infection,C0577709,Approved,CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3},,Infectious disease,,,,,,,,,,,,,,,,,,,Phenylephrine,,,,,,,,
6301,Urea,DB03904,Seborrheic dermatitis,C0036508,Approved,C(=O)(N)N},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,SIRT5,,,,,,,,
17910,CXCL8,C0026961,Tropicamide,DB00809,Mydriasis,Approved,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2},,,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
27833,DCTN1,C0085633,Atomoxetine,DB00289,Mood swings,Terminated,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2},Phase 1,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
28048,TRPV1,C0020429,Capsaicin,DB06774,Hyperalgesia,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,Nervous system,,,,,,,,,,,,,,,,,,,,,,,,,,
28325,TCL1A,C0023486,Thalidomide,DB01041,Prolymphocytic Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,TCL1,,,,,,,,,,,,,,,,,,,,,,,,,
31426,CX3CR1,C3873567,Erythropoietin,DB00016,Chemotherapy-induced peripheral neuropathy,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 2,,CMKDR1,V28,GPR13,CMKBRL1,,,,,,,,,,,,,,,,,,,,,,
35472,CDKN1A,C0035126,Nitric Oxide,DB00435,Reperfusion Injury,Terminated,[N]=O},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
33280,MPL,C0001815,Sunitinib,DB01268,Primary Myelofibrosis,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,CD110,TPOR,,,,,,,,,,,,,,,,,,,,,,,,
1089,Cefepime,DB01413,"Pneumonia, Bacterial",C0004626,Approved,C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,Nicotinamide,,,,,,,,
23183,CCR6,C0220656,Thiotepa,DB04572,Malignant ascites,Approved,C1CN1P(=S)(N2CC2)N3CC3},,Cancer,CKR-L3,GPR-CY4,CMKBR6,GPR29,DRY-6,DCR2,BN-1,CD196,STRL22,,,,,,,,,,,,,,,,,
10815,HLA-DQB1,C0027404,Sodium oxybate,DB09072,Narcolepsy,Approved,C(CC(=O)[O-])CO.[Na+]},,Nervous system disease,HLA-DQB,,,,,,,,,,,,,,,,,,,,,,,,,
13488,PTGS1,C0006444,Ketoprofen,DB01009,Bursitis,Terminated,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O},Phase 3,Musculoskeletal disease,PGHS-1,PTGHS,,,,,,,,,,,,,,,,,,,,,,,,
22882,LPP,C0677607,Levothyroxine,DB00451,Hashimoto Disease,Approved,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29592,CDK6,C0278883,Paclitaxel,DB01229,Metastatic melanoma,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26548,VEGFA,C0278884,Sorafenib,DB00398,Melanoma recurrent,Withdrawn,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
6027,Tobramycin,DB00684,Osteomyelitis due to Staphylococcus aureus,C1997728,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Immune system disease,,,,,,,,,,,,,,,,,,,GRB7,,,,,,,,
1332,Ceftibuten,DB01415,Tonsillitis,C0040425,Approved,C1C=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)/C(=C\\CC(=O)O)/C3=CSC(=N3)N)C(=O)O},,,,,,,,,,,,,,,,,,,,,Rifabutin,,,,,,,,
34865,DRD3,C0011206,Quetiapine,DB01224,Delirium,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
10074,FOXP3,C0022602,Masoprocol,DB00179,Actinic keratosis,Approved,C[C@H](CC1=CC(=C(C=C1)O)O)[C@@H](C)CC2=CC(=C(C=C2)O)O},,Skin disease,JM2,XPID,AIID,PIDX,DIETER,SCURFIN,IPEX,,,,,,,,,,,,,,,,,,,
13839,ITGA4,C0021390,Naltrexone,DB00704,Inflammatory Bowel Diseases,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,,CD49d,CD49D,,,,,,,,,,,,,,,,,,,,,,,,
21672,EGFR,C0037036,Hyoscyamine,DB00424,Sialorrhea,Approved,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3},,,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
15093,CXCR4,C0700345,Tioconazole,DB01007,"Candidiasis, Vulvovaginal",Approved,C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl},,Infectious disease,LESTR,NPY3R,HM89,NPYY3R,D2S201E,fusin,HSY3RR,CD184,,,,,,,,,,,,,,,,,,
1376,Ceftriaxone,DB01212,"Arthritis, Bacterial",C1692886,Approved,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Sertaconazole,,,,,,,,
31449,RBPJ,C0023529,Erythropoietin,DB00016,"Leukomalacia, Periventricular",Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 2,Cancer,IGKJRB,RBPJK,KBF2,RBP-J,CBF1,IGKJRB1,RBPSUH,,,,,,,,,,,,,,,,,,,
25035,SFTPA1,C0035235,Ribavirin,DB00811,Respiratory Syncytial Virus Infections,Approved,C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N},,Infectious disease,SP-A,SP-A1,COLEC4,SFTP1,,,,,,,,,,,,,,,,,,,,,,
34252,APOE,C0242339,Simvastatin,DB00641,Dyslipidemias,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Metabolic disease,AD2,,,,,,,,,,,,,,,,,,,,,,,,,
28498,TP53,C0278727,Metronidazole,DB00916,Small cell lung cancer recurrent,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23146,ENO2,C0033845,Thiopental,DB00599,Pseudotumor Cerebri,Approved,CCCC(C)C1(C(=O)NC(=S)NC1=O)CC},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
29234,PIK3CB,C1541317,Irinotecan,DB00762,adult gliosarcoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10049,PIP,C0346993,Aminoglutethimide,DB00357,Secondary malignant neoplasm of female breast,Approved,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N},,Cancer,GCDFP-15,GCDFP15,GPIP4,,,,,,,,,,,,,,,,,,,,,,,
4903,Phentolamine,DB00692,Paroxysmal hypertension,C0221154,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,MMP8,,,,,,,,
8241,B4GALT1-AS1,C0018099,Naproxen,DB00788,Gout,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29222,GFAP,C1541317,Irinotecan,DB00762,adult gliosarcoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,FLJ45472,,,,,,,,,,,,,,,,,,,,,,,,,
36342,IKZF1,C0011168,Lansoprazole,DB00448,Deglutition Disorders,Withdrawn,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F},Phase 1/Phase 2,,hIk-1,LyF-1,Hs.54452,IKAROS,PPP1R92,ZNFN1A1,,,,,,,,,,,,,,,,,,,,
9190,HMOX1,C0400877,Alvimopan,DB06274,Postoperative ileus,Approved,C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O},,,bK286B10,HO-1,,,,,,,,,,,,,,,,,,,,,,,,
20339,MXLPO,C0023827,Trabectedin,DB05109,liposarcoma,Approved,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12373,TSC1,C0007134,Thalidomide,DB01041,Renal Cell Carcinoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27811,MLKL,C1456624,Methamphetamine,DB01577,Methamphetamine abuse,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
26428,EGF,C0278987,Pemetrexed,DB00642,Non-small cell lung cancer metastatic,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
21561,LEP,C0751362,Viloxazine,DB09185,Narcolepsy-Cataplexy Syndrome,Approved,CCOC1=CC=CC=C1OCC2CNCCO2},,Nervous system disease,OBS,,,,,,,,,,,,,,,,,,,,,,,,,
29283,NBAS,C0021051,Vidarabine,DB00194,Immunologic Deficiency Syndromes,Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 1/Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5497,Salicylic acid,DB00936,Allergic rhinitis (disorder),C2607914,Approved,C1=CC=C(C(=C1)C(=O)O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,HK1,,,,,,,,
6624,PLXNA2,C0017605,Methazolamide,DB00703,Angle Closure Glaucoma,Approved,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C},,Nervous system disease,0,,,,,,,,,,,,,,,,,MIR31,,,,,,,,
34754,CEACAM5,C0030283,Ethanol,DB00898,Pancreatic Cyst,Terminated,CCO},Phase 3,Congenital malformation,CD66e,,,,,,,,,,,,,,,,,,,,,,,,,
18950,COL11A1,C0409959,Diclofenac,DB00586,"Osteoarthritis, Knee",Approved,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl},,Musculoskeletal disease,STL2,CO11A1,COLL6,,,,,,,,,,,,,,,,,,,,,,,
29996,TK2,C0152109,Sodium phenylbutyrate,DB06819,Juvenile Spinal Muscular Atrophy,Terminated,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},Phase 1/Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36185,CST6,C0220603,Valproic Acid,DB00313,childhood brain tumor,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30708,PTCH1,C0206663,Vincristine,DB00541,"Neuroectodermal Tumor, Primitive",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,BCNS,NBCCS,PTCH,,,,,,,,,,,,,,,,,,,,,,,
12835,HLA-DQB1,C0024301,Vincristine,DB00541,"Lymphoma, Follicular",Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,HLA-DQB,,,,,,,,,,,,,,,,,,,,,,,,,
2023,SLC29A1,C0001973,Zonisamide,DB00909,"Alcoholic Intoxication, Chronic",Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 2,Other,ENT1,,,,,,,,,,,,,,,,,ETFA,,,,,,,,
18039,IL12A-AS1,C0022575,Cyclosporine,DB00091,Keratoconjunctivitis Sicca,Approved,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17677,TLR2,C0022568,Loteprednol,DB00873,Keratitis,Withdrawn,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)OCCl)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 3,Skin disease,TIL4,CD282,,,,,,,,,,,,,,,,,,,,,,,,
818,Bupropion,DB01156,Depressive disorder,C0011581,Approved,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,LIMK1,,,,,,,,
16195,IFITM3,C0036117,Chloramphenicol,DB00446,Salmonella infections,Approved,C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]},,Infectious disease,1-8U,DSPA2b,,,,,,,,,,,,,,,,,,,,,,,,
29779,ZBTB16,C0023524,Mefloquine,DB00358,"Leukoencephalopathy, Progressive Multifocal",Terminated,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O},Phase 1/Phase 2,Cancer,PLZF,ZNF145,,,,,,,,,,,,,,,,,,,,,,,,
14358,COMT,C0009806,Oxycodone,DB00497,Constipation,Terminated,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O},Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32412,LMNA,C0007282,Minocycline,DB01017,Carotid Stenosis,Terminated,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},Phase 2,Cardiovascular disease,LMN1,CMD1A,LGMD1B,,,,,,,,,,,,,,,,,,,,,,,
27029,ADM,C0036983,Norepinephrine,DB00368,Septic Shock,Withdrawn,C1=CC(=C(C=C1[C@H](CN)O)O)O},Phase 3,,AM,,,,,,,,,,,,,,,,,,,,,,,,,
25812,AKR1A1,C0349464,Thiamine,DB00152,Wernicke-Korsakoff Syndrome,Approved,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
162,Amikacin,DB00479,Infection due to Pseudomonas aeruginosa,C0276075,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},,Infectious disease,,,,,,,,,,,,,,,,,,,Bisacodyl,,,,,,,,
15186,GPR101,C0013390,Naproxen,DB00788,Dysmenorrhea,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28832,P2RY8,C0023452,Vincristine,DB00541,"Leukemia, Lymphocytic, Acute, L1",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17412,RYR1,C0035220,Tyloxapol,DB06439,"Respiratory Distress Syndrome, Newborn",Approved,CC(C)(C)CC(C)(C)C1=CC=C(C=C1)O.C=O.C1CO1},,Lung disease,RYR,PPP1R137,MHS,MHS1,CCO,,,,,,,,,,,,,,,,,,,,,
17697,NTRK1,C0022568,Loteprednol,DB00873,Keratitis,Withdrawn,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)OCCl)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 3,Skin disease,TRKA,MTC,,,,,,,,,,,,,,,,,,,,,,,,
10291,ACE,C0042510,Metoprolol,DB00264,Ventricular Fibrillation,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,,ACE1,CD143,DCP1,,,,,,,,,,,,,,,,,,,,,,,
11144,IL1R1,C0276653,Anidulafungin,DB00362,Invasive Pulmonary Aspergillosis,Withdrawn,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC=C(C=C7)O)O)O)[C@@H](C)O)C)O)O)O},Phase 3,Infectious disease,D2S1473,CD121A,IL1R,,,,,,,,,,,,,,,,,,,,,,,
36502,MAP2K7,C0019621,Clofarabine,DB00631,"Histiocytosis, Langerhans-Cell",Withdrawn,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26836,CD274,C0349644,Vincristine,DB00541,Malignant lymphoma of testis,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,B7-H,B7H1,PD-L1,PDL1,B7-H1,PDCD1LG1,,,,,,,,,,,,,,,,,,,,
13868,PRDM1,C0024141,Mycophenolic acid,DB01024,"Lupus Erythematosus, Systemic",Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 2/Phase 3,Immune system disease,PRDI-BF1,BLIMP1,,,,,,,,,,,,,,,,,,,,,,,,
20926,NR1I3,C0345904,Floxuridine,DB00322,Malignant neoplasm of liver,Approved,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)F)CO)O},,Cancer,MB67,CAR1,,,,,,,,,,,,,,,,,,,,,,,,
20616,KIT,C0241961,Everolimus,DB01590,Angiomyolipoma of kidney,Approved,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC},,Cancer,CD117,SCFR,C-Kit,PBT,,,,,,,,,,,,,,,,,,,,,,
28767,ABCB1,C0009402,Levoleucovorin,DB11596,Colorectal Carcinoma,Withdrawn,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2/Phase 3,Cancer,P-gp,CD243,GP170,ABC20,PGY1,CLCS,,,,,,,,,,,,,,,,,,,,
23327,NFE2L2,C0042900,Tacrolimus,DB00864,Vitiligo,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20801,CRHR1,C4083212,Finasteride,DB01216,"Alopecia, Male Pattern",Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},,Skin disease,CRF-R,CRF1,CRHR,,,,,,,,,,,,,,,,,,,,,,,
3896,Masoprocol,DB00179,Actinic keratosis,C0022602,Approved,C[C@H](CC1=CC(=C(C=C1)O)O)[C@@H](C)CC2=CC(=C(C=C2)O)O},,Skin disease,,,,,,,,,,,,,,,,,,,KMT2B,,,,,,,,
11208,MAS1,C0024286,Tetracycline,DB00759,Lymphogranuloma Venereum,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7027,SNORA31,C0276226,Aciclovir,DB00787,Herpes encephalitis,Approved,C1=NC2=C(N1COCCO)N=C(NC2=O)N},,Infectious disease,0,,,,,,,,,,,,,,,,,ARHGAP26,,,,,,,,
8878,Atorvastatin,DB01076,Acute Coronary Syndrome,C0948089,Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
11036,LRRCC1,C0006846,Zinc oxide,DB09321,Cutaneous Candidiasis,Approved,O=[Zn]},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35955,IFNA1,C0019163,Tenofovir,DB00300,Hepatitis B,Terminated,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11915,MPO,C0023479,Arsenic trioxide,DB01169,Acute myelomonocytic leukemia,Approved,[O-2].[O-2].[O-2].[As+3].[As+3]},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
9407,SNCA,C0242422,Trihexyphenidyl,DB00376,Parkinsonian Disorders,Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Neurodegenerative disease,NACP,PARK1,PARK4,,,,,,,,,,,,,,,,,,,,,,,
11767,EPHA7,C0019080,Aprotinin,DB06692,Hemorrhage,Approved,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](CSSC[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N4CCC[C@@H]4C(=O)N5CCC[C@@H]5C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N6CCC[C@H]6C(=O)N[C@H](CSSC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CCC(=O)N)[C@@H](C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCNC(=N)N)C)CCCCN)[C@H](C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)[C@@H](C)CC},,,Hek11,,,,,,,,,,,,,,,,,,,,,,,,,
1866,Cortisone acetate,DB01380,Adrenogenital disorder,C0701163,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Congenital malformation,,,,,,,,,,,,,,,,,,,BACE1,,,,,,,,
935,Carbidopa,DB00190,Parkinson Disease,C0030567,Approved,C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN},,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,Maprotiline,,,,,,,,
492,Azithromycin,DB00207,Streptococcal tonsillitis,C0275804,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Disulfiram,,,,,,,,
3205,Gliquidone,DB01251,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,Approved,CC1(C2=C(C=C(C=C2)OC)C(=O)N(C1=O)CCC3=CC=C(C=C3)S(=O)(=O)NC(=O)NC4CCCCC4)C},,Endocrine disease,,,,,,,,,,,,,,,,,,,PCDH19,,,,,,,,
31199,ERVK-18,C0015674,Lipoic Acid,DB00166,Chronic Fatigue Syndrome,Withdrawn,C1CSS[C@@H]1CCCCC(=O)O},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
12748,F9,C0149871,Warfarin,DB00682,Deep Vein Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23925,CYBB,C0038525,Deferoxamine,DB00746,Subarachnoid Hemorrhage,Terminated,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O},Phase 0,,GP91-PHOX,NOX2,CGD,,,,,,,,,,,,,,,,,,,,,,,
35513,CCL2,C0011884,Octreotide,DB00104,Diabetic Retinopathy,Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 3,Nervous system disease,MCP1,MCP-1,MCAF,SMC-CF,GDCF-2,HC11,MGC9434,SCYA2,,,,,,,,,,,,,,,,,,
29634,CSF1R,C0279632,Vorinostat,DB02546,adult acute megakaryoblastic leukemia (M7),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,C-FMS,CSFR,CD115,FMS,,,,,,,,,,,,,,,,,,,,,,
28862,NME1,C0279681,Metronidazole,DB00916,Bladder Squamous Cell Carcinoma,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1851,Colistin,DB00803,Klebsiella Infections,C0022729,Approved,CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)[C@@H](C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,NPAS3,,,,,,,,
30621,MLANA,C0346990,Cisplatin,DB00515,Carcinomatosis of peritoneal cavity,Terminated,N.N.Cl[Pt]Cl},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
27022,GC,C0036983,Norepinephrine,DB00368,Septic Shock,Withdrawn,C1=CC(=C(C=C1[C@H](CN)O)O)O},Phase 3,,VDBP,hDBP,,,,,,,,,,,,,,,,,,,,,,,,
20266,BGLAP,C0042870,Ergocalciferol,DB00153,Vitamin D Deficiency,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,OCN,,,,,,,,,,,,,,,,,,,,,,,,,
5736,Sulfisoxazole,DB00263,"Malaria, Falciparum",C0024535,Approved,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,NCKAP1,,,,,,,,
26345,TGFB1,C1275684,Xanthophyll,DB00137,Meibomian gland dysfunction,Approved,CC1=C(C(C[C@@H](C1)O)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(\\C)/C=C/C=C(\\C)/C=C/[C@H]2C(=C[C@@H](CC2(C)C)O)C)/C)/C},,Nervous system disease,CED,TGFbeta,TGFB,DPD1,,,,,,,,,,,,,,,,,,,,,,
6165,Triamcinolone,DB00620,Rheumatoid Arthritis,C0003873,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,,,,,,,,,,,,,,,,,,,ENPP6,,,,,,,,
2940,Fluphenazine,DB00623,Schizophrenia,C0036341,Approved,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,MIR1976,,,,,,,,
27784,APC,C0278519,Pegaspargase,DB00059,recurrent childhood acute lymphoblastic leukemia,Terminated,CC1=CC(=C(C=C1)C(=O)C(=C)CN(C)C)C},Phase 1,Cancer,DP2.5,PPP1R46,,,,,,,,,,,,,,,,,,,,,,,,
7923,PTHLH,C0029458,Zoledronic acid,DB00399,"Osteoporosis, Postmenopausal",Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,PTHRP,,,,,,,,,,,,,,,,,,,,,,,,,
23065,CAMP,C0406486,Prednisolone,DB00860,Ocular Rosacea,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Infectious disease,CAP18,FALL39,FALL-39,LL37,,,,,,,,,,,,,,,,,,,,,,
36931,PDCD1,C0280803,Pemetrexed,DB00642,Primary central nervous system lymphoma,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,CD279,hSLE1,PD-1,SLEB2,,,,,,,,,,,,,,,,,,,,,,
34367,MIB1,C0007860,Cefixime,DB00671,Uterine Cervicitis,Terminated,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O},Phase 3,Reproductive system disease,DIP-1,MIB,KIAA1323,ZZANK2,ZZZ6,,,,,,,,,,,,,,,,,,,,,
26048,VEGFA,C0034063,Trimethaphan,DB01116,Pulmonary Edema,Approved,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5},,Lung disease,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
19884,THPO,C0002874,Heparin,DB01109,Aplastic Anemia,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28758,TP53,C0009402,Levoleucovorin,DB11596,Colorectal Carcinoma,Withdrawn,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2/Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29336,TNS4,C1332166,Paclitaxel,DB01229,Adenocarcinoma of the gastroesophageal junction,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36582,TP53,C0278506,Pemetrexed,DB00642,Non-small cell lung cancer stage III,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35323,RNA28SN5,C1262313,Micafungin,DB01141,Invasive Fungal Infections,Terminated,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)[C@@H](CC(=O)N)O)C)O)O)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19823,HCN4,C0235480,Propafenone,DB01182,Paroxysmal atrial fibrillation,Approved,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
1162,Cefotaxime,DB00493,Proteus pneumonia,C1260917,Approved,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Palonosetron,,,,,,,,
17022,CCDC122,C0023343,Dapsone,DB00250,Leprosy,Approved,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32826,TP53,C0040136,Ponatinib,DB08901,Thyroid Neoplasm,Terminated,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15955,CYP2C9,C0153633,Carmustine,DB00262,Malignant neoplasm of brain,Approved,C(CCl)NC(=O)N(CCCl)N=O},,Cancer,P450IIC9,CYP2C10,,,,,,,,,,,,,,,,,,,,,,,,
32464,PIK3CB,C0238461,Paclitaxel,DB01229,Anaplastic thyroid carcinoma,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
22336,CYBB,C0011849,Pramlintide,DB01278,Diabetes Mellitus,Withdrawn,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N)NC(=O)[C@@H]4CCCN4C(=O)CNC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CNC=N6)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@@H]8CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N8)[C@@H](C)O)C)[C@@H](C)O)CC(=O)N)NC(=O)[C@H](CCCCN)N},Phase 1/Phase 2,Endocrine disease,GP91-PHOX,NOX2,CGD,,,,,,,,,,,,,,,,,,,,,,,
37159,LINC02153,C0729264,Erythromycin,DB00199,Preterm premature rupture of membranes (disorder),Withdrawn,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
10398,GATA6,C0002962,Verapamil,DB00661,Angina Pectoris,Approved,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
15708,POLG,C0494475,Primidone,DB00794,Tonic - clonic seizures,Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31946,SLC25A20,C0349231,Hydrocortisone,DB00741,Phobic anxiety disorder,Terminated,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
12827,RRAGC,C0024301,Vincristine,DB00541,"Lymphoma, Follicular",Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4790,Pasireotide,DB06663,Adrenal Gland Hyperfunction,C0001622,Approved,C1[C@H](CN2[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN},,Endocrine disease,,,,,,,,,,,,,,,,,,,FCRL3,,,,,,,,
15029,IFNA2,C0279543,Nilotinib,DB04868,Philadelphia chromosome positive chronic myelogenous leukemia,Approved,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35385,CDKN2A,C0042075,Mitomycin,DB00305,Urologic Diseases,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Urinary system disease,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
19493,FLT4,C0276535,Doxorubicin,DB00997,AIDS with Kaposi's sarcoma,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},,Cancer,VEGFR3,,,,,,,,,,,,,,,,,,,,,,,,,
30411,ERBB2,C0494165,Oxaliplatin,DB00526,Secondary malignant neoplasm of liver,Withdrawn,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2/Phase 3,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
29133,ADM,C0280483,Irinotecan,DB00762,adult anaplastic astrocytoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,AM,,,,,,,,,,,,,,,,,,,,,,,,,
27922,NOTCH1,C0278769,Lenalidomide,DB00480,Chronic lymphocytic leukaemia stage 3,Withdrawn,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N},Phase 2,Cancer,TAN1,,,,,,,,,,,,,,,,,,,,,,,,,
1505,Chlorcyclizine,DB08936,Allergic Conjunctivitis,C0009766,Approved,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl},,Immune system disease,,,,,,,,,,,,,,,,,,,Ticlopidine,,,,,,,,
5594,Sodium Citrate,DB09154,Rhinitis,C0035455,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Immune system disease,,,,,,,,,,,,,,,,,,,HOXA11,,,,,,,,
13853,IRF5,C0024141,Mycophenolic acid,DB01024,"Lupus Erythematosus, Systemic",Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 2/Phase 3,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
29449,TLR4,C0021368,Methotrexate,DB00563,Inflammation,Withdrawn,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,,,,,,,,,
33178,IGHMBP2,C1145670,Dexmedetomidine,DB00633,Respiratory Failure,Terminated,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 3,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18970,PRDX1,C0040038,Warfarin,DB00682,Thromboembolism,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3508,Indomethacin,DB00328,Bursitis,C0006444,Approved,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,PSMB4,,,,,,,,
623,Benzylpenicillin,DB01053,Lung Abscess,C0024110,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,,,,,,,,,,,,,,,,,,,,Fenofibrate,,,,,,,,
33607,HSPB6,C0018799,Vitamin E,DB00163,Heart Diseases,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Cardiovascular disease,FLJ32389,Hsp20,PPP1R91,,,,,,,,,,,,,,,,,,,,,,,
30288,MAP3K8,C0007120,Bortezomib,DB00188,Bronchioloalveolar Adenocarcinoma,Terminated,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O},Phase 2,Cancer,Tpl-2,c-COT,MEKK8,ESTF,,,,,,,,,,,,,,,,,,,,,,
15285,FBN1,C0085682,"Sodium phosphate, monobasic, monohydrate",DB09525,Hypophosphatemia,Approved,OP(=O)(O)[O-].[Na+]},,Urinary system disease,MASS,OCTD,SGS,FBN,MFS1,WMS,,,,,,,,,,,,,,,,,,,,
4424,CCR1,C0003862,Salicylic acid,DB00936,Arthralgia,Approved,C1=CC=C(C(=C1)C(=O)O)O},,Immune system disease,MIP1aR,CD191,SCYAR1,CMKBR1,,,,,,,,,,,,,,PHOX2B,,,,,,,,
15414,KCNJ18,C0020621,Potassium Citrate,DB09125,Hypokalemia,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7143,RNF114,C0033860,Atorvastatin,DB01076,Psoriasis,Withdrawn,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Skin disease,0,,,,,,,,,,,,,,,,,CEP72,,,,,,,,
7772,IRF4,C0079773,Belinostat,DB05015,"Lymphoma, T-Cell, Cutaneous",Terminated,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)/C=C/C(=O)NO},Phase 2,Cancer,LSIRF,MUM1,,,,,,,,,,,,,,,,TTC21B,,,,,,,,
25105,ITIH2,C0022876,Ritodrine,DB00867,Premature Obstetric Labor,Approved,C[C@@H]([C@@H](C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
33591,PLG,C0007273,Vitamin E,DB00163,Carotid Artery Diseases,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Vascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
15825,CENPJ,C0032897,Somatropin recombinant,DB00052,Prader-Willi Syndrome,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Chromosomal abnormality,0,,,,,,,,,,,,,,,,,,,,,,,,,
22818,ARPC5,C0010308,Liothyronine,DB00279,Congenital Hypothyroidism,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
23374,PRKAA1,C0267176,Metoclopramide,DB01233,Gastroparesis due to diabetes mellitus,Approved,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35110,RPS20,C1333990,Norgestrel,DB09389,Hereditary Nonpolyposis Colorectal Cancer,Terminated,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13251,ADD1,C0025281,Penciclovir,DB00299,Meniere Disease,Terminated,C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N},Phase 3,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25603,TLR4,C0040560,Sulfadiazine,DB00359,"Toxoplasmosis, Congenital",Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,,,,,,,,,
31985,MLH1,C1319315,Sulindac,DB00605,Adenocarcinoma of large intestine,Terminated,CC\\1=C(C2=C(/C1=C\\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3012,Fusidic Acid,DB02703,Acne Vulgaris,C0001144,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,STS,,,,,,,,
19583,LOC110806263,C0007115,Liothyronine,DB00279,Malignant neoplasm of thyroid,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
6368,NAT2,C0392171,Salicylic acid,DB00936,Influenza-like symptoms,Approved,C1=CC=C(C(=C1)C(=O)O)O},,Infectious disease,0,,,,,,,,,,,,,,,,,ATP6V0A4,,,,,,,,
19875,NOP10,C0002874,Heparin,DB01109,Aplastic Anemia,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27531,TNNI3,C0878544,Milrinone,DB00235,Cardiomyopathies,Suspended,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2},Phase 3,Cardiovascular disease,TNNC1,CMH7,CMD2A,,,,,,,,,,,,,,,,,,,,,,,
13042,ADA,C0030848,Benzoic Acid,DB03793,Peyronie Disease,Approved,C1=CC=C(C=C1)C(=O)O},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13269,CLEC16A,C0001403,Triamcinolone,DB00620,Addison Disease,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31741,CNTNAP2,C0524528,Levoleucovorin,DB11596,Pervasive Development Disorder,Terminated,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Mental and behavioural disorder,Caspr2,KIAA0868,,,,,,,,,,,,,,,,,,,,,,,,
14225,MYDGF,C0040896,Triamcinolone,DB00620,Trichinellosis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16778,NGF,C0010692,Ofloxacin,DB01165,Cystitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,NGFB,,,,,,,,,,,,,,,,,,,,,,,,,
9535,AGER,C0684256,Vancomycin,DB00512,Bacterial sepsis,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,SCARJ1,,,,,,,,,,,,,,,,,,,,,,,,,
34470,SPI1,C0023470,Mycophenolic acid,DB01024,Myeloid Leukemia,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,Cancer,PU.1,SPI-A,SFPI1,SPI-1,,,,,,,,,,,,,,,,,,,,,,
9874,Bupivacaine,DB00297,Fracture of lower leg,C1542178,Withdrawn,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
17025,TNFSF15,C0023343,Dapsone,DB00250,Leprosy,Approved,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30679,CTNNB1,C0025149,Valproic Acid,DB00313,Medulloblastoma,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,beta-catenin,armadillo,CTNNB,,,,,,,,,,,,,,,,,,,,,,,
12236,TNF,C0020474,Simvastatin,DB00641,"Hyperlipidemia, Familial Combined",Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Metabolic disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
22030,P2RX7,C0855095,Idelalisib,DB09054,Small Lymphocytic Lymphoma,Approved,CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5},,Cancer,P2X7,MGC20089,,,,,,,,,,,,,,,,,,,,,,,,
9061,Lamivudine,DB00709,Diarrhea,C0011991,Terminated,C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N},Phase 3,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
21005,APC,C0007102,Oxaliplatin,DB00526,Malignant tumor of colon,Withdrawn,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,DP2.5,PPP1R46,,,,,,,,,,,,,,,,,,,,,,,,
2303,Diclofenac,DB00586,Sprains and Strains,C0038048,Approved,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl},,,,,,,,,,,,,,,,,,,,,CD276,,,,,,,,
14618,ITGB6,C0524910,Cyclosporine,DB00091,"Hepatitis C, Chronic",Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
20873,OPRM1,C0184567,Floctafenine,DB08976,Acute onset pain,Approved,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC=C(C3=NC=C2)C(F)(F)F},,,MOR1,,,,,,,,,,,,,,,,,,,,,,,,,
8269,VEGFA,C0740394,Sulfinpyrazone,DB01138,Hyperuricemia,Approved,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4},,,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
24410,TRIP4,C0010691,Tiopronin,DB06823,Cystinuria,Approved,CC(C(=O)NCC(=O)O)S},,Congenital disorder of metabolism,HsT17391,,,,,,,,,,,,,,,,,,,,,,,,,
3485,Imipenem,DB01598,Endometritis,C0014179,Approved,C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O},,Reproductive system disease,,,,,,,,,,,,,,,,,,,CXCR2,,,,,,,,
19925,ADA,C0740447,Pregabalin,DB00230,Diabetic peripheral neuropathy,Approved,CC(C)C[C@@H](CC(=O)O)CN},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29516,ERBB2,C0278502,Fluorouracil,DB00544,recurrent gastric cancer,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 1/Phase 2,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
27530,TNNT2,C0878544,Milrinone,DB00235,Cardiomyopathies,Suspended,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2},Phase 3,Cardiovascular disease,CMH2,CMD1D,,,,,,,,,,,,,,,,,,,,,,,,
5323,Progesterone,DB00396,Secondary physiologic amenorrhea,C0232940,Approved,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Reproductive system disease,,,,,,,,,,,,,,,,,,,ATXN10,,,,,,,,
36419,GSTT1,C0333875,Celecoxib,DB00482,High-Grade Squamous Intraepithelial Lesions,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
11360,PEX6,C0035021,Tetracycline,DB00759,Relapsing Fever,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18987,PROCR,C0040053,Warfarin,DB00682,Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,EPCR,CCD41,CD201,,,,,,,,,,,,,,,,,,,,,,,
32420,HABP2,C0007282,Minocycline,DB01017,Carotid Stenosis,Terminated,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13420,CD28,C0004364,Triamcinolone,DB00620,Autoimmune Diseases,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
19793,FOSB,C0036472,Fusidic Acid,DB02703,Scrub Typhus,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,G0S3,GOSB,GOS3,MGC42291,DKFZp686C0818,,,,,,,,,,,,,,,,,,,,,
2086,Demeclocycline,DB00618,Infective otitis media,C0729586,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3[C@@H](C4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O},,Infectious disease,,,,,,,,,,,,,,,,,,,HCG27,,,,,,,,
21723,PTPRA,C0040250,Tolnaftate,DB00525,Tinea Capitis,Approved,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2},,Infectious disease,HLPR,HPTPA,RPTPA,PTPRL2,PTPA,,,,,,,,,,,,,,,,,,,,,
12381,ERBB2,C0007134,Thalidomide,DB01041,Renal Cell Carcinoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 1/Phase 2,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
21605,HADHA,C0020615,Glucagon recombinant,DB00040,Hypoglycemia,Approved,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CNC=N7)N)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8115,SDR9C7,C0033774,Zinc oxide,DB09321,Pruritus,Approved,O=[Zn]},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
24449,HMGB1,C0232849,Pentosan Polysulfate,DB00686,Bladder pain,Approved,C1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2CO[C@H]([C@@H]([C@H]2OS(=O)(=O)O)OS(=O)(=O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
12223,LDLR,C0020474,Simvastatin,DB00641,"Hyperlipidemia, Familial Combined",Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1809,Clotrimazole,DB00257,Cutaneous Candidiasis,C0006846,Approved,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4},,Immune system disease,,,,,,,,,,,,,,,,,,,Nitrous oxide,,,,,,,,
24307,TNF,C1261473,Pazopanib,DB06589,Sarcoma,Approved,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N},,Cancer,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
24552,GLG1,C0042345,Sodium Tetradecyl Sulfate,DB00464,Varicosity,Approved,CCCCCCCCCCCCCCOS(=O)(=O)[O-].[Na+]},,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36523,SOST,C0019621,Clofarabine,DB00631,"Histiocytosis, Langerhans-Cell",Withdrawn,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl)N},Phase 2,Cancer,VBCH,DAND6,,,,,,,,,,,,,,,,,,,,,,,,
16261,KDM4C,C0236663,Diazepam,DB00829,Alcohol withdrawal syndrome,Approved,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
14139,MMP3,C0039103,Triamcinolone,DB00620,Synovitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,STMY1,STMY,,,,,,,,,,,,,,,,,,,,,,,,
3751,Liothyronine,DB00279,Congenital Hypothyroidism,C0010308,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Congenital malformation,,,,,,,,,,,,,,,,,,,CD4,,,,,,,,
5898,Thalidomide,DB01041,Erythema nodosum leprosum,C0343467,Approved,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},,Infectious disease,,,,,,,,,,,,,,,,,,,MMADHC,,,,,,,,
9867,Atorvastatin,DB01076,Psoriasis,C0033860,Withdrawn,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Skin disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
3794,Loratadine,DB00455,Allergic rhinitis (disorder),C2607914,Approved,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1},,Immune system disease,,,,,,,,,,,,,,,,,,,APOBEC1,,,,,,,,
10831,SOCS2,C0027404,Sodium oxybate,DB09072,Narcolepsy,Approved,C(CC(=O)[O-])CO.[Na+]},,Nervous system disease,STATI2,SSI2,SOCS-2,SSI-2,CIS2,Cish2,,,,,,,,,,,,,,,,,,,,
7612,IL1B,C0011615,Triamcinolone,DB00620,"Dermatitis, Atopic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,DHPS,,,,,,,,
1415,Ceftriaxone,DB01212,Rhinoscleroma,C0035468,Approved,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Spironolactone,,,,,,,,
33119,PCLO,C0041696,Scopolamine,DB00747,Unipolar Depression,Terminated,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},Phase 2,Mental and behavioural disorder,KIAA0559,DKFZp779G1236,ACZ,,,,,,,,,,,,,,,,,,,,,,,
27958,COL1A2,C0036421,Iloprost,DB01088,Systemic Scleroderma,Terminated,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Skin disease,,,,,,,,,,,,,,,,,,,,,,,,,,
27991,ALDH2,C0014859,Fluorouracil,DB00544,Esophageal Neoplasms,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
24598,NDUFB8,C0001126,Potassium Citrate,DB09125,Renal tubular acidosis,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34398,KL,C0451641,Ciprofloxacin,DB00537,Urolithiasis,Terminated,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
23580,POU2AF1,C0020651,Midodrine,DB00211,"Hypotension, Orthostatic",Approved,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O},,Cardiovascular disease,OBF1,BOB1,,,,,,,,,,,,,,,,,,,,,,,,
27933,PARP1,C0280100,Pegfilgrastim,DB00019,Solid tumour,Withdrawn,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Cancer,PARP,PPOL,ADPRT,,,,,,,,,,,,,,,,,,,,,,,
34959,BCL6,C0032310,Hydrocortisone,DB00741,"Pneumonia, Viral",Terminated,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},Phase 3,Infectious disease,ZBTB27,LAZ3,BCL5,BCL6A,ZNF51,,,,,,,,,,,,,,,,,,,,,
15447,TNF,C0264716,Amlodipine,DB00381,Chronic heart failure,Suspended,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN},Phase 2,Cardiovascular disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
7331,HLA-DQB2,C0524909,Tenofovir,DB00300,"Hepatitis B, Chronic",Approved,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},,Infectious disease,HLA-DXB,,,,,,,,,,,,,,,,,UPP2,,,,,,,,
9259,Simvastatin,DB00641,Diabetes Mellitus,C0011849,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
7391,GDF15,C0162568,Afamelanotide,DB04931,Erythropoietic Protoporphyria,Approved,CCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N5CCC[C@H]5C(=O)N[C@@H](C(C)C)C(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CC=C(C=C6)O)NC(=O)[C@H](CO)NC(=O)C},,Congenital disorder of metabolism,PLAB,MIC-1,PDF,NAG-1,PTGFB,,,,,,,,,,,,,SOX2-OT,,,,,,,,
14786,PTPRF,C0001206,Somatostatin,DB09099,Acromegaly,Terminated,C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=CC=C6)O},Phase 2,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22190,NR3C1,C0206141,Imatinib,DB00619,Idiopathic Hypereosinophilic Syndrome,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,GR,GRL,,,,,,,,,,,,,,,,,,,,,,,,
6307,Valaciclovir,DB00577,Chickenpox,C0008049,Approved,CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N},,Infectious disease,,,,,,,,,,,,,,,,,,,PRTFDC1,,,,,,,,
25828,PSCA,C0005684,Mitomycin,DB00305,Malignant neoplasm of urinary bladder,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
25206,TP63,C0870082,Tretinoin,DB00755,Hyperkeratosis,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Skin and connective tissue disease,SHFM4,EEC3,p63,p73L,OFC8,KET,p73H,p53CP,TP73L,TP53L,TP53CP,,,,,,,,,,,,,,,
26453,TP53,C0278517,Pemetrexed,DB00642,Non-small cell lung cancer recurrent,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34927,HTR2A,C0025517,Heparin,DB01109,Metabolic Diseases,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19568,NQO1,C0278498,Panobinostat,DB06603,Malignant neoplasm of stomach stage IV,Terminated,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)/C=C/C(=O)NO},Phase 2,Cancer,DHQU,QR1,NMOR1,DIA4,,,,,,,,,,,,,,,,,,,,,,
32997,GFAP,C0017150,Romidepsin,DB06176,Gastrinoma,Terminated,C/C=C\\1/C(=O)N[C@H](C(=O)O[C@H]\\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C},Phase 2,Cancer,FLJ45472,,,,,,,,,,,,,,,,,,,,,,,,,
32792,HAMP,C0039730,Pegfilgrastim,DB00019,Thalassemia,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Hematologic disease,LEAP-1,HEPC,HFE2B,LEAP1,,,,,,,,,,,,,,,,,,,,,,
35990,ALB,C0085119,Treprostinil,DB00374,Foot Ulcer,Terminated,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,
29659,JAK2,C0279629,Vorinostat,DB02546,adult acute monoblastic leukemia (M5a),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,JTK10,,,,,,,,,,,,,,,,,,,,,,,,,
15045,RALGAPB,C0279543,Nilotinib,DB04868,Philadelphia chromosome positive chronic myelogenous leukemia,Approved,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4819,TCIRG1,C0004604,Hydromorphone,DB00327,Back Pain,Terminated,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4},Phase 3,,TIRC7,OC-116,OC116,ATP6N1C,Atp6i,a3,ATP6V0A3,,,,,,,,,,,PCNA,,,,,,,,
1606,Cilastatin,DB01597,Pelvic Inflammatory Disease,C0242172,Approved,CC1(C[C@@H]1C(=O)N/C(=C\\CCCCSC[C@@H](C(=O)O)N)/C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,ADIPOQ,,,,,,,,
28031,GFAP,C0458247,Capsaicin,DB06774,Allodynia,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,,FLJ45472,,,,,,,,,,,,,,,,,,,,,,,,,
7072,IFNA13,C0019348,Aciclovir,DB00787,Herpes Simplex Infections,Approved,C1=NC2=C(N1COCCO)N=C(NC2=O)N},,Infectious disease,0,,,,,,,,,,,,,,,,,KIR2DL1,,,,,,,,
25209,RNU4ATAC,C0870082,Tretinoin,DB00755,Hyperkeratosis,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
741,CXCR1,C0019693,Trimethoprim,DB00440,HIV Infections,Terminated,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},Phase 2/Phase 3,Infectious disease,CDw128a,CD181,CMKAR1,IL8RA,,,,,,,,,,,,,,Heroin,,,,,,,,
24328,GNAS,C1261473,Pazopanib,DB06589,Sarcoma,Approved,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33762,CTLA4,C0018133,Tacrolimus,DB00864,Graft-vs-Host Disease,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Immune system disease,CD152,CELIAC3,IDDM12,,,,,,,,,,,,,,,,,,,,,,,
20827,WIPF1,C0028734,Flavoxate,DB01148,Nocturia,Approved,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4},,Urinary system disease,WIP,WASPIP,,,,,,,,,,,,,,,,,,,,,,,,
30444,AKR1B1,C0011882,Reboxetine,DB00234,Diabetic Neuropathies,Terminated,CCOC1=CC=CC=C1O[C@@H]([C@H]2CNCCO2)C3=CC=CC=C3},Phase 2,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20139,HAX1,C0017205,Voglibose,DB04878,Gaucher Disease,Approved,C1[C@@H]([C@@H]([C@H]([C@@H]([C@]1(CO)O)O)O)O)NC(CO)CO},,Lysosomal storage disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35566,ERICD,C0017160,Ondansetron,DB00904,Gastroenteritis,Terminated,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C},Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20930,IFNG,C0085436,Flucytosine,DB01099,"Meningitis, Cryptococcal",Terminated,C1=NC(=O)NC(=C1F)N},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
12536,MVK,C0031154,Tazobactam,DB01606,Peritonitis,Approved,C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10595,RFX5,C0271429,Trimethoprim,DB00440,Acute otitis media,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1368,Ceftizoxime,DB01332,Streptococcal sepsis,C0152964,Approved,CO/N=C(/C1=CSC(=N1)N)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Saxagliptin,,,,,,,,
18878,ACE2,C0745136,Trimethaphan,DB01116,Hypertensive emergency,Approved,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1668,Ciprofloxacin,DB00537,Shigella Infections,C0013371,Approved,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,COL4A1,,,,,,,,
13195,EXTL3,C0149985,Procaine benzylpenicillin,DB09320,"Syphilis, secondary",Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12704,CD58,C0079774,Thalidomide,DB01041,Peripheral T-Cell Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4100,Methylprednisolone,DB00959,Mycosis Fungoides,C0026948,Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O},,Infectious disease,,,,,,,,,,,,,,,,,,,PRKCB,,,,,,,,
26146,STAT5B,C0032463,Uracil mustard,DB00791,Polycythemia Vera,Approved,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3580,PODXL,C0917801,Citalopram,DB00215,Sleeplessness,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,,PCLP,Gp200,PC,,,,,,,,,,,,,,,FST,,,,,,,,
31379,ATRX,C0206754,Sunitinib,DB01268,Neuroendocrine Tumors,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,XH2,XNP,RAD54,JMS,MRX52,,,,,,,,,,,,,,,,,,,,,
29249,PSAT1,C1328504,Sirolimus,DB00877,Hormone refractory prostate cancer,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11727,CHI3L1,C0428974,Aprindine,DB01429,Supraventricular arrhythmia,Approved,CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C3=CC=CC=C3},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10983,IL23A,C0006840,Voriconazole,DB00582,Candidiasis,Terminated,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,SGRF,IL23P19,IL-23,IL-23A,P19,,,,,,,,,,,,,,,,,,,,,
2850,Floctafenine,DB08976,Acute onset pain,C0184567,Approved,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC=C(C3=NC=C2)C(F)(F)F},,,,,,,,,,,,,,,,,,,,,HLA-DRA,,,,,,,,
26389,GATA3,C0235950,Zinc sulfate,DB09322,Zinc deficiency,Approved,[O-]S(=O)(=O)[O-].[Zn+2]},,Metabolic disease,HDR,,,,,,,,,,,,,,,,,,,,,,,,,
21244,TAC3,C0151721,Testosterone Propionate,DB01420,Testicular hypogonadism,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17145,BDNF,C0028768,Sertraline,DB01104,Obsessive-Compulsive Disorder,Approved,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
15482,PIK3CG,C0278488,Vinblastine,DB00570,Carcinoma breast stage IV,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30250,TP53,C0079731,Dexamethasone,DB01234,B-Cell Lymphomas,Terminated,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
6717,Omeprazole,DB00338,Dyspepsia,C0013395,Suspended,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 2,Digestive system disease,,,,,,,,,,,,,,,,,,,RTN4,,,,,,,,
2860,Fluconazole,DB00196,Septicemia candida,C0349009,Approved,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O},,Infectious disease,,,,,,,,,,,,,,,,,,,STXBP3,,,,,,,,
30712,HES1,C0206663,Vincristine,DB00541,"Neuroectodermal Tumor, Primitive",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,FLJ20408,HES-1,Hes1,bHLHb39,HRY,,,,,,,,,,,,,,,,,,,,,
899,KRAS,C0376358,Sirolimus,DB00877,Malignant neoplasm of prostate,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,Lixisenatide,,,,,,,,
33094,NR3C1,C0041696,Scopolamine,DB00747,Unipolar Depression,Terminated,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},Phase 2,Mental and behavioural disorder,GR,GRL,,,,,,,,,,,,,,,,,,,,,,,,
23739,HLA-DRB1,C0002170,Norepinephrine,DB00368,Alopecia,Terminated,C1=CC(=C(C=C1[C@H](CN)O)O)O},Phase 1,Skin disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
23680,CXCR1,C1328252,Miltefosine,DB09031,Mucocutaneous leishmaniasis,Approved,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},,Infectious disease,CDw128a,CD181,CMKAR1,IL8RA,,,,,,,,,,,,,,,,,,,,,,
27199,MIR155,C1266050,Trametinib,DB08911,Poorly Differentiated Thyroid Carcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
6283,Ulobetasol,DB00596,Lichen Simplex Chronicus,C0149922,Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,VARS2,,,,,,,,
26420,EGFR,C0278987,Pemetrexed,DB00642,Non-small cell lung cancer metastatic,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
299,Amphotericin B,DB00681,Mycotic endocarditis,C0276648,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Chlorthalidone,,,,,,,,
2673,Ergotamine,DB00696,Vascular Headaches,C0042376,Approved,C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C},,,,,,,,,,,,,,,,,,,,,GJA5,,,,,,,,
34926,DSG1,C0025517,Heparin,DB01109,Metabolic Diseases,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24506,CRP,C0003615,Ropivacaine,DB00296,Appendicitis,Terminated,CCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C},Phase 2,Other disease,,,,,,,,,,,,,,,,,,,,,,,,,,
29342,HPGDS,C1332166,Paclitaxel,DB01229,Adenocarcinoma of the gastroesophageal junction,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1/Phase 2,Cancer,GSTS,H-PGDS,PGD2,GSTS1-1,GSTS1,,,,,,,,,,,,,,,,,,,,,
14888,TXN,C0017601,Echothiophate,DB01057,Glaucoma,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35499,AGT,C0011884,Octreotide,DB00104,Diabetic Retinopathy,Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 3,Nervous system disease,SERPINA8,,,,,,,,,,,,,,,,,,,,,,,,,
35201,MFN2,C0442874,Magnesium Sulfate,DB00653,Neuropathy,Terminated,[O-]S(=O)(=O)[O-].[Mg+2]},Phase 3,Urinary system disease,CPRP1,KIAA0214,MARF,CMT2A2,,,,,,,,,,,,,,,,,,,,,,
493,Azithromycin,DB00207,Streptococcus pyogenes infection,C0554628,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Dobutamine,,,,,,,,
32932,DMD,C0003125,Quetiapine,DB01224,Anorexia Nervosa,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 2,Mental and behavioural disorder,DXS142,DXS164,DXS206,DXS230,DXS239,DXS268,DXS269,DXS270,DXS272,MRX85,,,,,,,,,,,,,,,,
24719,PLXNA2,C0029077,Triamcinolone,DB00620,"Ophthalmia, Sympathetic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18420,EPOR,C0023440,Daunorubicin,DB00694,Acute Erythroblastic Leukemia,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
25695,MMP14,C0003864,Tenoxicam,DB00469,Arthritis,Approved,CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3},,Immune system disease,MT1-MMP,,,,,,,,,,,,,,,,,,,,,,,,,
29578,ERBB3,C0007114,Fludarabine,DB01073,Malignant neoplasm of skin,Terminated,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15480,PIK3CB,C0278488,Vinblastine,DB00570,Carcinoma breast stage IV,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
28254,MMP9,C0017636,Temozolomide,DB00853,Glioblastoma,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,CLG4B,,,,,,,,,,,,,,,,,,,,,,,,,
10015,HDAC6,C0456103,Vancomycin,DB00512,Sepsis of the newborn,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,,KIAA0901,JM21,HD6,FLJ16239,PPP1R90,,,,,,,,,,,,,,,,,,,,,
20132,SMPD1,C0017205,Voglibose,DB04878,Gaucher Disease,Approved,C1[C@@H]([C@@H]([C@H]([C@@H]([C@]1(CO)O)O)O)O)NC(CO)CO},,Lysosomal storage disease,,,,,,,,,,,,,,,,,,,,,,,,,,
19788,HBEGF,C0036472,Fusidic Acid,DB02703,Scrub Typhus,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,HEGFL,DTS,DTR,,,,,,,,,,,,,,,,,,,,,,,
21412,OAS1,C0021400,Zanamivir,DB00558,Influenza,Approved,CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)O)N=C(N)N},,Infectious disease,OIASI,IFI-4,OIAS,,,,,,,,,,,,,,,,,,,,,,,
24175,HTR1B,C0036337,Olanzapine,DB00334,Schizoaffective Disorder,Withdrawn,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C},Phase 3,Mental and behavioural disorder,5-HT1B,HTR1D2,5-HT1DB,,,,,,,,,,,,,,,,,,,,,,,
8830,Melatonin,DB01065,Depressive disorder,C0011581,Terminated,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC},Phase 2/Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,
9533,CRP,C0684256,Vancomycin,DB00512,Bacterial sepsis,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
7100,TNF,C0019360,Pregabalin,DB00230,Herpes zoster disease,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,Infectious disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,SLC44A2,,,,,,,,
5986,Timolol,DB00373,Hypertensive disease,C0020538,Approved,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,GPR151,,,,,,,,
27970,PHF21A,C0036421,Iloprost,DB01088,Systemic Scleroderma,Terminated,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22460,KRIT1,C0007820,Tolazoline,DB00797,Cerebrovascular Disorders,Approved,C1CN=C(N1)CC2=CC=CC=C2},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8796,TNF,C0013295,Sucralfate,DB00364,Duodenal Ulcer,Approved,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al]},,Digestive system disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
5928,CSF3,C0015967,Ciprofloxacin,DB00537,Fever,Terminated,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},Phase 3,Infectious disease,MGC45931,GCSF,G-CSF,C17orf33,,,,,,,,,,,,,,ZNF577,,,,,,,,
13237,COCH,C0025281,Penciclovir,DB00299,Meniere Disease,Terminated,C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N},Phase 3,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29591,CSNK2A2,C0007114,Fludarabine,DB01073,Malignant neoplasm of skin,Terminated,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23905,NTS,C0039254,Niclosamide,DB06803,Teniasis,Approved,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
21148,NQO1,C2936781,Fluoxymesterone,DB01185,Generalized Myotonia of Thomsen,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F},,Musculoskeletal disease,DHQU,QR1,NMOR1,DIA4,,,,,,,,,,,,,,,,,,,,,,
15966,PON1,C0153633,Carmustine,DB00262,Malignant neoplasm of brain,Approved,C(CCl)NC(=O)N(CCCl)N=O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26879,LOC102723407,C0242647,Vincristine,DB00541,Mucosa-Associated Lymphoid Tissue Lymphoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10373,IL6,C0038363,Triamcinolone,DB00620,Aphthous Stomatitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
10400,HLA-DPA1,C0002962,Verapamil,DB00661,Angina Pectoris,Approved,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},,Cardiovascular disease,HLA-DP1A,,,,,,,,,,,,,,,,,,,,,,,,,
12989,IFNA13,C1527383,Imiquimod,DB00724,Morphea,Withdrawn,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N},Phase 3,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29687,FABP4,C0280634,Vorinostat,DB02546,adult acute monocytic leukemia (M5b),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,A-FABP,aP2,,,,,,,,,,,,,,,,,,,,,,,,
3244,Guaifenesin,DB00874,Common Cold,C0009443,Approved,COC1=CC=CC=C1OCC(CO)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SLC27A5,,,,,,,,
31882,ANGPTL8,C0362046,Losartan,DB00678,Prediabetes syndrome,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
4354,Naltrexone,DB00704,Severe pain,C0278140,Approved,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},,,,,,,,,,,,,,,,,,,,,COL4A2,,,,,,,,
13995,SERPINC1,C0027726,Triamcinolone,DB00620,Nephrotic Syndrome,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35194,GDAP1,C0442874,Magnesium Sulfate,DB00653,Neuropathy,Terminated,[O-]S(=O)(=O)[O-].[Mg+2]},Phase 3,Urinary system disease,CMT4,CMT2K,CMT4A,,,,,,,,,,,,,,,,,,,,,,,
7537,Fludarabine,DB01073,Immunologic Deficiency Syndromes,C0021051,Terminated,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 1/Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,MINDY4,,,,,,,,
15796,MTCO2P12,C0033581,Ofloxacin,DB01165,prostatitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14826,MEN1,C0020514,Cabergoline,DB00248,Hyperprolactinemia,Approved,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C},,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,
25596,TBATA,C0040560,Sulfadiazine,DB00359,"Toxoplasmosis, Congenital",Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8902,CTBP1,C0013395,Omeprazole,DB00338,Dyspepsia,Suspended,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 2,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3773,Lithium,DB01356,Fever,C0015967,Approved,[Li]},,Infectious disease,,,,,,,,,,,,,,,,,,,LIPE,,,,,,,,
24138,SNCA,C0005697,Oxybutynin,DB01062,Neurogenic Urinary Bladder,Approved,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O},,Urinary system disease,NACP,PARK1,PARK4,,,,,,,,,,,,,,,,,,,,,,,
17272,CTNND1,C0007780,Warfarin,DB00682,Cerebral Embolism,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Vascular disease,KIAA0384,p120cas,p120ctn,CTNND,,,,,,,,,,,,,,,,,,,,,,
4818,Pentosan Polysulfate,DB00686,Interstitial Cystitis,C0282488,Approved,C1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2CO[C@H]([C@@H]([C@H]2OS(=O)(=O)O)OS(=O)(=O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)O},,Urinary system disease,,,,,,,,,,,,,,,,,,,NRARP,,,,,,,,
8530,ACE,C0030319,Venlafaxine,DB00285,Panic Disorder,Approved,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O},,Mental and behavioural disorder,ACE1,CD143,DCP1,,,,,,,,,,,,,,,,,,,,,,,
1297,Ceftazidime,DB00438,Enterobacter pneumonia,C1096258,Approved,CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,Prucalopride,,,,,,,,
12609,DNAH5,C0027430,Beclomethasone dipropionate,DB00394,Nasal Polyps,Approved,CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2312,Dicoumarol,DB00266,Thromboembolism,C0040038,Approved,C1=CC=C2C(=C1)C(=C(C(=O)O2)CC3=C(C4=CC=CC=C4OC3=O)O)O},,Hematologic disease,,,,,,,,,,,,,,,,,,,DNMT1,,,,,,,,
14855,LRP1B,C0026603,Scopolamine,DB00747,Motion Sickness,Approved,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7711,CYBB,C0024138,Ulobetasol,DB00596,"Lupus Erythematosus, Discoid",Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Immune system disease,GP91-PHOX,NOX2,CGD,,,,,,,,,,,,,,,ZNF148,,,,,,,,
2878,Fluocinolone Acetonide,DB00591,Chloasma,C0025218,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@@]53C)F)F)O},,Skin disease,,,,,,,,,,,,,,,,,,,ZNRD1,,,,,,,,
27269,IGF1R,C0281508,Vitamin C,DB00126,Desmoplastic Small Round Cell Tumor,Suspended,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O},Phase 2,Cancer,JTK13,CD221,IGFIR,MGC18216,IGFR,,,,,,,,,,,,,,,,,,,,,
15650,ADCY9,C0014547,Primidone,DB00794,"Epilepsies, Partial",Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
992,Cefadroxil,DB01140,Tonsillitis,C0040425,Approved,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)SC1)C(=O)O},,,,,,,,,,,,,,,,,,,,,Methotrexate,,,,,,,,
16568,PTH,C0238052,Cholic Acid,DB02659,"Xanthomatosis, Cerebrotendinous",Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,
13244,AQP4,C0025281,Penciclovir,DB00299,Meniere Disease,Terminated,C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N},Phase 3,Nervous system disease,MIWC,,,,,,,,,,,,,,,,,,,,,,,,,
28625,ACE,C1565489,Simeprevir,DB06290,Renal Insufficiency,Withdrawn,CC1=C(C=CC2=C1N=C(C=C2O[C@@H]3C[C@@H]4[C@@H](C3)C(=O)N(CCCC/C=C\\[C@@H]5C[C@]5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC},Phase 2,Endocrine disease,ACE1,CD143,DCP1,,,,,,,,,,,,,,,,,,,,,,,
13897,CREBBP,C0024305,Vidarabine,DB00194,"Lymphoma, Non-Hodgkin",Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13425,C4B,C0004364,Triamcinolone,DB00620,Autoimmune Diseases,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,CPAMD3,C4F,C4B1,C4B3,CH,,,,,,,,,,,,,,,,,,,,,
34138,ACE,C1960870,Cyclobenzaprine,DB00924,Transformed migraine,Terminated,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31},Phase 3,Nervous system disease,ACE1,CD143,DCP1,,,,,,,,,,,,,,,,,,,,,,,
9021,Fluoxetine,DB00472,Cerebral Hemorrhage,C2937358,Terminated,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F},Phase 3,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
25321,GNAQ,C0037299,Sulfadiazine,DB00359,Skin Ulcer,Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4840,Phenindamine,DB01619,Allergic Conjunctivitis,C0009766,Approved,CN1CCC2=C(C1)C(C3=CC=CC=C23)C4=CC=CC=C4},,Immune system disease,,,,,,,,,,,,,,,,,,,NT5C2,,,,,,,,
33983,AKR1B1,C0035222,Salbutamol,DB01001,"Respiratory Distress Syndrome, Adult",Terminated,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O},Phase 2/Phase 3,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15068,PPM1K,C0013428,Phenazopyridine,DB01438,Dysuria,Approved,C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25843,MTHFR,C0005684,Mitomycin,DB00305,Malignant neoplasm of urinary bladder,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3371,Hydrocortisone,DB00741,Otitis Externa,C0029878,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,PLA2G4B,,,,,,,,
7492,IL2RA,C0338437,Albendazole,DB00518,Neurocysticercosis,Approved,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC},,Infectious disease,IL2R,IDDM10,,,,,,,,,,,,,,,,MIRLET7D,,,,,,,,
23645,FLI1,C0023283,Fluconazole,DB00196,"Leishmaniasis, Cutaneous",Terminated,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O},Phase 3,Infectious disease,SIC-1,,,,,,,,,,,,,,,,,,,,,,,,,
24040,AFP,C0024586,Somatostatin,DB09099,Malignant Carcinoid Syndrome,Terminated,C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=CC=C6)O},Phase 2,Cancer,FETA,HPAFP,,,,,,,,,,,,,,,,,,,,,,,,
6319,Vancomycin,DB00512,Arthropathy associated with infection,C0157749,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Immune system disease,,,,,,,,,,,,,,,,,,,LHFPL6,,,,,,,,
30527,TP53,C0206698,Oxaliplatin,DB00526,Cholangiocarcinoma,Withdrawn,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13367,ERAP1,C0038013,Triamcinolone,DB00620,Ankylosing spondylitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27976,CSF1,C0036421,Iloprost,DB01088,Systemic Scleroderma,Terminated,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15543,TLR4,C0027796,Pregabalin,DB00230,Neuralgia,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,Nervous system disease,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,,,,,,,,,
34947,TNF,C0025517,Heparin,DB01109,Metabolic Diseases,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Endocrine and metabolic disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
34276,CRP,C0242339,Simvastatin,DB00641,Dyslipidemias,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
10104,TSLP,C0004096,Zafirlukast,DB00549,Asthma,Approved,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC},,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
27290,IL15,C0281508,Vitamin C,DB00126,Desmoplastic Small Round Cell Tumor,Suspended,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
22290,CRP,C0035435,Indomethacin,DB00328,Rheumatism,Approved,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
11079,PTH,C0019655,Ketoconazole,DB01026,Histoplasmosis,Approved,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
28884,PWAR4,C0278493,Tamoxifen,DB00675,Breast cancer recurrent,Withdrawn,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19330,HFE,C0002395,Rivastigmine,DB00989,Alzheimer's Disease,Approved,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C},,Neurodegenerative disease,HLA-H,,,,,,,,,,,,,,,,,,,,,,,,,
1251,Cefprozil,DB01150,Acute otitis media,C0271429,Approved,C/C=C/C1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Potassium Iodide,,,,,,,,
11719,SYNE1,C0428974,Aprindine,DB01429,Supraventricular arrhythmia,Approved,CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C3=CC=CC=C3},,Cardiovascular disease,SYNE-1B,KIAA0796,8B,Nesprin-1,enaptin,MYNE1,CPG2,dJ45H2.2,SCAR8,ARCA1,Nesp1,C6orf98,,,,,,,,,,,,,,
751,Biperiden,DB00810,Parkinsonian Disorders,C0242422,Approved,C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O},,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,Hydrocortisone,,,,,,,,
27759,CCND1,C0023418,Vincristine,DB00541,leukemia,Withdrawn,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16117,UGT1A9,C0008350,Ursodeoxycholic acid,DB01586,Cholelithiasis,Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31595,OCLN,C0035309,Finasteride,DB01216,Retinal Diseases,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},Phase 2,Nervous system disease,PPP1R115,,,,,,,,,,,,,,,,,,,,,,,,,
9513,TLR9,C0242429,Pheniramine,DB01620,Sore Throat,Approved,CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2},,Infectious disease,CD289,,,,,,,,,,,,,,,,,,,,,,,,,
20829,NPEPPS,C0028734,Flavoxate,DB01148,Nocturia,Approved,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33747,CXCL10,C0006272,Cyclosporine,DB00091,Bronchiolitis Obliterans,Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 2/Phase 3,Respiratory disease,IFI10,IP-10,crg-2,mob-1,C7,gIP-10,INP10,SCYB10,,,,,,,,,,,,,,,,,,
12944,FOXP3,C0011633,Benzoic Acid,DB03793,Dermatomyositis,Approved,C1=CC=C(C=C1)C(=O)O},,Musculoskeletal disease,JM2,XPID,AIID,PIDX,DIETER,SCURFIN,IPEX,,,,,,,,,,,,,,,,,,,
9484,CCN2,C2973725,Treprostinil,DB00374,Pulmonary arterial hypertension,Approved,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25352,FLAD1,C0751753,Sodium phenylbutyrate,DB06819,Carbamoyl-Phosphate Synthase I Deficiency Disease,Approved,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2602,Enalapril,DB00584,Congestive heart failure,C0018802,Approved,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O},,Congenital malformation,,,,,,,,,,,,,,,,,,,MECP2,,,,,,,,
1385,Ceftriaxone,DB01212,Escherichia coli septicemia,C0276088,Approved,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SLC17A5,,,,,,,,
25956,TGFB3,C0162810,Tranilast,DB07615,"Cicatrix, Hypertrophic",Approved,COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
36008,NTN1,C0085119,Treprostinil,DB00374,Foot Ulcer,Terminated,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},Phase 3,,NTN1L,,,,,,,,,,,,,,,,,,,,,,,,,
17949,LIN28B,C0027819,Topotecan,DB01030,Neuroblastoma,Withdrawn,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
5076,Pramocaine,DB09345,Hemorrhoids,C0019112,Approved,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2},,,,,,,,,,,,,,,,,,,,,TNNI3,,,,,,,,
16325,SLC6A19,C0017574,Chlorhexidine,DB00878,Gingivitis,Approved,C1=CC(=CC=C1N/C(=N/C(=NCCCCCCN=C(/N=C(/NC2=CC=C(C=C2)Cl)\\N)N)N)/N)Cl},,,,,,,,,,,,,,,,,,,,,,,,,,,,
27690,GAD1,C1533217,Methamphetamine,DB01577,Methamphetamine dependence,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 1,Mental and behavioural disorder,GAD,,,,,,,,,,,,,,,,,,,,,,,,,
9292,GCH1,C0015371,Trihexyphenidyl,DB00376,Extrapyramidal Disorders,Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4476,Norfloxacin,DB01059,Arthropathy associated with infection,C0157749,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,ZFPM1,,,,,,,,
7729,IFNA1,C0024138,Ulobetasol,DB00596,"Lupus Erythematosus, Discoid",Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Immune system disease,0,,,,,,,,,,,,,,,,,MIR28,,,,,,,,
14879,CPAMD8,C0017601,Echothiophate,DB01057,Glaucoma,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
443,Atorvastatin,DB01076,Hypertriglyceridemia,C0020557,Approved,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},,Metabolic disease,,,,,,,,,,,,,,,,,,,Dexbrompheniramine,,,,,,,,
26422,CD274,C0278987,Pemetrexed,DB00642,Non-small cell lung cancer metastatic,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,B7-H,B7H1,PD-L1,PDL1,B7-H1,PDCD1LG1,,,,,,,,,,,,,,,,,,,,
13472,GCLM,C0005138,Triamcinolone,DB00620,Berylliosis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6803,OLIG2,C0033975,Triflupromazine,DB00508,Psychotic Disorders,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F},,Mental and behavioural disorder,RACK17,OLIGO2,bHLHe19,PRKCBP2,BHLHB1,,,,,,,,,,,,,CSNK1E,,,,,,,,
9844,Cholecalciferol,DB00169,Hypercalcemia,C0020437,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 2/Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
5171,Prednisolone,DB00860,Laryngeal Edema,C0023052,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,,,,,,,,,,,,,,,,,,,,RAB40B,,,,,,,,
16513,GSN,C0029456,Calcium carbonate,DB06724,Osteoporosis,Withdrawn,C(=O)([O-])[O-].[Ca+2]},Phase 3,Musculoskeletal disease,DKFZp313L0718,,,,,,,,,,,,,,,,,,,,,,,,,
28905,BRAF,C0279680,Metronidazole,DB00916,Transitional cell carcinoma of bladder,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,BRAF1,,,,,,,,,,,,,,,,,,,,,,,,,
23564,ABCB1,C0020651,Midodrine,DB00211,"Hypotension, Orthostatic",Approved,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O},,Cardiovascular disease,P-gp,CD243,GP170,ABC20,PGY1,CLCS,,,,,,,,,,,,,,,,,,,,
28429,HBA1,C1292772,Sunitinib,DB01268,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,HBA-T3,,,,,,,,,,,,,,,,,,,,,,,,,
29669,AURKB,C0279629,Vorinostat,DB02546,adult acute monoblastic leukemia (M5a),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,Aik2,IPL1,AurB,ARK2,STK5,PPP1R48,STK12,,,,,,,,,,,,,,,,,,,
2890,Fluocinolone Acetonide,DB00591,Scalp psoriasis,C0406326,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@@]53C)F)F)O},,Immune system disease,,,,,,,,,,,,,,,,,,,CHST3,,,,,,,,
36069,RGR,C0035334,Unoprostone,DB06826,Retinitis Pigmentosa,Terminated,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},Phase 3,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21601,KCNJ11,C0020615,Glucagon recombinant,DB00040,Hypoglycemia,Approved,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CNC=N7)N)O},,Endocrine disease,Kir6.2,BIR,,,,,,,,,,,,,,,,,,,,,,,,
11052,IL10,C0018081,Tetracycline,DB00759,Gonorrhea,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
24326,WT1,C1261473,Pazopanib,DB06589,Sarcoma,Approved,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N},,Cancer,WIT-2,AWT1,NPHS4,GUD,,,,,,,,,,,,,,,,,,,,,,
27626,RETN,C0524620,Topiramate,DB00273,Metabolic Syndrome X,Suspended,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Endocrine and metabolic disease,FIZZ3,ADSF,RETN1,,,,,,,,,,,,,,,,,,,,,,,
2304,Diclofenamide,DB01144,Angle Closure Glaucoma,C0017605,Approved,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N},,Nervous system disease,,,,,,,,,,,,,,,,,,,Azacitidine,,,,,,,,
23976,DKK1,C0010418,Nitazoxanide,DB00507,Cryptosporidiosis,Approved,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]},,Infectious disease,SK,DKK-1,,,,,,,,,,,,,,,,,,,,,,,,
19815,KCNA5,C0235480,Propafenone,DB01182,Paroxysmal atrial fibrillation,Approved,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O},,,Kv1.5,HPCN1,,,,,,,,,,,,,,,,,,,,,,,,
21306,CD48,C0155880,Zileuton,DB00744,Intrinsic asthma,Approved,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O},,Immune system disease,BLAST,mCD48,hCD48,SLAMF2,BCM1,,,,,,,,,,,,,,,,,,,,,
19975,BDKRB2,C0019243,Stanozolol,DB06718,"Angioedemas, Hereditary",Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(CC5=C(C4)NN=C5)C},,Skin and connective tissue disease,BK-2,,,,,,,,,,,,,,,,,,,,,,,,,
23909,PPARG,C0038525,Deferoxamine,DB00746,Subarachnoid Hemorrhage,Terminated,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O},Phase 0,,PPARG1,PPARG2,NR1C3,PPARgamma,,,,,,,,,,,,,,,,,,,,,,
10310,GPD1L,C0042510,Metoprolol,DB00264,Ventricular Fibrillation,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
35784,ABCC8,C0730345,Rimonabant,DB06155,Microalbuminuria,Terminated,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl},Phase 3,Urinary system disease,PHHI,SUR1,ABC36,HHF1,TNDM2,SUR,HRINS,,,,,,,,,,,,,,,,,,,
25136,IL33,C0730607,Roflumilast,DB01656,Severe chronic obstructive pulmonary disease,Approved,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F},,Lung disease,DVS27,DKFZp586H0523,NF-HEV,IL1F11,C9orf26,,,,,,,,,,,,,,,,,,,,,
26642,STAT3,C0854750,Trametinib,DB08911,Colorectal cancer recurrent,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 1/Phase 2,Cancer,APRF,,,,,,,,,,,,,,,,,,,,,,,,,
35176,LDLR,C0947751,Linagliptin,DB08882,Vascular inflammations,Terminated,CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C},Phase 3,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11732,KCNQ1,C0085612,Tocainide,DB01056,Ventricular arrhythmia,Approved,CC1=C(C(=CC=C1)C)NC(=O)C(C)N},,Cardiovascular disease,Kv7.1,KCNA8,KVLQT1,JLNS1,LQT1,LQT,KCNA9,,,,,,,,,,,,,,,,,,,
5460,Ritodrine,DB00867,Premature Obstetric Labor,C0022876,Approved,C[C@@H]([C@@H](C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O},,,,,,,,,,,,,,,,,,,,,NDUFB8,,,,,,,,
28711,MLH1,C0009404,Sorafenib,DB00398,Colorectal Neoplasms,Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
31708,LEPR,C0021359,Ganirelix,DB06785,Infertility,Withdrawn,CCNC(=NCCCC[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C)NCC},Phase 3,Reproductive system disease,OBR,CD295,,,,,,,,,,,,,,,,,,,,,,,,
28225,CXCR4,C0153676,Ifosfamide,DB01181,Secondary malignant neoplasm of lung,Terminated,C1CN(P(=O)(OC1)NCCCl)CCCl},Phase 1,Cancer,LESTR,NPY3R,HM89,NPYY3R,D2S201E,fusin,HSY3RR,CD184,,,,,,,,,,,,,,,,,,
1298,Ceftazidime,DB00438,Enterobacteriaceae Infections,C0014347,Approved,CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,Prussian blue,,,,,,,,
17721,SLC6A8,C0033246,Mesalazine,DB00244,Proctitis,Terminated,C1=CC(=C(C=C1N)C(=O)O)O},Phase 3,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33711,CYP2E1,C0040332,Nicotine,DB00184,Tobacco Dependence,Terminated,CN1CCC[C@H]1C2=CN=CC=C2},Phase 3,Mental and behavioural disorder,CYP2E,,,,,,,,,,,,,,,,,,,,,,,,,
20333,TP53,C0023827,Trabectedin,DB05109,liposarcoma,Approved,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17186,CPLX1,C0014550,Stiripentol,DB09118,"Epilepsies, Myoclonic",Approved,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O},,Nervous system disease,CPX-I,,,,,,,,,,,,,,,,,,,,,,,,,
11068,NOD2,C0018081,Tetracycline,DB00759,Gonorrhea,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,BLAU,PSORAS1,CLR16.3,NLRC2,IBD1,CARD15,,,,,,,,,,,,,,,,,,,,
17938,CDK4,C0024299,Pegfilgrastim,DB00019,Lymphoma,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
7784,PRKCQ,C0079773,Belinostat,DB05015,"Lymphoma, T-Cell, Cutaneous",Terminated,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)/C=C/C(=O)NO},Phase 2,Cancer,,,,,,,,,,,,,,,,,,C1QTNF7-AS1,,,,,,,,
18153,CCND1,C0553580,Vincristine,DB00541,Ewings sarcoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2798,Famotidine,DB00927,Gastric ulcer,C0038358,Approved,C1=C(N=C(S1)N=C(N)N)CSCC/C(=N/S(=O)(=O)N)/N},,Digestive system disease,,,,,,,,,,,,,,,,,,,HMGN4,,,,,,,,
15844,B3GNT2,C0018213,Carbimazole,DB00389,Graves Disease,Approved,CCOC(=O)N1C=CN(C1=S)C},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20267,GC,C0042870,Ergocalciferol,DB00153,Vitamin D Deficiency,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,VDBP,hDBP,,,,,,,,,,,,,,,,,,,,,,,,
34654,TH,C0342687,Norepinephrine,DB00368,dopamine beta hydroxylase deficiency,Terminated,C1=CC(=C(C=C1[C@H](CN)O)O)O},Phase 3,Nervous system disease,DYT5b,,,,,,,,,,,,,,,,,,,,,,,,,
29526,DHDDS,C0278502,Fluorouracil,DB00544,recurrent gastric cancer,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4841,Phenindamine,DB01619,Allergic rhinitis (disorder),C2607914,Approved,CN1CCC2=C(C1)C(C3=CC=CC=C23)C4=CC=CC=C4},,Immune system disease,,,,,,,,,,,,,,,,,,,HNRNPD,,,,,,,,
20528,BMP4,C0014869,Omeprazole,DB00338,Peptic Esophagitis,Approved,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},,Digestive system disease,BMP2B,,,,,,,,,,,,,,,,,,,,,,,,,
11827,SHANK1,C0004352,Risperidone,DB00734,Autistic Disorder,Approved,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
25869,PKD2,C0085413,Tolvaptan,DB06212,"Polycystic Kidney, Autosomal Dominant",Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Congenital malformation,PKD4,Pc-2,TRPP2,,,,,,,,,,,,,,,,,,,,,,,
22475,VEGFA,C0034734,Moxisylyte,DB09205,Raynaud Disease,Approved,CC1=CC(=C(C=C1OC(=O)C)C(C)C)OCCN(C)C},,Cardiovascular disease,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
14167,CD46,C0039503,Ketoprofen,DB01009,Tendinitis,Terminated,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O},Phase 3,Musculoskeletal disease,TRA2.10,MGC26544,MIC10,,,,,,,,,,,,,,,,,,,,,,,
2802,Famotidine,DB00927,Zollinger-Ellison syndrome,C0043515,Approved,C1=C(N=C(S1)N=C(N)N)CSCC/C(=N/S(=O)(=O)N)/N},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,RFC2,,,,,,,,
27475,VHL,C1333015,Vincristine,DB00541,Childhood Kidney Wilms Tumor,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33424,NAT2,C0013221,Triptorelin,DB06825,Drug toxicity,Terminated,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
34498,IL17A,C0037278,Vancomycin,DB00512,"Skin Diseases, Infectious",Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
17118,MTHFR,C0021361,Clomifene,DB00882,Female infertility,Approved,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\Cl)/C3=CC=CC=C3},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17129,CACNA2D2,C0021361,Clomifene,DB00882,Female infertility,Approved,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\Cl)/C3=CC=CC=C3},,Reproductive system disease,KIAA0558,,,,,,,,,,,,,,,,,,,,,,,,,
4792,HGD,C0004604,Hydromorphone,DB00327,Back Pain,Terminated,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4},Phase 3,,HGO,AKU,,,,,,,,,,,,,,,,ARID5B,,,,,,,,
6112,Triamcinolone,DB00620,Aphthous Stomatitis,C0038363,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,,,,,,,,,,,,,,,,,,,DOCK11,,,,,,,,
37060,XIAP,C1168198,Propranolol,DB00571,Recurrent respiratory papillomatosis,Withdrawn,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},Phase 2/Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27528,MYBPC3,C0878544,Milrinone,DB00235,Cardiomyopathies,Suspended,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2},Phase 3,Cardiovascular disease,MYBP-C,CMH4,,,,,,,,,,,,,,,,,,,,,,,,
2664,Ergocalciferol,DB00153,"Osteoporosis, Postmenopausal",C0029458,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,AMER1,,,,,,,,
11289,IL6,C0032285,Simvastatin,DB00641,Pneumonia,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Infectious disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
27403,F5,C0852036,Magnesium Sulfate,DB00653,Pregnancy associated hypertension,Suspended,[O-]S(=O)(=O)[O-].[Mg+2]},Phase 2/Phase 3,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
24906,GC,C0041318,Pyrazinamide,DB00339,"Tuberculosis, Meningeal",Approved,C1=CN=C(C=N1)C(=O)N},,Infectious disease,VDBP,hDBP,,,,,,,,,,,,,,,,,,,,,,,,
1736,Clevidipine,DB04920,Hypertensive disease,C0020538,Approved,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,COL11A1,,,,,,,,
29183,PTGS1,C0278878,Irinotecan,DB00762,adult glioblastoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,PGHS-1,PTGHS,,,,,,,,,,,,,,,,,,,,,,,,
35613,OGG1,C0024121,Pemetrexed,DB00642,Lung Neoplasms,Terminated,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
24604,VIPAS39,C0001126,Potassium Citrate,DB09125,Renal tubular acidosis,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36457,DAB2,C0862312,Pemetrexed,DB00642,"Epithelioid mesothelioma, malignant",Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,DOC-2,,,,,,,,,,,,,,,,,,,,,,,,,
9357,Methyltestosterone,DB06710,Hypertensive disease,C0020538,Withdrawn,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C},Phase 0,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
12928,HLA-DPB1,C0011633,Benzoic Acid,DB03793,Dermatomyositis,Approved,C1=CC=C(C=C1)C(=O)O},,Musculoskeletal disease,HLA-DP1B,,,,,,,,,,,,,,,,,,,,,,,,,
19424,MAPT,C0235063,Doxapram,DB00561,Respiratory Depression,Approved,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4},,Lung disease,MTBT1,tau,PPND,FTDP-17,TAU,MSTD,MTBT2,FLJ31424,MGC138549,PPP1R103,DDPAC,MAPTL,,,,,,,,,,,,,,
31966,CDX2,C1368898,Ifosfamide,DB01181,Adult teratoma,Terminated,C1CN(P(=O)(OC1)NCCCl)CCCl},Phase 2,Cancer,CDX3,,,,,,,,,,,,,,,,,,,,,,,,,
36955,H3P40,C0279084,Sunitinib,DB01268,Kaposi's sarcoma classical type,Withdrawn,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26961,TP53,C0349632,Vincristine,DB00541,Splenic Marginal Zone B-Cell Lymphoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13779,FAS,C0019829,Tacrolimus,DB00864,Hodgkin Disease,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2,Cancer,CD95,APO-1,FAS1,APT1,TNFRSF6,,,,,,,,,,,,,,,,,,,,,
22631,EGF,C0036992,Glucagon recombinant,DB00040,Short Bowel Syndrome,Terminated,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CNC=N7)N)O},Phase 1/Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,
16282,ADH1B,C0236663,Diazepam,DB00829,Alcohol withdrawal syndrome,Approved,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
18949,COL9A2,C0409959,Diclofenac,DB00586,"Osteoarthritis, Knee",Approved,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20172,NRG1,C0018802,Levosimendan,DB00922,Congestive heart failure,Approved,C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N},,Congenital malformation,HRG,NDF,GGF,NRG1-IT2,,,,,,,,,,,,,,,,,,,,,,
32963,SLC7A7,C0549399,Simvastatin,DB00641,Low density lipoprotein increased,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Metabolic disease,y+LAT-1,LPI,,,,,,,,,,,,,,,,,,,,,,,,
11504,GATA6,C0014121,Vancomycin,DB00512,Bacterial Endocarditis,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
21093,HOXD13,C0010417,Testosterone Propionate,DB01420,Cryptorchidism,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
14946,OPRK1,C0524662,Naloxone,DB01183,Opiate Addiction,Approved,C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O},,Mental and behavioural disorder,KOR,OPRK,,,,,,,,,,,,,,,,,,,,,,,,
28807,CEBPE,C0023452,Vincristine,DB00541,"Leukemia, Lymphocytic, Acute, L1",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4269,RNU4ATAC,C0003862,Salicylic acid,DB00936,Arthralgia,Approved,C1=CC=C(C(=C1)C(=O)O)O},,Immune system disease,0,,,,,,,,,,,,,,,,,LRAT,,,,,,,,
1577,Cholic Acid,DB02659,Delta-4-3-oxosteroid-5-beta-reductase deficiency,C0342827,Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,Udenafil,,,,,,,,
26227,OAT,C0023381,Vinblastine,DB00570,Letterer-Siwe Disease,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12940,MORC3,C0011633,Benzoic Acid,DB03793,Dermatomyositis,Approved,C1=CC=C(C=C1)C(=O)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22063,MMP9,C0019357,Vidarabine,DB00194,"Keratitis, Herpetic",Approved,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},,Infectious disease,CLG4B,,,,,,,,,,,,,,,,,,,,,,,,,
25736,PROP1,C0020635,Testosterone,DB00624,Hypopituitarism,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18696,IL23R,C0042165,Tobramycin,DB00684,Anterior uveitis,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
35917,RAF1,C0235974,Sunitinib,DB01268,Pancreatic carcinoma,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16336,STAT3,C0017574,Chlorhexidine,DB00878,Gingivitis,Approved,C1=CC(=CC=C1N/C(=N/C(=NCCCCCCN=C(/N=C(/NC2=CC=C(C=C2)Cl)\\N)N)N)/N)Cl},,,APRF,,,,,,,,,,,,,,,,,,,,,,,,,
12586,COMT,C0600142,Testosterone,DB00624,Hot flushes,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
2191,Dexamethasone,DB01234,Exanthema,C0015230,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Cidofovir,,,,,,,,
2232,Dexamethasone,DB01234,Thyroiditis,C0040147,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Endocrine disease,,,,,,,,,,,,,,,,,,,F9,,,,,,,,
18772,RAN,C0022548,Triamcinolone,DB00620,Keloid,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1492,Chenodeoxycholic acid,DB06777,Cholelithiasis,C0008350,Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C},,Digestive system disease,,,,,,,,,,,,,,,,,,,Thiopental,,,,,,,,
35413,IL17A,C1720830,Mycophenolic acid,DB01024,Painful Bladder Syndrome,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
7394,BCL2L11,C1960925,Osimertinib,DB09330,Epidermal growth factor receptor positive non-small cell lung cancer,Approved,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC},,Cancer,0,,,,,,,,,,,,,,,,,CCDC115,,,,,,,,
26630,CEACAM3,C0854750,Trametinib,DB08911,Colorectal cancer recurrent,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27523,ABCC8,C0332890,Vincristine,DB00541,Congenital hemihypertrophy,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Congenital malformation,PHHI,SUR1,ABC36,HHF1,TNDM2,SUR,HRINS,,,,,,,,,,,,,,,,,,,
23861,NUP214,C1961099,Nelarabine,DB01280,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,Approved,COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
18556,ENTPD1,C0282193,Deferasirox,DB01609,Iron Overload,Withdrawn,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O},Phase 2,Mitochondrial disease,NTPDase-1,ATPDase,SPG64,CD39,,,,,,,,,,,,,,,,,,,,,,
9835,SFTPA2,C0949083,Vitamin E,DB00163,Nosocomial pneumonia,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22960,NPR3,C0267509,Lubiprostone,DB01046,Chronic idiopathic constipation,Approved,CCCCC([C@]1(CC[C@H]2[C@H](O1)CC(=O)[C@@H]2CCCCCCC(=O)O)O)(F)F},,Digestive system disease,FLJ14054,NPRC,ANPRC,C5orf23,,,,,,,,,,,,,,,,,,,,,,
895,Canagliflozin,DB08907,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,Approved,CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F},,Endocrine disease,,,,,,,,,,,,,,,,,,,Lisdexamfetamine,,,,,,,,
27639,AGT,C0524620,Topiramate,DB00273,Metabolic Syndrome X,Suspended,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Endocrine and metabolic disease,SERPINA8,,,,,,,,,,,,,,,,,,,,,,,,,
9591,KRT19,C0008311,Sulbactam,DB09324,Cholangitis,Approved,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C},,Digestive system disease,K19,CK19,K1CS,MGC15366,,,,,,,,,,,,,,,,,,,,,,
18453,KMT2A,C0023465,Daunorubicin,DB00694,Acute monocytic leukemia,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
20525,F11R,C0014869,Omeprazole,DB00338,Peptic Esophagitis,Approved,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},,Digestive system disease,PAM-1,JCAM,JAM-1,JAM-A,JAMA,CD321,JAM1,,,,,,,,,,,,,,,,,,,
7844,PTEN,C0007131,Carboplatin,DB00958,Non-Small Cell Lung Carcinoma,Withdrawn,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2]},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,ATHS,,,,,,,,
27761,WT1,C0023418,Vincristine,DB00541,leukemia,Withdrawn,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,WIT-2,AWT1,NPHS4,GUD,,,,,,,,,,,,,,,,,,,,,,
5985,Timolol,DB00373,"Glaucoma, Open-Angle",C0017612,Approved,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O},,Nervous system disease,,,,,,,,,,,,,,,,,,,MRGPRX4,,,,,,,,
4559,Ofloxacin,DB01165,Acute bacterial sinusitis,C0275556,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SLC4A4,,,,,,,,
20872,FES,C0184567,Floctafenine,DB08976,Acute onset pain,Approved,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC=C(C3=NC=C2)C(F)(F)F},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
8204,BAIAP2,C0003868,Triamcinolone,DB00620,"Arthritis, Gouty",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22444,NOTCH3,C0007820,Tolazoline,DB00797,Cerebrovascular Disorders,Approved,C1CN=C(N1)CC2=CC=CC=C2},,Cardiovascular disease,CASIL,CADASIL,,,,,,,,,,,,,,,,,,,,,,,,
6219,Trimethoprim,DB00440,Shigella Infections,C0013371,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,,,,,,,,,,,,,,,,,,,FOXN1,,,,,,,,
29574,AQP3,C0007114,Fludarabine,DB01073,Malignant neoplasm of skin,Terminated,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 1/Phase 2,Cancer,GIL,,,,,,,,,,,,,,,,,,,,,,,,,
25669,EGFR,C0334579,Valproic Acid,DB00313,Anaplastic astrocytoma,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
5740,Sulfisoxazole,DB00263,Urinary tract infection,C0042029,Approved,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,RNF165,,,,,,,,
26891,CDR3,C0242647,Vincristine,DB00541,Mucosa-Associated Lymphoid Tissue Lymphoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13587,MST1,C0010346,Naltrexone,DB00704,Crohn Disease,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10276,RNF34,C0041327,Streptomycin,DB01082,"Tuberculosis, Pulmonary",Approved,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6186,Triethylenetetramine,DB06824,Hepatolenticular Degeneration,C0019202,Approved,C(CNCCNCCN)N},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,CNGB1,,,,,,,,
16927,IL6,C0085166,Tinidazole,DB00911,Bacterial Vaginosis,Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Infectious disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
34003,ACE,C0267446,Zinc sulfate,DB09322,Acute gastroenteritis,Terminated,[O-]S(=O)(=O)[O-].[Zn+2]},Phase 2/Phase 3,Digestive system disease,ACE1,CD143,DCP1,,,,,,,,,,,,,,,,,,,,,,,
8823,IL1B,C0013395,Omeprazole,DB00338,Dyspepsia,Suspended,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 2,Digestive system disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
5513,Salicylic acid,DB00936,Plantar wart,C0042548,Approved,C1=CC=C(C(=C1)C(=O)O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,ADD3,,,,,,,,
26516,CTNNB1,C0235782,Oxaliplatin,DB00526,Gallbladder Carcinoma,Suspended,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 1,Cancer,beta-catenin,armadillo,CTNNB,,,,,,,,,,,,,,,,,,,,,,,
28692,CDH1,C0009404,Sorafenib,DB00398,Colorectal Neoplasms,Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,uvomorulin,CD324,UVO,,,,,,,,,,,,,,,,,,,,,,,
5982,Tigecycline,DB00560,Intraabdominal Infections,C1112209,Approved,CC(C)(C)NCC(=O)NC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,MIB1,,,,,,,,
18195,TRIP13,C0027708,Vincristine,DB00541,Nephroblastoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
7183,EEFSEC,C0024117,Salmeterol,DB00938,Chronic Obstructive Airway Disease,Withdrawn,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O},Phase 3,Lung disease,0,,,,,,,,,,,,,,,,,PURA,,,,,,,,
34033,OXT,C0018681,Naratriptan,DB00952,Headache,Withdrawn,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
19131,MAPK8,C0002438,Sulfacetamide,DB00634,Amebiasis,Approved,CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N},,Infectious disease,JNK,JNK1,SAPK1,PRKM8,,,,,,,,,,,,,,,,,,,,,,
20190,FCGR2A,C0002792,Epinephrine,DB00668,anaphylaxis,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Immune system disease,CD32A,IGFR2,CDw32,FCGR2A1,,,,,,,,,,,,,,,,,,,,,,
16880,KRT20,C0023443,Pentostatin,DB00552,Hairy Cell Leukemia,Approved,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O},,Cancer,CK20,K20,MGC35423,,,,,,,,,,,,,,,,,,,,,,,
31422,SIGMAR1,C3873567,Erythropoietin,DB00016,Chemotherapy-induced peripheral neuropathy,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
24928,PNPO,C1849508,Pyridoxine,DB00165,"EPILEPSY, PYRIDOXINE-DEPENDENT",Approved,CC1=NC=C(C(=C1O)CO)CO},,Nervous system disease,PDXPO,,,,,,,,,,,,,,,,,,,,,,,,,
24499,HLA-DRB1,C0043352,Cisplatin,DB00515,Xerostomia,Terminated,N.N.Cl[Pt]Cl},Phase 2,,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
9606,BCS1L,C0008311,Sulbactam,DB09324,Cholangitis,Approved,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32941,SLC25A13,C0549399,Simvastatin,DB00641,Low density lipoprotein increased,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30053,NOTCH2,C0004114,Temozolomide,DB00853,Astrocytoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
10678,ELANE,C0031350,Tetracycline,DB00759,Pharyngitis,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,NE,HNE,HLE,ELA2,,,,,,,,,,,,,,,,,,,,,,
19668,ARL2BP,C0004771,Minocycline,DB01017,Bartonella Infections,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26881,IGHV3OR16-7,C0242647,Vincristine,DB00541,Mucosa-Associated Lymphoid Tissue Lymphoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32756,HBA1,C0019045,Pegfilgrastim,DB00019,Hemoglobinopathies,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Congenital malformation,HBA-T3,,,,,,,,,,,,,,,,,,,,,,,,,
33468,MIR1236,C1701940,Vancomycin,DB00512,"Pneumonia, Ventilator-Associated",Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19400,BPGM,C0008325,Doripenem,DB06211,Cholecystitis,Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O},,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
24823,GPC6,C0018916,Propranolol,DB00571,Hemangioma,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17349,PTGS2,C0860594,Trametinib,DB08911,"Malignant melanoma, metastatic",Approved,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
25060,NEFH,C0002736,Pioglitazone,DB01132,Amyotrophic Lateral Sclerosis,Terminated,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3},Phase 2,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,,,,,,,,
18168,CIB2,C1135868,Vinblastine,DB00570,Gestational Trophoblastic Neoplasms,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,DFNB48,USH1J,,,,,,,,,,,,,,,,,,,,,,,,
13286,TRNH,C0001403,Triamcinolone,DB00620,Addison Disease,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25111,TAC3,C0022876,Ritodrine,DB00867,Premature Obstetric Labor,Approved,C[C@@H]([C@@H](C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
3855,Magnesium hydroxide,DB09104,Constipation,C0009806,Approved,[OH-].[OH-].[Mg+2]},,Digestive system disease,,,,,,,,,,,,,,,,,,,PAPOLA,,,,,,,,
23717,FPR1,C0032064,Streptomycin,DB01082,Plague,Approved,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O},,Infectious disease,FPR,FMLP,,,,,,,,,,,,,,,,,,,,,,,,
31110,NOX4,C0022661,Niacin,DB00627,"Kidney Failure, Chronic",Terminated,C1=CC(=CN=C1)C(=O)O},Phase 3,Urinary system disease,KOX-1,KOX,,,,,,,,,,,,,,,,,,,,,,,,
21172,GNRH1,C0022735,Testosterone Propionate,DB01420,Klinefelter Syndrome,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
32842,PRDM2,C0040136,Ponatinib,DB08901,Thyroid Neoplasm,Terminated,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12800,ACOXL,C0023434,Venetoclax,DB11581,Chronic Lymphocytic Leukemia,Approved,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9002,IDUA,C0038358,Roxatidine acetate,DB08806,Gastric ulcer,Approved,CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29792,ITGA3,C0001127,Nitric Oxide,DB00435,"Acidosis, Respiratory",Terminated,[N]=O},Phase 1/Phase 2,Respiratory diseases,CD49c,VLA3a,VCA-2,GAP-B3,MSK18,,,,,,,,,,,,,,,,,,,,,
11649,TET2,C0040028,Anagrelide,DB00261,"Thrombocythemia, Essential",Approved,C1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3},,Cancer,FLJ20032,KIAA1546,,,,,,,,,,,,,,,,,,,,,,,,
35509,AKR1B1,C0011884,Octreotide,DB00104,Diabetic Retinopathy,Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 3,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17283,TIRAP,C0919659,Miconazole,DB01110,Oropharyngeal candidiasis,Approved,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24750,CCN2,C0034069,Azathioprine,DB00993,Pulmonary Fibrosis,Terminated,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]},Phase 3,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8909,FAP,C0013395,Omeprazole,DB00338,Dyspepsia,Suspended,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 2,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
18354,DYSF,C0042023,Trospium,DB00209,Increased frequency of micturition,Approved,C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O},,,FER1L1,LGMD2B,,,,,,,,,,,,,,,,,,,,,,,,
16308,BDNF,C0022104,Milnacipran,DB04896,Irritable Bowel Syndrome,Terminated,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2},Phase 2,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
24209,CCL2,C0917798,Phentolamine,DB00692,Cerebral Ischemia,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cardiovascular disease,MCP1,MCP-1,MCAF,SMC-CF,GDCF-2,HC11,MGC9434,SCYA2,,,,,,,,,,,,,,,,,,
31222,GRM8,C2363741,Tenofovir,DB00300,HIV-1 infection,Withdrawn,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},Phase 2,Infectious disease,GLUR8,GPRC1H,mGlu8,MGLUR8,,,,,,,,,,,,,,,,,,,,,,
32974,PYGM,C0280089,Romidepsin,DB06176,Carcinoid tumor of lung,Terminated,C/C=C\\1/C(=O)N[C@H](C(=O)O[C@H]\\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
15565,BDNF,C0032768,Pregabalin,DB00230,Postherpetic neuralgia,Approved,CC(C)C[C@@H](CC(=O)O)CN},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
14334,PIK3CG,C0936223,Nilutamide,DB00665,Metastatic Prostate Carcinoma,Approved,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19458,ADCY2,C0005587,Quetiapine,DB01224,"Depression, Bipolar",Approved,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
5491,Salicylamide,DB08797,Arthralgia,C0003862,Approved,C1=CC=C(C(=C1)C(=O)N)O},,Immune system disease,,,,,,,,,,,,,,,,,,,TOMM40,,,,,,,,
31620,HMGB1,C0338106,Oxaliplatin,DB00526,Adenocarcinoma of colon,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2759,Ethinyl Estradiol,DB00977,Acne Vulgaris,C0001144,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O},,Infectious disease,,,,,,,,,,,,,,,,,,,VGF,,,,,,,,
6942,MBL2,C0392164,L-Cysteine,DB00151,Pulmonary Cystic Fibrosis,Approved,C([C@@H](C(=O)O)N)S},,Congenital disorder of metabolism,COLEC1,,,,,,,,,,,,,,,,,NSF,,,,,,,,
23284,CAVIN1,C0232940,Progesterone,DB00396,Secondary physiologic amenorrhea,Approved,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Reproductive system disease,cavin-1,CGL4,PTRF,,,,,,,,,,,,,,,,,,,,,,,
6563,Esmolol,DB00187,Septic Shock,C0036983,Suspended,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O},Phase 2,,,,,,,,,,,,,,,,,,,,POGLUT3,,,,,,,,
2314,Dicyclomine,DB00804,Irritable Bowel Syndrome,C0022104,Approved,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2},,Digestive system disease,,,,,,,,,,,,,,,,,,,IRF5,,,,,,,,
15538,NTRK1,C0027796,Pregabalin,DB00230,Neuralgia,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,Nervous system disease,TRKA,MTC,,,,,,,,,,,,,,,,,,,,,,,,
27371,MAPK8,C0334359,Trametinib,DB08911,Papillary serous cystadenocarcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2/Phase 3,Cancer,JNK,JNK1,SAPK1,PRKM8,,,,,,,,,,,,,,,,,,,,,,
25437,FOXM1,C2239176,Sorafenib,DB00398,Liver carcinoma,Approved,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},,Cancer,HFH-11,trident,HNF-3,INS-1,MPP2,MPHOSPH2,TGT3,FKHL16,,,,,,,,,,,,,,,,,,
1024,Cefamandole,DB01326,Pneumonia due to Escherichia coli,C0276089,Approved,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)[C@@H](C4=CC=CC=C4)O)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Mianserin,,,,,,,,
35060,AZIN1,C1535939,Prednisolone,DB00860,Pneumocystis jiroveci pneumonia,Withdrawn,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7971,GCM2,C0020626,Ergocalciferol,DB00153,Hypoparathyroidism,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Endocrine and metabolic disease,hGCMb,GCMB,,,,,,,,,,,,,,,,,,,,,,,,
19090,COMT,C0039621,Dihydrotachysterol,DB01070,Tetany,Approved,C[C@H]\\1CC[C@@H](C/C1=C\\C=C\\2/CCC[C@]3([C@H]2CC[C@@H]3[C@H](C)/C=C/[C@H](C)C(C)C)C)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29582,IGF1,C0007114,Fludarabine,DB01073,Malignant neoplasm of skin,Terminated,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 1/Phase 2,Cancer,IGF1A,IGFI,IGF-I,IGF,,,,,,,,,,,,,,,,,,,,,,
5839,Teriflunomide,DB08880,Rheumatoid Arthritis,C0003873,Approved,C/C(=C(\\C#N)/C(=O)NC1=CC=C(C=C1)C(F)(F)F)/O},,Immune system disease,,,,,,,,,,,,,,,,,,,ADH5,,,,,,,,
27919,FGFR1OP,C0023480,Sunitinib,DB01268,"Leukemia, Myelomonocytic, Chronic",Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27757,PTEN,C0023418,Vincristine,DB00541,leukemia,Withdrawn,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
22043,CIB3,C0855095,Idelalisib,DB09054,Small Lymphocytic Lymphoma,Approved,CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17240,GSTP1,C0948089,Citalopram,DB00215,Acute Coronary Syndrome,Withdrawn,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 1/Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30641,ESR2,C0346990,Cisplatin,DB00515,Carcinomatosis of peritoneal cavity,Terminated,N.N.Cl[Pt]Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27509,H19-ICR,C0332890,Vincristine,DB00541,Congenital hemihypertrophy,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
28284,CYP1A1,C0022665,Vincristine,DB00541,Kidney Neoplasm,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 1,Cancer,P450DX,P1-450,P450-C,CP11,,,,,,,,,,,,,,,,,,,,,,
25082,DGCR,C2363973,Riociguat,DB08931,Chronic thromboembolic pulmonary hypertension,Approved,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27464,HRAS,C0004903,Vincristine,DB00541,Beckwith-Wiedemann Syndrome,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
3827,Lovastatin,DB00227,Familial hypercholesterolemia - heterozygous,C0342882,Approved,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Inherited metabolic disease,,,,,,,,,,,,,,,,,,,TNFRSF25,,,,,,,,
29924,CD28,C0856825,Pentostatin,DB00552,Acute GVH disease,Terminated,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O},Phase 1/Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
23529,SARDH,C0031511,Phentolamine,DB00692,Pheochromocytoma,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
28434,PCM1,C1292772,Sunitinib,DB01268,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11573,MASP2,C0025295,Meropenem,DB00760,"Meningitis, Pneumococcal",Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O},,Infectious disease,MASP1P1,,,,,,,,,,,,,,,,,,,,,,,,,
7015,GEN1,C0019342,Valaciclovir,DB00577,Genital Herpes,Approved,CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,STRADB,,,,,,,,
26177,HIF1A,C0008312,Ursodeoxycholic acid,DB01586,Primary biliary cirrhosis,Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C},,Digestive system disease,MOP1,HIF-1alpha,PASD8,HIF1,bHLHe78,,,,,,,,,,,,,,,,,,,,,
36530,IL6,C0393819,Cyclophosphamide,DB00531,"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",Withdrawn,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 2,Nervous system disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
25904,CHEK2,C0023269,Gemcitabine,DB00441,leiomyosarcoma,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1/Phase 2,Cancer,CDS1,CHK2,HuCds1,PP1425,bA444G7,RAD53,,,,,,,,,,,,,,,,,,,,
1398,Ceftriaxone,DB01212,Haemophilus sepsis,C0854324,Approved,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Sodium phosphate,,,,,,,,
30748,RAD51C,C1514428,Paclitaxel,DB01229,Primary peritoneal carcinoma,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
14747,CNTNAP1,C0005699,Imatinib,DB00619,Blast Phase,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10894,IDO2,C0004030,Voriconazole,DB00582,Aspergillosis,Withdrawn,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35282,PRL,C0004093,Methylphenidate,DB00422,Asthenia,Terminated,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},Phase 3,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
2490,Doxycycline,DB00254,Endemic Flea-Borne Typhus,C0041472,Approved,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CDSN,,,,,,,,
11936,WT1,C0023487,Tretinoin,DB00755,Acute Promyelocytic Leukemia,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Cancer,WIT-2,AWT1,NPHS4,GUD,,,,,,,,,,,,,,,,,,,,,,
28696,CCND2,C0009404,Sorafenib,DB00398,Colorectal Neoplasms,Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
17624,PTGS2,C0010043,Prednisolone,DB00860,Corneal Ulcer,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,,,,,,,,,,,,,,,,,,,,,,,,,,,
18783,IL4R,C0013595,Dexpanthenol,DB09357,Eczema,Approved,CC(C)(CO)[C@H](C(=O)NCCCO)O},,Skin disease,CD124,,,,,,,,,,,,,,,,,,,,,,,,,
33440,CYP2C8,C0013221,Triptorelin,DB06825,Drug toxicity,Terminated,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8},Phase 2,,CPC8,,,,,,,,,,,,,,,,,,,,,,,,,
10181,IL25,C0006266,Theophylline,DB00277,Bronchial Spasm,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Lung disease,IL-17E,IL17E,,,,,,,,,,,,,,,,,,,,,,,,
12798,BMF,C0023434,Venetoclax,DB11581,Chronic Lymphocytic Leukemia,Approved,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36875,IL6,C0867389,Prednisolone,DB00860,Chronic graft-versus-host disease,Withdrawn,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Immune system disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
31928,LOC110806262,C0349231,Hydrocortisone,DB00741,Phobic anxiety disorder,Terminated,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
10139,CCL5,C0347950,Theophylline,DB00277,Asthma attack,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Immune system disease,RANTES,SISd,TCP228,MGC17164,D17S136E,SCYA5,,,,,,,,,,,,,,,,,,,,
7601,IL13,C0011615,Triamcinolone,DB00620,"Dermatitis, Atopic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,P600,IL-13,ALRH,BHR1,MGC116786,MGC116788,MGC116789,,,,,,,,,,,MIR132,,,,,,,,
26740,SLCO6A1,C0278787,Sunitinib,DB01268,chronic myelogenous leukemia in relapse,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33504,F8,C0005779,Vitamin E,DB00163,Blood Coagulation Disorders,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Hematologic disease,FVIII,DXS1253E,HEMA,F8C,,,,,,,,,,,,,,,,,,,,,,
28348,ABCB1,C0023486,Thalidomide,DB01041,Prolymphocytic Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,P-gp,CD243,GP170,ABC20,PGY1,CLCS,,,,,,,,,,,,,,,,,,,,
20435,TLR2,C0023241,Erythromycin,DB00199,Legionnaires' Disease,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,TIL4,CD282,,,,,,,,,,,,,,,,,,,,,,,,
25234,CACNA1A,C0751434,Verapamil,DB00661,Classical phenylketonuria,Terminated,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},Phase 2,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
2582,Edoxaban,DB09075,Pulmonary Embolism,C0034065,Approved,CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C},,Lung disease,,,,,,,,,,,,,,,,,,,GUCA2B,,,,,,,,
12357,DPEP1,C0034186,Ofloxacin,DB01165,Pyelonephritis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
1737,Clidinium,DB00771,Enterocolitis,C0014356,Approved,C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O},,Gastrointestinal disease,,,,,,,,,,,,,,,,,,,PLEKHA7,,,,,,,,
34954,CHI3L1,C0032310,Hydrocortisone,DB00741,"Pneumonia, Viral",Terminated,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
982,Cefaclor,DB00833,Tonsillitis,C0040425,Approved,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)Cl},,,,,,,,,,,,,,,,,,,,,Methazolamide,,,,,,,,
23671,ANXA1,C1328252,Miltefosine,DB09031,Mucocutaneous leishmaniasis,Approved,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},,Infectious disease,ANX1,LPC1,,,,,,,,,,,,,,,,,,,,,,,,
472,Azithromycin,DB00207,Acute exacerbation of chronic bronchitis,C0856695,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O},,Lung disease,,,,,,,,,,,,,,,,,,,Dihydroergotamine,,,,,,,,
11470,LYVE1,C0040592,Tetracycline,DB00759,Trachoma,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,LYVE-1,XLKD1,,,,,,,,,,,,,,,,,,,,,,,,
18657,WDHD1,C0019069,Desmopressin,DB00035,Hemophilia A,Approved,C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2445,Doxepin,DB01142,Anxiety,C0003467,Approved,CN(C)CC/C=C/1\\C2=CC=CC=C2COC3=CC=CC=C31},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,HADHA,,,,,,,,
11603,TNF,C0013371,Trimethoprim,DB00440,Shigella Infections,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
26921,KMT2A,C0280449,Cyclophosphamide,DB00531,secondary acute myeloid leukemia,Terminated,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35422,COL11A2,C1720830,Mycophenolic acid,DB01024,Painful Bladder Syndrome,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,,HKE5,DFNA13,DFNB53,,,,,,,,,,,,,,,,,,,,,,,
13786,PTHLH,C0149911,Zoledronic acid,DB00399,Humoral hypercalcemia of malignancy (disorder),Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Urinary system disease,PTHRP,,,,,,,,,,,,,,,,,,,,,,,,,
32166,STAT5B,C0079772,Isotretinoin,DB00982,T-Cell Lymphoma,Terminated,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\\C(=O)O)/C)/C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11188,IL10RA,C0023290,Miltefosine,DB09031,"Leishmaniasis, Visceral",Approved,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},,Infectious disease,HIL-10R,CDW210A,CD210a,CD210,IL10R,,,,,,,,,,,,,,,,,,,,,
24980,IL1B,C0040558,Sulfamethoxazole,DB01015,Toxoplasmosis,Approved,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
22458,ACTA2,C0007820,Tolazoline,DB00797,Cerebrovascular Disorders,Approved,C1CN=C(N1)CC2=CC=CC=C2},,Cardiovascular disease,ACTSA,,,,,,,,,,,,,,,,,,,,,,,,,
23301,SCFD2,C0021603,Cyclobenzaprine,DB00924,Sleep Initiation and Maintenance Disorders,Terminated,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
29022,C9,C0027412,Buprenorphine,DB00921,Opioid-Related Disorders,Terminated,C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)(C(C)(C)C)O},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
22031,RPS15,C0855095,Idelalisib,DB09054,Small Lymphocytic Lymphoma,Approved,CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13228,DEFA1,C0041912,Phenoxymethylpenicillin,DB00417,Upper Respiratory Infections,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C},,Infectious disease,HNP-1,DEF1,DEFA2,,,,,,,,,,,,,,,,,,,,,,,
4165,Metronidazole,DB00916,Infection of bone,C2242472,Approved,CC1=NC=C(N1CCO)[N+](=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,RPL23,,,,,,,,
20173,KNG1,C0002792,Epinephrine,DB00668,anaphylaxis,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32109,MSH6,C0034885,Oxaliplatin,DB00526,Rectal Neoplasms,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33159,MECP2,C1145670,Dexmedetomidine,DB00633,Respiratory Failure,Terminated,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 3,Lung disease,RTT,MRX16,MRX79,,,,,,,,,,,,,,,,,,,,,,,
31142,BCL6,C1292753,Doxorubicin,DB00997,Primary Effusion Lymphoma,Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},Phase 2,Cancer,ZBTB27,LAZ3,BCL5,BCL6A,ZNF51,,,,,,,,,,,,,,,,,,,,,
20390,IL3,C0012546,Erythromycin,DB00199,Diphtheria,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25730,LHX4,C0020635,Testosterone,DB00624,Hypopituitarism,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20145,ADRB1,C0018802,Levosimendan,DB00922,Congestive heart failure,Approved,C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N},,Congenital malformation,ADRB1R,,,,,,,,,,,,,,,,,,,,,,,,,
30599,CYP26A1,C0032580,Eflornithine,DB06243,Adenomatous Polyposis Coli,Terminated,C(CC(C(F)F)(C(=O)O)N)CN},Phase 2,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1347,Ceftizoxime,DB01332,Gonorrhea of rectum,C0275665,Approved,CO/N=C(/C1=CSC(=N1)N)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Rizatriptan,,,,,,,,
21321,DYNLL2,C0031572,Venlafaxine,DB00285,"Phobia, Social",Approved,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
24029,ETV6,C1278797,Trovafloxacin,DB00685,Postnatal infection,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,TEL,,,,,,,,,,,,,,,,,,,,,,,,,
3225,Glycopyrronium,DB00986,Chronic Obstructive Airway Disease,C0024117,Approved,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C},,Lung disease,,,,,,,,,,,,,,,,,,,SNTA1,,,,,,,,
9243,Rimonabant,DB06155,Microalbuminuria,C0730345,Terminated,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
32534,ABCB1,C0520909,Nicotine,DB00184,Postoperative Nausea and Vomiting,Terminated,CN1CCC[C@H]1C2=CN=CC=C2},Phase 2,,P-gp,CD243,GP170,ABC20,PGY1,CLCS,,,,,,,,,,,,,,,,,,,,
18773,S100A4,C0022548,Triamcinolone,DB00620,Keloid,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,P9KA,18A2,PEL98,42A,CAPL,,,,,,,,,,,,,,,,,,,,,
31858,CD274,C3495949,Valproic Acid,DB00313,Locally advanced breast cancer,Terminated,CCCC(CCC)C(=O)O},Phase 2,Cancer,B7-H,B7H1,PD-L1,PDL1,B7-H1,PDCD1LG1,,,,,,,,,,,,,,,,,,,,
21680,BCHE,C0037036,Hyoscyamine,DB00424,Sialorrhea,Approved,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3},,,CHE2,,,,,,,,,,,,,,,,,,,,,,,,,
6811,Vidarabine,DB00194,Mycosis fungoides/Sezary syndrome recurrent,C0862200,Suspended,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,WRAP53,,,,,,,,
23087,GCM2,C0151723,Magnesium Sulfate,DB00653,Hypomagnesemia,Approved,[O-]S(=O)(=O)[O-].[Mg+2]},,Congenital disorder of metabolism,hGCMb,GCMB,,,,,,,,,,,,,,,,,,,,,,,,
25199,GJB2,C0870082,Tretinoin,DB00755,Hyperkeratosis,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Skin and connective tissue disease,CX26,NSRD1,DFNB1,,,,,,,,,,,,,,,,,,,,,,,
4652,Ondansetron,DB00904,Chemotherapy-induced nausea and vomiting,C0401160,Approved,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C},,,,,,,,,,,,,,,,,,,,,SNX10,,,,,,,,
5201,Prednisolone,DB00860,Sjogren's Syndrome,C1527336,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,ATP4B,,,,,,,,
11595,PRKN,C0030528,Chloramphenicol,DB00446,Paratyphoid Fever,Approved,C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]},,Infectious disease,PDJ,AR-JP,parkin,PARK2,,,,,,,,,,,,,,,,,,,,,,
25462,CTRC,C0003962,Eplerenone,DB00700,Ascites,Withdrawn,C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC},Phase 2,,CLCR,ELA4,,,,,,,,,,,,,,,,,,,,,,,,
29072,PLPP3,C1956346,Heparin,DB01109,Coronary Artery Disease,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4545,Norgestimate,DB00957,Hot flushes,C0600142,Approved,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)OC(=O)C)CCC4=C/C(=N/O)/CC[C@H]34},,,,,,,,,,,,,,,,,,,,,POU6F2,,,,,,,,
29720,MYB,C0279627,Vorinostat,DB02546,adult acute myelomonocytic leukemia (M4),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,c-myb,,,,,,,,,,,,,,,,,,,,,,,,,
19021,CEL,C1527407,Prednisolone,DB00860,Eosinophilic Pneumonia,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Infectious disease,BSSL,MODY8,,,,,,,,,,,,,,,,,,,,,,,,
17090,CCR3,C0085652,Clofazimine,DB00845,Pyoderma Gangrenosum,Approved,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl},,Immune system disease,CC-CKR-3,CKR3,CD193,CMKBR3,,,,,,,,,,,,,,,,,,,,,,
3181,Gentamicin,DB00798,Meibomianitis,C0549398,Approved,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC},,Nervous system disease,,,,,,,,,,,,,,,,,,,CCNO,,,,,,,,
8295,HTR3E,C1262211,Ranolazine,DB00243,Diarrhoea predominant irritable bowel syndrome,Terminated,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O},Phase 2/Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20238,SCNN1B,C0043144,Epinephrine,DB00668,Wheezing,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Congenital malformation,ENaCbeta,,,,,,,,,,,,,,,,,,,,,,,,,
12305,IL6ST,C0003873,Thalidomide,DB01041,Rheumatoid Arthritis,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Immune system disease,CD130,,,,,,,,,,,,,,,,,,,,,,,,,
1811,Clotrimazole,DB00257,Oropharyngeal candidiasis,C0919659,Approved,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4},,Infectious disease,,,,,,,,,,,,,,,,,,,PAX6,,,,,,,,
33955,IL1RAPL1,C0006287,Nitric Oxide,DB00435,Bronchopulmonary Dysplasia,Terminated,[N]=O},Phase 2/Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
11294,TNF,C0032285,Simvastatin,DB00641,Pneumonia,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Infectious disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
29988,DYNC1H1,C0152109,Sodium phenylbutyrate,DB06819,Juvenile Spinal Muscular Atrophy,Terminated,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},Phase 1/Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22215,IKBKG,C0043037,Imiquimod,DB00724,Common wart,Approved,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26448,CDKN2A,C0278987,Pemetrexed,DB00642,Non-small cell lung cancer metastatic,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
19665,TTBK2,C0149925,Cisplatin,DB00515,Small cell carcinoma of lung,Terminated,N.N.Cl[Pt]Cl},Phase 2,Cancer,KIAA0847,SCA11,,,,,,,,,,,,,,,,,,,,,,,,
36807,MSMB,C0600139,Simvastatin,DB00641,Prostate carcinoma,Withdrawn,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35332,IL23R,C1262313,Micafungin,DB01141,Invasive Fungal Infections,Terminated,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)[C@@H](CC(=O)N)O)C)O)O)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7022,UNC93B1,C0276226,Aciclovir,DB00787,Herpes encephalitis,Approved,C1=NC2=C(N1COCCO)N=C(NC2=O)N},,Infectious disease,0,,,,,,,,,,,,,,,,,IGHV1-12,,,,,,,,
28077,BRAF,C0152013,Paclitaxel,DB01229,Adenocarcinoma of lung (disorder),Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,BRAF1,,,,,,,,,,,,,,,,,,,,,,,,,
3755,RORA,C2607914,Triprolidine,DB00427,Allergic rhinitis (disorder),Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Immune system disease,RZRA,ROR1,ROR2,ROR3,NR1F1,,,,,,,,,,,,,MSTN,,,,,,,,
4897,Phensuximide,DB00832,Absence Epilepsy,C0014553,Approved,CN1C(=O)CC(C1=O)C2=CC=CC=C2},,Nervous system disease,,,,,,,,,,,,,,,,,,,B4GALT7,,,,,,,,
30721,MYCN,C0206663,Vincristine,DB00541,"Neuroectodermal Tumor, Primitive",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,bHLHe37,N-myc,MYCNOT,NMYC,,,,,,,,,,,,,,,,,,,,,,
23823,AHSA1,C1262117,Natamycin,DB00826,Fungal keratitis,Approved,C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)O)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3899,Mebendazole,DB00643,Enterobiasis,C0086227,Approved,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3},,Infectious disease,,,,,,,,,,,,,,,,,,,CASP6,,,,,,,,
8214,Imatinib,DB00619,Scleroderma,C0011644,Terminated,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 2,Skin disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
33613,PNPLA2,C0018799,Vitamin E,DB00163,Heart Diseases,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Cardiovascular disease,desnutrin,TTS-2.2,ATGL,FP17548,iPLA2zeta,,,,,,,,,,,,,,,,,,,,,
22802,EHMT1,C0025323,Tranexamic Acid,DB00302,Menorrhagia,Approved,C1CC(CCC1CN)C(=O)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
4223,Minocycline,DB01017,Acute gonococcal endometritis,C0153196,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,UGT1A1,,,,,,,,
18089,TERT,C0023467,Tretinoin,DB00755,"Leukemia, Myelocytic, Acute",Withdrawn,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},Phase 3,Cancer,TRT,TCS1,hEST2,EST2,,,,,,,,,,,,,,,,,,,,,,
13610,TNF,C0011608,Triamcinolone,DB00620,Dermatitis Herpetiformis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
27300,CRH,C0008495,Sulbactam,DB09324,Chorioamnionitis,Suspended,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C},Phase 2/Phase 3,Infectious disease,CRH1,,,,,,,,,,,,,,,,,,,,,,,,,
15792,HLA-DPB1,C0033581,Ofloxacin,DB01165,prostatitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,HLA-DP1B,,,,,,,,,,,,,,,,,,,,,,,,,
13742,NIPAL4,C0011606,Triamcinolone,DB00620,Exfoliative dermatitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,ICHYN,,,,,,,,,,,,,,,,,,,,,,,,,
8454,MIR4505,C0270549,Quetiapine,DB01224,Generalized Anxiety Disorder,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
20999,CCND2,C0007102,Oxaliplatin,DB00526,Malignant tumor of colon,Withdrawn,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
20779,MTHFR,C4083212,Finasteride,DB01216,"Alopecia, Male Pattern",Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
90,Alfacalcidol,DB01436,Hyperparathyroidism,C0020502,Approved,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,Aranidipine,,,,,,,,
7371,Rifampicin,DB01045,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,Terminated,C[C@H]1/C=C/C=C(\\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C)/C},Phase 1,Endocrine disease,,,,,,,,,,,,,,,,,,,ADAMTS2,,,,,,,,
2169,Dexamethasone,DB01234,Blepharoconjunctivitis,C0005743,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Infectious disease,,,,,,,,,,,,,,,,,,,ABCB1,,,,,,,,
21715,LOC110806263,C0040250,Tolnaftate,DB00525,Tinea Capitis,Approved,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29113,PTEN,C0280483,Irinotecan,DB00762,adult anaplastic astrocytoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
21119,FGFR1,C0034012,Testosterone Propionate,DB01420,Delayed Puberty,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Endocrine and metabolic disease,CEK,FLG,BFGFR,N-SAM,CD331,FLT2,KAL2,,,,,,,,,,,,,,,,,,,
33390,IL6,C0878773,Lidocaine,DB00281,Overactive Bladder,Terminated,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},Phase 3,Urinary system disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
16912,CSF3,C0014356,Clidinium,DB00771,Enterocolitis,Approved,C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O},,Gastrointestinal disease,MGC45931,GCSF,G-CSF,C17orf33,,,,,,,,,,,,,,,,,,,,,,
31596,NOS2,C0035309,Finasteride,DB01216,Retinal Diseases,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},Phase 2,Nervous system disease,iNOS,HEP-NOS,NOS2A,,,,,,,,,,,,,,,,,,,,,,,
21512,POMC,C0035258,Rotigotine,DB05271,Restless Legs Syndrome,Approved,CCCN(CCC1=CC=CS1)[C@H]2CCC3=C(C2)C=CC=C3O},,Nervous system disease,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
13178,PAGR1,C0343532,Benzylpenicillin,DB01053,Streptococcal toxic shock syndrome,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9203,Oxytocin,DB00107,Dystocia,C0013418,Terminated,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34206,GFAP,C0349217,Aripiprazole,DB01238,"Depressive episode, unspecified",Terminated,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl},Phase 3,Mental and behavioural disorder,FLJ45472,,,,,,,,,,,,,,,,,,,,,,,,,
24125,COL6A1,C0005697,Oxybutynin,DB01062,Neurogenic Urinary Bladder,Approved,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O},,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
11617,TSPO,C0013371,Trimethoprim,DB00440,Shigella Infections,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,PBR,MBR,PKBS,mDRC,DBI,pk18,BZRP,,,,,,,,,,,,,,,,,,,
14055,GALNS,C0035439,Triamcinolone,DB00620,Rheumatic Heart Disease,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22243,YAP1,C0009663,Podofilox,DB01179,Condylomata Acuminata,Approved,COC1=CC(=CC(=C1OC)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](C4=CC5=C(C=C24)OCO5)O},,Infectious disease,YAP65,,,,,,,,,,,,,,,,,,,,,,,,,
5477,Rosuvastatin,DB01098,"Hyperlipidemia, Familial Combined",C0020474,Approved,CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C},,Metabolic disease,,,,,,,,,,,,,,,,,,,CFD,,,,,,,,
6332,Vancomycin,DB00512,Staphylococcus aureus infection,C1318973,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SLC3A1,,,,,,,,
14585,RARB,C0007137,Cisplatin,DB00515,Squamous cell carcinoma,Terminated,N.N.Cl[Pt]Cl},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
24296,CYRIB,C0038436,Sertraline,DB01104,Post-Traumatic Stress Disorder,Approved,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
436,Atorvastatin,DB01076,Cerebrovascular accident,C0038454,Approved,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,ADCY5,,,,,,,,
28062,CCKBR,C0020429,Capsaicin,DB06774,Hyperalgesia,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,Nervous system,,,,,,,,,,,,,,,,,,,,,,,,,,
9863,Amikacin,DB00479,Cystic Fibrosis,C0010674,Withdrawn,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},Phase 3,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,,
36267,SPP1,C0022658,Valsartan,DB00177,Kidney Diseases,Withdrawn,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Urinary system disease,BSPI,ETA-1,BNSP,OPN,,,,,,,,,,,,,,,,,,,,,,
14601,DMRT1,C1336708,Vinblastine,DB00570,Testicular Germ Cell Tumor,Terminated,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,CT154,,,,,,,,,,,,,,,,,,,,,,,,,
11997,CDKN2B,C0023449,Vindesine,DB00309,Acute lymphocytic leukemia,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
6176,Triamcinolone,DB00620,Thyroiditis,C0040147,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,,,,,,,,,,,,,,,,,,,PRKAA2,,,,,,,,
4848,Phenindamine,DB01619,Urticaria,C0042109,Approved,CN1CCC2=C(C1)C(C3=CC=CC=C23)C4=CC=CC=C4},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,UGT1A10,,,,,,,,
1200,Cefoxitin,DB01331,Endometritis,C0014179,Approved,CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3},,Reproductive system disease,,,,,,,,,,,,,,,,,,,Pethidine,,,,,,,,
1927,Cortisone acetate,DB01380,Otitis Externa,C0029878,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CXCR6,,,,,,,,
11814,RSPH9,C0008677,Vilanterol,DB09082,"Bronchitis, Chronic",Approved,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11998,CEBPE,C0023449,Vindesine,DB00309,Acute lymphocytic leukemia,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
18246,MLH1,C0035412,Vincristine,DB00541,Rhabdomyosarcoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25909,MDM2,C0023269,Gemcitabine,DB00441,leiomyosarcoma,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
21549,TAC1,C0751362,Viloxazine,DB09185,Narcolepsy-Cataplexy Syndrome,Approved,CCOC1=CC=CC=C1OCC2CNCCO2},,Nervous system disease,NPK,TAC2,NKNA,,,,,,,,,,,,,,,,,,,,,,,
31878,RBP4,C0362046,Losartan,DB00678,Prediabetes syndrome,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,
23919,TNF,C0038525,Deferoxamine,DB00746,Subarachnoid Hemorrhage,Terminated,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O},Phase 0,,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
20618,SLC12A3,C0241961,Everolimus,DB01590,Angiomyolipoma of kidney,Approved,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC},,Cancer,NCCT,,,,,,,,,,,,,,,,,,,,,,,,,
2472,AGT,C0020538,Propofol,DB00818,Hypertensive disease,Withdrawn,CC(C)C1=C(C(=CC=C1)C(C)C)O},Phase 3,Cardiovascular disease,SERPINA8,,,,,,,,,,,,,,,,,Ezogabine,,,,,,,,
6082,Trandolapril,DB00519,Chronic heart failure,C0264716,Approved,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCCC[C@@H]3C[C@H]2C(=O)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,BLOC1S3,,,,,,,,
29431,BDNF,C0021368,Methotrexate,DB00563,Inflammation,Withdrawn,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,
36990,VDR,C0221002,Cholecalciferol,DB00169,"Hyperparathyroidism, Primary",Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 2/Phase 3,Endocrine and metabolic disease,NR1I1,PPP1R163,,,,,,,,,,,,,,,,,,,,,,,,
17492,PROKR2,C1384606,Ospemifene,DB04938,Dyspareunia,Approved,C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\C3=CC=C(C=C3)OCCO)/CCCl},,Reproductive system disease,GPR73b,PKR2,GPRg2,dJ680N4.3,GPR73L1,KAL3,,,,,,,,,,,,,,,,,,,,
14426,BCL2L1,C0278996,Methotrexate,DB00563,Cancer of Head and Neck,Approved,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
20931,DPY19L1P1,C0085436,Flucytosine,DB01099,"Meningitis, Cryptococcal",Terminated,C1=NC(=O)NC(=C1F)N},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33625,NCF4,C0018799,Vitamin E,DB00163,Heart Diseases,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7989,HBB,C0020626,Ergocalciferol,DB00153,Hypoparathyroidism,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Endocrine and metabolic disease,CD113t-C,beta-globin,,,,,,,,,,,,,,,,,,,,,,,,
23377,PRRT2,C0267176,Metoclopramide,DB01233,Gastroparesis due to diabetes mellitus,Approved,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19735,IFNG,C0023860,Minocycline,DB01017,Listeriosis,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
25310,CYBA,C0037299,Sulfadiazine,DB00359,Skin Ulcer,Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Skin disease,p22-PHOX,,,,,,,,,,,,,,,,,,,,,,,,,
27883,AQP1,C2347748,Mitoxantrone,DB01204,Adult Erythroleukemia,Terminated,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},Phase 1,Cancer,CHIP28,CO,,,,,,,,,,,,,,,,,,,,,,,,
30697,RASSF1,C0025149,Valproic Acid,DB00313,Medulloblastoma,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15216,SLC2A1,C0026838,Tizanidine,DB00697,Muscle Spasticity,Approved,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl},,Nervous system disease,DYT18,DYT9,GLUT1,GLUT,HTLVR,CSE,,,,,,,,,,,,,,,,,,,,
24196,BPTF,C0267963,Pancrelipase,DB00085,Exocrine pancreatic insufficiency,Approved,C1CC2C(C(C1O2)C(=O)[O-])C(=O)[O-].[Na+].[Na+]},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36789,AUH,C0175694,Lovastatin,DB00227,Smith-Lemli-Opitz Syndrome,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
8913,Cefazolin,DB01327,Gram-Positive Bacterial Infections,C0085426,Terminated,CC1=NN=C(S1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
18252,AGER,C0038166,Tedizolid Phosphate,DB09042,Staphylococcal Skin Infections,Approved,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4C[C@@H](OC4=O)COP(=O)(O)O)F},,Infectious disease,SCARJ1,,,,,,,,,,,,,,,,,,,,,,,,,
4621,Ofloxacin,DB01165,Streptococcal pneumonia,C0155862,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,INHBA,,,,,,,,
20044,GNAZ,C0271093,Echothiophate,DB01057,Stargardt's disease,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
36991,HPT,C0221002,Cholecalciferol,DB00169,"Hyperparathyroidism, Primary",Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 2/Phase 3,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30635,CXCL12,C0346990,Cisplatin,DB00515,Carcinomatosis of peritoneal cavity,Terminated,N.N.Cl[Pt]Cl},Phase 2,Cancer,SCYB12,SDF-1a,SDF-1b,PBSF,TLSF-a,TLSF-b,TPAR1,SDF1A,SDF1B,SDF1,,,,,,,,,,,,,,,,
27996,MIR21,C0014859,Fluorouracil,DB00544,Esophageal Neoplasms,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29766,MAD1L1,C0023524,Mefloquine,DB00358,"Leukoencephalopathy, Progressive Multifocal",Terminated,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
28219,SPP1,C0153676,Ifosfamide,DB01181,Secondary malignant neoplasm of lung,Terminated,C1CN(P(=O)(OC1)NCCCl)CCCl},Phase 1,Cancer,BSPI,ETA-1,BNSP,OPN,,,,,,,,,,,,,,,,,,,,,,
2284,Dezocine,DB01209,Pain,C0030193,Approved,C[C@]12CCCCC[C@H]([C@@H]1N)CC3=C2C=C(C=C3)O},,,,,,,,,,,,,,,,,,,,,ERCC2,,,,,,,,
16304,TRPV1,C0022104,Milnacipran,DB04896,Irritable Bowel Syndrome,Terminated,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2},Phase 2,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
30000,SMN2,C0393538,Sodium phenylbutyrate,DB06819,"Muscular Atrophy, Spinal, Type II",Terminated,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},Phase 1/Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4973,Piperacillin,DB00319,Escherichia coli urinary tract infection,C0577708,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,DLST,,,,,,,,
27831,DAO,C0085633,Atomoxetine,DB00289,Mood swings,Terminated,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2},Phase 1,Mental and behavioural disorder,DAMOX,DAAO,,,,,,,,,,,,,,,,,,,,,,,,
33624,MT2A,C0018799,Vitamin E,DB00163,Heart Diseases,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Cardiovascular disease,MT2,,,,,,,,,,,,,,,,,,,,,,,,,
33117,CACNA1C,C0041696,Scopolamine,DB00747,Unipolar Depression,Terminated,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
25523,TNRC6A,C0751122,Stiripentol,DB09118,Infantile Severe Myoclonic Epilepsy,Approved,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9178,Omeprazole,DB00338,Nausea,C0027497,Terminated,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 3,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
29034,OPRM1,C0600427,Vigabatrin,DB01080,Cocaine Dependence,Terminated,C=CC(CCC(=O)O)N},Phase 2,Mental and behavioural disorder,MOR1,,,,,,,,,,,,,,,,,,,,,,,,,
2563,Dyphylline,DB00651,Asthma night-time symptoms,C1273489,Approved,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O},,Immune system disease,,,,,,,,,,,,,,,,,,,SLC2A6,,,,,,,,
20258,GSDMB,C0043144,Epinephrine,DB00668,Wheezing,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
17380,ACE,C0031069,Colchicine,DB01394,Familial Mediterranean Fever,Approved,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC},,Infectious disease,ACE1,CD143,DCP1,,,,,,,,,,,,,,,,,,,,,,,
22762,PHGDH,C0002888,Levoleucovorin,DB11596,"Anemia, Megaloblastic",Approved,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15484,BRCA2,C0278488,Vinblastine,DB00570,Carcinoma breast stage IV,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
310,Amphotericin B,DB00681,Rocky Mountain Spotted Fever,C0035793,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Cimetidine,,,,,,,,
2138,Desoximetasone,DB00547,"Dermatitis, Atopic",C0011615,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)CO)C)O)F)C},,Immune system disease,,,,,,,,,,,,,,,,,,,ABCG2,,,,,,,,
15460,AHSG,C0264716,Amlodipine,DB00381,Chronic heart failure,Suspended,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN},Phase 2,Cardiovascular disease,FETUA,A2HS,HSGA,,,,,,,,,,,,,,,,,,,,,,,
6464,TGFBR2,C0149931,Zolmitriptan,DB00315,Migraine Disorders,Approved,CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3},,Nervous system disease,TBRII,TBR-ii,MFS2,,,,,,,,,,,,,,,SHOX,,,,,,,,
344,Ampicillin,DB00415,"Meningitis, Bacterial",C0085437,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Clozapine,,,,,,,,
19068,NEURL1,C0004238,Verapamil,DB00661,Atrial Fibrillation,Approved,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11341,IL1RN,C0035021,Tetracycline,DB00759,Relapsing Fever,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,ICIL-1RA,IL1F3,IL-1RN,MGC10430,,,,,,,,,,,,,,,,,,,,,,
20075,CDKN1C,C0020437,Cholecalciferol,DB00169,Hypercalcemia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 2/Phase 3,Urinary system disease,P57,BWCR,BWS,,,,,,,,,,,,,,,,,,,,,,,
14831,DRD3,C0020514,Cabergoline,DB00248,Hyperprolactinemia,Approved,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C},,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,
6348,Verteporfin,DB00460,Exudative age-related macular degeneration,C0271084,Approved,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C.CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)O)C(=C3C)CCC(=O)OC)C=C},,,,,,,,,,,,,,,,,,,,,ASMT,,,,,,,,
6761,MBL2,C0042029,Trovafloxacin,DB00685,Urinary tract infection,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,COLEC1,,,,,,,,,,,,,,,,,NAGPA,,,,,,,,
19449,S100B,C0005587,Quetiapine,DB01224,"Depression, Bipolar",Approved,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},,Mental and behavioural disorder,S100beta,,,,,,,,,,,,,,,,,,,,,,,,,
19198,NR4A2,C0311375,Dimercaprol,DB06782,Arsenic Poisoning,Approved,C(C(CS)S)O},,,TINUR,NOT,RNR1,HZF-3,NURR1,,,,,,,,,,,,,,,,,,,,,
34913,FOXO1,C0278704,Heparin,DB01109,Malignant Childhood Neoplasm,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Cancer,FKH1,FKHR,FOXO1A,,,,,,,,,,,,,,,,,,,,,,,
5897,Tetryzoline,DB06764,Rhinorrhea,C1260880,Approved,C1CC(C2=CC=CC=C2C1)C3=NCCN3},,Nervous system disease,,,,,,,,,,,,,,,,,,,SLC25A2,,,,,,,,
16746,COCH,C0042571,Meclizine,DB00737,Vertigo,Approved,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
24109,CTSB,C0036323,Praziquantel,DB01058,Schistosomiasis,Approved,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
36540,PTGS2,C0393819,Cyclophosphamide,DB00531,"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",Withdrawn,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 2,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
22412,KCNH2,C0004245,Isoprenaline,DB01064,Atrioventricular Block,Approved,CC(C)NCC(C1=CC(=C(C=C1)O)O)O},,Cardiovascular disease,Kv11.1,HERG,erg1,LQT2,,,,,,,,,,,,,,,,,,,,,,
36431,RASSF1,C0333875,Celecoxib,DB00482,High-Grade Squamous Intraepithelial Lesions,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34791,OPRM1,C1135120,Fentanyl,DB00813,Breakthrough Pain,Terminated,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3},Phase 3,,MOR1,,,,,,,,,,,,,,,,,,,,,,,,,
32707,STK35,C0015944,Oxytocin,DB00107,"Fetal Membranes, Premature Rupture",Terminated,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
14280,VANGL1,C0080274,Tamsulosin,DB00706,Urinary Retention,Terminated,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
512,Aztreonam,DB00355,Escherichia coli Infections,C0014836,Approved,C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\\OC(C)(C)C(=O)O)/C2=CSC(=N2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,LIPC,,,,,,,,
32103,TYMS,C0034885,Oxaliplatin,DB00526,Rectal Neoplasms,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,Tsase,TMS,HsT422,,,,,,,,,,,,,,,,,,,,,,,
8084,HLA-DRB1,C0002994,Triamcinolone,DB00620,Angioedema,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
18166,SPP1,C1135868,Vinblastine,DB00570,Gestational Trophoblastic Neoplasms,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,BSPI,ETA-1,BNSP,OPN,,,,,,,,,,,,,,,,,,,,,,
23706,LBP,C0031099,Lidocaine,DB00281,Periodontitis,Terminated,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},Phase 2,Infectious disease,BPIFD2,,,,,,,,,,,,,,,,,,,,,,,,,
24919,CSTB,C1849508,Pyridoxine,DB00165,"EPILEPSY, PYRIDOXINE-DEPENDENT",Approved,CC1=NC=C(C(=C1O)CO)CO},,Nervous system disease,CST6,PME,EPM1,STFB,,,,,,,,,,,,,,,,,,,,,,
28409,ERBB2,C0007682,Temozolomide,DB00853,CNS disorder,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Nervous system disease,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
32444,LAMC2,C0265110,Nicardipine,DB00622,Cerebral Vasospasm,Terminated,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC},Phase 2,Cardiovascular disease,nicein-100kDa,kalinin-105kDa,BM600-100kDa,EBR2,LAMB2T,LAMNB2,EBR2A,,,,,,,,,,,,,,,,,,,
35377,AVP,C0005686,Mitomycin,DB00305,Urinary Bladder Diseases,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Urinary system disease,ADH,ARVP,,,,,,,,,,,,,,,,,,,,,,,,
27110,MIR181C,C2921627,Prednisolone,DB00860,Clinically isolated syndrome,Suspended,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
16425,TAL1,C0012734,Promazine,DB00420,Disruptive Behavior Disorder,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Mental and behavioural disorder,bHLHa17,TCL5,,,,,,,,,,,,,,,,,,,,,,,,
28534,MEFV,C0281479,Doxorubicin,DB00997,Primary Systemic Amyloidosis,Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},Phase 1,Skin disease,FMF,TRIM20,,,,,,,,,,,,,,,,,,,,,,,,
33539,AGER,C0004153,Simvastatin,DB00641,Atherosclerosis,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Cardiovascular disease,SCARJ1,,,,,,,,,,,,,,,,,,,,,,,,,
8374,TP53,C0003467,Citalopram,DB00215,Anxiety,Withdrawn,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
396,Apraclonidine,DB00964,"Glaucoma, Open-Angle",C0017612,Approved,C1CN=C(N1)NC2=C(C=C(C=C2Cl)N)Cl},,Nervous system disease,,,,,,,,,,,,,,,,,,,Dalbavancin,,,,,,,,
9795,Pravastatin,DB00175,HIV-1 infection,C2363741,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
17115,LHB,C0021361,Clomifene,DB00882,Female infertility,Approved,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\Cl)/C3=CC=CC=C3},,Reproductive system disease,LSH-B,CGB4,hLHB,,,,,,,,,,,,,,,,,,,,,,,
36223,ADARB2,C1510472,Varenicline,DB01273,Drug Dependence,Withdrawn,C1C2CNCC1C3=CC4=NC=CN=C4C=C23},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
35157,HMGB1,C0947751,Linagliptin,DB08882,Vascular inflammations,Terminated,CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C},Phase 3,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2894,Fluocinonide,DB01047,Contact Dermatitis,C0011616,Approved,CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3C[C@@H](C5=CC(=O)C=C[C@@]54C)F)F)O)C)OC(O2)(C)C},,Immune system disease,,,,,,,,,,,,,,,,,,,CNOT1,,,,,,,,
9530,TLR4,C0684256,Vancomycin,DB00512,Bacterial sepsis,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,,,,,,,,,
20668,TBC1D7,C0041341,Everolimus,DB01590,Tuberous Sclerosis,Approved,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25900,HMGA1,C0023269,Gemcitabine,DB00441,leiomyosarcoma,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1/Phase 2,Cancer,HMGIY,,,,,,,,,,,,,,,,,,,,,,,,,
15647,SCN2A,C0014547,Primidone,DB00794,"Epilepsies, Partial",Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,Nav1.2,HBSCII,SCN2A1,SCN2A2,,,,,,,,,,,,,,,,,,,,,,
5954,Ticarcillin,DB01607,Genitourinary tract infection,C1279247,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,ND2,,,,,,,,
3266,Halcinonide,DB06786,"Lupus Erythematosus, Discoid",C0024138,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3C[C@@H]5[C@]4(OC(O5)(C)C)C(=O)CCl)C)O)F},,Immune system disease,,,,,,,,,,,,,,,,,,,TDGF1P6,,,,,,,,
20307,PRRT2,C3536984,Ergocalciferol,DB00153,"Vitamin D-Resistant Rickets, X-Linked",Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12580,CYP1B1,C0600142,Testosterone,DB00624,Hot flushes,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,,CP1B,GLC3A,,,,,,,,,,,,,,,,,,,,,,,,
5822,Terbinafine,DB00857,Onychomycosis of fingernails,C1274469,Approved,CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21},,Infectious disease,,,,,,,,,,,,,,,,,,,EIF2S3,,,,,,,,
21545,CTSH,C0751362,Viloxazine,DB09185,Narcolepsy-Cataplexy Syndrome,Approved,CCOC1=CC=CC=C1OCC2CNCCO2},,Nervous system disease,ACC-4,ACC-5,ACC4,ACC5,CPSB,,,,,,,,,,,,,,,,,,,,,
23514,SDHC,C0031511,Phentolamine,DB00692,Pheochromocytoma,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
8117,Fluticasone Propionate,DB00588,Bronchiolitis,C0006271,Terminated,CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF},Phase 2,Lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
23306,PRKDC,C0021603,Cyclobenzaprine,DB00924,Sleep Initiation and Maintenance Disorders,Terminated,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
9717,IL10,C1112209,Trovafloxacin,DB00685,Intraabdominal Infections,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
7452,COMT,C1269683,Quetiapine,DB01224,Major Depressive Disorder,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,MIR30A,,,,,,,,
20031,NR2E3,C0271093,Echothiophate,DB01057,Stargardt's disease,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Infectious disease,rd7,RP37,,,,,,,,,,,,,,,,,,,,,,,,
26783,TICAM2,C0280451,Allopurinol,DB00437,de novo myelodysplastic syndromes,Terminated,C1=NNC2=C1C(=O)NC=N2},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11051,CXCL8,C0018081,Tetracycline,DB00759,Gonorrhea,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
31695,IL13,C0006271,Fluticasone Propionate,DB00588,Bronchiolitis,Terminated,CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF},Phase 2,Lung disease,P600,IL-13,ALRH,BHR1,MGC116786,MGC116788,MGC116789,,,,,,,,,,,,,,,,,,,
2808,Fenofibrate,DB01039,Familial hypercholesterolemia - heterozygous,C0342882,Approved,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},,Inherited metabolic disease,,,,,,,,,,,,,,,,,,,TCF21,,,,,,,,
279,Amphotericin B,DB00681,Cutaneous Candidiasis,C0006846,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Immune system disease,,,,,,,,,,,,,,,,,,,Cetirizine,,,,,,,,
18988,ADAMTS13,C0040053,Warfarin,DB00682,Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,VWFCP,vWF-CP,FLJ42993,MGC118899,MGC118900,DKFZp434C2322,C9orf8,,,,,,,,,,,,,,,,,,,
15219,ALDH3A2,C0026838,Tizanidine,DB00697,Muscle Spasticity,Approved,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3897,Mazindol,DB00579,Obesity,C0028754,Approved,C1CN2C(=N1)C3=CC=CC=C3C2(C4=CC=C(C=C4)Cl)O},,Metabolic disease,,,,,,,,,,,,,,,,,,,ESD,,,,,,,,
24432,SNCA,C0019202,Triethylenetetramine,DB06824,Hepatolenticular Degeneration,Approved,C(CNCCNCCN)N},,Congenital disorder of metabolism,NACP,PARK1,PARK4,,,,,,,,,,,,,,,,,,,,,,,
3028,Fusidic Acid,DB02703,Blepharoconjunctivitis,C0005743,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,IL7R,,,,,,,,
8044,CLU,C1739363,Terazosin,DB01162,Prostatic Hypertrophy,Approved,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC},,,SGP-2,SP-40,TRPM-2,KUB1,CLU2,CLI,APOJ,,,,,,,,,,,,,,,,,,,
33230,MPO,C0280141,Sunitinib,DB01268,Acute Undifferentiated Leukemia,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
33809,EPAS1,C0022680,Sirolimus,DB00877,Polycystic Kidney Diseases,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2/Phase 3,Congenital malformation,MOP2,PASD2,HIF2A,HLF,bHLHe73,,,,,,,,,,,,,,,,,,,,,
22114,MKI67,C0392784,Imatinib,DB00619,Dermatofibrosarcoma Protuberans,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,MIB-,PPP1R105,,,,,,,,,,,,,,,,,,,,,,,,
10362,COMT,C0011581,Norepinephrine,DB00368,Depressive disorder,Terminated,C1=CC(=C(C=C1[C@H](CN)O)O)O},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
9601,IL21R,C0008311,Sulbactam,DB09324,Cholangitis,Approved,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C},,Digestive system disease,CD360,,,,,,,,,,,,,,,,,,,,,,,,,
30043,ESR1,C0004114,Temozolomide,DB00853,Astrocytoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,NR3A1,Era,ER-alpha,ESR,,,,,,,,,,,,,,,,,,,,,,
36413,IRF1,C0751956,Nimodipine,DB00393,Acute Cerebrovascular Accidents,Withdrawn,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
597,Benzylpenicillin,DB01053,Actinomycosis,C0001261,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Eszopiclone,,,,,,,,
8201,B4GALT1-AS1,C0003868,Triamcinolone,DB00620,"Arthritis, Gouty",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1365,Ceftizoxime,DB01332,Staphylococcal Pneumonia,C0032308,Approved,CO/N=C(/C1=CSC(=N1)N)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Salsalate,,,,,,,,
15308,RNU4ATAC,C0035579,Calcitriol,DB00136,Rickets,Terminated,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},Phase 2,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
4426,Nitazoxanide,DB00507,Cryptosporidiosis,C0010418,Approved,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,SEMA3C,,,,,,,,
109,Allopurinol,DB00437,Uric acid renal calculus,C0558595,Approved,C1=NNC2=C1C(=O)NC=N2},,Urinary system disease,,,,,,,,,,,,,,,,,,,Avibactam,,,,,,,,
21204,RASA2,C0028326,Fluoxymesterone,DB01185,Noonan Syndrome,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
2999,Fosfomycin,DB00828,Escherichia coli urinary tract infection,C0577708,Approved,C[C@H]1[C@H](O1)P(=O)(O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,PGM3,,,,,,,,
29284,CHD7,C0021051,Vidarabine,DB00194,Immunologic Deficiency Syndromes,Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 1/Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20355,SMAD4,C0281361,Mitomycin,DB00305,Adenocarcinoma of pancreas,Approved,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},,Cancer,DPC4,MADH4,,,,,,,,,,,,,,,,,,,,,,,,
1240,Cefpodoxime,DB01416,Pharyngitis,C0031350,Approved,COCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Polidocanol,,,,,,,,
871,Calcium Acetate,DB00258,Cardiac Arrest,C0018790,Approved,CC(=O)[O-].CC(=O)[O-].[Ca+2]},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,Levobunolol,,,,,,,,
36705,PTGS2,C1153706,Norgestrel,DB09389,Endometrial adenocarcinoma,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
12849,GJC2,C0014733,Procaine benzylpenicillin,DB09320,Erysipelas,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,CX47,CX46.6,SPG44,GJA12,,,,,,,,,,,,,,,,,,,,,,
23629,CCL2,C0023283,Fluconazole,DB00196,"Leishmaniasis, Cutaneous",Terminated,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O},Phase 3,Infectious disease,MCP1,MCP-1,MCAF,SMC-CF,GDCF-2,HC11,MGC9434,SCYA2,,,,,,,,,,,,,,,,,,
32572,OPRL1,C0745133,Nitrendipine,DB01054,Isolated systolic hypertension,Terminated,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11924,ZBTB16,C0023487,Tretinoin,DB00755,Acute Promyelocytic Leukemia,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Cancer,PLZF,ZNF145,,,,,,,,,,,,,,,,,,,,,,,,
18214,GLIPR1,C0027708,Vincristine,DB00541,Nephroblastoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33656,SP7,C0206638,Zoledronic acid,DB00399,Giant Cell Tumor of Bone,Terminated,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},Phase 2,Cancer,osterix,OSX,,,,,,,,,,,,,,,,,,,,,,,,
9043,NUS1,C0017168,Sodium Citrate,DB09154,Gastroesophageal reflux disease,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19038,SOSTDC1,C0029001,Ivermectin,DB00602,Onchocerciasis,Approved,CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C},,Infectious disease,DKFZp564D206,USAG1,DAND7,,,,,,,,,,,,,,,,,,,,,,,
19560,RUNX3,C0278498,Panobinostat,DB06603,Malignant neoplasm of stomach stage IV,Terminated,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)/C=C/C(=O)NO},Phase 2,Cancer,AML2,PEBP2A3,CBFA3,,,,,,,,,,,,,,,,,,,,,,,
2845,Flavoxate,DB01148,Urgency of micturition,C0085606,Approved,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4},,,,,,,,,,,,,,,,,,,,,DRD1,,,,,,,,
102,Alimemazine,DB01246,Symptomatic dermographism,C0343065,Approved,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)CN(C)C},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,Atazanavir,,,,,,,,
14504,CTLA4,C0007847,Topotecan,DB01030,Malignant tumor of cervix,Approved,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O},,Cancer,CD152,CELIAC3,IDDM12,,,,,,,,,,,,,,,,,,,,,,,
29455,GSTP1,C0005695,Mitomycin,DB00305,Bladder Neoplasm,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17462,SCNN1G,C0020625,Tolvaptan,DB06212,Hyponatremia,Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Urinary system disease,ENaCgamma,SCNEG,,,,,,,,,,,,,,,,,,,,,,,,
19476,DTNBP1,C0270458,Doxepin,DB01142,Severe major depression with psychotic features,Approved,CN(C)CC/C=C/1\\C2=CC=CC=C2COC3=CC=CC=C31},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
2964,Fluticasone Propionate,DB00588,"Dermatitis, Atopic",C0011615,Approved,CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF},,Immune system disease,,,,,,,,,,,,,,,,,,,PTX3,,,,,,,,
31527,CYP19A1,C3495917,Exemestane,DB00990,Advanced breast cancer,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C},Phase 2,Cancer,ARO,P-450AROM,CPV1,ARO1,CYAR,aromatase,CYP19,,,,,,,,,,,,,,,,,,,
26948,BCL2,C0280449,Cyclophosphamide,DB00531,secondary acute myeloid leukemia,Terminated,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 3,Cancer,Bcl-2,PPP1R50,,,,,,,,,,,,,,,,,,,,,,,,
35963,MIR192,C0019163,Tenofovir,DB00300,Hepatitis B,Terminated,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7689,IL1B,C0085074,Ulobetasol,DB00596,Granuloma Annulare,Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Skin disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,TRA2B,,,,,,,,
31652,MAGEB6,C0149978,Oxaliplatin,DB00526,Adenocarcinoma of rectum,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
18930,MMP1,C0409959,Diclofenac,DB00586,"Osteoarthritis, Knee",Approved,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,,,,,,,,
2987,Folic Acid,DB00158,Vitamin Deficiency,C1510471,Approved,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N},,Metabolic disease,,,,,,,,,,,,,,,,,,,IFNGR1,,,,,,,,
5695,Sulfacetamide,DB00634,Seborrheic dermatitis,C0036508,Approved,CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,PRKDC,,,,,,,,
2231,Dexamethasone,DB01234,Tenosynovitis,C0039520,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,H3P13,,,,,,,,
24438,SMPD1,C0019202,Triethylenetetramine,DB06824,Hepatolenticular Degeneration,Approved,C(CNCCNCCN)N},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,
13944,ACE,C0026857,Triamcinolone,DB00620,Musculoskeletal Diseases,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,ACE1,CD143,DCP1,,,,,,,,,,,,,,,,,,,,,,,
19385,IL1B,C0020649,Phentermine,DB00191,Hypotension,Approved,CC(C)(CC1=CC=CC=C1)N},,Cardiovascular disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
32414,MMP9,C0007282,Minocycline,DB01017,Carotid Stenosis,Terminated,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},Phase 2,Cardiovascular disease,CLG4B,,,,,,,,,,,,,,,,,,,,,,,,,
36544,CD80,C0393819,Cyclophosphamide,DB00531,"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",Withdrawn,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 2,Nervous system disease,B7.1,B7-1,CD28LG,CD28LG1,,,,,,,,,,,,,,,,,,,,,,
3261,Halcinonide,DB06786,Contact Dermatitis,C0011616,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3C[C@@H]5[C@]4(OC(O5)(C)C)C(=O)CCl)C)O)F},,Immune system disease,,,,,,,,,,,,,,,,,,,RHD,,,,,,,,
36120,GSTM5,C0279663,Paclitaxel,DB01229,Serous cystadenocarcinoma ovary,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
34576,FGF2,C0023890,Dexamethasone,DB01234,Liver Cirrhosis,Terminated,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,Liver disease,FGFB,,,,,,,,,,,,,,,,,,,,,,,,,
6938,Methylprednisolone,DB00959,"Complication of anesthesia during pregnancy, unspecified",C0495199,Terminated,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O},Phase 0,,,,,,,,,,,,,,,,,,,,NKAIN2,,,,,,,,
33025,FOXA2,C0017689,Romidepsin,DB06176,Glucagonoma,Terminated,C/C=C\\1/C(=O)N[C@H](C(=O)O[C@H]\\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C},Phase 2,Cancer,HNF3B,,,,,,,,,,,,,,,,,,,,,,,,,
8987,Ezogabine,DB04953,Epilepsy,C0014544,Terminated,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N},Phase 3,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
35707,MTHFR,C0856169,Valsartan,DB00177,Endothelial dysfunction,Terminated,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26033,ADM,C0023646,Triamcinolone,DB00620,Lichen Planus,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,AM,,,,,,,,,,,,,,,,,,,,,,,,,
31468,BACE1,C0240059,Erythropoietin,DB00016,Ventricular hemorrhage,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 2,,BACE,,,,,,,,,,,,,,,,,,,,,,,,,
28502,FHIT,C0042076,Mitomycin,DB00305,Urologic Neoplasms,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17681,GJB6,C0022568,Loteprednol,DB00873,Keratitis,Withdrawn,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)OCCl)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 3,Skin disease,EDH,CX30,ED2,,,,,,,,,,,,,,,,,,,,,,,
19312,AKT2,C0678222,Paclitaxel,DB01229,Breast Carcinoma,Approved,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
5697,Sulfacetamide,DB00634,Vulvovaginitis,C0042998,Approved,CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N},,Infectious disease,,,,,,,,,,,,,,,,,,,NAIP,,,,,,,,
27233,CDK4,C0007097,Cisplatin,DB00515,Carcinoma,Withdrawn,N.N.Cl[Pt]Cl},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16356,TNFSF13B,C0024537,Primaquine,DB01087,"Malaria, Vivax",Approved,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2},,Infectious disease,BAFF,THANK,BLYS,TALL-1,TALL1,CD257,TNFSF20,,,,,,,,,,,,,,,,,,,
34246,VEGFA,C0010054,Fenofibrate,DB01039,Coronary Arteriosclerosis,Terminated,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 3,Vascular disease,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
13179,RBM45,C0343532,Benzylpenicillin,DB01053,Streptococcal toxic shock syndrome,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34040,HELLPAR,C0018681,Naratriptan,DB00952,Headache,Withdrawn,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
1348,Ceftizoxime,DB01332,Haemophilus influenzae pneumonia,C0276026,Approved,CO/N=C(/C1=CSC(=N1)N)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Roflumilast,,,,,,,,
5837,Teriflunomide,DB08880,"Arthritis, Psoriatic",C0003872,Approved,C/C(=C(\\C#N)/C(=O)NC1=CC=C(C=C1)C(F)(F)F)/O},,Immune system disease,,,,,,,,,,,,,,,,,,,SET,,,,,,,,
4532,Norfloxacin,DB01059,Shigella Infections,C0013371,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SLC20A1,,,,,,,,
22255,TFAP2B,C0013274,Ibuprofen,DB01050,Patent ductus arteriosus,Withdrawn,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O},Phase 2,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
6108,Triamcinolone,DB00620,Alopecia Areata,C0002171,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,,,,,,,,,,,,,,,,,,,PKD2L1,,,,,,,,
5900,Theophylline,DB00277,Asthma,C0004096,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Immune system disease,,,,,,,,,,,,,,,,,,,PEMT,,,,,,,,
36771,FDFT1,C0175694,Lovastatin,DB00227,Smith-Lemli-Opitz Syndrome,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13710,EPO,C0014742,Triamcinolone,DB00620,Erythema Multiforme,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,EP,,,,,,,,,,,,,,,,,,,,,,,,,
32238,MECP2,C0236792,Memantine,DB01043,Asperger Syndrome,Terminated,CC12CC3CC(C1)(CC(C3)(C2)N)C},Phase 2,Mental and behavioural disorder,RTT,MRX16,MRX79,,,,,,,,,,,,,,,,,,,,,,,
16295,IKBKG,C0022104,Milnacipran,DB04896,Irritable Bowel Syndrome,Terminated,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2},Phase 2,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14596,ALOX5,C1336708,Vinblastine,DB00570,Testicular Germ Cell Tumor,Terminated,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,5-LOX,,,,,,,,,,,,,,,,,,,,,,,,,
5666,Streptomycin,DB01082,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,Approved,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,NADSYN1,,,,,,,,
22616,HADH,C1142132,L-Carnitine,DB00583,Carnitine deficiency,Approved,C[N+](C)(C)C[C@@H](CC(=O)[O-])O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15411,NPPB,C0020621,Potassium Citrate,DB09125,Hypokalemia,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
9650,CYBA,C0014836,Tobramycin,DB00684,Escherichia coli Infections,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Infectious disease,p22-PHOX,,,,,,,,,,,,,,,,,,,,,,,,,
1686,Clarithromycin,DB01211,Acute Moraxella catarrhalis bronchitis,C0339932,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,TAC1,,,,,,,,
17863,EPO,C0162316,Succinic acid,DB00139,Iron deficiency anemia,Approved,C(CC(=O)O)C(=O)O},,Hematologic disease,EP,,,,,,,,,,,,,,,,,,,,,,,,,
27797,FLG,C0678306,Atomoxetine,DB00289,alcohol sensitivity,Terminated,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2},Phase 1,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,
33791,PRKCSH,C0022680,Sirolimus,DB00877,Polycystic Kidney Diseases,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2/Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
34538,HCCS,C0149778,Vancomycin,DB00512,Soft Tissue Infections,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25947,AKT1,C0162810,Tranilast,DB07615,"Cicatrix, Hypertrophic",Approved,COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC},,,RAC,PKB,PRKBA,AKT,,,,,,,,,,,,,,,,,,,,,,
5631,Sparfloxacin,DB01208,Chlamydial pneumonia,C0339959,Approved,C[C@@H]1CN(C[C@@H](N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F},,Infectious disease,,,,,,,,,,,,,,,,,,,CILK1,,,,,,,,
25500,SLC12A1,C0020428,Spironolactone,DB00421,Hyperaldosteronism,Approved,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C},,Endocrine disease,NKCC2,,,,,,,,,,,,,,,,,,,,,,,,,
10745,FGF22,C1318973,Vancomycin,DB00512,Staphylococcus aureus infection,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22432,SCN4B,C0004245,Isoprenaline,DB01064,Atrioventricular Block,Approved,CC(C)NCC(C1=CC(=C(C=C1)O)O)O},,Cardiovascular disease,LQT10,,,,,,,,,,,,,,,,,,,,,,,,,
27313,NFKB1,C0008495,Sulbactam,DB09324,Chorioamnionitis,Suspended,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C},Phase 2/Phase 3,Infectious disease,KBF1,NFKB-p50,NF-kappaB,NFkappaB,NF-kB1,,,,,,,,,,,,,,,,,,,,,
14449,PIK3CB,C0079744,Vincristine,DB00541,Diffuse Large B-Cell Lymphoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4235,Minocycline,DB01017,Gonorrhea of rectum,C0275665,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,VN1R31P,,,,,,,,
25207,CDH3,C0870082,Tretinoin,DB00755,Hyperkeratosis,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Skin and connective tissue disease,CDHP,PCAD,,,,,,,,,,,,,,,,,,,,,,,,
21460,IFNG,C0022573,Tobramycin,DB00684,Keratoconjunctivitis,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
25254,PAM,C0751434,Verapamil,DB00661,Classical phenylketonuria,Terminated,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},Phase 2,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
35937,CEACAM3,C1328479,Sunitinib,DB01268,Pancreatic Endocrine Carcinoma,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11131,PERCC1,C0276653,Anidulafungin,DB00362,Invasive Pulmonary Aspergillosis,Withdrawn,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC=C(C=C7)O)O)O)[C@@H](C)O)C)O)O)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18393,ABCB1,C0023474,Nilotinib,DB04868,"Leukemia, Myeloid, Chronic-Phase",Approved,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,P-gp,CD243,GP170,ABC20,PGY1,CLCS,,,,,,,,,,,,,,,,,,,,
20906,KRAS,C0345904,Floxuridine,DB00322,Malignant neoplasm of liver,Approved,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)F)CO)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35713,PTX3,C0856169,Valsartan,DB00177,Endothelial dysfunction,Terminated,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Endocrine and metabolic disease,TSG-14,TNFAIP5,,,,,,,,,,,,,,,,,,,,,,,,
303,Amphotericin B,DB00681,Pneumonia,C0032285,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Cholic Acid,,,,,,,,
34728,ALDH2,C0549393,Ethanol,DB00898,Alcohol problem,Terminated,CCO},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
24639,IL15,C0004031,Prednisolone,DB00860,"Aspergillosis, Allergic Bronchopulmonary",Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5308,Procaine benzylpenicillin,DB09320,"Syphilis, tertiary",C0153188,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,BIN1,,,,,,,,
21384,F3,C0524702,Fondaparinux sodium,DB00569,Pulmonary Thromboembolisms,Approved,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4768,Pantoprazole,DB00213,Gastroesophageal reflux disease,C0017168,Approved,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC},,Digestive system disease,,,,,,,,,,,,,,,,,,,MAGEL2,,,,,,,,
17710,ALB,C0033246,Mesalazine,DB00244,Proctitis,Terminated,C1=CC(=C(C=C1N)C(=O)O)O},Phase 3,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
35286,PPARG,C0017658,Prednisolone,DB00860,Glomerulonephritis,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 3,Urinary system disease,PPARG1,PPARG2,NR1C3,PPARgamma,,,,,,,,,,,,,,,,,,,,,,
27102,HRH2,C2921627,Prednisolone,DB00860,Clinically isolated syndrome,Suspended,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
16204,TNF,C0041466,Ofloxacin,DB01165,Typhoid Fever,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
28964,TP53,C0027627,Sirolimus,DB00877,Neoplasm Metastasis,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27880,GYPB,C2347748,Mitoxantrone,DB01204,Adult Erythroleukemia,Terminated,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},Phase 1,Cancer,GPB,CD235b,,,,,,,,,,,,,,,,,,,,,,,,
13477,CD28,C0005138,Triamcinolone,DB00620,Berylliosis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,
28653,EGFR,C0153690,Ketoconazole,DB01026,Secondary malignant neoplasm of bone,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
15754,GFAP,C0040997,Carbamazepine,DB00564,Trigeminal Neuralgia,Approved,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N},,,FLJ45472,,,,,,,,,,,,,,,,,,,,,,,,,
27195,IL1B,C1266050,Trametinib,DB08911,Poorly Differentiated Thyroid Carcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2,Cancer,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
26717,CYGB,C0020981,Thalidomide,DB01041,Angioimmunoblastic Lymphadenopathy,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Immune system disease,HGB,STAP,,,,,,,,,,,,,,,,,,,,,,,,
2667,Ergocalciferol,DB00153,Vitamin D-dependent rickets,C0221468,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,,,,,,,,,,,,,,,,,,,PUF60,,,,,,,,
23907,CASP3,C0038525,Deferoxamine,DB00746,Subarachnoid Hemorrhage,Terminated,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O},Phase 0,,0,,,,,,,,,,,,,,,,,,,,,,,,,
3353,Hydrocortisone,DB00741,Infective otitis externa,C0021355,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,IDO2,,,,,,,,
35542,OC90,C0154830,Octreotide,DB00104,Proliferative diabetic retinopathy,Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 3,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34784,ABCG5,C0023772,Ezetimibe,DB00973,"Lipid Metabolism, Inborn Errors",Terminated,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O},Phase 3,Congenital disorder of metabolism,STSL,,,,,,,,,,,,,,,,,,,,,,,,,
23205,FHIT,C0220656,Thiotepa,DB04572,Malignant ascites,Approved,C1CN1P(=S)(N2CC2)N3CC3},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26249,ZNF654,C0153594,Vinblastine,DB00570,Malignant neoplasm of testis,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12629,STK36,C0027430,Beclomethasone dipropionate,DB00394,Nasal Polyps,Approved,CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15717,CHAT,C0494475,Primidone,DB00794,Tonic - clonic seizures,Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
36190,SMUG1,C0220603,Valproic Acid,DB00313,childhood brain tumor,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
22835,TPO,C0018021,Liothyronine,DB00279,Goiter,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Endocrine disease,TPX,,,,,,,,,,,,,,,,,,,,,,,,,
22705,PIK3CD,C0206682,Lenvatinib,DB09078,Follicular thyroid carcinoma,Approved,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
18311,ARNT,C0014175,Pioglitazone,DB01132,Endometriosis,Withdrawn,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3},Phase 2/Phase 3,Reproductive system disease,HIF-1beta,bHLHe2,,,,,,,,,,,,,,,,,,,,,,,,
1437,Cefuroxime,DB01112,Escherichia coli urinary tract infection,C0577708,Approved,CO/N=C(/C1=CC=CO1)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Sulfisoxazole,,,,,,,,
2997,Fosamprenavir,DB01319,HIV Infections,C0019693,Approved,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N},,Infectious disease,,,,,,,,,,,,,,,,,,,Ganirelix,,,,,,,,
24654,CEL,C0002390,Prednisolone,DB00860,Extrinsic allergic alveolitis,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Immune system disease,BSSL,MODY8,,,,,,,,,,,,,,,,,,,,,,,,
4085,Methylprednisolone,DB00959,Exfoliative dermatitis,C0011606,Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O},,Skin disease,,,,,,,,,,,,,,,,,,,MIR93,,,,,,,,
31512,H3P10,C3898222,Sirolimus,DB00877,Mucosal Melanoma,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26213,VLDLR,C0271066,Imatinib,DB00619,Choroidal retinal neovascularization,Withdrawn,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 1,Congenital malformation,CARMQ1,CHRMQ1,VLDLRCH,,,,,,,,,,,,,,,,,,,,,,,
29524,CHPT1,C0278502,Fluorouracil,DB00544,recurrent gastric cancer,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32949,PCSK9,C0549399,Simvastatin,DB00641,Low density lipoprotein increased,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Metabolic disease,NARC-1,FH3,HCHOLA3,,,,,,,,,,,,,,,,,,,,,,,
2211,ENPP1,C0011860,Atorvastatin,DB01076,"Diabetes Mellitus, Non-Insulin-Dependent",Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Endocrine disease,PC-1,NPPS,M6S1,PDNP1,,,,,,,,,,,,,,IRF1,,,,,,,,
6934,EDNRA,C0392164,L-Cysteine,DB00151,Pulmonary Cystic Fibrosis,Approved,C([C@@H](C(=O)O)N)S},,Congenital disorder of metabolism,ET-A,ETA-R,hET-AR,,,,,,,,,,,,,,,CAMK1D,,,,,,,,
1592,Cilastatin,DB01597,Abdominal Abscess,C0243001,Approved,CC1(C[C@@H]1C(=O)N/C(=C\\CCCCSC[C@@H](C(=O)O)N)/C(=O)O)C},,,,,,,,,,,,,,,,,,,,,Valsartan,,,,,,,,
25389,ZFY,C0041408,Somatropin recombinant,DB00052,Turner Syndrome,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
8794,JRK,C0013295,Sucralfate,DB00364,Duodenal Ulcer,Approved,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al]},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12524,PRMT1,C0014179,Ertapenem,DB00303,Endometritis,Terminated,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)[C@@H](C)O},Phase 1,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14132,PTPN11,C0039103,Triamcinolone,DB00620,Synovitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,BPTP3,SH-PTP2,SHP-2,PTP2C,SHP2,NS1,,,,,,,,,,,,,,,,,,,,
12162,ABCG8,C0342881,Simvastatin,DB00641,Familial hypercholesterolemia - homozygous,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Inherited metabolic disease,GBD4,,,,,,,,,,,,,,,,,,,,,,,,,
15328,IFNG,C0018790,Metoprolol,DB00264,Cardiac Arrest,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
18992,MERTK,C0040053,Warfarin,DB00682,Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,mer,RP38,c-Eyk,Tyro12,,,,,,,,,,,,,,,,,,,,,,
28476,SMUG1,C0278554,Levoleucovorin,DB11596,Recurrent Rectal Cancer,Withdrawn,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
31825,WNT2,C4048328,Gemcitabine,DB00441,cervical cancer,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 2,Cancer,IRP,INT1L1,,,,,,,,,,,,,,,,,,,,,,,,
2249,Dexchlorpheniramine maleate,DB09555,"Rhinitis, Vasomotor",C0035460,Approved,CN(C)CC[C@@H](C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=C\\C(=O)O)\\C(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,KIF2C,,,,,,,,
31114,PAX2,C0022661,Niacin,DB00627,"Kidney Failure, Chronic",Terminated,C1=CC(=CN=C1)C(=O)O},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
26151,UMPS,C0220987,Uridine triacetate,DB09144,Hereditary orotic aciduria,Approved,CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=O)NC2=O)OC(=O)C)OC(=O)C},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
3272,Halofantrine,DB01218,"Malaria, Falciparum",C0024535,Approved,CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O},,Infectious disease,,,,,,,,,,,,,,,,,,,PDE4B,,,,,,,,
35850,UQCR11,C0032927,Celecoxib,DB00482,Precancerous Conditions,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2/Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
28910,MTOR,C0279680,Metronidazole,DB00916,Transitional cell carcinoma of bladder,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16801,PTGER4,C0010692,Ofloxacin,DB01165,Cystitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,EP4,,,,,,,,,,,,,,,,,,,,,,,,,
727,Betamethasone,DB00443,Thyroiditis,C0040147,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Endocrine disease,,,,,,,,,,,,,,,,,,,Guaifenesin,,,,,,,,
13968,TP53,C0026948,Isotretinoin,DB00982,Mycosis Fungoides,Terminated,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\\C(=O)O)/C)/C},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2341,Digoxin,DB00390,Atrial Fibrillation,C0004238,Approved,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,JUNB,,,,,,,,
12939,PLAAT4,C0011633,Benzoic Acid,DB03793,Dermatomyositis,Approved,C1=CC=C(C=C1)C(=O)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24465,GDNF,C0221154,Phentolamine,DB00692,Paroxysmal hypertension,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cardiovascular disease,ATF1,ATF2,HFB1-GDNF,,,,,,,,,,,,,,,,,,,,,,,
22932,TRNS1,C0030757,Spinosad,DB08823,Pediculus capitis infestation,Approved,CC[C@H]1CCCC([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3[C@@H]2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCCC([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33686,SAT1,C0001956,Zonisamide,DB00909,alcohol use disorder,Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
5663,Streptomycin,DB01082,Proteus urinary tract infection,C0577709,Approved,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CDHR3,,,,,,,,
28860,GSTM2,C0279681,Metronidazole,DB00916,Bladder Squamous Cell Carcinoma,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4475,Norfloxacin,DB01059,Anthrax disease,C0003175,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,DMRT1,,,,,,,,
36417,STS,C0333875,Celecoxib,DB00482,High-Grade Squamous Intraepithelial Lesions,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3042,Fusidic Acid,DB02703,Dacryocystitis,C0010930,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,,,,,,,,,,,,,,,,,,,,BRMS1,,,,,,,,
8921,PRLHR,C0013395,Omeprazole,DB00338,Dyspepsia,Suspended,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 2,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17891,THAP11,C0042847,Thiamine,DB00152,Vitamin B 12 Deficiency,Approved,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16717,ABCB1,C0027497,Haloperidol,DB00502,Nausea,Withdrawn,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F},Phase 0,Digestive system disease,P-gp,CD243,GP170,ABC20,PGY1,CLCS,,,,,,,,,,,,,,,,,,,,
25878,KIF3A,C0085413,Tolvaptan,DB06212,"Polycystic Kidney, Autosomal Dominant",Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
34446,CFTR,C0010034,Cyclosporine,DB00091,Corneal Diseases,Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 3,,ABC35,TNR-CFTR,CFTR/MRP,CF,ABCC7,,,,,,,,,,,,,,,,,,,,,
9390,BPIFA2,C0030568,Trihexyphenidyl,DB00376,"Parkinson Disease, Postencephalitic",Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17021,HLA-DRB1,C0023343,Dapsone,DB00250,Leprosy,Approved,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
8353,Lidocaine,DB00281,Pain,C0030193,Terminated,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
3069,Fusidic Acid,DB02703,Meibomianitis,C0549398,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Nervous system disease,,,,,,,,,,,,,,,,,,,RNASE3,,,,,,,,
23492,LTB4R,C0040921,Tinidazole,DB00911,Trichomonas Infections,Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Infectious disease,BLTR,P2Y7,LTB4R1,P2RY7,GPR16,CMKRL1,,,,,,,,,,,,,,,,,,,,
16873,SOX11,C0023443,Pentostatin,DB00552,Hairy Cell Leukemia,Approved,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
7666,ERCC2,C0015230,Zinc oxide,DB09321,Exanthema,Approved,O=[Zn]},,Infectious disease,0,,,,,,,,,,,,,,,,,NAALADL2,,,,,,,,
32785,PPP1R15A,C0039730,Pegfilgrastim,DB00019,Thalassemia,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
684,Betamethasone,DB00443,Contact Dermatitis,C0011616,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Immune system disease,,,,,,,,,,,,,,,,,,,Fosfomycin,,,,,,,,
14455,JAK2,C0079744,Vincristine,DB00541,Diffuse Large B-Cell Lymphoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,JTK10,,,,,,,,,,,,,,,,,,,,,,,,,
35693,CRP,C0856169,Valsartan,DB00177,Endothelial dysfunction,Terminated,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
20851,ABCD1,C0042024,Tolterodine,DB01036,Urinary Incontinence,Terminated,CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
22098,VN1R17P,C0346421,Imatinib,DB00619,Chronic eosinophilic leukemia,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
21932,AKT1,C0025202,Lovastatin,DB00227,melanoma,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,RAC,PKB,PRKBA,AKT,,,,,,,,,,,,,,,,,,,,,,
32885,MAPK1,C0178782,Pregabalin,DB00230,Orofacial Pain,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,,ERK2,p41mapk,MAPK2,PRKM2,PRKM1,,,,,,,,,,,,,,,,,,,,,
10311,KCNE5,C0042510,Metoprolol,DB00264,Ventricular Fibrillation,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
19003,CYP3A5,C0040053,Warfarin,DB00682,Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17386,HBA2,C0031069,Colchicine,DB01394,Familial Mediterranean Fever,Approved,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC},,Infectious disease,HBA-T2,,,,,,,,,,,,,,,,,,,,,,,,,
20697,AHR,C0473527,Simvastatin,DB00641,Hypoalphalipoproteinemias,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Endocrine and metabolic disease,bHLHe76,,,,,,,,,,,,,,,,,,,,,,,,,
16738,FSHR,C0027497,Haloperidol,DB00502,Nausea,Withdrawn,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F},Phase 0,Digestive system disease,FSHRO,LGR1,ODG1,,,,,,,,,,,,,,,,,,,,,,,
37041,ALAD,C0023176,Penicillamine,DB00859,Lead Poisoning,Withdrawn,CC(C)([C@H](C(=O)O)N)S},Phase 2/Phase 3,,ALADH,PBGS,,,,,,,,,,,,,,,,,,,,,,,,
34547,CCL28,C0149778,Vancomycin,DB00512,Soft Tissue Infections,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13653,SGCZ,C0037274,Triamcinolone,DB00620,Dermatologic disorders,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29066,LDLR,C1956346,Heparin,DB01109,Coronary Artery Disease,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14787,GHRH,C0001206,Somatostatin,DB09099,Acromegaly,Terminated,C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=CC=C6)O},Phase 2,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14318,PSAT1,C0936223,Nilutamide,DB00665,Metastatic Prostate Carcinoma,Approved,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3649,Lansoprazole,DB00448,Zollinger-Ellison syndrome,C0043515,Approved,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,SLC35A1,,,,,,,,
7383,TFRC,C0162568,Afamelanotide,DB04931,Erythropoietic Protoporphyria,Approved,CCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N5CCC[C@H]5C(=O)N[C@@H](C(C)C)C(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CC=C(C=C6)O)NC(=O)[C@H](CO)NC(=O)C},,Congenital disorder of metabolism,CD71,TFR1,p90,,,,,,,,,,,,,,,RAP1GAP,,,,,,,,
14228,TLR2,C0040896,Triamcinolone,DB00620,Trichinellosis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,TIL4,CD282,,,,,,,,,,,,,,,,,,,,,,,,
18808,IL1RL1,C0013595,Dexpanthenol,DB09357,Eczema,Approved,CC(C)(CO)[C@H](C(=O)NCCCO)O},,Skin disease,ST2,FIT-1,ST2V,DER4,IL33R,,,,,,,,,,,,,,,,,,,,,
13783,CCHCR1,C0019829,Tacrolimus,DB00864,Hodgkin Disease,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29965,IGFALS,C0043116,Sodium phenylbutyrate,DB06819,HMN (Hereditary Motor Neuropathy) Proximal Type I,Terminated,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},Phase 1/Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5023,Polaprezinc,DB09221,Peptic Ulcer,C0030920,Approved,C1=C(NC=N1)C[C@@H](C(=O)O)[N-]C(=O)CCN.[Zn]},,Digestive system disease,,,,,,,,,,,,,,,,,,,RAB32,,,,,,,,
20397,ABCB6,C0012546,Erythromycin,DB00199,Diphtheria,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
339,Ampicillin,DB00415,Gonorrhea of rectum,C0275665,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Clonidine,,,,,,,,
16149,ISG15,C0006060,Fusidic Acid,DB02703,Boutonneuse Fever,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,IFI15,G1P2,,,,,,,,,,,,,,,,,,,,,,,,
22566,F12,C0001622,Trilostane,DB01108,Adrenal Gland Hyperfunction,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(CC(=C([C@H]4O5)O)C#N)C},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12915,CD1A,C0040247,Benzocaine,DB01086,Tinea,Approved,CCOC(=O)C1=CC=C(C=C1)N},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
20724,PRKAR1A,C0085681,Sevelamer,DB00658,Hyperphosphatemia (disorder),Terminated,C=CCN.C1C(O1)CCl},Phase 3,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29400,MYD88,C0004623,Triamcinolone,DB00620,Bacterial Infections,Terminated,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},Phase 1/Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
26744,GSTK1,C0278787,Sunitinib,DB01268,chronic myelogenous leukemia in relapse,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32777,RN7SL263P,C0019045,Pegfilgrastim,DB00019,Hemoglobinopathies,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
11807,PIH1D3,C0008677,Vilanterol,DB09082,"Bronchitis, Chronic",Approved,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10600,NT5E,C0271429,Trimethoprim,DB00440,Acute otitis media,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,CD73,eN,eNT,CALJA,NT5,,,,,,,,,,,,,,,,,,,,,
27595,CSE1L,C0010073,Sildenafil,DB00203,Coronary Artery Vasospasm,Suspended,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C},Phase 3,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
653,Benzylpenicillin,DB01053,"Syphilis, tertiary",C0153188,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Fluorouracil,,,,,,,,
26463,BRCA2,C0279661,Sirolimus,DB00877,Acinar cell carcinoma of pancreas,Suspended,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25237,MAPK14,C0751434,Verapamil,DB00661,Classical phenylketonuria,Terminated,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},Phase 2,Congenital disorder of metabolism,PRKM14,Mxi2,PRKM15,CSPB1,CSBP1,CSBP2,,,,,,,,,,,,,,,,,,,,
14498,KRAS,C0007847,Topotecan,DB01030,Malignant tumor of cervix,Approved,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
24359,MSLN,C0812413,Pemetrexed,DB00642,Malignant Pleural Mesothelioma,Approved,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,MPF,,,,,,,,,,,,,,,,,,,,,,,,,
14419,DPYD,C0278996,Methotrexate,DB00563,Cancer of Head and Neck,Approved,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12604,SELENBP1,C0600142,Testosterone,DB00624,Hot flushes,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,,hSP56,hSBP,LPSB,,,,,,,,,,,,,,,,,,,,,,,
21271,HLA-DRB1,C0155877,Zileuton,DB00744,Allergic asthma,Approved,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O},,Immune system disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
34573,CTNNB1,C0023890,Dexamethasone,DB01234,Liver Cirrhosis,Terminated,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,Liver disease,beta-catenin,armadillo,CTNNB,,,,,,,,,,,,,,,,,,,,,,,
27099,H2AX,C2921627,Prednisolone,DB00860,Clinically isolated syndrome,Suspended,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
21736,ACHE,C0022972,Guanidine,DB00536,Lambert-Eaton Myasthenic Syndrome,Approved,C(=N)(N)N},,Nervous system disease,YT,,,,,,,,,,,,,,,,,,,,,,,,,
1990,Cyclopentolate,DB00979,Mydriasis,C0026961,Approved,CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O},,,,,,,,,,,,,,,,,,,,,TNC,,,,,,,,
27286,PATZ1,C0281508,Vitamin C,DB00126,Desmoplastic Small Round Cell Tumor,Suspended,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
8288,IL10,C1262211,Ranolazine,DB00243,Diarrhoea predominant irritable bowel syndrome,Terminated,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O},Phase 2/Phase 3,Digestive system disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
32884,IL1B,C0178782,Pregabalin,DB00230,Orofacial Pain,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
18319,RYR1,C0024591,Dantrolene,DB01219,Malignant hyperpyrexia due to anesthesia,Approved,C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-]},,,RYR,PPP1R137,MHS,MHS1,CCO,,,,,,,,,,,,,,,,,,,,,
25817,HRAS,C0005684,Mitomycin,DB00305,Malignant neoplasm of urinary bladder,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15513,ZBTB20,C0024623,Citalopram,DB00215,Malignant neoplasm of stomach,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9954,TLR4,C0276089,Trovafloxacin,DB00685,Pneumonia due to Escherichia coli,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,,,,,,,,,
2322,Diethylcarbamazine,DB00711,Onchocerciasis,C0029001,Approved,CCN(CC)C(=O)N1CCN(CC1)C},,Infectious disease,,,,,,,,,,,,,,,,,,,TNFSF13B,,,,,,,,
13728,ALOX12B,C0011606,Triamcinolone,DB00620,Exfoliative dermatitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16250,SLC6A4,C0001957,Oxazepam,DB00842,Alcohol Withdrawal Delirium,Approved,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O},,Mental and behavioural disorder,5-HTT,SERT1,HTT,OCD1,,,,,,,,,,,,,,,,,,,,,,
35678,ABCA1,C0747820,Sulfadoxine,DB01299,"Malaria, antepartum",Terminated,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N},Phase 3,Infectious disease,TGD,HDLDT1,,,,,,,,,,,,,,,,,,,,,,,,
33083,TMPRSS11F,C2076600,Rosuvastatin,DB01098,Influenza due to Influenza A virus subtype H1N1,Terminated,CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6966,GPR42,C0392164,L-Cysteine,DB00151,Pulmonary Cystic Fibrosis,Approved,C([C@@H](C(=O)O)N)S},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,TNFRSF12A,,,,,,,,
22117,VIM,C0392784,Imatinib,DB00619,Dermatofibrosarcoma Protuberans,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
24386,MIR34B,C0812413,Pemetrexed,DB00642,Malignant Pleural Mesothelioma,Approved,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
24512,ALB,C0003615,Ropivacaine,DB00296,Appendicitis,Terminated,CCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C},Phase 2,Other disease,,,,,,,,,,,,,,,,,,,,,,,,,,
8042,AR,C1739363,Terazosin,DB01162,Prostatic Hypertrophy,Approved,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC},,,AIS,NR3C4,SMAX1,HUMARA,DHTR,SBMA,,,,,,,,,,,,,,,,,,,,
34048,SLC19A2,C0018681,Naratriptan,DB00952,Headache,Withdrawn,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
9858,ANO5,C0029443,Amikacin,DB00479,Osteomyelitis,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29362,ESR1,C1699634,Letrozole,DB01006,HER-2 positive breast cancer,Withdrawn,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3},Phase 1/Phase 2,Cancer,NR3A1,Era,ER-alpha,ESR,,,,,,,,,,,,,,,,,,,,,,
5368,Pseudoephedrine,DB00852,Hay fever,C0018621,Approved,C[C@@H]([C@H](C1=CC=CC=C1)O)NC},,Infectious disease,,,,,,,,,,,,,,,,,,,CABIN1,,,,,,,,
32670,PIK3CA,C0206695,Octreotide,DB00104,"Carcinoma, Neuroendocrine",Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 2,Cancer,PI3K,,,,,,,,,,,,,,,,,,,,,,,,,
25982,CXCL9,C0002171,Triamcinolone,DB00620,Alopecia Areata,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26190,LEP,C0600518,Imatinib,DB00619,Choroidal Neovascularization,Withdrawn,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 1,Congenital malformation,OBS,,,,,,,,,,,,,,,,,,,,,,,,,
12025,HLP,C0578870,Loratadine,DB00455,Chronic idiopathic urticaria,Approved,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21056,FAAH,C2267227,Acetylcysteine,DB06151,Bulimia Nervosa,Terminated,CC(=O)N[C@@H](CS)C(=O)O},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
4945,Phenytoin,DB00252,Simple Partial Seizures,C0234974,Approved,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3},,Nervous system disease,,,,,,,,,,,,,,,,,,,RNA28SN5,,,,,,,,
30825,IL10,C1321872,Fludarabine,DB01073,Stage IV Skin Melanoma,Terminated,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 2,Cancer,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
14208,TRNL1,C0040147,Triamcinolone,DB00620,Thyroiditis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16337,TNF,C0017574,Chlorhexidine,DB00878,Gingivitis,Approved,C1=CC(=CC=C1N/C(=N/C(=NCCCCCCN=C(/N=C(/NC2=CC=C(C=C2)Cl)\\N)N)N)/N)Cl},,,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
3777,Lixisenatide,DB09265,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCC[C@H]3C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@H](CC6=CC=CC=C6)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC8=CNC=N8)N},,Endocrine disease,,,,,,,,,,,,,,,,,,,NDUFS6,,,,,,,,
33411,AKR1A1,C0687132,Topiramate,DB00273,heavy drinking,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
34946,REN,C0025517,Heparin,DB01109,Metabolic Diseases,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
15703,GAMT,C0494475,Primidone,DB00794,Tonic - clonic seizures,Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,PIG2,TP53I2,,,,,,,,,,,,,,,,,,,,,,,,
5539,Scopolamine,DB00747,Mydriasis,C0026961,Approved,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},,,,,,,,,,,,,,,,,,,,,TPCN1,,,,,,,,
4208,Midazolam,DB00683,Agitation,C0085631,Approved,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F},,,,,,,,,,,,,,,,,,,,,PRKACA,,,,,,,,
13709,DSP,C0014742,Triamcinolone,DB00620,Erythema Multiforme,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22554,VWF,C0001622,Trilostane,DB01108,Adrenal Gland Hyperfunction,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(CC(=C([C@H]4O5)O)C#N)C},,Endocrine disease,F8VWF,,,,,,,,,,,,,,,,,,,,,,,,,
10161,GTF2H5,C0006266,Theophylline,DB00277,Bronchial Spasm,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33397,PON1,C0687132,Topiramate,DB00273,heavy drinking,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
30524,ABCD1,C0152025,Capsaicin,DB06774,Polyneuropathy,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29172,IDH2,C1541316,Irinotecan,DB00762,adult giant cell glioblastoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
20349,AKT1,C0023827,Trabectedin,DB05109,liposarcoma,Approved,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O},,Cancer,RAC,PKB,PRKBA,AKT,,,,,,,,,,,,,,,,,,,,,,
24987,EMP1,C0040558,Sulfamethoxazole,DB01015,Toxoplasmosis,Approved,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,TMP,CL-20,,,,,,,,,,,,,,,,,,,,,,,,
8235,MUC22,C0018099,Naproxen,DB00788,Gout,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31047,HLA-DRB1,C0030809,Dapsone,DB00250,Pemphigus Vulgaris,Terminated,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N},Phase 2,Skin and connective tissue disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
28320,CASP9,C0242006,Azacitidine,DB00928,Myelofibrosis due to another disorder,Terminated,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15816,SNORD116-1,C0032897,Somatropin recombinant,DB00052,Prader-Willi Syndrome,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Chromosomal abnormality,0,,,,,,,,,,,,,,,,,,,,,,,,,
15014,OPN1SW,C0085159,Bupropion,DB01156,Seasonal Affective Disorder,Approved,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
11369,SLC12A3,C0035021,Tetracycline,DB00759,Relapsing Fever,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,NCCT,,,,,,,,,,,,,,,,,,,,,,,,,
23416,CELP,C0017536,Tinidazole,DB00911,Giardiasis,Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9167,Norepinephrine,DB00368,Depressive disorder,C0011581,Terminated,C1=CC(=C(C=C1[C@H](CN)O)O)O},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,
20558,KISS1,C0271578,Tranexamic Acid,DB00302,Female hypogonadism syndrome,Approved,C1CC(CCC1CN)C(=O)O},,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,
15116,KRAS,C0238462,Sorafenib,DB00398,Medullary carcinoma of thyroid,Withdrawn,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9140,Mycophenolate mofetil,DB00688,Lupus Nephritis,C0024143,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)OCCN3CCOCC3)O},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
30211,KLKB1,C1861172,Atorvastatin,DB01076,Venous Thromboembolism,Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 2,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19223,NOS2,C0751967,Mitoxantrone,DB01204,"Multiple Sclerosis, Relapsing-Remitting",Approved,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},,Nervous system disease,iNOS,HEP-NOS,NOS2A,,,,,,,,,,,,,,,,,,,,,,,
15942,IDH1,C0153633,Carmustine,DB00262,Malignant neoplasm of brain,Approved,C(CCl)NC(=O)N(CCCl)N=O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33841,CCL2,C0011875,Heparin,DB01109,Diabetic Angiopathies,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2/Phase 3,Vascular disease,MCP1,MCP-1,MCAF,SMC-CF,GDCF-2,HC11,MGC9434,SCYA2,,,,,,,,,,,,,,,,,,
20061,CALCR,C0020437,Cholecalciferol,DB00169,Hypercalcemia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 2/Phase 3,Urinary system disease,CTR,,,,,,,,,,,,,,,,,,,,,,,,,
19737,HSP90B1,C0023860,Minocycline,DB01017,Listeriosis,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8021,ERAL1,C0035086,Calcitriol,DB00136,Renal Osteodystrophy,Approved,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4417,Nifedipine,DB01115,Hypertensive disease,C0020538,Approved,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,SLC5A6,,,,,,,,
16494,CYP19A1,C0029456,Calcium carbonate,DB06724,Osteoporosis,Withdrawn,C(=O)([O-])[O-].[Ca+2]},Phase 3,Musculoskeletal disease,ARO,P-450AROM,CPV1,ARO1,CYAR,aromatase,CYP19,,,,,,,,,,,,,,,,,,,
19854,TPH1,C0520676,Sertraline,DB01104,Premenstrual Dysphoric Disorder,Approved,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl},,Endocrine and metabolic disease,TPRH,TPH,,,,,,,,,,,,,,,,,,,,,,,,
33858,MAP2K7,C0751690,Imatinib,DB00619,Malignant Peripheral Nerve Sheath Tumor,Terminated,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 2/Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
22070,SFTPD,C0019357,Vidarabine,DB00194,"Keratitis, Herpetic",Approved,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},,Infectious disease,SP-D,COLEC7,SFTP4,,,,,,,,,,,,,,,,,,,,,,,
21517,PRKN,C0035258,Rotigotine,DB05271,Restless Legs Syndrome,Approved,CCCN(CCC1=CC=CS1)[C@H]2CCC3=C(C2)C=CC=C3O},,Nervous system disease,PDJ,AR-JP,parkin,PARK2,,,,,,,,,,,,,,,,,,,,,,
24659,PARP9,C0002390,Prednisolone,DB00860,Extrinsic allergic alveolitis,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1238,Cefpodoxime,DB01416,Infective otitis media,C0729586,Approved,COCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Podofilox,,,,,,,,
36210,OPRM1,C1510472,Varenicline,DB01273,Drug Dependence,Withdrawn,C1C2CNCC1C3=CC4=NC=CN=C4C=C23},Phase 1,Mental and behavioural disorder,MOR1,,,,,,,,,,,,,,,,,,,,,,,,,
24156,DRD5,C0036337,Olanzapine,DB00334,Schizoaffective Disorder,Withdrawn,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
5183,Prednisolone,DB00860,Ocular Rosacea,C0406486,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,POLH,,,,,,,,
300,Amphotericin B,DB00681,Oral candidiasis,C0006849,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Chlorzoxazone,,,,,,,,
25600,HLA-DQA1,C0040560,Sulfadiazine,DB00359,"Toxoplasmosis, Congenital",Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,HLA-DQA,,,,,,,,,,,,,,,,,,,,,,,,,
23509,VHL,C0031511,Phentolamine,DB00692,Pheochromocytoma,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13060,SERPINA1,C0030848,Benzoic Acid,DB03793,Peyronie Disease,Approved,C1=CC=C(C=C1)C(=O)O},,Reproductive system disease,AAT,A1A,PI1,alpha-1-antitrypsin,A1AT,alpha1AT,PI,,,,,,,,,,,,,,,,,,,
12141,C20orf181,C0342882,Simvastatin,DB00641,Familial hypercholesterolemia - heterozygous,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Inherited metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3152,Gemifloxacin,DB01155,Acute exacerbation of chronic bronchitis,C0856695,Approved,CO/N=C/1\\CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F},,Lung disease,,,,,,,,,,,,,,,,,,,NLRP12,,,,,,,,
1948,Cortisone acetate,DB01380,Thyroiditis,C0040147,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Endocrine disease,,,,,,,,,,,,,,,,,,,TRPV4,,,,,,,,
8739,Thalidomide,DB01041,Stomatitis,C0038362,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
14360,EDNRB,C0009806,Oxycodone,DB00497,Constipation,Terminated,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O},Phase 3,Digestive system disease,ETB,HSCR2,HSCR,,,,,,,,,,,,,,,,,,,,,,,
27341,TRRAP,C1335177,Trametinib,DB08911,Ovarian Serous Adenocarcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2/Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
18579,XYLT2,C0019156,Defibrotide,DB04932,Hepatic Veno-Occlusive Disease,Approved,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21538,HLA-DQB1,C0751362,Viloxazine,DB09185,Narcolepsy-Cataplexy Syndrome,Approved,CCOC1=CC=CC=C1OCC2CNCCO2},,Nervous system disease,HLA-DQB,,,,,,,,,,,,,,,,,,,,,,,,,
17482,OCRL,C0020625,Tolvaptan,DB06212,Hyponatremia,Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2397,Dipyridamole,DB00975,Atrial Fibrillation,C0004238,Approved,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,VCP,,,,,,,,
25193,PTPN11,C0027022,Vidarabine,DB00194,Myeloproliferative disease,Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 2,Cancer,BPTP3,SH-PTP2,SHP-2,PTP2C,SHP2,NS1,,,,,,,,,,,,,,,,,,,,
29441,CALCA,C0021368,Methotrexate,DB00563,Inflammation,Withdrawn,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,,CALC1,,,,,,,,,,,,,,,,,,,,,,,,,
22583,TNF,C0030409,Ketoconazole,DB01026,Paracoccidioidomycosis,Approved,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},,Infectious disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
6623,NTF4,C0017605,Methazolamide,DB00703,Angle Closure Glaucoma,Approved,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C},,Nervous system disease,0,,,,,,,,,,,,,,,,,SLC30A2,,,,,,,,
33831,ASS1,C0011875,Heparin,DB01109,Diabetic Angiopathies,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2/Phase 3,Vascular disease,CTLN1,ASS,,,,,,,,,,,,,,,,,,,,,,,,
23324,IKZF4,C0042900,Tacrolimus,DB00864,Vitiligo,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32015,TWIST1,C0003614,Oxaliplatin,DB00526,Appendiceal Neoplasms,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30889,TTR,C0162429,Nandrolone phenpropionate,DB00984,Malnutrition,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CC[C@H]35},Phase 2,Cancer,HsT2651,CTS,PALB,CTS1,,,,,,,,,,,,,,,,,,,,,,
15714,IL6,C0494475,Primidone,DB00794,Tonic - clonic seizures,Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
26053,CFI,C0034063,Trimethaphan,DB01116,Pulmonary Edema,Approved,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24203,HFE,C0267963,Pancrelipase,DB00085,Exocrine pancreatic insufficiency,Approved,C1CC2C(C(C1O2)C(=O)[O-])C(=O)[O-].[Na+].[Na+]},,Digestive system disease,HLA-H,,,,,,,,,,,,,,,,,,,,,,,,,
10900,IL15,C0004030,Voriconazole,DB00582,Aspergillosis,Withdrawn,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19553,ERCC1,C0278498,Panobinostat,DB06603,Malignant neoplasm of stomach stage IV,Terminated,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)/C=C/C(=O)NO},Phase 2,Cancer,RAD10,,,,,,,,,,,,,,,,,,,,,,,,,
394,Apomorphine,DB00714,Parkinson Disease,C0030567,Approved,CN1CCC2=C3[C@H]1CC4=C(C3=CC=C2)C(=C(C=C4)O)O},,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,FTO,,,,,,,,
27063,FOXP1,C0205824,Ifosfamide,DB01181,"Liposarcoma, Dedifferentiated",Suspended,C1CN(P(=O)(OC1)NCCCl)CCCl},Phase 2,Cancer,QRF1,12CC4,HSPC215,hFKH1B,,,,,,,,,,,,,,,,,,,,,,
15464,LOX,C0264716,Amlodipine,DB00381,Chronic heart failure,Suspended,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN},Phase 2,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
3235,Granisetron,DB00889,Chemotherapy-induced nausea and vomiting,C0401160,Approved,CN1[C@@H]2CCC[C@H]1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C},,,,,,,,,,,,,,,,,,,,,CCR7,,,,,,,,
8363,GABRG2,C0003467,Citalopram,DB00215,Anxiety,Withdrawn,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
4767,Pantoprazole,DB00213,Erosive esophagitis,C0267055,Approved,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC},,Digestive system disease,,,,,,,,,,,,,,,,,,,TBCA,,,,,,,,
33608,CYBA,C0018799,Vitamin E,DB00163,Heart Diseases,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Cardiovascular disease,p22-PHOX,,,,,,,,,,,,,,,,,,,,,,,,,
16972,IL4,C3875321,Pramocaine,DB09345,Inflammatory dermatosis,Approved,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2},,Skin and connective tissue disease,BSF1,IL-4,BCGF1,BCGF-1,MGC79402,,,,,,,,,,,,,,,,,,,,,
3588,Kanamycin,DB01172,Meningitis,C0025289,Approved,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N},,Infectious disease,,,,,,,,,,,,,,,,,,,STX1A,,,,,,,,
248,Amoxicillin,DB01060,Pharyngitis,C0031350,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Carteolol,,,,,,,,
32714,SPATA6,C0015944,Oxytocin,DB00107,"Fetal Membranes, Premature Rupture",Terminated,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
12101,NOS3,C0003850,Simvastatin,DB00641,Arteriosclerosis,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Vascular disease,ECNOS,eNOS,,,,,,,,,,,,,,,,,,,,,,,,
17988,CDK6,C0035335,Melphalan,DB01042,Retinoblastoma,Terminated,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35647,AVP,C1536220,Ticagrelor,DB08816,ST segment elevation myocardial infarction,Terminated,CCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)OCCO)N[C@@H]4C[C@H]4C5=CC(=C(C=C5)F)F},Phase 3,Cardiovascular disease,ADH,ARVP,,,,,,,,,,,,,,,,,,,,,,,,
34950,CXCL1,C0032310,Hydrocortisone,DB00741,"Pneumonia, Viral",Terminated,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},Phase 3,Infectious disease,SCYB1,GROa,MGSA-a,NAP-3,MGSA,GRO1,FSP,,,,,,,,,,,,,,,,,,,
35741,SNCA,C0038868,Rasagiline,DB01367,Progressive supranuclear palsy,Terminated,C#CCN[C@@H]1CCC2=CC=CC=C12},Phase 3,Neurodegenerative disease,NACP,PARK1,PARK4,,,,,,,,,,,,,,,,,,,,,,,
22542,AKT1,C0022354,Kappadione,DB09332,"Jaundice, Obstructive",Approved,CC1=C(C2=CC=CC=C2C(=C1)OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+]},,Liver disease,RAC,PKB,PRKBA,AKT,,,,,,,,,,,,,,,,,,,,,,
8554,Pregabalin,DB00230,Vulvar Vestibulitis,C0269084,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
12339,CFI,C0034186,Ofloxacin,DB01165,Pyelonephritis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28612,SMUG1,C0238033,Goserelin,DB00014,Carcinoma of Male Breast,Terminated,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
21725,CCDC6,C0040250,Tolnaftate,DB00525,Tinea Capitis,Approved,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17919,ATM,C0024299,Pegfilgrastim,DB00019,Lymphoma,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1824,Clozapine,DB00363,Treatment-resistant schizophrenia,C3544321,Approved,CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,EMP1,,,,,,,,
14480,DNMT3B,C0153601,Bleomycin,DB00290,Malignant neoplasm of penis,Approved,CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
29280,CFD,C0021051,Vidarabine,DB00194,Immunologic Deficiency Syndromes,Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 1/Phase 2,Immune system disease,ADN,DF,PFD,,,,,,,,,,,,,,,,,,,,,,,
14551,MIR4772,C0080032,Thiotepa,DB04572,"Pleural Effusion, Malignant",Approved,C1CN1P(=S)(N2CC2)N3CC3},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2464,ECE1,C0020538,Propofol,DB00818,Hypertensive disease,Withdrawn,CC(C)C1=C(C(=CC=C1)C(C)C)O},Phase 3,Cardiovascular disease,ECE,,,,,,,,,,,,,,,,,CDK4,,,,,,,,
22165,PDGFRA,C0206141,Imatinib,DB00619,Idiopathic Hypereosinophilic Syndrome,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,CD140a,PDGFR2,GAS9,,,,,,,,,,,,,,,,,,,,,,,
19795,GAPDH,C0036472,Fusidic Acid,DB02703,Scrub Typhus,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,GAPD,,,,,,,,,,,,,,,,,,,,,,,,,
31712,ESR1,C0021359,Ganirelix,DB06785,Infertility,Withdrawn,CCNC(=NCCCC[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C)NCC},Phase 3,Reproductive system disease,NR3A1,Era,ER-alpha,ESR,,,,,,,,,,,,,,,,,,,,,,
35334,ESR1,C1262313,Micafungin,DB01141,Invasive Fungal Infections,Terminated,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)[C@@H](CC(=O)N)O)C)O)O)O},Phase 3,Infectious disease,NR3A1,Era,ER-alpha,ESR,,,,,,,,,,,,,,,,,,,,,,
6561,HTR7,C0014553,Valproic Acid,DB00313,Absence Epilepsy,Approved,CCCC(CCC)C(=O)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,CCDC57,,,,,,,,
26924,TBX22,C0280449,Cyclophosphamide,DB00531,secondary acute myeloid leukemia,Terminated,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33833,THBS2,C0011875,Heparin,DB01109,Diabetic Angiopathies,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2/Phase 3,Vascular disease,TSP2,,,,,,,,,,,,,,,,,,,,,,,,,
29837,CYP2C19,C0850666,Omeprazole,DB00338,Infection caused by Helicobacter pylori,Terminated,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 1/Phase 2,Infectious disease,P450IIC19,CPCJ,,,,,,,,,,,,,,,,,,,,,,,,
17363,IL1B,C0031069,Colchicine,DB01394,Familial Mediterranean Fever,Approved,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC},,Infectious disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
28990,CCL5,C0019187,Pentoxifylline,DB00806,"Hepatitis, Alcoholic",Terminated,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C},Phase 1,Digestive system disease,RANTES,SISd,TCP228,MGC17164,D17S136E,SCYA5,,,,,,,,,,,,,,,,,,,,
31669,B3GALT5-AS1,C0149978,Oxaliplatin,DB00526,Adenocarcinoma of rectum,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23384,PIK3CB,C0267176,Metoclopramide,DB01233,Gastroparesis due to diabetes mellitus,Approved,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3938,Mefloquine,DB00358,"Malaria, Vivax",C0024537,Approved,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O},,Infectious disease,,,,,,,,,,,,,,,,,,,INHA,,,,,,,,
21837,PNKP,C0034013,Nafarelin,DB00666,Precocious Puberty,Approved,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CC3=CC=CC=C3C=C2)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
30571,PIK3CA,C0151779,Temozolomide,DB00853,Cutaneous Melanoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,PI3K,,,,,,,,,,,,,,,,,,,,,,,,,
25924,VCAN,C0023269,Gemcitabine,DB00441,leiomyosarcoma,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1/Phase 2,Cancer,PG-M,CSPG2,,,,,,,,,,,,,,,,,,,,,,,,
20814,AMBP,C0028734,Flavoxate,DB01148,Nocturia,Approved,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4},,Urinary system disease,UTI,EDC1,HI30,IATIL,ITILC,ITI,ITIL,,,,,,,,,,,,,,,,,,,
11667,STAT5A,C0040028,Anagrelide,DB00261,"Thrombocythemia, Essential",Approved,C1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29821,NME1,C0700292,Nitric Oxide,DB00435,Hypoxemia,Terminated,[N]=O},Phase 1/Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29294,MAGT1,C0021051,Vidarabine,DB00194,Immunologic Deficiency Syndromes,Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 1/Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9059,L-Carnitine,DB00583,Ulcerative Colitis,C0009324,Terminated,C[N+](C)(C)C[C@@H](CC(=O)[O-])O},Phase 3,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
25015,TACR1,C0035235,Ribavirin,DB00811,Respiratory Syncytial Virus Infections,Approved,C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N},,Infectious disease,SPR,NK1R,TAC1R,,,,,,,,,,,,,,,,,,,,,,,
32911,HTR2A,C0003125,Quetiapine,DB01224,Anorexia Nervosa,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
15868,MUC22,C0018213,Carbimazole,DB00389,Graves Disease,Approved,CCOC(=O)N1C=CN(C1=S)C},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35709,NOS3,C0856169,Valsartan,DB00177,Endothelial dysfunction,Terminated,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Endocrine and metabolic disease,ECNOS,eNOS,,,,,,,,,,,,,,,,,,,,,,,,
16520,CYP3A4,C0221468,Ergocalciferol,DB00153,Vitamin D-dependent rickets,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,CYP3A3,,,,,,,,,,,,,,,,,,,,,,,,,
14483,CADM1,C0153601,Bleomycin,DB00290,Malignant neoplasm of penis,Approved,CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O},,Cancer,NECL2,ST17,BL2,SYNCAM,IGSF4A,Necl-2,SYNCAM1,RA175,TSLC1,IGSF4,,,,,,,,,,,,,,,,
32056,RET,C0014132,Oxaliplatin,DB00526,Endocrine Gland Neoplasms,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,CDHF12,RET51,CDHR16,HSCR1,MEN2A,MTC1,MEN2B,,,,,,,,,,,,,,,,,,,
31872,ADA,C0362046,Losartan,DB00678,Prediabetes syndrome,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
22035,LEF1,C0855095,Idelalisib,DB09054,Small Lymphocytic Lymphoma,Approved,CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5},,Cancer,TCF1ALPHA,TCF10,TCF7L3,,,,,,,,,,,,,,,,,,,,,,,
11217,GOLPH3,C0026718,Isavuconazonium,DB06636,Mucormycosis,Approved,C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=[N+](C=N3)C(C)OC(=O)N(C)C4=C(C=CC=N4)COC(=O)CNC)(C5=C(C=CC(=C5)F)F)O},,Infectious disease,GPP34,GOPP1,MIDAS,Vps74,,,,,,,,,,,,,,,,,,,,,,
4384,SRCAP,C0003862,Salicylic acid,DB00936,Arthralgia,Approved,C1=CC=C(C(=C1)C(=O)O)O},,Immune system disease,0,,,,,,,,,,,,,,,,,CAPG,,,,,,,,
3416,Hydroxychloroquine,DB01611,"Malaria, Falciparum",C0024535,Approved,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO},,Infectious disease,,,,,,,,,,,,,,,,,,,FOLH1B,,,,,,,,
19502,IL6,C0276535,Doxorubicin,DB00997,AIDS with Kaposi's sarcoma,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},,Cancer,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
27453,TGM1,C0004903,Vincristine,DB00541,Beckwith-Wiedemann Syndrome,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Congenital malformation,TGASE,TGK,LI,LI1,ICR2,,,,,,,,,,,,,,,,,,,,,
28659,PSAT1,C0153690,Ketoconazole,DB01026,Secondary malignant neoplasm of bone,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15786,CCL11,C0033581,Ofloxacin,DB01165,prostatitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,eotaxin,MGC22554,SCYA11,,,,,,,,,,,,,,,,,,,,,,,
35710,OLR1,C0856169,Valsartan,DB00177,Endothelial dysfunction,Terminated,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Endocrine and metabolic disease,LOX-1,SCARE1,CLEC8A,,,,,,,,,,,,,,,,,,,,,,,
1478,Cephalexin,DB00567,prostatitis,C0033581,Approved,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)SC1)C(=O)O},,Urinary system disease,,,,,,,,,,,,,,,,,,,Teriparatide,,,,,,,,
4591,Ofloxacin,DB01165,Haemophilus influenzae pneumonia,C0276026,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,ARNTL,,,,,,,,
679,Betamethasone,DB00443,Berylliosis,C0005138,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Lung disease,,,,,,,,,,,,,,,,,,,Formaldehyde,,,,,,,,
6959,Atomoxetine,DB00289,Alcohol dependence,C0556385,Terminated,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2},Phase 1,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,AURKB,,,,,,,,
14699,NQO1,C0026764,Vorinostat,DB02546,Multiple Myeloma,Withdrawn,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,DHQU,QR1,NMOR1,DIA4,,,,,,,,,,,,,,,,,,,,,,
32755,HBB,C0019045,Pegfilgrastim,DB00019,Hemoglobinopathies,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Congenital malformation,CD113t-C,beta-globin,,,,,,,,,,,,,,,,,,,,,,,,
29789,ARSF,C0023524,Mefloquine,DB00358,"Leukoencephalopathy, Progressive Multifocal",Terminated,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23900,LAMP3,C0039254,Niclosamide,DB06803,Teniasis,Approved,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O},,Infectious disease,TSC403,DC-LAMP,DCLAMP,CD208,,,,,,,,,,,,,,,,,,,,,,
22356,IL10,C0011854,Pentoxifylline,DB00806,"Diabetes Mellitus, Insulin-Dependent",Terminated,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C},Phase 1/Phase 2,Endocrine disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
1072,Cefdinir,DB00535,Streptococcal tonsillitis,C0275804,Approved,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\O)/C3=CSC(=N3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Naratriptan,,,,,,,,
9037,Hydrocortisone,DB00741,"Pneumonia, Viral",C0032310,Terminated,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
26899,CRP,C0432487,Vidarabine,DB00194,Post-transplant lymphoproliferative disorder,Suspended,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
16044,PRF1,C0025289,Gemcitabine,DB00441,Meningitis,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1,Infectious disease,PFP,HPLH2,,,,,,,,,,,,,,,,,,,,,,,,
28777,KLK3,C0036916,Methamphetamine,DB01577,Sexually Transmitted Diseases,Terminated,C[C@@H](CC1=CC=CC=C1)NC},Phase 1,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
19213,IFNG,C0751967,Mitoxantrone,DB01204,"Multiple Sclerosis, Relapsing-Remitting",Approved,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
30177,ERCC4,C3463824,Azacitidine,DB00928,MYELODYSPLASTIC SYNDROME,Terminated,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7129,IL7,C0019360,Pregabalin,DB00230,Herpes zoster disease,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,Infectious disease,IL-7,,,,,,,,,,,,,,,,,AGBL4,,,,,,,,
31682,SLC35C1,C0006271,Fluticasone Propionate,DB00588,Bronchiolitis,Terminated,CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF},Phase 2,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31518,MIRLET7B,C3898222,Sirolimus,DB00877,Mucosal Melanoma,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30993,CYP2B6,C0206726,Temozolomide,DB00853,gliosarcoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,CPB6,CYPIIB6,,,,,,,,,,,,,,,,,,,,,,,,
33602,AGT,C0018799,Vitamin E,DB00163,Heart Diseases,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Cardiovascular disease,SERPINA8,,,,,,,,,,,,,,,,,,,,,,,,,
13559,HBG2,C0002875,Triamcinolone,DB00620,Cooley's anemia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Hematologic disease,HBG-T1,,,,,,,,,,,,,,,,,,,,,,,,,
6995,EDIL3,C0029408,Salmon Calcitonin,DB00017,Degenerative polyarthritis,Terminated,CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CN=CN2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO},Phase 3,Immune system disease,DEL1,,,,,,,,,,,,,,,,,CCN4,,,,,,,,
9486,HLA-DRB1,C2973725,Treprostinil,DB00374,Pulmonary arterial hypertension,Approved,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},,Infectious disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
19623,ERCC2,C0585442,Methotrexate,DB00563,Osteosarcoma of bone,Approved,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
18365,ATXN10,C0085606,Trospium,DB00209,Urgency of micturition,Approved,C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
24977,P2RX7,C0040558,Sulfamethoxazole,DB01015,Toxoplasmosis,Approved,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,P2X7,MGC20089,,,,,,,,,,,,,,,,,,,,,,,,
26975,MALT1,C0349632,Vincristine,DB00541,Splenic Marginal Zone B-Cell Lymphoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3651,Latanoprost,DB00654,Ocular Hypertension,C0028840,Approved,CC(C)OC(=O)CCC/C=C\\C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O},,Nervous system disease,,,,,,,,,,,,,,,,,,,BDKRB2,,,,,,,,
29407,IL10,C0004623,Triamcinolone,DB00620,Bacterial Infections,Terminated,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},Phase 1/Phase 2,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
9180,Ondansetron,DB00904,Vomiting,C0042963,Terminated,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
12617,LRRC56,C0027430,Beclomethasone dipropionate,DB00394,Nasal Polyps,Approved,CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2074,Demeclocycline,DB00618,Acute gonococcal cervicitis,C0153195,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3[C@@H](C4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O},,Infectious disease,,,,,,,,,,,,,,,,,,,NR1I2,,,,,,,,
18008,MDM2,C0035335,Melphalan,DB01042,Retinoblastoma,Terminated,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29863,CDH1,C0850666,Omeprazole,DB00338,Infection caused by Helicobacter pylori,Terminated,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 1/Phase 2,Infectious disease,uvomorulin,CD324,UVO,,,,,,,,,,,,,,,,,,,,,,,
14359,DDC,C0009806,Oxycodone,DB00497,Constipation,Terminated,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O},Phase 3,Digestive system disease,AADC,,,,,,,,,,,,,,,,,,,,,,,,,
24170,RBM12,C0036337,Olanzapine,DB00334,Schizoaffective Disorder,Withdrawn,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
17810,PLG,C0022577,Lodoxamide,DB06794,"Keratoconjunctivitis, Vernal",Approved,C1=C(C=C(C(=C1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
21378,CAT,C0524702,Fondaparinux sodium,DB00569,Pulmonary Thromboembolisms,Approved,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15603,GABRA2,C0003469,Paroxetine,DB00715,Anxiety Disorders,Terminated,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
937,Carbidopa,DB00190,Parkinsonian Disorders,C0242422,Approved,C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN},,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,Mazindol,,,,,,,,
28976,EGF,C0027627,Sirolimus,DB00877,Neoplasm Metastasis,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
35628,TNF,C1136321,Pioglitazone,DB01132,HIV-Associated Lipodystrophy Syndrome,Terminated,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3},Phase 3,Immune system disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
5465,Rizatriptan,DB00953,Migraine Disorders,C0149931,Approved,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3},,Nervous system disease,,,,,,,,,,,,,,,,,,,MIR326,,,,,,,,
11108,CLEC6A,C0010414,Amphotericin B,DB00681,Infection by Cryptococcus neoformans,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17,Acetaminophen,DB00316,Fever,C0015967,Approved,CC(=O)NC1=CC=C(C=C1)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Acrivastine,,,,,,,,
19544,IL24,C0242379,Vinorelbine,DB00361,Malignant neoplasm of lung,Withdrawn,CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC},Phase 3,Cancer,mda-7,IL10B,Mob-5,C49A,FISP,IL-24,ST16,,,,,,,,,,,,,,,,,,,
26949,CSF3,C0280745,Decitabine,DB01262,secondary myelodysplastic syndromes,Terminated,C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O},Phase 1,Cancer,MGC45931,GCSF,G-CSF,C17orf33,,,,,,,,,,,,,,,,,,,,,,
9937,Phenylephrine,DB00388,Fecal Incontinence,C0015732,Withdrawn,CNC[C@@H](C1=CC(=CC=C1)O)O},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
971,Caspofungin,DB00520,Candidemia,C0877445,Approved,CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4=CC=C(C=C4)O)O)O)[C@@H](CCN)O)O)NCCN)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Mesalazine,,,,,,,,
21236,CISD2,C0151721,Testosterone Propionate,DB01420,Testicular hypogonadism,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16537,JPH3,C1510471,Vitamin C,DB00126,Vitamin Deficiency,Approved,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O},,Metabolic disease,JP-3,CAGL237,HDL2,JP3,TNRC22,,,,,,,,,,,,,,,,,,,,,
26518,HIF1A,C0235782,Oxaliplatin,DB00526,Gallbladder Carcinoma,Suspended,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 1,Cancer,MOP1,HIF-1alpha,PASD8,HIF1,bHLHe78,,,,,,,,,,,,,,,,,,,,,
10734,DEFB4B,C1318973,Vancomycin,DB00512,Staphylococcus aureus infection,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24583,SLC4A1,C0001126,Potassium Citrate,DB09125,Renal tubular acidosis,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Urinary system disease,RTA1A,CD233,FR,SW,WR,EPB3,AE1,DI,WD,,,,,,,,,,,,,,,,,
20402,C4BPA,C0012546,Erythromycin,DB00199,Diphtheria,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10114,CDH13,C0347950,Theophylline,DB00277,Asthma attack,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Immune system disease,CDHH,,,,,,,,,,,,,,,,,,,,,,,,,
8506,SGCZ,C0030319,Venlafaxine,DB00285,Panic Disorder,Approved,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
20757,SYNM,C0343386,Vancomycin,DB00512,Clostridium difficile infection,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,KIAA0353,DMN,,,,,,,,,,,,,,,,,,,,,,,,
37,Acetylcysteine,DB06151,Bronchiectasis,C0006267,Approved,CC(=O)N[C@@H](CS)C(=O)O},,Respiratory disease,,,,,,,,,,,,,,,,,,,Aliskiren,,,,,,,,
10213,KIT,C0024115,Theophylline,DB00277,Lung diseases,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Lung disease,CD117,SCFR,C-Kit,PBT,,,,,,,,,,,,,,,,,,,,,,
27950,NTRK1,C0280100,Pegfilgrastim,DB00019,Solid tumour,Withdrawn,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Cancer,TRKA,MTC,,,,,,,,,,,,,,,,,,,,,,,,
28039,IL1B,C0458247,Capsaicin,DB06774,Allodynia,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
27201,TP53,C0001418,Cisplatin,DB00515,Adenocarcinoma,Withdrawn,N.N.Cl[Pt]Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32479,CCDC6,C0238461,Paclitaxel,DB01229,Anaplastic thyroid carcinoma,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12346,TIMP1,C0034186,Ofloxacin,DB01165,Pyelonephritis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,TIMP,CLGI,,,,,,,,,,,,,,,,,,,,,,,,
4782,Paroxetine,DB00715,Generalized Anxiety Disorder,C0270549,Approved,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,CENPJ,,,,,,,,
20196,OGA,C0002792,Epinephrine,DB00668,anaphylaxis,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8948,Dexamethasone,DB01234,Acute fungal otitis externa,C0728738,Terminated,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
6120,Triamcinolone,DB00620,Berylliosis,C0005138,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Lung disease,,,,,,,,,,,,,,,,,,,ATP1A1,,,,,,,,
33118,CYP2D6,C0041696,Scopolamine,DB00747,Unipolar Depression,Terminated,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},Phase 2,Mental and behavioural disorder,CPD6,P450-DB1,P450C2D,CYP2DL1,CYP2D7P2,CYP2D7BP,CYP2D8P2,CYP2D7AP,,,,,,,,,,,,,,,,,,
35535,ZFP82,C0154830,Octreotide,DB00104,Proliferative diabetic retinopathy,Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 3,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3192,Gentamicin,DB00798,Pseudomonas aeruginosa meningitis,C3665869,Approved,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC},,Infectious disease,,,,,,,,,,,,,,,,,,,CST6,,,,,,,,
16459,VDR,C0029442,Ergocalciferol,DB00153,Osteomalacia,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Urinary system disease,NR1I1,PPP1R163,,,,,,,,,,,,,,,,,,,,,,,,
15744,EFHC1,C0014549,Topiramate,DB00273,Tonic-Clonic Epilepsy,Approved,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15493,PARP1,C0278488,Vinblastine,DB00570,Carcinoma breast stage IV,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,PARP,PPOL,ADPRT,,,,,,,,,,,,,,,,,,,,,,,
19179,CXCL2,C0311375,Dimercaprol,DB06782,Arsenic Poisoning,Approved,C(C(CS)S)O},,,SCYB2,GROb,MIP-2a,MGSA-b,CINC-2a,GRO2,,,,,,,,,,,,,,,,,,,,
5136,Prednisolone,DB00860,Bacterial keratitis,C0854211,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CCDC141,,,,,,,,
28654,ERBB2,C0153690,Ketoconazole,DB01026,Secondary malignant neoplasm of bone,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
11996,TRIM13,C0023449,Vindesine,DB00309,Acute lymphocytic leukemia,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19708,ATP8B1,C0008354,Minocycline,DB01017,Cholera,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12970,CA5A,C0220994,Phenylacetic acid,DB09269,Hyperammonemia,Approved,C1=CC=C(C=C1)CC(=O)O},,Inherited metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5882,Tetracycline,DB00759,Pharyngitis,C0031350,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,MYT1,,,,,,,,
27808,DRD1,C1456624,Methamphetamine,DB01577,Methamphetamine abuse,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
27118,CD81,C0019196,Paroxetine,DB00715,Hepatitis C,Terminated,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4},Phase 2,Infectious disease,TAPA-1,TSPAN28,TAPA1,,,,,,,,,,,,,,,,,,,,,,,
36353,TNF,C1960048,Lovastatin,DB00227,Severe persistent asthma,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 1/Phase 2,Immune system disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
37164,EGFR,C0023051,Omeprazole,DB00338,Laryngeal Diseases,Withdrawn,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 3,,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
35134,IL1B,C0007286,Lidocaine,DB00281,Carpal Tunnel Syndrome,Terminated,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},Phase 3,Nervous system disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
9144,Mycophenolic acid,DB01024,Interstitial Cystitis,C0282488,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
1818,Cloxacillin,DB01147,Pharyngitis,C0031350,Approved,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SLC9A6,,,,,,,,
28181,MSH2,C0919267,Paclitaxel,DB01229,ovarian neoplasm,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 3,Cancer,HNPCC1,COCA1,,,,,,,,,,,,,,,,,,,,,,,,
4189,Mezlocillin,DB00948,Intraabdominal Infections,C1112209,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,HLA-DPB2,,,,,,,,
8762,Vigabatrin,DB01080,"Alcoholic Intoxication, Chronic",C0001973,Terminated,C=CC(CCC(=O)O)N},Phase 2,Other,,,,,,,,,,,,,,,,,,,,,,,,,,,
2034,Dalfampridine,DB06637,Multiple Sclerosis,C0026769,Approved,C1=CN=CC=C1N},,Nervous system disease,,,,,,,,,,,,,,,,,,,IL12B,,,,,,,,
21741,RBM45,C0022972,Guanidine,DB00536,Lambert-Eaton Myasthenic Syndrome,Approved,C(=N)(N)N},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8348,BDNF,C0003467,Citalopram,DB00215,Anxiety,Withdrawn,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
16241,DRD2,C0001957,Oxazepam,DB00842,Alcohol Withdrawal Delirium,Approved,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
9354,Haloperidol,DB00502,Vomiting,C0042963,Withdrawn,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F},Phase 0,,,,,,,,,,,,,,,,,,,,,,,,,,,,
20433,MIP,C0023241,Erythromycin,DB00199,Legionnaires' Disease,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15733,FGF2,C0014549,Topiramate,DB00273,Tonic-Clonic Epilepsy,Approved,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},,Nervous system disease,FGFB,,,,,,,,,,,,,,,,,,,,,,,,,
14604,PPM1E,C1336708,Vinblastine,DB00570,Testicular Germ Cell Tumor,Terminated,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,POPX1,KIAA1072,PP2CH,CaMKP-N,,,,,,,,,,,,,,,,,,,,,,
27375,HMGA2,C0334359,Trametinib,DB08911,Papillary serous cystadenocarcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2/Phase 3,Cancer,BABL,LIPO,HMGIC,,,,,,,,,,,,,,,,,,,,,,,
8879,Atorvastatin,DB01076,Coronary Arteriosclerosis,C0010054,Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Vascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
11012,ADGRV1,C0239295,Voriconazole,DB00582,Candidiasis of the esophagus,Approved,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31157,FGF2,C1292753,Doxorubicin,DB00997,Primary Effusion Lymphoma,Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},Phase 2,Cancer,FGFB,,,,,,,,,,,,,,,,,,,,,,,,,
16809,IL10,C0275982,Ofloxacin,DB01165,Enteric campylobacteriosis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
4375,Natamycin,DB00826,Fungal conjunctivitis,C0339170,Approved,C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)O)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CSN1S1,,,,,,,,
24013,TYR,C0268490,Nitisinone,DB00348,"Tyrosinemia, Type I",Approved,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-]},,Congenital disorder of metabolism,OCAIA,OCA1A,OCA1,,,,,,,,,,,,,,,,,,,,,,,
35544,SLC16A7,C0154830,Octreotide,DB00104,Proliferative diabetic retinopathy,Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 3,Endocrine and metabolic disease,MCT2,,,,,,,,,,,,,,,,,,,,,,,,,
26704,CR2,C0020981,Thalidomide,DB01041,Angioimmunoblastic Lymphadenopathy,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Immune system disease,CD21,C3DR,,,,,,,,,,,,,,,,,,,,,,,,
29006,PIK3CA,C0019187,Pentoxifylline,DB00806,"Hepatitis, Alcoholic",Terminated,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C},Phase 1,Digestive system disease,PI3K,,,,,,,,,,,,,,,,,,,,,,,,,
14629,C20orf194,C0524910,Cyclosporine,DB00091,"Hepatitis C, Chronic",Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9123,Micafungin,DB01141,Invasive Fungal Infections,C1262313,Terminated,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)[C@@H](CC(=O)N)O)C)O)O)O},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
20293,PHEX,C3536984,Ergocalciferol,DB00153,"Vitamin D-Resistant Rickets, X-Linked",Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,PEX,HPDR1,HYP1,XLH,HYP,HPDR,,,,,,,,,,,,,,,,,,,,
28795,DEFA5,C0036916,Methamphetamine,DB01577,Sexually Transmitted Diseases,Terminated,C[C@@H](CC1=CC=CC=C1)NC},Phase 1,Infectious disease,HD-5,DEF5,,,,,,,,,,,,,,,,,,,,,,,,
8903,CYBA,C0013395,Omeprazole,DB00338,Dyspepsia,Suspended,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 2,Digestive system disease,p22-PHOX,,,,,,,,,,,,,,,,,,,,,,,,,
12870,FCN2,C0038395,Procaine benzylpenicillin,DB09320,Streptococcal Infections,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,P35,FCNL,EBP-37,ficolin-2,,,,,,,,,,,,,,,,,,,,,,
14444,ALK,C0079744,Vincristine,DB00541,Diffuse Large B-Cell Lymphoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32741,ERBB2,C0553723,Paclitaxel,DB01229,Squamous cell carcinoma of skin,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
6823,AGER,C0002726,L-Cysteine,DB00151,Amyloidosis,Approved,C([C@@H](C(=O)O)N)S},,Hematology,SCARJ1,,,,,,,,,,,,,,,,,ACSL5,,,,,,,,
5250,Prednisone,DB00635,Nephrotic Syndrome,C0027726,Approved,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},,Urinary system disease,,,,,,,,,,,,,,,,,,,ETV4,,,,,,,,
24149,GRIA1,C0036337,Olanzapine,DB00334,Schizoaffective Disorder,Withdrawn,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C},Phase 3,Mental and behavioural disorder,GluA1,GLURA,GLUR1,,,,,,,,,,,,,,,,,,,,,,,
23383,PIK3CA,C0267176,Metoclopramide,DB01233,Gastroparesis due to diabetes mellitus,Approved,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl},,Digestive system disease,PI3K,,,,,,,,,,,,,,,,,,,,,,,,,
22642,ODC1,C0036992,Glucagon recombinant,DB00040,Short Bowel Syndrome,Terminated,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CNC=N7)N)O},Phase 1/Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
5562,Sertraline,DB01104,Panic Disorder,C0030319,Approved,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,ZNRF4,,,,,,,,
29678,CAB39L,C0280634,Vorinostat,DB02546,adult acute monocytic leukemia (M5b),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32531,OPRM1,C0520909,Nicotine,DB00184,Postoperative Nausea and Vomiting,Terminated,CN1CCC[C@H]1C2=CN=CC=C2},Phase 2,,MOR1,,,,,,,,,,,,,,,,,,,,,,,,,
16944,HSPD1,C0085166,Tinidazole,DB00911,Bacterial Vaginosis,Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3688,Levofloxacin,DB01137,Bacterial urinary infection,C0729524,Approved,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,KMO,,,,,,,,
35792,SNX17,C0730345,Rimonabant,DB06155,Microalbuminuria,Terminated,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12266,SULF2,C0020479,Simvastatin,DB00641,Hyperlipoproteinemia Type III,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32059,CALCA,C0014132,Oxaliplatin,DB00526,Endocrine Gland Neoplasms,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,CALC1,,,,,,,,,,,,,,,,,,,,,,,,,
7301,Lamotrigine,DB00555,Bipolar Disorder,C0005586,Terminated,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N},Phase 1,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,RELB,,,,,,,,
17188,CSNK2B,C0014550,Stiripentol,DB09118,"Epilepsies, Myoclonic",Approved,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18999,THBD,C0040053,Warfarin,DB00682,Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,CD141,,,,,,,,,,,,,,,,,,,,,,,,,
36447,CD44,C0278577,Cisplatin,DB00515,Cervix carcinoma stage III,Withdrawn,N.N.Cl[Pt]Cl},Phase 2,Cancer,IN,MC56,Pgp1,CD44R,HCELL,CSPG8,MIC4,MDU2,MDU3,,,,,,,,,,,,,,,,,
10017,NAMPT,C0456103,Vancomycin,DB00512,Sepsis of the newborn,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
7056,APOE,C0019345,Valaciclovir,DB00577,Herpes Labialis,Approved,CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N},,Infectious disease,AD2,,,,,,,,,,,,,,,,,ATP5F1B,,,,,,,,
35512,SERPINF1,C0011884,Octreotide,DB00104,Diabetic Retinopathy,Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 3,Nervous system disease,EPC-1,PIG35,PEDF,,,,,,,,,,,,,,,,,,,,,,,
25253,OXCT1,C0751434,Verapamil,DB00661,Classical phenylketonuria,Terminated,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},Phase 2,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
2171,ADCY5,C0011860,Atorvastatin,DB01076,"Diabetes Mellitus, Non-Insulin-Dependent",Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Endocrine disease,0,,,,,,,,,,,,,,,,,SYNPO,,,,,,,,
7662,LACC1,C0015230,Zinc oxide,DB09321,Exanthema,Approved,O=[Zn]},,Infectious disease,0,,,,,,,,,,,,,,,,,RDH14,,,,,,,,
8418,Miltefosine,DB09031,Chronic urticaria,C0263338,Terminated,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},Phase 2,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
17936,NOTCH1,C0024299,Pegfilgrastim,DB00019,Lymphoma,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Cancer,TAN1,,,,,,,,,,,,,,,,,,,,,,,,,
35069,CEL,C1535939,Prednisolone,DB00860,Pneumocystis jiroveci pneumonia,Withdrawn,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 3,Infectious disease,BSSL,MODY8,,,,,,,,,,,,,,,,,,,,,,,,
7504,CCL5,C0009766,Triprolidine,DB00427,Allergic Conjunctivitis,Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Immune system disease,RANTES,SISd,TCP228,MGC17164,D17S136E,SCYA5,,,,,,,,,,,,MRVI1,,,,,,,,
12638,HRH1,C0035455,Sodium Citrate,DB09154,Rhinitis,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
33078,SERHL2,C2076600,Rosuvastatin,DB01098,Influenza due to Influenza A virus subtype H1N1,Terminated,CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33894,CRP,C0041296,Moxifloxacin,DB00218,Tuberculosis,Withdrawn,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O},Phase 1,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
18831,TRNL1,C0152020,Domperidone,DB01184,Gastroparesis,Withdrawn,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O},Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23342,HLA-A,C0042900,Tacrolimus,DB00864,Vitiligo,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Skin disease,,,,,,,,,,,,,,,,,,,,,,,,,,
14621,IFNL3,C0524910,Cyclosporine,DB00091,"Hepatitis C, Chronic",Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3104,Fusidic Acid,DB02703,Sinusitis,C0037199,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,SNRPF,,,,,,,,
19932,TAC1,C0016053,Pramipexole,DB00413,Fibromyalgia,Terminated,CCCN[C@H]1CCC2=C(C1)SC(=N2)N},Phase 2,Musculoskeletal disease,NPK,TAC2,NKNA,,,,,,,,,,,,,,,,,,,,,,,
5203,Prednisolone,DB00860,Stevens-Johnson Syndrome,C0038325,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,ABCD3,,,,,,,,
35978,LOX,C0019163,Tenofovir,DB00300,Hepatitis B,Terminated,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
482,Azithromycin,DB00207,Infective otitis media,C0729586,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Dinoprostone,,,,,,,,
36977,TLR4,C0279084,Sunitinib,DB01268,Kaposi's sarcoma classical type,Withdrawn,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,,,,,,,,,
18011,MUC5AC,C0013238,Xanthophyll,DB00137,Dry Eye Syndromes,Approved,CC1=C(C(C[C@@H](C1)O)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(\\C)/C=C/C=C(\\C)/C=C/[C@H]2C(=C[C@@H](CC2(C)C)O)C)/C)/C},,,,,,,,,,,,,,,,,,,,,,,,,,,,
10650,LCN2,C0149725,Piperacillin,DB00319,Lower respiratory tract infection,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,,NGAL,24p3,,,,,,,,,,,,,,,,,,,,,,,,
28545,IGSF3,C0281479,Doxorubicin,DB00997,Primary Systemic Amyloidosis,Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},Phase 1,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25939,IL6,C0162810,Tranilast,DB07615,"Cicatrix, Hypertrophic",Approved,COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC},,,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
11890,MYH11,C0023479,Arsenic trioxide,DB01169,Acute myelomonocytic leukemia,Approved,[O-2].[O-2].[O-2].[As+3].[As+3]},,Cancer,SMMHC,SMHC,,,,,,,,,,,,,,,,,,,,,,,,
26356,PNOC,C0423673,Ziconotide,DB06283,Pain in spine,Approved,C[C@H]1C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N3)CO)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCN},,,PPNOC,N/OFQ,NOP,,,,,,,,,,,,,,,,,,,,,,,
28953,CCR5,C0024143,Tacrolimus,DB00864,Lupus Nephritis,Withdrawn,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 3,Urinary system disease,CKR-5,CC-CKR-5,CKR5,CD195,IDDM22,CMKBR5,,,,,,,,,,,,,,,,,,,,
7439,CYP2D6,C1269683,Quetiapine,DB01224,Major Depressive Disorder,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,CPD6,P450-DB1,P450C2D,CYP2DL1,CYP2D7P2,CYP2D7BP,CYP2D8P2,CYP2D7AP,,,,,,,,,,MDFIC,,,,,,,,
6504,Aprepitant,DB00673,Nausea,C0027497,Suspended,C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F},Phase 2,Digestive system disease,,,,,,,,,,,,,,,,,,,TMBIM6,,,,,,,,
26181,CXCL9,C0008312,Ursodeoxycholic acid,DB01586,Primary biliary cirrhosis,Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9511,OTC,C0242429,Pheniramine,DB01620,Sore Throat,Approved,CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
28662,IL11,C0153690,Ketoconazole,DB01026,Secondary malignant neoplasm of bone,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
7265,IL13,C0037383,Tripelennamine,DB00792,Sneezing,Approved,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2},,,P600,IL-13,ALRH,BHR1,MGC116786,MGC116788,MGC116789,,,,,,,,,,,SDCCAG8,,,,,,,,
19591,LGALS3,C0007115,Liothyronine,DB00279,Malignant neoplasm of thyroid,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Cancer,MAC-2,GALIG,LGALS2,,,,,,,,,,,,,,,,,,,,,,,
856,Caffeine,DB00201,Rhinorrhea,C1260880,Approved,CN1C=NC2=C1C(=O)N(C(=O)N2C)C},,Nervous system disease,,,,,,,,,,,,,,,,,,,Lansoprazole,,,,,,,,
1333,Ceftizoxime,DB01332,Acute gonococcal cervicitis,C0153195,Approved,CO/N=C(/C1=CSC(=N1)N)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Rifampicin,,,,,,,,
12462,GSK3B,C0554628,Quinupristin,DB01369,Streptococcus pyogenes infection,Approved,CC[C@@H]1C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)N3C[C@H](C(=O)C[C@H]3C(=O)N[C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CS[C@@H]6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28068,BDKRB1,C0020429,Capsaicin,DB06774,Hyperalgesia,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,Nervous system,BKR1,B1BKR,bradyb1,,,,,,,,,,,,,,,,,,,,,,,
35911,ALOX12B,C0235974,Sunitinib,DB01268,Pancreatic carcinoma,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35609,GSTM1,C0024121,Pemetrexed,DB00642,Lung Neoplasms,Terminated,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13388,IL18R1,C0038013,Triamcinolone,DB00620,Ankylosing spondylitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,IL1RRP,IL-1Rrp,CD218a,,,,,,,,,,,,,,,,,,,,,,,
34778,SCT,C0030283,Ethanol,DB00898,Pancreatic Cyst,Terminated,CCO},Phase 3,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
11752,TWNK,C0085612,Tocainide,DB01056,Ventricular arrhythmia,Approved,CC1=C(C(=CC=C1)C)NC(=O)C(C)N},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6099,Tretinoin,DB00755,Hyperkeratosis,C0870082,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,TIMM23,,,,,,,,
2671,Ergotamine,DB00696,Cluster Headache,C0009088,Approved,C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C},,,,,,,,,,,,,,,,,,,,,GATA6,,,,,,,,
24521,CDS1,C0003615,Ropivacaine,DB00296,Appendicitis,Terminated,CCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C},Phase 2,Other disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6635,IL6,C0013604,Triamterene,DB00384,Edema,Approved,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N},,,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,IL4I1,,,,,,,,
10696,MEFV,C0031350,Tetracycline,DB00759,Pharyngitis,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,FMF,TRIM20,,,,,,,,,,,,,,,,,,,,,,,,
16909,CDX1,C0014356,Clidinium,DB00771,Enterocolitis,Approved,C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O},,Gastrointestinal disease,,,,,,,,,,,,,,,,,,,,,,,,,,
19973,SERPINF2,C0019243,Stanozolol,DB06718,"Angioedemas, Hereditary",Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(CC5=C(C4)NN=C5)C},,Skin and connective tissue disease,API,ALPHA-2-PI,A2AP,AAP,PLI,,,,,,,,,,,,,,,,,,,,,
15606,MIR34A,C0003469,Paroxetine,DB00715,Anxiety Disorders,Terminated,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
3752,Liothyronine,DB00279,Endemic goiter,C0018022,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Endocrine disease,,,,,,,,,,,,,,,,,,,ADCY1,,,,,,,,
4463,Norethisterone,DB00717,Metrorrhagia,C0025874,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},,,,,,,,,,,,,,,,,,,,,XPC,,,,,,,,
22322,SIRT1,C0011849,Pramlintide,DB01278,Diabetes Mellitus,Withdrawn,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N)NC(=O)[C@@H]4CCCN4C(=O)CNC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CNC=N6)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@@H]8CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N8)[C@@H](C)O)C)[C@@H](C)O)CC(=O)N)NC(=O)[C@H](CCCCN)N},Phase 1/Phase 2,Endocrine disease,SIR2L1,,,,,,,,,,,,,,,,,,,,,,,,,
524,Aztreonam,DB00355,Pneumonia due to Escherichia coli,C0276089,Approved,C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\\OC(C)(C)C(=O)O)/C2=CSC(=N2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,ADD1,,,,,,,,
8022,GUCY2D,C0035086,Calcitriol,DB00136,Renal Osteodystrophy,Approved,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6661,ELANE,C0013604,Triamterene,DB00384,Edema,Approved,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N},,,NE,HNE,HLE,ELA2,,,,,,,,,,,,,,MIR664A,,,,,,,,
36348,IL5,C1960048,Lovastatin,DB00227,Severe persistent asthma,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 1/Phase 2,Immune system disease,IL-5,EDF,,,,,,,,,,,,,,,,,,,,,,,,
9385,GSTM1,C0030567,Trihexyphenidyl,DB00376,Parkinson Disease,Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14940,C9,C0524662,Naloxone,DB01183,Opiate Addiction,Approved,C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
14775,MEG3,C0023472,Nilotinib,DB04868,"Leukemia, Myeloid, Accelerated Phase",Approved,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,GTL2,NCRNA00023,LINC00023,onco-lncRNA-83,,,,,,,,,,,,,,,,,,,,,,
36347,CCN2,C1960048,Lovastatin,DB00227,Severe persistent asthma,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 1/Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27981,TNFAIP3,C0036421,Iloprost,DB01088,Systemic Scleroderma,Terminated,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Skin disease,OTUD7C,,,,,,,,,,,,,,,,,,,,,,,,,
773,Bosentan,DB00559,Pulmonary Hypertension,C0020542,Approved,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC},,Lung disease,,,,,,,,,,,,,,,,,,,FARS2,,,,,,,,
15969,GAST,C0040425,Dirithromycin,DB00954,Tonsillitis,Approved,CC[C@@H]1[C@@]([C@H]2[C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)N(C)C)O)(C)O)C)N[C@H](O2)COCCOC)C)(C)O},,,,,,,,,,,,,,,,,,,,,,,,,,,,
8059,ADRA1A,C1739363,Terazosin,DB01162,Prostatic Hypertrophy,Approved,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
28131,TTBK1,C0345958,Paclitaxel,DB01229,Large cell carcinoma of lung,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9047,SYT2,C0017168,Sodium Citrate,DB09154,Gastroesophageal reflux disease,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
27558,PLAT,C2937358,Fluoxetine,DB00472,Cerebral Hemorrhage,Terminated,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F},Phase 3,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
2435,Doripenem,DB06211,Cholecystitis,C0008325,Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O},,Digestive system disease,,,,,,,,,,,,,,,,,,,PHEX,,,,,,,,
15441,EDN1,C0264716,Amlodipine,DB00381,Chronic heart failure,Suspended,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN},Phase 2,Cardiovascular disease,ET1,,,,,,,,,,,,,,,,,,,,,,,,,
11130,AKR1A1,C0276653,Anidulafungin,DB00362,Invasive Pulmonary Aspergillosis,Withdrawn,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC=C(C=C7)O)O)O)[C@@H](C)O)C)O)O)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15850,TG,C0018213,Carbimazole,DB00389,Graves Disease,Approved,CCOC(=O)N1C=CN(C1=S)C},,Immune system disease,TGN,AITD3,,,,,,,,,,,,,,,,,,,,,,,,
35371,AMBP,C0005686,Mitomycin,DB00305,Urinary Bladder Diseases,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Urinary system disease,UTI,EDC1,HI30,IATIL,ITILC,ITI,ITIL,,,,,,,,,,,,,,,,,,,
20807,POLG,C0028734,Flavoxate,DB01148,Nocturia,Approved,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2159,Dexamethasone,DB01234,Angioedema,C0002994,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,AGA,,,,,,,,
28781,IL1B,C0036916,Methamphetamine,DB01577,Sexually Transmitted Diseases,Terminated,C[C@@H](CC1=CC=CC=C1)NC},Phase 1,Infectious disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
4496,Norfloxacin,DB01059,Escherichia coli urinary tract infection,C0577708,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,ARHGAP29,,,,,,,,
7817,RREB1,C0036508,Urea,DB03904,Seborrheic dermatitis,Approved,C(=O)(N)N},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,RBP1,,,,,,,,
14505,CTNNB1,C0007847,Topotecan,DB01030,Malignant tumor of cervix,Approved,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O},,Cancer,beta-catenin,armadillo,CTNNB,,,,,,,,,,,,,,,,,,,,,,,
7585,FABP4,C0011616,Urea,DB03904,Contact Dermatitis,Approved,C(=O)(N)N},,Immune system disease,A-FABP,aP2,,,,,,,,,,,,,,,,CSPP1,,,,,,,,
2005,Cyproheptadine,DB00434,Allergic rhinitis (disorder),C2607914,Approved,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1},,Immune system disease,,,,,,,,,,,,,,,,,,,CEACAM5,,,,,,,,
15244,SLC12A3,C0020598,Teriparatide,DB06285,Hypocalcemia,Terminated,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N},Phase 2,Urinary system disease,NCCT,,,,,,,,,,,,,,,,,,,,,,,,,
37248,RTN2,C0015732,Phenylephrine,DB00388,Fecal Incontinence,Withdrawn,CNC[C@@H](C1=CC(=CC=C1)O)O},Phase 3,,NSPL1,SPG12,,,,,,,,,,,,,,,,,,,,,,,,
12083,GATA4,C0027051,Fondaparinux sodium,DB00569,Myocardial Infarction,Withdrawn,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},Phase 2,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
27392,MTHFR,C0852036,Magnesium Sulfate,DB00653,Pregnancy associated hypertension,Suspended,[O-]S(=O)(=O)[O-].[Mg+2]},Phase 2/Phase 3,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12126,NR1H3,C0003850,Simvastatin,DB00641,Arteriosclerosis,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Vascular disease,LXR-a,RLD-1,LXRa,,,,,,,,,,,,,,,,,,,,,,,
29562,TP53,C0007114,Fludarabine,DB01073,Malignant neoplasm of skin,Terminated,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30938,CSF3,C0279644,Idarubicin,DB01177,childhood acute myelomonocytic leukemia (M4),Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O},Phase 2,Cancer,MGC45931,GCSF,G-CSF,C17orf33,,,,,,,,,,,,,,,,,,,,,,
1757,Clindamycin,DB01190,Streptococcus pyogenes infection,C0554628,Approved,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,TGFB2,,,,,,,,
23644,LMLN,C0023283,Fluconazole,DB00196,"Leishmaniasis, Cutaneous",Terminated,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16391,CXCR5,C0162565,Promazine,DB00420,Acute intermittent porphyria,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Congenital disorder of metabolism,MDR15,CD185,BLR1,,,,,,,,,,,,,,,,,,,,,,,
16048,TLR4,C0025289,Gemcitabine,DB00441,Meningitis,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1,Infectious disease,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,,,,,,,,,
34833,BRCA2,C0030297,Gemcitabine,DB00441,Pancreatic Neoplasm,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32398,APOE,C0007282,Minocycline,DB01017,Carotid Stenosis,Terminated,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},Phase 2,Cardiovascular disease,AD2,,,,,,,,,,,,,,,,,,,,,,,,,
22821,EGR1,C0010308,Liothyronine,DB00279,Congenital Hypothyroidism,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Congenital malformation,TIS8,G0S30,NGFI-A,KROX-24,ZIF-268,AT225,ZNF225,,,,,,,,,,,,,,,,,,,
2939,Fluphenazine,DB00623,Psychotic Disorders,C0033975,Approved,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,MCHR2,,,,,,,,
28786,ARTN,C0036916,Methamphetamine,DB01577,Sexually Transmitted Diseases,Terminated,C[C@@H](CC1=CC=CC=C1)NC},Phase 1,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31496,IGF2,C0349604,Sirolimus,DB00877,Intracranial Meningioma,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,FLJ44734,IGF-II,C11orf43,,,,,,,,,,,,,,,,,,,,,,,
4308,Moxifloxacin,DB00218,Infection of skin AND/OR subcutaneous tissue,C0178299,Approved,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,LPAR2,,,,,,,,
24117,IGHE,C0036323,Praziquantel,DB01058,Schistosomiasis,Approved,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
30405,SLC6A2,C0220647,Gemcitabine,DB00441,Carcinoma of unknown primary,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 2,Cancer,SLC6A5,,,,,,,,,,,,,,,,,,,,,,,,,
34669,ERBB2,C0220650,Temozolomide,DB00853,Metastatic malignant neoplasm to brain,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
275,Amphotericin B,DB00681,Candidiasis,C0006840,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Cefuroxime,,,,,,,,
33488,ENG,C0005779,Vitamin E,DB00163,Blood Coagulation Disorders,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Hematologic disease,END,HHT1,CD105,ORW1,ORW,,,,,,,,,,,,,,,,,,,,,
16134,GCGR,C0008350,Ursodeoxycholic acid,DB01586,Cholelithiasis,Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C},,Digestive system disease,GGR,,,,,,,,,,,,,,,,,,,,,,,,,
13018,HLA-A,C0030807,Sirolimus,DB00877,Pemphigus,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 0,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,,,,,,,,
32113,LINC01847,C0034885,Oxaliplatin,DB00526,Rectal Neoplasms,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16075,SUMF2,C0021099,Retapamulin,DB01256,Impetigo,Approved,C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC4C[C@H]5CC[C@@H](C4)N5C)C},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12863,GALNS,C0036285,Procaine benzylpenicillin,DB09320,Scarlet Fever,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9298,Terlipressin,DB02638,Septic Shock,C0036983,Terminated,C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
20581,SRD5A1,C0033578,Flutamide,DB00499,Prostatic Neoplasms,Approved,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33158,TLR3,C0032914,Sildenafil,DB00203,Pre-Eclampsia,Terminated,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C},Phase 2,Hematologic disease,CD283,,,,,,,,,,,,,,,,,,,,,,,,,
28448,MIR301B,C0236736,Dextroamphetamine,DB01576,Cocaine-Related Disorders,Terminated,C[C@@H](CC1=CC=CC=C1)N},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
28087,CLPTM1L,C0152013,Paclitaxel,DB01229,Adenocarcinoma of lung (disorder),Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27155,FN1,C0206728,Sunitinib,DB01268,Plexiform Neurofibroma,Suspended,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Congenital malformation,CIG,LETS,GFND2,FINC,,,,,,,,,,,,,,,,,,,,,,
36972,GORASP1,C0279084,Sunitinib,DB01268,Kaposi's sarcoma classical type,Withdrawn,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11701,TNIP1,C0003872,Triamcinolone,DB00620,"Arthritis, Psoriatic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11604,VCL,C0013371,Trimethoprim,DB00440,Shigella Infections,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
20037,AAVS1,C0271093,Echothiophate,DB01057,Stargardt's disease,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34598,CSF2,C0751965,Dimethyl fumarate,DB08908,"Multiple Sclerosis, Secondary Progressive",Terminated,COC(=O)/C=C/C(=O)OC},Phase 3,Nervous system disease,GM-CSF,GMCSF,,,,,,,,,,,,,,,,,,,,,,,,
28340,SIRT1,C0023486,Thalidomide,DB01041,Prolymphocytic Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,SIR2L1,,,,,,,,,,,,,,,,,,,,,,,,,
15352,KCNE5,C0018790,Metoprolol,DB00264,Cardiac Arrest,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20919,AHR,C0345904,Floxuridine,DB00322,Malignant neoplasm of liver,Approved,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)F)CO)O},,Cancer,bHLHe76,,,,,,,,,,,,,,,,,,,,,,,,,
4998,Piperacillin,DB00319,Serratia sepsis,C0152973,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,GCY,,,,,,,,
25686,TNFRSF1A,C0003864,Tenoxicam,DB00469,Arthritis,Approved,CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3},,Immune system disease,TNF-R,TNFAR,TNFR60,TNF-R-I,CD120a,TNF-R55,TNFR1,,,,,,,,,,,,,,,,,,,
8500,CCKBR,C0030319,Venlafaxine,DB00285,Panic Disorder,Approved,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
36276,AGT,C0003811,Phenylephrine,DB00388,Cardiac Arrhythmia,Withdrawn,CNC[C@@H](C1=CC(=CC=C1)O)O},Phase 1/Phase 2,Cardiovascular disease,SERPINA8,,,,,,,,,,,,,,,,,,,,,,,,,
8704,SEC24C,C0243002,Alprostadil,DB00770,Tricuspid Atresia,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
2757,Ethchlorvynol,DB00189,Sleeplessness,C0917801,Approved,CCC(/C=C/Cl)(C#C)O},,,,,,,,,,,,,,,,,,,,,Dexmedetomidine,,,,,,,,
5422,Ranolazine,DB00243,Angina Pectoris,C0002962,Approved,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,ZGLP1,,,,,,,,
15682,ABAT,C0238111,Topiramate,DB00273,Lennox-Gastaut syndrome,Approved,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},,Nervous system disease,GABAT,,,,,,,,,,,,,,,,,,,,,,,,,
6584,VEGFA,C0002351,Acetazolamide,DB00819,Altitude Sickness,Approved,CC(=O)NC1=NN=C(S1)S(=O)(=O)N},,,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,MAGEA4,,,,,,,,
35108,PTPRJ,C1333990,Norgestrel,DB09389,Hereditary Nonpolyposis Colorectal Cancer,Terminated,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 3,Cancer,DEP1,HPTPeta,CD148,,,,,,,,,,,,,,,,,,,,,,,
12851,VEGFC,C0014733,Procaine benzylpenicillin,DB09320,Erysipelas,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
13019,HLA-DQB1,C0030807,Sirolimus,DB00877,Pemphigus,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 0,Skin and connective tissue disease,HLA-DQB,,,,,,,,,,,,,,,,,,,,,,,,,
7450,ITIH1,C1269683,Quetiapine,DB01224,Major Depressive Disorder,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,ATP5PF,,,,,,,,
4473,Norfloxacin,DB01059,Acute Moraxella catarrhalis bronchitis,C0339932,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,DAZL,,,,,,,,
4110,Methylprednisolone,DB00959,Sarcoidosis,C0036202,Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O},,Immune system disease,,,,,,,,,,,,,,,,,,,KIR2DS2,,,,,,,,
29958,DYNC1H1,C0043116,Sodium phenylbutyrate,DB06819,HMN (Hereditary Motor Neuropathy) Proximal Type I,Terminated,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},Phase 1/Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21513,DRD3,C0035258,Rotigotine,DB05271,Restless Legs Syndrome,Approved,CCCN(CCC1=CC=CS1)[C@H]2CCC3=C(C2)C=CC=C3O},,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
33099,NPY,C0041696,Scopolamine,DB00747,Unipolar Depression,Terminated,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},Phase 2,Mental and behavioural disorder,PYY4,,,,,,,,,,,,,,,,,,,,,,,,,
27013,IL15RA,C1955861,Thalidomide,DB01041,T-Cell Large Granular Lymphocyte Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3523,Insulin Glargine,DB00047,"Diabetes Mellitus, Insulin-Dependent",C0011854,Approved,CC[C@H](C)[C@H]1C(=O)N[C@H]2CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)NCC(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)N[C@@H](CC7=CC=C(C=C7)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N8CCC[C@H]8C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CNC=N2)CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CO)[C@@H](C)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)CN},,Endocrine disease,,,,,,,,,,,,,,,,,,,EXTL3,,,,,,,,
33452,GC,C0013221,Triptorelin,DB06825,Drug toxicity,Terminated,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8},Phase 2,,VDBP,hDBP,,,,,,,,,,,,,,,,,,,,,,,,
7564,SLBP,C0406317,Ulobetasol,DB00596,Chronic small plaque psoriasis,Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Skin disease,,,,,,,,,,,,,,,,,,SIPA1,,,,,,,,
34966,F5,C0085278,Hydroxychloroquine,DB01611,Antiphospholipid Syndrome,Terminated,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO},Phase 3,Hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
9822,Timolol,DB00373,Strawberry nevus of skin,C0206733,Withdrawn,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O},Phase 2,Vascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
11178,TNF,C0023290,Miltefosine,DB09031,"Leishmaniasis, Visceral",Approved,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},,Infectious disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
14776,CCND1,C0023472,Nilotinib,DB04868,"Leukemia, Myeloid, Accelerated Phase",Approved,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23854,CDKN2A,C1961099,Nelarabine,DB01280,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,Approved,COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},,Cancer,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
25112,VCAM1,C0022876,Ritodrine,DB00867,Premature Obstetric Labor,Approved,C[C@@H]([C@@H](C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O},,,CD106,,,,,,,,,,,,,,,,,,,,,,,,,
30085,PDAP1,C0206708,Aminolevulinic acid,DB00855,Cervical Intraepithelial Neoplasia,Terminated,C(CC(=O)O)C(=O)CN},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30,Acetazolamide,DB00819,Malignant glaucoma,C0271152,Approved,CC(=O)NC1=NN=C(S1)S(=O)(=O)N},,Nervous system disease,,,,,,,,,,,,,,,,,,,Alclometasone,,,,,,,,
8182,POMC,C0003868,Triamcinolone,DB00620,"Arthritis, Gouty",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
10649,IL10,C0149725,Piperacillin,DB00319,Lower respiratory tract infection,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
9741,Lithium,DB01356,Canavan Disease,C0206307,Withdrawn,[Li]},Phase 2,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
34136,CYP3A4,C1960870,Cyclobenzaprine,DB00924,Transformed migraine,Terminated,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31},Phase 3,Nervous system disease,CYP3A3,,,,,,,,,,,,,,,,,,,,,,,,,
27675,VAV1,C0023493,Thalidomide,DB01041,Adult T-Cell Lymphoma/Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 0,Cancer,VAV,,,,,,,,,,,,,,,,,,,,,,,,,
19408,CTLA4,C0008325,Doripenem,DB06211,Cholecystitis,Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O},,Digestive system disease,CD152,CELIAC3,IDDM12,,,,,,,,,,,,,,,,,,,,,,,
33696,AHR,C0040332,Nicotine,DB00184,Tobacco Dependence,Terminated,CN1CCC[C@H]1C2=CN=CC=C2},Phase 3,Mental and behavioural disorder,bHLHe76,,,,,,,,,,,,,,,,,,,,,,,,,
1885,Cortisone acetate,DB01380,Chronic small plaque psoriasis,C0406317,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Skin disease,,,,,,,,,,,,,,,,,,,NME8,,,,,,,,
36163,KRT6B,C0264303,Omeprazole,DB00338,Laryngomalacia,Withdrawn,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 1,,KRTL1,,,,,,,,,,,,,,,,,,,,,,,,,
8104,TAC1,C0033774,Zinc oxide,DB09321,Pruritus,Approved,O=[Zn]},,,NPK,TAC2,NKNA,,,,,,,,,,,,,,,,,,,,,,,
7135,TRAF3IP2,C0033860,Atorvastatin,DB01076,Psoriasis,Withdrawn,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Skin disease,0,,,,,,,,,,,,,,,,,MPZ,,,,,,,,
30185,EPO,C3463824,Azacitidine,DB00928,MYELODYSPLASTIC SYNDROME,Terminated,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N},Phase 2,Hematologic disease,EP,,,,,,,,,,,,,,,,,,,,,,,,,
14213,DEFB4A,C1384589,Zinc oxide,DB09321,Tinea cruris,Approved,O=[Zn]},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12831,TNFAIP3,C0024301,Vincristine,DB00541,"Lymphoma, Follicular",Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,OTUD7C,,,,,,,,,,,,,,,,,,,,,,,,,
15622,TXNIP,C0011881,Losartan,DB00678,Diabetic Nephropathy,Approved,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl},,Urinary system disease,VDUP1,EST01027,HHCPA78,THIF,ARRDC6,,,,,,,,,,,,,,,,,,,,,
5434,Ribavirin,DB00811,Respiratory Syncytial Virus Infections,C0035235,Approved,C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N},,Infectious disease,,,,,,,,,,,,,,,,,,,LGMN,,,,,,,,
165,Amikacin,DB00479,Intraabdominal Infections,C1112209,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},,Infectious disease,,,,,,,,,,,,,,,,,,,CDKN1A,,,,,,,,
12416,IFNG,C0035243,Azidocillin,DB08795,Respiratory Tract Infections,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N=[N+]=[N-])C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
16519,RSS,C0221468,Ergocalciferol,DB00153,Vitamin D-dependent rickets,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12155,APOBEC1,C0342882,Simvastatin,DB00641,Familial hypercholesterolemia - heterozygous,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Inherited metabolic disease,CDAR1,APOBEC-1,HEPR,,,,,,,,,,,,,,,,,,,,,,,
30810,CD274,C1321872,Fludarabine,DB01073,Stage IV Skin Melanoma,Terminated,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 2,Cancer,B7-H,B7H1,PD-L1,PDL1,B7-H1,PDCD1LG1,,,,,,,,,,,,,,,,,,,,
10743,SMUG1,C1318973,Vancomycin,DB00512,Staphylococcus aureus infection,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32257,GNRH1,C0020619,Testosterone,DB00624,Hypogonadism,Withdrawn,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},Phase 1,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5786,Tazobactam,DB01606,Haemophilus influenzae pneumonia,C0276026,Approved,C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3},,Infectious disease,,,,,,,,,,,,,,,,,,,STAT2,,,,,,,,
25707,KISS1R,C0271623,Methyltestosterone,DB06710,Hypogonadotropic hypogonadism,Terminated,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C},Phase 2,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13107,EPHB2,C0003175,Procaine benzylpenicillin,DB09320,Anthrax disease,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,Hek5,Tyro5,DRT,EPHT3,,,,,,,,,,,,,,,,,,,,,,
18654,VIPR1,C0019069,Desmopressin,DB00035,Hemophilia A,Approved,C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13131,IFNG,C0025293,Benzylpenicillin,DB01053,"Meningitis, Listeria",Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
30111,PON1,C0235032,Methylphenidate,DB00422,Neurotoxicity Syndromes,Terminated,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},Phase 2,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9639,ABCB1,C0014836,Tobramycin,DB00684,Escherichia coli Infections,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Infectious disease,P-gp,CD243,GP170,ABC20,PGY1,CLCS,,,,,,,,,,,,,,,,,,,,
34957,IL6,C0032310,Hydrocortisone,DB00741,"Pneumonia, Viral",Terminated,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},Phase 3,Infectious disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
15397,GNA11,C0151714,Calcium Gluceptate,DB00326,Hypermagnesemia,Approved,C([C@H]([C@H]([C@@H]([C@H](C(C(=O)[O-])O)O)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(C(=O)[O-])O)O)O)O)O)O.[Ca+2]},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9830,ATP4A,C0949083,Vitamin E,DB00163,Nosocomial pneumonia,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2725,Erythromycin,DB00199,Syphilis,C0039128,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CHMP4C,,,,,,,,
12347,PRADC1,C0034186,Ofloxacin,DB01165,Pyelonephritis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27568,HMOX2,C2937358,Fluoxetine,DB00472,Cerebral Hemorrhage,Terminated,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F},Phase 3,Cardiovascular disease,HO-2,,,,,,,,,,,,,,,,,,,,,,,,,
12214,USF1,C0020474,Simvastatin,DB00641,"Hyperlipidemia, Familial Combined",Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32764,FUT1,C0019045,Pegfilgrastim,DB00019,Hemoglobinopathies,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
27700,PROK2,C1533217,Methamphetamine,DB01577,Methamphetamine dependence,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 1,Mental and behavioural disorder,PK2,BV8,MIT1,KAL4,,,,,,,,,,,,,,,,,,,,,,
28761,KLF5,C0009402,Levoleucovorin,DB11596,Colorectal Carcinoma,Withdrawn,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2/Phase 3,Cancer,IKLF,CKLF,BTEB2,,,,,,,,,,,,,,,,,,,,,,,
20781,PRKAR1A,C4083212,Finasteride,DB01216,"Alopecia, Male Pattern",Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16313,CNR1,C0022104,Milnacipran,DB04896,Irritable Bowel Syndrome,Terminated,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2},Phase 2,Digestive system disease,CB1K5,CB-R,CB1,CANN6,CB1A,CNR,,,,,,,,,,,,,,,,,,,,
9267,Simvastatin,DB00641,Primary hypercholesterolemia,C0342879,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Inherited metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
1616,Cimetidine,DB00501,Heartburn,C0018834,Approved,CC1=C(N=CN1)CSCCNC(=NC)NC#N},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,EGF,,,,,,,,
15626,CNDP1,C0011881,Losartan,DB00678,Diabetic Nephropathy,Approved,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1157,Cefotaxime,DB00493,Ophthalmia Neonatorum,C0029076,Approved,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,IRF4,,,,,,,,
1092,Cefepime,DB01413,Staphylococcus aureus infection,C1318973,Approved,C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,AFG3L2,,,,,,,,
12923,IL1A,C0011633,Benzoic Acid,DB03793,Dermatomyositis,Approved,C1=CC=C(C=C1)C(=O)O},,Musculoskeletal disease,IL1F1,IL-1A,IL1-ALPHA,IL1,,,,,,,,,,,,,,,,,,,,,,
23801,TRNK,C0231528,Naproxen,DB00788,Myalgia,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
14270,HMBS,C0080274,Tamsulosin,DB00706,Urinary Retention,Terminated,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N},Phase 3,,PBGD,UPS,,,,,,,,,,,,,,,,,,,,,,,,
20450,ACOT7,C0043167,Erythromycin,DB00199,Pertussis,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4625,Ofloxacin,DB01165,Urinary tract infection,C0042029,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,MYL12A,,,,,,,,
8962,VGF,C0038358,Roxatidine acetate,DB08806,Gastric ulcer,Approved,CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2},,Digestive system disease,SCG7,SgVII,,,,,,,,,,,,,,,,,,,,,,,,
766,PTEN,C0376358,Sirolimus,DB00877,Malignant neoplasm of prostate,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,HCRT,,,,,,,,
13901,IKBKB,C0024305,Vidarabine,DB00194,"Lymphoma, Non-Hodgkin",Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26411,CYP19A1,C0007124,Oxytocin,DB00107,Noninfiltrating Intraductal Carcinoma,Suspended,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N},Phase 0,Cancer,ARO,P-450AROM,CPV1,ARO1,CYAR,aromatase,CYP19,,,,,,,,,,,,,,,,,,,
13751,ALOXE3,C0011606,Triamcinolone,DB00620,Exfoliative dermatitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3912,Meclizine,DB00737,Motion Sickness,C0026603,Approved,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,MST1,,,,,,,,
984,Cefaclor,DB00833,Urinary tract infection,C0042029,Approved,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,Methimazole,,,,,,,,
14796,POU1F1,C0001206,Somatostatin,DB09099,Acromegaly,Terminated,C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=CC=C6)O},Phase 2,Endocrine disease,GHF-1,POU1F1a,PIT-1,PIT1,,,,,,,,,,,,,,,,,,,,,,
10869,LBP,C0028754,Fenofibrate,DB01039,Obesity,Withdrawn,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 1,Metabolic disease,BPIFD2,,,,,,,,,,,,,,,,,,,,,,,,,
30585,NF1,C0151779,Temozolomide,DB00853,Cutaneous Melanoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
17918,PHOX2B,C0026961,Tropicamide,DB00809,Mydriasis,Approved,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2},,,Phox2b,NBPhox,PMX2B,,,,,,,,,,,,,,,,,,,,,,,
32486,LGALS3,C0238461,Paclitaxel,DB01229,Anaplastic thyroid carcinoma,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 3,Cancer,MAC-2,GALIG,LGALS2,,,,,,,,,,,,,,,,,,,,,,,
23054,DAPK1,C0006118,Lomustine,DB01206,Brain Neoplasms,Approved,C1CCC(CC1)NC(=O)N(CCCl)N=O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
21002,VEGFA,C0007102,Oxaliplatin,DB00526,Malignant tumor of colon,Withdrawn,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
35916,HNRNPA2B1,C0235974,Sunitinib,DB01268,Pancreatic carcinoma,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
22811,IGSF1,C0010308,Liothyronine,DB00279,Congenital Hypothyroidism,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Congenital malformation,KIAA0364,IGDC1,IGCD1,INHBP,MGC75490,PGSF2,,,,,,,,,,,,,,,,,,,,
4774,Paramethadione,DB00617,Absence Epilepsy,C0014553,Approved,CCC1(C(=O)N(C(=O)O1)C)C},,Nervous system disease,,,,,,,,,,,,,,,,,,,PWAR1,,,,,,,,
31844,WIF1,C3495949,Valproic Acid,DB00313,Locally advanced breast cancer,Terminated,CCCC(CCC)C(=O)O},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
34344,MBL2,C0085426,Vancomycin,DB00512,Gram-Positive Bacterial Infections,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,COLEC1,,,,,,,,,,,,,,,,,,,,,,,,,
3908,Mechlorethamine,DB00888,Malignant pericardial effusion,C0220655,Approved,CN(CCCl)CCCl},,,,,,,,,,,,,,,,,,,,,MIR148A,,,,,,,,
278,Amphotericin B,DB00681,Coccidioidomycosis,C0009186,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Cephalexin,,,,,,,,
37032,CREBBP,C0520679,Dexmedetomidine,DB00633,"Sleep Apnea, Obstructive",Withdrawn,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 2/Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
13924,IFNG,C0026769,Zoledronic acid,DB00399,Multiple Sclerosis,Terminated,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},Phase 3,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
18144,C1orf127,C0553580,Vincristine,DB00541,Ewings sarcoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
28724,PTGS2,C0339573,Latanoprost,DB00654,"Glaucoma, Primary Open Angle",Terminated,CC(C)OC(=O)CCC/C=C\\C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O},Phase 1,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
14014,FGF2,C0027726,Triamcinolone,DB00620,Nephrotic Syndrome,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Urinary system disease,FGFB,,,,,,,,,,,,,,,,,,,,,,,,,
1848,Colistimethate,DB01111,Klebsiella Infections,C0022729,Approved,CCC(C)CCCCC(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC(C(C)O)C(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCNCS(=O)(=O)[O-])CC(C)C)CC(C)C)CCNCS(=O)(=O)[O-])CCNCS(=O)(=O)[O-])C(C)O.[Na+].[Na+].[Na+].[Na+].[Na+]},,Infectious disease,,,,,,,,,,,,,,,,,,,CYP2B6,,,,,,,,
10199,HIF1A,C0024115,Theophylline,DB00277,Lung diseases,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Lung disease,MOP1,HIF-1alpha,PASD8,HIF1,bHLHe78,,,,,,,,,,,,,,,,,,,,,
34768,CSPP1,C0030283,Ethanol,DB00898,Pancreatic Cyst,Terminated,CCO},Phase 3,Congenital malformation,FLJ22490,CSPP,JBTS21,,,,,,,,,,,,,,,,,,,,,,,
3621,L-Cysteine,DB00151,Pulmonary Cystic Fibrosis,C0392164,Approved,C([C@@H](C(=O)O)N)S},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,SRSF2,,,,,,,,
26611,KRAS,C1335302,Paclitaxel,DB01229,Pancreatic Ductal Adenocarcinoma,Suspended,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
798,Brompheniramine,DB00835,Pruritus,C0033774,Approved,CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2},,,,,,,,,,,,,,,,,,,,,HLA-DRB1,,,,,,,,
29404,TLR4,C0004623,Triamcinolone,DB00620,Bacterial Infections,Terminated,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},Phase 1/Phase 2,Infectious disease,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,,,,,,,,,
29858,IL18,C0850666,Omeprazole,DB00338,Infection caused by Helicobacter pylori,Terminated,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 1/Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
64,Afamelanotide,DB04931,Erythropoietic Protoporphyria,C0162568,Approved,CCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N5CCC[C@H]5C(=O)N[C@@H](C(C)C)C(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CC=C(C=C6)O)NC(=O)[C@H](CO)NC(=O)C},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,Amlodipine,,,,,,,,
20759,CDKN3,C0343386,Vancomycin,DB00512,Clostridium difficile infection,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23289,LHB,C0232940,Progesterone,DB00396,Secondary physiologic amenorrhea,Approved,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Reproductive system disease,LSH-B,CGB4,hLHB,,,,,,,,,,,,,,,,,,,,,,,
28839,FOLH1,C0279682,Metronidazole,DB00916,Bladder Adenocarcinoma,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2458,APOA1,C0020538,Propofol,DB00818,Hypertensive disease,Withdrawn,CC(C)C1=C(C(=CC=C1)C(C)C)O},Phase 3,Cardiovascular disease,,,,,,,,,,,,,,,,,,ERAL1,,,,,,,,
23612,IFNG,C0220756,Miglustat,DB00419,"Niemann-Pick Disease, Type C",Approved,CCCCN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,
30324,TP53,C0024314,Bortezomib,DB00188,Lymphoproliferative Disorders,Terminated,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O},Phase 2,Primary immunodeficiency,0,,,,,,,,,,,,,,,,,,,,,,,,,
13289,TRNS1,C0001403,Triamcinolone,DB00620,Addison Disease,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16113,UGT1A6,C0008350,Ursodeoxycholic acid,DB01586,Cholelithiasis,Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30663,CTNNB1,C0685938,Erythropoietin,DB00016,Malignant neoplasm of gastrointestinal tract,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 3,Cancer,beta-catenin,armadillo,CTNNB,,,,,,,,,,,,,,,,,,,,,,,
6780,MAOA,C0033975,Triflupromazine,DB00508,Psychotic Disorders,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,CITED1,,,,,,,,
18915,IGF1,C0027773,Diazoxide,DB01119,Nesidioblastosis,Approved,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl},,Metabolic disease,IGF1A,IGFI,IGF-I,IGF,,,,,,,,,,,,,,,,,,,,,,
2803,Febuxostat,DB04854,Hyperuricemia,C0740394,Approved,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O},,,,,,,,,,,,,,,,,,,,,CLIP2,,,,,,,,
3570,Itraconazole,DB01167,Invasive Pulmonary Aspergillosis,C0276653,Approved,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5CO[C@](O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,ODF3,,,,,,,,
33868,CDK4,C0751690,Imatinib,DB00619,Malignant Peripheral Nerve Sheath Tumor,Terminated,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 2/Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32760,KLF1,C0019045,Pegfilgrastim,DB00019,Hemoglobinopathies,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Congenital malformation,EKLF,,,,,,,,,,,,,,,,,,,,,,,,,
17844,HLA-DQA1,C0162316,Succinic acid,DB00139,Iron deficiency anemia,Approved,C(CC(=O)O)C(=O)O},,Hematologic disease,HLA-DQA,,,,,,,,,,,,,,,,,,,,,,,,,
3497,Imipramine,DB00458,Bedwetting,C0270327,Approved,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31},,,,,,,,,,,,,,,,,,,,,LPIN2,,,,,,,,
16916,ALOX5,C0014356,Clidinium,DB00771,Enterocolitis,Approved,C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O},,Gastrointestinal disease,5-LOX,,,,,,,,,,,,,,,,,,,,,,,,,
17168,POMC,C0014550,Stiripentol,DB09118,"Epilepsies, Myoclonic",Approved,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O},,Nervous system disease,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
21094,HSD3B2,C0342527,Testosterone Propionate,DB01420,Deficiency of testosterone biosynthesis,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12456,IRAK1,C0032302,Trovafloxacin,DB00685,Mycoplasma pneumonia,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36234,C10orf82,C1510472,Varenicline,DB01273,Drug Dependence,Withdrawn,C1C2CNCC1C3=CC4=NC=CN=C4C=C23},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
3810,Lornoxicam,DB06725,Pain,C0030193,Approved,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3},,,,,,,,,,,,,,,,,,,,,CTF1,,,,,,,,
6234,Triprolidine,DB00427,Allergic rhinitis (disorder),C2607914,Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Immune system disease,,,,,,,,,,,,,,,,,,,CLEC4E,,,,,,,,
2235,Dexamethasone,DB01234,"Tuberculosis, Miliary",C0041321,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Infectious disease,,,,,,,,,,,,,,,,,,,IL17RA,,,,,,,,
7488,HLA-A,C0338437,Albendazole,DB00518,Neurocysticercosis,Approved,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC},,Infectious disease,,,,,,,,,,,,,,,,,,ACAA2,,,,,,,,
13265,ANKRD26,C0154301,Triamcinolone,DB00620,Acquired thrombocytopenia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29811,AHCY,C0700292,Nitric Oxide,DB00435,Hypoxemia,Terminated,[N]=O},Phase 1/Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16231,CDK2AP1,C0041466,Ofloxacin,DB01165,Typhoid Fever,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10675,IGHG1,C0149725,Piperacillin,DB00319,Lower respiratory tract infection,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,,,,,,,,,,,,,,,,,,,,,,,,,,,
20997,PLXNA2,C0008526,Fluocinolone Acetonide,DB00591,Choroiditis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@@]53C)F)F)O},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
27033,CRP,C0036983,Norepinephrine,DB00368,Septic Shock,Withdrawn,C1=CC(=C(C=C1[C@H](CN)O)O)O},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,
23316,CXCL16,C3697010,Olsalazine,DB01250,Ulcerative colitis in remission,Approved,C1=CC(=C(C=C1N=NC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O},,Immune system disease,SR-PSOX,CXCLG16,SRPSOX,,,,,,,,,,,,,,,,,,,,,,,
21640,DDC,C0019880,Glycine betaine,DB06756,Homocystinuria,Approved,C[N+](C)(C)CC(=O)[O-]},,Congenital disorder of metabolism,AADC,,,,,,,,,,,,,,,,,,,,,,,,,
33193,IL10,C0948780,Simvastatin,DB00641,Rhinosinusitis,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Immune system disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
2747,Estradiol,DB00783,Urethral atrophy,C0520577,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O},,,,,,,,,,,,,,,,,,,,,CHGA,,,,,,,,
63,Adenosine monophosphate,DB00131,Pulmonary Cystic Fibrosis,C0392164,Approved,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,Amlexanox,,,,,,,,
16553,CYP27B1,C0238052,Cholic Acid,DB02659,"Xanthomatosis, Cerebrotendinous",Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C},,Congenital disorder of metabolism,P450c1,VDD1,PDDR,,,,,,,,,,,,,,,,,,,,,,,
24223,HIF1A,C0917798,Phentolamine,DB00692,Cerebral Ischemia,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cardiovascular disease,MOP1,HIF-1alpha,PASD8,HIF1,bHLHe78,,,,,,,,,,,,,,,,,,,,,
14256,ASB10,C0028840,Unoprostone,DB06826,Ocular Hypertension,Approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36507,IL17A,C0019621,Clofarabine,DB00631,"Histiocytosis, Langerhans-Cell",Withdrawn,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl)N},Phase 2,Cancer,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
24351,AMD1,C0271084,Verteporfin,DB00460,Exudative age-related macular degeneration,Approved,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C.CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)O)C(=C3C)CCC(=O)OC)C=C},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
13691,SEMA4A,C0015397,Triamcinolone,DB00620,Disorder of eye,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,,SemB,FLJ12287,CORD10,SEMAB,,,,,,,,,,,,,,,,,,,,,,
2190,Dexamethasone,DB01234,Exacerbation of asthma,C0349790,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Immune system disease,,,,,,,,,,,,,,,,,,,IL9,,,,,,,,
22423,GLA,C0004245,Isoprenaline,DB01064,Atrioventricular Block,Approved,CC(C)NCC(C1=CC(=C(C=C1)O)O)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27124,LOX,C0019196,Paroxetine,DB00715,Hepatitis C,Terminated,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
20465,TLR4,C0043167,Erythromycin,DB00199,Pertussis,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,,,,,,,,,
24936,CISH,C0936215,Pyridoxine,DB00165,Vitamin B 6 Deficiency,Approved,CC1=NC=C(C(=C1O)CO)CO},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7155,IL1B,C0033860,Atorvastatin,DB01076,Psoriasis,Withdrawn,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Skin disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,PRKACB,,,,,,,,
25205,TGM1,C0870082,Tretinoin,DB00755,Hyperkeratosis,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Skin and connective tissue disease,TGASE,TGK,LI,LI1,ICR2,,,,,,,,,,,,,,,,,,,,,
21276,SEMA3E,C0155877,Zileuton,DB00744,Allergic asthma,Approved,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O},,Immune system disease,M-SemaK,KIAA0331,coll-5,SEMAH,,,,,,,,,,,,,,,,,,,,,,
7941,CDKN2C,C0020502,Alfacalcidol,DB01436,Hyperparathyroidism,Approved,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7211,XKR6,C0018621,Triprolidine,DB00427,Hay fever,Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Infectious disease,0,,,,,,,,,,,,,,,,,MIR662,,,,,,,,
26970,FCER2,C0349632,Vincristine,DB00541,Splenic Marginal Zone B-Cell Lymphoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,CLEC4J,CD23,CD23A,FCE2,,,,,,,,,,,,,,,,,,,,,,
18403,CES2,C0023474,Nilotinib,DB04868,"Leukemia, Myeloid, Chronic-Phase",Approved,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36179,CD274,C0220603,Valproic Acid,DB00313,childhood brain tumor,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,B7-H,B7H1,PD-L1,PDL1,B7-H1,PDCD1LG1,,,,,,,,,,,,,,,,,,,,
13840,SFRP2,C0021390,Naltrexone,DB00704,Inflammatory Bowel Diseases,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,,SARP1,SDF-5,FRP-2,,,,,,,,,,,,,,,,,,,,,,,
1622,Cinchocaine,DB00527,Skin irritation,C0152030,Approved,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC},,Skin disease,,,,,,,,,,,,,,,,,,,IFNA1,,,,,,,,
4427,Nitazoxanide,DB00507,Giardiasis,C0017536,Approved,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,DGAT1,,,,,,,,
27400,ADIPOQ,C0852036,Magnesium Sulfate,DB00653,Pregnancy associated hypertension,Suspended,[O-]S(=O)(=O)[O-].[Mg+2]},Phase 2/Phase 3,Cardiovascular disease,ACRP30,AdipoQ,apM1,GBP28,adiponectin,ACDC,,,,,,,,,,,,,,,,,,,,
21154,NFE2L2,C2936781,Fluoxymesterone,DB01185,Generalized Myotonia of Thomsen,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1708,Clavulanate,DB00766,Escherichia coli urinary tract infection,C0577708,Approved,C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,JRK,,,,,,,,
28984,SIRT1,C0027627,Sirolimus,DB00877,Neoplasm Metastasis,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 3,Cancer,SIR2L1,,,,,,,,,,,,,,,,,,,,,,,,,
31836,TBC1D9,C3495949,Valproic Acid,DB00313,Locally advanced breast cancer,Terminated,CCCC(CCC)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
31367,SMUG1,C0220654,Erlotinib,DB00530,Meningeal Carcinomatosis,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27548,ACTC1,C0878544,Milrinone,DB00235,Cardiomyopathies,Suspended,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2},Phase 3,Cardiovascular disease,CMD1R,ACTC,,,,,,,,,,,,,,,,,,,,,,,,
19511,SNORA73A,C0276535,Doxorubicin,DB00997,AIDS with Kaposi's sarcoma,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36806,KLK3,C0600139,Simvastatin,DB00641,Prostate carcinoma,Withdrawn,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
23836,TGFB1,C1262117,Natamycin,DB00826,Fungal keratitis,Approved,C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)O)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)N)O},,Infectious disease,CED,TGFbeta,TGFB,DPD1,,,,,,,,,,,,,,,,,,,,,,
24019,LINC01081,C0031190,Sildenafil,DB00203,Persistent Fetal Circulation Syndrome,Withdrawn,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
34485,CCR7,C0023470,Mycophenolic acid,DB01024,Myeloid Leukemia,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,Cancer,BLR2,CDw197,CD197,CMKBR7,EBI1,,,,,,,,,,,,,,,,,,,,,
8934,TNF,C0038358,Roxatidine acetate,DB08806,Gastric ulcer,Approved,CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2},,Digestive system disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
24806,FAS,C1527336,Prednisolone,DB00860,Sjogren's Syndrome,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Cardiovascular disease,CD95,APO-1,FAS1,APT1,TNFRSF6,,,,,,,,,,,,,,,,,,,,,
31035,IGFBP2,C0280793,Temozolomide,DB00853,Mixed Oligodendroglioma-Astrocytoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,IBP2,,,,,,,,,,,,,,,,,,,,,,,,,
21450,CD69,C0016867,Gentamicin,DB00798,Furunculosis,Approved,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC},,Infectious disease,CLEC2C,,,,,,,,,,,,,,,,,,,,,,,,,
2576,Econazole,DB01127,Tinea cruris,C1384589,Approved,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,OCLN,,,,,,,,
27927,MEN1,C0280100,Pegfilgrastim,DB00019,Solid tumour,Withdrawn,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
2998,Fosaprepitant,DB06717,Chemotherapy-induced nausea and vomiting,C0401160,Approved,C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NN(C(=O)N3)P(=O)(O)O)C4=CC=C(C=C4)F},,,,,,,,,,,,,,,,,,,,,ATL1,,,,,,,,
22531,SYCE1L,C0022354,Kappadione,DB09332,"Jaundice, Obstructive",Approved,CC1=C(C2=CC=CC=C2C(=C1)OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+]},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19284,SIRT1,C1961112,Dobutamine,DB00841,Heart Decompensation,Approved,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O},,Cardiovascular disease,SIR2L1,,,,,,,,,,,,,,,,,,,,,,,,,
5118,Prednisolone,DB00860,Addison Disease,C0001403,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Endocrine disease,,,,,,,,,,,,,,,,,,,MYH3,,,,,,,,
37095,CCL20,C0037011,Dexamethasone,DB01234,Shoulder Pain,Withdrawn,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,Musculoskeletal disease,LARC,MIP-3a,exodus-1,ST38,CKb4,SCYA20,,,,,,,,,,,,,,,,,,,,
35012,TP53RK,C0151526,Progesterone,DB00396,Premature Birth,Terminated,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
32767,HP,C0019045,Pegfilgrastim,DB00019,Hemoglobinopathies,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
20396,IL13,C0012546,Erythromycin,DB00199,Diphtheria,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,P600,IL-13,ALRH,BHR1,MGC116786,MGC116788,MGC116789,,,,,,,,,,,,,,,,,,,
16932,CST4,C0085166,Tinidazole,DB00911,Bacterial Vaginosis,Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23698,NTRK1,C0031099,Lidocaine,DB00281,Periodontitis,Terminated,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},Phase 2,Infectious disease,TRKA,MTC,,,,,,,,,,,,,,,,,,,,,,,,
28577,CCDC81,C0341106,Lansoprazole,DB00448,Eosinophilic esophagitis,Withdrawn,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F},Phase 1/Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4519,Norfloxacin,DB01059,Pneumonia,C0032285,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,DNTT,,,,,,,,
295,Amphotericin B,DB00681,"Leishmaniasis, Visceral",C0023290,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Chlorpromazine,,,,,,,,
10112,IKZF3,C0004096,Zafirlukast,DB00549,Asthma,Approved,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22005,COX1,C0917796,Idebenone,DB09081,"Optic Atrophy, Hereditary, Leber",Approved,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
24427,PPP3CA,C0019202,Triethylenetetramine,DB06824,Hepatolenticular Degeneration,Approved,C(CNCCNCCN)N},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
18106,ERBB2,C1704231,Cytarabine,DB00987,Metastatic Malignant Neoplasm to the Leptomeninges,Approved,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O},,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
33786,CD34,C0018133,Tacrolimus,DB00864,Graft-vs-Host Disease,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
4238,Minocycline,DB01017,Infection of skin AND/OR subcutaneous tissue,C0178299,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,MMP21,,,,,,,,
25805,HNF1A,C0039841,Thiamine,DB00152,Thiamine Deficiency,Approved,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
28451,SIGMAR1,C0236736,Dextroamphetamine,DB01576,Cocaine-Related Disorders,Terminated,C[C@@H](CC1=CC=CC=C1)N},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
33187,TARDBP,C1145670,Dexmedetomidine,DB00633,Respiratory Failure,Terminated,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 3,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10275,VDR,C0041327,Streptomycin,DB01082,"Tuberculosis, Pulmonary",Approved,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O},,Infectious disease,NR1I1,PPP1R163,,,,,,,,,,,,,,,,,,,,,,,,
22403,PDIA3,C0346976,Gemcitabine,DB00441,Secondary malignant neoplasm of pancreas,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34075,GC,C0029453,Cholecalciferol,DB00169,Osteopenia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 2/Phase 3,Musculoskeletal disease,VDBP,hDBP,,,,,,,,,,,,,,,,,,,,,,,,
35814,HLA-DRA,C0272285,Rivaroxaban,DB06228,Heparin-induced thrombocytopenia,Terminated,C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl},Phase 3,Hematologic disease,HLA-DRA1,,,,,,,,,,,,,,,,,,,,,,,,,
23428,PRDX5,C0017536,Tinidazole,DB00911,Giardiasis,Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23613,LINC01193,C0220756,Miglustat,DB00419,"Niemann-Pick Disease, Type C",Approved,CCCCN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
33537,TAF15,C0036974,Vitamin C,DB00126,Shock,Terminated,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5083,Pramocaine,DB09345,Pruritus Ani,C0033775,Approved,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2},,,,,,,,,,,,,,,,,,,,,LDHB,,,,,,,,
14667,BTK,C0334634,Thalidomide,DB01041,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 3,Cancer,ATK,XLA,PSCTK1,AGMX1,IMD1,,,,,,,,,,,,,,,,,,,,,
27552,RBM20,C0878544,Milrinone,DB00235,Cardiomyopathies,Suspended,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2},Phase 3,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
3601,Ketoconazole,DB01026,Seborrheic dermatitis,C0036508,Approved,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,ATP6AP2,,,,,,,,
23835,CCL2,C1262117,Natamycin,DB00826,Fungal keratitis,Approved,C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)O)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)N)O},,Infectious disease,MCP1,MCP-1,MCAF,SMC-CF,GDCF-2,HC11,MGC9434,SCYA2,,,,,,,,,,,,,,,,,,
5848,Testosterone,DB00624,Hypogonadotropic hypogonadism,C0271623,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,Endocrine disease,,,,,,,,,,,,,,,,,,,RSAD2,,,,,,,,
24367,MTAP,C0812413,Pemetrexed,DB00642,Malignant Pleural Mesothelioma,Approved,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23674,HLA-C,C1328252,Miltefosine,DB09031,Mucocutaneous leishmaniasis,Approved,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},,Infectious disease,HLA-JY3,D6S204,PSORS1,,,,,,,,,,,,,,,,,,,,,,,
32753,KRT14,C0553723,Paclitaxel,DB01229,Squamous cell carcinoma of skin,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,EBS3,EBS4,,,,,,,,,,,,,,,,,,,,,,,,
33584,CRP,C0007273,Vitamin E,DB00163,Carotid Artery Diseases,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Vascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
30684,NBN,C0025149,Valproic Acid,DB00313,Medulloblastoma,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
31892,PLN,C1696708,Losartan,DB00678,Prehypertension,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl},Phase 2,Cardiovascular disease,CMD1P,,,,,,,,,,,,,,,,,,,,,,,,,
17453,MBL2,C0854135,Colistin,DB00803,Pseudomonas aeruginosa infection,Approved,CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)[C@@H](C)O},,Infectious disease,COLEC1,,,,,,,,,,,,,,,,,,,,,,,,,
32548,MLN,C0520909,Nicotine,DB00184,Postoperative Nausea and Vomiting,Terminated,CN1CCC[C@H]1C2=CN=CC=C2},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,
9058,Ketoprofen,DB01009,Tendinitis,C0039503,Terminated,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O},Phase 3,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
29314,ELMO1,C0279628,Cisplatin,DB00515,Adenocarcinoma Of Esophagus,Terminated,N.N.Cl[Pt]Cl},Phase 2,Cancer,KIAA0281,ELMO-1,,,,,,,,,,,,,,,,,,,,,,,,
25324,HLA-B,C0037299,Sulfadiazine,DB00359,Skin Ulcer,Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Skin disease,,,,,,,,,,,,,,,,,,,,,,,,,,
20815,GJA5,C0028734,Flavoxate,DB01148,Nocturia,Approved,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4},,Urinary system disease,CX40,,,,,,,,,,,,,,,,,,,,,,,,,
15760,TNF,C0040997,Carbamazepine,DB00564,Trigeminal Neuralgia,Approved,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N},,,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
8147,HLA-DRB1,C0042109,Methotrexate,DB00563,Urticaria,Terminated,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Skin and connective tissue disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
28144,TMSB4X,C0278505,Paclitaxel,DB01229,Non-small cell lung cancer stage II,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4359,Naproxen,DB00788,Arthralgia,C0003862,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,NCK2,,,,,,,,
4514,Norfloxacin,DB01059,Mycoplasma pneumonia,C0032302,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CNTNAP1,,,,,,,,
20501,CAP2,C0039240,Propranolol,DB00571,Supraventricular tachycardia,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14650,NOTCH1,C0334634,Thalidomide,DB01041,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 3,Cancer,TAN1,,,,,,,,,,,,,,,,,,,,,,,,,
9943,Salmeterol,DB00938,Chronic Obstructive Airway Disease,C0024117,Withdrawn,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O},Phase 3,Lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
508,Aztreonam,DB00355,Bacterial urinary infection,C0729524,Approved,C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\\OC(C)(C)C(=O)O)/C2=CSC(=N2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,Dosulepin,,,,,,,,
20684,ERVW-1,C1274323,Valaciclovir,DB00577,Recurrent genital herpes simplex,Approved,CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28390,NLRP3,C0007682,Temozolomide,DB00853,CNS disorder,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Nervous system disease,AGTAVPRL,AII,AVP,FCAS,FCU,NALP3,PYPAF1,MWS,CLR1.1,C1orf7,CIAS1,,,,,,,,,,,,,,,
1218,Cefoxitin,DB01331,Postoperative infection,C0392618,Approved,CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3},,Infectious disease,,,,,,,,,,,,,,,,,,,Phenylacetic acid,,,,,,,,
21750,IL2RA,C0022972,Guanidine,DB00536,Lambert-Eaton Myasthenic Syndrome,Approved,C(=N)(N)N},,Nervous system disease,IL2R,IDDM10,,,,,,,,,,,,,,,,,,,,,,,,
28093,ARAF,C0152013,Paclitaxel,DB01229,Adenocarcinoma of lung (disorder),Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26130,EPO,C0032463,Uracil mustard,DB00791,Polycythemia Vera,Approved,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl},,Cancer,EP,,,,,,,,,,,,,,,,,,,,,,,,,
28566,CCL26,C0341106,Lansoprazole,DB00448,Eosinophilic esophagitis,Withdrawn,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F},Phase 1/Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22618,ACADL,C1142132,L-Carnitine,DB00583,Carnitine deficiency,Approved,C[N+](C)(C)C[C@@H](CC(=O)[O-])O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10117,PPARGC1B,C0347950,Theophylline,DB00277,Asthma attack,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17094,IL37,C0085652,Clofazimine,DB00845,Pyoderma Gangrenosum,Approved,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1406,Ceftriaxone,DB01212,"Meningitis, Bacterial",C0085437,Approved,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Sofosbuvir,,,,,,,,
12386,GSTT1,C0007134,Thalidomide,DB01041,Renal Cell Carcinoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 1/Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
31195,EIF2AK2,C0015674,Lipoic Acid,DB00166,Chronic Fatigue Syndrome,Withdrawn,C1CSS[C@@H]1CCCCC(=O)O},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
4468,Norfloxacin,DB01059,Acute exacerbation of chronic bronchitis,C0856695,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Lung disease,,,,,,,,,,,,,,,,,,,MIR205,,,,,,,,
17292,CD207,C0919659,Miconazole,DB01110,Oropharyngeal candidiasis,Approved,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl},,Infectious disease,Langerin,CLEC4K,,,,,,,,,,,,,,,,,,,,,,,,
20606,SMAD4,C0029396,Etidronic acid,DB01077,Heterotopic Ossification,Approved,CC(O)(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,DPC4,MADH4,,,,,,,,,,,,,,,,,,,,,,,,
8464,Omeprazole,DB00338,Cystic Fibrosis,C0010674,Terminated,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 2,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,,
13120,LCN2,C0003175,Procaine benzylpenicillin,DB09320,Anthrax disease,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,NGAL,24p3,,,,,,,,,,,,,,,,,,,,,,,,
9722,NT5E,C1112209,Trovafloxacin,DB00685,Intraabdominal Infections,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,CD73,eN,eNT,CALJA,NT5,,,,,,,,,,,,,,,,,,,,,
9018,DEAF1,C0017168,Sodium Citrate,DB09154,Gastroesophageal reflux disease,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13204,FBLN5,C0041912,Phenoxymethylpenicillin,DB00417,Upper Respiratory Infections,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C},,Infectious disease,EVEC,UP50,DANCE,ARMD3,,,,,,,,,,,,,,,,,,,,,,
19703,PCYT1B,C0008354,Minocycline,DB01017,Cholera,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23334,PIK3R1,C0042900,Tacrolimus,DB00864,Vitiligo,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7384,TXN,C0162568,Afamelanotide,DB04931,Erythropoietic Protoporphyria,Approved,CCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N5CCC[C@H]5C(=O)N[C@@H](C(C)C)C(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CC=C(C=C6)O)NC(=O)[C@H](CO)NC(=O)C},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,ENPP2,,,,,,,,
9363,DRD1,C0030567,Trihexyphenidyl,DB00376,Parkinson Disease,Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5722,Sulfanilamide,DB00259,"Candidiasis, Vulvovaginal",C0700345,Approved,C1=CC(=CC=C1N)S(=O)(=O)N},,Infectious disease,,,,,,,,,,,,,,,,,,,TBC1D7,,,,,,,,
23539,PARK7,C0085631,Midazolam,DB00683,Agitation,Approved,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
9353,Haloperidol,DB00502,Nausea,C0027497,Withdrawn,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F},Phase 0,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
4454,Norepinephrine,DB00368,Parkinson Disease,C0030567,Approved,C1=CC(=C(C=C1[C@H](CN)O)O)O},,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,MGMT,,,,,,,,
10075,TLR7,C0022602,Masoprocol,DB00179,Actinic keratosis,Approved,C[C@H](CC1=CC(=C(C=C1)O)O)[C@@H](C)CC2=CC(=C(C=C2)O)O},,Skin disease,,,,,,,,,,,,,,,,,,,,,,,,,,
22761,SLC46A1,C0002888,Levoleucovorin,DB11596,"Anemia, Megaloblastic",Approved,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2443,Doxazosin,DB00590,Hypertensive disease,C0020538,Approved,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,COL4A5,,,,,,,,
17921,BLM,C0024299,Pegfilgrastim,DB00019,Lymphoma,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16911,RBM45,C0014356,Clidinium,DB00771,Enterocolitis,Approved,C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O},,Gastrointestinal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34866,IL1RN,C0011206,Quetiapine,DB01224,Delirium,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,ICIL-1RA,IL1F3,IL-1RN,MGC10430,,,,,,,,,,,,,,,,,,,,,,
37171,CYP2D6,C0023051,Omeprazole,DB00338,Laryngeal Diseases,Withdrawn,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 3,,CPD6,P450-DB1,P450C2D,CYP2DL1,CYP2D7P2,CYP2D7BP,CYP2D8P2,CYP2D7AP,,,,,,,,,,,,,,,,,,
10693,GCLC,C0031350,Tetracycline,DB00759,Pharyngitis,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,GLCLC,GLCL,,,,,,,,,,,,,,,,,,,,,,,,
4647,Omeprazole,DB00338,Gastric ulcer,C0038358,Approved,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},,Digestive system disease,,,,,,,,,,,,,,,,,,,ORAI1,,,,,,,,
18251,CSF2,C0038166,Tedizolid Phosphate,DB09042,Staphylococcal Skin Infections,Approved,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4C[C@@H](OC4=O)COP(=O)(O)O)F},,Infectious disease,GM-CSF,GMCSF,,,,,,,,,,,,,,,,,,,,,,,,
30331,ACSBG1,C0024314,Bortezomib,DB00188,Lymphoproliferative Disorders,Terminated,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O},Phase 2,Primary immunodeficiency,BGM,FLJ30320,MGC14352,BG1,KIAA0631,hBG1,hsBG,,,,,,,,,,,,,,,,,,,
35352,CRP,C0001723,Mifepristone,DB00834,"Affective Disorders, Psychotic",Terminated,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
4864,Pheniramine,DB01620,Sneezing,C0037383,Approved,CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2},,,,,,,,,,,,,,,,,,,,,USP18,,,,,,,,
20270,CYP2R1,C0042870,Ergocalciferol,DB00153,Vitamin D Deficiency,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30129,CYP19A1,C2938924,Letrozole,DB01006,Oestrogen receptor positive breast cancer,Terminated,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3},Phase 2,Cancer,ARO,P-450AROM,CPV1,ARO1,CYAR,aromatase,CYP19,,,,,,,,,,,,,,,,,,,
4749,Paclitaxel,DB01229,"Glaucoma, Open-Angle",C0017612,Approved,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},,Nervous system disease,,,,,,,,,,,,,,,,,,,TBCD,,,,,,,,
8039,Erythropoietin,DB00016,Ventricular hemorrhage,C0240059,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
11376,IL13,C0037199,Pseudoephedrine,DB00852,Sinusitis,Withdrawn,C[C@@H]([C@H](C1=CC=CC=C1)O)NC},Phase 2,Infectious disease,P600,IL-13,ALRH,BHR1,MGC116786,MGC116788,MGC116789,,,,,,,,,,,,,,,,,,,
23818,CCR1,C0231528,Naproxen,DB00788,Myalgia,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,,MIP1aR,CD191,SCYAR1,CMKBR1,,,,,,,,,,,,,,,,,,,,,,
8054,KDR,C1739363,Terazosin,DB01162,Prostatic Hypertrophy,Approved,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC},,,FLK1,VEGFR,VEGFR2,CD309,,,,,,,,,,,,,,,,,,,,,,
1826,GABRA2,C0001973,Zonisamide,DB00909,"Alcoholic Intoxication, Chronic",Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 2,Other,0,,,,,,,,,,,,,,,,,CYLD,,,,,,,,
709,Betamethasone,DB00443,Nephrotic Syndrome,C0027726,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Urinary system disease,,,,,,,,,,,,,,,,,,,Gliquidone,,,,,,,,
19438,JAG1,C0235063,Doxapram,DB00561,Respiratory Depression,Approved,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4},,Lung disease,AHD,AWS,HJ1,CD339,AGS,JAGL1,,,,,,,,,,,,,,,,,,,,
9768,Mupirocin,DB00410,Strawberry nevus of skin,C0206733,Withdrawn,C[C@H]([C@H]1[C@@H](O1)C[C@H]2CO[C@H]([C@@H]([C@@H]2O)O)C/C(=C/C(=O)OCCCCCCCCC(=O)O)/C)[C@H](C)O},Phase 2,Vascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
20881,TRPV1,C0184567,Floctafenine,DB08976,Acute onset pain,Approved,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC=C(C3=NC=C2)C(F)(F)F},,,,,,,,,,,,,,,,,,,,,,,,,,,,
30326,MS4A1,C0024314,Bortezomib,DB00188,Lymphoproliferative Disorders,Terminated,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O},Phase 2,Primary immunodeficiency,Bp35,MS4A2,CD20,,,,,,,,,,,,,,,,,,,,,,,
5702,Sulfadiazine,DB00359,"Toxoplasmosis, Congenital",C0040560,Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,SCN1B,,,,,,,,
16197,CEBPB,C0036117,Chloramphenicol,DB00446,Salmonella infections,Approved,C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]},,Infectious disease,NFIL6,IL6DBP,C/EBP-beta,TCF5,,,,,,,,,,,,,,,,,,,,,,
14842,LINC02641,C0026603,Scopolamine,DB00747,Motion Sickness,Approved,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10447,ITGA2B,C0038454,Vorapaxar,DB09030,Cerebrovascular accident,Approved,CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@H]([C@H]2/C=C/C4=NC=C(C=C4)C5=CC(=CC=C5)F)[C@H](OC3=O)C},,Cardiovascular disease,CD41B,CD41,PPP1R93,GP2B,,,,,,,,,,,,,,,,,,,,,,
13161,AQP4,C0027927,Procaine benzylpenicillin,DB09320,Neurosyphilis,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,MIWC,,,,,,,,,,,,,,,,,,,,,,,,,
16802,CX3CL1,C0010692,Ofloxacin,DB01165,Cystitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,C3Xkine,ABCD-3,CXC3C,CXC3,fractalkine,neurotactin,SCYD1,,,,,,,,,,,,,,,,,,,
2569,Ecallantide,DB05311,"Angioedemas, Hereditary",C0019243,Approved,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N4CCC[C@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N5CCC[C@H]5C(=O)N3)CC(=O)O)CC(=O)O)C)CCCCN)CC6=CC=CC=C6)C)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CO)NC(=O)[C@H](CC8=CN=CN8)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)CCSC)CCCCN)CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC2=O)CCC(=O)O)CC(=O)N)CCC(=O)N)CC(=O)N)CCCNC(=N)N)CC9=CC=CC=C9)CCC(=O)O)CO)CC(C)C)CCC(=O)O)CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC1=CC=CC=C1)CCC(=O)O)CCC(=O)O)CCC(=O)N)CCCNC(=N)N)[C@H](C)O)CC1=CC=CC=C1)[C@@H](C)CC)CC(=O)N)CC1=CC=CC=C1)CC1=CC=CC=C1)CC1=CNC2=CC=CC=C21)CCCNC(=N)N)CC1=CN=CN1)C)C)CCCNC(=N)N)CC1=CC=C(C=C1)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,SIPA1L3,,,,,,,,
22212,TCF3,C0043037,Imiquimod,DB00724,Common wart,Approved,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30384,TP53,C0018939,Melphalan,DB01042,Hematological Disease,Terminated,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27884,ACTB,C2347748,Mitoxantrone,DB01204,Adult Erythroleukemia,Terminated,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35618,LMNA,C1136321,Pioglitazone,DB01132,HIV-Associated Lipodystrophy Syndrome,Terminated,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3},Phase 3,Immune system disease,LMN1,CMD1A,LGMD1B,,,,,,,,,,,,,,,,,,,,,,,
34525,SLC9A6,C0149778,Vancomycin,DB00512,Soft Tissue Infections,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12384,SETD2,C0007134,Thalidomide,DB01041,Renal Cell Carcinoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33942,HIF1A,C0006287,Nitric Oxide,DB00435,Bronchopulmonary Dysplasia,Terminated,[N]=O},Phase 2/Phase 3,Congenital malformation,MOP1,HIF-1alpha,PASD8,HIF1,bHLHe78,,,,,,,,,,,,,,,,,,,,,
30015,IFNA1,C0024137,Tretinoin,DB00755,"Lupus Erythematosus, Cutaneous",Terminated,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11033,ACTB,C0006846,Zinc oxide,DB09321,Cutaneous Candidiasis,Approved,O=[Zn]},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29129,METAP2,C0280483,Irinotecan,DB00762,adult anaplastic astrocytoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3165,Gentamicin,DB00798,Blepharoconjunctivitis,C0005743,Approved,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC},,Infectious disease,,,,,,,,,,,,,,,,,,,CSH1,,,,,,,,
662,Betamethasone,DB00443,Acquired thrombocytopenia,C0154301,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Immune system disease,,,,,,,,,,,,,,,,,,,RYR1,,,,,,,,
21920,MAP2K1,C0025202,Lovastatin,DB00227,melanoma,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
28809,ETV6,C0023452,Vincristine,DB00541,"Leukemia, Lymphocytic, Acute, L1",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 1,Cancer,TEL,,,,,,,,,,,,,,,,,,,,,,,,,
30209,ZFPM2,C1861172,Atorvastatin,DB01076,Venous Thromboembolism,Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 2,Vascular disease,FOG2,hFOG-2,ZNF89B,ZC2HC11B,,,,,,,,,,,,,,,,,,,,,,
19949,IL37,C0016053,Pramipexole,DB00413,Fibromyalgia,Terminated,CCCN[C@H]1CCC2=C(C1)SC(=N2)N},Phase 2,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10551,NPY,C0014544,Zonisamide,DB00909,Epilepsy,Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 3,Nervous system disease,PYY4,,,,,,,,,,,,,,,,,,,,,,,,,
21177,GH1,C0022735,Testosterone Propionate,DB01420,Klinefelter Syndrome,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Congenital malformation,GH-N,GHN,GH,hGH-N,,,,,,,,,,,,,,,,,,,,,,
34222,ESR1,C0010054,Fenofibrate,DB01039,Coronary Arteriosclerosis,Terminated,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 3,Vascular disease,NR3A1,Era,ER-alpha,ESR,,,,,,,,,,,,,,,,,,,,,,
8792,Vitamin E,DB00163,Intracranial Arteriosclerosis,C0007771,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Vascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
28639,UMOD,C1565489,Simeprevir,DB06290,Renal Insufficiency,Withdrawn,CC1=C(C=CC2=C1N=C(C=C2O[C@@H]3C[C@@H]4[C@@H](C3)C(=O)N(CCCC/C=C\\[C@@H]5C[C@]5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC},Phase 2,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,
516,Aztreonam,DB00355,Haemophilus influenzae pneumonia,C0276026,Approved,C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\\OC(C)(C)C(=O)O)/C2=CSC(=N2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,NR3C1,,,,,,,,
36007,SELENBP1,C0085119,Treprostinil,DB00374,Foot Ulcer,Terminated,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},Phase 3,,hSP56,hSBP,LPSB,,,,,,,,,,,,,,,,,,,,,,,
4325,Nabumetone,DB00461,Degenerative polyarthritis,C0029408,Approved,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC},,Immune system disease,,,,,,,,,,,,,,,,,,,SHMT1,,,,,,,,
12226,APOA5,C0020474,Simvastatin,DB00641,"Hyperlipidemia, Familial Combined",Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Metabolic disease,RAP3,APOA-V,,,,,,,,,,,,,,,,,,,,,,,,
35721,VWF,C0856169,Valsartan,DB00177,Endothelial dysfunction,Terminated,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Endocrine and metabolic disease,F8VWF,,,,,,,,,,,,,,,,,,,,,,,,,
35383,LRIG2,C0005686,Mitomycin,DB00305,Urinary Bladder Diseases,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23322,FOXP1,C0042900,Tacrolimus,DB00864,Vitiligo,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Skin disease,QRF1,12CC4,HSPC215,hFKH1B,,,,,,,,,,,,,,,,,,,,,,
20027,CRB1,C0271093,Echothiophate,DB01057,Stargardt's disease,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Infectious disease,LCA8,RP12,,,,,,,,,,,,,,,,,,,,,,,,
7892,CFDP1,C0029401,Zoledronic acid,DB00399,Osteitis Deformans,Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16502,IGF1,C0029456,Calcium carbonate,DB06724,Osteoporosis,Withdrawn,C(=O)([O-])[O-].[Ca+2]},Phase 3,Musculoskeletal disease,IGF1A,IGFI,IGF-I,IGF,,,,,,,,,,,,,,,,,,,,,,
34631,THAS,C0020450,Thiamine,DB00152,Hyperemesis Gravidarum,Terminated,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},Phase 3,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23910,NTN1,C0038525,Deferoxamine,DB00746,Subarachnoid Hemorrhage,Terminated,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O},Phase 0,,NTN1L,,,,,,,,,,,,,,,,,,,,,,,,,
24059,PIK3CA,C0341823,Olaparib,DB09074,Epithelial tumor of ovary,Approved,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F},,Cancer,PI3K,,,,,,,,,,,,,,,,,,,,,,,,,
25853,TLR3,C0036130,Ticarcillin,DB01607,Salpingitis,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,CD283,,,,,,,,,,,,,,,,,,,,,,,,,
11949,IDH2,C0023487,Tretinoin,DB00755,Acute Promyelocytic Leukemia,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36023,ACE2,C1135191,Udenafil,DB06267,"Heart Failure, Systolic",Terminated,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C},Phase 3,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24734,TNF,C0032533,Prednisone,DB00635,Polymyalgia Rheumatica,Terminated,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 3,Musculoskeletal disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
21102,FOXO3,C0342527,Testosterone Propionate,DB01420,Deficiency of testosterone biosynthesis,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25586,IL1A,C0008513,Sulfadiazine,DB00359,Chorioretinitis,Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,IL1F1,IL-1A,IL1-ALPHA,IL1,,,,,,,,,,,,,,,,,,,,,,
9477,ENG,C2973725,Treprostinil,DB00374,Pulmonary arterial hypertension,Approved,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},,Infectious disease,END,HHT1,CD105,ORW1,ORW,,,,,,,,,,,,,,,,,,,,,
810,Bupivacaine,DB00297,Pruritus,C0033774,Approved,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C},,,,,,,,,,,,,,,,,,,,,Insulin Degludec,,,,,,,,
18959,F12,C0040038,Warfarin,DB00682,Thromboembolism,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29513,ERBB2,C0279633,Fluorouracil,DB00544,intestinal adenocarcinoma of the stomach,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 1/Phase 2,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
262,Amphetamine,DB00182,Obesity,C0028754,Approved,CC(CC1=CC=CC=C1)N},,Metabolic disease,,,,,,,,,,,,,,,,,,,Cefonicid,,,,,,,,
27947,MIR21,C0280100,Pegfilgrastim,DB00019,Solid tumour,Withdrawn,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3174,Gentamicin,DB00798,Furunculosis,C0016867,Approved,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC},,Infectious disease,,,,,,,,,,,,,,,,,,,LPA,,,,,,,,
23995,TAC1,C0010418,Nitazoxanide,DB00507,Cryptosporidiosis,Approved,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]},,Infectious disease,NPK,TAC2,NKNA,,,,,,,,,,,,,,,,,,,,,,,
21138,VPS13B,C0034012,Testosterone Propionate,DB01420,Delayed Puberty,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31177,FURIN,C0015674,Lipoic Acid,DB00166,Chronic Fatigue Syndrome,Withdrawn,C1CSS[C@@H]1CCCCC(=O)O},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
10211,HPS1,C0024115,Theophylline,DB00277,Lung diseases,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36726,PIK3CB,C0278802,Norgestrel,DB09389,Recurrent Endometrial Cancer,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
8729,OPCML,C1140680,Fondaparinux sodium,DB00569,Malignant neoplasm of ovary,Withdrawn,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
14989,SLC6A3,C0028043,Varenicline,DB01273,Nicotine Dependence,Terminated,C1C2CNCC1C3=CC4=NC=CN=C4C=C23},Phase 2/Phase 3,Mental and behavioural disorder,DAT,,,,,,,,,,,,,,,,,,,,,,,,,
35199,RNMT,C0442874,Magnesium Sulfate,DB00653,Neuropathy,Terminated,[O-]S(=O)(=O)[O-].[Mg+2]},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5508,Salicylic acid,DB00936,Hyperkeratosis,C0870082,Approved,C1=CC=C(C(=C1)C(=O)O)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,GUSB,,,,,,,,
31987,EGFR,C1319315,Sulindac,DB00605,Adenocarcinoma of large intestine,Terminated,CC\\1=C(C2=C(/C1=C\\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O},Phase 2,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
16386,PRSS1,C0162565,Promazine,DB00420,Acute intermittent porphyria,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Congenital disorder of metabolism,TRY1,,,,,,,,,,,,,,,,,,,,,,,,,
32952,APOE,C0549399,Simvastatin,DB00641,Low density lipoprotein increased,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Metabolic disease,AD2,,,,,,,,,,,,,,,,,,,,,,,,,
27959,CCN2,C0036421,Iloprost,DB01088,Systemic Scleroderma,Terminated,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32470,TERT,C0238461,Paclitaxel,DB01229,Anaplastic thyroid carcinoma,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 3,Cancer,TRT,TCS1,hEST2,EST2,,,,,,,,,,,,,,,,,,,,,,
2935,Fluoxymesterone,DB01185,Klinefelter Syndrome,C0022735,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F},,Congenital malformation,,,,,,,,,,,,,,,,,,,SRL,,,,,,,,
31204,PSIP1,C0015674,Lipoic Acid,DB00166,Chronic Fatigue Syndrome,Withdrawn,C1CSS[C@@H]1CCCCC(=O)O},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
26038,TGFA,C0034063,Trimethaphan,DB01116,Pulmonary Edema,Approved,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5},,Lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,
13879,CSF3,C0024305,Vidarabine,DB00194,"Lymphoma, Non-Hodgkin",Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 3,Cancer,MGC45931,GCSF,G-CSF,C17orf33,,,,,,,,,,,,,,,,,,,,,,
23916,MMP9,C0038525,Deferoxamine,DB00746,Subarachnoid Hemorrhage,Terminated,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O},Phase 0,,CLG4B,,,,,,,,,,,,,,,,,,,,,,,,,
5364,Prussian blue,DB06783,Thallium poisoning,C0238452,Approved,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3]},,,,,,,,,,,,,,,,,,,,,HJV,,,,,,,,
21139,CYP11A1,C0034012,Testosterone Propionate,DB01420,Delayed Puberty,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Endocrine and metabolic disease,P450SCC,CYP11A,,,,,,,,,,,,,,,,,,,,,,,,
22500,HMOX1,C0042373,Tolazoline,DB00797,Vascular Diseases,Approved,C1CN=C(N1)CC2=CC=CC=C2},,Vascular disease,bK286B10,HO-1,,,,,,,,,,,,,,,,,,,,,,,,
21028,MMP9,C0007102,Oxaliplatin,DB00526,Malignant tumor of colon,Withdrawn,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,CLG4B,,,,,,,,,,,,,,,,,,,,,,,,,
19671,CD34,C0004771,Minocycline,DB01017,Bartonella Infections,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
31543,AR,C3495917,Exemestane,DB00990,Advanced breast cancer,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C},Phase 2,Cancer,AIS,NR3C4,SMAX1,HUMARA,DHTR,SBMA,,,,,,,,,,,,,,,,,,,,
4240,Minocycline,DB01017,Listeriosis,C0023860,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,FGFR2,,,,,,,,
10782,ELANE,C0155862,Troleandomycin,DB01361,Streptococcal pneumonia,Approved,C[C@@H]1C[C@@H]([C@H]([C@@H](O1)O[C@H]2[C@H](C[C@@]3(CO3)C(=O)[C@@H]([C@H]([C@H]([C@H](OC(=O)[C@@H]([C@H]([C@@H]2C)O[C@H]4C[C@@H]([C@H]([C@@H](O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C},,Infectious disease,NE,HNE,HLE,ELA2,,,,,,,,,,,,,,,,,,,,,,
17438,NLRP3,C0854135,Colistin,DB00803,Pseudomonas aeruginosa infection,Approved,CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)[C@@H](C)O},,Infectious disease,AGTAVPRL,AII,AVP,FCAS,FCU,NALP3,PYPAF1,MWS,CLR1.1,C1orf7,CIAS1,,,,,,,,,,,,,,,
23519,COMT,C0031511,Phentolamine,DB00692,Pheochromocytoma,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2775,Etodolac,DB00749,Degenerative polyarthritis,C0029408,Approved,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,STAG1,,,,,,,,
17968,ATRX,C0027819,Topotecan,DB01030,Neuroblastoma,Withdrawn,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O},Phase 2,Cancer,XH2,XNP,RAD54,JMS,MRX52,,,,,,,,,,,,,,,,,,,,,
857,Caffeine,DB00201,Sinus headache,C0037195,Approved,CN1C=NC2=C1C(=O)N(C(=O)N2C)C},,Nervous system disease,,,,,,,,,,,,,,,,,,,Latanoprost,,,,,,,,
27274,SS18,C0281508,Vitamin C,DB00126,Desmoplastic Small Round Cell Tumor,Suspended,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23052,DTX2,C0006118,Lomustine,DB01206,Brain Neoplasms,Approved,C1CCC(CC1)NC(=O)N(CCCl)N=O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33352,PRKAR1A,C0038362,Thalidomide,DB01041,Stomatitis,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11380,PPP1R9B,C0037199,Pseudoephedrine,DB00852,Sinusitis,Withdrawn,C[C@@H]([C@H](C1=CC=CC=C1)O)NC},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12423,IL10,C0007947,Sulfisoxazole,DB00263,Chancroids,Approved,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
12843,MME,C0024301,Vincristine,DB00541,"Lymphoma, Follicular",Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,CALLA,CD10,,,,,,,,,,,,,,,,,,,,,,,,
12834,ATP6AP1,C0024301,Vincristine,DB00541,"Lymphoma, Follicular",Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12469,TNF,C0554628,Quinupristin,DB01369,Streptococcus pyogenes infection,Approved,CC[C@@H]1C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)N3C[C@H](C(=O)C[C@H]3C(=O)N[C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CS[C@@H]6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C},,Infectious disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
28382,EPO,C0007682,Temozolomide,DB00853,CNS disorder,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Nervous system disease,EP,,,,,,,,,,,,,,,,,,,,,,,,,
15899,F2,C0032797,Oxytocin,DB00107,Postpartum Hemorrhage,Approved,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
19048,HSPD1,C0029001,Ivermectin,DB00602,Onchocerciasis,Approved,CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3472,TBL2,C0917801,Citalopram,DB00215,Sleeplessness,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,,0,,,,,,,,,,,,,,,,,CD19,,,,,,,,
682,Betamethasone,DB00443,Chronic small plaque psoriasis,C0406317,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Skin disease,,,,,,,,,,,,,,,,,,,Fosamprenavir,,,,,,,,
3538,Irbesartan,DB01029,Diabetic Nephropathy,C0011881,Approved,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5},,Urinary system disease,,,,,,,,,,,,,,,,,,,TMEM199,,,,,,,,
23166,IFNLR1,C0040954,Thiabendazole,DB00730,Infection by Trichuris trichiura,Approved,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9358,Testosterone,DB00624,Hypertensive disease,C0020538,Withdrawn,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},Phase 0,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
36329,ATXN8OS,C0011168,Lansoprazole,DB00448,Deglutition Disorders,Withdrawn,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F},Phase 1/Phase 2,,NCRNA00003,SCA8,KLHL1AS,,,,,,,,,,,,,,,,,,,,,,,
29258,PLAG1,C1328504,Sirolimus,DB00877,Hormone refractory prostate cancer,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12293,G6PD,C0020557,Topiramate,DB00273,Hypertriglyceridemia,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Metabolic disease,G6PD1,,,,,,,,,,,,,,,,,,,,,,,,,
4226,Minocycline,DB01017,Bronchitis,C0006277,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Lung disease,,,,,,,,,,,,,,,,,,,NCF4,,,,,,,,
8498,Oxytocin,DB00107,"Fetal Membranes, Premature Rupture",C0015944,Terminated,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
4874,Phenobarbital,DB01174,Migraine Disorders,C0149931,Approved,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2},,Nervous system disease,,,,,,,,,,,,,,,,,,,MAGT1,,,,,,,,
12781,F13A1,C0034065,Edoxaban,DB09075,Pulmonary Embolism,Approved,CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C},,Lung disease,F13A,,,,,,,,,,,,,,,,,,,,,,,,,
12965,HADH,C0220994,Phenylacetic acid,DB09269,Hyperammonemia,Approved,C1=CC=C(C=C1)CC(=O)O},,Inherited metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11760,EDN1,C0085612,Tocainide,DB01056,Ventricular arrhythmia,Approved,CC1=C(C(=CC=C1)C)NC(=O)C(C)N},,Cardiovascular disease,ET1,,,,,,,,,,,,,,,,,,,,,,,,,
23510,GDNF,C0031511,Phentolamine,DB00692,Pheochromocytoma,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cancer,ATF1,ATF2,HFB1-GDNF,,,,,,,,,,,,,,,,,,,,,,,
16073,DSG1,C0021099,Retapamulin,DB01256,Impetigo,Approved,C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC4C[C@H]5CC[C@@H](C4)N5C)C},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19958,F12,C0019243,Stanozolol,DB06718,"Angioedemas, Hereditary",Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(CC5=C(C4)NN=C5)C},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26995,SOAT1,C1955861,Thalidomide,DB01041,T-Cell Large Granular Lymphocyte Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,STAT,,,,,,,,,,,,,,,,,,,,,,,,,
8992,Fentanyl,DB00813,Chronic pain,C0150055,Terminated,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
18182,AKT2,C1135868,Vinblastine,DB00570,Gestational Trophoblastic Neoplasms,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
12734,PLAT,C0149871,Warfarin,DB00682,Deep Vein Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
19310,EP300,C0678222,Paclitaxel,DB01229,Breast Carcinoma,Approved,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27358,ERVK-22,C0334359,Trametinib,DB08911,Papillary serous cystadenocarcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2/Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
20343,CD274,C0023827,Trabectedin,DB05109,liposarcoma,Approved,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O},,Cancer,B7-H,B7H1,PD-L1,PDL1,B7-H1,PDCD1LG1,,,,,,,,,,,,,,,,,,,,
18891,PDX1,C0021670,Romidepsin,DB06176,insulinoma,Terminated,C/C=C\\1/C(=O)N[C@H](C(=O)O[C@H]\\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C},Phase 2,Cancer,IDX-1,STF-1,PDX-1,MODY4,IPF1,,,,,,,,,,,,,,,,,,,,,
29035,SLC6A4,C0600427,Vigabatrin,DB01080,Cocaine Dependence,Terminated,C=CC(CCC(=O)O)N},Phase 2,Mental and behavioural disorder,5-HTT,SERT1,HTT,OCD1,,,,,,,,,,,,,,,,,,,,,,
4102,Methylprednisolone,DB00959,Pemphigus,C0030807,Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,COCH,,,,,,,,
15506,CASP10,C0024623,Citalopram,DB00215,Malignant neoplasm of stomach,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10599,IL10,C0271429,Trimethoprim,DB00440,Acute otitis media,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
3414,Hydroxychloroquine,DB01611,"Lupus Erythematosus, Discoid",C0024138,Approved,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO},,Immune system disease,,,,,,,,,,,,,,,,,,,GKN1,,,,,,,,
1966,Crotamiton,DB00265,Pruritus,C0033774,Approved,CCN(C1=CC=CC=C1C)C(=O)/C=C/C},,,,,,,,,,,,,,,,,,,,,ITIH4,,,,,,,,
16045,CYBB,C0025289,Gemcitabine,DB00441,Meningitis,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1,Infectious disease,GP91-PHOX,NOX2,CGD,,,,,,,,,,,,,,,,,,,,,,,
15698,MICAL1,C0234974,Topiramate,DB00273,Simple Partial Seizures,Approved,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18142,RPL24P2,C0553580,Vincristine,DB00541,Ewings sarcoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35745,CD8B,C0038868,Rasagiline,DB01367,Progressive supranuclear palsy,Terminated,C#CCN[C@@H]1CCC2=CC=CC=C12},Phase 3,Neurodegenerative disease,CD8B1,,,,,,,,,,,,,,,,,,,,,,,,,
34895,TP53,C0278704,Heparin,DB01109,Malignant Childhood Neoplasm,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2024,GGT1,C0001973,Zonisamide,DB00909,"Alcoholic Intoxication, Chronic",Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 2,Other,D22S672,D22S732,CD224,,,,,,,,,,,,,,,PART1,,,,,,,,
5280,Probenecid,DB01032,Gonorrhea,C0018081,Approved,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SIX2,,,,,,,,
8023,IL6,C0035086,Calcitriol,DB00136,Renal Osteodystrophy,Approved,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},,Endocrine and metabolic disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
15617,PPARG,C0011881,Losartan,DB00678,Diabetic Nephropathy,Approved,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl},,Urinary system disease,PPARG1,PPARG2,NR1C3,PPARgamma,,,,,,,,,,,,,,,,,,,,,,
10531,DDB2,C0151908,Pramocaine,DB09345,Dry skin,Approved,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21161,AR,C0022735,Testosterone Propionate,DB01420,Klinefelter Syndrome,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Congenital malformation,AIS,NR3C4,SMAX1,HUMARA,DHTR,SBMA,,,,,,,,,,,,,,,,,,,,
29827,PDYN,C0700292,Nitric Oxide,DB00435,Hypoxemia,Terminated,[N]=O},Phase 1/Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24724,IL6,C0032533,Prednisone,DB00635,Polymyalgia Rheumatica,Terminated,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 3,Musculoskeletal disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
4644,Omega-3-carboxylic acids,DB09568,Hypertriglyceridemia,C0020557,Approved,CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCC(=O)O},,Metabolic disease,,,,,,,,,,,,,,,,,,,FXN,,,,,,,,
8359,DAO,C0003467,Citalopram,DB00215,Anxiety,Withdrawn,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Mental and behavioural disorder,DAMOX,DAAO,,,,,,,,,,,,,,,,,,,,,,,,
24671,IL1A,C0002390,Prednisolone,DB00860,Extrinsic allergic alveolitis,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Immune system disease,IL1F1,IL-1A,IL1-ALPHA,IL1,,,,,,,,,,,,,,,,,,,,,,
34322,FN1,C0004610,Vancomycin,DB00512,Bacteremia,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,CIG,LETS,GFND2,FINC,,,,,,,,,,,,,,,,,,,,,,
18615,AMY1A,C0270327,Imipramine,DB00458,Bedwetting,Approved,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
14138,IL17A,C0039103,Triamcinolone,DB00620,Synovitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
9905,Esomeprazole,DB00736,Laryngeal Diseases,C0023051,Withdrawn,CC1=CN=C(C(=C1OC)C)C[S@](=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
3101,Fusidic Acid,DB02703,Sepsis of the newborn,C0456103,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,TGFB3,,,,,,,,
1965,SLC6A4,C0001973,Zonisamide,DB00909,"Alcoholic Intoxication, Chronic",Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 2,Other,5-HTT,SERT1,HTT,OCD1,,,,,,,,,,,,,,GEN1,,,,,,,,
15841,FCRL3,C0018213,Carbimazole,DB00389,Graves Disease,Approved,CCOC(=O)N1C=CN(C1=S)C},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3427,Hydroxyzine,DB00557,Allergic Conjunctivitis,C0009766,Approved,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl},,Immune system disease,,,,,,,,,,,,,,,,,,,FKBP1AP1,,,,,,,,
13108,ERBB2,C0003175,Procaine benzylpenicillin,DB09320,Anthrax disease,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
35972,MIR365A,C0019163,Tenofovir,DB00300,Hepatitis B,Terminated,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23126,CXCL8,C0010674,Amikacin,DB00479,Cystic Fibrosis,Withdrawn,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},Phase 3,Congenital disorder of metabolism,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
32143,TET2,C0376545,Isotretinoin,DB00982,Hematologic Neoplasms,Terminated,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\\C(=O)O)/C)/C},Phase 2,Cancer,FLJ20032,KIAA1546,,,,,,,,,,,,,,,,,,,,,,,,
18874,CD68,C0020459,Diazoxide,DB01119,Hyperinsulinism,Approved,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl},,Endocrine and metabolic disease,SCARD1,macrosialin,DKFZp686M18236,LAMP4,,,,,,,,,,,,,,,,,,,,,,
2908,Fluorometholone,DB00324,Cyclitis,C0010543,Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@]2([C@@]4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O},,,,,,,,,,,,,,,,,,,,,S1PR3,,,,,,,,
31821,YY1,C4048328,Gemcitabine,DB00441,cervical cancer,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10131,MUC5AC,C0347950,Theophylline,DB00277,Asthma attack,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
6203,Trimethadione,DB00347,Absence Epilepsy,C0014553,Approved,CC1(C(=O)N(C(=O)O1)C)C},,Nervous system disease,,,,,,,,,,,,,,,,,,,GLE1,,,,,,,,
22057,LAT,C0019357,Vidarabine,DB00194,"Keratitis, Herpetic",Approved,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
16713,TNF,C0043515,Roxatidine acetate,DB08806,Zollinger-Ellison syndrome,Approved,CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2},,Endocrine and metabolic disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
33347,NUMA1,C0038362,Thalidomide,DB01041,Stomatitis,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12960,GLUL,C0220994,Phenylacetic acid,DB09269,Hyperammonemia,Approved,C1=CC=C(C=C1)CC(=O)O},,Inherited metabolic disease,GLNS,,,,,,,,,,,,,,,,,,,,,,,,,
19298,AKT1,C0678222,Paclitaxel,DB01229,Breast Carcinoma,Approved,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},,Cancer,RAC,PKB,PRKBA,AKT,,,,,,,,,,,,,,,,,,,,,,
16166,SPP1,C0035585,Fusidic Acid,DB02703,Rickettsia Infections,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,BSPI,ETA-1,BNSP,OPN,,,,,,,,,,,,,,,,,,,,,,
442,Atorvastatin,DB01076,Hypertensive disease,C0020538,Approved,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,ENPP1,,,,,,,,
3052,Fusidic Acid,DB02703,GONOCOCCAL INFECTION DISSEMINATED,C0744451,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,INPP5A,,,,,,,,
34881,SRPX,C0011206,Quetiapine,DB01224,Delirium,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,ETX1,,,,,,,,,,,,,,,,,,,,,,,,,
31381,PTHLH,C0206754,Sunitinib,DB01268,Neuroendocrine Tumors,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,PTHRP,,,,,,,,,,,,,,,,,,,,,,,,,
22197,CARMIL2,C0043037,Imiquimod,DB00724,Common wart,Approved,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4139,Meticillin,DB01603,Sinusitis,C0037199,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C3=C(C=CC=C3OC)OC)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,RPS19,,,,,,,,
5228,LMX1B,C0004604,Hydromorphone,DB00327,Back Pain,Terminated,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4},Phase 3,,NPS1,,,,,,,,,,,,,,,,,AURKA,,,,,,,,
20181,VCAM1,C0002792,Epinephrine,DB00668,anaphylaxis,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Immune system disease,CD106,,,,,,,,,,,,,,,,,,,,,,,,,
28970,CSF1R,C0027627,Sirolimus,DB00877,Neoplasm Metastasis,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 3,Cancer,C-FMS,CSFR,CD115,FMS,,,,,,,,,,,,,,,,,,,,,,
21262,IL18,C0155877,Zileuton,DB00744,Allergic asthma,Approved,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4967,Piperacillin,DB00319,Bacterial sepsis,C0684256,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,TMED7,,,,,,,,
9847,Dexmedetomidine,DB00633,"Sleep Apnea, Obstructive",C0520679,Withdrawn,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 2/Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
4282,Mometasone,DB00764,Granuloma Annulare,C0085074,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)Cl)C},,Skin disease,,,,,,,,,,,,,,,,,,,ALOX12B,,,,,,,,
6100,Tretinoin,DB00755,Senile lentigo,C0036651,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Skin disease,,,,,,,,,,,,,,,,,,,TRIM60,,,,,,,,
22674,G6PD,C0019151,Phenylacetic acid,DB09269,Hepatic Encephalopathy,Terminated,C1=CC=C(C=C1)CC(=O)O},Phase 2,Liver disease,G6PD1,,,,,,,,,,,,,,,,,,,,,,,,,
1936,Cortisone acetate,DB01380,Rheumatic Heart Disease,C0035439,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,COMP,,,,,,,,
29655,GPHN,C0279629,Vorinostat,DB02546,adult acute monoblastic leukemia (M5a),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,KIAA1385,,,,,,,,,,,,,,,,,,,,,,,,,
3391,Hydrocortisone,DB00741,Tenosynovitis,C0039520,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,RNA18SN5,,,,,,,,
26734,PIK3CA,C0278791,Thalidomide,DB01041,Chronic lymphocytic leukaemia refractory,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,PI3K,,,,,,,,,,,,,,,,,,,,,,,,,
32804,SORBS1,C0039730,Pegfilgrastim,DB00019,Thalassemia,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20986,NOS2,C0025218,Tretinoin,DB00755,Chloasma,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Skin disease,iNOS,HEP-NOS,NOS2A,,,,,,,,,,,,,,,,,,,,,,,
27455,WDR20,C0004903,Vincristine,DB00541,Beckwith-Wiedemann Syndrome,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
3787,Lomitapide,DB08827,Familial hypercholesterolemia - homozygous,C0342881,Approved,C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F},,Inherited metabolic disease,,,,,,,,,,,,,,,,,,,C20orf181,,,,,,,,
3215,Glycine,DB00145,Nasal congestion (finding),C0027424,Approved,C(C(=O)O)N},,,,,,,,,,,,,,,,,,,,,TSC1,,,,,,,,
5670,Sucralfate,DB00364,Duodenal Ulcer,C0013295,Approved,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al]},,Digestive system disease,,,,,,,,,,,,,,,,,,,RPS6KA3,,,,,,,,
5294,Procaine benzylpenicillin,DB09320,Pinta,C0031946,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,GREB1,,,,,,,,
2778,Etofenamate,DB08984,Degenerative polyarthritis,C0029408,Approved,C1=CC=C(C(=C1)C(=O)OCCOCCO)NC2=CC=CC(=C2)C(F)(F)F},,Immune system disease,,,,,,,,,,,,,,,,,,,ARFGEF2,,,,,,,,
3610,Ketoprofen,DB01009,Rheumatoid Arthritis,C0003873,Approved,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,PDGFA,,,,,,,,
7836,CDKN2A,C0007131,Carboplatin,DB00958,Non-Small Cell Lung Carcinoma,Withdrawn,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2]},Phase 2,Cancer,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,DVL3,,,,,,,,
6105,Triamcinolone,DB00620,Adrenal cortical hypofunction,C0405580,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,,,,,,,,,,,,,,,,,,,TNRC6C-AS1,,,,,,,,
20838,RAB39B,C0042024,Tolterodine,DB01036,Urinary Incontinence,Terminated,CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
2551,Droxidopa,DB06262,Parkinson Disease,C0030567,Approved,C1=CC(=C(C=C1[C@H]([C@@H](C(=O)O)N)O)O)O},,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,ALPK1,,,,,,,,
31348,HPGDS,C0014852,Erlotinib,DB00530,Esophageal Diseases,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Digestive system disease,GSTS,H-PGDS,PGD2,GSTS1-1,GSTS1,,,,,,,,,,,,,,,,,,,,,
23970,PTGES3,C0010418,Nitazoxanide,DB00507,Cryptosporidiosis,Approved,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9096,HMOX1,C0030920,Sodium Citrate,DB09154,Peptic Ulcer,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Digestive system disease,bK286B10,HO-1,,,,,,,,,,,,,,,,,,,,,,,,
21969,KRT20,C0024419,Thalidomide,DB01041,Waldenstrom Macroglobulinemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,CK20,K20,MGC35423,,,,,,,,,,,,,,,,,,,,,,,
26578,EGFR,C0278838,Ketoconazole,DB01026,Prostate cancer recurrent,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
28674,TNFSF11,C0153690,Ketoconazole,DB01026,Secondary malignant neoplasm of bone,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,TRANCE,RANKL,OPGL,ODF,CD254,,,,,,,,,,,,,,,,,,,,,
14639,MIR122,C0524910,Cyclosporine,DB00091,"Hepatitis C, Chronic",Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27470,GRB10,C0004903,Vincristine,DB00541,Beckwith-Wiedemann Syndrome,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
7309,CXCL8,C0001144,Tretinoin,DB00755,Acne Vulgaris,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Infectious disease,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,ARHGAP44,,,,,,,,
4396,Neostigmine,DB01400,Myasthenia Gravis,C0026896,Approved,CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C},,Immune system disease,,,,,,,,,,,,,,,,,,,C1QB,,,,,,,,
5394,Quinapril,DB00881,Hypertensive disease,C0020538,Approved,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,SALL3,,,,,,,,
23520,DDC,C0031511,Phentolamine,DB00692,Pheochromocytoma,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cancer,AADC,,,,,,,,,,,,,,,,,,,,,,,,,
24722,CRP,C0032533,Prednisone,DB00635,Polymyalgia Rheumatica,Terminated,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 3,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,,,,,,,,
11591,C7,C0025294,Sulfisoxazole,DB00263,Meningococcal meningitis,Approved,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
3409,Hydroquinone,DB09526,Facial hyperpigmentation,C2677857,Approved,C1=CC(=CC=C1O)O},,Skin disease,,,,,,,,,,,,,,,,,,,MME,,,,,,,,
16854,LTF,C0277528,Ofloxacin,DB01165,Traveler's diarrhea,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Digestive system disease,HLF2,,,,,,,,,,,,,,,,,,,,,,,,,
19948,NGF,C0016053,Pramipexole,DB00413,Fibromyalgia,Terminated,CCCN[C@H]1CCC2=C(C1)SC(=N2)N},Phase 2,Musculoskeletal disease,NGFB,,,,,,,,,,,,,,,,,,,,,,,,,
1286,Ceftaroline fosamil,DB06590,Pneumonia due to Staphylococcus aureus,C2349530,Approved,CCO/N=C(/C1=NSC(=N1)NP(=O)(O)O)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,COPD,,,,,,,,
36549,LYVE1,C0393819,Cyclophosphamide,DB00531,"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",Withdrawn,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 2,Nervous system disease,LYVE-1,XLKD1,,,,,,,,,,,,,,,,,,,,,,,,
22603,APOA2,C0030409,Ketoconazole,DB01026,Paracoccidioidomycosis,Approved,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
26072,PWAR1,C0349506,Trioxsalen,DB04571,Photosensitivity of skin,Approved,CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12074,MMP2,C0027051,Fondaparinux sodium,DB00569,Myocardial Infarction,Withdrawn,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},Phase 2,Cardiovascular disease,TBE-1,CLG4,CLG4A,,,,,,,,,,,,,,,,,,,,,,,
5523,Salmeterol,DB00938,Intrinsic asthma,C0155880,Approved,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O},,Immune system disease,,,,,,,,,,,,,,,,,,,ABCC1,,,,,,,,
33694,CHRNA7,C0040332,Nicotine,DB00184,Tobacco Dependence,Terminated,CN1CCC[C@H]1C2=CN=CC=C2},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
24964,IFNG,C0024530,Prednisone,DB00635,Malaria,Withdrawn,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
21260,IL1B,C0155877,Zileuton,DB00744,Allergic asthma,Approved,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O},,Immune system disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
11444,FXYD4,C0153252,Voriconazole,DB00582,Systemic candidiasis,Approved,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},,Infectious disease,CHIF,,,,,,,,,,,,,,,,,,,,,,,,,
20086,MSR1,C0041228,Suramin,DB04786,African Trypanosomiasis,Approved,CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C},,Infectious disease,SCARA1,CD204,SR-AI,SR-AII,SR-AIII,SR-A,,,,,,,,,,,,,,,,,,,,
22887,RET,C0677607,Levothyroxine,DB00451,Hashimoto Disease,Approved,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N},,Immune system disease,CDHF12,RET51,CDHR16,HSCR1,MEN2A,MTC1,MEN2B,,,,,,,,,,,,,,,,,,,
24929,MAPK1,C1849508,Pyridoxine,DB00165,"EPILEPSY, PYRIDOXINE-DEPENDENT",Approved,CC1=NC=C(C(=C1O)CO)CO},,Nervous system disease,ERK2,p41mapk,MAPK2,PRKM2,PRKM1,,,,,,,,,,,,,,,,,,,,,
32601,CHRM3,C0343401,Nitric Oxide,DB00435,MRSA - Methicillin resistant Staphylococcus aureus infection,Terminated,[N]=O},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
23647,IL13,C0023283,Fluconazole,DB00196,"Leishmaniasis, Cutaneous",Terminated,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O},Phase 3,Infectious disease,P600,IL-13,ALRH,BHR1,MGC116786,MGC116788,MGC116789,,,,,,,,,,,,,,,,,,,
28113,LMTK2,C0345958,Paclitaxel,DB01229,Large cell carcinoma of lung,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17559,PHACTR1,C0037769,Vigabatrin,DB01080,West Syndrome,Approved,C=CC(CCC(=O)O)N},,Nervous system disease,KIAA1733,dJ257A7.2,RPEL1,,,,,,,,,,,,,,,,,,,,,,,
30297,SFTPC,C0007120,Bortezomib,DB00188,Bronchioloalveolar Adenocarcinoma,Terminated,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O},Phase 2,Cancer,SP-C,PSP-C,SMDP2,BRICD6,SFTP2,,,,,,,,,,,,,,,,,,,,,
3882,Magnesium Sulfate,DB00653,Mild pre-eclampsia,C0269658,Approved,[O-]S(=O)(=O)[O-].[Mg+2]},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,MTHFS,,,,,,,,
29915,IL22,C0856825,Pentostatin,DB00552,Acute GVH disease,Terminated,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O},Phase 1/Phase 2,Immune system disease,ILTIF,zcyto18,IL-TIF,IL-D110,TIFa,TIFIL-23,MGC79382,MGC79384,,,,,,,,,,,,,,,,,,
18612,DRD4,C0270327,Imipramine,DB00458,Bedwetting,Approved,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31},,,,,,,,,,,,,,,,,,,,,,,,,,,,
37052,TP53,C1168198,Propranolol,DB00571,Recurrent respiratory papillomatosis,Withdrawn,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},Phase 2/Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34994,IL6,C0151526,Progesterone,DB00396,Premature Birth,Terminated,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},Phase 3,,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
34013,PAK3,C0267446,Zinc sulfate,DB09322,Acute gastroenteritis,Terminated,[O-]S(=O)(=O)[O-].[Zn+2]},Phase 2/Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1287,Ceftaroline fosamil,DB06590,Rhinoscleroma,C0035468,Approved,CCO/N=C(/C1=NSC(=N1)NP(=O)(O)O)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,SARS2,,,,,,,,
10205,AP3B1,C0024115,Theophylline,DB00277,Lung diseases,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2731,Esmolol,DB00187,Atrial Fibrillation,C0004238,Approved,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,LNCOC1,,,,,,,,
15445,ADIPOQ,C0264716,Amlodipine,DB00381,Chronic heart failure,Suspended,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN},Phase 2,Cardiovascular disease,ACRP30,AdipoQ,apM1,GBP28,adiponectin,ACDC,,,,,,,,,,,,,,,,,,,,
19996,ADAT3,C0014877,Echothiophate,DB01057,Esotropia,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
12307,FCGR2A,C0003873,Thalidomide,DB01041,Rheumatoid Arthritis,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Immune system disease,CD32A,IGFR2,CDw32,FCGR2A1,,,,,,,,,,,,,,,,,,,,,,
30581,ERCC5,C0151779,Temozolomide,DB00853,Cutaneous Melanoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
14236,NR3C1,C0028840,Unoprostone,DB06826,Ocular Hypertension,Approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},,Nervous system disease,GR,GRL,,,,,,,,,,,,,,,,,,,,,,,,
22519,PCNA,C0022354,Kappadione,DB09332,"Jaundice, Obstructive",Approved,CC1=C(C2=CC=CC=C2C(=C1)OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+]},,Liver disease,,,,,,,,,,,,,,,,,,,,,,,,,,
22801,VWF,C0025323,Tranexamic Acid,DB00302,Menorrhagia,Approved,C1CC(CCC1CN)C(=O)O},,,F8VWF,,,,,,,,,,,,,,,,,,,,,,,,,
27809,DRD2,C1456624,Methamphetamine,DB01577,Methamphetamine abuse,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 1,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
34715,LEPR,C0035078,Erythropoietin,DB00016,Kidney Failure,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 3,Urinary system disease,OBR,CD295,,,,,,,,,,,,,,,,,,,,,,,,
17114,LEPR,C0021361,Clomifene,DB00882,Female infertility,Approved,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\Cl)/C3=CC=CC=C3},,Reproductive system disease,OBR,CD295,,,,,,,,,,,,,,,,,,,,,,,,
11500,TRIT1,C0041471,Tetracycline,DB00759,TYPHUS,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17326,BRAF,C0860594,Trametinib,DB08911,"Malignant melanoma, metastatic",Approved,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},,Cancer,BRAF1,,,,,,,,,,,,,,,,,,,,,,,,,
35568,PRRT2,C0017160,Ondansetron,DB00904,Gastroenteritis,Terminated,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C},Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10561,IQSEC2,C0014544,Zonisamide,DB00909,Epilepsy,Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 3,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10506,ADA,C0151908,Pramocaine,DB09345,Dry skin,Approved,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20306,MEPE,C3536984,Ergocalciferol,DB00153,"Vitamin D-Resistant Rickets, X-Linked",Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11908,OPN1LW,C0023479,Arsenic trioxide,DB01169,Acute myelomonocytic leukemia,Approved,[O-2].[O-2].[O-2].[As+3].[As+3]},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16667,MEN1,C0027662,Erlotinib,DB00530,Multiple Endocrine Neoplasia,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
36439,NOS1,C0333875,Celecoxib,DB00482,High-Grade Squamous Intraepithelial Lesions,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2,Immune system disease,nNOS,,,,,,,,,,,,,,,,,,,,,,,,,
17979,RB1,C0035335,Melphalan,DB01042,Retinoblastoma,Terminated,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
5997,Tiotropium,DB01409,"Bronchitis, Chronic",C0008677,Approved,C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C},,Lung disease,,,,,,,,,,,,,,,,,,,ZBTB11,,,,,,,,
18005,IFI27,C0035335,Melphalan,DB01042,Retinoblastoma,Terminated,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl},Phase 2,Cancer,P27,FAM14D,ISG12,,,,,,,,,,,,,,,,,,,,,,,
25431,APC,C2239176,Sorafenib,DB00398,Liver carcinoma,Approved,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},,Cancer,DP2.5,PPP1R46,,,,,,,,,,,,,,,,,,,,,,,,
7495,CYTB,C0338437,Albendazole,DB00518,Neurocysticercosis,Approved,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC},,Infectious disease,0,,,,,,,,,,,,,,,,,CHN1,,,,,,,,
16603,PTX3,C0744130,Tazobactam,DB01606,Diabetic foot infection,Approved,C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3},,Infectious disease,TSG-14,TNFAIP5,,,,,,,,,,,,,,,,,,,,,,,,
32278,CACNA1C,C0085298,Metoprolol,DB00264,Sudden Cardiac Death,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23579,ATP7A,C0020651,Midodrine,DB00211,"Hypotension, Orthostatic",Approved,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O},,Cardiovascular disease,MNK,,,,,,,,,,,,,,,,,,,,,,,,,
948,Carbinoxamine,DB00748,Urticaria,C0042109,Approved,CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,Meclizine,,,,,,,,
30932,RUNX1,C0279644,Idarubicin,DB01177,childhood acute myelomonocytic leukemia (M4),Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O},Phase 2,Cancer,PEBP2A2,AMLCR1,AML1,CBFA2,,,,,,,,,,,,,,,,,,,,,,
22958,ST11,C0041976,Lidocaine,DB00281,Urethritis,Approved,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9579,IL13,C0684256,Vancomycin,DB00512,Bacterial sepsis,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,P600,IL-13,ALRH,BHR1,MGC116786,MGC116788,MGC116789,,,,,,,,,,,,,,,,,,,
6736,POMC,C0042029,Trovafloxacin,DB00685,Urinary tract infection,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,MIR338,,,,,,,,
1939,Cortisone acetate,DB01380,Sarcoidosis,C0036202,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Immune system disease,,,,,,,,,,,,,,,,,,,ALDH1A2,,,,,,,,
23450,DECR1,C0023885,Metronidazole,DB00916,Liver Abscess,Approved,CC1=NC=C(N1CCO)[N+](=O)[O-]},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19736,NOD2,C0023860,Minocycline,DB01017,Listeriosis,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,BLAU,PSORAS1,CLR16.3,NLRC2,IBD1,CARD15,,,,,,,,,,,,,,,,,,,,
8973,MUC6,C0038358,Roxatidine acetate,DB08806,Gastric ulcer,Approved,CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14865,HRH1,C0026603,Scopolamine,DB00747,Motion Sickness,Approved,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,,,,,,,,
9067,EIF6,C0018834,Sodium Citrate,DB09154,Heartburn,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1512,Chlorcyclizine,DB08936,Rhinorrhea,C1260880,Approved,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl},,Nervous system disease,,,,,,,,,,,,,,,,,,,Tiopronin,,,,,,,,
29721,ATM,C0279627,Vorinostat,DB02546,adult acute myelomonocytic leukemia (M4),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17778,IL18,C0042164,Triamcinolone,DB00620,Uveitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14917,OPRM1,C0150055,Pregabalin,DB00230,Chronic pain,Withdrawn,CC(C)C[C@@H](CC(=O)O)CN},Phase 3,,MOR1,,,,,,,,,,,,,,,,,,,,,,,,,
22491,SLC12A3,C0042373,Tolazoline,DB00797,Vascular Diseases,Approved,C1CN=C(N1)CC2=CC=CC=C2},,Vascular disease,NCCT,,,,,,,,,,,,,,,,,,,,,,,,,
20836,MID2,C0042024,Tolterodine,DB01036,Urinary Incontinence,Terminated,CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
5828,Terbinafine,DB00857,Tinea Versicolor,C0040262,Approved,CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21},,Infectious disease,,,,,,,,,,,,,,,,,,,STATH,,,,,,,,
14774,MECP2,C0023472,Nilotinib,DB04868,"Leukemia, Myeloid, Accelerated Phase",Approved,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,RTT,MRX16,MRX79,,,,,,,,,,,,,,,,,,,,,,,
19694,RBM45,C0008149,Fusidic Acid,DB02703,Chlamydia Infections,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13863,C1QA,C0024141,Mycophenolic acid,DB01024,"Lupus Erythematosus, Systemic",Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 2/Phase 3,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
32383,PTPN22,C0263338,Miltefosine,DB09031,Chronic urticaria,Terminated,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},Phase 2,Skin and connective tissue disease,Lyp,Lyp1,Lyp2,PTPN8,,,,,,,,,,,,,,,,,,,,,,
12274,GCKR,C0020557,Topiramate,DB00273,Hypertriglyceridemia,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11766,NQO1,C0019080,Aprotinin,DB06692,Hemorrhage,Approved,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](CSSC[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N4CCC[C@@H]4C(=O)N5CCC[C@@H]5C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N6CCC[C@H]6C(=O)N[C@H](CSSC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CCC(=O)N)[C@@H](C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCNC(=N)N)C)CCCCN)[C@H](C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)[C@@H](C)CC},,,DHQU,QR1,NMOR1,DIA4,,,,,,,,,,,,,,,,,,,,,,
26573,FSD1,C0278838,Ketoconazole,DB01026,Prostate cancer recurrent,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,MGC3213,MIR1,,,,,,,,,,,,,,,,,,,,,,,,
36889,GNAQ,C0206733,Timolol,DB00373,Strawberry nevus of skin,Withdrawn,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O},Phase 2,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17627,SFTPD,C0010043,Prednisolone,DB00860,Corneal Ulcer,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,,SP-D,COLEC7,SFTP4,,,,,,,,,,,,,,,,,,,,,,,
10230,TGFBR2,C0034067,Vilanterol,DB09082,Pulmonary Emphysema,Approved,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl},,Lung disease,TBRII,TBR-ii,MFS2,,,,,,,,,,,,,,,,,,,,,,,
22905,BDNF,C0020676,Liothyronine,DB00279,Hypothyroidism,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,
37109,BMP15,C0032460,Metformin,DB00331,Polycystic Ovary Syndrome,Withdrawn,CN(C)C(=N)N=C(N)N},Phase 3,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30259,EAF2,C0079731,Dexamethasone,DB01234,B-Cell Lymphomas,Terminated,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 2,Cancer,BM040,TRAITS,,,,,,,,,,,,,,,,,,,,,,,,
261,Amphetamine,DB00182,Narcolepsy,C0027404,Approved,CC(CC1=CC=CC=C1)N},,Nervous system disease,,,,,,,,,,,,,,,,,,,Cefmetazole,,,,,,,,
673,Betamethasone,DB00443,"Arthritis, Psoriatic",C0003872,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Immune system disease,,,,,,,,,,,,,,,,,,,SLC25A20,,,,,,,,
12885,IL10,C0038395,Procaine benzylpenicillin,DB09320,Streptococcal Infections,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
17410,ZC4H2,C0035220,Tyloxapol,DB06439,"Respiratory Distress Syndrome, Newborn",Approved,CC(C)(C)CC(C)(C)C1=CC=C(C=C1)O.C=O.C1CO1},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32858,PTPN6,C1290884,Prednisone,DB00635,Inflammatory disorder,Terminated,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14341,MIR203A,C0936223,Nilutamide,DB00665,Metastatic Prostate Carcinoma,Approved,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30223,TRAIP,C1292778,Prednisolone,DB00860,Chronic myeloproliferative disorder,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9979,PECAM1,C0004626,Tobramycin,DB00684,"Pneumonia, Bacterial",Terminated,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},Phase 2,Infectious disease,CD31,,,,,,,,,,,,,,,,,,,,,,,,,
25279,HESX1,C0013338,Somatropin recombinant,DB00052,Pituitary dwarfism,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30950,RANBP2,C0279644,Idarubicin,DB01177,childhood acute myelomonocytic leukemia (M4),Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
24990,MIF,C0040558,Sulfamethoxazole,DB01015,Toxoplasmosis,Approved,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1170,Cefotaxime,DB00493,Streptococcal sepsis,C0152964,Approved,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Papaverine,,,,,,,,
3402,Hydromorphone,DB00327,Acute postoperative pain,C2215257,Approved,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4},,,,,,,,,,,,,,,,,,,,,SH2D1A,,,,,,,,
14627,AFP,C0524910,Cyclosporine,DB00091,"Hepatitis C, Chronic",Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 3,Infectious disease,FETA,HPAFP,,,,,,,,,,,,,,,,,,,,,,,,
6919,CFTR,C0392164,L-Cysteine,DB00151,Pulmonary Cystic Fibrosis,Approved,C([C@@H](C(=O)O)N)S},,Congenital disorder of metabolism,ABC35,TNR-CFTR,CFTR/MRP,CF,ABCC7,,,,,,,,,,,,,ARTN,,,,,,,,
8480,IL6,C0338908,Perphenazine,DB00850,Mixed anxiety and depressive disorder,Approved,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO},,Mental and behavioural disorder,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
10741,FCGR2B,C1318973,Vancomycin,DB00512,Staphylococcus aureus infection,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,CD32B,,,,,,,,,,,,,,,,,,,,,,,,,
5816,Tenofovir,DB00300,HIV Infections,C0019693,Approved,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SOS2,,,,,,,,
27533,TNF,C0878544,Milrinone,DB00235,Cardiomyopathies,Suspended,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2},Phase 3,Cardiovascular disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
17075,NLRP3,C0085652,Clofazimine,DB00845,Pyoderma Gangrenosum,Approved,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl},,Immune system disease,AGTAVPRL,AII,AVP,FCAS,FCU,NALP3,PYPAF1,MWS,CLR1.1,C1orf7,CIAS1,,,,,,,,,,,,,,,
8162,Hydrochlorothiazide,DB00999,Prediabetes syndrome,C0362046,Terminated,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
31467,NES,C0023529,Erythropoietin,DB00016,"Leukomalacia, Periventricular",Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 2,Cancer,FLJ21841,,,,,,,,,,,,,,,,,,,,,,,,,
12537,CFB,C0031154,Tazobactam,DB01606,Peritonitis,Approved,C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3},,Infectious disease,H2-Bf,BFD,BF,,,,,,,,,,,,,,,,,,,,,,,
7607,OVOL1,C0011615,Triamcinolone,DB00620,"Dermatitis, Atopic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,SNHG22,,,,,,,,
4822,Pergolide,DB01186,Parkinsonian Disorders,C0242422,Approved,CCCN1C[C@@H](C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34)CSC},,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,KIR2DS1,,,,,,,,
29750,RMND5B,C0265965,Danazol,DB01406,Dyskeratosis Congenita,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5},Phase 1/Phase 2,Ribosomopathy,0,,,,,,,,,,,,,,,,,,,,,,,,,
2358,Dihydrotachysterol,DB01070,Tetany,C0039621,Approved,C[C@H]\\1CC[C@@H](C/C1=C\\C=C\\2/CCC[C@]3([C@H]2CC[C@@H]3[C@H](C)/C=C/[C@H](C)C(C)C)C)O},,Endocrine disease,,,,,,,,,,,,,,,,,,,HIRA,,,,,,,,
18575,OCLN,C0019156,Defibrotide,DB04932,Hepatic Veno-Occlusive Disease,Approved,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O},,Liver disease,PPP1R115,,,,,,,,,,,,,,,,,,,,,,,,,
36307,IL1A,C0877578,Clonidine,DB00575,Treatment related secondary malignancy,Withdrawn,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl},Phase 1/Phase 2,Cancer,IL1F1,IL-1A,IL1-ALPHA,IL1,,,,,,,,,,,,,,,,,,,,,,
4723,Oxytetracycline,DB00595,Chlamydia trachomatis infection of genital structure,C1997322,Approved,C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,NID1,,,,,,,,
18546,CP,C0282193,Deferasirox,DB01609,Iron Overload,Withdrawn,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O},Phase 2,Mitochondrial disease,,,,,,,,,,,,,,,,,,,,,,,,,,
26691,DNMT3A,C0020981,Thalidomide,DB01041,Angioimmunoblastic Lymphadenopathy,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
554,CCL3,C0019693,Trimethoprim,DB00440,HIV Infections,Terminated,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},Phase 2/Phase 3,Infectious disease,G0S19-1,LD78ALPHA,MIP-1-alpha,SCYA3,,,,,,,,,,,,,,Eltrombopag,,,,,,,,
23813,POLR3A,C0231528,Naproxen,DB00788,Myalgia,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
28174,HSPB3,C0029928,Gemcitabine,DB00441,Ovarian Diseases,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13370,IL12B,C0038013,Triamcinolone,DB00620,Ankylosing spondylitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15838,LEP,C0032897,Somatropin recombinant,DB00052,Prader-Willi Syndrome,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Chromosomal abnormality,OBS,,,,,,,,,,,,,,,,,,,,,,,,,
34556,AGT,C0023890,Dexamethasone,DB01234,Liver Cirrhosis,Terminated,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,Liver disease,SERPINA8,,,,,,,,,,,,,,,,,,,,,,,,,
35750,CIT,C0038868,Rasagiline,DB01367,Progressive supranuclear palsy,Terminated,C#CCN[C@@H]1CCC2=CC=CC=C12},Phase 3,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6424,Zinc oxide,DB09321,Exanthema,C0015230,Approved,O=[Zn]},,Infectious disease,,,,,,,,,,,,,,,,,,,VAPB,,,,,,,,
11069,TP53,C0018081,Tetracycline,DB00759,Gonorrhea,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32207,PCNA,C1370419,Ketoconazole,DB01026,Granulosa cell tumor of the ovary,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
29208,AKT1,C0278878,Irinotecan,DB00762,adult glioblastoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,RAC,PKB,PRKBA,AKT,,,,,,,,,,,,,,,,,,,,,,
30834,FCGR3A,C1522378,Cyclosporine,DB00091,"Leukemia, Large Granular Lymphocytic",Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 2,Cancer,CD16a,,,,,,,,,,,,,,,,,,,,,,,,,
27032,CPB2,C0036983,Norepinephrine,DB00368,Septic Shock,Withdrawn,C1=CC(=C(C=C1[C@H](CN)O)O)O},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
7557,MIR146A,C0406317,Ulobetasol,DB00596,Chronic small plaque psoriasis,Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Skin disease,0,,,,,,,,,,,,,,,,,TOP2B,,,,,,,,
1241,Cefpodoxime,DB01416,"Pneumonia, Bacterial",C0004626,Approved,COCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Polyethylene glycol,,,,,,,,
37133,SETD2,C0280099,Docetaxel,DB01248,adult solid tumor,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17794,CCL26,C0022577,Lodoxamide,DB06794,"Keratoconjunctivitis, Vernal",Approved,C1=C(C=C(C(=C1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13956,TRAT1,C0026857,Triamcinolone,DB00620,Musculoskeletal Diseases,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14835,HTR6,C0020514,Cabergoline,DB00248,Hyperprolactinemia,Approved,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22033,DLEU1,C0855095,Idelalisib,DB09054,Small Lymphocytic Lymphoma,Approved,CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34995,EDN1,C0151526,Progesterone,DB00396,Premature Birth,Terminated,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},Phase 3,,ET1,,,,,,,,,,,,,,,,,,,,,,,,,
33659,CTSZ,C0206638,Zoledronic acid,DB00399,Giant Cell Tumor of Bone,Terminated,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
24191,CTRC,C0267963,Pancrelipase,DB00085,Exocrine pancreatic insufficiency,Approved,C1CC2C(C(C1O2)C(=O)[O-])C(=O)[O-].[Na+].[Na+]},,Digestive system disease,CLCR,ELA4,,,,,,,,,,,,,,,,,,,,,,,,
13515,SMS,C0006114,Hydroxocobalamin,DB00200,Cerebral Edema,Terminated,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]\\4([C@H]([C@@H]5[C@]6([C@@]([C@@H](C(=N6)/C(=C\\7/[C@@]([C@@H](C(=N7)/C=C\\8/C([C@@H](C(=N8)/C(=C4\\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2]},Phase 2,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16742,GPT,C0027497,Haloperidol,DB00502,Nausea,Withdrawn,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F},Phase 0,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32855,MEFV,C1290884,Prednisone,DB00635,Inflammatory disorder,Terminated,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 2,Immune system disease,FMF,TRIM20,,,,,,,,,,,,,,,,,,,,,,,,
35483,MPO,C0035126,Nitric Oxide,DB00435,Reperfusion Injury,Terminated,[N]=O},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,
32149,CDKN2A,C0376545,Isotretinoin,DB00982,Hematologic Neoplasms,Terminated,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\\C(=O)O)/C)/C},Phase 2,Cancer,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
34420,CTNNB1,C0278601,Tamoxifen,DB00675,Inflammatory Breast Carcinoma,Terminated,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},Phase 3,Cancer,beta-catenin,armadillo,CTNNB,,,,,,,,,,,,,,,,,,,,,,,
5204,Prednisolone,DB00860,Synovitis,C0039103,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Immune system disease,,,,,,,,,,,,,,,,,,,SOX5,,,,,,,,
21050,MCL1,C2267227,Acetylcysteine,DB06151,Bulimia Nervosa,Terminated,CC(=O)N[C@@H](CS)C(=O)O},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
19718,IL17A,C0008354,Minocycline,DB01017,Cholera,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
17467,MAGED2,C0020625,Tolvaptan,DB06212,Hyponatremia,Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11044,NR3C1,C0018081,Tetracycline,DB00759,Gonorrhea,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,GR,GRL,,,,,,,,,,,,,,,,,,,,,,,,
35960,SLC10A1,C0019163,Tenofovir,DB00300,Hepatitis B,Terminated,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},Phase 3,Infectious disease,NTCP,,,,,,,,,,,,,,,,,,,,,,,,,
17189,DIRAS1,C0014550,Stiripentol,DB09118,"Epilepsies, Myoclonic",Approved,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32396,PTGER4,C0263338,Miltefosine,DB09031,Chronic urticaria,Terminated,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},Phase 2,Skin and connective tissue disease,EP4,,,,,,,,,,,,,,,,,,,,,,,,,
16661,BCL2,C0221013,Rabeprazole,DB01129,"Mastocytosis, Systemic",Approved,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC},,Cancer,Bcl-2,PPP1R50,,,,,,,,,,,,,,,,,,,,,,,,
7342,GPT,C0524909,Tenofovir,DB00300,"Hepatitis B, Chronic",Approved,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},,Infectious disease,0,,,,,,,,,,,,,,,,,UTS2,,,,,,,,
32940,ADIPOQ,C0003125,Quetiapine,DB01224,Anorexia Nervosa,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 2,Mental and behavioural disorder,ACRP30,AdipoQ,apM1,GBP28,adiponectin,ACDC,,,,,,,,,,,,,,,,,,,,
15757,PRKCG,C0040997,Carbamazepine,DB00564,Trigeminal Neuralgia,Approved,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N},,,PKCC,MGC57564,PKCG,SCA14,,,,,,,,,,,,,,,,,,,,,,
24865,NDUFS1,C0007194,Propranolol,DB00571,Hypertrophic Cardiomyopathy,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22380,PLAU,C0346976,Gemcitabine,DB00441,Secondary malignant neoplasm of pancreas,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 3,Cancer,URK,,,,,,,,,,,,,,,,,,,,,,,,,
26322,HIC1,C0242383,Xanthophyll,DB00137,Age related macular degeneration,Approved,CC1=C(C(C[C@@H](C1)O)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(\\C)/C=C/C=C(\\C)/C=C/[C@H]2C(=C[C@@H](CC2(C)C)O)C)/C)/C},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11325,SMUG1,C0034362,Tetracycline,DB00759,Q Fever,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
35315,CLEC7A,C1262313,Micafungin,DB01141,Invasive Fungal Infections,Terminated,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)[C@@H](CC(=O)N)O)C)O)O)O},Phase 3,Infectious disease,dectin-1,hDectin-1,CD369,SCARE2,CLECSF12,,,,,,,,,,,,,,,,,,,,,
9346,Ziprasidone,DB00246,Bipolar Disorder,C0005586,Terminated,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,
29733,TINF2,C0265965,Danazol,DB01406,Dyskeratosis Congenita,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5},Phase 1/Phase 2,Ribosomopathy,0,,,,,,,,,,,,,,,,,,,,,,,,,
5795,Tedizolid Phosphate,DB09042,Streptococcal infection of skin,C1274355,Approved,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4C[C@@H](OC4=O)COP(=O)(O)O)F},,Infectious disease,,,,,,,,,,,,,,,,,,,CCAT1,,,,,,,,
28005,LGALS3,C0014859,Fluorouracil,DB00544,Esophageal Neoplasms,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 3,Cancer,MAC-2,GALIG,LGALS2,,,,,,,,,,,,,,,,,,,,,,,
29567,NFE2L2,C0007114,Fludarabine,DB01073,Malignant neoplasm of skin,Terminated,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
6423,Zinc oxide,DB09321,Cutaneous Candidiasis,C0006846,Approved,O=[Zn]},,Immune system disease,,,,,,,,,,,,,,,,,,,PRPH,,,,,,,,
6330,Vancomycin,DB00512,Staphylococcal Infections,C0038160,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,MIR34B,,,,,,,,
13427,TIMP1,C0004364,Triamcinolone,DB00620,Autoimmune Diseases,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,TIMP,CLGI,,,,,,,,,,,,,,,,,,,,,,,,
16883,MS4A1,C0023443,Pentostatin,DB00552,Hairy Cell Leukemia,Approved,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O},,Cancer,Bp35,MS4A2,CD20,,,,,,,,,,,,,,,,,,,,,,,
17708,RBM45,C0033246,Mesalazine,DB00244,Proctitis,Terminated,C1=CC(=C(C=C1N)C(=O)O)O},Phase 3,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3378,Hydrocortisone,DB00741,Punctate keratopathy,C0423234,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,HMX1,,,,,,,,
27430,LAMC2,C0038506,Asenapine,DB06216,Stuttering,Suspended,CN1C[C@@H]2[C@@H](C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24},Phase 3,,nicein-100kDa,kalinin-105kDa,BM600-100kDa,EBR2,LAMB2T,LAMNB2,EBR2A,,,,,,,,,,,,,,,,,,,
8476,OPRK1,C0338908,Perphenazine,DB00850,Mixed anxiety and depressive disorder,Approved,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO},,Mental and behavioural disorder,KOR,OPRK,,,,,,,,,,,,,,,,,,,,,,,,
33407,CRHR1,C0687132,Topiramate,DB00273,heavy drinking,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 2,Mental and behavioural disorder,CRF-R,CRF1,CRHR,,,,,,,,,,,,,,,,,,,,,,,
7476,IL10,C0338437,Albendazole,DB00518,Neurocysticercosis,Approved,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC},,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,LILRA1,,,,,,,,
36207,TNFRSF11B,C0220603,Valproic Acid,DB00313,childhood brain tumor,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
24287,CRHR1,C0038436,Sertraline,DB01104,Post-Traumatic Stress Disorder,Approved,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl},,Mental and behavioural disorder,CRF-R,CRF1,CRHR,,,,,,,,,,,,,,,,,,,,,,,
4236,Minocycline,DB01017,Granuloma Inguinale,C0018190,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Skin disease,,,,,,,,,,,,,,,,,,,ZNF267,,,,,,,,
4070,Methylprednisolone,DB00959,Bursitis,C0006444,Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,COL11A2,,,,,,,,
19930,BDNF,C0016053,Pramipexole,DB00413,Fibromyalgia,Terminated,CCCN[C@H]1CCC2=C(C1)SC(=N2)N},Phase 2,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,,,,,,,,
2088,Demeclocycline,DB00618,Lymphogranuloma Venereum,C0024286,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3[C@@H](C4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CDK9,,,,,,,,
14769,GADD45A,C0023472,Nilotinib,DB04868,"Leukemia, Myeloid, Accelerated Phase",Approved,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36137,KCNMA1-AS1,C0264303,Omeprazole,DB00338,Laryngomalacia,Withdrawn,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 1,,0,,,,,,,,,,,,,,,,,,,,,,,,,
32417,CSE1L,C0007282,Minocycline,DB01017,Carotid Stenosis,Terminated,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21445,CD274,C0016867,Gentamicin,DB00798,Furunculosis,Approved,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC},,Infectious disease,B7-H,B7H1,PD-L1,PDL1,B7-H1,PDCD1LG1,,,,,,,,,,,,,,,,,,,,
1378,Ceftriaxone,DB01212,Bacterial infection due to Klebsiella pneumoniae,C0343402,Approved,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Sertraline,,,,,,,,
9405,PRKN,C0242422,Trihexyphenidyl,DB00376,Parkinsonian Disorders,Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Neurodegenerative disease,PDJ,AR-JP,parkin,PARK2,,,,,,,,,,,,,,,,,,,,,,
2831,Fexofenadine,DB00950,Hay fever,C0018621,Approved,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,HTR2C,,,,,,,,
3935,Medrysone,DB00253,Uveitis,C0042164,Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@H]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)CC4)C)O)C)C(=O)C},,Immune system disease,,,,,,,,,,,,,,,,,,,CYP2S1,,,,,,,,
34430,APC,C0278601,Tamoxifen,DB00675,Inflammatory Breast Carcinoma,Terminated,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},Phase 3,Cancer,DP2.5,PPP1R46,,,,,,,,,,,,,,,,,,,,,,,,
2925,Fluoxetine,DB00472,Major Depressive Disorder,C1269683,Approved,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,RFXANK,,,,,,,,
30316,KRAS,C0024314,Bortezomib,DB00188,Lymphoproliferative Disorders,Terminated,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O},Phase 2,Primary immunodeficiency,0,,,,,,,,,,,,,,,,,,,,,,,,,
1375,Ceftriaxone,DB01212,Acute gonococcal urethritis,C0275652,Approved,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Sermorelin,,,,,,,,
25284,PROP1,C0013338,Somatropin recombinant,DB00052,Pituitary dwarfism,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27651,IFNA1,C0023493,Thalidomide,DB01041,Adult T-Cell Lymphoma/Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 0,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35706,MPO,C0856169,Valsartan,DB00177,Endothelial dysfunction,Terminated,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
22027,IKZF3,C0855095,Idelalisib,DB09054,Small Lymphocytic Lymphoma,Approved,CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13680,CRX,C0015397,Triamcinolone,DB00620,Disorder of eye,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,,LCA7,CORD2,,,,,,,,,,,,,,,,,,,,,,,,
7094,HLA-B,C0019360,Pregabalin,DB00230,Herpes zoster disease,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,CRISPLD2,,,,,,,,
11095,FKBP1AP1,C0010414,Amphotericin B,DB00681,Infection by Cryptococcus neoformans,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20613,CDKN1B,C0241961,Everolimus,DB01590,Angiomyolipoma of kidney,Approved,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
14599,STK10,C1336708,Vinblastine,DB00570,Testicular Germ Cell Tumor,Terminated,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15033,A2ML1,C0279543,Nilotinib,DB04868,Philadelphia chromosome positive chronic myelogenous leukemia,Approved,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12597,CCHCR1,C0600142,Testosterone,DB00624,Hot flushes,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
29772,LAMC2,C0023524,Mefloquine,DB00358,"Leukoencephalopathy, Progressive Multifocal",Terminated,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O},Phase 1/Phase 2,Cancer,nicein-100kDa,kalinin-105kDa,BM600-100kDa,EBR2,LAMB2T,LAMNB2,EBR2A,,,,,,,,,,,,,,,,,,,
1853,Colistin,DB00803,Pseudomonas aeruginosa infection,C0854135,Approved,CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)[C@@H](C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,NDEL1,,,,,,,,
20568,SPRY4,C0271578,Tranexamic Acid,DB00302,Female hypogonadism syndrome,Approved,C1CC(CCC1CN)C(=O)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29981,GTF2H5,C0043116,Sodium phenylbutyrate,DB06819,HMN (Hereditary Motor Neuropathy) Proximal Type I,Terminated,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},Phase 1/Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10896,BACE1,C0004030,Voriconazole,DB00582,Aspergillosis,Withdrawn,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,BACE,,,,,,,,,,,,,,,,,,,,,,,,,
29456,HRAS,C0005695,Mitomycin,DB00305,Bladder Neoplasm,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26437,CEACAM5,C0278987,Pemetrexed,DB00642,Non-small cell lung cancer metastatic,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,CD66e,,,,,,,,,,,,,,,,,,,,,,,,,
25530,PVALB,C0751122,Stiripentol,DB09118,Infantile Severe Myoclonic Epilepsy,Approved,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O},,Nervous system disease,D22S749,,,,,,,,,,,,,,,,,,,,,,,,,
18125,BRAF,C1704231,Cytarabine,DB00987,Metastatic Malignant Neoplasm to the Leptomeninges,Approved,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O},,Cancer,BRAF1,,,,,,,,,,,,,,,,,,,,,,,,,
1854,Conivaptan,DB00872,Hyponatremia,C0020625,Approved,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6},,Urinary system disease,,,,,,,,,,,,,,,,,,,RBM12,,,,,,,,
17745,FGF2,C0035854,Tobramycin,DB00684,Rosacea,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Skin disease,FGFB,,,,,,,,,,,,,,,,,,,,,,,,,
28041,IL6,C0458247,Capsaicin,DB06774,Allodynia,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
27276,TWIST1,C0281508,Vitamin C,DB00126,Desmoplastic Small Round Cell Tumor,Suspended,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36471,VSIR,C0862312,Pemetrexed,DB00642,"Epithelioid mesothelioma, malignant",Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
21698,MEN1,C0002453,Lisuride,DB00589,Amenorrhea,Approved,CCN(CC)C(=O)N[C@@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C},,Reproductive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
15526,FHIT,C0024623,Citalopram,DB00215,Malignant neoplasm of stomach,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
28513,EPCAM,C0042076,Mitomycin,DB00305,Urologic Neoplasms,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,Ly74,TROP1,GA733-2,EGP34,EGP40,EGP-2,KSA,CD326,Ep-CAM,HEA125,KS1/4,MK-1,MH99,MOC31,323/A3,17-1A,TACST-1,,,,,,,,,
13605,PPARG,C0010346,Naltrexone,DB00704,Crohn Disease,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,Immune system disease,PPARG1,PPARG2,NR1C3,PPARgamma,,,,,,,,,,,,,,,,,,,,,,
14458,GLI1,C0079744,Vincristine,DB00541,Diffuse Large B-Cell Lymphoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,GLI,,,,,,,,,,,,,,,,,,,,,,,,,
19407,CMM,C0008325,Doripenem,DB06211,Cholecystitis,Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30952,TFRC,C0279644,Idarubicin,DB01177,childhood acute myelomonocytic leukemia (M4),Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O},Phase 2,Cancer,CD71,TFR1,p90,,,,,,,,,,,,,,,,,,,,,,,
6138,Triamcinolone,DB00620,Gingival Diseases,C0017563,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,,,,,,,,,,,,,,,,,,,,RPH3AL,,,,,,,,
16319,B4GALT7,C0017574,Chlorhexidine,DB00878,Gingivitis,Approved,C1=CC(=CC=C1N/C(=N/C(=NCCCCCCN=C(/N=C(/NC2=CC=C(C=C2)Cl)\\N)N)N)/N)Cl},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
33538,LDLR,C0004153,Simvastatin,DB00641,Atherosclerosis,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11502,SMUG1,C0014121,Vancomycin,DB00512,Bacterial Endocarditis,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21488,IL1B,C0032269,Lincomycin,DB01627,Pneumococcal Infections,Approved,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O},,Infectious disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
18869,ITGAM,C0020459,Diazoxide,DB01119,Hyperinsulinism,Approved,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl},,Endocrine and metabolic disease,CD11b,CR3A,CD11B,,,,,,,,,,,,,,,,,,,,,,,
18842,FAH,C0030446,Dexpanthenol,DB09357,Paralytic Ileus,Approved,CC(C)(CO)[C@H](C(=O)NCCCO)O},,,,,,,,,,,,,,,,,,,,,,,,,,,,
27728,TERT,C0023532,Aminolevulinic acid,DB00855,"Leukoplakia, Oral",Terminated,C(CC(=O)O)C(=O)CN},Phase 1,Cancer,TRT,TCS1,hEST2,EST2,,,,,,,,,,,,,,,,,,,,,,
12452,HPR,C0032302,Trovafloxacin,DB00685,Mycoplasma pneumonia,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
36363,GABRA2,C0149654,Methylphenidate,DB00422,Conduct Disorder,Withdrawn,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},Phase 1/Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
18264,IGF1,C0016034,Danazol,DB01406,Breast Fibrocystic Disease,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5},,Other disease,IGF1A,IGFI,IGF-I,IGF,,,,,,,,,,,,,,,,,,,,,,
8364,Lorazepam,DB00186,Vomiting,C0042963,Terminated,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
17513,CLEC7A,C1384606,Ospemifene,DB04938,Dyspareunia,Approved,C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\C3=CC=C(C=C3)OCCO)/CCCl},,Reproductive system disease,dectin-1,hDectin-1,CD369,SCARE2,CLECSF12,,,,,,,,,,,,,,,,,,,,,
29547,NFE2L2,C0279626,Fluorouracil,DB00544,Squamous cell carcinoma of esophagus,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
24884,MMP9,C0041318,Pyrazinamide,DB00339,"Tuberculosis, Meningeal",Approved,C1=CN=C(C=N1)C(=O)N},,Infectious disease,CLG4B,,,,,,,,,,,,,,,,,,,,,,,,,
35003,RNU4ATAC,C0151526,Progesterone,DB00396,Premature Birth,Terminated,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
22837,DUOX2,C0018021,Liothyronine,DB00279,Goiter,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1409,Ceftriaxone,DB01212,Meningococcal meningitis,C0025294,Approved,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,NANOS2,,,,,,,,
2732,Esmolol,DB00187,Perioperative hypertension,C3661921,Approved,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O},,,,,,,,,,,,,,,,,,,,,EYS,,,,,,,,
22396,ALB,C0346976,Gemcitabine,DB00441,Secondary malignant neoplasm of pancreas,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
23496,MIF,C0040921,Tinidazole,DB00911,Trichomonas Infections,Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22537,CRK,C0022354,Kappadione,DB09332,"Jaundice, Obstructive",Approved,CC1=C(C2=CC=CC=C2C(=C1)OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+]},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8180,ERCC3,C0042109,Methotrexate,DB00563,Urticaria,Terminated,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18791,JAK1,C0013595,Dexpanthenol,DB09357,Eczema,Approved,CC(C)(CO)[C@H](C(=O)NCCCO)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23547,C9orf72,C0085631,Midazolam,DB00683,Agitation,Approved,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
30755,EGFR,C1514428,Paclitaxel,DB01229,Primary peritoneal carcinoma,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
17676,NDEL1,C0022081,Prednisolone,DB00860,Iritis,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
8489,FLT4,C0338908,Perphenazine,DB00850,Mixed anxiety and depressive disorder,Approved,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO},,Mental and behavioural disorder,VEGFR3,,,,,,,,,,,,,,,,,,,,,,,,,
2914,Fluorometholone,DB00324,Uveitis,C0042164,Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@]2([C@@]4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O},,Immune system disease,,,,,,,,,,,,,,,,,,,ABCB4,,,,,,,,
17013,SLC11A1,C0023343,Dapsone,DB00250,Leprosy,Approved,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,NRAMP,NRAMP1,,,,,,,,,,,,,,,,,,,,,,,,
32334,CYBB,C0238013,Voriconazole,DB00582,Invasive aspergillosis,Terminated,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,GP91-PHOX,NOX2,CGD,,,,,,,,,,,,,,,,,,,,,,,
10695,IL6,C0031350,Tetracycline,DB00759,Pharyngitis,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
32353,NPPB,C0018798,Milrinone,DB00235,Congenital Heart Defects,Terminated,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2},Phase 2,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
9125,GTF2I,C0030920,Sodium Citrate,DB09154,Peptic Ulcer,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18258,PAEP,C0038166,Tedizolid Phosphate,DB09042,Staphylococcal Skin Infections,Approved,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4C[C@@H](OC4=O)COP(=O)(O)O)F},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22083,FGFR1,C0346421,Imatinib,DB00619,Chronic eosinophilic leukemia,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,CEK,FLG,BFGFR,N-SAM,CD331,FLT2,KAL2,,,,,,,,,,,,,,,,,,,
27322,ALK,C1335177,Trametinib,DB08911,Ovarian Serous Adenocarcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2/Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
31200,MASP2,C0015674,Lipoic Acid,DB00166,Chronic Fatigue Syndrome,Withdrawn,C1CSS[C@@H]1CCCCC(=O)O},Phase 1,Mental and behavioural disorder,MASP1P1,,,,,,,,,,,,,,,,,,,,,,,,,
27736,ALDH1A1,C0023532,Aminolevulinic acid,DB00855,"Leukoplakia, Oral",Terminated,C(CC(=O)O)C(=O)CN},Phase 1,Cancer,RALDH1,PUMB1,ALDH1,,,,,,,,,,,,,,,,,,,,,,,
10888,CSF2,C0004030,Voriconazole,DB00582,Aspergillosis,Withdrawn,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,GM-CSF,GMCSF,,,,,,,,,,,,,,,,,,,,,,,,
17901,BAP1,C0026961,Tropicamide,DB00809,Mydriasis,Approved,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
29730,KAT6A,C0279627,Vorinostat,DB02546,adult acute myelomonocytic leukemia (M4),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35479,CXCL1,C0035126,Nitric Oxide,DB00435,Reperfusion Injury,Terminated,[N]=O},Phase 3,,SCYB1,GROa,MGSA-a,NAP-3,MGSA,GRO1,FSP,,,,,,,,,,,,,,,,,,,
21213,ATR,C0028326,Fluoxymesterone,DB01185,Noonan Syndrome,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
28563,CEP295NL,C0341106,Lansoprazole,DB00448,Eosinophilic esophagitis,Withdrawn,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F},Phase 1/Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12745,PIGM,C0149871,Warfarin,DB00682,Deep Vein Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20756,ACAD8,C0343386,Vancomycin,DB00512,Clostridium difficile infection,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11112,RABEPK,C0010414,Amphotericin B,DB00681,Infection by Cryptococcus neoformans,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28982,ETV4,C0027627,Sirolimus,DB00877,Neoplasm Metastasis,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1785,Clofedanol,DB04837,Coughing,C0010200,Approved,CN(C)CCC(C1=CC=CC=C1)(C2=CC=CC=C2Cl)O},,,,,,,,,,,,,,,,,,,,,Mycophenolic acid,,,,,,,,
34419,MTCO2P12,C0278601,Tamoxifen,DB00675,Inflammatory Breast Carcinoma,Terminated,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10639,CCL20,C0343378,Clarithromycin,DB01211,Helicobacter-associated gastritis,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O},,Digestive system disease,LARC,MIP-3a,exodus-1,ST38,CKb4,SCYA20,,,,,,,,,,,,,,,,,,,,
29945,MAD1L1,C0007112,Prednisone,DB00635,Adenocarcinoma of prostate,Withdrawn,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
152,Amikacin,DB00479,Arthropathy associated with infection,C0157749,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},,Immune system disease,,,,,,,,,,,,,,,,,,,SIRT1,,,,,,,,
11499,CXCL2,C0041471,Tetracycline,DB00759,TYPHUS,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,SCYB2,GROb,MIP-2a,MGSA-b,CINC-2a,GRO2,,,,,,,,,,,,,,,,,,,,
19442,SCNN1B,C0235063,Doxapram,DB00561,Respiratory Depression,Approved,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4},,Lung disease,ENaCbeta,,,,,,,,,,,,,,,,,,,,,,,,,
10522,TWIST2,C0151908,Pramocaine,DB09345,Dry skin,Approved,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2},,Skin and connective tissue disease,DERMO1,Dermo-1,bHLHa39,,,,,,,,,,,,,,,,,,,,,,,
31029,DCX,C0280793,Temozolomide,DB00853,Mixed Oligodendroglioma-Astrocytoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,SCLH,DC,LISX,DBCN,XLIS,,,,,,,,,,,,,,,,,,,,,
12182,CD14,C0342881,Simvastatin,DB00641,Familial hypercholesterolemia - homozygous,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Inherited metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
14559,FAS,C0007137,Cisplatin,DB00515,Squamous cell carcinoma,Terminated,N.N.Cl[Pt]Cl},Phase 3,Cancer,CD95,APO-1,FAS1,APT1,TNFRSF6,,,,,,,,,,,,,,,,,,,,,
18686,F3,C0042974,Desmopressin,DB00035,von Willebrand Disease,Approved,C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15214,ATXN3,C0026838,Tizanidine,DB00697,Muscle Spasticity,Approved,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16215,GYPA,C0041466,Ofloxacin,DB01165,Typhoid Fever,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,GPA,CD235a,,,,,,,,,,,,,,,,,,,,,,,,
21386,COPD,C0524702,Fondaparinux sodium,DB00569,Pulmonary Thromboembolisms,Approved,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4886,Phenoxymethylpenicillin,DB00417,Gingivostomatitis,C0149704,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C},,,,,,,,,,,,,,,,,,,,,CDK2AP1,,,,,,,,
20764,ALAS2,C0343386,Vancomycin,DB00512,Clostridium difficile infection,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,ASB,,,,,,,,,,,,,,,,,,,,,,,,,
4324,Mupirocin,DB00410,Impetigo,C0021099,Approved,C[C@H]([C@H]1[C@@H](O1)C[C@H]2CO[C@H]([C@@H]([C@@H]2O)O)C/C(=C/C(=O)OCCCCCCCCC(=O)O)/C)[C@H](C)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,RAD54L,,,,,,,,
13686,GPR143,C0015397,Triamcinolone,DB00620,Disorder of eye,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
3036,Fusidic Acid,DB02703,Cholangitis,C0008311,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Digestive system disease,,,,,,,,,,,,,,,,,,,MAPK14,,,,,,,,
12219,ABCG5,C0020474,Simvastatin,DB00641,"Hyperlipidemia, Familial Combined",Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Metabolic disease,STSL,,,,,,,,,,,,,,,,,,,,,,,,,
1860,Cortisone acetate,DB01380,Acne Vulgaris,C0001144,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,APOC3,,,,,,,,
19134,RELA,C0002438,Sulfacetamide,DB00634,Amebiasis,Approved,CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27480,IGF2,C1333015,Vincristine,DB00541,Childhood Kidney Wilms Tumor,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,FLJ44734,IGF-II,C11orf43,,,,,,,,,,,,,,,,,,,,,,,
29304,PTGS2,C0279628,Cisplatin,DB00515,Adenocarcinoma Of Esophagus,Terminated,N.N.Cl[Pt]Cl},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
17096,IL5,C0085652,Clofazimine,DB00845,Pyoderma Gangrenosum,Approved,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl},,Immune system disease,IL-5,EDF,,,,,,,,,,,,,,,,,,,,,,,,
33394,MIR143,C0687132,Topiramate,DB00273,heavy drinking,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
22328,PTGS2,C0011849,Pramlintide,DB01278,Diabetes Mellitus,Withdrawn,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N)NC(=O)[C@@H]4CCCN4C(=O)CNC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CNC=N6)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@@H]8CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N8)[C@@H](C)O)C)[C@@H](C)O)CC(=O)N)NC(=O)[C@H](CCCCN)N},Phase 1/Phase 2,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,
27390,AGTR1,C0852036,Magnesium Sulfate,DB00653,Pregnancy associated hypertension,Suspended,[O-]S(=O)(=O)[O-].[Mg+2]},Phase 2/Phase 3,Cardiovascular disease,AT2R1,AGTR1A,AT2R1A,HAT1R,AG2S,AT2R1B,AT1B,AGTR1B,,,,,,,,,,,,,,,,,,
12001,H3P9,C0023449,Vindesine,DB00309,Acute lymphocytic leukemia,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1556,Chlorpropamide,DB00672,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,Approved,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl},,Endocrine disease,,,,,,,,,,,,,,,,,,,Triethylenetetramine,,,,,,,,
1898,Cortisone acetate,DB01380,Erythema Multiforme,C0014742,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,MUC5B,,,,,,,,
35913,RNF43,C0235974,Sunitinib,DB01268,Pancreatic carcinoma,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
28439,TRBV20OR9-2,C1292772,Sunitinib,DB01268,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12954,GLUD1,C0220994,Phenylacetic acid,DB09269,Hyperammonemia,Approved,C1=CC=C(C=C1)CC(=O)O},,Inherited metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13618,ATN1,C0011608,Triamcinolone,DB00620,Dermatitis Herpetiformis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
37123,CLDN4,C0032460,Metformin,DB00331,Polycystic Ovary Syndrome,Withdrawn,CN(C)C(=N)N=C(N)N},Phase 3,Reproductive system disease,CPE-R,WBSCR8,hCPE-R,CPETR,CPETR1,,,,,,,,,,,,,,,,,,,,,
16288,CRHR1,C0022104,Milnacipran,DB04896,Irritable Bowel Syndrome,Terminated,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2},Phase 2,Digestive system disease,CRF-R,CRF1,CRHR,,,,,,,,,,,,,,,,,,,,,,,
17843,HBB,C0162316,Succinic acid,DB00139,Iron deficiency anemia,Approved,C(CC(=O)O)C(=O)O},,Hematologic disease,CD113t-C,beta-globin,,,,,,,,,,,,,,,,,,,,,,,,
20971,DOCK8,C0006848,Nystatin,DB00646,Mucocutaneous candidiasis,Approved,C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/C(CC2C(C(C[C@](O2)(CC(C(CCC(CC(CC(CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,FLJ00026,FLJ00152,ZIR8,FLJ00346,,,,,,,,,,,,,,,,,,,,,,
28762,AKT1,C0009402,Levoleucovorin,DB11596,Colorectal Carcinoma,Withdrawn,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2/Phase 3,Cancer,RAC,PKB,PRKBA,AKT,,,,,,,,,,,,,,,,,,,,,,
32718,RNASET2,C0015944,Oxytocin,DB00107,"Fetal Membranes, Premature Rupture",Terminated,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
10593,JAK3,C0271429,Trimethoprim,DB00440,Acute otitis media,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14328,ERG,C0936223,Nilutamide,DB00665,Metastatic Prostate Carcinoma,Approved,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C},,Cancer,erg-3,,,,,,,,,,,,,,,,,,,,,,,,,
22592,NLRP3,C0030409,Ketoconazole,DB01026,Paracoccidioidomycosis,Approved,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},,Infectious disease,AGTAVPRL,AII,AVP,FCAS,FCU,NALP3,PYPAF1,MWS,CLR1.1,C1orf7,CIAS1,,,,,,,,,,,,,,,
24713,MLANA,C0029077,Triamcinolone,DB00620,"Ophthalmia, Sympathetic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
12482,TBC1D24,C0032290,Ticarcillin,DB01607,Aspiration Pneumonia,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5811,P2RY12,C0009443,Triprolidine,DB00427,Common Cold,Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Infectious disease,P2Y12,SP1999,HORK3,,,,,,,,,,,,,,,TBC1D20,,,,,,,,
29109,TP53,C0280483,Irinotecan,DB00762,adult anaplastic astrocytoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23829,HEYL,C1262117,Natamycin,DB00826,Fungal keratitis,Approved,C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)O)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)N)O},,Infectious disease,bHLHb33,HEY3,HESR3,,,,,,,,,,,,,,,,,,,,,,,
15939,ALK,C0153633,Carmustine,DB00262,Malignant neoplasm of brain,Approved,C(CCl)NC(=O)N(CCCl)N=O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16271,SLC6A4,C0236663,Diazepam,DB00829,Alcohol withdrawal syndrome,Approved,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3},,Mental and behavioural disorder,5-HTT,SERT1,HTT,OCD1,,,,,,,,,,,,,,,,,,,,,,
27225,BCL2,C0001418,Cisplatin,DB00515,Adenocarcinoma,Withdrawn,N.N.Cl[Pt]Cl},Phase 2,Cancer,Bcl-2,PPP1R50,,,,,,,,,,,,,,,,,,,,,,,,
30518,NAGS,C0152025,Capsaicin,DB06774,Polyneuropathy,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33053,VSIG4,C0278689,Paclitaxel,DB01229,Ovarian epithelial cancer recurrent,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,Z39IG,,,,,,,,,,,,,,,,,,,,,,,,,
32183,IL2,C0079772,Isotretinoin,DB00982,T-Cell Lymphoma,Terminated,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\\C(=O)O)/C)/C},Phase 2,Cancer,IL-2,TCGF,,,,,,,,,,,,,,,,,,,,,,,,
15511,PRKAA1,C0024623,Citalopram,DB00215,Malignant neoplasm of stomach,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25974,IL2RA,C0002171,Triamcinolone,DB00620,Alopecia Areata,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,IL2R,IDDM10,,,,,,,,,,,,,,,,,,,,,,,,
14057,IL1B,C0035439,Triamcinolone,DB00620,Rheumatic Heart Disease,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Cardiovascular disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
29606,EPHB4,C0278883,Paclitaxel,DB01229,Metastatic melanoma,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,Tyro11,HTK,,,,,,,,,,,,,,,,,,,,,,,,
33365,ADCYAP1,C0878773,Lidocaine,DB00281,Overactive Bladder,Terminated,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
789,Bromocriptine,DB01200,"Parkinson Disease, Postencephalitic",C0030568,Approved,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O},,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,DCTN1,,,,,,,,
22449,REN,C0007820,Tolazoline,DB00797,Cerebrovascular Disorders,Approved,C1CN=C(N1)CC2=CC=CC=C2},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
447,Avibactam,DB09060,Intraabdominal Infections,C1112209,Approved,C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)C(=O)N},,Infectious disease,,,,,,,,,,,,,,,,,,,Dexmethylphenidate,,,,,,,,
13556,CAD,C0002875,Triamcinolone,DB00620,Cooley's anemia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10961,IRGM,C0877445,Voriconazole,DB00582,Candidemia,Approved,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16387,AIP,C0162565,Promazine,DB00420,Acute intermittent porphyria,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
18738,ETV6,C0006413,Vincristine,DB00541,Burkitt Lymphoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,TEL,,,,,,,,,,,,,,,,,,,,,,,,,
7389,TNFSF14,C0162568,Afamelanotide,DB04931,Erythropoietic Protoporphyria,Approved,CCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N5CCC[C@H]5C(=O)N[C@@H](C(C)C)C(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CC=C(C=C6)O)NC(=O)[C@H](CO)NC(=O)C},,Congenital disorder of metabolism,LIGHT,LTg,HVEM-L,CD258,,,,,,,,,,,,,,CPP,,,,,,,,
31350,IL1B,C0014852,Erlotinib,DB00530,Esophageal Diseases,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Digestive system disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
18692,CCL3,C0042165,Tobramycin,DB00684,Anterior uveitis,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,,G0S19-1,LD78ALPHA,MIP-1-alpha,SCYA3,,,,,,,,,,,,,,,,,,,,,,
20639,PPARG,C0241961,Everolimus,DB01590,Angiomyolipoma of kidney,Approved,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC},,Cancer,PPARG1,PPARG2,NR1C3,PPARgamma,,,,,,,,,,,,,,,,,,,,,,
23754,IL1B,C0524688,Moxifloxacin,DB00218,Pneumonic Plague,Approved,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O},,Infectious disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
36727,PIK3CD,C0278802,Norgestrel,DB09389,Recurrent Endometrial Cancer,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32035,ERBB2,C0009375,Oxaliplatin,DB00526,Colonic Neoplasms,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
15508,IL1B,C0024623,Citalopram,DB00215,Malignant neoplasm of stomach,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Cancer,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
33171,SLC23A1,C1145670,Dexmedetomidine,DB00633,Respiratory Failure,Terminated,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 3,Lung disease,YSPL3,SVCT1,SLC23A2,,,,,,,,,,,,,,,,,,,,,,,
11538,MME,C0013369,Ampicillin,DB00415,Dysentery,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C},,Infectious disease,CALLA,CD10,,,,,,,,,,,,,,,,,,,,,,,,
31186,SLC6A4,C0015674,Lipoic Acid,DB00166,Chronic Fatigue Syndrome,Withdrawn,C1CSS[C@@H]1CCCCC(=O)O},Phase 1,Mental and behavioural disorder,5-HTT,SERT1,HTT,OCD1,,,,,,,,,,,,,,,,,,,,,,
36723,PIK3CA,C0278802,Norgestrel,DB09389,Recurrent Endometrial Cancer,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Cancer,PI3K,,,,,,,,,,,,,,,,,,,,,,,,,
8779,IL1RN,C0013295,Sucralfate,DB00364,Duodenal Ulcer,Approved,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al]},,Digestive system disease,ICIL-1RA,IL1F3,IL-1RN,MGC10430,,,,,,,,,,,,,,,,,,,,,,
7386,TXNRD1,C0162568,Afamelanotide,DB04931,Erythropoietic Protoporphyria,Approved,CCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N5CCC[C@H]5C(=O)N[C@@H](C(C)C)C(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CC=C(C=C6)O)NC(=O)[C@H](CO)NC(=O)C},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,RIPK1,,,,,,,,
6825,GFAP,C0002726,L-Cysteine,DB00151,Amyloidosis,Approved,C([C@@H](C(=O)O)N)S},,Hematology,FLJ45472,,,,,,,,,,,,,,,,,HIP1,,,,,,,,
33768,HSPA1B,C0018133,Tacrolimus,DB00864,Graft-vs-Host Disease,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30856,FSCN1,C1522378,Cyclosporine,DB00091,"Leukemia, Large Granular Lymphocytic",Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9567,HIF1A,C0684256,Vancomycin,DB00512,Bacterial sepsis,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,MOP1,HIF-1alpha,PASD8,HIF1,bHLHe78,,,,,,,,,,,,,,,,,,,,,
7494,MMP9,C0338437,Albendazole,DB00518,Neurocysticercosis,Approved,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC},,Infectious disease,CLG4B,,,,,,,,,,,,,,,,,SH2D3A,,,,,,,,
27369,MSH3,C0334359,Trametinib,DB08911,Papillary serous cystadenocarcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2/Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23413,SF3B4,C0017536,Tinidazole,DB00911,Giardiasis,Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13214,IL17B,C0041912,Phenoxymethylpenicillin,DB00417,Upper Respiratory Infections,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22785,GP1BB,C0025323,Tranexamic Acid,DB00302,Menorrhagia,Approved,C1CC(CCC1CN)C(=O)O},,,CD42c,GPIbbeta,,,,,,,,,,,,,,,,,,,,,,,,
20342,TARDBP,C0023827,Trabectedin,DB05109,liposarcoma,Approved,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17334,TBC1D9,C0860594,Trametinib,DB08911,"Malignant melanoma, metastatic",Approved,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15787,CXCL6,C0033581,Ofloxacin,DB01165,prostatitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,GCP-2,CKA-3,SCYB6,,,,,,,,,,,,,,,,,,,,,,,
24669,HLA-DRB1,C0002390,Prednisolone,DB00860,Extrinsic allergic alveolitis,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Immune system disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
132,Amantadine,DB00915,Extrapyramidal Disorders,C0015371,Approved,C1C2CC3CC1CC(C2)(C3)N},,Nervous system disease,,,,,,,,,,,,,,,,,,,Bendroflumethiazide,,,,,,,,
13778,IL13,C0019829,Tacrolimus,DB00864,Hodgkin Disease,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2,Cancer,P600,IL-13,ALRH,BHR1,MGC116786,MGC116788,MGC116789,,,,,,,,,,,,,,,,,,,
19152,CASR,C0042963,Haloperidol,DB00502,Vomiting,Withdrawn,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F},Phase 0,,FHH,NSHPT,GPRC2A,HHC,HHC1,,,,,,,,,,,,,,,,,,,,,
27228,TGFB1,C0001418,Cisplatin,DB00515,Adenocarcinoma,Withdrawn,N.N.Cl[Pt]Cl},Phase 2,Cancer,CED,TGFbeta,TGFB,DPD1,,,,,,,,,,,,,,,,,,,,,,
20398,IL2RA,C0012546,Erythromycin,DB00199,Diphtheria,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,IL2R,IDDM10,,,,,,,,,,,,,,,,,,,,,,,,
24838,HRAS,C0018916,Propranolol,DB00571,Hemangioma,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35000,PTGS2,C0151526,Progesterone,DB00396,Premature Birth,Terminated,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,
5987,Timolol,DB00373,Ocular Hypertension,C0028840,Approved,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O},,Nervous system disease,,,,,,,,,,,,,,,,,,,OXER1,,,,,,,,
4318,Moxifloxacin,DB00218,Staphylococcal Pneumonia,C0032308,Approved,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,BLK,,,,,,,,
34283,NCOA2,C0032962,Betamethasone,DB00443,Pregnancy Complications,Terminated,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,,TIF2,NCoA-2,KAT13C,bHLHe75,,,,,,,,,,,,,,,,,,,,,,
27863,JAK2,C2347748,Mitoxantrone,DB01204,Adult Erythroleukemia,Terminated,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},Phase 1,Cancer,JTK10,,,,,,,,,,,,,,,,,,,,,,,,,
12519,NLRP5,C0014179,Ertapenem,DB00303,Endometritis,Terminated,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)[C@@H](C)O},Phase 1,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35470,MMP9,C0035126,Nitric Oxide,DB00435,Reperfusion Injury,Terminated,[N]=O},Phase 3,,CLG4B,,,,,,,,,,,,,,,,,,,,,,,,,
28372,TSC2,C0006111,Temozolomide,DB00853,Brain Diseases,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28561,JAZF1,C0341106,Lansoprazole,DB00448,Eosinophilic esophagitis,Withdrawn,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F},Phase 1/Phase 2,Immune system disease,TIP27,DKFZp761K2222,ZNF802,,,,,,,,,,,,,,,,,,,,,,,
36014,IL1B,C1135191,Udenafil,DB06267,"Heart Failure, Systolic",Terminated,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C},Phase 3,Cardiovascular disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
15449,ADRB1,C0264716,Amlodipine,DB00381,Chronic heart failure,Suspended,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN},Phase 2,Cardiovascular disease,ADRB1R,,,,,,,,,,,,,,,,,,,,,,,,,
26938,DNMT3A,C0280449,Cyclophosphamide,DB00531,secondary acute myeloid leukemia,Terminated,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34843,EGFR,C0030297,Gemcitabine,DB00441,Pancreatic Neoplasm,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 3,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
12409,IL4,C0035243,Azidocillin,DB08795,Respiratory Tract Infections,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N=[N+]=[N-])C(=O)O)C},,Infectious disease,BSF1,IL-4,BCGF1,BCGF-1,MGC79402,,,,,,,,,,,,,,,,,,,,,
28584,FLG,C0341106,Lansoprazole,DB00448,Eosinophilic esophagitis,Withdrawn,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F},Phase 1/Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
34558,MMP2,C0023890,Dexamethasone,DB01234,Liver Cirrhosis,Terminated,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,Liver disease,TBE-1,CLG4,CLG4A,,,,,,,,,,,,,,,,,,,,,,,
14190,GPR35,C0040147,Triamcinolone,DB00620,Thyroiditis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6595,EGLN1,C0002351,Acetazolamide,DB00819,Altitude Sickness,Approved,CC(=O)NC1=NN=C(S1)S(=O)(=O)N},,,0,,,,,,,,,,,,,,,,,RDH11,,,,,,,,
22650,GLB1,C0022951,Lactose,DB04465,Lactose Intolerance,Approved,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)O)CO)O)O)O)O},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
33446,AHSG,C0013221,Triptorelin,DB06825,Drug toxicity,Terminated,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8},Phase 2,,FETUA,A2HS,HSGA,,,,,,,,,,,,,,,,,,,,,,,
25876,MYC,C0085413,Tolvaptan,DB06212,"Polycystic Kidney, Autosomal Dominant",Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Congenital malformation,c-Myc,bHLHe39,MYCC,,,,,,,,,,,,,,,,,,,,,,,
20928,TNF,C0085436,Flucytosine,DB01099,"Meningitis, Cryptococcal",Terminated,C1=NC(=O)NC(=C1F)N},Phase 2,Infectious disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
20162,CCN2,C0018802,Levosimendan,DB00922,Congestive heart failure,Approved,C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
27376,MAP1LC3A,C0334359,Trametinib,DB08911,Papillary serous cystadenocarcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2/Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3939,FCER1G,C2607914,Triprolidine,DB00427,Allergic rhinitis (disorder),Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Immune system disease,0,,,,,,,,,,,,,,,,,PRG4,,,,,,,,
34665,THM,C0393911,Norepinephrine,DB00368,Pure Autonomic Failure,Terminated,C1=CC(=C(C=C1[C@H](CN)O)O)O},Phase 3,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21043,KRT7,C2267227,Acetylcysteine,DB06151,Bulimia Nervosa,Terminated,CC(=O)N[C@@H](CS)C(=O)O},Phase 3,Mental and behavioural disorder,CK7,K2C7,,,,,,,,,,,,,,,,,,,,,,,,
34965,F3,C0085278,Hydroxychloroquine,DB01611,Antiphospholipid Syndrome,Terminated,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO},Phase 3,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34705,IFNG,C0035078,Erythropoietin,DB00016,Kidney Failure,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
11123,IL10,C0276653,Anidulafungin,DB00362,Invasive Pulmonary Aspergillosis,Withdrawn,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC=C(C=C7)O)O)O)[C@@H](C)O)C)O)O)O},Phase 3,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
8712,CTNNB1,C1140680,Fondaparinux sodium,DB00569,Malignant neoplasm of ovary,Withdrawn,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},Phase 1,Cancer,beta-catenin,armadillo,CTNNB,,,,,,,,,,,,,,,,,,,,,,,
34236,LTA,C0010054,Fenofibrate,DB01039,Coronary Arteriosclerosis,Terminated,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 3,Vascular disease,TNFSF1,LT,TNFB,,,,,,,,,,,,,,,,,,,,,,,
31902,CHI3L1,C1696708,Losartan,DB00678,Prehypertension,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8139,SPIB,C0343065,Triprolidine,DB00427,Symptomatic dermographism,Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Skin and connective tissue disease,SPI-B,,,,,,,,,,,,,,,,,,,,,,,,,
3778,Lobeglitazone,DB09198,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,Approved,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC(=NC=N3)OC4=CC=C(C=C4)OC},,Endocrine disease,,,,,,,,,,,,,,,,,,,LIPA,,,,,,,,
25239,ALB,C0751434,Verapamil,DB00661,Classical phenylketonuria,Terminated,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},Phase 2,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,
13669,CHM,C0015397,Triamcinolone,DB00620,Disorder of eye,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
3884,Magnesium Trisilicate,DB09281,Dyspepsia,C0013395,Approved,[O-][Si](=O)O[Si]([O-])([O-])O[Si](=O)[O-].[Mg+2].[Mg+2]},,Digestive system disease,,,,,,,,,,,,,,,,,,,CLEC5A,,,,,,,,
25923,PTEN,C0023269,Gemcitabine,DB00441,leiomyosarcoma,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9301,Thiamine,DB00152,Hyperemesis Gravidarum,C0020450,Terminated,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},Phase 3,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
7415,NOTCH3,C0002986,Agalsidase beta,DB00103,Fabry Disease,Approved,CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O.CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O},,Congenital disorder of metabolism,CASIL,CADASIL,,,,,,,,,,,,,,,,DLG2,,,,,,,,
27351,BRCA1,C0334359,Trametinib,DB08911,Papillary serous cystadenocarcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2/Phase 3,Cancer,RNF53,PPP1R53,FANCS,,,,,,,,,,,,,,,,,,,,,,,
97,Alimemazine,DB01246,Angioedema,C0002994,Approved,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)CN(C)C},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,Artesunate,,,,,,,,
23010,OR2AG1,C0029104,Methadone,DB00333,Opioid withdrawal,Approved,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
5908,Theophylline,DB00277,Status Asthmaticus,C0038218,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Immune system disease,,,,,,,,,,,,,,,,,,,HFM1,,,,,,,,
32786,HBA1,C0039730,Pegfilgrastim,DB00019,Thalassemia,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Hematologic disease,HBA-T3,,,,,,,,,,,,,,,,,,,,,,,,,
13832,APC,C0021390,Naltrexone,DB00704,Inflammatory Bowel Diseases,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,,DP2.5,PPP1R46,,,,,,,,,,,,,,,,,,,,,,,,
32853,TNF,C1290884,Prednisone,DB00635,Inflammatory disorder,Terminated,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 2,Immune system disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
14921,CALCA,C0150055,Pregabalin,DB00230,Chronic pain,Withdrawn,CC(C)C[C@@H](CC(=O)O)CN},Phase 3,,CALC1,,,,,,,,,,,,,,,,,,,,,,,,,
26480,FAN1,C1561643,Sevelamer,DB00658,Chronic Kidney Diseases,Terminated,C=CCN.C1C(O1)CCl},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10459,ZFHX3,C0038454,Vorapaxar,DB09030,Cerebrovascular accident,Approved,CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@H]([C@H]2/C=C/C4=NC=C(C=C4)C5=CC(=CC=C5)F)[C@H](OC3=O)C},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23667,IL27,C1328252,Miltefosine,DB09031,Mucocutaneous leishmaniasis,Approved,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5599,Sodium Iodide I-131,DB09293,Hyperthyroidism,C0020550,Approved,[Na+].[131I-]},,Endocrine disease,,,,,,,,,,,,,,,,,,,RPS14,,,,,,,,
23888,MSH2,C1292758,Nelarabine,DB01280,Precursor T-cell lymphoblastic lymphoma,Approved,COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},,Cancer,HNPCC1,COCA1,,,,,,,,,,,,,,,,,,,,,,,,
31801,HOTAIR,C4048328,Gemcitabine,DB00441,cervical cancer,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25141,GATA1,C0026987,Teriparatide,DB06285,Myelofibrosis,Terminated,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N},Phase 2,Cancer,ERYF1,NFE1,GATA-1,,,,,,,,,,,,,,,,,,,,,,,
5887,Tetracycline,DB00759,Rickettsialpox,C0035597,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SKOR1,,,,,,,,
27600,EDN1,C0010073,Sildenafil,DB00203,Coronary Artery Vasospasm,Suspended,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C},Phase 3,Vascular disease,ET1,,,,,,,,,,,,,,,,,,,,,,,,,
24183,SPINK1,C0267963,Pancrelipase,DB00085,Exocrine pancreatic insufficiency,Approved,C1CC2C(C(C1O2)C(=O)[O-])C(=O)[O-].[Na+].[Na+]},,Digestive system disease,Spink3,PCTT,PSTI,TATI,,,,,,,,,,,,,,,,,,,,,,
1184,Cefotetan,DB01330,Lower respiratory tract infection,C0149725,Approved,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O},,,,,,,,,,,,,,,,,,,,,Pemirolast,,,,,,,,
13024,PRRT2,C0030807,Sirolimus,DB00877,Pemphigus,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 0,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6036,Tobramycin,DB00684,Staphylococcal Pneumonia,C0032308,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Infectious disease,,,,,,,,,,,,,,,,,,,ARMC5,,,,,,,,
20261,CD14,C0043144,Epinephrine,DB00668,Wheezing,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
8244,BAIAP2,C0018099,Naproxen,DB00788,Gout,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20425,PRKDC,C0019147,Paromomycin,DB01421,Hepatic Coma,Approved,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26867,FOXP1,C0242647,Vincristine,DB00541,Mucosa-Associated Lymphoid Tissue Lymphoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,QRF1,12CC4,HSPC215,hFKH1B,,,,,,,,,,,,,,,,,,,,,,
21108,POMC,C0342527,Testosterone Propionate,DB01420,Deficiency of testosterone biosynthesis,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Metabolic disease,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
22086,BCR,C0346421,Imatinib,DB00619,Chronic eosinophilic leukemia,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
21502,ENO1,C0032269,Lincomycin,DB01627,Pneumococcal Infections,Approved,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25944,COL1A1,C0162810,Tranilast,DB07615,"Cicatrix, Hypertrophic",Approved,COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC},,,,,,,,,,,,,,,,,,,,,,,,,,,,
28746,MSH2,C0009402,Levoleucovorin,DB11596,Colorectal Carcinoma,Withdrawn,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2/Phase 3,Cancer,HNPCC1,COCA1,,,,,,,,,,,,,,,,,,,,,,,,
33750,SIX1,C0006272,Cyclosporine,DB00091,Bronchiolitis Obliterans,Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 2/Phase 3,Respiratory disease,DFNA23,,,,,,,,,,,,,,,,,,,,,,,,,
24038,PTPRF,C0024586,Somatostatin,DB09099,Malignant Carcinoid Syndrome,Terminated,C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=CC=C6)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33995,MIRLET7B,C0035222,Salbutamol,DB01001,"Respiratory Distress Syndrome, Adult",Terminated,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O},Phase 2/Phase 3,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28450,GPHN,C0236736,Dextroamphetamine,DB01576,Cocaine-Related Disorders,Terminated,C[C@@H](CC1=CC=CC=C1)N},Phase 1,Mental and behavioural disorder,KIAA1385,,,,,,,,,,,,,,,,,,,,,,,,,
14220,DNASE2,C0040896,Triamcinolone,DB00620,Trichinellosis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27145,SUZ12,C0206728,Sunitinib,DB01268,Plexiform Neurofibroma,Suspended,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
4777,Pargyline,DB01626,Hypertensive disease,C0020538,Approved,CN(CC#C)CC1=CC=CC=C1},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,SNORD115-1,,,,,,,,
26274,BCO2,C0042842,Vitamin A,DB00162,Vitamin A Deficiency,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5206,Prednisolone,DB00860,Tenosynovitis,C0039520,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,ABCD4,,,,,,,,
31706,JUN,C0006271,Fluticasone Propionate,DB00588,Bronchiolitis,Terminated,CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF},Phase 2,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18121,CASZ1,C1704231,Cytarabine,DB00987,Metastatic Malignant Neoplasm to the Leptomeninges,Approved,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O},,Cancer,FLJ20321,ZNF693,castor,cst,SRG,,,,,,,,,,,,,,,,,,,,,
12959,PRKCQ,C0220994,Phenylacetic acid,DB09269,Hyperammonemia,Approved,C1=CC=C(C=C1)CC(=O)O},,Inherited metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
35906,AKT2,C0235974,Sunitinib,DB01268,Pancreatic carcinoma,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
30871,TYMP,C0162429,Nandrolone phenpropionate,DB00984,Malnutrition,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CC[C@H]35},Phase 2,Cancer,MNGIE,ECGF1,,,,,,,,,,,,,,,,,,,,,,,,
1155,Cefotaxime,DB00493,Neonatal meningitis,C0456107,Approved,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,KDM6B,,,,,,,,
3816,Loteprednol,DB00873,Anterior uveitis,C0042165,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)OCCl)O)CCC4=CC(=O)C=C[C@]34C)O},,,,,,,,,,,,,,,,,,,,,LPAL2,,,,,,,,
36574,AZIN2,C0278506,Pemetrexed,DB00642,Non-small cell lung cancer stage III,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9217,Pentoxifylline,DB00806,Glomerulonephritis,C0017658,Terminated,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
29061,CDKN2B,C1956346,Heparin,DB01109,Coronary Artery Disease,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15644,CNR1,C0014547,Primidone,DB00794,"Epilepsies, Partial",Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,CB1K5,CB-R,CB1,CANN6,CB1A,CNR,,,,,,,,,,,,,,,,,,,,
12722,FGFR3,C0079774,Thalidomide,DB01041,Peripheral T-Cell Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,CEK2,JTK4,CD333,ACH,,,,,,,,,,,,,,,,,,,,,,
35746,LRRK2,C0038868,Rasagiline,DB01367,Progressive supranuclear palsy,Terminated,C#CCN[C@@H]1CCC2=CC=CC=C12},Phase 3,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30725,CHGA,C0206663,Vincristine,DB00541,"Neuroectodermal Tumor, Primitive",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
35245,LRP2,C0018784,Methotrexate,DB00563,Sensorineural Hearing Loss (disorder),Terminated,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 3,Cardiovascular disease,gp330,,,,,,,,,,,,,,,,,,,,,,,,,
27865,FANCB,C2347748,Mitoxantrone,DB01204,Adult Erythroleukemia,Terminated,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35031,IL17A,C1609538,Ofloxacin,DB01165,Latent Tuberculosis,Terminated,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},Phase 3,Infectious disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
20404,LGR5,C0012546,Erythromycin,DB00199,Diphtheria,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,HG38,FEX,GPR67,GPR49,,,,,,,,,,,,,,,,,,,,,,
16175,IL1B,C0036117,Chloramphenicol,DB00446,Salmonella infections,Approved,C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]},,Infectious disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
3437,Hyoscyamine,DB00424,Sinus bradycardia,C0085610,Approved,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,EOMES,,,,,,,,
2111,Desloratadine,DB00967,Common Cold,C0009443,Approved,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4},,Infectious disease,,,,,,,,,,,,,,,,,,,FOXO1,,,,,,,,
36213,FAAH,C1510472,Varenicline,DB01273,Drug Dependence,Withdrawn,C1C2CNCC1C3=CC4=NC=CN=C4C=C23},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
1653,Ciprofloxacin,DB00537,Infective otitis externa,C0021355,Approved,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,LTA,,,,,,,,
36165,KRT17,C0264303,Omeprazole,DB00338,Laryngomalacia,Withdrawn,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 1,,PCHC1,,,,,,,,,,,,,,,,,,,,,,,,,
27193,CD274,C1266050,Trametinib,DB08911,Poorly Differentiated Thyroid Carcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2,Cancer,B7-H,B7H1,PD-L1,PDL1,B7-H1,PDCD1LG1,,,,,,,,,,,,,,,,,,,,
30146,AKT1,C2938924,Letrozole,DB01006,Oestrogen receptor positive breast cancer,Terminated,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3},Phase 2,Cancer,RAC,PKB,PRKBA,AKT,,,,,,,,,,,,,,,,,,,,,,
35345,SLC6A4,C0001723,Mifepristone,DB00834,"Affective Disorders, Psychotic",Terminated,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O},Phase 3,Mental and behavioural disorder,5-HTT,SERT1,HTT,OCD1,,,,,,,,,,,,,,,,,,,,,,
8523,Pegfilgrastim,DB00019,Hemoglobinopathies,C0019045,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,,
25698,STAT4,C0003864,Tenoxicam,DB00469,Arthritis,Approved,CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26263,LRAT,C0042842,Vitamin A,DB00162,Vitamin A Deficiency,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8474,CRHR1,C0338908,Perphenazine,DB00850,Mixed anxiety and depressive disorder,Approved,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO},,Mental and behavioural disorder,CRF-R,CRF1,CRHR,,,,,,,,,,,,,,,,,,,,,,,
29087,CRP,C1956346,Heparin,DB01109,Coronary Artery Disease,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2,Vascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
29085,PROCR,C1956346,Heparin,DB01109,Coronary Artery Disease,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2,Vascular disease,EPCR,CCD41,CD201,,,,,,,,,,,,,,,,,,,,,,,
34237,MIR146A,C0010054,Fenofibrate,DB01039,Coronary Arteriosclerosis,Terminated,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 3,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28736,MTHFR,C0339573,Latanoprost,DB00654,"Glaucoma, Primary Open Angle",Terminated,CC(C)OC(=O)CCC/C=C\\C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O},Phase 1,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6690,FARS2,C0017612,Unoprostone,DB06826,"Glaucoma, Open-Angle",Approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,TBX22,,,,,,,,
14316,VAC14,C0936223,Nilutamide,DB00665,Metastatic Prostate Carcinoma,Approved,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
18009,TGM1,C0013238,Xanthophyll,DB00137,Dry Eye Syndromes,Approved,CC1=C(C(C[C@@H](C1)O)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(\\C)/C=C/C=C(\\C)/C=C/[C@H]2C(=C[C@@H](CC2(C)C)O)C)/C)/C},,,TGASE,TGK,LI,LI1,ICR2,,,,,,,,,,,,,,,,,,,,,
21930,CTNNB1,C0025202,Lovastatin,DB00227,melanoma,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,beta-catenin,armadillo,CTNNB,,,,,,,,,,,,,,,,,,,,,,,
26735,PIK3CB,C0278791,Thalidomide,DB01041,Chronic lymphocytic leukaemia refractory,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
18494,TNFRSF4,C0036220,Vinblastine,DB00570,Kaposi Sarcoma,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,ACT35,OX40,CD134,TXGP1L,,,,,,,,,,,,,,,,,,,,,,
25458,SPP1,C0003962,Eplerenone,DB00700,Ascites,Withdrawn,C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC},Phase 2,,BSPI,ETA-1,BNSP,OPN,,,,,,,,,,,,,,,,,,,,,,
35174,ICAM1,C0947751,Linagliptin,DB08882,Vascular inflammations,Terminated,CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C},Phase 3,Vascular disease,CD54,,,,,,,,,,,,,,,,,,,,,,,,,
16698,CDKN2B,C0043515,Roxatidine acetate,DB08806,Zollinger-Ellison syndrome,Approved,CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19983,ADM,C0019243,Stanozolol,DB06718,"Angioedemas, Hereditary",Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(CC5=C(C4)NN=C5)C},,Skin and connective tissue disease,AM,,,,,,,,,,,,,,,,,,,,,,,,,
29723,PDK1,C0279627,Vorinostat,DB02546,adult acute myelomonocytic leukemia (M4),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
28504,WWOX,C0042076,Mitomycin,DB00305,Urologic Neoplasms,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
21200,RRAS2,C0028326,Fluoxymesterone,DB01185,Noonan Syndrome,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
391,Antazoline,DB08799,Urticaria,C0042109,Approved,C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,Daclatasvir,,,,,,,,
28330,WLS,C0023486,Thalidomide,DB01041,Prolymphocytic Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25317,PTPN22,C0037299,Sulfadiazine,DB00359,Skin Ulcer,Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Skin disease,Lyp,Lyp1,Lyp2,PTPN8,,,,,,,,,,,,,,,,,,,,,,
26248,LINC00328,C0153594,Vinblastine,DB00570,Malignant neoplasm of testis,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36043,CRX,C0035334,Unoprostone,DB06826,Retinitis Pigmentosa,Terminated,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},Phase 3,Nervous system disease,LCA7,CORD2,,,,,,,,,,,,,,,,,,,,,,,,
14792,AHR,C0001206,Somatostatin,DB09099,Acromegaly,Terminated,C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=CC=C6)O},Phase 2,Endocrine disease,bHLHe76,,,,,,,,,,,,,,,,,,,,,,,,,
15120,BRAF,C0238462,Sorafenib,DB00398,Medullary carcinoma of thyroid,Withdrawn,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,BRAF1,,,,,,,,,,,,,,,,,,,,,,,,,
15652,NID1,C0014547,Primidone,DB00794,"Epilepsies, Partial",Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,entactin,NID,,,,,,,,,,,,,,,,,,,,,,,,
34122,PTGS2,C1704272,Finasteride,DB01216,Benign Prostatic Hyperplasia,Withdrawn,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},Phase 3,Reproductive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
529,Aztreonam,DB00355,Rhinoscleroma,C0035468,Approved,C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\\OC(C)(C)C(=O)O)/C2=CSC(=N2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,ACE,,,,,,,,
21181,POMC,C0022735,Testosterone Propionate,DB01420,Klinefelter Syndrome,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Congenital malformation,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
7912,COL1A1,C0029458,Zoledronic acid,DB00399,"Osteoporosis, Postmenopausal",Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,,,,,,,,
36881,SERPINH1,C0867389,Prednisolone,DB00860,Chronic graft-versus-host disease,Withdrawn,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Immune system disease,HSP47,colligen,CBP1,CBP2,SERPINH2,,,,,,,,,,,,,,,,,,,,,
12209,COL3A1,C0020443,Vitamin E,DB00163,Hypercholesterolemia,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 3,Metabolic disease,EDS4A,,,,,,,,,,,,,,,,,,,,,,,,,
16193,ADAR,C0036117,Chloramphenicol,DB00446,Salmonella infections,Approved,C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28440,TP53BP1,C1292772,Sunitinib,DB01268,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16185,HAMP,C0036117,Chloramphenicol,DB00446,Salmonella infections,Approved,C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]},,Infectious disease,LEAP-1,HEPC,HFE2B,LEAP1,,,,,,,,,,,,,,,,,,,,,,
3142,Gatifloxacin,DB01044,Staphylococcus aureus infection,C1318973,Approved,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F},,Infectious disease,,,,,,,,,,,,,,,,,,,NRG3,,,,,,,,
32592,PKD1,C0343401,Nitric Oxide,DB00435,MRSA - Methicillin resistant Staphylococcus aureus infection,Terminated,[N]=O},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33721,OPRM1,C0027609,Clonidine,DB00575,Neonatal Abstinence Syndrome,Terminated,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl},Phase 2/Phase 3,Vascular disease,MOR1,,,,,,,,,,,,,,,,,,,,,,,,,
2605,Enalaprilat,DB09477,Congestive heart failure,C0018802,Approved,C[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N[C@@H](CCC2=CC=CC=C2)C(=O)O},,Congenital malformation,,,,,,,,,,,,,,,,,,,Melphalan,,,,,,,,
31803,EGFR,C4048328,Gemcitabine,DB00441,cervical cancer,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 2,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
33364,TRPA1,C0878773,Lidocaine,DB00281,Overactive Bladder,Terminated,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},Phase 3,Urinary system disease,ANKTM1,,,,,,,,,,,,,,,,,,,,,,,,,
33501,COX8A,C0005779,Vitamin E,DB00163,Blood Coagulation Disorders,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22672,NOS2,C0019151,Phenylacetic acid,DB09269,Hepatic Encephalopathy,Terminated,C1=CC=C(C=C1)CC(=O)O},Phase 2,Liver disease,iNOS,HEP-NOS,NOS2A,,,,,,,,,,,,,,,,,,,,,,,
9989,IL22,C0004626,Tobramycin,DB00684,"Pneumonia, Bacterial",Terminated,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},Phase 2,Infectious disease,ILTIF,zcyto18,IL-TIF,IL-D110,TIFa,TIFIL-23,MGC79382,MGC79384,,,,,,,,,,,,,,,,,,
6155,Triamcinolone,DB00620,Mycosis Fungoides,C0026948,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,,,,,,,,,,,,,,,,,,,BMP15,,,,,,,,
28650,CAV1,C1565489,Simeprevir,DB06290,Renal Insufficiency,Withdrawn,CC1=C(C=CC2=C1N=C(C=C2O[C@@H]3C[C@@H]4[C@@H](C3)C(=O)N(CCCC/C=C\\[C@@H]5C[C@]5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC},Phase 2,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,
16255,AR,C0236663,Diazepam,DB00829,Alcohol withdrawal syndrome,Approved,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3},,Mental and behavioural disorder,AIS,NR3C4,SMAX1,HUMARA,DHTR,SBMA,,,,,,,,,,,,,,,,,,,,
22539,GPBAR1,C0022354,Kappadione,DB09332,"Jaundice, Obstructive",Approved,CC1=C(C2=CC=CC=C2C(=C1)OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+]},,Liver disease,BG37,TGR5,M-BAR,GPCR19,GPR131,MGC40597,,,,,,,,,,,,,,,,,,,,
19420,TIMP4,C1632842,Tigecycline,DB00560,Complicated appendicitis,Approved,CC(C)(C)NCC(=O)NC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
33862,H3P10,C0751690,Imatinib,DB00619,Malignant Peripheral Nerve Sheath Tumor,Terminated,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 2/Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30574,PPP6C,C0151779,Temozolomide,DB00853,Cutaneous Melanoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36848,ANO4,C0038580,Methamphetamine,DB01577,Substance Dependence,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
34340,ALK,C0085426,Vancomycin,DB00512,Gram-Positive Bacterial Infections,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26288,BCO1,C0042842,Vitamin A,DB00162,Vitamin A Deficiency,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3710,Levoleucovorin,DB11596,Poisoning by pyrimethamine,C0274478,Approved,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,,,,,,,,,,,,,,,,,,,,NUMA1,,,,,,,,
36631,MED12,C0016048,Hydroxyurea,DB01005,Fibromatosis,Withdrawn,C(=O)(N)NO},Phase 2,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26719,BCL2,C0278791,Thalidomide,DB01041,Chronic lymphocytic leukaemia refractory,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,Bcl-2,PPP1R50,,,,,,,,,,,,,,,,,,,,,,,,
16572,CLEC7A,C0040261,Terbinafine,DB00857,Onychomycosis,Approved,CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21},,Infectious disease,dectin-1,hDectin-1,CD369,SCARE2,CLECSF12,,,,,,,,,,,,,,,,,,,,,
1706,Clavulanate,DB00766,Escherichia coli Infections,C0014836,Approved,C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CACNA2D2,,,,,,,,
34688,CXCR4,C0220650,Temozolomide,DB00853,Metastatic malignant neoplasm to brain,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,LESTR,NPY3R,HM89,NPYY3R,D2S201E,fusin,HSY3RR,CD184,,,,,,,,,,,,,,,,,,
16516,CYP27B1,C0221468,Ergocalciferol,DB00153,Vitamin D-dependent rickets,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,P450c1,VDD1,PDDR,,,,,,,,,,,,,,,,,,,,,,,
25247,GRM5,C0751434,Verapamil,DB00661,Classical phenylketonuria,Terminated,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},Phase 2,Congenital disorder of metabolism,MGLUR5,GPRC1E,mGlu5,PPP1R86,,,,,,,,,,,,,,,,,,,,,,
34067,IGF1,C0029453,Cholecalciferol,DB00169,Osteopenia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 2/Phase 3,Musculoskeletal disease,IGF1A,IGFI,IGF-I,IGF,,,,,,,,,,,,,,,,,,,,,,
16728,DLST,C0027497,Haloperidol,DB00502,Nausea,Withdrawn,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F},Phase 0,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15505,MUTYH,C0024623,Citalopram,DB00215,Malignant neoplasm of stomach,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12740,CSF2,C0149871,Warfarin,DB00682,Deep Vein Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,GM-CSF,GMCSF,,,,,,,,,,,,,,,,,,,,,,,,
11925,STAT5B,C0023487,Tretinoin,DB00755,Acute Promyelocytic Leukemia,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13957,ANGPTL4,C0026857,Triamcinolone,DB00620,Musculoskeletal Diseases,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,pp1158,PGAR,ARP4,HFARP,FIAF,,,,,,,,,,,,,,,,,,,,,
26597,ABCD2,C1335302,Paclitaxel,DB01229,Pancreatic Ductal Adenocarcinoma,Suspended,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4265,Mitiglinide,DB01252,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,Approved,C1CC[C@H]2CN(C[C@H]2C1)C(=O)C[C@H](CC3=CC=CC=C3)C(=O)O},,Endocrine disease,,,,,,,,,,,,,,,,,,,RDH5,,,,,,,,
31372,CCL16,C0220654,Erlotinib,DB00530,Meningeal Carcinomatosis,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1821,Cloxacillin,DB01147,Staphylococcal meningitis,C0154640,Approved,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SLC5A2,,,,,,,,
3840,Luliconazole,DB08933,Tinea cruris,C1384589,Approved,C1[C@H](S/C(=C(\\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,TRAF6,,,,,,,,
37191,POMC,C0221406,Mifepristone,DB00834,Pituitary-dependent Cushing's disease,Withdrawn,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O},Phase 3,Endocrine and metabolic disease,POC,ACTH,NPP,LPH,,,,,,,,,,,,,,,,,,,,,,
658,Bepotastine,DB04890,Allergic Conjunctivitis,C0009766,Approved,C1CN(CCC1O[C@@H](C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,MYBPC3,,,,,,,,
12138,LPL,C0342882,Simvastatin,DB00641,Familial hypercholesterolemia - heterozygous,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Inherited metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23589,SELENBP1,C0020651,Midodrine,DB00211,"Hypotension, Orthostatic",Approved,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O},,Cardiovascular disease,hSP56,hSBP,LPSB,,,,,,,,,,,,,,,,,,,,,,,
14852,HOXB3,C0026603,Scopolamine,DB00747,Motion Sickness,Approved,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8412,Micafungin,DB01141,Invasive aspergillosis,C0238013,Terminated,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)[C@@H](CC(=O)N)O)C)O)O)O},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
7481,FGF2,C0338437,Albendazole,DB00518,Neurocysticercosis,Approved,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC},,Infectious disease,FGFB,,,,,,,,,,,,,,,,,SPOCK2,,,,,,,,
24377,PDPN,C0812413,Pemetrexed,DB00642,Malignant Pleural Mesothelioma,Approved,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,T1A-2,Gp38,aggrus,PA2.26,,,,,,,,,,,,,,,,,,,,,,
22121,CDKN2A,C0392784,Imatinib,DB00619,Dermatofibrosarcoma Protuberans,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
24341,LHFPL6,C0271084,Verteporfin,DB00460,Exudative age-related macular degeneration,Approved,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C.CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)O)C(=C3C)CCC(=O)OC)C=C},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
14063,CTLA4,C0035439,Triamcinolone,DB00620,Rheumatic Heart Disease,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Cardiovascular disease,CD152,CELIAC3,IDDM12,,,,,,,,,,,,,,,,,,,,,,,
5484,Roxatidine acetate,DB08806,Zollinger-Ellison syndrome,C0043515,Approved,CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,TBX3,,,,,,,,
28969,CREB1,C0027627,Sirolimus,DB00877,Neoplasm Metastasis,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
20887,ADRA2A,C0184567,Floctafenine,DB08976,Acute onset pain,Approved,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC=C(C3=NC=C2)C(F)(F)F},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
6918,LTA,C0006277,Theophylline,DB00277,Bronchitis,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Lung disease,TNFSF1,LT,TNFB,,,,,,,,,,,,,,,PREP,,,,,,,,
25393,PTCH1,C0007117,Vismodegib,DB08828,Basal cell carcinoma,Approved,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl},,Cancer,BCNS,NBCCS,PTCH,,,,,,,,,,,,,,,,,,,,,,,
28408,CYP2D6,C0007682,Temozolomide,DB00853,CNS disorder,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Nervous system disease,CPD6,P450-DB1,P450C2D,CYP2DL1,CYP2D7P2,CYP2D7BP,CYP2D8P2,CYP2D7AP,,,,,,,,,,,,,,,,,,
12295,IL6ST,C0020557,Topiramate,DB00273,Hypertriglyceridemia,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Metabolic disease,CD130,,,,,,,,,,,,,,,,,,,,,,,,,
3392,Hydrocortisone,DB00741,Thyroiditis,C0040147,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,Endocrine disease,,,,,,,,,,,,,,,,,,,ADAM10,,,,,,,,
21958,CALM2,C0085610,Hyoscyamine,DB00424,Sinus bradycardia,Approved,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35485,PLAT,C0035126,Nitric Oxide,DB00435,Reperfusion Injury,Terminated,[N]=O},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,
7535,Exenatide,DB01276,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,Terminated,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCC[C@H]3C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N6CCC[C@H]6C(=O)N[C@@H](CO)C(=O)N)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC8=CC=CC=C8)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC9=CNC=N9)N},Phase 1/Phase 2,Endocrine disease,,,,,,,,,,,,,,,,,,,MAP3K3,,,,,,,,
9305,Tigecycline,DB00560,Dialysis Catheter Infection,C1400574,Terminated,CC(C)(C)NCC(=O)NC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
31267,NAT2,C0220624,Erlotinib,DB00530,adult brain tumor,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26656,KMT2A,C1332153,Homoharringtonine,DB04865,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Terminated,CC(C)(CCC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2C3=CC4=C(C=C3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12817,HLA-DRB1,C0024301,Vincristine,DB00541,"Lymphoma, Follicular",Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
34907,OPN1SW,C0278704,Heparin,DB01109,Malignant Childhood Neoplasm,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15607,MIF,C0003469,Paroxetine,DB00715,Anxiety Disorders,Terminated,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
23679,CXCL8,C1328252,Miltefosine,DB09031,Mucocutaneous leishmaniasis,Approved,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},,Infectious disease,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
2812,Fenofibrate,DB01039,Hypertriglyceridemia,C0020557,Approved,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},,Metabolic disease,,,,,,,,,,,,,,,,,,,MAPKAPK2,,,,,,,,
27231,PTEN,C0007097,Cisplatin,DB00515,Carcinoma,Withdrawn,N.N.Cl[Pt]Cl},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29652,KMT2A,C0279629,Vorinostat,DB02546,adult acute monoblastic leukemia (M5a),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
8066,Finasteride,DB01216,Retinal Diseases,C0035309,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},Phase 2,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
9326,Valsartan,DB00177,Oxidative Stress,C0242606,Terminated,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5359,Propranolol,DB00571,Supraventricular tachycardia,C0039240,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,CDA,,,,,,,,
36149,SETBP1,C0264303,Omeprazole,DB00338,Laryngomalacia,Withdrawn,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 1,,0,,,,,,,,,,,,,,,,,,,,,,,,,
24569,CYP2B6,C0024449,Posaconazole,DB01263,Mycetoma,Approved,CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F},,Infectious disease,CPB6,CYPIIB6,,,,,,,,,,,,,,,,,,,,,,,,
25369,SHOX,C0041408,Somatropin recombinant,DB00052,Turner Syndrome,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Congenital malformation,PHOG,GCFX,SHOXY,,,,,,,,,,,,,,,,,,,,,,,
36552,CSH1,C0393819,Cyclophosphamide,DB00531,"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",Withdrawn,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 2,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2982,Folic Acid,DB00158,Breastfeeding (mother),C1623040,Approved,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N},,,,,,,,,,,,,,,,,,,,,MIR125A,,,,,,,,
29630,MIR100HG,C0279632,Vorinostat,DB02546,adult acute megakaryoblastic leukemia (M7),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1831,Codeine,DB00318,Headache Disorders,C0393735,Approved,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O},,Nervous system disease,,,,,,,,,,,,,,,,,,,CCL18,,,,,,,,
10761,PTAFR,C0155862,Troleandomycin,DB01361,Streptococcal pneumonia,Approved,C[C@@H]1C[C@@H]([C@H]([C@@H](O1)O[C@H]2[C@H](C[C@@]3(CO3)C(=O)[C@@H]([C@H]([C@H]([C@H](OC(=O)[C@@H]([C@H]([C@@H]2C)O[C@H]4C[C@@H]([C@H]([C@@H](O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
16372,GPI,C0024537,Primaquine,DB01087,"Malaria, Vivax",Approved,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26161,POU2AF1,C0008312,Ursodeoxycholic acid,DB01586,Primary biliary cirrhosis,Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C},,Digestive system disease,OBF1,BOB1,,,,,,,,,,,,,,,,,,,,,,,,
3082,Fusidic Acid,DB02703,Pneumonia due to Escherichia coli,C0276089,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,ARID3B,,,,,,,,
30071,PDXP,C0206708,Aminolevulinic acid,DB00855,Cervical Intraepithelial Neoplasia,Terminated,C(CC(=O)O)C(=O)CN},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33662,GABRA2,C0001956,Zonisamide,DB00909,alcohol use disorder,Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
10063,CCL27,C0022602,Masoprocol,DB00179,Actinic keratosis,Approved,C[C@H](CC1=CC(=C(C=C1)O)O)[C@@H](C)CC2=CC(=C(C=C2)O)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3011,Furosemide,DB00695,Hypertensive disease,C0020538,Approved,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,PYCARD,,,,,,,,
19467,DRD1,C0005587,Quetiapine,DB01224,"Depression, Bipolar",Approved,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
17940,BRAF,C0024299,Pegfilgrastim,DB00019,Lymphoma,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Cancer,BRAF1,,,,,,,,,,,,,,,,,,,,,,,,,
8103,HRH4,C0033774,Zinc oxide,DB09321,Pruritus,Approved,O=[Zn]},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
3447,Ibuprofen,DB01050,Fever,C0015967,Approved,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,IL10RA,,,,,,,,
8158,ICAM1,C0042109,Methotrexate,DB00563,Urticaria,Terminated,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Skin and connective tissue disease,CD54,,,,,,,,,,,,,,,,,,,,,,,,,
31690,CD14,C0006271,Fluticasone Propionate,DB00588,Bronchiolitis,Terminated,CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF},Phase 2,Lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,
8892,ATP12A,C0013395,Omeprazole,DB00338,Dyspepsia,Suspended,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 2,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14182,PIK3CA,C0040147,Triamcinolone,DB00620,Thyroiditis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,PI3K,,,,,,,,,,,,,,,,,,,,,,,,,
14556,CDKN2A,C0007137,Cisplatin,DB00515,Squamous cell carcinoma,Terminated,N.N.Cl[Pt]Cl},Phase 3,Cancer,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
4975,Piperacillin,DB00319,Gonorrhea,C0018081,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,ETFB,,,,,,,,
5778,Tavaborole,DB09041,Onychomycosis due to Trichophyton rubrum,C0276754,Approved,B1(C2=C(CO1)C=C(C=C2)F)O},,Infectious disease,,,,,,,,,,,,,,,,,,,APLNR,,,,,,,,
7132,VEGFA,C0033860,Atorvastatin,DB01076,Psoriasis,Withdrawn,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Skin disease,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,QRSL1,,,,,,,,
22914,PCNA,C0020676,Liothyronine,DB00279,Hypothyroidism,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,
19765,CUL9,C1112709,Ofloxacin,DB01165,non-gonococcal urethritis (NGU),Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29609,FLT4,C0278883,Paclitaxel,DB01229,Metastatic melanoma,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,VEGFR3,,,,,,,,,,,,,,,,,,,,,,,,,
26267,VCAM1,C0042842,Vitamin A,DB00162,Vitamin A Deficiency,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C},,Metabolic disease,CD106,,,,,,,,,,,,,,,,,,,,,,,,,
21886,UMPS,C0002895,Hydroxyurea,DB01005,"Anemia, Sickle Cell",Approved,C(=O)(N)NO},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7787,ARID1A,C0079773,Belinostat,DB05015,"Lymphoma, T-Cell, Cutaneous",Terminated,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)/C=C/C(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,FOXK2,,,,,,,,
13292,MRPS7,C0001403,Triamcinolone,DB00620,Addison Disease,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8631,PRL,C0242350,Vardenafil,DB00862,Erectile dysfunction,Approved,CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C},,Reproductive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
20780,ZDHHC13,C4083212,Finasteride,DB01216,"Alopecia, Male Pattern",Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},,Skin disease,FLJ10852,FLJ10941,HIP14L,,,,,,,,,,,,,,,,,,,,,,,
23769,ADAM10,C0038160,Vancomycin,DB00512,Staphylococcal Infections,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,kuz,HsT18717,CD156c,,,,,,,,,,,,,,,,,,,,,,,
24863,SLC25A4,C0007194,Propranolol,DB00571,Hypertrophic Cardiomyopathy,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36147,KAT6B,C0264303,Omeprazole,DB00338,Laryngomalacia,Withdrawn,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 1,,0,,,,,,,,,,,,,,,,,,,,,,,,,
26219,HIF1A,C0271066,Imatinib,DB00619,Choroidal retinal neovascularization,Withdrawn,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 1,Congenital malformation,MOP1,HIF-1alpha,PASD8,HIF1,bHLHe78,,,,,,,,,,,,,,,,,,,,,
17018,LTA,C0023343,Dapsone,DB00250,Leprosy,Approved,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,TNFSF1,LT,TNFB,,,,,,,,,,,,,,,,,,,,,,,
17927,BCL2,C0024299,Pegfilgrastim,DB00019,Lymphoma,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Cancer,Bcl-2,PPP1R50,,,,,,,,,,,,,,,,,,,,,,,,
24605,SURF1,C0001126,Potassium Citrate,DB09125,Renal tubular acidosis,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
20413,CCR2,C0012546,Erythromycin,DB00199,Diphtheria,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O},,Infectious disease,CC-CKR-2,CKR2,MCP-1-R,CD192,FLJ78302,CMKBR2,,,,,,,,,,,,,,,,,,,,
19326,ACE,C0002395,Rivastigmine,DB00989,Alzheimer's Disease,Approved,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C},,Neurodegenerative disease,ACE1,CD143,DCP1,,,,,,,,,,,,,,,,,,,,,,,
18576,CSF3,C0019156,Defibrotide,DB04932,Hepatic Veno-Occlusive Disease,Approved,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O},,Liver disease,MGC45931,GCSF,G-CSF,C17orf33,,,,,,,,,,,,,,,,,,,,,,
20295,FGF23,C3536984,Ergocalciferol,DB00153,"Vitamin D-Resistant Rickets, X-Linked",Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
22730,NTRK3,C0238463,Lenvatinib,DB09078,Papillary thyroid carcinoma,Approved,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl},,Cancer,TRKC,,,,,,,,,,,,,,,,,,,,,,,,,
3365,MEIS1,C0917801,Citalopram,DB00215,Sleeplessness,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,,,,,,,,,,,,,,,,,,,MICA,,,,,,,,
9402,ATP13A2,C0242422,Trihexyphenidyl,DB00376,Parkinsonian Disorders,Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Neurodegenerative disease,HSA9947,CLN12,PARK9,,,,,,,,,,,,,,,,,,,,,,,
615,Benzylpenicillin,DB01053,Infection by Pasteurella multocida,C1260911,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,NPPA,,,,,,,,
22957,ZAP70,C0041976,Lidocaine,DB00281,Urethritis,Approved,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23483,SOD1,C0023886,Tinidazole,DB00911,"Liver Abscess, Amebic",Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32566,SARDH,C0745133,Nitrendipine,DB01054,Isolated systolic hypertension,Terminated,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16403,TNF,C0162565,Promazine,DB00420,Acute intermittent porphyria,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Congenital disorder of metabolism,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
7907,CAT,C0029458,Zoledronic acid,DB00399,"Osteoporosis, Postmenopausal",Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6410,Zafirlukast,DB00549,Asthma,C0004096,Approved,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC},,Immune system disease,,,,,,,,,,,,,,,,,,,PIGV,,,,,,,,
31050,RBM45,C0030809,Dapsone,DB00250,Pemphigus Vulgaris,Terminated,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N},Phase 2,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33384,GNRHR,C0878773,Lidocaine,DB00281,Overactive Bladder,Terminated,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},Phase 3,Urinary system disease,LHRHR,GRHR,,,,,,,,,,,,,,,,,,,,,,,,
27610,CAD,C0010073,Sildenafil,DB00203,Coronary Artery Vasospasm,Suspended,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C},Phase 3,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36453,CEACAM5,C0862312,Pemetrexed,DB00642,"Epithelioid mesothelioma, malignant",Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,CD66e,,,,,,,,,,,,,,,,,,,,,,,,,
11624,ATP6AP2,C0013371,Trimethoprim,DB00440,Shigella Infections,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15685,GABRA1,C0238111,Topiramate,DB00273,Lennox-Gastaut syndrome,Approved,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},,Nervous system disease,EJM5,,,,,,,,,,,,,,,,,,,,,,,,,
10787,DRD5,C1263846,Methylphenidate,DB00422,Attention deficit hyperactivity disorder,Approved,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
31643,MSH2,C0338106,Oxaliplatin,DB00526,Adenocarcinoma of colon,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 3,Cancer,HNPCC1,COCA1,,,,,,,,,,,,,,,,,,,,,,,,
34105,GATA5,C1704272,Finasteride,DB01216,Benign Prostatic Hyperplasia,Withdrawn,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},Phase 3,Reproductive system disease,bB379O24.1,GATAS,,,,,,,,,,,,,,,,,,,,,,,,
4002,Methantheline,DB00940,Gastric ulcer,C0038358,Approved,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13},,Digestive system disease,,,,,,,,,,,,,,,,,,,KIF11,,,,,,,,
33405,CHRNA4,C0687132,Topiramate,DB00273,heavy drinking,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
10865,SIRT1,C0028754,Fenofibrate,DB01039,Obesity,Withdrawn,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 1,Metabolic disease,SIR2L1,,,,,,,,,,,,,,,,,,,,,,,,,
10796,SLC6A3,C1263846,Methylphenidate,DB00422,Attention deficit hyperactivity disorder,Approved,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},,Mental and behavioural disorder,DAT,,,,,,,,,,,,,,,,,,,,,,,,,
3723,Levothyroxine,DB00451,Hypothyroidism,C0020676,Approved,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N},,Endocrine disease,,,,,,,,,,,,,,,,,,,ATAD1,,,,,,,,
11565,PECAM1,C0025295,Meropenem,DB00760,"Meningitis, Pneumococcal",Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O},,Infectious disease,CD31,,,,,,,,,,,,,,,,,,,,,,,,,
7190,CXCL1,C0024117,Salmeterol,DB00938,Chronic Obstructive Airway Disease,Withdrawn,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O},Phase 3,Lung disease,SCYB1,GROa,MGSA-a,NAP-3,MGSA,GRO1,FSP,,,,,,,,,,,ISCU,,,,,,,,
21747,HSPA5,C0022972,Guanidine,DB00536,Lambert-Eaton Myasthenic Syndrome,Approved,C(=N)(N)N},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15330,SLC4A3,C0018790,Metoprolol,DB00264,Cardiac Arrest,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8778,EYS,C0013295,Sucralfate,DB00364,Duodenal Ulcer,Approved,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al]},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34417,ERBB3,C0278601,Tamoxifen,DB00675,Inflammatory Breast Carcinoma,Terminated,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4766,NOL3,C0857177,Salicylic acid,DB00936,Arthritic pains,Approved,C1=CC=C(C(=C1)C(=O)O)O},,,0,,,,,,,,,,,,,,,,,ACP3,,,,,,,,
25831,CDKN1A,C0005684,Mitomycin,DB00305,Malignant neoplasm of urinary bladder,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11261,WAS,C0242172,Ticarcillin,DB01607,Pelvic Inflammatory Disease,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26136,CD34,C0032463,Uracil mustard,DB00791,Polycythemia Vera,Approved,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
2643,Epinephrine,DB00668,Exacerbation of asthma,C0349790,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,SGCZ,,,,,,,,
31360,CD44,C0014852,Erlotinib,DB00530,Esophageal Diseases,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Digestive system disease,IN,MC56,Pgp1,CD44R,HCELL,CSPG8,MIC4,MDU2,MDU3,,,,,,,,,,,,,,,,,
13448,IL2RB,C0002880,Triamcinolone,DB00620,Autoimmune hemolytic anemia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,CD122,IL15RB,,,,,,,,,,,,,,,,,,,,,,,,
34582,VIM,C0023890,Dexamethasone,DB01234,Liver Cirrhosis,Terminated,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,Liver disease,,,,,,,,,,,,,,,,,,,,,,,,,,
17204,CHRNA5,C0270846,Lorazepam,DB00186,Epileptic drop attack,Approved,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12247,LPL,C0020479,Simvastatin,DB00641,Hyperlipoproteinemia Type III,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8559,Promethazine,DB01069,Vomiting,C0042963,Terminated,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
17504,IRF5,C1384606,Ospemifene,DB04938,Dyspareunia,Approved,C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\C3=CC=C(C=C3)OCCO)/CCCl},,Reproductive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
17835,TFRC,C0162316,Succinic acid,DB00139,Iron deficiency anemia,Approved,C(CC(=O)O)C(=O)O},,Hematologic disease,CD71,TFR1,p90,,,,,,,,,,,,,,,,,,,,,,,
27621,CRP,C0524620,Topiramate,DB00273,Metabolic Syndrome X,Suspended,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
7142,TYK2,C0033860,Atorvastatin,DB01076,Psoriasis,Withdrawn,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Skin disease,0,,,,,,,,,,,,,,,,,PEX11B,,,,,,,,
27698,PDYN,C1533217,Methamphetamine,DB01577,Methamphetamine dependence,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
35864,TP53,C0861876,Sorafenib,DB00398,Hepatoma recurrent,Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
16252,VEGFA,C0001957,Oxazepam,DB00842,Alcohol Withdrawal Delirium,Approved,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O},,Mental and behavioural disorder,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
28776,IFNE,C0036916,Methamphetamine,DB01577,Sexually Transmitted Diseases,Terminated,C[C@@H](CC1=CC=CC=C1)NC},Phase 1,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35861,FGF23,C0006666,Sodium thiosulfate,DB09499,Calciphylaxis,Terminated,[O-]S(=O)(=S)[O-].[Na+].[Na+]},Phase 3,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
26790,RPS14,C0280451,Allopurinol,DB00437,de novo myelodysplastic syndromes,Terminated,C1=NNC2=C1C(=O)NC=N2},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16919,HLA-DRB1,C0014356,Clidinium,DB00771,Enterocolitis,Approved,C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O},,Gastrointestinal disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
31231,IL1B,C2363741,Tenofovir,DB00300,HIV-1 infection,Withdrawn,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},Phase 2,Infectious disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
27079,CTNNB1,C0205824,Ifosfamide,DB01181,"Liposarcoma, Dedifferentiated",Suspended,C1CN(P(=O)(OC1)NCCCl)CCCl},Phase 2,Cancer,beta-catenin,armadillo,CTNNB,,,,,,,,,,,,,,,,,,,,,,,
22170,CD52,C0206141,Imatinib,DB00619,Idiopathic Hypereosinophilic Syndrome,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,HE5,EDDM5,CDW52,,,,,,,,,,,,,,,,,,,,,,,
23632,SLC11A1,C0023283,Fluconazole,DB00196,"Leishmaniasis, Cutaneous",Terminated,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O},Phase 3,Infectious disease,NRAMP,NRAMP1,,,,,,,,,,,,,,,,,,,,,,,,
35022,MBL2,C0857825,Ofloxacin,DB01165,Infection in solid organ transplant recipients,Terminated,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},Phase 3,Infectious disease,COLEC1,,,,,,,,,,,,,,,,,,,,,,,,,
9704,FCGR1A,C1112209,Trovafloxacin,DB00685,Intraabdominal Infections,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,CD64,CD64A,,,,,,,,,,,,,,,,,,,,,,,,
23320,CD68,C3697010,Olsalazine,DB01250,Ulcerative colitis in remission,Approved,C1=CC(=C(C=C1N=NC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O},,Immune system disease,SCARD1,macrosialin,DKFZp686M18236,LAMP4,,,,,,,,,,,,,,,,,,,,,,
22125,MRGPRX3,C0392784,Imatinib,DB00619,Dermatofibrosarcoma Protuberans,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10886,CFTR,C0004030,Voriconazole,DB00582,Aspergillosis,Withdrawn,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,ABC35,TNR-CFTR,CFTR/MRP,CF,ABCC7,,,,,,,,,,,,,,,,,,,,,
30337,CTLA4,C0024314,Bortezomib,DB00188,Lymphoproliferative Disorders,Terminated,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O},Phase 2,Primary immunodeficiency,CD152,CELIAC3,IDDM12,,,,,,,,,,,,,,,,,,,,,,,
26748,JUNB,C1511566,Thalidomide,DB01041,Cutaneous B-Cell Non-Hodgkin Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
18879,RAPGEF5,C0745136,Trimethaphan,DB01116,Hypertensive emergency,Approved,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3982,Meropenem,DB00760,Meningococcal meningitis,C0025294,Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,C11orf21,,,,,,,,
6574,Fludarabine,DB01073,Angioimmunoblastic Lymphadenopathy,C0020981,Suspended,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,MYP2,,,,,,,,
457,Azatadine,DB00719,Rhinorrhea,C1260880,Approved,CN1CCC(=C2C3=CC=CC=C3CCC4=C2N=CC=C4)CC1},,Nervous system disease,,,,,,,,,,,,,,,,,,,Diclofenac,,,,,,,,
24332,APOE,C0271084,Verteporfin,DB00460,Exudative age-related macular degeneration,Approved,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C.CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)O)C(=C3C)CCC(=O)OC)C=C},,,AD2,,,,,,,,,,,,,,,,,,,,,,,,,
8678,INVS,C0039685,Alprostadil,DB00770,Tetralogy of Fallot,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
6740,IL1A,C0042029,Trovafloxacin,DB00685,Urinary tract infection,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,IL1F1,IL-1A,IL1-ALPHA,IL1,,,,,,,,,,,,,,MYO3A,,,,,,,,
13945,EBM,C0026857,Triamcinolone,DB00620,Musculoskeletal Diseases,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8843,Sirolimus,DB00877,Polycystic Kidney Diseases,C0022680,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2/Phase 3,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,,
23797,COMT,C0231528,Naproxen,DB00788,Myalgia,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
35896,KRAS,C0235974,Sunitinib,DB01268,Pancreatic carcinoma,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23705,CXCL2,C0031099,Lidocaine,DB00281,Periodontitis,Terminated,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},Phase 2,Infectious disease,SCYB2,GROb,MIP-2a,MGSA-b,CINC-2a,GRO2,,,,,,,,,,,,,,,,,,,,
17085,TNF,C0085652,Clofazimine,DB00845,Pyoderma Gangrenosum,Approved,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl},,Immune system disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
3678,Levocetirizine,DB06282,Hay fever,C0018621,Approved,C1CN(CCN1CCOCC(=O)O)[C@H](C2=CC=CC=C2)C3=CC=C(C=C3)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,CAMK2A,,,,,,,,
35931,EPHB1,C1328479,Sunitinib,DB01268,Pancreatic Endocrine Carcinoma,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 3,Cancer,Hek6,EPHT2,,,,,,,,,,,,,,,,,,,,,,,,
30424,VEGFA,C0494165,Oxaliplatin,DB00526,Secondary malignant neoplasm of liver,Withdrawn,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2/Phase 3,Cancer,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
36048,MERTK,C0035334,Unoprostone,DB06826,Retinitis Pigmentosa,Terminated,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},Phase 3,Nervous system disease,mer,RP38,c-Eyk,Tyro12,,,,,,,,,,,,,,,,,,,,,,
22402,GRB7,C0346976,Gemcitabine,DB00441,Secondary malignant neoplasm of pancreas,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
31989,TP53,C1319315,Sulindac,DB00605,Adenocarcinoma of large intestine,Terminated,CC\\1=C(C2=C(/C1=C\\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34089,B3GAT3,C0029453,Cholecalciferol,DB00169,Osteopenia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 2/Phase 3,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8918,CELA3B,C0013395,Omeprazole,DB00338,Dyspepsia,Suspended,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 2,Digestive system disease,CBPP,ELA3B,,,,,,,,,,,,,,,,,,,,,,,,
33048,CEACAM5,C0278689,Paclitaxel,DB01229,Ovarian epithelial cancer recurrent,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,CD66e,,,,,,,,,,,,,,,,,,,,,,,,,
9306,Topiramate,DB00273,Epilepsy,C0014544,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
34535,ALB,C0149778,Vancomycin,DB00512,Soft Tissue Infections,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
5046,Posaconazole,DB01263,Chromoblastomycosis,C0008582,Approved,CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F},,Infectious disease,,,,,,,,,,,,,,,,,,,NR5A2,,,,,,,,
32309,CLEC7A,C0238013,Voriconazole,DB00582,Invasive aspergillosis,Terminated,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,dectin-1,hDectin-1,CD369,SCARE2,CLECSF12,,,,,,,,,,,,,,,,,,,,,
29522,ZNF654,C0278502,Fluorouracil,DB00544,recurrent gastric cancer,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33795,DNAJB11,C0022680,Sirolimus,DB00877,Polycystic Kidney Diseases,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2/Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
25958,NREP,C0162810,Tranilast,DB07615,"Cicatrix, Hypertrophic",Approved,COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC},,,P311,D4S114,PRO1873,PTZ17,SEZ17,C5orf13,,,,,,,,,,,,,,,,,,,,
29961,SNRPN,C0043116,Sodium phenylbutyrate,DB06819,HMN (Hereditary Motor Neuropathy) Proximal Type I,Terminated,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},Phase 1/Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20006,CYB5A,C0014877,Echothiophate,DB01057,Esotropia,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
29561,CREBBP,C0279626,Fluorouracil,DB00544,Squamous cell carcinoma of esophagus,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1644,Ciprofloxacin,DB00537,Enterobacteriaceae Infections,C0014347,Approved,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Zinc oxide,,,,,,,,
36160,KIF7,C0264303,Omeprazole,DB00338,Laryngomalacia,Withdrawn,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 1,,0,,,,,,,,,,,,,,,,,,,,,,,,,
16389,ALAD,C0162565,Promazine,DB00420,Acute intermittent porphyria,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Congenital disorder of metabolism,ALADH,PBGS,,,,,,,,,,,,,,,,,,,,,,,,
18973,CBS,C0040038,Warfarin,DB00682,Thromboembolism,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,HIP4,,,,,,,,,,,,,,,,,,,,,,,,,
3687,Levofloxacin,DB01137,Bacterial infection due to Klebsiella pneumoniae,C0343402,Approved,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,PPP1R1B,,,,,,,,
27862,GATA1,C2347748,Mitoxantrone,DB01204,Adult Erythroleukemia,Terminated,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},Phase 1,Cancer,ERYF1,NFE1,GATA-1,,,,,,,,,,,,,,,,,,,,,,,
14907,BDNF,C0150055,Pregabalin,DB00230,Chronic pain,Withdrawn,CC(C)C[C@@H](CC(=O)O)CN},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,
17125,NR2F2,C0021361,Clomifene,DB00882,Female infertility,Approved,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\Cl)/C3=CC=CC=C3},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22452,HP,C0007820,Tolazoline,DB00797,Cerebrovascular Disorders,Approved,C1CN=C(N1)CC2=CC=CC=C2},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
33941,POSTN,C0006287,Nitric Oxide,DB00435,Bronchopulmonary Dysplasia,Terminated,[N]=O},Phase 2/Phase 3,Congenital malformation,OSF-2,PN,periostin,,,,,,,,,,,,,,,,,,,,,,,
9493,CCR6,C2973725,Treprostinil,DB00374,Pulmonary arterial hypertension,Approved,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},,Infectious disease,CKR-L3,GPR-CY4,CMKBR6,GPR29,DRY-6,DCR2,BN-1,CD196,STRL22,,,,,,,,,,,,,,,,,
35236,TRBV20OR9-2,C0012813,Mesalazine,DB00244,Diverticulitis,Terminated,C1=CC(=C(C=C1N)C(=O)O)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23812,PRDM5,C0231528,Naproxen,DB00788,Myalgia,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,,,,,,,,,,,,,,,,,,,,,,,,,,,
3073,Fusidic Acid,DB02703,Neonatal pneumonia,C0339968,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,MIR145,,,,,,,,
8788,Vitamin E,DB00163,Atherosclerosis,C0004153,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
36470,ITLN1,C0862312,Pemetrexed,DB00642,"Epithelioid mesothelioma, malignant",Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,ITLN,FLJ20022,LFR,HL-1,hIntL,,,,,,,,,,,,,,,,,,,,,
22059,IFNB1,C0019357,Vidarabine,DB00194,"Keratitis, Herpetic",Approved,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15635,HNF1A,C0011881,Losartan,DB00678,Diabetic Nephropathy,Approved,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33161,TBCD,C1145670,Dexmedetomidine,DB00633,Respiratory Failure,Terminated,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 3,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31529,ESR1,C3495917,Exemestane,DB00990,Advanced breast cancer,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C},Phase 2,Cancer,NR3A1,Era,ER-alpha,ESR,,,,,,,,,,,,,,,,,,,,,,
24988,IDO1,C0040558,Sulfamethoxazole,DB01015,Toxoplasmosis,Approved,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,IDO,INDO,,,,,,,,,,,,,,,,,,,,,,,,
20564,PROK2,C0271578,Tranexamic Acid,DB00302,Female hypogonadism syndrome,Approved,C1CC(CCC1CN)C(=O)O},,Endocrine disease,PK2,BV8,MIT1,KAL4,,,,,,,,,,,,,,,,,,,,,,
4291,Montelukast,DB00471,Allergic asthma,C0155877,Approved,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,RMRP,,,,,,,,
29462,KDM6A,C0005695,Mitomycin,DB00305,Bladder Neoplasm,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17384,PYCARD,C0031069,Colchicine,DB01394,Familial Mediterranean Fever,Approved,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC},,Infectious disease,CARD5,ASC,,,,,,,,,,,,,,,,,,,,,,,,
4379,Nedocromil,DB00716,Allergic Conjunctivitis,C0009766,Approved,CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)O)C(=O)C=C(N2CC)C(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,POLR3A,,,,,,,,
35843,PSCA,C0032927,Celecoxib,DB00482,Precancerous Conditions,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2/Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,
8988,Ezogabine,DB04953,Epilepsy,C0014544,Terminated,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N},Phase 3,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
13307,CRH,C0405580,Triamcinolone,DB00620,Adrenal cortical hypofunction,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,CRH1,,,,,,,,,,,,,,,,,,,,,,,,,
33126,AGTR1,C1135361,Sildenafil,DB00203,Persistent pulmonary hypertension,Terminated,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C},Phase 2,Lung disease,AT2R1,AGTR1A,AT2R1A,HAT1R,AG2S,AT2R1B,AT1B,AGTR1B,,,,,,,,,,,,,,,,,,
15932,FGFR1,C0555198,Ondansetron,DB00904,Malignant Glioma,Withdrawn,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C},Phase 2,Cancer,CEK,FLG,BFGFR,N-SAM,CD331,FLT2,KAL2,,,,,,,,,,,,,,,,,,,
26049,HELLPAR,C0034063,Trimethaphan,DB01116,Pulmonary Edema,Approved,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25168,MPL,C0027022,Vidarabine,DB00194,Myeloproliferative disease,Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 2,Cancer,CD110,TPOR,,,,,,,,,,,,,,,,,,,,,,,,
25903,DMD,C0023269,Gemcitabine,DB00441,leiomyosarcoma,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1/Phase 2,Cancer,DXS142,DXS164,DXS206,DXS230,DXS239,DXS268,DXS269,DXS270,DXS272,MRX85,,,,,,,,,,,,,,,,
24426,SDHAF2,C0019202,Triethylenetetramine,DB06824,Hepatolenticular Degeneration,Approved,C(CNCCNCCN)N},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
11536,CCL2,C0341503,Tobramycin,DB00684,Bacterial peritonitis,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Infectious disease,MCP1,MCP-1,MCAF,SMC-CF,GDCF-2,HC11,MGC9434,SCYA2,,,,,,,,,,,,,,,,,,
28019,CRHR1,C0458247,Capsaicin,DB06774,Allodynia,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,,CRF-R,CRF1,CRHR,,,,,,,,,,,,,,,,,,,,,,,
20174,ASPG,C0002792,Epinephrine,DB00668,anaphylaxis,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15999,CHI3L1,C1997728,Vancomycin,DB00512,Osteomyelitis due to Staphylococcus aureus,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14733,ARG2,C0020542,Iloprost,DB01088,Pulmonary Hypertension,Withdrawn,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O},Phase 2,Lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,
5734,Sulfisoxazole,DB00263,Inclusion conjunctivitis,C0009770,Approved,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,SLC34A2,,,,,,,,
16591,RNA28SN5,C0040261,Terbinafine,DB00857,Onychomycosis,Approved,CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3583,Kanamycin,DB01172,Bacterial sepsis,C0684256,Approved,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N},,Infectious disease,,,,,,,,,,,,,,,,,,,MMP13,,,,,,,,
9514,SMN1,C0242429,Pheniramine,DB01620,Sore Throat,Approved,CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29877,MIR4300HG,C0085136,Vincristine,DB00541,Central Nervous System Neoplasms,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
979,Cefaclor,DB00833,Pneumonia,C0032285,Approved,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,Methadyl Acetate,,,,,,,,
27188,AIF1,C1266050,Trametinib,DB08911,Poorly Differentiated Thyroid Carcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2,Cancer,IRT-1,AIF-1,Em:AF129756.17,IBA1,,,,,,,,,,,,,,,,,,,,,,
5108,Prednicarbate,DB01130,Granuloma Annulare,C0085074,Approved,CCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)OC(=O)OCC},,Skin disease,,,,,,,,,,,,,,,,,,,SAA2,,,,,,,,
18588,ERCC1,C0019156,Defibrotide,DB04932,Hepatic Veno-Occlusive Disease,Approved,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O},,Liver disease,RAD10,,,,,,,,,,,,,,,,,,,,,,,,,
18348,CBSL,C0024591,Dantrolene,DB01219,Malignant hyperpyrexia due to anesthesia,Approved,C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-]},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
7963,TNFRSF11B,C0020502,Alfacalcidol,DB01436,Hyperparathyroidism,Approved,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
2858,Fluconazole,DB00196,Oral candidiasis,C0006849,Approved,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O},,Infectious disease,,,,,,,,,,,,,,,,,,,PSPN,,,,,,,,
34767,TMEM231,C0030283,Ethanol,DB00898,Pancreatic Cyst,Terminated,CCO},Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
33866,BRAF,C0751690,Imatinib,DB00619,Malignant Peripheral Nerve Sheath Tumor,Terminated,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 2/Phase 3,Cancer,BRAF1,,,,,,,,,,,,,,,,,,,,,,,,,
5918,Thiamine,DB00152,Mineral deficiency,C0687148,Approved,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},,,,,,,,,,,,,,,,,,,,,GMPPB,,,,,,,,
18905,SSTR2,C0021670,Romidepsin,DB06176,insulinoma,Terminated,C/C=C\\1/C(=O)N[C@H](C(=O)O[C@H]\\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
19576,PLA2G15,C0278498,Panobinostat,DB06603,Malignant neoplasm of stomach stage IV,Terminated,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)/C=C/C(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4111,Methylprednisolone,DB00959,Scalp psoriasis,C0406326,Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O},,Immune system disease,,,,,,,,,,,,,,,,,,,ANKRD26,,,,,,,,
30269,RASGRP1,C0079731,Dexamethasone,DB01234,B-Cell Lymphomas,Terminated,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26805,TCL1B,C1333984,Thalidomide,DB01041,Hepatosplenic T-cell lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10893,DAPK1,C0004030,Voriconazole,DB00582,Aspergillosis,Withdrawn,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21089,FGFR1,C0010417,Testosterone Propionate,DB01420,Cryptorchidism,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Congenital malformation,CEK,FLG,BFGFR,N-SAM,CD331,FLT2,KAL2,,,,,,,,,,,,,,,,,,,
36152,AHDC1,C0264303,Omeprazole,DB00338,Laryngomalacia,Withdrawn,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 1,,DJ159A19.3,RP1-159A19.1,,,,,,,,,,,,,,,,,,,,,,,,
14605,TFCP2L1,C1336708,Vinblastine,DB00570,Testicular Germ Cell Tumor,Terminated,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,LBP-9,CRTR1,,,,,,,,,,,,,,,,,,,,,,,,
15779,IL10,C0033581,Ofloxacin,DB01165,prostatitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
21520,LINC01478,C0035258,Rotigotine,DB05271,Restless Legs Syndrome,Approved,CCCN(CCC1=CC=CS1)[C@H]2CCC3=C(C2)C=CC=C3O},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5974,Ticarcillin,DB01607,Staphylococcal Pneumonia,C0032308,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,SIGLEC8,,,,,,,,
36864,PECAM1,C0867389,Prednisolone,DB00860,Chronic graft-versus-host disease,Withdrawn,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Immune system disease,CD31,,,,,,,,,,,,,,,,,,,,,,,,,
22862,COX3,C0018021,Liothyronine,DB00279,Goiter,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30130,ERBB2,C2938924,Letrozole,DB01006,Oestrogen receptor positive breast cancer,Terminated,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3},Phase 2,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
1043,Cefapirin,DB01139,Klebsiella cystitis,C0520775,Approved,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)O},,Urinary system disease,,,,,,,,,,,,,,,,,,,NOD2,,,,,,,,
2376,Dinoprost Tromethamine,DB01160,Incomplete spontaneous abortion,C0000810,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O)O.C(C(CO)(CO)N)O},,,,,,,,,,,,,,,,,,,,,ENO2,,,,,,,,
34629,RYR2,C0020450,Thiamine,DB00152,Hyperemesis Gravidarum,Terminated,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},Phase 3,Endocrine and metabolic disease,ARVC2,VTSIP,ARVD2,,,,,,,,,,,,,,,,,,,,,,,
30965,RASSF1,C0206704,Temozolomide,DB00853,"Carcinoma, Large Cell",Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
22496,AGT,C0042373,Tolazoline,DB00797,Vascular Diseases,Approved,C1CN=C(N1)CC2=CC=CC=C2},,Vascular disease,SERPINA8,,,,,,,,,,,,,,,,,,,,,,,,,
18786,SPINK5,C0013595,Dexpanthenol,DB09357,Eczema,Approved,CC(C)(CO)[C@H](C(=O)NCCCO)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1658,Ciprofloxacin,DB00537,Nosocomial pneumonia,C0949083,Approved,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,VEGFA,,,,,,,,
35521,INS,C0011884,Octreotide,DB00104,Diabetic Retinopathy,Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 3,Nervous system disease,IDDM2,,,,,,,,,,,,,,,,,,,,,,,,,
33879,SLC11A1,C0041296,Moxifloxacin,DB00218,Tuberculosis,Withdrawn,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O},Phase 1,Infectious disease,NRAMP,NRAMP1,,,,,,,,,,,,,,,,,,,,,,,,
9818,ACACA,C0949083,Vitamin E,DB00163,Nosocomial pneumonia,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19794,RNF19A,C0036472,Fusidic Acid,DB02703,Scrub Typhus,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8745,Topiramate,DB00273,"Alcoholic Intoxication, Chronic",C0001973,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 2,Other,,,,,,,,,,,,,,,,,,,,,,,,,,,
21539,HLA-DRB1,C0751362,Viloxazine,DB09185,Narcolepsy-Cataplexy Syndrome,Approved,CCOC1=CC=CC=C1OCC2CNCCO2},,Nervous system disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
24779,MMP2,C0034069,Azathioprine,DB00993,Pulmonary Fibrosis,Terminated,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]},Phase 3,Lung disease,TBE-1,CLG4,CLG4A,,,,,,,,,,,,,,,,,,,,,,,
33474,ELANE,C1701940,Vancomycin,DB00512,"Pneumonia, Ventilator-Associated",Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 2,Infectious disease,NE,HNE,HLE,ELA2,,,,,,,,,,,,,,,,,,,,,,
10392,CTLA4,C0002962,Verapamil,DB00661,Angina Pectoris,Approved,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},,Cardiovascular disease,CD152,CELIAC3,IDDM12,,,,,,,,,,,,,,,,,,,,,,,
29770,SUMO1,C0023524,Mefloquine,DB00358,"Leukoencephalopathy, Progressive Multifocal",Terminated,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26044,ALOX5,C0034063,Trimethaphan,DB01116,Pulmonary Edema,Approved,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5},,Lung disease,5-LOX,,,,,,,,,,,,,,,,,,,,,,,,,
25125,GZMA,C0730607,Roflumilast,DB01656,Severe chronic obstructive pulmonary disease,Approved,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F},,Lung disease,HFSP,CTLA3,,,,,,,,,,,,,,,,,,,,,,,,
18006,TICAM2,C0035335,Melphalan,DB01042,Retinoblastoma,Terminated,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11071,GP1BA,C0019655,Ketoconazole,DB01026,Histoplasmosis,Approved,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},,Infectious disease,CD42b,GPIbalpha,GP1B,,,,,,,,,,,,,,,,,,,,,,,
2348,Dihydrocodeine,DB01551,Pain,C0030193,Approved,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](CC4)O},,,,,,,,,,,,,,,,,,,,,GP1BB,,,,,,,,
21737,SCLC1,C0022972,Guanidine,DB00536,Lambert-Eaton Myasthenic Syndrome,Approved,C(=N)(N)N},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29914,TLR4,C0856825,Pentostatin,DB00552,Acute GVH disease,Terminated,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O},Phase 1/Phase 2,Immune system disease,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,,,,,,,,,
7631,EMSY,C0011615,Triamcinolone,DB00620,"Dermatitis, Atopic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,COLQ,,,,,,,,
3988,Mesalazine,DB00244,Ulcerative colitis in remission,C3697010,Approved,C1=CC(=C(C=C1N)C(=O)O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,BCL10,,,,,,,,
30820,SGSM3,C1321872,Fludarabine,DB01073,Stage IV Skin Melanoma,Terminated,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12506,IL1B,C0014179,Ertapenem,DB00303,Endometritis,Terminated,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)[C@@H](C)O},Phase 1,Reproductive system disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
26559,PAWR,C3898877,Doxorubicin,DB00997,Hormone-Resistant Prostate Cancer,Suspended,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},Phase 1/Phase 2,Cancer,par-4,,,,,,,,,,,,,,,,,,,,,,,,,
7987,GP1BB,C0020626,Ergocalciferol,DB00153,Hypoparathyroidism,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Endocrine and metabolic disease,CD42c,GPIbbeta,,,,,,,,,,,,,,,,,,,,,,,,
32793,HBFQTL2,C0039730,Pegfilgrastim,DB00019,Thalassemia,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14083,HLA-DQB1,C0036202,Triamcinolone,DB00620,Sarcoidosis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,HLA-DQB,,,,,,,,,,,,,,,,,,,,,,,,,
13882,NPM1,C0024305,Vidarabine,DB00194,"Lymphoma, Non-Hodgkin",Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16622,XYLT2,C0021775,Cilostazol,DB01166,Intermittent Claudication,Approved,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
19309,CDKN1B,C0678222,Paclitaxel,DB01229,Breast Carcinoma,Approved,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34852,TGFB1,C0030297,Gemcitabine,DB00441,Pancreatic Neoplasm,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 3,Cancer,CED,TGFbeta,TGFB,DPD1,,,,,,,,,,,,,,,,,,,,,,
5412,Ramipril,DB00178,Hypertensive disease,C0020538,Approved,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,CLMP,,,,,,,,
13950,IL12B,C0026857,Triamcinolone,DB00620,Musculoskeletal Diseases,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16232,GRM8,C0001957,Oxazepam,DB00842,Alcohol Withdrawal Delirium,Approved,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O},,Mental and behavioural disorder,GLUR8,GPRC1H,mGlu8,MGLUR8,,,,,,,,,,,,,,,,,,,,,,
14793,PPARG,C0001206,Somatostatin,DB09099,Acromegaly,Terminated,C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=CC=C6)O},Phase 2,Endocrine disease,PPARG1,PPARG2,NR1C3,PPARgamma,,,,,,,,,,,,,,,,,,,,,,
14655,WNT10A,C0334634,Thalidomide,DB01041,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
5552,Selegiline,DB01037,Parkinson Disease,C0030567,Approved,C[C@H](CC1=CC=CC=C1)N(C)CC#C},,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,PPP1R14A,,,,,,,,
17011,TSC2,C0343467,Thalidomide,DB01041,Erythema nodosum leprosum,Approved,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24280,PRTFDC1,C0038436,Sertraline,DB01104,Post-Traumatic Stress Disorder,Approved,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
25430,CDKN2A,C2239176,Sorafenib,DB00398,Liver carcinoma,Approved,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},,Cancer,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
12554,HLA-DRB1,C0009324,Naltrexone,DB00704,Ulcerative Colitis,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,Immune system disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
32938,TNF,C0003125,Quetiapine,DB01224,Anorexia Nervosa,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 2,Mental and behavioural disorder,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
20748,NAP1L1,C0343386,Vancomycin,DB00512,Clostridium difficile infection,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,MGC8688,MGC23410,,,,,,,,,,,,,,,,,,,,,,,,
15515,CDKN1A,C0024623,Citalopram,DB00215,Malignant neoplasm of stomach,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4734,Oxytetracycline,DB00595,Q Fever,C0034362,Approved,C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O},,,,,,,,,,,,,,,,,,,,,ADGRG1,,,,,,,,
19842,NKX2-5,C0235480,Propafenone,DB01182,Paroxysmal atrial fibrillation,Approved,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O},,,CSX1,NKX2.5,NKX4-1,CSX,NKX2E,,,,,,,,,,,,,,,,,,,,,
24437,HMGCR,C0019202,Triethylenetetramine,DB06824,Hepatolenticular Degeneration,Approved,C(CNCCNCCN)N},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
13565,F2,C0002875,Triamcinolone,DB00620,Cooley's anemia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12049,DAG1,C0013264,Ataluren,DB05016,"Muscular Dystrophy, Duchenne",Approved,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21211,RASA1,C0028326,Fluoxymesterone,DB01185,Noonan Syndrome,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
7472,HPGDS,C0338437,Albendazole,DB00518,Neurocysticercosis,Approved,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC},,Infectious disease,GSTS,H-PGDS,PGD2,GSTS1-1,GSTS1,,,,,,,,,,,,,SLC14A2-AS1,,,,,,,,
25166,PRB1,C0026987,Teriparatide,DB06285,Myelofibrosis,Terminated,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
21398,DDX58,C0021400,Zanamivir,DB00558,Influenza,Approved,CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)O)N=C(N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14798,REN,C0001206,Somatostatin,DB09099,Acromegaly,Terminated,C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=CC=C6)O},Phase 2,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,
23604,RASSF1,C0220756,Miglustat,DB00419,"Niemann-Pick Disease, Type C",Approved,CCCCN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
29152,MSH2,C0280790,Irinotecan,DB00762,adult anaplastic oligodendroglioma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,HNPCC1,COCA1,,,,,,,,,,,,,,,,,,,,,,,,
115,Alprazolam,DB00404,Anxiety,C0003467,Approved,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,Azelnidipine,,,,,,,,
17484,SAMD9,C0020625,Tolvaptan,DB06212,Hyponatremia,Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34804,IL10,C0010823,Cidofovir,DB00369,Cytomegalovirus Infections,Withdrawn,C1=CN(C(=O)N=C1N)C[C@@H](CO)OCP(=O)(O)O},Phase 1,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
2022,CCKAR,C0001973,Zonisamide,DB00909,"Alcoholic Intoxication, Chronic",Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 2,Other,,,,,,,,,,,,,,,,,,CYP17A1,,,,,,,,
36114,MIR744,C0279663,Paclitaxel,DB01229,Serous cystadenocarcinoma ovary,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
223,Ammonium lactate,DB06768,Granuloma Annulare,C0085074,Approved,CC(C(=O)[O-])O.[NH4+]},,Skin disease,,,,,,,,,,,,,,,,,,,KRAS,,,,,,,,
34052,NLRP3,C0018681,Naratriptan,DB00952,Headache,Withdrawn,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C},Phase 3,,AGTAVPRL,AII,AVP,FCAS,FCU,NALP3,PYPAF1,MWS,CLR1.1,C1orf7,CIAS1,,,,,,,,,,,,,,,
37222,COMT,C0015732,Phenylephrine,DB00388,Fecal Incontinence,Withdrawn,CNC[C@@H](C1=CC(=CC=C1)O)O},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
22012,CEP290,C0917796,Idebenone,DB09081,"Optic Atrophy, Hereditary, Leber",Approved,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
37215,HDAC2,C0221406,Mifepristone,DB00834,Pituitary-dependent Cushing's disease,Withdrawn,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O},Phase 3,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29638,CCDC28A,C0279632,Vorinostat,DB02546,adult acute megakaryoblastic leukemia (M7),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
14045,GAPDH,C0035439,Triamcinolone,DB00620,Rheumatic Heart Disease,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Cardiovascular disease,GAPD,,,,,,,,,,,,,,,,,,,,,,,,,
23389,PRKCB,C0267176,Metoclopramide,DB01233,Gastroparesis due to diabetes mellitus,Approved,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl},,Digestive system disease,PRKCB2,PKCB,PRKCB1,,,,,,,,,,,,,,,,,,,,,,,
33310,BCL2,C0033117,Tadalafil,DB00820,Priapism,Terminated,CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36},Phase 2,,Bcl-2,PPP1R50,,,,,,,,,,,,,,,,,,,,,,,,
23382,MFAP1,C0267176,Metoclopramide,DB01233,Gastroparesis due to diabetes mellitus,Approved,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10641,TNF,C0343378,Clarithromycin,DB01211,Helicobacter-associated gastritis,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O},,Digestive system disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
34941,PPARD,C0025517,Heparin,DB01109,Metabolic Diseases,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Endocrine and metabolic disease,NUC1,NUCII,FAAR,NR1C2,,,,,,,,,,,,,,,,,,,,,,
15270,SLC34A3,C0085682,"Sodium phosphate, monobasic, monohydrate",DB09525,Hypophosphatemia,Approved,OP(=O)(O)[O-].[Na+]},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30018,TRIM21,C0024137,Tretinoin,DB00755,"Lupus Erythematosus, Cutaneous",Terminated,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15281,CYP2R1,C0085682,"Sodium phosphate, monobasic, monohydrate",DB09525,Hypophosphatemia,Approved,OP(=O)(O)[O-].[Na+]},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6972,MATN3,C0029408,Salmon Calcitonin,DB00017,Degenerative polyarthritis,Terminated,CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CN=CN2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO},Phase 3,Immune system disease,EDM5,HOA,,,,,,,,,,,,,,,,DOCK2,,,,,,,,
12119,TBXAS1,C0003850,Simvastatin,DB00641,Arteriosclerosis,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Vascular disease,CYP5,CYP5A1,THAS,TXS,TXAS,,,,,,,,,,,,,,,,,,,,,
14850,GPD2,C0026603,Scopolamine,DB00747,Motion Sickness,Approved,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20857,ADNP,C0042024,Tolterodine,DB01036,Urinary Incontinence,Terminated,CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
12290,NOS3,C0020557,Topiramate,DB00273,Hypertriglyceridemia,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Metabolic disease,ECNOS,eNOS,,,,,,,,,,,,,,,,,,,,,,,,
17803,IL10,C0022577,Lodoxamide,DB06794,"Keratoconjunctivitis, Vernal",Approved,C1=C(C=C(C(=C1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N},,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
14124,IL33,C0242459,Triamcinolone,DB00620,Simple Pulmonary Eosinophilia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,DVS27,DKFZp586H0523,NF-HEV,IL1F11,C9orf26,,,,,,,,,,,,,,,,,,,,,
33285,GATA1,C0001815,Sunitinib,DB01268,Primary Myelofibrosis,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,ERYF1,NFE1,GATA-1,,,,,,,,,,,,,,,,,,,,,,,
20585,EGFR,C0033578,Flutamide,DB00499,Prostatic Neoplasms,Approved,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F},,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
137,Ambenonium,DB01122,Myasthenia Gravis,C0026896,Approved,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC2=CC=CC=C2Cl},,Immune system disease,,,,,,,,,,,,,,,,,,,Benzonatate,,,,,,,,
14134,BRAF,C0039103,Triamcinolone,DB00620,Synovitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,BRAF1,,,,,,,,,,,,,,,,,,,,,,,,,
7068,LAT,C0019348,Aciclovir,DB00787,Herpes Simplex Infections,Approved,C1=NC2=C(N1COCCO)N=C(NC2=O)N},,Infectious disease,,,,,,,,,,,,,,,,,,GOLGA3,,,,,,,,
6794,GRIN1,C0033975,Triflupromazine,DB00508,Psychotic Disorders,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F},,Mental and behavioural disorder,GluN1,NMDAR1,,,,,,,,,,,,,,,,TRIB3,,,,,,,,
22045,LRRC34,C0855095,Idelalisib,DB09054,Small Lymphocytic Lymphoma,Approved,CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
24315,MCL1,C1261473,Pazopanib,DB06589,Sarcoma,Approved,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26708,PDGFRA,C0020981,Thalidomide,DB01041,Angioimmunoblastic Lymphadenopathy,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Immune system disease,CD140a,PDGFR2,GAS9,,,,,,,,,,,,,,,,,,,,,,,
25311,CYBB,C0037299,Sulfadiazine,DB00359,Skin Ulcer,Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Skin disease,GP91-PHOX,NOX2,CGD,,,,,,,,,,,,,,,,,,,,,,,
26911,PIK3CG,C0432487,Vidarabine,DB00194,Post-transplant lymphoproliferative disorder,Suspended,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31478,ALAD,C0349604,Sirolimus,DB00877,Intracranial Meningioma,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,ALADH,PBGS,,,,,,,,,,,,,,,,,,,,,,,,
22732,ALK,C0238463,Lenvatinib,DB09078,Papillary thyroid carcinoma,Approved,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27227,STK11,C0001418,Cisplatin,DB00515,Adenocarcinoma,Withdrawn,N.N.Cl[Pt]Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19316,FOXA1,C0678222,Paclitaxel,DB01229,Breast Carcinoma,Approved,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},,Cancer,HNF3A,,,,,,,,,,,,,,,,,,,,,,,,,
19862,KIT,C0002874,Heparin,DB01109,Aplastic Anemia,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Hematologic disease,CD117,SCFR,C-Kit,PBT,,,,,,,,,,,,,,,,,,,,,,
19150,NR3C2,C0042963,Haloperidol,DB00502,Vomiting,Withdrawn,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F},Phase 0,,MR,MLR,,,,,,,,,,,,,,,,,,,,,,,,
28567,HSF2BP,C0341106,Lansoprazole,DB00448,Eosinophilic esophagitis,Withdrawn,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F},Phase 1/Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21562,ACHE,C0751362,Viloxazine,DB09185,Narcolepsy-Cataplexy Syndrome,Approved,CCOC1=CC=CC=C1OCC2CNCCO2},,Nervous system disease,YT,,,,,,,,,,,,,,,,,,,,,,,,,
7680,Aminosalicylic Acid,DB00233,Crohn Disease,C0010346,Terminated,C1=CC(=C(C=C1N)O)C(=O)O},Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,NEDD8,,,,,,,,
7475,ICAM1,C0338437,Albendazole,DB00518,Neurocysticercosis,Approved,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC},,Infectious disease,CD54,,,,,,,,,,,,,,,,,TRAP,,,,,,,,
7516,IL17A,C0009766,Triprolidine,DB00427,Allergic Conjunctivitis,Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Immune system disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,SPESP1,,,,,,,,
32089,CYP2E1,C0023903,Sirolimus,DB00877,Liver neoplasms,Withdrawn,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,CYP2E,,,,,,,,,,,,,,,,,,,,,,,,,
25767,FSHB,C0948896,Testosterone,DB00624,Primary hypogonadism,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,Endocrine disease,,,,,,,,,,,,,,,,,,,,,,,,,,
37039,PLCB1,C0520679,Dexmedetomidine,DB00633,"Sleep Apnea, Obstructive",Withdrawn,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 2/Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
25379,RPS4X,C0041408,Somatropin recombinant,DB00052,Turner Syndrome,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
36235,LDLRAD3,C1510472,Varenicline,DB01273,Drug Dependence,Withdrawn,C1C2CNCC1C3=CC4=NC=CN=C4C=C23},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
4648,Omeprazole,DB00338,Gastroesophageal reflux disease,C0017168,Approved,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},,Digestive system disease,,,,,,,,,,,,,,,,,,,STX16,,,,,,,,
26763,IL2,C0278580,Thalidomide,DB01041,Cutaneous T-cell lymphoma recurrent,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,IL-2,TCGF,,,,,,,,,,,,,,,,,,,,,,,,
14023,ACLY,C2894027,Triamcinolone,DB00620,Post traumatic osteoarthritis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,ATPCL,CLATP,ACL,,,,,,,,,,,,,,,,,,,,,,,
23040,YAP1,C0006118,Lomustine,DB01206,Brain Neoplasms,Approved,C1CCC(CC1)NC(=O)N(CCCl)N=O},,Cancer,YAP65,,,,,,,,,,,,,,,,,,,,,,,,,
527,Aztreonam,DB00355,Proteus septicemia,C0577690,Approved,C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\\OC(C)(C)C(=O)O)/C2=CSC(=N2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,CYBA,,,,,,,,
23851,RPL5,C1961099,Nelarabine,DB01280,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,Approved,COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32553,TACR1,C0520909,Nicotine,DB00184,Postoperative Nausea and Vomiting,Terminated,CN1CCC[C@H]1C2=CN=CC=C2},Phase 2,,SPR,NK1R,TAC1R,,,,,,,,,,,,,,,,,,,,,,,
36740,FOXP3,C0278802,Norgestrel,DB09389,Recurrent Endometrial Cancer,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Cancer,JM2,XPID,AIID,PIDX,DIETER,SCURFIN,IPEX,,,,,,,,,,,,,,,,,,,
6351,Vidarabine,DB00194,"Keratitis, Herpetic",C0019357,Approved,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},,Infectious disease,,,,,,,,,,,,,,,,,,,PPP3CB,,,,,,,,
27724,NOP10,C0023532,Aminolevulinic acid,DB00855,"Leukoplakia, Oral",Terminated,C(CC(=O)O)C(=O)CN},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34198,CRP,C0349217,Aripiprazole,DB01238,"Depressive episode, unspecified",Terminated,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
28337,FCER2,C0023486,Thalidomide,DB01041,Prolymphocytic Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,CLEC4J,CD23,CD23A,FCE2,,,,,,,,,,,,,,,,,,,,,,
33589,MTHFR,C0007273,Vitamin E,DB00163,Carotid Artery Diseases,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31168,MIR126,C0877438,Doxycycline,DB00254,Non-ischemic cardiomyopathy,Terminated,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31545,MPZL2,C3495917,Exemestane,DB00990,Advanced breast cancer,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
8369,Magnesium Sulfate,DB00653,Traumatic Brain Injury,C0876926,Terminated,[O-]S(=O)(=O)[O-].[Mg+2]},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
6215,Trimethoprim,DB00440,Escherichia coli urinary tract infection,C0577708,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,,,,,,,,,,,,,,,,,,,MFSD1,,,,,,,,
13308,ABCD1,C0405580,Triamcinolone,DB00620,Adrenal cortical hypofunction,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13201,CD14,C0149985,Procaine benzylpenicillin,DB09320,"Syphilis, secondary",Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
17619,LGALS3,C0010043,Prednisolone,DB00860,Corneal Ulcer,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,,MAC-2,GALIG,LGALS2,,,,,,,,,,,,,,,,,,,,,,,
20301,ENPP1,C3536984,Ergocalciferol,DB00153,"Vitamin D-Resistant Rickets, X-Linked",Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,PC-1,NPPS,M6S1,PDNP1,,,,,,,,,,,,,,,,,,,,,,
13164,MIR27B,C0027927,Procaine benzylpenicillin,DB09320,Neurosyphilis,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23228,VEGFA,C0476089,Arsenic trioxide,DB01169,Endometrial Carcinoma,Terminated,[O-2].[O-2].[O-2].[As+3].[As+3]},Phase 2,Cancer,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
22904,ATP2A2,C0020676,Liothyronine,DB00279,Hypothyroidism,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Endocrine disease,SERCA2,ATP2B,DAR,,,,,,,,,,,,,,,,,,,,,,,
30426,CD44,C0494165,Oxaliplatin,DB00526,Secondary malignant neoplasm of liver,Withdrawn,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2/Phase 3,Cancer,IN,MC56,Pgp1,CD44R,HCELL,CSPG8,MIC4,MDU2,MDU3,,,,,,,,,,,,,,,,,
34604,LGALS3,C0751965,Dimethyl fumarate,DB08908,"Multiple Sclerosis, Secondary Progressive",Terminated,COC(=O)/C=C/C(=O)OC},Phase 3,Nervous system disease,MAC-2,GALIG,LGALS2,,,,,,,,,,,,,,,,,,,,,,,
9516,PAGR1,C0242429,Pheniramine,DB01620,Sore Throat,Approved,CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3331,Hydrocortisone,DB00741,Cerebral Edema,C0006114,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,Nervous system disease,,,,,,,,,,,,,,,,,,,C9orf92,,,,,,,,
35962,IFNAR2,C0019163,Tenofovir,DB00300,Hepatitis B,Terminated,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},Phase 3,Infectious disease,IFNABR,,,,,,,,,,,,,,,,,,,,,,,,,
7002,THBS1,C0019342,Valaciclovir,DB00577,Genital Herpes,Approved,CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N},,Infectious disease,TSP1,THBS,TSP,THBS-1,TSP-1,,,,,,,,,,,,,CSNK2A2,,,,,,,,
27657,IFNG,C0023493,Thalidomide,DB01041,Adult T-Cell Lymphoma/Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 0,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
20088,IL10,C0041228,Suramin,DB04786,African Trypanosomiasis,Approved,CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C},,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
7875,PML,C0029401,Zoledronic acid,DB00399,Osteitis Deformans,Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,MYL,TRIM19,RNF71,,,,,,,,,,,,,,,,,,,,,,,
24495,TBK1,C0043352,Cisplatin,DB00515,Xerostomia,Terminated,N.N.Cl[Pt]Cl},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
5473,Rosuvastatin,DB01098,Cerebrovascular accident,C0038454,Approved,CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,MGLL,,,,,,,,
36836,SLC22A3,C0038580,Methamphetamine,DB01577,Substance Dependence,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 2,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
29969,GUSBP1,C0043116,Sodium phenylbutyrate,DB06819,HMN (Hereditary Motor Neuropathy) Proximal Type I,Terminated,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},Phase 1/Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28641,HNF1B,C1565489,Simeprevir,DB06290,Renal Insufficiency,Withdrawn,CC1=C(C=CC2=C1N=C(C=C2O[C@@H]3C[C@@H]4[C@@H](C3)C(=O)N(CCCC/C=C\\[C@@H]5C[C@]5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC},Phase 2,Endocrine disease,LFB3,VHNF1,HNF1beta,MODY5,TCF2,,,,,,,,,,,,,,,,,,,,,
30917,BPTF,C0279650,Idarubicin,DB01177,childhood acute megakaryocytic leukemia (M7),Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13095,NLRP1,C0003175,Procaine benzylpenicillin,DB09320,Anthrax disease,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15023,PADI4,C0085159,Bupropion,DB01156,Seasonal Affective Disorder,Approved,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C},,Mental and behavioural disorder,PDI5,PDI4,PADI5,,,,,,,,,,,,,,,,,,,,,,,
20894,AKT2,C0184567,Floctafenine,DB08976,Acute onset pain,Approved,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC=C(C3=NC=C2)C(F)(F)F},,,,,,,,,,,,,,,,,,,,,,,,,,,,
26070,CPOX,C0349506,Trioxsalen,DB04571,Photosensitivity of skin,Approved,CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1672,Ciprofloxacin,DB00537,Typhoid Fever,C0041466,Approved,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,HTR7,,,,,,,,
1656,Ciprofloxacin,DB00537,Lower respiratory tract infection,C0149725,Approved,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},,,,,,,,,,,,,,,,,,,,,TPMT,,,,,,,,
16363,DBP,C0024537,Primaquine,DB01087,"Malaria, Vivax",Approved,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20484,LMNA,C0039240,Propranolol,DB00571,Supraventricular tachycardia,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,LMN1,CMD1A,LGMD1B,,,,,,,,,,,,,,,,,,,,,,,
530,Aztreonam,DB00355,Sepsis due to Gram negative bacteria,C3163829,Approved,C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\\OC(C)(C)C(=O)O)/C2=CSC(=N2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,AGT,,,,,,,,
32886,TTN,C0178782,Pregabalin,DB00230,Orofacial Pain,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,,CMPD4,FLJ32040,TMD,CMH9,LGMD2J,MYLK5,CMD1G,,,,,,,,,,,,,,,,,,,
9558,Alprostadil,DB00770,Pulmonary Hypertension,C0020542,Withdrawn,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},Phase 2,Lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
26145,SOAT1,C0032463,Uracil mustard,DB00791,Polycythemia Vera,Approved,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl},,Cancer,STAT,,,,,,,,,,,,,,,,,,,,,,,,,
7290,ADORA2A-AS1,C0001144,Tretinoin,DB00755,Acne Vulgaris,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Infectious disease,0,,,,,,,,,,,,,,,,,MRTFB,,,,,,,,
1624,Cinnarizine,DB00568,Nausea,C0027497,Approved,C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4},,Digestive system disease,,,,,,,,,,,,,,,,,,,IFNB1,,,,,,,,
18889,IAPP,C0021670,Romidepsin,DB06176,insulinoma,Terminated,C/C=C\\1/C(=O)N[C@H](C(=O)O[C@H]\\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C},Phase 2,Cancer,AMYLIN,,,,,,,,,,,,,,,,,,,,,,,,,
34008,CBLIF,C0267446,Zinc sulfate,DB09322,Acute gastroenteritis,Terminated,[O-]S(=O)(=O)[O-].[Zn+2]},Phase 2/Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8817,Bupropion,DB01156,Tobacco Dependence,C0040332,Terminated,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C},Phase 2/Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,
13036,LOX,C0030848,Benzoic Acid,DB03793,Peyronie Disease,Approved,C1=CC=C(C=C1)C(=O)O},,Reproductive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
21495,VWF,C0032269,Lincomycin,DB01627,Pneumococcal Infections,Approved,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O},,Infectious disease,F8VWF,,,,,,,,,,,,,,,,,,,,,,,,,
3360,Hydrocortisone,DB00741,Laryngeal Edema,C0023052,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,,,,,,,,,,,,,,,,,,,,REV1,,,,,,,,
23617,ATM,C0220756,Miglustat,DB00419,"Niemann-Pick Disease, Type C",Approved,CCCCN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
34261,HP,C0242339,Simvastatin,DB00641,Dyslipidemias,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
12779,VCAM1,C0034065,Edoxaban,DB09075,Pulmonary Embolism,Approved,CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C},,Lung disease,CD106,,,,,,,,,,,,,,,,,,,,,,,,,
16,Acetaminophen,DB00316,Common Cold,C0009443,Approved,CC(=O)NC1=CC=C(C=C1)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Aclidinium,,,,,,,,
21835,RAI1,C0034013,Nafarelin,DB00666,Precocious Puberty,Approved,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CC3=CC=CC=C3C=C2)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
4478,Norfloxacin,DB01059,Bacterial infection due to Klebsiella pneumoniae,C0343402,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,TFCP2L1,,,,,,,,
19269,ADRA2C,C1961112,Dobutamine,DB00841,Heart Decompensation,Approved,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13507,ASL,C0006114,Hydroxocobalamin,DB00200,Cerebral Edema,Terminated,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]\\4([C@H]([C@@H]5[C@]6([C@@]([C@@H](C(=N6)/C(=C\\7/[C@@]([C@@H](C(=N7)/C=C\\8/C([C@@H](C(=N8)/C(=C4\\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2]},Phase 2,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
11773,PLAT,C0019080,Aprotinin,DB06692,Hemorrhage,Approved,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](CSSC[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N4CCC[C@@H]4C(=O)N5CCC[C@@H]5C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N6CCC[C@H]6C(=O)N[C@H](CSSC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CCC(=O)N)[C@@H](C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCNC(=N)N)C)CCCCN)[C@H](C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)[C@@H](C)CC},,,,,,,,,,,,,,,,,,,,,,,,,,,,
4740,Oxytetracycline,DB00595,Trachoma,C0040592,Approved,C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,GABRB2,,,,,,,,
34622,KRT7,C0020450,Thiamine,DB00152,Hyperemesis Gravidarum,Terminated,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},Phase 3,Endocrine and metabolic disease,CK7,K2C7,,,,,,,,,,,,,,,,,,,,,,,,
11823,CHD8,C0004352,Risperidone,DB00734,Autistic Disorder,Approved,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
2825,Fesoterodine,DB06702,Increased frequency of micturition,C0042023,Approved,CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2},,,,,,,,,,,,,,,,,,,,,LOC107987479,,,,,,,,
11539,SLC26A3,C0013369,Ampicillin,DB00415,Dysentery,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C},,Infectious disease,DRA,CLD,,,,,,,,,,,,,,,,,,,,,,,,
19546,CRP,C0242379,Vinorelbine,DB00361,Malignant neoplasm of lung,Withdrawn,CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
2267,Dextroamphetamine,DB01576,Narcolepsy,C0027404,Approved,C[C@@H](CC1=CC=CC=C1)N},,Nervous system disease,,,,,,,,,,,,,,,,,,,CARD11,,,,,,,,
15970,GALNS,C0040425,Dirithromycin,DB00954,Tonsillitis,Approved,CC[C@@H]1[C@@]([C@H]2[C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)N(C)C)O)(C)O)C)N[C@H](O2)COCCOC)C)(C)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
24045,GRN,C0024586,Somatostatin,DB09099,Malignant Carcinoid Syndrome,Terminated,C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)[C@H](C)N)C(=O)O)CO)[C@@H](C)O)CC6=CC=CC=C6)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26197,AGXT,C0600518,Imatinib,DB00619,Choroidal Neovascularization,Withdrawn,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 1,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
19395,SMAD4,C0008325,Doripenem,DB06211,Cholecystitis,Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O},,Digestive system disease,DPC4,MADH4,,,,,,,,,,,,,,,,,,,,,,,,
8222,XDH,C0018099,Naproxen,DB00788,Gout,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,Musculoskeletal disease,XOR,XO,,,,,,,,,,,,,,,,,,,,,,,,
3983,Meropenem,DB00760,Peritonitis,C0031154,Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,BIRC3,,,,,,,,
32657,EPHB1,C0206695,Octreotide,DB00104,"Carcinoma, Neuroendocrine",Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 2,Cancer,Hek6,EPHT2,,,,,,,,,,,,,,,,,,,,,,,,
6646,Mycophenolate mofetil,DB00688,Post-transplant lymphoproliferative disorder,C0432487,Suspended,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)OCCN3CCOCC3)O},Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,ACACB,,,,,,,,
20020,CNGB3,C0271093,Echothiophate,DB01057,Stargardt's disease,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18353,FA2H,C0042023,Trospium,DB00209,Increased frequency of micturition,Approved,C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O},,,FAAH,FLJ25287,FAXDC1,SPG35,,,,,,,,,,,,,,,,,,,,,,
17233,TNNT2,C0948089,Citalopram,DB00215,Acute Coronary Syndrome,Withdrawn,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 1/Phase 2,Cardiovascular disease,CMH2,CMD1D,,,,,,,,,,,,,,,,,,,,,,,,
16522,SMS,C0221468,Ergocalciferol,DB00153,Vitamin D-dependent rickets,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33065,TUBGCP2,C2076600,Rosuvastatin,DB01098,Influenza due to Influenza A virus subtype H1N1,Terminated,CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30732,CDK4,C0206663,Vincristine,DB00541,"Neuroectodermal Tumor, Primitive",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
7511,LOC102723971,C0009766,Triprolidine,DB00427,Allergic Conjunctivitis,Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Immune system disease,0,,,,,,,,,,,,,,,,,PLS3,,,,,,,,
25085,ALB,C2363973,Riociguat,DB08931,Chronic thromboembolic pulmonary hypertension,Approved,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
10669,PCSK9,C0149725,Piperacillin,DB00319,Lower respiratory tract infection,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,,NARC-1,FH3,HCHOLA3,,,,,,,,,,,,,,,,,,,,,,,
5587,Sodium Citrate,DB09154,Common Cold,C0009443,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Infectious disease,,,,,,,,,,,,,,,,,,,MTF2,,,,,,,,
30759,PARP2,C1514428,Paclitaxel,DB01229,Primary peritoneal carcinoma,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17750,HLA-DMA,C0035854,Tobramycin,DB00684,Rosacea,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Skin disease,D6S222E,RING6,,,,,,,,,,,,,,,,,,,,,,,,
26837,MYD88,C0349644,Vincristine,DB00541,Malignant lymphoma of testis,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
3957,Mepenzolate,DB04843,Peptic Ulcer,C0030920,Approved,C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C},,Digestive system disease,,,,,,,,,,,,,,,,,,,F8,,,,,,,,
32362,EYA1,C0018798,Milrinone,DB00235,Congenital Heart Defects,Terminated,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2},Phase 2,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
33782,FOXP3,C0018133,Tacrolimus,DB00864,Graft-vs-Host Disease,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Immune system disease,JM2,XPID,AIID,PIDX,DIETER,SCURFIN,IPEX,,,,,,,,,,,,,,,,,,,
13241,HLA-C,C0025281,Penciclovir,DB00299,Meniere Disease,Terminated,C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N},Phase 3,Nervous system disease,HLA-JY3,D6S204,PSORS1,,,,,,,,,,,,,,,,,,,,,,,
26020,ABCB6,C0023646,Triamcinolone,DB00620,Lichen Planus,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33059,ESR1,C0278689,Paclitaxel,DB01229,Ovarian epithelial cancer recurrent,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,NR3A1,Era,ER-alpha,ESR,,,,,,,,,,,,,,,,,,,,,,
36093,HPSE,C0004779,Verteporfin,DB00460,Basal Cell Nevus Syndrome,Terminated,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C.CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)O)C(=C3C)CCC(=O)OC)C=C},Phase 3,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1570,Cholecalciferol,DB00169,Vitamin Deficiency,C1510471,Approved,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,,,,,,,,,,,,,,,,,,,Tripelennamine,,,,,,,,
28464,FDFT1,C0236736,Dextroamphetamine,DB01576,Cocaine-Related Disorders,Terminated,C[C@@H](CC1=CC=CC=C1)N},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
16548,OCLN,C0238052,Cholic Acid,DB02659,"Xanthomatosis, Cerebrotendinous",Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C},,Congenital disorder of metabolism,PPP1R115,,,,,,,,,,,,,,,,,,,,,,,,,
12982,LMNA,C1527383,Imiquimod,DB00724,Morphea,Withdrawn,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N},Phase 3,Skin disease,LMN1,CMD1A,LGMD1B,,,,,,,,,,,,,,,,,,,,,,,
14913,USH2A,C0150055,Pregabalin,DB00230,Chronic pain,Withdrawn,CC(C)C[C@@H](CC(=O)O)CN},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
7438,CAT,C1269683,Quetiapine,DB01224,Major Depressive Disorder,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,BRD1,,,,,,,,
14027,ELF3,C2894027,Triamcinolone,DB00620,Post traumatic osteoarthritis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,ESE-1,ERT,ESX,,,,,,,,,,,,,,,,,,,,,,,
21371,EPO,C0524702,Fondaparinux sodium,DB00569,Pulmonary Thromboembolisms,Approved,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},,Hematologic disease,EP,,,,,,,,,,,,,,,,,,,,,,,,,
26475,SEC61A1,C1561643,Sevelamer,DB00658,Chronic Kidney Diseases,Terminated,C=CCN.C1C(O1)CCl},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
15454,ALB,C0264716,Amlodipine,DB00381,Chronic heart failure,Suspended,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN},Phase 2,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
15001,ARNTL,C0085159,Bupropion,DB01156,Seasonal Affective Disorder,Approved,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
23258,FGF4,C0153685,Progesterone,DB00396,Secondary malignant neoplasm of kidney,Approved,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Cancer,K-FGF,HBGF-4,HST,HST-1,KFGF,,,,,,,,,,,,,,,,,,,,,
6883,POSTN,C0006277,Theophylline,DB00277,Bronchitis,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Lung disease,OSF-2,PN,periostin,,,,,,,,,,,,,,,IGKV3D-15,,,,,,,,
30279,KRAS,C0007120,Bortezomib,DB00188,Bronchioloalveolar Adenocarcinoma,Terminated,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34691,EML4,C0220650,Temozolomide,DB00853,Metastatic malignant neoplasm to brain,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4517,Norfloxacin,DB01059,Otitis Externa,C0029878,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,YY1,,,,,,,,
20317,FRZB,C3536984,Ergocalciferol,DB00153,"Vitamin D-Resistant Rickets, X-Linked",Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,FRZB-PEN,FRZB1,SRFP3,FRP-3,SFRP3,FRE,FRITZ,FRZB-1,FZRB,hFIZ,,,,,,,,,,,,,,,,
14578,MMP9,C0007137,Cisplatin,DB00515,Squamous cell carcinoma,Terminated,N.N.Cl[Pt]Cl},Phase 3,Cancer,CLG4B,,,,,,,,,,,,,,,,,,,,,,,,,
10970,FXYD4,C0877445,Voriconazole,DB00582,Candidemia,Approved,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},,Infectious disease,CHIF,,,,,,,,,,,,,,,,,,,,,,,,,
26349,SHANK2,C0423673,Ziconotide,DB06283,Pain in spine,Approved,C[C@H]1C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N3)CO)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCN},,,CTTNBP1,ProSAP1,SHANK,SPANK-3,CORTBP1,,,,,,,,,,,,,,,,,,,,,
20856,FMR1,C0042024,Tolterodine,DB01036,Urinary Incontinence,Terminated,CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
32677,ERCC1,C2931822,Oxaliplatin,DB00526,Nasopharyngeal carcinoma,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,RAD10,,,,,,,,,,,,,,,,,,,,,,,,,
9027,SEC63,C0017168,Sodium Citrate,DB09154,Gastroesophageal reflux disease,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21377,XDH,C0524702,Fondaparinux sodium,DB00569,Pulmonary Thromboembolisms,Approved,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},,Hematologic disease,XOR,XO,,,,,,,,,,,,,,,,,,,,,,,,
6875,MUC5B,C0006267,Pirbuterol,DB01291,Bronchiectasis,Approved,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O},,Respiratory disease,MG1,,,,,,,,,,,,,,,,,FDFT1,,,,,,,,
9839,Vitamin C,DB00126,Growth Hormone Secretion Abnormality,C3536718,Withdrawn,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O},Phase 2,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
15931,PPM1D,C0555198,Ondansetron,DB00904,Malignant Glioma,Withdrawn,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
24308,RB1,C1261473,Pazopanib,DB06589,Sarcoma,Approved,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25587,IL6,C0008513,Sulfadiazine,DB00359,Chorioretinitis,Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
3927,Medrysone,DB00253,Corneal abrasion,C0010032,Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@H]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)CC4)C)O)C)C(=O)C},,,,,,,,,,,,,,,,,,,,,SULT1A1,,,,,,,,
9342,Voriconazole,DB00582,Candidiasis,C0006840,Terminated,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
11764,F7,C0019080,Aprotinin,DB06692,Hemorrhage,Approved,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](CSSC[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N4CCC[C@@H]4C(=O)N5CCC[C@@H]5C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N6CCC[C@H]6C(=O)N[C@H](CSSC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CCC(=O)N)[C@@H](C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCNC(=N)N)C)CCCCN)[C@H](C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)[C@@H](C)CC},,,,,,,,,,,,,,,,,,,,,,,,,,,,
3540,LIMK1,C0917801,Citalopram,DB00215,Sleeplessness,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,,0,,,,,,,,,,,,,,,,,FBXW7,,,,,,,,
13990,NAV3,C0026948,Isotretinoin,DB00982,Mycosis Fungoides,Terminated,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\\C(=O)O)/C)/C},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3451,Ibuprofen,DB01050,Rheumatoid Arthritis,C0003873,Approved,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,HCL2,,,,,,,,
21001,BCL2,C0007102,Oxaliplatin,DB00526,Malignant tumor of colon,Withdrawn,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,Bcl-2,PPP1R50,,,,,,,,,,,,,,,,,,,,,,,,
30972,SFTPB,C0206704,Temozolomide,DB00853,"Carcinoma, Large Cell",Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,SP-B,SFTP3,,,,,,,,,,,,,,,,,,,,,,,,
3702,Levofloxacin,DB01137,Staphylococcal Pneumonia,C0032308,Approved,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,PCBP4,,,,,,,,
28719,CAV2,C0339573,Latanoprost,DB00654,"Glaucoma, Primary Open Angle",Terminated,CC(C)OC(=O)CCC/C=C\\C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O},Phase 1,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36246,ACE,C0022658,Valsartan,DB00177,Kidney Diseases,Withdrawn,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Urinary system disease,ACE1,CD143,DCP1,,,,,,,,,,,,,,,,,,,,,,,
26520,AKT1,C0235782,Oxaliplatin,DB00526,Gallbladder Carcinoma,Suspended,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 1,Cancer,RAC,PKB,PRKBA,AKT,,,,,,,,,,,,,,,,,,,,,,
7721,Bortezomib,DB00188,Lymphoproliferative Disorders,C0024314,Terminated,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O},Phase 2,Primary immunodeficiency,,,,,,,,,,,,,,,,,,,MIR192,,,,,,,,
16988,STAT3,C3875321,Pramocaine,DB09345,Inflammatory dermatosis,Approved,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2},,Skin and connective tissue disease,APRF,,,,,,,,,,,,,,,,,,,,,,,,,
21199,MAP2K2,C0028326,Fluoxymesterone,DB01185,Noonan Syndrome,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
27635,HMGA1,C0524620,Topiramate,DB00273,Metabolic Syndrome X,Suspended,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Endocrine and metabolic disease,HMGIY,,,,,,,,,,,,,,,,,,,,,,,,,
9828,ATP12A,C0949083,Vitamin E,DB00163,Nosocomial pneumonia,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17568,CRH,C0037769,Vigabatrin,DB01080,West Syndrome,Approved,C=CC(CCC(=O)O)N},,Nervous system disease,CRH1,,,,,,,,,,,,,,,,,,,,,,,,,
33190,SLC9A6,C0948780,Simvastatin,DB00641,Rhinosinusitis,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31464,PLA2G6,C0023529,Erythropoietin,DB00016,"Leukomalacia, Periventricular",Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
8980,Ethanol,DB00898,AOD misuse,C0678254,Terminated,CCO},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,
16346,CYP2D6,C0024537,Primaquine,DB01087,"Malaria, Vivax",Approved,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2},,Infectious disease,CPD6,P450-DB1,P450C2D,CYP2DL1,CYP2D7P2,CYP2D7BP,CYP2D8P2,CYP2D7AP,,,,,,,,,,,,,,,,,,
16791,ADCYAP1R1,C0010692,Ofloxacin,DB01165,Cystitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7761,C1R,C0024138,Ulobetasol,DB00596,"Lupus Erythematosus, Discoid",Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Immune system disease,0,,,,,,,,,,,,,,,,,CASP14,,,,,,,,
5055,Potassium Chloride,DB00761,Hypokalemia,C0020621,Approved,[Cl-].[K+]},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,CARMIL1,,,,,,,,
27096,GH1,C2921627,Prednisolone,DB00860,Clinically isolated syndrome,Suspended,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Congenital malformation,GH-N,GHN,GH,hGH-N,,,,,,,,,,,,,,,,,,,,,,
1280,Cefradine,DB01333,Urinary tract infection,C0042029,Approved,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CCC=CC3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Probucol,,,,,,,,
6063,Topiramate,DB00273,Epilepsy characterized by intractable complex partial seizures,C2711653,Approved,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},,Nervous system disease,,,,,,,,,,,,,,,,,,,NCOA4,,,,,,,,
21182,AZF1,C0022735,Testosterone Propionate,DB01420,Klinefelter Syndrome,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
9901,NTRK1,C0029443,Amikacin,DB00479,Osteomyelitis,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},,Immune system disease,TRKA,MTC,,,,,,,,,,,,,,,,,,,,,,,,
14914,TRPV1,C0150055,Pregabalin,DB00230,Chronic pain,Withdrawn,CC(C)C[C@@H](CC(=O)O)CN},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,
36396,PRPF8,C0751956,Nimodipine,DB00393,Acute Cerebrovascular Accidents,Withdrawn,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5738,Sulfisoxazole,DB00263,Nocardia Infections,C0028242,Approved,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,CACNG4,,,,,,,,
16495,TNFRSF11B,C0029456,Calcium carbonate,DB06724,Osteoporosis,Withdrawn,C(=O)([O-])[O-].[Ca+2]},Phase 3,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,,,,,,,,
267,Amphotericin B,DB00681,Aspergillosis,C0004030,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Cefprozil,,,,,,,,
23476,HSPA4,C0023886,Tinidazole,DB00911,"Liver Abscess, Amebic",Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33338,STAT3,C0038362,Thalidomide,DB01041,Stomatitis,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Infectious disease,APRF,,,,,,,,,,,,,,,,,,,,,,,,,
34045,BTN2A2,C0018681,Naratriptan,DB00952,Headache,Withdrawn,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C},Phase 3,,BT2.2,BTN2.2,,,,,,,,,,,,,,,,,,,,,,,,
9832,PON1,C0949083,Vitamin E,DB00163,Nosocomial pneumonia,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11423,COL17A1,C0039128,Tetracycline,DB00759,Syphilis,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19590,CXCL8,C0007115,Liothyronine,DB00279,Malignant neoplasm of thyroid,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Cancer,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
20680,CNBP,C0342907,Ezetimibe,DB00973,Sitosterolemia,Approved,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
21853,CSF3R,C0023473,Vindesine,DB00309,"Myeloid Leukemia, Chronic",Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O},,Cancer,GCSFR,CD114,,,,,,,,,,,,,,,,,,,,,,,,
30496,NMNAT2,C0152025,Capsaicin,DB06774,Polyneuropathy,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22673,EPOR,C0019151,Phenylacetic acid,DB09269,Hepatic Encephalopathy,Terminated,C1=CC=C(C=C1)CC(=O)O},Phase 2,Liver disease,,,,,,,,,,,,,,,,,,,,,,,,,,
16397,IFNA13,C0162565,Promazine,DB00420,Acute intermittent porphyria,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
20156,TNF,C0018802,Levosimendan,DB00922,Congestive heart failure,Approved,C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N},,Congenital malformation,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
13243,AQP1,C0025281,Penciclovir,DB00299,Meniere Disease,Terminated,C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N},Phase 3,Nervous system disease,CHIP28,CO,,,,,,,,,,,,,,,,,,,,,,,,
12297,RPS12,C0020557,Topiramate,DB00273,Hypertriglyceridemia,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32626,FOXC2,C0042344,Nitric Oxide,DB00435,Varicose Ulcer,Terminated,[N]=O},Phase 2,Reproductive system disease,MFH-1,FKHL14,,,,,,,,,,,,,,,,,,,,,,,,
11666,IFNA13,C0040028,Anagrelide,DB00261,"Thrombocythemia, Essential",Approved,C1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27741,FANCA,C0023418,Vincristine,DB00541,leukemia,Withdrawn,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29736,PARN,C0265965,Danazol,DB01406,Dyskeratosis Congenita,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5},Phase 1/Phase 2,Ribosomopathy,,,,,,,,,,,,,,,,,,,,,,,,,,
10086,IL13,C0004096,Zafirlukast,DB00549,Asthma,Approved,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC},,Immune system disease,P600,IL-13,ALRH,BHR1,MGC116786,MGC116788,MGC116789,,,,,,,,,,,,,,,,,,,
14895,EPOR,C0017601,Echothiophate,DB01057,Glaucoma,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
13899,SPEN,C0024305,Vidarabine,DB00194,"Lymphoma, Non-Hodgkin",Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30221,CENPE,C1292778,Prednisolone,DB00860,Chronic myeloproliferative disorder,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1677,CTBP2,C0376358,Sirolimus,DB00877,Malignant neoplasm of prostate,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,OPA1,,,,,,,,
35599,AKT1,C0024121,Pemetrexed,DB00642,Lung Neoplasms,Terminated,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 3,Cancer,RAC,PKB,PRKBA,AKT,,,,,,,,,,,,,,,,,,,,,,
13047,DCN,C0030848,Benzoic Acid,DB03793,Peyronie Disease,Approved,C1=CC=C(C=C1)C(=O)O},,Reproductive system disease,DSPG2,SLRR1B,,,,,,,,,,,,,,,,,,,,,,,,
35437,CS,C0003129,Nitric Oxide,DB00435,Anoxemia,Terminated,[N]=O},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
15568,CYP2D6,C0032768,Pregabalin,DB00230,Postherpetic neuralgia,Approved,CC(C)C[C@@H](CC(=O)O)CN},,Infectious disease,CPD6,P450-DB1,P450C2D,CYP2DL1,CYP2D7P2,CYP2D7BP,CYP2D8P2,CYP2D7AP,,,,,,,,,,,,,,,,,,
25183,PDGFRB,C0027022,Vidarabine,DB00194,Myeloproliferative disease,Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 2,Cancer,JTK12,CD140b,PDGFR1,PDGFR,,,,,,,,,,,,,,,,,,,,,,
31668,AZIN2,C0149978,Oxaliplatin,DB00526,Adenocarcinoma of rectum,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16471,LRP2,C0029442,Ergocalciferol,DB00153,Osteomalacia,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Urinary system disease,gp330,,,,,,,,,,,,,,,,,,,,,,,,,
20533,PTGS2,C0014869,Omeprazole,DB00338,Peptic Esophagitis,Approved,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
21797,TFPI,C0012739,Heparin,DB01109,Disseminated Intravascular Coagulation,Approved,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28854,CD44,C0278827,Metronidazole,DB00916,Bladder cancer recurrent,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,IN,MC56,Pgp1,CD44R,HCELL,CSPG8,MIC4,MDU2,MDU3,,,,,,,,,,,,,,,,,
17346,ABCB1,C0860594,Trametinib,DB08911,"Malignant melanoma, metastatic",Approved,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},,Cancer,P-gp,CD243,GP170,ABC20,PGY1,CLCS,,,,,,,,,,,,,,,,,,,,
28510,MLH3,C0042076,Mitomycin,DB00305,Urologic Neoplasms,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
6649,SLC9A2,C0013604,Triamterene,DB00384,Edema,Approved,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N},,,0,,,,,,,,,,,,,,,,,SYDE1,,,,,,,,
26874,CDKN2A,C0242647,Vincristine,DB00541,Mucosa-Associated Lymphoid Tissue Lymphoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
36557,HMOX1,C0012715,Deferasirox,DB01609,Iron Metabolism Disorders,Withdrawn,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O},Phase 2,Hematologic disease,bK286B10,HO-1,,,,,,,,,,,,,,,,,,,,,,,,
25189,FGFR3,C0027022,Vidarabine,DB00194,Myeloproliferative disease,Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 2,Cancer,CEK2,JTK4,CD333,ACH,,,,,,,,,,,,,,,,,,,,,,
24664,MARCHF8,C0002390,Prednisolone,DB00860,Extrinsic allergic alveolitis,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5133,Prednisolone,DB00860,Autoimmune hemolytic anemia,C0002880,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Hematologic disease,,,,,,,,,,,,,,,,,,,DUSP6,,,,,,,,
12588,CYP17A1,C0600142,Testosterone,DB00624,Hot flushes,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,,P450C17,CPT7,S17AH,CYP17,,,,,,,,,,,,,,,,,,,,,,
21448,ISG20,C0016867,Gentamicin,DB00798,Furunculosis,Approved,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC},,Infectious disease,HEM45,,,,,,,,,,,,,,,,,,,,,,,,,
36169,VEGFA,C0751711,Timolol,DB00373,Anterior Ischemic Optic Neuropathy,Withdrawn,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O},Phase 1,Nervous system disease,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
19133,REG1A,C0002438,Sulfacetamide,DB00634,Amebiasis,Approved,CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N},,Infectious disease,PSPS,PSPS1,REG,,,,,,,,,,,,,,,,,,,,,,,
16655,FCER2,C0221013,Rabeprazole,DB01129,"Mastocytosis, Systemic",Approved,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC},,Cancer,CLEC4J,CD23,CD23A,FCE2,,,,,,,,,,,,,,,,,,,,,,
19397,PKLR,C0008325,Doripenem,DB06211,Cholecystitis,Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O},,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
19558,VEGFA,C0278498,Panobinostat,DB06603,Malignant neoplasm of stomach stage IV,Terminated,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)/C=C/C(=O)NO},Phase 2,Cancer,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
18430,HBG1,C0023440,Daunorubicin,DB00694,Acute Erythroblastic Leukemia,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O},,Cancer,HBG-T2,,,,,,,,,,,,,,,,,,,,,,,,,
6683,ASB10,C0017612,Unoprostone,DB06826,"Glaucoma, Open-Angle",Approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,PIM2,,,,,,,,
21735,GMPPB,C0022972,Guanidine,DB00536,Lambert-Eaton Myasthenic Syndrome,Approved,C(=N)(N)N},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16201,LILRB4,C0036117,Chloramphenicol,DB00446,Salmonella infections,Approved,C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]},,Infectious disease,LIR-5,ILT3,HM18,LIR5,CD85k,,,,,,,,,,,,,,,,,,,,,
33796,PMM2,C0022680,Sirolimus,DB00877,Polycystic Kidney Diseases,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2/Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
29816,GNAS,C0700292,Nitric Oxide,DB00435,Hypoxemia,Terminated,[N]=O},Phase 1/Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26294,CD36,C0042875,Vitamin E,DB00163,Vitamin E Deficiency,Approved,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},,Metabolic disease,SCARB3,GPIV,GP4,GP3B,,,,,,,,,,,,,,,,,,,,,,
8959,Diphenhydramine,DB01075,Hyperemesis Gravidarum,C0020450,Terminated,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2},Phase 3,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
2143,SLC2A4,C0011860,Atorvastatin,DB01076,"Diabetes Mellitus, Non-Insulin-Dependent",Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Endocrine disease,GLUT4,,,,,,,,,,,,,,,,,CLPX,,,,,,,,
5636,Sparfloxacin,DB01208,Pneumonia,C0032285,Approved,C[C@@H]1CN(C[C@@H](N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F},,Infectious disease,,,,,,,,,,,,,,,,,,,APOL1,,,,,,,,
1076,Cefditoren,DB01066,Haemophilus parainfluenzae pneumonia,C0877633,Approved,CC1=C(SC=N1)/C=C\\C2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Nedocromil,,,,,,,,
36733,CTNNB1,C0278802,Norgestrel,DB09389,Recurrent Endometrial Cancer,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Cancer,beta-catenin,armadillo,CTNNB,,,,,,,,,,,,,,,,,,,,,,,
4470,Norfloxacin,DB01059,Acute gonococcal endometritis,C0153196,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,RFWD3,,,,,,,,
14309,F7,C0020473,Cholecalciferol,DB00169,Hyperlipidemia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 1,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
23949,STN1,C0085786,Warfarin,DB00682,Hamman-Rich syndrome,Terminated,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},Phase 3,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26951,CCR7,C0280745,Decitabine,DB01262,secondary myelodysplastic syndromes,Terminated,C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O},Phase 1,Cancer,BLR2,CDw197,CD197,CMKBR7,EBI1,,,,,,,,,,,,,,,,,,,,,
9252,Salicylic acid,DB00936,Adenomatous polyp of colon,C0850572,Terminated,C1=CC=C(C(=C1)C(=O)O)O},Phase 3,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
18054,HLA-DRB1,C0022575,Cyclosporine,DB00091,Keratoconjunctivitis Sicca,Approved,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},,Infectious disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
5218,Prednisone,DB00635,"Anemia, Diamond-Blackfan",C1260899,Approved,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},,Hematologic disease,,,,,,,,,,,,,,,,,,,KCTD10,,,,,,,,
22307,VIP,C0035435,Indomethacin,DB00328,Rheumatism,Approved,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
3685,Levofloxacin,DB01137,Anthrax disease,C0003175,Approved,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,ZDHHC8,,,,,,,,
34280,JAK2,C0032962,Betamethasone,DB00443,Pregnancy Complications,Terminated,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,,JTK10,,,,,,,,,,,,,,,,,,,,,,,,,
968,Carvedilol,DB01136,Chronic heart failure,C0264716,Approved,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,RTF1,,,,,,,,
18176,KHDC3L,C1135868,Vinblastine,DB00570,Gestational Trophoblastic Neoplasms,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,ECAT1,C6orf221,,,,,,,,,,,,,,,,,,,,,,,,
3672,Levobetaxolol,DB09351,Ocular Hypertension,C0028840,Approved,CC(C)NC[C@@H](COC1=CC=C(C=C1)CCOCC2CC2)O},,Nervous system disease,,,,,,,,,,,,,,,,,,,IL1RAPL1,,,,,,,,
12475,TNF,C0032290,Ticarcillin,DB01607,Aspiration Pneumonia,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
18259,ESR1,C0016034,Danazol,DB01406,Breast Fibrocystic Disease,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5},,Other disease,NR3A1,Era,ER-alpha,ESR,,,,,,,,,,,,,,,,,,,,,,
21120,SNORD116-1,C0034012,Testosterone Propionate,DB01420,Delayed Puberty,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4667,Oxacillin,DB00713,Infection of bone,C2242472,Approved,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,BAAT,,,,,,,,
4001,Methamphetamine,DB01577,Obesity,C0028754,Approved,C[C@@H](CC1=CC=CC=C1)NC},,Metabolic disease,,,,,,,,,,,,,,,,,,,CCBE1,,,,,,,,
11329,MMP1,C0034362,Tetracycline,DB00759,Q Fever,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,,,,,,,,,,,,,,,,,,,,,,,,,,,
35474,CYBB,C0035126,Nitric Oxide,DB00435,Reperfusion Injury,Terminated,[N]=O},Phase 3,,GP91-PHOX,NOX2,CGD,,,,,,,,,,,,,,,,,,,,,,,
31856,BBC3,C3495949,Valproic Acid,DB00313,Locally advanced breast cancer,Terminated,CCCC(CCC)C(=O)O},Phase 2,Cancer,JFY1,PUMA,,,,,,,,,,,,,,,,,,,,,,,,
22467,APOB,C0007820,Tolazoline,DB00797,Cerebrovascular Disorders,Approved,C1CN=C(N1)CC2=CC=CC=C2},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
31731,PWAR1,C0021359,Ganirelix,DB06785,Infertility,Withdrawn,CCNC(=NCCCC[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C)NCC},Phase 3,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3061,Fusidic Acid,DB02703,Infective blepharitis,C0729587,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,PDE4D,,,,,,,,
36111,PIK3CD,C0279663,Paclitaxel,DB01229,Serous cystadenocarcinoma ovary,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33559,NOS3,C0004153,Simvastatin,DB00641,Atherosclerosis,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Cardiovascular disease,ECNOS,eNOS,,,,,,,,,,,,,,,,,,,,,,,,
36193,GSTM3,C0220603,Valproic Acid,DB00313,childhood brain tumor,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,GST5,,,,,,,,,,,,,,,,,,,,,,,,,
4481,Norfloxacin,DB01059,Chancroids,C0007947,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,TFDP2,,,,,,,,
16245,GRM7,C0001957,Oxazepam,DB00842,Alcohol Withdrawal Delirium,Approved,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
20337,CDKN2A,C0023827,Trabectedin,DB05109,liposarcoma,Approved,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O},,Cancer,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
21296,IL3,C0155880,Zileuton,DB00744,Intrinsic asthma,Approved,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24591,CLCNKB,C0001126,Potassium Citrate,DB09125,Renal tubular acidosis,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]},,Urinary system disease,hClC-Kb,,,,,,,,,,,,,,,,,,,,,,,,,
34318,CFH,C0004610,Vancomycin,DB00512,Bacteremia,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34625,SCLY,C0020450,Thiamine,DB00152,Hyperemesis Gravidarum,Terminated,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},Phase 3,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36446,TP53,C0278577,Cisplatin,DB00515,Cervix carcinoma stage III,Withdrawn,N.N.Cl[Pt]Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
28887,ADAM11,C0278493,Tamoxifen,DB00675,Breast cancer recurrent,Withdrawn,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4130,Methylscopolamine bromide,DB00462,Rhinorrhea,C1260880,Approved,C[N+]1([C@H]2CC(C[C@H]1C3C2O3)OC(=O)[C@H](CO)C4=CC=CC=C4)C.[Br-]},,Nervous system disease,,,,,,,,,,,,,,,,,,,MCM4,,,,,,,,
11712,CYP21A2,C0003872,Triamcinolone,DB00620,"Arthritis, Psoriatic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14438,PIK3CD,C0079744,Vincristine,DB00541,Diffuse Large B-Cell Lymphoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3799,Loratadine,DB00455,"Rhinitis, Vasomotor",C0035460,Approved,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1},,Immune system disease,,,,,,,,,,,,,,,,,,,ADH1A,,,,,,,,
25196,FIP1L1,C0027022,Vidarabine,DB00194,Myeloproliferative disease,Terminated,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25338,SERPINA1,C0751753,Sodium phenylbutyrate,DB06819,Carbamoyl-Phosphate Synthase I Deficiency Disease,Approved,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]},,Endocrine and metabolic disease,AAT,A1A,PI1,alpha-1-antitrypsin,A1AT,alpha1AT,PI,,,,,,,,,,,,,,,,,,,
5944,Ticarcillin,DB01607,Aspiration Pneumonia,C0032290,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,SELL,,,,,,,,
370,Ampicillin,DB00415,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Cyclobenzaprine,,,,,,,,
7598,GSTP1,C0011616,Urea,DB03904,Contact Dermatitis,Approved,C(=O)(N)N},,Immune system disease,0,,,,,,,,,,,,,,,,,KMT5B,,,,,,,,
30287,ERBB2,C0007120,Bortezomib,DB00188,Bronchioloalveolar Adenocarcinoma,Terminated,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O},Phase 2,Cancer,HER-2,CD340,HER2,NGL,,,,,,,,,,,,,,,,,,,,,,
12504,CASP9,C0014179,Ertapenem,DB00303,Endometritis,Terminated,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)[C@@H](C)O},Phase 1,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5200,Prednisolone,DB00860,Simple Pulmonary Eosinophilia,C0242459,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Immune system disease,,,,,,,,,,,,,,,,,,,MT3,,,,,,,,
22909,DCX,C0020676,Liothyronine,DB00279,Hypothyroidism,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Endocrine disease,SCLH,DC,LISX,DBCN,XLIS,,,,,,,,,,,,,,,,,,,,,
21063,ADIPOQ,C2267227,Acetylcysteine,DB06151,Bulimia Nervosa,Terminated,CC(=O)N[C@@H](CS)C(=O)O},Phase 3,Mental and behavioural disorder,ACRP30,AdipoQ,apM1,GBP28,adiponectin,ACDC,,,,,,,,,,,,,,,,,,,,
7013,IFNB1,C0019342,Valaciclovir,DB00577,Genital Herpes,Approved,CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,ROR1,,,,,,,,
6352,Vigabatrin,DB01080,Epilepsy characterized by intractable complex partial seizures,C2711653,Approved,C=CC(CCC(=O)O)N},,Nervous system disease,,,,,,,,,,,,,,,,,,,ANKS1B,,,,,,,,
11876,SYNGAP1,C0036341,Glycine,DB00145,Schizophrenia,Withdrawn,C(C(=O)O)N},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
5653,Streptomycin,DB01082,Acute tuberculosis,C0275959,Approved,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,HEXA,,,,,,,,
23971,CNE7,C0010418,Nitazoxanide,DB00507,Cryptosporidiosis,Approved,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18538,CD34,C0005283,Deferiprone,DB08826,beta Thalassemia,Approved,CC1=C(C(=O)C=CN1C)O},,Hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
26591,LMNA,C0278838,Ketoconazole,DB01026,Prostate cancer recurrent,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,LMN1,CMD1A,LGMD1B,,,,,,,,,,,,,,,,,,,,,,,
1549,Chlorpromazine,DB00477,Acute intermittent porphyria,C0162565,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,ASPG,,,,,,,,
7723,C1QA,C0024138,Ulobetasol,DB00596,"Lupus Erythematosus, Discoid",Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Immune system disease,,,,,,,,,,,,,,,,,,MIR365B,,,,,,,,
25988,PTCSC2,C0002171,Triamcinolone,DB00620,Alopecia Areata,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10241,VEGFA,C0034067,Vilanterol,DB09082,Pulmonary Emphysema,Approved,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl},,Lung disease,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
9997,NLRP3,C0004626,Tobramycin,DB00684,"Pneumonia, Bacterial",Terminated,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},Phase 2,Infectious disease,AGTAVPRL,AII,AVP,FCAS,FCU,NALP3,PYPAF1,MWS,CLR1.1,C1orf7,CIAS1,,,,,,,,,,,,,,,
36226,CHRNA5,C1510472,Varenicline,DB01273,Drug Dependence,Withdrawn,C1C2CNCC1C3=CC4=NC=CN=C4C=C23},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
30926,IL1A,C0279650,Idarubicin,DB01177,childhood acute megakaryocytic leukemia (M7),Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O},Phase 2,Cancer,IL1F1,IL-1A,IL1-ALPHA,IL1,,,,,,,,,,,,,,,,,,,,,,
16526,PARK7,C1510471,Vitamin C,DB00126,Vitamin Deficiency,Approved,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2243,Dexbrompheniramine,DB00405,Symptomatic dermographism,C0343065,Approved,CN(C)CC[C@@H](C1=CC=C(C=C1)Br)C2=CC=CC=N2},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,SLBP,,,,,,,,
32790,HBG1,C0039730,Pegfilgrastim,DB00019,Thalassemia,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Hematologic disease,HBG-T2,,,,,,,,,,,,,,,,,,,,,,,,,
25899,USP18,C0023269,Gemcitabine,DB00441,leiomyosarcoma,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1/Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
24696,IL17A,C0039483,Triamcinolone,DB00620,Giant Cell Arteritis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Cardiovascular disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
35317,IFNG,C1262313,Micafungin,DB01141,Invasive Fungal Infections,Terminated,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)[C@@H](CC(=O)N)O)C)O)O)O},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
20665,IL1B,C0041341,Everolimus,DB01590,Tuberous Sclerosis,Approved,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC},,Nervous system disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
2581,Edoxaban,DB09075,Embolism,C0013922,Approved,CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,GOT2,,,,,,,,
16293,PDIA3,C0022104,Milnacipran,DB04896,Irritable Bowel Syndrome,Terminated,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2},Phase 2,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26150,IL6,C0032463,Uracil mustard,DB00791,Polycythemia Vera,Approved,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl},,Cancer,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
24851,PRKAG2,C0007194,Propranolol,DB00571,Hypertrophic Cardiomyopathy,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25656,LATS2,C0334579,Valproic Acid,DB00313,Anaplastic astrocytoma,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
9812,VIM2P,C0949083,Vitamin E,DB00163,Nosocomial pneumonia,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12466,PLG,C0554628,Quinupristin,DB01369,Streptococcus pyogenes infection,Approved,CC[C@@H]1C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)N3C[C@H](C(=O)C[C@H]3C(=O)N[C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CS[C@@H]6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
11098,FKBP1AP4,C0010414,Amphotericin B,DB00681,Infection by Cryptococcus neoformans,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34104,ODF3,C1704272,Finasteride,DB01216,Benign Prostatic Hyperplasia,Withdrawn,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},Phase 3,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5007,Piperonyl butoxide,DB09350,Pediculus capitis infestation,C0030757,Approved,CCCCOCCOCCOCC1=CC2=C(C=C1CCC)OCO2},,Infectious disease,,,,,,,,,,,,,,,,,,,MAP2K7,,,,,,,,
16467,FGF7,C0029442,Ergocalciferol,DB00153,Osteomalacia,Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Urinary system disease,KGF,,,,,,,,,,,,,,,,,,,,,,,,,
34124,TBX3,C1704272,Finasteride,DB01216,Benign Prostatic Hyperplasia,Withdrawn,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},Phase 3,Reproductive system disease,TBX3-ISO,XHL,UMS,,,,,,,,,,,,,,,,,,,,,,,
10866,HSD11B1,C0028754,Fenofibrate,DB01039,Obesity,Withdrawn,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 1,Metabolic disease,SDR26C1,HSD11B,HSD11,,,,,,,,,,,,,,,,,,,,,,,
36379,MAOB,C0149654,Methylphenidate,DB00422,Conduct Disorder,Withdrawn,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},Phase 1/Phase 2,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
26713,TNFRSF8,C0020981,Thalidomide,DB01041,Angioimmunoblastic Lymphadenopathy,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Immune system disease,KI-1,CD30,D1S166E,,,,,,,,,,,,,,,,,,,,,,,
25057,UBQLN2,C0002736,Pioglitazone,DB01132,Amyotrophic Lateral Sclerosis,Terminated,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3},Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3484,Imipenem,DB01598,Diabetic foot infection,C0744130,Approved,C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CCL24,,,,,,,,
31815,MTOR,C4048328,Gemcitabine,DB00441,cervical cancer,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17385,HBA1,C0031069,Colchicine,DB01394,Familial Mediterranean Fever,Approved,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC},,Infectious disease,HBA-T3,,,,,,,,,,,,,,,,,,,,,,,,,
7502,IRF1,C0009766,Triprolidine,DB00427,Allergic Conjunctivitis,Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Immune system disease,0,,,,,,,,,,,,,,,,,AD10,,,,,,,,
17848,FASLG,C0162316,Succinic acid,DB00139,Iron deficiency anemia,Approved,C(CC(=O)O)C(=O)O},,Hematologic disease,FasL,CD178,APT1LG1,TNFSF6,,,,,,,,,,,,,,,,,,,,,,
21817,ZBTB16,C0012739,Heparin,DB01109,Disseminated Intravascular Coagulation,Approved,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},,Hematologic disease,PLZF,ZNF145,,,,,,,,,,,,,,,,,,,,,,,,
11177,IL10,C0023290,Miltefosine,DB09031,"Leishmaniasis, Visceral",Approved,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
17502,HLA-B,C1384606,Ospemifene,DB04938,Dyspareunia,Approved,C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\C3=CC=C(C=C3)OCCO)/CCCl},,Reproductive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
15090,ERVK-7,C0700345,Tioconazole,DB01007,"Candidiasis, Vulvovaginal",Approved,C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19243,FZD8,C0282488,Mycophenolic acid,DB01024,Interstitial Cystitis,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4367,Naproxen,DB00788,Myalgia,C0231528,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,,,,,,,,,,,,,,,,,,,,ANXA11,,,,,,,,
4580,Ofloxacin,DB01165,Cystitis,C0010692,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,,,,,,,,,,,,,,,,,,,CNIH3,,,,,,,,
36855,C19orf18,C0038580,Methamphetamine,DB01577,Substance Dependence,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
4981,Piperacillin,DB00319,Klebsiella cystitis,C0520775,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Urinary system disease,,,,,,,,,,,,,,,,,,,GCDH,,,,,,,,
10854,ENPP1,C0028754,Fenofibrate,DB01039,Obesity,Withdrawn,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 1,Metabolic disease,PC-1,NPPS,M6S1,PDNP1,,,,,,,,,,,,,,,,,,,,,,
9419,PNOC,C0242422,Trihexyphenidyl,DB00376,Parkinsonian Disorders,Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Neurodegenerative disease,PPNOC,N/OFQ,NOP,,,,,,,,,,,,,,,,,,,,,,,
6979,SMAD3,C0029408,Salmon Calcitonin,DB00017,Degenerative polyarthritis,Terminated,CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CN=CN2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO},Phase 3,Immune system disease,JV15-2,HsT17436,MADH3,,,,,,,,,,,,,,,PAK1,,,,,,,,
12589,AHR,C0600142,Testosterone,DB00624,Hot flushes,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,,bHLHe76,,,,,,,,,,,,,,,,,,,,,,,,,
18866,FANCA,C0020459,Diazoxide,DB01119,Hyperinsulinism,Approved,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12102,KL,C0003850,Simvastatin,DB00641,Arteriosclerosis,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Vascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
15195,MYL12B,C0013390,Naproxen,DB00788,Dysmenorrhea,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21887,CACNA1C,C0002895,Hydroxyurea,DB01005,"Anemia, Sickle Cell",Approved,C(=O)(N)NO},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19776,TLR4,C0036472,Fusidic Acid,DB02703,Scrub Typhus,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,,,,,,,,,
16529,LRP2,C1510471,Vitamin C,DB00126,Vitamin Deficiency,Approved,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O},,Metabolic disease,gp330,,,,,,,,,,,,,,,,,,,,,,,,,
12279,CETP,C0020557,Topiramate,DB00273,Hypertriglyceridemia,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24710,RBM45,C0029077,Triamcinolone,DB00620,"Ophthalmia, Sympathetic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8958,Dimethyl fumarate,DB08908,"Multiple Sclerosis, Secondary Progressive",C0751965,Terminated,COC(=O)/C=C/C(=O)OC},Phase 3,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
33113,ABCB1,C0041696,Scopolamine,DB00747,Unipolar Depression,Terminated,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},Phase 2,Mental and behavioural disorder,P-gp,CD243,GP170,ABC20,PGY1,CLCS,,,,,,,,,,,,,,,,,,,,
31845,H3P40,C3495949,Valproic Acid,DB00313,Locally advanced breast cancer,Terminated,CCCC(CCC)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
31151,MAPK14,C1292753,Doxorubicin,DB00997,Primary Effusion Lymphoma,Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},Phase 2,Cancer,PRKM14,Mxi2,PRKM15,CSPB1,CSBP1,CSBP2,,,,,,,,,,,,,,,,,,,,
37251,NFE2L2,C3241937,Vitamin E,DB00163,Nonalcoholic Steatohepatitis,Withdrawn,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 3,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29198,COL11A2,C0278878,Irinotecan,DB00762,adult glioblastoma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,HKE5,DFNA13,DFNB53,,,,,,,,,,,,,,,,,,,,,,,
18540,DECR1,C1739382,Deferoxamine,DB00746,Chronic iron overload,Approved,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
22591,CHRM3,C0030409,Ketoconazole,DB01026,Paracoccidioidomycosis,Approved,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
3118,gabapentin enacarbil,DB08872,Restless Legs Syndrome,C0035258,Approved,CC(C)C(=O)OC(C)OC(=O)NCC1(CCCCC1)CC(=O)O},,Nervous system disease,,,,,,,,,,,,,,,,,,,KCNE2,,,,,,,,
12096,PSMA6,C0027051,Fondaparinux sodium,DB00569,Myocardial Infarction,Withdrawn,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4041,Methyl salicylate,DB09543,Sprains and Strains,C0038048,Approved,COC(=O)C1=CC=CC=C1O},,,,,,,,,,,,,,,,,,,,,CPT1A,,,,,,,,
3237,Griseofulvin,DB00400,Onychomycosis,C0040261,Approved,C[C@@H]1CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC},,Infectious disease,,,,,,,,,,,,,,,,,,,HBEGF,,,,,,,,
13650,ZNF267,C0037274,Triamcinolone,DB00620,Dermatologic disorders,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28580,ANKRD27,C0341106,Lansoprazole,DB00448,Eosinophilic esophagitis,Withdrawn,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F},Phase 1/Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28487,CHPT1,C0278726,Metronidazole,DB00916,Small cell lung cancer extensive stage,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
5146,Prednisolone,DB00860,Corneal Ulcer,C0010043,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,,,,,,,,,,,,,,,,,,,,NUCB1,,,,,,,,
4614,Ofloxacin,DB01165,Proteus urinary tract infection,C0577709,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,ADCYAP1,,,,,,,,
6296,IAPP,C0393735,Salicylic acid,DB00936,Headache Disorders,Approved,C1=CC=C(C(=C1)C(=O)O)O},,Nervous system disease,AMYLIN,,,,,,,,,,,,,,,,,PEX3,,,,,,,,
4799,Pemirolast,DB00885,Allergic rhinitis (disorder),C2607914,Approved,CC1=CC=CN2C1=NC=C(C2=O)C3=NNN=N3},,Immune system disease,,,,,,,,,,,,,,,,,,,ITPR3,,,,,,,,
32439,AGTR1,C0265110,Nicardipine,DB00622,Cerebral Vasospasm,Terminated,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC},Phase 2,Cardiovascular disease,AT2R1,AGTR1A,AT2R1A,HAT1R,AG2S,AT2R1B,AT1B,AGTR1B,,,,,,,,,,,,,,,,,,
6581,SCN8A,C0014553,Valproic Acid,DB00313,Absence Epilepsy,Approved,CCCC(CCC)C(=O)O},,Nervous system disease,Nav1.6,NaCh6,PN4,CerIII,CIAT,,,,,,,,,,,,,LINC00328,,,,,,,,
12750,ABO,C0149871,Warfarin,DB00682,Deep Vein Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21435,MBTPS2,C0016436,Gentamicin,DB00798,Folliculitis,Approved,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6663,IL18,C0013604,Triamterene,DB00384,Edema,Approved,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N},,,0,,,,,,,,,,,,,,,,,IBTK,,,,,,,,
18108,CSF2,C1704231,Cytarabine,DB00987,Metastatic Malignant Neoplasm to the Leptomeninges,Approved,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O},,Cancer,GM-CSF,GMCSF,,,,,,,,,,,,,,,,,,,,,,,,
15502,PIK3CA,C0024623,Citalopram,DB00215,Malignant neoplasm of stomach,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Cancer,PI3K,,,,,,,,,,,,,,,,,,,,,,,,,
1438,Cefuroxime,DB01112,GONOCOCCAL INFECTION DISSEMINATED,C0744451,Approved,CO/N=C(/C1=CC=CO1)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Sulfur,,,,,,,,
4947,Phenytoin,DB00252,Tonic - clonic seizures,C0494475,Approved,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3},,Nervous system disease,,,,,,,,,,,,,,,,,,,SLN,,,,,,,,
21738,CEACAM4,C0022972,Guanidine,DB00536,Lambert-Eaton Myasthenic Syndrome,Approved,C(=N)(N)N},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24788,FCGR2A,C1527336,Prednisolone,DB00860,Sjogren's Syndrome,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Cardiovascular disease,CD32A,IGFR2,CDw32,FCGR2A1,,,,,,,,,,,,,,,,,,,,,,
9162,Nitazoxanide,DB00507,Clostridium Infections,C0009062,Terminated,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
33593,TNFSF4,C0007273,Vitamin E,DB00163,Carotid Artery Diseases,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Vascular disease,OX-40L,gp34,CD252,TXGP1,,,,,,,,,,,,,,,,,,,,,,
31520,MIR23A,C3898222,Sirolimus,DB00877,Mucosal Melanoma,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9231,Promethazine,DB01069,Hyperemesis Gravidarum,C0020450,Terminated,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C},Phase 3,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
22889,DCLRE1C,C0677607,Levothyroxine,DB00451,Hashimoto Disease,Approved,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34868,LIF,C0011206,Quetiapine,DB01224,Delirium,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,CDF,HILDA,,,,,,,,,,,,,,,,,,,,,,,,
18917,MCL1,C0027773,Diazoxide,DB01119,Nesidioblastosis,Approved,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2992,Formaldehyde,DB03843,Influenza,C0021400,Approved,C=O},,Infectious disease,,,,,,,,,,,,,,,,,,,BLNK,,,,,,,,
22182,JAK2,C0206141,Imatinib,DB00619,Idiopathic Hypereosinophilic Syndrome,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,JTK10,,,,,,,,,,,,,,,,,,,,,,,,,
34158,PTPRVP,C0085082,Caspofungin,DB00520,Fungemia,Terminated,CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4=CC=C(C=C4)O)O)O)[C@@H](CCN)O)O)NCCN)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17534,MIF,C0038325,Prednisolone,DB00860,Stevens-Johnson Syndrome,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
23984,IL10,C0010418,Nitazoxanide,DB00507,Cryptosporidiosis,Approved,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]},,Infectious disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
22245,DEFA1,C0009663,Podofilox,DB01179,Condylomata Acuminata,Approved,COC1=CC(=CC(=C1OC)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](C4=CC5=C(C=C24)OCO5)O},,Infectious disease,HNP-1,DEF1,DEFA2,,,,,,,,,,,,,,,,,,,,,,,
34268,MACO1,C0242339,Simvastatin,DB00641,Dyslipidemias,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26973,BIRC3,C0349632,Vincristine,DB00541,Splenic Marginal Zone B-Cell Lymphoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,cIAP2,hiap-1,MIHC,RNF49,MALT2,c-IAP2,API2,,,,,,,,,,,,,,,,,,,
6775,PAH,C0033975,Triflupromazine,DB00508,Psychotic Disorders,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F},,Mental and behavioural disorder,PH,,,,,,,,,,,,,,,,,H3P47,,,,,,,,
9546,Lovastatin,DB00227,Severe persistent asthma,C1960048,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 1/Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
26575,KLF6,C0278838,Ketoconazole,DB01026,Prostate cancer recurrent,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,CPBP,GBF,Zf9,ST12,COPEB,,,,,,,,,,,,,,,,,,,,,
28385,SOD2,C0007682,Temozolomide,DB00853,CNS disorder,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9447,CTLA4,C0026896,Pyridostigmine,DB00545,Myasthenia Gravis,Approved,C[N+]1=CC=CC(=C1)OC(=O)N(C)C},,Immune system disease,CD152,CELIAC3,IDDM12,,,,,,,,,,,,,,,,,,,,,,,
433,Atorvastatin,DB01076,Angina Pectoris,C0002962,Approved,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,SLC2A4,,,,,,,,
16311,COMT,C0022104,Milnacipran,DB04896,Irritable Bowel Syndrome,Terminated,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2},Phase 2,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5304,Procaine benzylpenicillin,DB09320,Syphilis,C0039128,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,CHRND,,,,,,,,
22297,CAST,C0035435,Indomethacin,DB00328,Rheumatism,Approved,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18170,RASSF1,C1135868,Vinblastine,DB00570,Gestational Trophoblastic Neoplasms,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2020,GABRG2,C0001973,Zonisamide,DB00909,"Alcoholic Intoxication, Chronic",Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 2,Other,,,,,,,,,,,,,,,,,,CCR5,,,,,,,,
3665,Leucovorin,DB00650,Poisoning by pyrimethamine,C0274478,Approved,C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,,,,,,,,,,,,,,,,,,,,TBR1,,,,,,,,
16584,MMEL1,C0040261,Terbinafine,DB00857,Onychomycosis,Approved,CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10058,MAL,C0022602,Masoprocol,DB00179,Actinic keratosis,Approved,C[C@H](CC1=CC(=C(C=C1)O)O)[C@@H](C)CC2=CC(=C(C=C2)O)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22971,MAS1,C1868889,Lubiprostone,DB01046,Irritable bowel syndrome characterized by constipation,Approved,CCCCC([C@]1(CC[C@H]2[C@H](O1)CC(=O)[C@@H]2CCCCCCC(=O)O)O)(F)F},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7629,CCR3,C0011615,Triamcinolone,DB00620,"Dermatitis, Atopic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,CC-CKR-3,CKR3,CD193,CMKBR3,,,,,,,,,,,,,,FAM155A,,,,,,,,
5070,Pramipexole,DB00413,Restless Legs Syndrome,C0035258,Approved,CCCN[C@H]1CCC2=C(C1)SC(=N2)N},,Nervous system disease,,,,,,,,,,,,,,,,,,,PPR1,,,,,,,,
28866,TERT,C0279681,Metronidazole,DB00916,Bladder Squamous Cell Carcinoma,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,TRT,TCS1,hEST2,EST2,,,,,,,,,,,,,,,,,,,,,,
2410,Dirithromycin,DB00954,Tonsillitis,C0040425,Approved,CC[C@@H]1[C@@]([C@H]2[C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)N(C)C)O)(C)O)C)N[C@H](O2)COCCOC)C)(C)O},,,,,,,,,,,,,,,,,,,,,COL1A1,,,,,,,,
24373,SPP1,C0812413,Pemetrexed,DB00642,Malignant Pleural Mesothelioma,Approved,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,BSPI,ETA-1,BNSP,OPN,,,,,,,,,,,,,,,,,,,,,,
6450,Zopiclone,DB01198,Sleeplessness,C0917801,Approved,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl},,,,,,,,,,,,,,,,,,,,,AXL,,,,,,,,
10883,AOS,C0004030,Voriconazole,DB00582,Aspergillosis,Withdrawn,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13203,ABO,C0039614,Diazepam,DB00829,Tetanus,Approved,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4159,Metronidazole,DB00916,Bacteroides empyema,C2062454,Approved,CC1=NC=C(N1CCO)[N+](=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,RPL31,,,,,,,,
36524,NFASC,C0393819,Cyclophosphamide,DB00531,"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",Withdrawn,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 2,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26723,KRT20,C0278791,Thalidomide,DB01041,Chronic lymphocytic leukaemia refractory,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,CK20,K20,MGC35423,,,,,,,,,,,,,,,,,,,,,,,
4356,Naphazoline,DB06711,Itching of eye,C0022281,Approved,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32},,,,,,,,,,,,,,,,,,,,,XPO5,,,,,,,,
13806,TNF,C0149911,Zoledronic acid,DB00399,Humoral hypercalcemia of malignancy (disorder),Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Urinary system disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
16941,CST3,C0085166,Tinidazole,DB00911,Bacterial Vaginosis,Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15075,IL1B,C0700345,Tioconazole,DB01007,"Candidiasis, Vulvovaginal",Approved,C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl},,Infectious disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
18150,IGF1R,C0553580,Vincristine,DB00541,Ewings sarcoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,JTK13,CD221,IGFIR,MGC18216,IGFR,,,,,,,,,,,,,,,,,,,,,
34238,MMP3,C0010054,Fenofibrate,DB01039,Coronary Arteriosclerosis,Terminated,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 3,Vascular disease,STMY1,STMY,,,,,,,,,,,,,,,,,,,,,,,,
17092,ALB,C0085652,Clofazimine,DB00845,Pyoderma Gangrenosum,Approved,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl},,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
27212,APC,C0001418,Cisplatin,DB00515,Adenocarcinoma,Withdrawn,N.N.Cl[Pt]Cl},Phase 2,Cancer,DP2.5,PPP1R46,,,,,,,,,,,,,,,,,,,,,,,,
16629,C20orf181,C0021775,Cilostazol,DB01166,Intermittent Claudication,Approved,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
10572,ABCC2,C0038220,Secobarbital,DB00418,Status Epilepticus,Approved,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C},,Nervous system disease,DJS,cMRP,CMOAT,,,,,,,,,,,,,,,,,,,,,,,
29862,TLR5,C0850666,Omeprazole,DB00338,Infection caused by Helicobacter pylori,Terminated,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 1/Phase 2,Infectious disease,TIL3,MGC126430,MGC126431,SLEB1,,,,,,,,,,,,,,,,,,,,,,
6136,Triamcinolone,DB00620,Exfoliative dermatitis,C0011606,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,,,,,,,,,,,,,,,,,,,FAM8A1,,,,,,,,
14739,MECOM,C0005699,Imatinib,DB00619,Blast Phase,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,MDS1-EVI1,PRDM3,KMT8E,MDS1,EVI1,,,,,,,,,,,,,,,,,,,,,
14959,HCRT,C0524662,Naloxone,DB01183,Opiate Addiction,Approved,C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
16347,ACKR1,C0024537,Primaquine,DB01087,"Malaria, Vivax",Approved,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2},,Infectious disease,CCBP1,GPD,Dfy,CD234,FY,DARC,,,,,,,,,,,,,,,,,,,,
3281,Heparin,DB01109,Deep Vein Thrombosis,C0149871,Approved,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},,Hematologic disease,,,,,,,,,,,,,,,,,,,C3,,,,,,,,
31398,CD274,C0206754,Sunitinib,DB01268,Neuroendocrine Tumors,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,B7-H,B7H1,PD-L1,PDL1,B7-H1,PDCD1LG1,,,,,,,,,,,,,,,,,,,,
25409,ZFHX4-AS1,C0007117,Vismodegib,DB08828,Basal cell carcinoma,Approved,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
37234,ARSA,C0015732,Phenylephrine,DB00388,Fecal Incontinence,Withdrawn,CNC[C@@H](C1=CC(=CC=C1)O)O},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
20246,HPGDS,C0043144,Epinephrine,DB00668,Wheezing,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Congenital malformation,GSTS,H-PGDS,PGD2,GSTS1-1,GSTS1,,,,,,,,,,,,,,,,,,,,,
23161,COX1,C0086227,Thiabendazole,DB00730,Enterobiasis,Approved,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3},,Gastrointestinal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
37033,CRP,C0520679,Dexmedetomidine,DB00633,"Sleep Apnea, Obstructive",Withdrawn,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 2/Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,
25367,CAT,C0041408,Somatropin recombinant,DB00052,Turner Syndrome,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
1172,Cefotaxime,DB00493,URINARY TRACT INFECTION ENTEROCOCCUS,C0749958,Approved,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Paramethadione,,,,,,,,
16609,MDM2,C0021775,Cilostazol,DB01166,Intermittent Claudication,Approved,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
15129,MT1A,C0238462,Sorafenib,DB00398,Medullary carcinoma of thyroid,Withdrawn,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
7782,Celecoxib,DB00482,Adenomatous Polyposis Coli,C0032580,Terminated,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2,Digestive system disease,,,,,,,,,,,,,,,,,,,TUBB4A,,,,,,,,
24014,REEP5,C0268490,Nitisinone,DB00348,"Tyrosinemia, Type I",Approved,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-]},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
12118,TBXA2R,C0003850,Simvastatin,DB00641,Arteriosclerosis,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8090,DNASE1L3,C0002994,Triamcinolone,DB00620,Angioedema,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,DNAS1L3,LSD,,,,,,,,,,,,,,,,,,,,,,,,
27683,ADORA2A,C1533217,Methamphetamine,DB01577,Methamphetamine dependence,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 1,Mental and behavioural disorder,RDC8,ADORA2,,,,,,,,,,,,,,,,,,,,,,,,
127,Aluminum hydroxide,DB06723,Gastric ulcer,C0038358,Approved,[OH-].[OH-].[OH-].[Al+3]},,Digestive system disease,,,,,,,,,,,,,,,,,,,CCL3,,,,,,,,
8170,RASGRP1,C0042109,Methotrexate,DB00563,Urticaria,Terminated,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34510,LTB4R,C0037278,Vancomycin,DB00512,"Skin Diseases, Infectious",Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,BLTR,P2Y7,LTB4R1,P2RY7,GPR16,CMKRL1,,,,,,,,,,,,,,,,,,,,
25233,PTS,C0751434,Verapamil,DB00661,Classical phenylketonuria,Terminated,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},Phase 2,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
24839,CYP26C1,C0018916,Propranolol,DB00571,Hemangioma,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19760,NOP53,C0023860,Minocycline,DB01017,Listeriosis,Approved,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7281,MEFV,C0001144,Tretinoin,DB00755,Acne Vulgaris,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Infectious disease,FMF,TRIM20,,,,,,,,,,,,,,,,TAPBP,,,,,,,,
7961,Dexamethasone,DB01234,Vomiting,C0042963,Terminated,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
11813,CFAP221,C0008677,Vilanterol,DB09082,"Bronchitis, Chronic",Approved,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16623,VEGFA,C0021775,Cilostazol,DB01166,Intermittent Claudication,Approved,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4},,,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
14241,CRYBA1,C0028840,Unoprostone,DB06826,Ocular Hypertension,Approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},,Nervous system disease,CRYB1,,,,,,,,,,,,,,,,,,,,,,,,,
17143,ADCK1,C0028768,Sertraline,DB01104,Obsessive-Compulsive Disorder,Approved,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
36028,CYP19A1,C1135191,Udenafil,DB06267,"Heart Failure, Systolic",Terminated,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C},Phase 3,Cardiovascular disease,ARO,P-450AROM,CPV1,ARO1,CYAR,aromatase,CYP19,,,,,,,,,,,,,,,,,,,
4097,IL10,C0003862,Salicylic acid,DB00936,Arthralgia,Approved,C1=CC=C(C(=C1)C(=O)O)O},,Immune system disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,IL20,,,,,,,,
25481,GPR35,C0003962,Eplerenone,DB00700,Ascites,Withdrawn,C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
33465,BAG1,C1701940,Vancomycin,DB00512,"Pneumonia, Ventilator-Associated",Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3511,Indomethacin,DB00328,Patent ductus arteriosus,C0013274,Approved,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O},,Congenital malformation,,,,,,,,,,,,,,,,,,,PTS,,,,,,,,
1698,Clarithromycin,DB01211,Staphylococcus aureus infection,C1318973,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,AQP1,,,,,,,,
559,CX3CR1,C0019693,Trimethoprim,DB00440,HIV Infections,Terminated,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},Phase 2/Phase 3,Infectious disease,CMKDR1,V28,GPR13,CMKBRL1,,,,,,,,,,,,,,Emtricitabine,,,,,,,,
5676,Sulbactam,DB09324,Escherichia coli Infections,C0014836,Approved,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,MXLPO,,,,,,,,
26904,XIAP,C0432487,Vidarabine,DB00194,Post-transplant lymphoproliferative disorder,Suspended,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21282,RBM45,C0155880,Zileuton,DB00744,Intrinsic asthma,Approved,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21045,GHRL,C2267227,Acetylcysteine,DB06151,Bulimia Nervosa,Terminated,CC(=O)N[C@@H](CS)C(=O)O},Phase 3,Mental and behavioural disorder,MTLRP,ghrelin,obestatin,,,,,,,,,,,,,,,,,,,,,,,
4632,Olanzapine,DB00334,Mixed bipolar I disorder,C0236780,Approved,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,EIF2B5,,,,,,,,
17978,HGF,C0027819,Topotecan,DB01030,Neuroblastoma,Withdrawn,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O},Phase 2,Cancer,F-TCF,HGFB,HPTA,DFNB39,,,,,,,,,,,,,,,,,,,,,,
30189,F5,C1861172,Atorvastatin,DB01076,Venous Thromboembolism,Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 2,Vascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
24809,HMOX1,C1527336,Prednisolone,DB00860,Sjogren's Syndrome,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Cardiovascular disease,bK286B10,HO-1,,,,,,,,,,,,,,,,,,,,,,,,
15406,STX16,C0151940,Calcium Gluceptate,DB00326,Hypocalcemic tetany,Approved,C([C@H]([C@H]([C@@H]([C@H](C(C(=O)[O-])O)O)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(C(=O)[O-])O)O)O)O)O)O.[Ca+2]},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15665,PRRT2,C0014547,Primidone,DB00794,"Epilepsies, Partial",Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2766,Ethosuximide,DB00593,Absence Epilepsy,C0014553,Approved,CCC1(CC(=O)NC1=O)C},,Nervous system disease,,,,,,,,,,,,,,,,,,,F13A1,,,,,,,,
26471,BRCA1,C0279661,Sirolimus,DB00877,Acinar cell carcinoma of pancreas,Suspended,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 1,Cancer,RNF53,PPP1R53,FANCS,,,,,,,,,,,,,,,,,,,,,,,
3534,Ipratropium bromide,DB00332,Chronic Obstructive Airway Disease,C0024117,Approved,CC(C)[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C.[Br-]},,Lung disease,,,,,,,,,,,,,,,,,,,FEB1,,,,,,,,
1637,Ciprofloxacin,DB00537,Bacterial urinary infection,C0729524,Approved,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Zafirlukast,,,,,,,,
9655,Fentanyl,DB00813,Hb-SS disease with vasoocclusive pain,C2873760,Withdrawn,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3},Phase 2,Hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
13126,C5,C0744451,Spectinomycin,DB00919,GONOCOCCAL INFECTION DISSEMINATED,Approved,C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26810,NPM1,C0206180,Thalidomide,DB01041,Ki-1+ Anaplastic Large Cell Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
22797,PRKACG,C0025323,Tranexamic Acid,DB00302,Menorrhagia,Approved,C1CC(CCC1CN)C(=O)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
17255,ESM1,C1303258,Clopidogrel,DB00758,Acute ST segment elevation myocardial infarction (disorder),Approved,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
26753,IGHV3-52,C1511566,Thalidomide,DB01041,Cutaneous B-Cell Non-Hodgkin Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23470,CYLC2,C0023886,Tinidazole,DB00911,"Liver Abscess, Amebic",Approved,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C},,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10002,ZMPSTE24,C0456103,Vancomycin,DB00512,Sepsis of the newborn,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
3354,Hydrocortisone,DB00741,Inflammatory Bowel Diseases,C0021390,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,,,,,,,,,,,,,,,,,,,,ICAM3,,,,,,,,
14912,TGFB2,C0150055,Pregabalin,DB00230,Chronic pain,Withdrawn,CC(C)C[C@@H](CC(=O)O)CN},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,
26945,NRAS,C0280449,Cyclophosphamide,DB00531,secondary acute myeloid leukemia,Terminated,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9361,SLC18A2,C0030567,Trihexyphenidyl,DB00376,Parkinson Disease,Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Neurodegenerative disease,SVMT,SVAT,VMAT2,,,,,,,,,,,,,,,,,,,,,,,
31278,NRAS,C0220624,Erlotinib,DB00530,adult brain tumor,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
30981,AKT1,C0206704,Temozolomide,DB00853,"Carcinoma, Large Cell",Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,RAC,PKB,PRKBA,AKT,,,,,,,,,,,,,,,,,,,,,,
8615,GATA4,C0242855,Alprostadil,DB00770,Congenital atresia of pulmonary valve,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
18478,CCR7,C0023465,Daunorubicin,DB00694,Acute monocytic leukemia,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O},,Cancer,BLR2,CDw197,CD197,CMKBR7,EBI1,,,,,,,,,,,,,,,,,,,,,
6676,Mycophenolic acid,DB01024,Angioimmunoblastic Lymphadenopathy,C0020981,Suspended,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,GLIS2,,,,,,,,
8689,JMJD1C,C0243002,Alprostadil,DB00770,Tricuspid Atresia,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
780,Brexpiprazole,DB09128,Schizophrenia,C0036341,Approved,C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,CLCNKB,,,,,,,,
15194,BDNF,C0013390,Naproxen,DB00788,Dysmenorrhea,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,Reproductive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
5855,Testosterone Propionate,DB01420,Delayed Puberty,C0034012,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,IFI44,,,,,,,,
30158,ASXL1,C3463824,Azacitidine,DB00928,MYELODYSPLASTIC SYNDROME,Terminated,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11228,TNF,C0006849,Nystatin,DB00646,Oral candidiasis,Approved,C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/C(CC2C(C(C[C@](O2)(CC(C(CCC(CC(CC(CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
21203,MRAS,C0028326,Fluoxymesterone,DB01185,Noonan Syndrome,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
32736,OCA2,C0553723,Paclitaxel,DB01229,Squamous cell carcinoma of skin,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17053,ICAM1,C1562585,Clofazimine,DB00845,"Leprosy, Multibacillary",Approved,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl},,Infectious disease,CD54,,,,,,,,,,,,,,,,,,,,,,,,,
2318,Dienestrol,DB00890,Dyspareunia,C1384606,Approved,C/C=C(/C(=C/C)/C1=CC=C(C=C1)O)\\C2=CC=C(C=C2)O},,Reproductive system disease,,,,,,,,,,,,,,,,,,,NCF1,,,,,,,,
15362,CAD,C1704431,Calcium Gluceptate,DB00326,Disorder of electrolytes,Approved,C([C@H]([C@H]([C@@H]([C@H](C(C(=O)[O-])O)O)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(C(=O)[O-])O)O)O)O)O)O.[Ca+2]},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33587,HGF,C0007273,Vitamin E,DB00163,Carotid Artery Diseases,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Vascular disease,F-TCF,HGFB,HPTA,DFNB39,,,,,,,,,,,,,,,,,,,,,,
23046,PTCH1,C0006118,Lomustine,DB01206,Brain Neoplasms,Approved,C1CCC(CC1)NC(=O)N(CCCl)N=O},,Cancer,BCNS,NBCCS,PTCH,,,,,,,,,,,,,,,,,,,,,,,
26600,ACACB,C1335302,Paclitaxel,DB01229,Pancreatic Ductal Adenocarcinoma,Suspended,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15210,ADRA2A,C0026838,Tizanidine,DB00697,Muscle Spasticity,Approved,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6583,HMOX1,C0002351,Acetazolamide,DB00819,Altitude Sickness,Approved,CC(=O)NC1=NN=C(S1)S(=O)(=O)N},,,bK286B10,HO-1,,,,,,,,,,,,,,,,ANKRD36B,,,,,,,,
14288,CETP,C0020473,Cholecalciferol,DB00169,Hyperlipidemia,Withdrawn,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},Phase 1,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25307,COL3A1,C0037299,Sulfadiazine,DB00359,Skin Ulcer,Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Skin disease,EDS4A,,,,,,,,,,,,,,,,,,,,,,,,,
1651,Ciprofloxacin,DB00537,Infection of skin AND/OR subcutaneous tissue,C0178299,Approved,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Zopiclone,,,,,,,,
1636,Ciprofloxacin,DB00537,Bacterial infection due to Klebsiella pneumoniae,C0343402,Approved,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Xylometazoline,,,,,,,,
5480,Rotigotine,DB05271,Parkinson Disease,C0030567,Approved,CCCN(CCC1=CC=CS1)[C@H]2CCC3=C(C2)C=CC=C3O},,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,GATM,,,,,,,,
5952,Ticarcillin,DB01607,Escherichia coli septicemia,C0276088,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,CD27,,,,,,,,
1716,Clavulanate,DB00766,Pneumonia due to Klebsiella pneumoniae,C0519030,Approved,C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,YWHAZ,,,,,,,,
35427,LDLR,C0342879,Simvastatin,DB00641,Primary hypercholesterolemia,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Inherited metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36948,GNAS,C0006664,Sodium thiosulfate,DB09499,Calcinosis cutis,Withdrawn,[O-]S(=O)(=S)[O-].[Na+].[Na+]},Phase 2,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32224,AR,C0269084,Pregabalin,DB00230,Vulvar Vestibulitis,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,,AIS,NR3C4,SMAX1,HUMARA,DHTR,SBMA,,,,,,,,,,,,,,,,,,,,
21308,SLC6A4,C0031572,Venlafaxine,DB00285,"Phobia, Social",Approved,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O},,Mental and behavioural disorder,5-HTT,SERT1,HTT,OCD1,,,,,,,,,,,,,,,,,,,,,,
13316,MC2R,C0405580,Triamcinolone,DB00620,Adrenal cortical hypofunction,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,ACTHR,,,,,,,,,,,,,,,,,,,,,,,,,
32322,ERVK-21,C0238013,Voriconazole,DB00582,Invasive aspergillosis,Terminated,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25140,TET2,C0026987,Teriparatide,DB06285,Myelofibrosis,Terminated,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N},Phase 2,Cancer,FLJ20032,KIAA1546,,,,,,,,,,,,,,,,,,,,,,,,
4061,Methylprednisolone,DB00959,Ankylosing spondylitis,C0038013,Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,LEMD3,,,,,,,,
21287,ALCAM,C0155880,Zileuton,DB00744,Intrinsic asthma,Approved,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O},,Immune system disease,CD166,MEMD,,,,,,,,,,,,,,,,,,,,,,,,
28916,DLC1,C0279680,Metronidazole,DB00916,Transitional cell carcinoma of bladder,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
831,Butenafine,DB01091,Tinea Pedis,C0040259,Approved,CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32},,Infectious disease,,,,,,,,,,,,,,,,,,,Itraconazole,,,,,,,,
16775,ABO,C0158371,Ofloxacin,DB01165,Acute osteomyelitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7937,Dapsone,DB00250,Pemphigus Vulgaris,C0030809,Terminated,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N},Phase 2,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
9698,Ibuprofen,DB01050,Other sickle-cell disease with vaso-occlusive pain,C1260331,Withdrawn,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
15499,FGFR2,C0024623,Citalopram,DB00215,Malignant neoplasm of stomach,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Cancer,CEK3,TK14,TK25,ECT1,K-SAM,CD332,KGFR,BEK,JWS,,,,,,,,,,,,,,,,,
17015,TLR1,C0023343,Dapsone,DB00250,Leprosy,Approved,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,rsc786,KIAA0012,CD281,,,,,,,,,,,,,,,,,,,,,,,
25319,GBE1,C0037299,Sulfadiazine,DB00359,Skin Ulcer,Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9250,Rosuvastatin,DB01098,Precancerous Conditions,C0032927,Terminated,CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
37276,IL1A,C3241937,Vitamin E,DB00163,Nonalcoholic Steatohepatitis,Withdrawn,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 3,Endocrine disease,IL1F1,IL-1A,IL1-ALPHA,IL1,,,,,,,,,,,,,,,,,,,,,,
6235,Triprolidine,DB00427,Common Cold,C0009443,Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Infectious disease,,,,,,,,,,,,,,,,,,,PHF6,,,,,,,,
12673,FASTK,C0206525,Bedaquiline,DB08903,"Tuberculosis, Drug-Resistant",Approved,CN(C)CC[C@@](C1=CC=CC2=CC=CC=C21)([C@H](C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11211,ETFA,C0026718,Isavuconazonium,DB06636,Mucormycosis,Approved,C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=[N+](C=N3)C(C)OC(=O)N(C)C4=C(C=CC=N4)COC(=O)CNC)(C5=C(C=CC(=C5)F)F)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24242,ATXN2,C0085096,Treprostinil,DB00374,Peripheral Vascular Diseases,Terminated,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9434,HLA-DQA1,C0026896,Pyridostigmine,DB00545,Myasthenia Gravis,Approved,C[N+]1=CC=CC(=C1)OC(=O)N(C)C},,Immune system disease,HLA-DQA,,,,,,,,,,,,,,,,,,,,,,,,,
26032,COL17A1,C0023646,Triamcinolone,DB00620,Lichen Planus,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
203,Aminophylline,DB01223,Status Asthmaticus,C0038218,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N},,Congenital malformation,,,,,,,,,,,,,,,,,,,Butethal,,,,,,,,
25219,DNAJC21,C0870082,Tretinoin,DB00755,Hyperkeratosis,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15276,PTCHD1-AS,C0085682,"Sodium phosphate, monobasic, monohydrate",DB09525,Hypophosphatemia,Approved,OP(=O)(O)[O-].[Na+]},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4307,Moxifloxacin,DB00218,Haemophilus influenzae pneumonia,C0276026,Approved,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,BRS3,,,,,,,,
29890,IDH1,C0085136,Vincristine,DB00541,Central Nervous System Neoplasms,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26474,SOAT1,C0854777,Gemcitabine,DB00441,Pancreatic carcinoma recurrent,Withdrawn,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 2,Cancer,STAT,,,,,,,,,,,,,,,,,,,,,,,,,
17851,FOXP3,C0162316,Succinic acid,DB00139,Iron deficiency anemia,Approved,C(CC(=O)O)C(=O)O},,Hematologic disease,JM2,XPID,AIID,PIDX,DIETER,SCURFIN,IPEX,,,,,,,,,,,,,,,,,,,
20763,AGA,C0343386,Vancomycin,DB00512,Clostridium difficile infection,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,ASRG,,,,,,,,,,,,,,,,,,,,,,,,,
25585,GPT,C0008513,Sulfadiazine,DB00359,Chorioretinitis,Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26217,AMD1P2,C0271066,Imatinib,DB00619,Choroidal retinal neovascularization,Withdrawn,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 1,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
20251,IL4R,C0043144,Epinephrine,DB00668,Wheezing,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Congenital malformation,CD124,,,,,,,,,,,,,,,,,,,,,,,,,
35090,PMS2,C1333990,Norgestrel,DB09389,Hereditary Nonpolyposis Colorectal Cancer,Terminated,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
31486,NTHL1,C0349604,Sirolimus,DB00877,Intracranial Meningioma,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
28027,FOS,C0458247,Capsaicin,DB06774,Allodynia,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,,c-fos,,,,,,,,,,,,,,,,,,,,,,,,,
5396,Quinestrol,DB04575,Female hypogonadism syndrome,C0271578,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)OC5CCCC5},,Endocrine disease,,,,,,,,,,,,,,,,,,,AFF1,,,,,,,,
6146,Triamcinolone,DB00620,Lichen Planus,C0023646,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,LRRC26,,,,,,,,
25774,TACR3,C0948896,Testosterone,DB00624,Primary hypogonadism,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35976,MIR6881,C0019163,Tenofovir,DB00300,Hepatitis B,Terminated,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33392,INSRR,C0878773,Lidocaine,DB00281,Overactive Bladder,Terminated,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},Phase 3,Urinary system disease,IRR,,,,,,,,,,,,,,,,,,,,,,,,,
12359,AMBP,C0034186,Ofloxacin,DB01165,Pyelonephritis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,UTI,EDC1,HI30,IATIL,ITILC,ITI,ITIL,,,,,,,,,,,,,,,,,,,
22863,ND1,C0018021,Liothyronine,DB00279,Goiter,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
340,Ampicillin,DB00415,Haemophilus influenzae pneumonia,C0276026,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Clopidogrel,,,,,,,,
21915,ERBB4,C0025202,Lovastatin,DB00227,melanoma,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,ALS19,HER4,,,,,,,,,,,,,,,,,,,,,,,,
21946,KCNE1,C0085610,Hyoscyamine,DB00424,Sinus bradycardia,Approved,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3},,Cardiovascular disease,minK,ISK,JLNS2,LQT5,,,,,,,,,,,,,,,,,,,,,,
10852,LEPR,C0028754,Fenofibrate,DB01039,Obesity,Withdrawn,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 1,Metabolic disease,OBR,CD295,,,,,,,,,,,,,,,,,,,,,,,,
20315,FGF2,C3536984,Ergocalciferol,DB00153,"Vitamin D-Resistant Rickets, X-Linked",Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,FGFB,,,,,,,,,,,,,,,,,,,,,,,,,
36086,TGFBR1,C0004779,Verteporfin,DB00460,Basal Cell Nevus Syndrome,Terminated,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C.CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)O)C(=C3C)CCC(=O)OC)C=C},Phase 3,Skin and connective tissue disease,ALK-5,ALK5,TBRI,TBR-i,MSSE,ESS1,,,,,,,,,,,,,,,,,,,,
11859,CLOCK,C0236780,Ziprasidone,DB00246,Mixed bipolar I disorder,Approved,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54},,Mental and behavioural disorder,KIAA0334,KAT13D,bHLHe8,,,,,,,,,,,,,,,,,,,,,,,
5706,Sulfamethizole,DB00576,Escherichia coli urinary tract infection,C0577708,Approved,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,CAP2,,,,,,,,
36128,TP53,C0677866,Sirolimus,DB00877,Brain Stem Neoplasms,Withdrawn,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13246,TRPV4,C0025281,Penciclovir,DB00299,Meniere Disease,Terminated,C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N},Phase 3,Nervous system disease,OTRPC4,TRP12,VROAC,VRL-2,VR-OAC,CMT2C,,,,,,,,,,,,,,,,,,,,
21877,HES1,C0023473,Vindesine,DB00309,"Myeloid Leukemia, Chronic",Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O},,Cancer,FLJ20408,HES-1,Hes1,bHLHb39,HRY,,,,,,,,,,,,,,,,,,,,,
26538,IL4I1,C0278884,Sorafenib,DB00398,Melanoma recurrent,Withdrawn,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32612,TSPO,C0343401,Nitric Oxide,DB00435,MRSA - Methicillin resistant Staphylococcus aureus infection,Terminated,[N]=O},Phase 2,Infectious disease,PBR,MBR,PKBS,mDRC,DBI,pk18,BZRP,,,,,,,,,,,,,,,,,,,
21443,IL10,C0016436,Gentamicin,DB00798,Folliculitis,Approved,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC},,Skin disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
13785,RASGRP1,C0019829,Tacrolimus,DB00864,Hodgkin Disease,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25840,MIR145,C0005684,Mitomycin,DB00305,Malignant neoplasm of urinary bladder,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
5356,Propranolol,DB00571,Hypertensive disease,C0020538,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,PMCH,,,,,,,,
24897,NAT2,C0041318,Pyrazinamide,DB00339,"Tuberculosis, Meningeal",Approved,C1=CN=C(C=N1)C(=O)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25581,S100A7,C0042998,Sulfathiazole,DB06147,Vulvovaginitis,Approved,C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2},,Infectious disease,S100A7c,PSOR1,,,,,,,,,,,,,,,,,,,,,,,,
11642,BAG3,C0581377,Torasemide,DB00214,Decompensated cardiac failure,Approved,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
11602,IL6,C0013371,Trimethoprim,DB00440,Shigella Infections,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
1918,Cortisone acetate,DB01380,"Lupus Erythematosus, Systemic",C0024141,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Immune system disease,,,,,,,,,,,,,,,,,,,ENG,,,,,,,,
35842,PRKAA1,C0032927,Celecoxib,DB00482,Precancerous Conditions,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2/Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
32820,MSH6,C0040136,Ponatinib,DB08901,Thyroid Neoplasm,Terminated,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
14626,PLIN3,C0524910,Cyclosporine,DB00091,"Hepatitis C, Chronic",Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 3,Infectious disease,TIP47,M6PRBP1,,,,,,,,,,,,,,,,,,,,,,,,
31252,IGF2,C0001624,Erlotinib,DB00530,Adrenal Gland Neoplasms,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Endocrine disease,FLJ44734,IGF-II,C11orf43,,,,,,,,,,,,,,,,,,,,,,,
29428,ICAM1,C0021368,Methotrexate,DB00563,Inflammation,Withdrawn,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,,CD54,,,,,,,,,,,,,,,,,,,,,,,,,
701,Betamethasone,DB00443,"Lupus Erythematosus, Discoid",C0024138,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Immune system disease,,,,,,,,,,,,,,,,,,,Gemifloxacin,,,,,,,,
18362,CPT1C,C0085606,Trospium,DB00209,Urgency of micturition,Approved,C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
13617,DMD,C0011608,Triamcinolone,DB00620,Dermatitis Herpetiformis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,DXS142,DXS164,DXS206,DXS230,DXS239,DXS268,DXS269,DXS270,DXS272,MRX85,,,,,,,,,,,,,,,,
5796,Teduglutide,DB08900,Short Bowel Syndrome,C0036992,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC5=CN=CN5)N},,Gastrointestinal disease,,,,,,,,,,,,,,,,,,,MMP7,,,,,,,,
29802,TRPM8,C0001127,Nitric Oxide,DB00435,"Acidosis, Respiratory",Terminated,[N]=O},Phase 1/Phase 2,Respiratory diseases,,,,,,,,,,,,,,,,,,,,,,,,,,
18800,MS4A2,C0013595,Dexpanthenol,DB09357,Eczema,Approved,CC(C)(CO)[C@H](C(=O)NCCCO)O},,Skin disease,MS4A1,FCER1B,APY,,,,,,,,,,,,,,,,,,,,,,,
23386,PIK3CG,C0267176,Metoclopramide,DB01233,Gastroparesis due to diabetes mellitus,Approved,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32432,S100B,C0265110,Nicardipine,DB00622,Cerebral Vasospasm,Terminated,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC},Phase 2,Cardiovascular disease,S100beta,,,,,,,,,,,,,,,,,,,,,,,,,
37172,CTTN,C0023051,Omeprazole,DB00338,Laryngeal Diseases,Withdrawn,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
27232,SCD,C0007097,Cisplatin,DB00515,Carcinoma,Withdrawn,N.N.Cl[Pt]Cl},Phase 3,Cancer,FADS5,SCDOS,,,,,,,,,,,,,,,,,,,,,,,,
26556,HIF1A,C3898877,Doxorubicin,DB00997,Hormone-Resistant Prostate Cancer,Suspended,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},Phase 1/Phase 2,Cancer,MOP1,HIF-1alpha,PASD8,HIF1,bHLHe78,,,,,,,,,,,,,,,,,,,,,
30657,MLH1,C0685938,Erythropoietin,DB00016,Malignant neoplasm of gastrointestinal tract,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27597,CYBA,C0010073,Sildenafil,DB00203,Coronary Artery Vasospasm,Suspended,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C},Phase 3,Vascular disease,p22-PHOX,,,,,,,,,,,,,,,,,,,,,,,,,
22123,NES,C0392784,Imatinib,DB00619,Dermatofibrosarcoma Protuberans,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,FLJ21841,,,,,,,,,,,,,,,,,,,,,,,,,
28025,AIF1,C0458247,Capsaicin,DB06774,Allodynia,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,,IRT-1,AIF-1,Em:AF129756.17,IBA1,,,,,,,,,,,,,,,,,,,,,,
23222,MLH3,C0476089,Arsenic trioxide,DB01169,Endometrial Carcinoma,Terminated,[O-2].[O-2].[O-2].[As+3].[As+3]},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
4281,Mometasone,DB00764,Exanthema,C0015230,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)Cl)C},,Infectious disease,,,,,,,,,,,,,,,,,,,ACSS2,,,,,,,,
31826,WNT5A,C4048328,Gemcitabine,DB00441,cervical cancer,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 2,Cancer,hWNT5A,,,,,,,,,,,,,,,,,,,,,,,,,
34387,FTO,C0451641,Ciprofloxacin,DB00537,Urolithiasis,Terminated,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35251,DMXL2,C0018784,Methotrexate,DB00563,Sensorineural Hearing Loss (disorder),Terminated,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 3,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
546,Bazedoxifene,DB06401,"Osteoporosis, Postmenopausal",C0029458,Approved,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,Edoxaban,,,,,,,,
24578,IL25,C0024449,Posaconazole,DB01263,Mycetoma,Approved,CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F},,Infectious disease,IL-17E,IL17E,,,,,,,,,,,,,,,,,,,,,,,,
36467,MUC1,C0862312,Pemetrexed,DB00642,"Epithelioid mesothelioma, malignant",Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,CD227,PEM,ADMCKD,ADMCKD1,MCKD,MCKD1,,,,,,,,,,,,,,,,,,,,
18632,F10,C0019069,Desmopressin,DB00035,Hemophilia A,Approved,C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N},,Hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
17900,CYSLTR2,C0026961,Tropicamide,DB00809,Mydriasis,Approved,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
36628,FOSL1,C0016048,Hydroxyurea,DB01005,Fibromatosis,Withdrawn,C(=O)(N)NO},Phase 2,Musculoskeletal disease,fra-1,,,,,,,,,,,,,,,,,,,,,,,,,
32768,BCL11A,C0019045,Pegfilgrastim,DB00019,Hemoglobinopathies,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Congenital malformation,BCL11A-XL,BCL11A-L,BCL11A-S,CTIP1,HBFQTL5,ZNF856,EVI9,,,,,,,,,,,,,,,,,,,
23967,IFNG,C0010418,Nitazoxanide,DB00507,Cryptosporidiosis,Approved,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
14915,COMT,C0150055,Pregabalin,DB00230,Chronic pain,Withdrawn,CC(C)C[C@@H](CC(=O)O)CN},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
33494,COL5A2,C0005779,Vitamin E,DB00163,Blood Coagulation Disorders,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
26069,MPLKIP,C0349506,Trioxsalen,DB04571,Photosensitivity of skin,Approved,CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35714,REN,C0856169,Valsartan,DB00177,Endothelial dysfunction,Terminated,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
1721,Clavulanate,DB00766,Sepsis due to Staphylococcus aureus,C2887088,Approved,C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Fludarabine,,,,,,,,
24159,HFE,C0036337,Olanzapine,DB00334,Schizoaffective Disorder,Withdrawn,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C},Phase 3,Mental and behavioural disorder,HLA-H,,,,,,,,,,,,,,,,,,,,,,,,,
9619,GPT,C0008311,Sulbactam,DB09324,Cholangitis,Approved,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34421,COX2,C0278601,Tamoxifen,DB00675,Inflammatory Breast Carcinoma,Terminated,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
13679,CNGA3,C0015397,Triamcinolone,DB00620,Disorder of eye,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,,CCNC1,CCNCa,CNG3,CNCG3,ACHM2,,,,,,,,,,,,,,,,,,,,,
37064,CXCL8,C1168198,Propranolol,DB00571,Recurrent respiratory papillomatosis,Withdrawn,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},Phase 2/Phase 3,Infectious disease,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
14364,NRTN,C0009806,Oxycodone,DB00497,Constipation,Terminated,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O},Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26917,TWIST2,C0278785,Sunitinib,DB01268,recurrent adult acute lymphoblastic leukemia,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,DERMO1,Dermo-1,bHLHa39,,,,,,,,,,,,,,,,,,,,,,,
11609,DEFA5,C0013371,Trimethoprim,DB00440,Shigella Infections,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,HD-5,DEF5,,,,,,,,,,,,,,,,,,,,,,,,
31835,EGFR,C3495949,Valproic Acid,DB00313,Locally advanced breast cancer,Terminated,CCCC(CCC)C(=O)O},Phase 2,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
4533,Norfloxacin,DB01059,Staphylococcal Pneumonia,C0032308,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,FGF21,,,,,,,,
28459,CRHR2,C0236736,Dextroamphetamine,DB01576,Cocaine-Related Disorders,Terminated,C[C@@H](CC1=CC=CC=C1)N},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
5581,SLC17A5,C0009443,Triprolidine,DB00427,Common Cold,Approved,CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC=N3},,Infectious disease,0,,,,,,,,,,,,,,,,,CFL2,,,,,,,,
21931,ERCC2,C0025202,Lovastatin,DB00227,melanoma,Withdrawn,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29262,TMPRSS2,C1328504,Sirolimus,DB00877,Hormone refractory prostate cancer,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 1/Phase 2,Cancer,PRSS10,,,,,,,,,,,,,,,,,,,,,,,,,
11415,AKR1B10,C0039128,Tetracycline,DB00759,Syphilis,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,AKR1B12,ARL-1,ARL1,HSI,ALDRLn,AKR1B11,,,,,,,,,,,,,,,,,,,,
5189,Prednisolone,DB00860,Pruritus of genital organs,C0033777,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,,,,,,,,,,,,,,,,,,,,DIO2,,,,,,,,
24773,STAT3,C0034069,Azathioprine,DB00993,Pulmonary Fibrosis,Terminated,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]},Phase 3,Lung disease,APRF,,,,,,,,,,,,,,,,,,,,,,,,,
11651,TGFB1,C0040028,Anagrelide,DB00261,"Thrombocythemia, Essential",Approved,C1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3},,Cancer,CED,TGFbeta,TGFB,DPD1,,,,,,,,,,,,,,,,,,,,,,
8941,Cyclosporine,DB00091,"Hepatitis C, Chronic",C0524910,Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
9458,Imatinib,DB00619,Choroidal retinal neovascularization,C0271066,Withdrawn,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 1,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,,
23980,ICAM1,C0010418,Nitazoxanide,DB00507,Cryptosporidiosis,Approved,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]},,Infectious disease,CD54,,,,,,,,,,,,,,,,,,,,,,,,,
1070,Cefdinir,DB00535,Moraxella catarrhalis pneumonia,C0857831,Approved,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\O)/C3=CSC(=N3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Naphazoline,,,,,,,,
26315,RAX2,C0242383,Xanthophyll,DB00137,Age related macular degeneration,Approved,CC1=C(C(C[C@@H](C1)O)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(\\C)/C=C/C=C(\\C)/C=C/[C@H]2C(=C[C@@H](CC2(C)C)O)C)/C)/C},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28332,LOC102723407,C0023486,Thalidomide,DB01041,Prolymphocytic Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25268,GHRH,C0013338,Somatropin recombinant,DB00052,Pituitary dwarfism,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32902,PTGS2,C0178782,Pregabalin,DB00230,Orofacial Pain,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,
24119,CHRM2,C0005697,Oxybutynin,DB01062,Neurogenic Urinary Bladder,Approved,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17953,MYCN,C0027819,Topotecan,DB01030,Neuroblastoma,Withdrawn,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O},Phase 2,Cancer,bHLHe37,N-myc,MYCNOT,NMYC,,,,,,,,,,,,,,,,,,,,,,
5609,"Sodium phosphate, monobasic, monohydrate",DB09525,Calcium renal calculus,C1959799,Approved,OP(=O)(O)[O-].[Na+]},,Urinary system disease,,,,,,,,,,,,,,,,,,,RBPJ,,,,,,,,
32316,MUC1,C0238013,Voriconazole,DB00582,Invasive aspergillosis,Terminated,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,CD227,PEM,ADMCKD,ADMCKD1,MCKD,MCKD1,,,,,,,,,,,,,,,,,,,,
6473,CALCA,C0149931,Zolmitriptan,DB00315,Migraine Disorders,Approved,CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3},,Nervous system disease,CALC1,,,,,,,,,,,,,,,,,FOXP1-IT1,,,,,,,,
36407,CXCR3,C0751956,Nimodipine,DB00393,Acute Cerebrovascular Accidents,Withdrawn,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC},Phase 2,Cardiovascular disease,CKR-L2,CMKAR3,IP10-R,MigR,CD183,GPR9,,,,,,,,,,,,,,,,,,,,
15509,IL1RN,C0024623,Citalopram,DB00215,Malignant neoplasm of stomach,Terminated,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F},Phase 3,Cancer,ICIL-1RA,IL1F3,IL-1RN,MGC10430,,,,,,,,,,,,,,,,,,,,,,
17638,EDN1,C0019112,Zinc oxide,DB09321,Hemorrhoids,Approved,O=[Zn]},,,ET1,,,,,,,,,,,,,,,,,,,,,,,,,
32049,CGA,C0014132,Oxaliplatin,DB00526,Endocrine Gland Neoplasms,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,GPHa,GPHA1,FSHA,LHA,TSHA,,,,,,,,,,,,,,,,,,,,,
33824,SERPINF1,C0011875,Heparin,DB01109,Diabetic Angiopathies,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2/Phase 3,Vascular disease,EPC-1,PIG35,PEDF,,,,,,,,,,,,,,,,,,,,,,,
20893,APLNR,C0184567,Floctafenine,DB08976,Acute onset pain,Approved,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC=C(C3=NC=C2)C(F)(F)F},,,FLJ90771,APJ,APJR,AGTRL1,,,,,,,,,,,,,,,,,,,,,,
36037,GRK5,C1135191,Udenafil,DB06267,"Heart Failure, Systolic",Terminated,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C},Phase 3,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29255,PIK3CB,C1328504,Sirolimus,DB00877,Hormone refractory prostate cancer,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
6768,KLK3,C0042029,Trovafloxacin,DB00685,Urinary tract infection,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,,,,,,,,,,,,,,,,,,PAX2,,,,,,,,
7048,CXCR3,C0276226,Aciclovir,DB00787,Herpes encephalitis,Approved,C1=NC2=C(N1COCCO)N=C(NC2=O)N},,Infectious disease,CKR-L2,CMKAR3,IP10-R,MigR,CD183,GPR9,,,,,,,,,,,,PDIK1L,,,,,,,,
32903,BDNF,C0178782,Pregabalin,DB00230,Orofacial Pain,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,
32296,CHRNB4,C0085298,Metoprolol,DB00264,Sudden Cardiac Death,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
24914,AHSA1,C1849508,Pyridoxine,DB00165,"EPILEPSY, PYRIDOXINE-DEPENDENT",Approved,CC1=NC=C(C(=C1O)CO)CO},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6982,GDF5,C0029408,Salmon Calcitonin,DB00017,Degenerative polyarthritis,Terminated,CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CN=CN2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO},Phase 3,Immune system disease,CDMP1,BMP14,,,,,,,,,,,,,,,,ALDH1A3,,,,,,,,
27404,HSD11B2,C0852036,Magnesium Sulfate,DB00653,Pregnancy associated hypertension,Suspended,[O-]S(=O)(=O)[O-].[Mg+2]},Phase 2/Phase 3,Cardiovascular disease,SDR9C3,,,,,,,,,,,,,,,,,,,,,,,,,
27575,MMP9,C2937358,Fluoxetine,DB00472,Cerebral Hemorrhage,Terminated,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F},Phase 3,Cardiovascular disease,CLG4B,,,,,,,,,,,,,,,,,,,,,,,,,
34258,LEPR,C0242339,Simvastatin,DB00641,Dyslipidemias,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Metabolic disease,OBR,CD295,,,,,,,,,,,,,,,,,,,,,,,,
18194,TRIM28,C0027708,Vincristine,DB00541,Nephroblastoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,TIF1B,KAP1,TF1B,RNF96,PPP1R157,,,,,,,,,,,,,,,,,,,,,
33718,TAS2R38,C0040332,Nicotine,DB00184,Tobacco Dependence,Terminated,CN1CCC[C@H]1C2=CN=CC=C2},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
5749,Sulindac,DB00605,"Arthritis, Gouty",C0003868,Approved,CC\\1=C(C2=C(/C1=C\\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,ASPM,,,,,,,,
30718,TP53,C0206663,Vincristine,DB00541,"Neuroectodermal Tumor, Primitive",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19439,GUSB,C0235063,Doxapram,DB00561,Respiratory Depression,Approved,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17454,MMP12,C0854135,Colistin,DB00803,Pseudomonas aeruginosa infection,Approved,CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)[C@@H](C)O},,Infectious disease,HME,,,,,,,,,,,,,,,,,,,,,,,,,
14033,MMP13,C2894027,Triamcinolone,DB00620,Post traumatic osteoarthritis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,CLG3,,,,,,,,,,,,,,,,,,,,,,,,,
35860,VDR,C0006666,Sodium thiosulfate,DB09499,Calciphylaxis,Terminated,[O-]S(=O)(=S)[O-].[Na+].[Na+]},Phase 3,Endocrine and metabolic disease,NR1I1,PPP1R163,,,,,,,,,,,,,,,,,,,,,,,,
823,Buspirone,DB00490,Generalized Anxiety Disorder,C0270549,Approved,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,Isoniazid,,,,,,,,
12422,CCR4,C0007947,Sulfisoxazole,DB00263,Chancroids,Approved,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,CC-CKR-4,CMKBR4,CKR4,k5-5,ChemR13,CD194,,,,,,,,,,,,,,,,,,,,
283,Amphotericin B,DB00681,Gingivostomatitis,C0149704,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,,,,,,,,,,,,,,,,,,,,BRCA1,,,,,,,,
2828,Fexofenadine,DB00950,Allergic Conjunctivitis,C0009766,Approved,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,PLB1,,,,,,,,
11187,CRP,C0023290,Miltefosine,DB09031,"Leishmaniasis, Visceral",Approved,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
19428,PLAT,C0235063,Doxapram,DB00561,Respiratory Depression,Approved,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4},,Lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,
13985,IL17A,C0026948,Isotretinoin,DB00982,Mycosis Fungoides,Terminated,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\\C(=O)O)/C)/C},Phase 2,Infectious disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
17666,CD247,C0022073,Sulfacetamide,DB00634,Iridocyclitis,Approved,CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N},,,CD3H,CD3Q,CD3Z,,,,,,,,,,,,,,,,,,,,,,,
32697,HLA-B,C2931822,Oxaliplatin,DB00526,Nasopharyngeal carcinoma,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
26391,SLC2A1,C0007124,Oxytocin,DB00107,Noninfiltrating Intraductal Carcinoma,Suspended,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N},Phase 0,Cancer,DYT18,DYT9,GLUT1,GLUT,HTLVR,CSE,,,,,,,,,,,,,,,,,,,,
26958,TPMT,C0280745,Decitabine,DB01262,secondary myelodysplastic syndromes,Terminated,C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
5381,Pyridoxine,DB00165,"EPILEPSY, PYRIDOXINE-DEPENDENT",C1849508,Approved,CC1=NC=C(C(=C1O)CO)CO},,Nervous system disease,,,,,,,,,,,,,,,,,,,BOP,,,,,,,,
1794,Clonazepam,DB01068,"Epilepsies, Myoclonic",C0014550,Approved,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl},,Nervous system disease,,,,,,,,,,,,,,,,,,,PKN2-AS1,,,,,,,,
10799,GRM7,C1263846,Methylphenidate,DB00422,Attention deficit hyperactivity disorder,Approved,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
18661,F8,C0042974,Desmopressin,DB00035,von Willebrand Disease,Approved,C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N},,Hematologic disease,FVIII,DXS1253E,HEMA,F8C,,,,,,,,,,,,,,,,,,,,,,
13577,IL23R,C0010346,Naltrexone,DB00704,Crohn Disease,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28971,CSF3,C0027627,Sirolimus,DB00877,Neoplasm Metastasis,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 3,Cancer,MGC45931,GCSF,G-CSF,C17orf33,,,,,,,,,,,,,,,,,,,,,,
8716,AKT1,C1140680,Fondaparinux sodium,DB00569,Malignant neoplasm of ovary,Withdrawn,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},Phase 1,Cancer,RAC,PKB,PRKBA,AKT,,,,,,,,,,,,,,,,,,,,,,
243,Amoxicillin,DB01060,Infection of skin AND/OR subcutaneous tissue,C0178299,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,KLF6,,,,,,,,
31544,MDM2,C3495917,Exemestane,DB00990,Advanced breast cancer,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12498,MECP2,C0032290,Ticarcillin,DB01607,Aspiration Pneumonia,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,RTT,MRX16,MRX79,,,,,,,,,,,,,,,,,,,,,,,
11837,SHANK3,C0004352,Risperidone,DB00734,Autistic Disorder,Approved,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
13368,CARD9,C0038013,Triamcinolone,DB00620,Ankylosing spondylitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13521,PRKAR1A,C0001627,Triamcinolone,DB00620,Congenital adrenal hyperplasia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6166,Triamcinolone,DB00620,Sarcoidosis,C0036202,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,,,,,,,,,,,,,,,,,,,SCFD2,,,,,,,,
9781,EGFR,C0085437,Tobramycin,DB00684,"Meningitis, Bacterial",Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Infectious disease,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
26679,NXT1,C1332153,Homoharringtonine,DB04865,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Terminated,CC(C)(CCC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2C3=CC4=C(C=C3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11620,MUL1,C0013371,Trimethoprim,DB00440,Shigella Infections,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1527,Chloroquine,DB00608,Ovale malaria,C0152072,Approved,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,Toloxatone,,,,,,,,
13539,CACNA1D,C0001627,Triamcinolone,DB00620,Congenital adrenal hyperplasia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine and metabolic disease,Cav1.3,CACH3,CACN4,CCHL1A2,CACNL1A2,,,,,,,,,,,,,,,,,,,,,
13281,ND1,C0001403,Triamcinolone,DB00620,Addison Disease,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36175,NOS3,C0155305,Timolol,DB00373,"Optic Neuropathy, Ischemic",Withdrawn,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O},Phase 1,,ECNOS,eNOS,,,,,,,,,,,,,,,,,,,,,,,,
17364,SAA1,C0031069,Colchicine,DB01394,Familial Mediterranean Fever,Approved,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36132,IL6,C0034544,Ganciclovir,DB01004,Radiculitis,Withdrawn,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N},Phase 1,Nervous system disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
5733,Sulfisoxazole,DB00263,Chlamydial urethritis,C1278807,Approved,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,,,,,,,,,,,,,,,,,,,PGAP2,,,,,,,,
25689,CCR6,C0003864,Tenoxicam,DB00469,Arthritis,Approved,CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3},,Immune system disease,CKR-L3,GPR-CY4,CMKBR6,GPR29,DRY-6,DCR2,BN-1,CD196,STRL22,,,,,,,,,,,,,,,,,
14548,CCL22,C0080032,Thiotepa,DB04572,"Pleural Effusion, Malignant",Approved,C1CN1P(=S)(N2CC2)N3CC3},,Lung disease,STCP-1,ABCD-1,DC/B-CK,A-152E5.1,MGC34554,SCYA22,,,,,,,,,,,,,,,,,,,,
36527,CSF2,C0393819,Cyclophosphamide,DB00531,"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",Withdrawn,C1CNP(=O)(OC1)N(CCCl)CCCl},Phase 2,Nervous system disease,GM-CSF,GMCSF,,,,,,,,,,,,,,,,,,,,,,,,
23982,IL1B,C0010418,Nitazoxanide,DB00507,Cryptosporidiosis,Approved,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]},,Infectious disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
9647,Erythropoietin,DB00016,Traumatic Brain Injury,C0876926,Withdrawn,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26808,HSP90AA1,C0206180,Thalidomide,DB01041,Ki-1+ Anaplastic Large Cell Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
15573,COPD,C0032768,Pregabalin,DB00230,Postherpetic neuralgia,Approved,CC(C)C[C@@H](CC(=O)O)CN},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6782,GCH1,C0033975,Triflupromazine,DB00508,Psychotic Disorders,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,IH,,,,,,,,
25859,AQP4,C0021141,Tolvaptan,DB06212,Inappropriate ADH Syndrome,Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Endocrine and metabolic disease,MIWC,,,,,,,,,,,,,,,,,,,,,,,,,
16528,IL17A,C1510471,Vitamin C,DB00126,Vitamin Deficiency,Approved,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O},,Metabolic disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
25123,GSTM1,C0730607,Roflumilast,DB01656,Severe chronic obstructive pulmonary disease,Approved,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15750,MAPK1,C0040997,Carbamazepine,DB00564,Trigeminal Neuralgia,Approved,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N},,,ERK2,p41mapk,MAPK2,PRKM2,PRKM1,,,,,,,,,,,,,,,,,,,,,
2589,Elbasvir,DB11574,"Hepatitis C, Chronic",C0524910,Approved,CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC4=C(C=C3)N5[C@@H](OC6=C(C5=C4)C=CC(=C6)C7=CN=C(N7)[C@@H]8CCCN8C(=O)[C@H](C(C)C)NC(=O)OC)C9=CC=CC=C9)NC(=O)OC},,Infectious disease,,,,,,,,,,,,,,,,,,,VCL,,,,,,,,
4878,Phenobarbital,DB01174,Vascular Headaches,C0042376,Approved,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2},,,,,,,,,,,,,,,,,,,,,HDAC11,,,,,,,,
28929,MMP2,C0024143,Tacrolimus,DB00864,Lupus Nephritis,Withdrawn,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 3,Urinary system disease,TBE-1,CLG4,CLG4A,,,,,,,,,,,,,,,,,,,,,,,
4499,Norfloxacin,DB01059,Gonorrhea,C0018081,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SOX11,,,,,,,,
6480,HTR1A,C0149931,Zolmitriptan,DB00315,Migraine Disorders,Approved,CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3},,Nervous system disease,0,,,,,,,,,,,,,,,,,GPR183,,,,,,,,
3689,Levofloxacin,DB01137,Chlamydial pneumonia,C0339959,Approved,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,MYH11,,,,,,,,
6367,PER2,C0392171,Salicylic acid,DB00936,Influenza-like symptoms,Approved,C1=CC=C(C(=C1)C(=O)O)O},,Infectious disease,0,,,,,,,,,,,,,,,,,GLG1,,,,,,,,
10671,GPI,C0149725,Piperacillin,DB00319,Lower respiratory tract infection,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
10133,NEUROD1,C0347950,Theophylline,DB00277,Asthma attack,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Immune system disease,BETA2,BHF-1,NeuroD,bHLHa3,MODY6,NEUROD,,,,,,,,,,,,,,,,,,,,
30045,MET,C0004114,Temozolomide,DB00853,Astrocytoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,HGFR,RCCP2,DFNB97,,,,,,,,,,,,,,,,,,,,,,,
12235,HNF4A,C0020474,Simvastatin,DB00641,"Hyperlipidemia, Familial Combined",Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Metabolic disease,NR2A1,HNF4,TCF14,MODY,MODY1,,,,,,,,,,,,,,,,,,,,,
30017,IL3RA,C0024137,Tretinoin,DB00755,"Lupus Erythematosus, Cutaneous",Terminated,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},Phase 2,Immune system disease,CD123,,,,,,,,,,,,,,,,,,,,,,,,,
8342,TRC-GCA24-1,C0348898,Ranolazine,DB00243,Irritable bowel syndrome with diarrhea,Terminated,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O},Phase 2/Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1112,Cefmetazole,DB00274,Lower respiratory tract infection,C0149725,Approved,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O},,,,,,,,,,,,,,,,,,,,,Norgestrel,,,,,,,,
34036,SLC12A3,C0018681,Naratriptan,DB00952,Headache,Withdrawn,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C},Phase 3,,NCCT,,,,,,,,,,,,,,,,,,,,,,,,,
26022,GNLY,C0023646,Triamcinolone,DB00620,Lichen Planus,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,NKG5,LAG-2,D2S69E,TLA519,LAG2,,,,,,,,,,,,,,,,,,,,,
14554,POSTN,C0080032,Thiotepa,DB04572,"Pleural Effusion, Malignant",Approved,C1CN1P(=S)(N2CC2)N3CC3},,Lung disease,OSF-2,PN,periostin,,,,,,,,,,,,,,,,,,,,,,,
1265,Cefradine,DB01333,Infection of bone,C2242472,Approved,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CCC=CC3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SYNE2,,,,,,,,
3505,Indapamide,DB00808,Hypertensive disease,C0020538,Approved,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,PEX6,,,,,,,,
9952,Valsartan,DB00177,Kidney Diseases,C0022658,Withdrawn,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
31793,FGFR2,C0750952,Fluorouracil,DB00544,Biliary Tract Cancer,Terminated,C1=C(C(=O)NC(=O)N1)F},Phase 3,Cancer,CEK3,TK14,TK25,ECT1,K-SAM,CD332,KGFR,BEK,JWS,,,,,,,,,,,,,,,,,
35711,SERPINE1,C0856169,Valsartan,DB00177,Endothelial dysfunction,Terminated,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Endocrine and metabolic disease,PAI,PLANH1,PAI1,,,,,,,,,,,,,,,,,,,,,,,
14178,PRTN3,C0039520,Triamcinolone,DB00620,Tenosynovitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,PR-3,ACPA,C-ANCA,AGP7,MBT,P29,,,,,,,,,,,,,,,,,,,,
7741,Calcitriol,DB00136,Rickets,C0035579,Terminated,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},Phase 2,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,RP2,,,,,,,,
32271,KISS1R,C0020619,Testosterone,DB00624,Hypogonadism,Withdrawn,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},Phase 1,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20323,CDK4,C0023827,Trabectedin,DB05109,liposarcoma,Approved,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16108,ASPG,C0008350,Ursodeoxycholic acid,DB01586,Cholelithiasis,Approved,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13836,MAGI2,C0021390,Naltrexone,DB00704,Inflammatory Bowel Diseases,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,,ACVRIP1,MAGI-2,,,,,,,,,,,,,,,,,,,,,,,,
3624,L-Serine,DB00133,Bacterial urinary infection,C0729524,Approved,C([C@@H](C(=O)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,KCNK10,,,,,,,,
6560,GLUD1,C0014553,Valproic Acid,DB00313,Absence Epilepsy,Approved,CCCC(CCC)C(=O)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,BET1L,,,,,,,,
16593,COX8A,C0040261,Terbinafine,DB00857,Onychomycosis,Approved,CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17496,FGF8,C1384606,Ospemifene,DB04938,Dyspareunia,Approved,C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\C3=CC=C(C=C3)OCCO)/CCCl},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
33020,GPR119,C0017689,Romidepsin,DB06176,Glucagonoma,Terminated,C/C=C\\1/C(=O)N[C@H](C(=O)O[C@H]\\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C},Phase 2,Cancer,hGPCR2,GPCR2,,,,,,,,,,,,,,,,,,,,,,,,
8964,CCK,C0038358,Roxatidine acetate,DB08806,Gastric ulcer,Approved,CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2},,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
8691,Tenofovir,DB00300,HIV-1 infection,C2363741,Terminated,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
12912,TEAD1,C0040247,Benzocaine,DB01086,Tinea,Approved,CCOC(=O)C1=CC=C(C=C1)N},,Infectious disease,TEF-1,TCF13,AA,,,,,,,,,,,,,,,,,,,,,,,
25795,HIF1A,C0039841,Thiamine,DB00152,Thiamine Deficiency,Approved,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},,,MOP1,HIF-1alpha,PASD8,HIF1,bHLHe78,,,,,,,,,,,,,,,,,,,,,
477,Azithromycin,DB00207,Chlamydial cervicitis,C0341834,Approved,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Dimenhydrinate,,,,,,,,
28704,CHD1,C0009404,Sorafenib,DB00398,Colorectal Neoplasms,Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
14473,AKT1,C0153601,Bleomycin,DB00290,Malignant neoplasm of penis,Approved,CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O},,Cancer,RAC,PKB,PRKBA,AKT,,,,,,,,,,,,,,,,,,,,,,
32294,IKZF1,C0085298,Metoprolol,DB00264,Sudden Cardiac Death,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,Cardiovascular disease,hIk-1,LyF-1,Hs.54452,IKAROS,PPP1R92,ZNFN1A1,,,,,,,,,,,,,,,,,,,,
8610,STPG4,C0242855,Alprostadil,DB00770,Congenital atresia of pulmonary valve,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
36301,GSTM1,C0877578,Clonidine,DB00575,Treatment related secondary malignancy,Withdrawn,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16247,NPY,C0001957,Oxazepam,DB00842,Alcohol Withdrawal Delirium,Approved,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O},,Mental and behavioural disorder,PYY4,,,,,,,,,,,,,,,,,,,,,,,,,
12963,ASL,C0220994,Phenylacetic acid,DB09269,Hyperammonemia,Approved,C1=CC=C(C=C1)CC(=O)O},,Inherited metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
17388,SFTPB,C0035220,Tyloxapol,DB06439,"Respiratory Distress Syndrome, Newborn",Approved,CC(C)(C)CC(C)(C)C1=CC=C(C=C1)O.C=O.C1CO1},,Lung disease,SP-B,SFTP3,,,,,,,,,,,,,,,,,,,,,,,,
10079,VDR,C0022602,Masoprocol,DB00179,Actinic keratosis,Approved,C[C@H](CC1=CC(=C(C=C1)O)O)[C@@H](C)CC2=CC(=C(C=C2)O)O},,Skin disease,NR1I1,PPP1R163,,,,,,,,,,,,,,,,,,,,,,,,
19687,P2RX5-TAX1BP3,C0008149,Fusidic Acid,DB02703,Chlamydia Infections,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24305,MDM4,C1261473,Pazopanib,DB06589,Sarcoma,Approved,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
11424,CRP,C0039128,Tetracycline,DB00759,Syphilis,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
10119,AHR,C0347950,Theophylline,DB00277,Asthma attack,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Immune system disease,bHLHe76,,,,,,,,,,,,,,,,,,,,,,,,,
11400,MGP,C0037199,Pseudoephedrine,DB00852,Sinusitis,Withdrawn,C[C@@H]([C@H](C1=CC=CC=C1)O)NC},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
16315,ELANE,C0017574,Chlorhexidine,DB00878,Gingivitis,Approved,C1=CC(=CC=C1N/C(=N/C(=NCCCCCCN=C(/N=C(/NC2=CC=C(C=C2)Cl)\\N)N)N)/N)Cl},,,NE,HNE,HLE,ELA2,,,,,,,,,,,,,,,,,,,,,,
28324,TP53,C0023486,Thalidomide,DB01041,Prolymphocytic Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9568,IL1A,C0684256,Vancomycin,DB00512,Bacterial sepsis,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,IL1F1,IL-1A,IL1-ALPHA,IL1,,,,,,,,,,,,,,,,,,,,,,
29762,PML,C0023524,Mefloquine,DB00358,"Leukoencephalopathy, Progressive Multifocal",Terminated,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O},Phase 1/Phase 2,Cancer,MYL,TRIM19,RNF71,,,,,,,,,,,,,,,,,,,,,,,
31897,CCHCR1,C1696708,Losartan,DB00678,Prehypertension,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl},Phase 2,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14054,GAST,C0035439,Triamcinolone,DB00620,Rheumatic Heart Disease,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
8236,ABCC9,C0018099,Naproxen,DB00788,Gout,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,Musculoskeletal disease,SUR2,CMD1O,,,,,,,,,,,,,,,,,,,,,,,,
6737,NOS2,C0042029,Trovafloxacin,DB00685,Urinary tract infection,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,iNOS,HEP-NOS,NOS2A,,,,,,,,,,,,,,,MAP2K4,,,,,,,,
7630,ACTL9,C0011615,Triamcinolone,DB00620,"Dermatitis, Atopic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,ARHGAP15,,,,,,,,
16917,ACAD8,C0014356,Clidinium,DB00771,Enterocolitis,Approved,C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O},,Gastrointestinal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35454,ATP5F1B,C0003129,Nitric Oxide,DB00435,Anoxemia,Terminated,[N]=O},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
5637,Spectinomycin,DB00919,Acute gonococcal cervicitis,C0153195,Approved,C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,TMPRSS11D,,,,,,,,
6911,Nicardipine,DB00622,Cerebral Hemorrhage,C2937358,Suspended,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC},Phase 3,Cardiovascular disease,,,,,,,,,,,,,,,,,,,GUCY1A1,,,,,,,,
27888,ABL1,C2347753,Mitoxantrone,DB01204,Adult Pure Erythroid Leukemia,Terminated,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32732,KNSTRN,C0553723,Paclitaxel,DB01229,Squamous cell carcinoma of skin,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1891,Cortisone acetate,DB01380,Corneal Ulcer,C0010043,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,,,,,,,,,,,,,,,,,,,,DNAI2,,,,,,,,
12309,HLA-DPB1,C0003873,Thalidomide,DB01041,Rheumatoid Arthritis,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Immune system disease,HLA-DP1B,,,,,,,,,,,,,,,,,,,,,,,,,
19855,IFNG,C0002874,Heparin,DB01109,Aplastic Anemia,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
10535,ABCB1,C0014544,Zonisamide,DB00909,Epilepsy,Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 3,Nervous system disease,P-gp,CD243,GP170,ABC20,PGY1,CLCS,,,,,,,,,,,,,,,,,,,,
1801,Clonidine,DB00575,Severe pain,C0278140,Approved,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl},,,,,,,,,,,,,,,,,,,,,FSHR,,,,,,,,
33548,ABCA1,C0004153,Simvastatin,DB00641,Atherosclerosis,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Cardiovascular disease,TGD,HDLDT1,,,,,,,,,,,,,,,,,,,,,,,,
17310,CYP2D7,C3544321,Thioridazine,DB00679,Treatment-resistant schizophrenia,Approved,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
6415,Ziconotide,DB06283,Chronic pain,C0150055,Approved,C[C@H]1C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N3)CO)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCN},,,,,,,,,,,,,,,,,,,,,GBP5,,,,,,,,
894,Camphor,DB01744,Sprains and Strains,C0038048,Approved,CC1(C2CCC1(C(=O)C2)C)C},,,,,,,,,,,,,,,,,,,,,Liraglutide,,,,,,,,
25435,HTATIP2,C2239176,Sorafenib,DB00398,Liver carcinoma,Approved,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23923,NFE2L2,C0038525,Deferoxamine,DB00746,Subarachnoid Hemorrhage,Terminated,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O},Phase 0,,0,,,,,,,,,,,,,,,,,,,,,,,,,
11422,CCR5,C0039128,Tetracycline,DB00759,Syphilis,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,CKR-5,CC-CKR-5,CKR5,CD195,IDDM22,CMKBR5,,,,,,,,,,,,,,,,,,,,
36245,CST3,C0022658,Valsartan,DB00177,Kidney Diseases,Withdrawn,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35374,CXCL8,C0005686,Mitomycin,DB00305,Urinary Bladder Diseases,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Urinary system disease,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
19146,EGFR,C0042963,Haloperidol,DB00502,Vomiting,Withdrawn,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F},Phase 0,,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
35451,NOS1,C0003129,Nitric Oxide,DB00435,Anoxemia,Terminated,[N]=O},Phase 3,,nNOS,,,,,,,,,,,,,,,,,,,,,,,,,
17852,PLA2G4A,C0162316,Succinic acid,DB00139,Iron deficiency anemia,Approved,C(CC(=O)O)C(=O)O},,Hematologic disease,cPLA2-alpha,PLA2G4,,,,,,,,,,,,,,,,,,,,,,,,
5199,Prednisolone,DB00860,Serum Sickness,C0036830,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,FUT6,,,,,,,,
4663,Oseltamivir,DB00198,Influenza,C0021400,Approved,CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC},,Infectious disease,,,,,,,,,,,,,,,,,,,ALG13,,,,,,,,
31316,RAB3A,C0014474,Erlotinib,DB00530,Ependymoma,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
14844,POU6F2,C0026603,Scopolamine,DB00747,Motion Sickness,Approved,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},,Musculoskeletal disease,RPF-1,,,,,,,,,,,,,,,,,,,,,,,,,
25742,GNRH1,C0020635,Testosterone,DB00624,Hypopituitarism,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5858,Testosterone Propionate,DB01420,Testicular hypogonadism,C0151721,Approved,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Reproductive system disease,,,,,,,,,,,,,,,,,,,GBP1,,,,,,,,
15041,MNDA,C0279543,Nilotinib,DB04868,Philadelphia chromosome positive chronic myelogenous leukemia,Approved,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,PYHIN3,,,,,,,,,,,,,,,,,,,,,,,,,
25723,POLR3A,C0271623,Methyltestosterone,DB06710,Hypogonadotropic hypogonadism,Terminated,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C},Phase 2,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30797,LOC102723407,C0242596,Methotrexate,DB00563,"Neoplasm, Residual",Terminated,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10858,BBS4,C0028754,Fenofibrate,DB01039,Obesity,Withdrawn,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 1,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10530,CTLA4,C0151908,Pramocaine,DB09345,Dry skin,Approved,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2},,Skin and connective tissue disease,CD152,CELIAC3,IDDM12,,,,,,,,,,,,,,,,,,,,,,,
25301,IL17F,C0037299,Sulfadiazine,DB00359,Skin Ulcer,Approved,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N},,Skin disease,IL-17F,ML1,,,,,,,,,,,,,,,,,,,,,,,,
32551,UBE2Z,C0520909,Nicotine,DB00184,Postoperative Nausea and Vomiting,Terminated,CN1CCC[C@H]1C2=CN=CC=C2},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
19816,KCNJ5,C0235480,Propafenone,DB01182,Paroxysmal atrial fibrillation,Approved,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
22084,ABL1,C0346421,Imatinib,DB00619,Chronic eosinophilic leukemia,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12590,GAD1,C0600142,Testosterone,DB00624,Hot flushes,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,,GAD,,,,,,,,,,,,,,,,,,,,,,,,,
23609,FCER2,C0220756,Miglustat,DB00419,"Niemann-Pick Disease, Type C",Approved,CCCCN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O},,Congenital disorder of metabolism,CLEC4J,CD23,CD23A,FCE2,,,,,,,,,,,,,,,,,,,,,,
30967,FN1,C0206704,Temozolomide,DB00853,"Carcinoma, Large Cell",Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,CIG,LETS,GFND2,FINC,,,,,,,,,,,,,,,,,,,,,,
5443,Rifaximin,DB01220,Hepatic Encephalopathy,C0019151,Approved,C[C@H]1/C=C/C=C(\\C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)/C},,Liver disease,,,,,,,,,,,,,,,,,,,CAND2,,,,,,,,
11222,APCS,C0006849,Nystatin,DB00646,Oral candidiasis,Approved,C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/C(CC2C(C(C[C@](O2)(CC(C(CCC(CC(CC(CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36947,IL4,C0280803,Pemetrexed,DB00642,Primary central nervous system lymphoma,Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,BSF1,IL-4,BCGF1,BCGF-1,MGC79402,,,,,,,,,,,,,,,,,,,,,
24898,SIGLEC14,C0041318,Pyrazinamide,DB00339,"Tuberculosis, Meningeal",Approved,C1=CN=C(C=N1)C(=O)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19503,CXCL8,C0276535,Doxorubicin,DB00997,AIDS with Kaposi's sarcoma,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},,Cancer,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
3072,Fusidic Acid,DB02703,Neonatal meningitis,C0456107,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,BBC3,,,,,,,,
24489,UNC13A,C0043352,Cisplatin,DB00515,Xerostomia,Terminated,N.N.Cl[Pt]Cl},Phase 2,,KIAA1032,Munc13-1,,,,,,,,,,,,,,,,,,,,,,,,
30081,TNF,C0206708,Aminolevulinic acid,DB00855,Cervical Intraepithelial Neoplasia,Terminated,C(CC(=O)O)C(=O)CN},Phase 2,Cancer,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
26502,CD36,C1561643,Sevelamer,DB00658,Chronic Kidney Diseases,Terminated,C=CCN.C1C(O1)CCl},Phase 3,Urinary system disease,SCARB3,GPIV,GP4,GP3B,,,,,,,,,,,,,,,,,,,,,,
3944,Meloxicam,DB00814,Rheumatoid Arthritis,C0003873,Approved,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O},,Immune system disease,,,,,,,,,,,,,,,,,,,KCNA4,,,,,,,,
3608,Ketoprofen,DB01009,Dysmenorrhea,C0013390,Approved,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O},,Reproductive system disease,,,,,,,,,,,,,,,,,,,BAG3,,,,,,,,
15006,HTR2C,C0085159,Bupropion,DB01156,Seasonal Affective Disorder,Approved,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C},,Mental and behavioural disorder,5-HT2C,5HTR2C,HTR1C,,,,,,,,,,,,,,,,,,,,,,,
12493,DPP4,C0032290,Ticarcillin,DB01607,Aspiration Pneumonia,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,CD26,ADCP2,,,,,,,,,,,,,,,,,,,,,,,,
4128,Methylscopolamine bromide,DB00462,Peptic Ulcer,C0030920,Approved,C[N+]1([C@H]2CC(C[C@H]1C3C2O3)OC(=O)[C@H](CO)C4=CC=CC=C4)C.[Br-]},,Digestive system disease,,,,,,,,,,,,,,,,,,,SF1,,,,,,,,
12270,CD44,C0020479,Simvastatin,DB00641,Hyperlipoproteinemia Type III,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Metabolic disease,IN,MC56,Pgp1,CD44R,HCELL,CSPG8,MIC4,MDU2,MDU3,,,,,,,,,,,,,,,,,
14469,KRAS,C0153601,Bleomycin,DB00290,Malignant neoplasm of penis,Approved,CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2372,Dimercaprol,DB06782,Arsenic Poisoning,C0311375,Approved,C(C(CS)S)O},,,,,,,,,,,,,,,,,,,,,CLPTM1L,,,,,,,,
5225,Prednisone,DB00635,Autoimmune hemolytic anemia,C0002880,Approved,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},,Hematologic disease,,,,,,,,,,,,,,,,,,,HACE1,,,,,,,,
2301,Diclofenac,DB00586,Pain,C0030193,Approved,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl},,,,,,,,,,,,,,,,,,,,,H3P10,,,,,,,,
29150,MDM4,C0280790,Irinotecan,DB00762,adult anaplastic oligodendroglioma,Withdrawn,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27497,CITED1,C1333015,Vincristine,DB00541,Childhood Kidney Wilms Tumor,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Cancer,MSG1,,,,,,,,,,,,,,,,,,,,,,,,,
6391,Voglibose,DB04878,"Diabetes Mellitus, Non-Insulin-Dependent",C0011860,Approved,C1[C@@H]([C@@H]([C@H]([C@@H]([C@]1(CO)O)O)O)O)NC(CO)CO},,Endocrine disease,,,,,,,,,,,,,,,,,,,CYP26C1,,,,,,,,
2755,Ethambutol,DB00330,Acute tuberculosis,C0275959,Approved,CC[C@@H](CO)NCCN[C@@H](CC)CO},,Infectious disease,,,,,,,,,,,,,,,,,,,ADM,,,,,,,,
18797,WAS,C0013595,Dexpanthenol,DB09357,Eczema,Approved,CC(C)(CO)[C@H](C(=O)NCCCO)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20602,KLK3,C0033578,Flutamide,DB00499,Prostatic Neoplasms,Approved,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
24164,PLA2G4A,C0036337,Olanzapine,DB00334,Schizoaffective Disorder,Withdrawn,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C},Phase 3,Mental and behavioural disorder,cPLA2-alpha,PLA2G4,,,,,,,,,,,,,,,,,,,,,,,,
17573,ABAT,C0037769,Vigabatrin,DB01080,West Syndrome,Approved,C=CC(CCC(=O)O)N},,Nervous system disease,GABAT,,,,,,,,,,,,,,,,,,,,,,,,,
24694,TP53,C0039483,Triamcinolone,DB00620,Giant Cell Arteritis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5651,Stiripentol,DB09118,"Epilepsies, Myoclonic",C0014550,Approved,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O},,Nervous system disease,,,,,,,,,,,,,,,,,,,GBAP1,,,,,,,,
33609,EPO,C0018799,Vitamin E,DB00163,Heart Diseases,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Cardiovascular disease,EP,,,,,,,,,,,,,,,,,,,,,,,,,
3972,Mepyramine,DB06691,Symptomatic dermographism,C0343065,Approved,CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,IGHV3-21,,,,,,,,
20195,STK11,C0002792,Epinephrine,DB00668,anaphylaxis,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22649,MTOR,C0022951,Lactose,DB04465,Lactose Intolerance,Approved,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)O)CO)O)O)O)O},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
5010,Pirbuterol,DB01291,Asthma attack,C0347950,Approved,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O},,Immune system disease,,,,,,,,,,,,,,,,,,,OPLAH,,,,,,,,
16780,IL11,C0010692,Ofloxacin,DB01165,Cystitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6069,HTR2A,C0015967,Ciprofloxacin,DB00537,Fever,Terminated,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,SNAI1,,,,,,,,
13357,RPL36,C1260899,Triamcinolone,DB00620,"Anemia, Diamond-Blackfan",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24017,NOS3,C0031190,Sildenafil,DB00203,Persistent Fetal Circulation Syndrome,Withdrawn,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C},Phase 2,,ECNOS,eNOS,,,,,,,,,,,,,,,,,,,,,,,,
2147,Desoximetasone,DB00547,Seborrheic dermatitis,C0036508,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)CO)C)O)F)C},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,TFRC,,,,,,,,
5343,Promethazine,DB01069,Allergic Conjunctivitis,C0009766,Approved,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C},,Immune system disease,,,,,,,,,,,,,,,,,,,FANCI,,,,,,,,
31463,ARID1A,C0023529,Erythropoietin,DB00016,"Leukomalacia, Periventricular",Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
9426,PRL,C0242422,Trihexyphenidyl,DB00376,Parkinsonian Disorders,Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,,,,,,,,
11026,TTR,C0009186,Posaconazole,DB01263,Coccidioidomycosis,Approved,CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F},,Infectious disease,HsT2651,CTS,PALB,CTS1,,,,,,,,,,,,,,,,,,,,,,
24007,ACAT1,C0268490,Nitisinone,DB00348,"Tyrosinemia, Type I",Approved,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-]},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
13659,ZNF658,C0037274,Triamcinolone,DB00620,Dermatologic disorders,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21400,CXCL10,C0021400,Zanamivir,DB00558,Influenza,Approved,CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)O)N=C(N)N},,Infectious disease,IFI10,IP-10,crg-2,mob-1,C7,gIP-10,INP10,SCYB10,,,,,,,,,,,,,,,,,,
4800,Pemirolast,DB00885,Asthma,C0004096,Approved,CC1=CC=CN2C1=NC=C(C2=O)C3=NNN=N3},,Immune system disease,,,,,,,,,,,,,,,,,,,BHLHB9P1,,,,,,,,
19244,MIR320E,C0282488,Mycophenolic acid,DB01024,Interstitial Cystitis,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22241,DEFB4B,C0009663,Podofilox,DB01179,Condylomata Acuminata,Approved,COC1=CC(=CC(=C1OC)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](C4=CC5=C(C=C24)OCO5)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
282,Amphotericin B,DB00681,Fungal septicemia,C2960008,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,RNASEL,,,,,,,,
31693,TLR10,C0006271,Fluticasone Propionate,DB00588,Bronchiolitis,Terminated,CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF},Phase 2,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
8065,Ezogabine,DB04953,Epilepsy,C0014544,Terminated,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N},Phase 2,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
5521,Salicylic acid,DB00936,Toothache,C0040460,Approved,C1=CC=C(C(=C1)C(=O)O)O},,,,,,,,,,,,,,,,,,,,,MIR126,,,,,,,,
10569,DMD,C0038220,Secobarbital,DB00418,Status Epilepticus,Approved,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C},,Nervous system disease,DXS142,DXS164,DXS206,DXS230,DXS239,DXS268,DXS269,DXS270,DXS272,MRX85,,,,,,,,,,,,,,,,
24631,ALOX15,C0004031,Prednisolone,DB00860,"Aspergillosis, Allergic Bronchopulmonary",Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Infectious disease,15-LOX-1,,,,,,,,,,,,,,,,,,,,,,,,,
30951,BCR,C0279644,Idarubicin,DB01177,childhood acute myelomonocytic leukemia (M4),Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3377,Hydrocortisone,DB00741,Psoriasis,C0033860,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,Skin disease,,,,,,,,,,,,,,,,,,,BTBD8,,,,,,,,
27859,HBB,C2347748,Mitoxantrone,DB01204,Adult Erythroleukemia,Terminated,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO},Phase 1,Cancer,CD113t-C,beta-globin,,,,,,,,,,,,,,,,,,,,,,,,
15705,INS,C0494475,Primidone,DB00794,Tonic - clonic seizures,Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,IDDM2,,,,,,,,,,,,,,,,,,,,,,,,,
15663,GRIN2A,C0014547,Primidone,DB00794,"Epilepsies, Partial",Approved,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6922,FCGR2A,C0392164,L-Cysteine,DB00151,Pulmonary Cystic Fibrosis,Approved,C([C@@H](C(=O)O)N)S},,Congenital disorder of metabolism,CD32A,IGFR2,CDw32,FCGR2A1,,,,,,,,,,,,,,SMC5,,,,,,,,
9160,Nicotine,DB00184,Tobacco Dependence,C0040332,Terminated,CN1CCC[C@H]1C2=CN=CC=C2},Phase 3,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,
27896,EZH2,C0023480,Sunitinib,DB01268,"Leukemia, Myelomonocytic, Chronic",Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,EZH1,ENX-1,KMT6,KMT6A,,,,,,,,,,,,,,,,,,,,,,
17626,CCL11,C0010043,Prednisolone,DB00860,Corneal Ulcer,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,,eotaxin,MGC22554,SCYA11,,,,,,,,,,,,,,,,,,,,,,,
2996,Formoterol,DB00983,Pulmonary Emphysema,C0034067,Approved,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O},,Lung disease,,,,,,,,,,,,,,,,,,,Etomidate,,,,,,,,
26875,IGHV3-69-1,C0242647,Vincristine,DB00541,Mucosa-Associated Lymphoid Tissue Lymphoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
5678,Sulbactam,DB09324,Infection of skin AND/OR subcutaneous tissue,C0178299,Approved,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,MIR193B,,,,,,,,
25217,KDF1,C0870082,Tretinoin,DB00755,Hyperkeratosis,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29387,PTPRC,C1697878,Cidofovir,DB00369,BK virus nephropathy,Terminated,C1=CN(C(=O)N=C1N)C[C@@H](CO)OCP(=O)(O)O},Phase 1/Phase 2,Urinary system disease,T200,CD45,,,,,,,,,,,,,,,,,,,,,,,,
1667,Ciprofloxacin,DB00537,Rhinoscleroma,C0035468,Approved,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Trametinib,,,,,,,,
29935,FANCA,C0007112,Prednisone,DB00635,Adenocarcinoma of prostate,Withdrawn,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
31412,HSPB1,C3873567,Erythropoietin,DB00016,Chemotherapy-induced peripheral neuropathy,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 2,,HSP27,HSP28,Hs.76067,Hsp25,CMT2F,,,,,,,,,,,,,,,,,,,,,
11811,DNMT3B,C0008677,Vilanterol,DB09082,"Bronchitis, Chronic",Approved,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl},,Lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,
7080,TP53,C0019348,Aciclovir,DB00787,Herpes Simplex Infections,Approved,C1=NC2=C(N1COCCO)N=C(NC2=O)N},,Infectious disease,0,,,,,,,,,,,,,,,,,PLP1,,,,,,,,
18183,ERV3-1,C1135868,Vinblastine,DB00570,Gestational Trophoblastic Neoplasms,Approved,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
14092,USP8P1,C0036202,Triamcinolone,DB00620,Sarcoidosis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20377,MYCN,C0281361,Mitomycin,DB00305,Adenocarcinoma of pancreas,Approved,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},,Cancer,bHLHe37,N-myc,MYCNOT,NMYC,,,,,,,,,,,,,,,,,,,,,,
7714,TSPYL2,C0024138,Ulobetasol,DB00596,"Lupus Erythematosus, Discoid",Approved,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F},,Immune system disease,0,,,,,,,,,,,,,,,,,ODAM,,,,,,,,
23364,CCL24,C0035457,Methylprednisolone,DB00959,"Rhinitis, Allergic, Perennial",Approved,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O},,Immune system disease,Ckb-6,MPIF-2,eotaxin-2,MPIF2,SCYA24,,,,,,,,,,,,,,,,,,,,,
17049,TBX21,C1562585,Clofazimine,DB00845,"Leprosy, Multibacillary",Approved,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl},,Infectious disease,TBLYM,T-bet,,,,,,,,,,,,,,,,,,,,,,,,
29629,JAK3,C0279632,Vorinostat,DB02546,adult acute megakaryoblastic leukemia (M7),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25366,SOD2,C0041408,Somatropin recombinant,DB00052,Turner Syndrome,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
20248,CRP,C0043144,Epinephrine,DB00668,Wheezing,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
11599,SETD1A,C0013371,Trimethoprim,DB00440,Shigella Infections,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6442,Zoledronic acid,DB00399,Humoral hypercalcemia of malignancy (disorder),C0149911,Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Urinary system disease,,,,,,,,,,,,,,,,,,,COG6,,,,,,,,
17277,CLEC7A,C0919659,Miconazole,DB01110,Oropharyngeal candidiasis,Approved,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl},,Infectious disease,dectin-1,hDectin-1,CD369,SCARE2,CLECSF12,,,,,,,,,,,,,,,,,,,,,
10717,PLAT,C0519030,Norfloxacin,DB01059,Pneumonia due to Klebsiella pneumoniae,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
33304,STAT5B,C0001815,Sunitinib,DB01268,Primary Myelofibrosis,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27601,UTS2R,C0010073,Sildenafil,DB00203,Coronary Artery Vasospasm,Suspended,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C},Phase 3,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3602,Ketoconazole,DB01026,Systemic candidiasis,C0153252,Approved,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,CALCOCO2,,,,,,,,
16921,IGF1,C0014356,Clidinium,DB00771,Enterocolitis,Approved,C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O},,Gastrointestinal disease,IGF1A,IGFI,IGF-I,IGF,,,,,,,,,,,,,,,,,,,,,,
6094,Trazodone,DB00656,Major Depressive Disorder,C1269683,Approved,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,INHBB,,,,,,,,
7192,Everolimus,DB01590,Eosinophilic gastroenteritis,C1262481,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC},Phase 1,Digestive system disease,,,,,,,,,,,,,,,,,,,CHL1,,,,,,,,
37113,RBP4,C0032460,Metformin,DB00331,Polycystic Ovary Syndrome,Withdrawn,CN(C)C(=N)N=C(N)N},Phase 3,Reproductive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
35828,MUC1,C0032927,Celecoxib,DB00482,Precancerous Conditions,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2/Phase 3,,CD227,PEM,ADMCKD,ADMCKD1,MCKD,MCKD1,,,,,,,,,,,,,,,,,,,,
3168,Gentamicin,DB00798,Dacryocystitis,C0010930,Approved,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC},,,,,,,,,,,,,,,,,,,,,HTR1D,,,,,,,,
18090,TP53,C0023467,Tretinoin,DB00755,"Leukemia, Myelocytic, Acute",Withdrawn,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
31851,EGF,C3495949,Valproic Acid,DB00313,Locally advanced breast cancer,Terminated,CCCC(CCC)C(=O)O},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
35528,VEGFA,C0154830,Octreotide,DB00104,Proliferative diabetic retinopathy,Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 3,Endocrine and metabolic disease,VEGF-A,VPF,VEGF,,,,,,,,,,,,,,,,,,,,,,,
1128,Cefonicid,DB01328,Pneumonia,C0032285,Approved,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)O)C(=O)O)CSC4=NN=NN4CS(=O)(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Omeprazole,,,,,,,,
30727,EGFR,C0206663,Vincristine,DB00541,"Neuroectodermal Tumor, Primitive",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
2417,SLC2A2,C0011860,Atorvastatin,DB01076,"Diabetes Mellitus, Non-Insulin-Dependent",Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Endocrine disease,GLUT2,,,,,,,,,,,,,,,,,BGLAP,,,,,,,,
18376,NR4A2,C0085606,Trospium,DB00209,Urgency of micturition,Approved,C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O},,,TINUR,NOT,RNR1,HZF-3,NURR1,,,,,,,,,,,,,,,,,,,,,
22840,CLCN5,C0018021,Liothyronine,DB00279,Goiter,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1519,Chlordiazepoxide,DB00475,Peptic Ulcer,C0030920,Approved,CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O},,Digestive system disease,,,,,,,,,,,,,,,,,,,Tocainide,,,,,,,,
17322,SLC6A3,C3544321,Thioridazine,DB00679,Treatment-resistant schizophrenia,Approved,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC},,Mental and behavioural disorder,DAT,,,,,,,,,,,,,,,,,,,,,,,,,
29677,NME1,C0280634,Vorinostat,DB02546,adult acute monocytic leukemia (M5b),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33740,IL17A,C0006272,Cyclosporine,DB00091,Bronchiolitis Obliterans,Terminated,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C},Phase 2/Phase 3,Respiratory disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
30910,GLIS2,C0279650,Idarubicin,DB01177,childhood acute megakaryocytic leukemia (M7),Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
28500,DNER,C0278727,Metronidazole,DB00916,Small cell lung cancer recurrent,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,UNQ26,bet,,,,,,,,,,,,,,,,,,,,,,,,
29463,RB1,C0005695,Mitomycin,DB00305,Bladder Neoplasm,Terminated,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33566,TLR4,C0004153,Simvastatin,DB00641,Atherosclerosis,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Cardiovascular disease,hToll,CD284,TLR-4,ARMD10,,,,,,,,,,,,,,,,,,,,,,
8915,FHIT,C0013395,Omeprazole,DB00338,Dyspepsia,Suspended,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 2,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13602,DNMT3A,C0010346,Naltrexone,DB00704,Crohn Disease,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16789,TACR1,C0010692,Ofloxacin,DB01165,Cystitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Urinary system disease,SPR,NK1R,TAC1R,,,,,,,,,,,,,,,,,,,,,,,
12574,ABCB1,C0009324,Naltrexone,DB00704,Ulcerative Colitis,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,Immune system disease,P-gp,CD243,GP170,ABC20,PGY1,CLCS,,,,,,,,,,,,,,,,,,,,
25018,CCL5,C0035235,Ribavirin,DB00811,Respiratory Syncytial Virus Infections,Approved,C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N},,Infectious disease,RANTES,SISd,TCP228,MGC17164,D17S136E,SCYA5,,,,,,,,,,,,,,,,,,,,
844,Caffeine,DB00201,Apnea in the newborn,C0232058,Approved,CN1C=NC2=C1C(=O)N(C(=O)N2C)C},,,,,,,,,,,,,,,,,,,,,L-Aspartic Acid,,,,,,,,
25406,TYR,C0007117,Vismodegib,DB08828,Basal cell carcinoma,Approved,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl},,Cancer,OCAIA,OCA1A,OCA1,,,,,,,,,,,,,,,,,,,,,,,
14158,LRP5,C0039503,Ketoprofen,DB01009,Tendinitis,Terminated,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O},Phase 3,Musculoskeletal disease,LR3,BMND1,HBM,OPS,OPTA1,VBCH2,EVR4,LRP7,OPPG,,,,,,,,,,,,,,,,,
9060,L-Carnitine,DB00583,Ulcerative Colitis,C0009324,Terminated,C[N+](C)(C)C[C@@H](CC(=O)[O-])O},Phase 3,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
32863,NR0B2,C1290884,Prednisone,DB00635,Inflammatory disorder,Terminated,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
17972,TH,C0027819,Topotecan,DB01030,Neuroblastoma,Withdrawn,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O},Phase 2,Cancer,DYT5b,,,,,,,,,,,,,,,,,,,,,,,,,
14518,GSTT1,C0007847,Topotecan,DB01030,Malignant tumor of cervix,Approved,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
3282,Heparin,DB01109,Disseminated Intravascular Coagulation,C0012739,Approved,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},,Hematologic disease,,,,,,,,,,,,,,,,,,,PTAFR,,,,,,,,
6615,BEST1,C0017605,Methazolamide,DB00703,Angle Closure Glaucoma,Approved,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C},,Nervous system disease,0,,,,,,,,,,,,,,,,,SPRR3,,,,,,,,
14133,NOD2,C0039103,Triamcinolone,DB00620,Synovitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,BLAU,PSORAS1,CLR16.3,NLRC2,IBD1,CARD15,,,,,,,,,,,,,,,,,,,,
19010,CYP19A1,C0221392,Quinestrol,DB04575,Atrophic Vaginitis,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)OC5CCCC5},,Reproductive system disease,ARO,P-450AROM,CPV1,ARO1,CYAR,aromatase,CYP19,,,,,,,,,,,,,,,,,,,
26599,ABCA12,C1335302,Paclitaxel,DB01229,Pancreatic Ductal Adenocarcinoma,Suspended,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1/Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32106,MUC2,C0034885,Oxaliplatin,DB00526,Rectal Neoplasms,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
5301,Procaine benzylpenicillin,DB09320,Streptococcal pneumonia,C0155862,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,ABCC4,,,,,,,,
22548,GH1,C0001622,Trilostane,DB01108,Adrenal Gland Hyperfunction,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(CC(=C([C@H]4O5)O)C#N)C},,Endocrine disease,GH-N,GHN,GH,hGH-N,,,,,,,,,,,,,,,,,,,,,,
26582,SMUG1,C0278838,Ketoconazole,DB01026,Prostate cancer recurrent,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
8876,Armodafinil,DB06413,Postpoliomyelitis Syndrome,C0080040,Terminated,C1=CC=C(C=C1)C(C2=CC=CC=C2)[S@](=O)CC(=O)N},Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5128,Prednisolone,DB00860,"Arthritis, Psoriatic",C0003872,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Immune system disease,,,,,,,,,,,,,,,,,,,RCAN1,,,,,,,,
9439,MSH5-SAPCD1,C0026896,Pyridostigmine,DB00545,Myasthenia Gravis,Approved,C[N+]1=CC=CC(=C1)OC(=O)N(C)C},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5340,Promazine,DB00420,Symptomatic dermographism,C0343065,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,MAD2L2,,,,,,,,
31604,MIR183,C0035309,Finasteride,DB01216,Retinal Diseases,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},Phase 2,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29601,SIK1,C0278883,Paclitaxel,DB01229,Metastatic melanoma,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,msk,SNF1LK,,,,,,,,,,,,,,,,,,,,,,,,
36916,SLC2A1,C0206733,Timolol,DB00373,Strawberry nevus of skin,Withdrawn,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O},Phase 2,Vascular disease,DYT18,DYT9,GLUT1,GLUT,HTLVR,CSE,,,,,,,,,,,,,,,,,,,,
4151,Metoprolol,DB00264,Chronic heart failure,C0264716,Approved,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,RPL18,,,,,,,,
2196,Dexamethasone,DB01234,Humoral hypercalcemia of malignancy (disorder),C0149911,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Urinary system disease,,,,,,,,,,,,,,,,,,,GSTK1,,,,,,,,
24066,BRCA2,C0153467,Olaparib,DB09074,Malignant tumor of peritoneum,Approved,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10792,TPH2,C1263846,Methylphenidate,DB00422,Attention deficit hyperactivity disorder,Approved,COC(=O)C(C1CCCCN1)C2=CC=CC=C2},,Mental and behavioural disorder,NTPH,FLJ37295,,,,,,,,,,,,,,,,,,,,,,,,
16675,DCTN6,C0027662,Erlotinib,DB00530,Multiple Endocrine Neoplasia,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
27817,TAT,C1456624,Methamphetamine,DB01577,Methamphetamine abuse,Withdrawn,C[C@@H](CC1=CC=CC=C1)NC},Phase 1,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
10184,SERPINA1,C0024115,Theophylline,DB00277,Lung diseases,Approved,CN1C2=C(C(=O)N(C1=O)C)NC=N2},,Lung disease,AAT,A1A,PI1,alpha-1-antitrypsin,A1AT,alpha1AT,PI,,,,,,,,,,,,,,,,,,,
18631,F2,C0019069,Desmopressin,DB00035,Hemophilia A,Approved,C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2653,Epoprostenol,DB01240,Nasal congestion (finding),C0027424,Approved,CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/O2)O)O},,,,,,,,,,,,,,,,,,,,,ARSI,,,,,,,,
34724,PARP1,C0035078,Erythropoietin,DB00016,Kidney Failure,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]},Phase 3,Urinary system disease,PARP,PPOL,ADPRT,,,,,,,,,,,,,,,,,,,,,,,
22714,BRAF,C0206682,Lenvatinib,DB09078,Follicular thyroid carcinoma,Approved,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl},,Cancer,BRAF1,,,,,,,,,,,,,,,,,,,,,,,,,
21647,HRG,C0019880,Glycine betaine,DB06756,Homocystinuria,Approved,C[N+](C)(C)CC(=O)[O-]},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
242,Amoxicillin,DB01060,Helicobacter-associated gastritis,C0343378,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C},,Digestive system disease,,,,,,,,,,,,,,,,,,,PCAT1,,,,,,,,
21716,F9,C0040250,Tolnaftate,DB00525,Tinea Capitis,Approved,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
26417,S100A7,C0007124,Oxytocin,DB00107,Noninfiltrating Intraductal Carcinoma,Suspended,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N},Phase 0,Cancer,S100A7c,PSOR1,,,,,,,,,,,,,,,,,,,,,,,,
8920,GGT1,C0013395,Omeprazole,DB00338,Dyspepsia,Suspended,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 2,Digestive system disease,D22S672,D22S732,CD224,,,,,,,,,,,,,,,,,,,,,,,
32604,DAP,C0343401,Nitric Oxide,DB00435,MRSA - Methicillin resistant Staphylococcus aureus infection,Terminated,[N]=O},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32062,CDKN2A,C0023903,Sirolimus,DB00877,Liver neoplasms,Withdrawn,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
17883,RN7SL263P,C0042847,Thiamine,DB00152,Vitamin B 12 Deficiency,Approved,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35889,AS3MT,C0027660,Sorafenib,DB00398,"Neoplasms, Glandular and Epithelial",Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23339,NLRP1,C0042900,Tacrolimus,DB00864,Vitiligo,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
693,Betamethasone,DB00443,Exanthema,C0015230,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Infectious disease,,,,,,,,,,,,,,,,,,,Gamma Hydroxybutyric Acid,,,,,,,,
24402,CYCS,C0010691,Tiopronin,DB06823,Cystinuria,Approved,CC(C(=O)NCC(=O)O)S},,Congenital disorder of metabolism,CYC,,,,,,,,,,,,,,,,,,,,,,,,,
7632,S100A8,C0011615,Triamcinolone,DB00620,"Dermatitis, Atopic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,P8,CGLA,CAGA,,,,,,,,,,,,,,,PDE7B,,,,,,,,
29603,STK32A,C0278883,Paclitaxel,DB01229,Metastatic melanoma,Withdrawn,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
21588,GSR,C0020615,Glucagon recombinant,DB00040,Hypoglycemia,Approved,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CNC=N7)N)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20605,RUNX2,C0029396,Etidronic acid,DB01077,Heterotopic Ossification,Approved,CC(O)(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,AML3,PEBP2A1,PEBP2aA1,CCD,CBFA1,CCD1,,,,,,,,,,,,,,,,,,,,
11805,CCDC151,C0008677,Vilanterol,DB09082,"Bronchitis, Chronic",Approved,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
18131,EGR2,C0553580,Vincristine,DB00541,Ewings sarcoma,Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35064,EMP1,C1535939,Prednisolone,DB00860,Pneumocystis jiroveci pneumonia,Withdrawn,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 3,Infectious disease,TMP,CL-20,,,,,,,,,,,,,,,,,,,,,,,,
18276,PSG2,C0016034,Danazol,DB01406,Breast Fibrocystic Disease,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5},,Other disease,PSGGB,PSG1,PSBG2,,,,,,,,,,,,,,,,,,,,,,,
32638,GADD45B,C0042344,Nitric Oxide,DB00435,Varicose Ulcer,Terminated,[N]=O},Phase 2,Reproductive system disease,GADD45BETA,DKFZP566B133,MYD118,,,,,,,,,,,,,,,,,,,,,,,
25138,JAK2,C0026987,Teriparatide,DB06285,Myelofibrosis,Terminated,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N},Phase 2,Cancer,JTK10,,,,,,,,,,,,,,,,,,,,,,,,,
11516,INSRR,C0014121,Vancomycin,DB00512,Bacterial Endocarditis,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,IRR,,,,,,,,,,,,,,,,,,,,,,,,,
28473,CEACAM3,C0278554,Levoleucovorin,DB11596,Recurrent Rectal Cancer,Withdrawn,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2592,Eltrombopag,DB06210,Chronic idiopathic thrombocytopenic purpura,C0272293,Approved,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C},,Cardiovascular disease,,,,,,,,,,,,,,,,,,,CELA1,,,,,,,,
5815,Tenofovir,DB00300,"Hepatitis B, Chronic",C0524909,Approved,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SHOC2,,,,,,,,
5376,Pyrazinamide,DB00339,Acute tuberculosis,C0275959,Approved,C1=CN=C(C=N1)C(=O)N},,Infectious disease,,,,,,,,,,,,,,,,,,,LMAN1,,,,,,,,
29839,FLT1,C0850666,Omeprazole,DB00338,Infection caused by Helicobacter pylori,Terminated,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 1/Phase 2,Infectious disease,VEGFR1,FLT,,,,,,,,,,,,,,,,,,,,,,,,
8733,Thalidomide,DB01041,Rheumatoid Arthritis,C0003873,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
6149,Triamcinolone,DB00620,"Lupus Erythematosus, Systemic",C0024141,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,,,,,,,,,,,,,,,,,,,MIR4270,,,,,,,,
22275,LMNA,C0013274,Ibuprofen,DB01050,Patent ductus arteriosus,Withdrawn,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O},Phase 2,Congenital malformation,LMN1,CMD1A,LGMD1B,,,,,,,,,,,,,,,,,,,,,,,
11170,IGF1,C0023281,Sodium stibogluconate,DB05630,Leishmaniasis,Approved,C([C@H]([C@@H]1[C@@H]([C@@H](O[Sb](=O)(O1)O[Sb]2(=O)O[C@@H]([C@@H]([C@@H](O2)C(=O)[O-])O)[C@@H](CO)O)C(=O)[O-])O)O)O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+]},,Infectious disease,IGF1A,IGFI,IGF-I,IGF,,,,,,,,,,,,,,,,,,,,,,
9380,CP,C0030567,Trihexyphenidyl,DB00376,Parkinson Disease,Approved,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O},,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,,,,,,,,
23187,CD44,C0220656,Thiotepa,DB04572,Malignant ascites,Approved,C1CN1P(=S)(N2CC2)N3CC3},,Cancer,IN,MC56,Pgp1,CD44R,HCELL,CSPG8,MIC4,MDU2,MDU3,,,,,,,,,,,,,,,,,
6012,Tobramycin,DB00684,Corneal abrasion,C0010032,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,,,,,,,,,,,,,,,,,,,,RO60,,,,,,,,
18379,TRPV4,C0085606,Trospium,DB00209,Urgency of micturition,Approved,C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O},,,OTRPC4,TRP12,VROAC,VRL-2,VR-OAC,CMT2C,,,,,,,,,,,,,,,,,,,,
35549,EPO,C0154830,Octreotide,DB00104,Proliferative diabetic retinopathy,Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 3,Endocrine and metabolic disease,EP,,,,,,,,,,,,,,,,,,,,,,,,,
33682,NPY,C0001956,Zonisamide,DB00909,alcohol use disorder,Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 2,Mental and behavioural disorder,PYY4,,,,,,,,,,,,,,,,,,,,,,,,,
18816,LRRK2,C0152020,Domperidone,DB01184,Gastroparesis,Withdrawn,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O},Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5037,Polymyxin B Sulfate,DB00781,Urinary tract infection,C0042029,Approved,CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CCN)NC(=O)C(CCN)NC(=O)C(CCO)NC(=O)C(CCN)NC=O)CCO)CCN)CCN.OS(=O)(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,WASF5P,,,,,,,,
3775,Lithium,DB01356,Pain,C0030193,Approved,[Li]},,,,,,,,,,,,,,,,,,,,,TBXAS1,,,,,,,,
7949,PTH,C0020502,Alfacalcidol,DB01436,Hyperparathyroidism,Approved,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
18836,RRM2B,C0152020,Domperidone,DB01184,Gastroparesis,Withdrawn,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O},Phase 3,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21417,IFI44L,C0021400,Zanamivir,DB00558,Influenza,Approved,CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)O)N=C(N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
6953,CHI3L1,C0392164,L-Cysteine,DB00151,Pulmonary Cystic Fibrosis,Approved,C([C@@H](C(=O)O)N)S},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,APTX,,,,,,,,
22295,IL1B,C0035435,Indomethacin,DB00328,Rheumatism,Approved,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O},,Immune system disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
5310,SUFU,C0004604,Hydromorphone,DB00327,Back Pain,Terminated,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4},Phase 3,,0,,,,,,,,,,,,,,,,,MTMR14,,,,,,,,
7355,PRKAG2,C0030590,Verapamil,DB00661,Paroxysmal supraventricular tachycardia,Approved,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,BLOC1S2,,,,,,,,
36237,C19orf18,C1510472,Varenicline,DB01273,Drug Dependence,Withdrawn,C1C2CNCC1C3=CC4=NC=CN=C4C=C23},Phase 1,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
20521,CLDN3,C0014869,Omeprazole,DB00338,Peptic Esophagitis,Approved,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31666,KCNQ1OT1,C0149978,Oxaliplatin,DB00526,Adenocarcinoma of rectum,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12221,APOC3,C0020474,Simvastatin,DB00641,"Hyperlipidemia, Familial Combined",Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
30327,PLAA,C0024314,Bortezomib,DB00188,Lymphoproliferative Disorders,Terminated,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O},Phase 2,Primary immunodeficiency,0,,,,,,,,,,,,,,,,,,,,,,,,,
33135,SERPINE1,C0032914,Sildenafil,DB00203,Pre-Eclampsia,Terminated,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C},Phase 2,Hematologic disease,PAI,PLANH1,PAI1,,,,,,,,,,,,,,,,,,,,,,,
24015,FOXF1,C0031190,Sildenafil,DB00203,Persistent Fetal Circulation Syndrome,Withdrawn,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C},Phase 2,,FREAC1,FKHL5,,,,,,,,,,,,,,,,,,,,,,,,
17922,WAS,C0024299,Pegfilgrastim,DB00019,Lymphoma,Terminated,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
20240,IL10,C0043144,Epinephrine,DB00668,Wheezing,Approved,CNC[C@@H](C1=CC(=C(C=C1)O)O)O},,Congenital malformation,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
19266,CSF2,C1961112,Dobutamine,DB00841,Heart Decompensation,Approved,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O},,Cardiovascular disease,GM-CSF,GMCSF,,,,,,,,,,,,,,,,,,,,,,,,
18122,PTPN6,C1704231,Cytarabine,DB00987,Metastatic Malignant Neoplasm to the Leptomeninges,Approved,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
4798,Pemirolast,DB00885,Allergic Conjunctivitis,C0009766,Approved,CC1=CC=CN2C1=NC=C(C2=O)C3=NNN=N3},,Immune system disease,,,,,,,,,,,,,,,,,,,CEP128,,,,,,,,
15121,SST,C0238462,Sorafenib,DB00398,Medullary carcinoma of thyroid,Withdrawn,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,SMST,,,,,,,,,,,,,,,,,,,,,,,,,
10347,DISC1,C0011581,Norepinephrine,DB00368,Depressive disorder,Terminated,C1=CC(=C(C=C1[C@H](CN)O)O)O},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
37194,CDH23,C0221406,Mifepristone,DB00834,Pituitary-dependent Cushing's disease,Withdrawn,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O},Phase 3,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
28828,NOTCH1,C0023452,Vincristine,DB00541,"Leukemia, Lymphocytic, Acute, L1",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 1,Cancer,TAN1,,,,,,,,,,,,,,,,,,,,,,,,,
25626,LMNA,C1134719,Tamoxifen,DB00675,Invasive Ductal Breast Carcinoma,Approved,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},,Cancer,LMN1,CMD1A,LGMD1B,,,,,,,,,,,,,,,,,,,,,,,
15378,INVS,C0020461,Polystyrene sulfonate,DB01344,Hyperkalemia,Approved,C=CC1=CC=C(C=C1)S(=O)(=O)O},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25987,TH2LCRR,C0002171,Triamcinolone,DB00620,Alopecia Areata,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13624,CELIAC2,C0011608,Triamcinolone,DB00620,Dermatitis Herpetiformis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21153,TRBC1,C2936781,Fluoxymesterone,DB01185,Generalized Myotonia of Thomsen,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F},,Musculoskeletal disease,TCRBC1,BV05S1J2.2,,,,,,,,,,,,,,,,,,,,,,,,
12699,DNMT3A,C0079774,Thalidomide,DB01041,Peripheral T-Cell Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
28658,SMUG1,C0153690,Ketoconazole,DB01026,Secondary malignant neoplasm of bone,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
6734,SLC9A6,C0029878,Thonzonium bromide,DB09552,Otitis Externa,Approved,CCCCCCCCCCCCCCCC[N+](C)(C)CCN(CC1=CC=C(C=C1)OC)C2=NC=CC=N2.[Br-]},,Infectious disease,0,,,,,,,,,,,,,,,,,PATZ1,,,,,,,,
8033,FGF7,C1739363,Terazosin,DB01162,Prostatic Hypertrophy,Approved,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC},,,KGF,,,,,,,,,,,,,,,,,,,,,,,,,
15038,HRAS,C0279543,Nilotinib,DB04868,Philadelphia chromosome positive chronic myelogenous leukemia,Approved,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
23338,CD44,C0042900,Tacrolimus,DB00864,Vitiligo,Terminated,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 2/Phase 3,Skin disease,IN,MC56,Pgp1,CD44R,HCELL,CSPG8,MIC4,MDU2,MDU3,,,,,,,,,,,,,,,,,
22636,CTNNB1,C0036992,Glucagon recombinant,DB00040,Short Bowel Syndrome,Terminated,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CNC=N7)N)O},Phase 1/Phase 2,,beta-catenin,armadillo,CTNNB,,,,,,,,,,,,,,,,,,,,,,,
36025,CMA1,C1135191,Udenafil,DB06267,"Heart Failure, Systolic",Terminated,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C},Phase 3,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
28245,EGF,C0017636,Temozolomide,DB00853,Glioblastoma,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
2194,Dexamethasone,DB01234,Herpes zoster keratitis,C1275687,Approved,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Infectious disease,,,,,,,,,,,,,,,,,,,GSTM1,,,,,,,,
35728,SLCO1A2,C0038868,Rasagiline,DB01367,Progressive supranuclear palsy,Terminated,C#CCN[C@@H]1CCC2=CC=CC=C12},Phase 3,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4849,Pheniramine,DB01620,Allergic Conjunctivitis,C0009766,Approved,CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2},,Immune system disease,,,,,,,,,,,,,,,,,,,UGT1A8,,,,,,,,
19405,OPN1MW3,C0008325,Doripenem,DB06211,Cholecystitis,Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10570,HMOX1,C0038220,Secobarbital,DB00418,Status Epilepticus,Approved,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C},,Nervous system disease,bK286B10,HO-1,,,,,,,,,,,,,,,,,,,,,,,,
975,Cefaclor,DB00833,Infection of skin AND/OR subcutaneous tissue,C0178299,Approved,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,Metaxalone,,,,,,,,
22341,CPT1A,C0011849,Pramlintide,DB01278,Diabetes Mellitus,Withdrawn,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N)NC(=O)[C@@H]4CCCN4C(=O)CNC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CNC=N6)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@@H]8CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N8)[C@@H](C)O)C)[C@@H](C)O)CC(=O)N)NC(=O)[C@H](CCCCN)N},Phase 1/Phase 2,Endocrine disease,CPT1-L,L-CPT1,,,,,,,,,,,,,,,,,,,,,,,,
36967,MDM2,C0279084,Sunitinib,DB01268,Kaposi's sarcoma classical type,Withdrawn,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3552,Isoprenaline,DB01064,Common Cold,C0009443,Approved,CC(C)NCC(C1=CC(=C(C=C1)O)O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,HSPD1,,,,,,,,
20600,HIF1A,C0033578,Flutamide,DB00499,Prostatic Neoplasms,Approved,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F},,Cancer,MOP1,HIF-1alpha,PASD8,HIF1,bHLHe78,,,,,,,,,,,,,,,,,,,,,
10263,CXCL10,C0041327,Streptomycin,DB01082,"Tuberculosis, Pulmonary",Approved,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O},,Infectious disease,IFI10,IP-10,crg-2,mob-1,C7,gIP-10,INP10,SCYB10,,,,,,,,,,,,,,,,,,
18628,F8,C0019069,Desmopressin,DB00035,Hemophilia A,Approved,C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N},,Hematologic disease,FVIII,DXS1253E,HEMA,F8C,,,,,,,,,,,,,,,,,,,,,,
18269,COMT,C0016034,Danazol,DB01406,Breast Fibrocystic Disease,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5},,Other disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12636,RSPH4A,C0035455,Sodium Citrate,DB09154,Rhinitis,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30733,CHP1,C0206663,Vincristine,DB00541,"Neuroectodermal Tumor, Primitive",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10306,AKAP9,C0042510,Metoprolol,DB00264,Ventricular Fibrillation,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
36709,THEMIS2,C1153706,Norgestrel,DB09389,Endometrial adenocarcinoma,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2062,IRS1,C0011860,Atorvastatin,DB01076,"Diabetes Mellitus, Non-Insulin-Dependent",Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Endocrine disease,0,,,,,,,,,,,,,,,,,VAV3,,,,,,,,
11158,CXCL10,C0023281,Sodium stibogluconate,DB05630,Leishmaniasis,Approved,C([C@H]([C@@H]1[C@@H]([C@@H](O[Sb](=O)(O1)O[Sb]2(=O)O[C@@H]([C@@H]([C@@H](O2)C(=O)[O-])O)[C@@H](CO)O)C(=O)[O-])O)O)O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+]},,Infectious disease,IFI10,IP-10,crg-2,mob-1,C7,gIP-10,INP10,SCYB10,,,,,,,,,,,,,,,,,,
19830,UBE4B,C0235480,Propafenone,DB01182,Paroxysmal atrial fibrillation,Approved,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
15864,SLC12A3,C0018213,Carbimazole,DB00389,Graves Disease,Approved,CCOC(=O)N1C=CN(C1=S)C},,Immune system disease,NCCT,,,,,,,,,,,,,,,,,,,,,,,,,
22843,PAX8,C0018021,Liothyronine,DB00279,Goiter,Approved,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O},,Endocrine disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12436,IL17A,C0032302,Trovafloxacin,DB00685,Mycoplasma pneumonia,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,IL-17A,IL-17,CTLA8,IL17,,,,,,,,,,,,,,,,,,,,,,
9258,Simvastatin,DB00641,Atherosclerosis,C0004153,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
31605,MIR96,C0035309,Finasteride,DB01216,Retinal Diseases,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},Phase 2,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20916,MALAT1,C0345904,Floxuridine,DB00322,Malignant neoplasm of liver,Approved,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)F)CO)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
32922,NCKIPSD,C0003125,Quetiapine,DB01224,Anorexia Nervosa,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
7734,Bupivacaine,DB00297,Periodontitis,C0031099,Terminated,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C},Phase 2,Infectious disease,,,,,,,,,,,,,,,,,,,HSPB7,,,,,,,,
20022,PROM1,C0271093,Echothiophate,DB01057,Stargardt's disease,Approved,CCOP(=O)(OCC)SCC[N+](C)(C)C},,Infectious disease,AC133,CD133,RP41,CORD12,PROML1,STGD4,,,,,,,,,,,,,,,,,,,,
25090,FCGR3A,C2363973,Riociguat,DB08931,Chronic thromboembolic pulmonary hypertension,Approved,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC},,Cardiovascular disease,CD16a,,,,,,,,,,,,,,,,,,,,,,,,,
15676,CUX2,C0238111,Topiramate,DB00273,Lennox-Gastaut syndrome,Approved,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},,Nervous system disease,KIAA0293,CDP2,CUTL2,,,,,,,,,,,,,,,,,,,,,,,
28173,VEZT,C0029928,Gemcitabine,DB00441,Ovarian Diseases,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1,Reproductive system disease,DKFZP761C241,,,,,,,,,,,,,,,,,,,,,,,,,
1862,HTR2A,C0001973,Zonisamide,DB00909,"Alcoholic Intoxication, Chronic",Terminated,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N},Phase 2,Other,0,,,,,,,,,,,,,,,,,ZDHHC13,,,,,,,,
12324,RUNX1,C0003873,Thalidomide,DB01041,Rheumatoid Arthritis,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Immune system disease,PEBP2A2,AMLCR1,AML1,CBFA2,,,,,,,,,,,,,,,,,,,,,,
5383,Pyrimethamine,DB00205,Malaria,C0024530,Approved,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,CLCA1,,,,,,,,
3010,Furosemide,DB00695,Edema,C0013604,Approved,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl},,,,,,,,,,,,,,,,,,,,,CD44,,,,,,,,
28111,EPHA5,C0345958,Paclitaxel,DB01229,Large cell carcinoma of lung,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
10024,IL27,C0456103,Vancomycin,DB00512,Sepsis of the newborn,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
28901,BCR,C0279680,Metronidazole,DB00916,Transitional cell carcinoma of bladder,Terminated,CC1=NC=C(N1CCO)[N+](=O)[O-]},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17500,NSMF,C1384606,Ospemifene,DB04938,Dyspareunia,Approved,C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\C3=CC=C(C=C3)OCCO)/CCCl},,Reproductive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9205,GHS,C0400877,Alvimopan,DB06274,Postoperative ileus,Approved,C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
20491,SCN5A,C0039240,Propranolol,DB00571,Supraventricular tachycardia,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12896,CARD9,C0040247,Benzocaine,DB01086,Tinea,Approved,CCOC(=O)C1=CC=C(C=C1)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30632,CEACAM7,C0346990,Cisplatin,DB00515,Carcinomatosis of peritoneal cavity,Terminated,N.N.Cl[Pt]Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
19698,SERPINB1,C0008149,Fusidic Acid,DB02703,Chlamydia Infections,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,EI,PI2,anti-elastase,ELANH2,,,,,,,,,,,,,,,,,,,,,,
12715,MS4A1,C0079774,Thalidomide,DB01041,Peripheral T-Cell Lymphoma,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,Bp35,MS4A2,CD20,,,,,,,,,,,,,,,,,,,,,,,
26526,CEACAM5,C0235782,Oxaliplatin,DB00526,Gallbladder Carcinoma,Suspended,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 1,Cancer,CD66e,,,,,,,,,,,,,,,,,,,,,,,,,
15278,AP2S1,C0085682,"Sodium phosphate, monobasic, monohydrate",DB09525,Hypophosphatemia,Approved,OP(=O)(O)[O-].[Na+]},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13102,ADAMTS13,C0003175,Procaine benzylpenicillin,DB09320,Anthrax disease,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,VWFCP,vWF-CP,FLJ42993,MGC118899,MGC118900,DKFZp434C2322,C9orf8,,,,,,,,,,,,,,,,,,,
24804,TRAF3IP2,C1527336,Prednisolone,DB00860,Sjogren's Syndrome,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7372,CLPX,C0162568,Afamelanotide,DB04931,Erythropoietic Protoporphyria,Approved,CCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N5CCC[C@H]5C(=O)N[C@@H](C(C)C)C(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CC=C(C=C6)O)NC(=O)[C@H](CO)NC(=O)C},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,VGLL4,,,,,,,,
29020,TTC9,C0027412,Buprenorphine,DB00921,Opioid-Related Disorders,Terminated,C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)(C(C)(C)C)O},Phase 2,,KIAA0227,TTC9A,,,,,,,,,,,,,,,,,,,,,,,,
35548,MMP9,C0154830,Octreotide,DB00104,Proliferative diabetic retinopathy,Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 3,Endocrine and metabolic disease,CLG4B,,,,,,,,,,,,,,,,,,,,,,,,,
11748,KCNH2,C0085612,Tocainide,DB01056,Ventricular arrhythmia,Approved,CC1=C(C(=CC=C1)C)NC(=O)C(C)N},,Cardiovascular disease,Kv11.1,HERG,erg1,LQT2,,,,,,,,,,,,,,,,,,,,,,
33811,ANGPT2,C0022680,Sirolimus,DB00877,Polycystic Kidney Diseases,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2/Phase 3,Congenital malformation,Ang2,,,,,,,,,,,,,,,,,,,,,,,,,
36073,GLI2,C0004779,Verteporfin,DB00460,Basal Cell Nevus Syndrome,Terminated,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C.CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)O)C(=C3C)CCC(=O)OC)C=C},Phase 3,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27011,HTC2,C1955861,Thalidomide,DB01041,T-Cell Large Granular Lymphocyte Leukemia,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
14269,GABRA3,C0080274,Tamsulosin,DB00706,Urinary Retention,Terminated,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
22752,TCN1,C0002888,Levoleucovorin,DB11596,"Anemia, Megaloblastic",Approved,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
25011,NGF,C0035235,Ribavirin,DB00811,Respiratory Syncytial Virus Infections,Approved,C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N},,Infectious disease,NGFB,,,,,,,,,,,,,,,,,,,,,,,,,
35556,LGALS1,C0154830,Octreotide,DB00104,Proliferative diabetic retinopathy,Terminated,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O},Phase 3,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34050,PDCD10,C0018681,Naratriptan,DB00952,Headache,Withdrawn,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C},Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
8172,GJB6,C0042109,Methotrexate,DB00563,Urticaria,Terminated,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Skin and connective tissue disease,EDH,CX30,ED2,,,,,,,,,,,,,,,,,,,,,,,
13223,CTAA1,C0041912,Phenoxymethylpenicillin,DB00417,Upper Respiratory Infections,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7888,IL6,C0029401,Zoledronic acid,DB00399,Osteitis Deformans,Approved,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O},,Musculoskeletal disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
8203,H2AC5P,C0003868,Triamcinolone,DB00620,"Arthritis, Gouty",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3178,Gentamicin,DB00798,Infective blepharitis,C0729587,Approved,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC},,Infectious disease,,,,,,,,,,,,,,,,,,,LRCH1,,,,,,,,
19410,ESR1,C0008325,Doripenem,DB06211,Cholecystitis,Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O},,Digestive system disease,NR3A1,Era,ER-alpha,ESR,,,,,,,,,,,,,,,,,,,,,,
27335,SNRK,C1335177,Trametinib,DB08911,Ovarian Serous Adenocarcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2/Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2851,SCN5A,C0151636,Encainide,DB01228,Premature ventricular contractions,Approved,CN1CCCCC1CCC2=CC=CC=C2NC(=O)C3=CC=C(C=C3)OC},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,PARK16,,,,,,,,
9843,Celecoxib,DB00482,Precancerous Conditions,C0032927,Withdrawn,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},Phase 2/Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
30493,TNF,C0031117,Capsaicin,DB06774,Peripheral Neuropathy,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 3,Nervous system disease,TNFSF2,DIF,TNF-alpha,TNFA,,,,,,,,,,,,,,,,,,,,,,
9200,Oxycodone,DB00497,Constipation,C0009806,Terminated,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O},Phase 3,Digestive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
30728,IGF1,C0206663,Vincristine,DB00541,"Neuroectodermal Tumor, Primitive",Terminated,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 2,Cancer,IGF1A,IGFI,IGF-I,IGF,,,,,,,,,,,,,,,,,,,,,,
1431,Cefuroxime,DB01112,Arthropathy associated with infection,C0157749,Approved,CO/N=C(/C1=CC=CO1)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O},,Immune system disease,,,,,,,,,,,,,,,,,,,Sulfamethoxazole,,,,,,,,
36459,ETFA,C0862312,Pemetrexed,DB00642,"Epithelioid mesothelioma, malignant",Withdrawn,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16907,NOD2,C0014356,Clidinium,DB00771,Enterocolitis,Approved,C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O},,Gastrointestinal disease,BLAU,PSORAS1,CLR16.3,NLRC2,IBD1,CARD15,,,,,,,,,,,,,,,,,,,,
10772,CHI3L1,C0155862,Troleandomycin,DB01361,Streptococcal pneumonia,Approved,C[C@@H]1C[C@@H]([C@H]([C@@H](O1)O[C@H]2[C@H](C[C@@]3(CO3)C(=O)[C@@H]([C@H]([C@H]([C@H](OC(=O)[C@@H]([C@H]([C@@H]2C)O[C@H]4C[C@@H]([C@H]([C@@H](O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11809,DNAAF4,C0008677,Vilanterol,DB09082,"Bronchitis, Chronic",Approved,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl},,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
35197,TTR,C0442874,Magnesium Sulfate,DB00653,Neuropathy,Terminated,[O-]S(=O)(=O)[O-].[Mg+2]},Phase 3,Urinary system disease,HsT2651,CTS,PALB,CTS1,,,,,,,,,,,,,,,,,,,,,,
294,Amphotericin B,DB00681,Leishmaniasis,C0023281,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Chlorphenesin,,,,,,,,
30563,TP53,C0151779,Temozolomide,DB00853,Cutaneous Melanoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
36177,NTRK2,C0155305,Timolol,DB00373,"Optic Neuropathy, Ischemic",Withdrawn,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O},Phase 1,,0,,,,,,,,,,,,,,,,,,,,,,,,,
29830,ACTB,C0700292,Nitric Oxide,DB00435,Hypoxemia,Terminated,[N]=O},Phase 1/Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27437,SHBG,C0038506,Asenapine,DB06216,Stuttering,Suspended,CN1C[C@@H]2[C@@H](C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24},Phase 3,,ABP,TEBG,MGC126834,MGC138391,,,,,,,,,,,,,,,,,,,,,,
36180,NGF,C0220603,Valproic Acid,DB00313,childhood brain tumor,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,NGFB,,,,,,,,,,,,,,,,,,,,,,,,,
21478,TIRAP,C0032269,Lincomycin,DB01627,Pneumococcal Infections,Approved,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
10462,SH2B3,C0038454,Vorapaxar,DB09030,Cerebrovascular accident,Approved,CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@H]([C@H]2/C=C/C4=NC=C(C=C4)C5=CC(=CC=C5)F)[C@H](OC3=O)C},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14239,OPA1,C0028840,Unoprostone,DB06826,Ocular Hypertension,Approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32332,CRHR1,C0238013,Voriconazole,DB00582,Invasive aspergillosis,Terminated,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},Phase 3,Infectious disease,CRF-R,CRF1,CRHR,,,,,,,,,,,,,,,,,,,,,,,
5945,Ticarcillin,DB01607,Bacterial infection due to Klebsiella pneumoniae,C0343402,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,PPP6C,,,,,,,,
32846,CRP,C1290884,Prednisone,DB00635,Inflammatory disorder,Terminated,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},Phase 2,Immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
28882,CNTN6,C0278493,Tamoxifen,DB00675,Breast cancer recurrent,Withdrawn,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
12943,IL2,C0011633,Benzoic Acid,DB03793,Dermatomyositis,Approved,C1=CC=C(C=C1)C(=O)O},,Musculoskeletal disease,IL-2,TCGF,,,,,,,,,,,,,,,,,,,,,,,,
19785,MAPK14,C0036472,Fusidic Acid,DB02703,Scrub Typhus,Approved,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C},,Infectious disease,PRKM14,Mxi2,PRKM15,CSPB1,CSBP1,CSBP2,,,,,,,,,,,,,,,,,,,,
28120,DDR2,C0345958,Paclitaxel,DB01229,Large cell carcinoma of lung,Terminated,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1,Cancer,TKT,TYRO10,NTRKR3,,,,,,,,,,,,,,,,,,,,,,,
9778,CPB2,C0085437,Tobramycin,DB00684,"Meningitis, Bacterial",Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
22742,TPR,C0238463,Lenvatinib,DB09078,Papillary thyroid carcinoma,Approved,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
17758,CRYAA,C0042164,Triamcinolone,DB00620,Uveitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
29632,MPO,C0279632,Vorinostat,DB02546,adult acute megakaryoblastic leukemia (M7),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
25118,CHRNA3,C0730607,Roflumilast,DB01656,Severe chronic obstructive pulmonary disease,Approved,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F},,Lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,
26576,CSF2,C0278838,Ketoconazole,DB01026,Prostate cancer recurrent,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,GM-CSF,GMCSF,,,,,,,,,,,,,,,,,,,,,,,,
1371,Ceftolozane,DB09050,Intraabdominal Infections,C1112209,Approved,CC(C)(C(=O)O)O/N=C(/C1=NSC(=N1)N)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC(=C(N4C)N)NC(=O)NCCN)C(=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,Secobarbital,,,,,,,,
34696,CTLA4,C0220650,Temozolomide,DB00853,Metastatic malignant neoplasm to brain,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,CD152,CELIAC3,IDDM12,,,,,,,,,,,,,,,,,,,,,,,
28397,P2RX7,C0007682,Temozolomide,DB00853,CNS disorder,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Nervous system disease,P2X7,MGC20089,,,,,,,,,,,,,,,,,,,,,,,,
19393,HK1,C0008325,Doripenem,DB06211,Cholecystitis,Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16181,PARP1,C0036117,Chloramphenicol,DB00446,Salmonella infections,Approved,C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]},,Infectious disease,PARP,PPOL,ADPRT,,,,,,,,,,,,,,,,,,,,,,,
15762,CDK5R1,C0040997,Carbamazepine,DB00564,Trigeminal Neuralgia,Approved,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
31680,PLCG2,C0006271,Fluticasone Propionate,DB00588,Bronchiolitis,Terminated,CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF},Phase 2,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3922,Medroxyprogesterone acetate,DB00603,Hot flushes,C0600142,Approved,C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C},,,,,,,,,,,,,,,,,,,,,CYP3A4,,,,,,,,
1804,Clopidogrel,DB00758,Cerebral Embolism,C0007780,Approved,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3},,Vascular disease,,,,,,,,,,,,,,,,,,,LTBP2,,,,,,,,
23588,SHBG,C0020651,Midodrine,DB00211,"Hypotension, Orthostatic",Approved,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O},,Cardiovascular disease,ABP,TEBG,MGC126834,MGC138391,,,,,,,,,,,,,,,,,,,,,,
8025,NPPC,C0035086,Calcitriol,DB00136,Renal Osteodystrophy,Approved,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},,Endocrine and metabolic disease,CNP,,,,,,,,,,,,,,,,,,,,,,,,,
25662,NOTCH1,C0334579,Valproic Acid,DB00313,Anaplastic astrocytoma,Withdrawn,CCCC(CCC)C(=O)O},Phase 1,Cancer,TAN1,,,,,,,,,,,,,,,,,,,,,,,,,
15690,EJM2,C0238111,Topiramate,DB00273,Lennox-Gastaut syndrome,Approved,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27637,CELA2A,C0524620,Topiramate,DB00273,Metabolic Syndrome X,Suspended,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 3,Endocrine and metabolic disease,ELA2A,,,,,,,,,,,,,,,,,,,,,,,,,
15028,MTTP,C0279543,Nilotinib,DB04868,Philadelphia chromosome positive chronic myelogenous leukemia,Approved,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,MTP,,,,,,,,,,,,,,,,,,,,,,,,,
20475,ABCC9,C0039240,Propranolol,DB00571,Supraventricular tachycardia,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,SUR2,CMD1O,,,,,,,,,,,,,,,,,,,,,,,,
10712,CADM1,C0519030,Norfloxacin,DB01059,Pneumonia due to Klebsiella pneumoniae,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,NECL2,ST17,BL2,SYNCAM,IGSF4A,Necl-2,SYNCAM1,RA175,TSLC1,IGSF4,,,,,,,,,,,,,,,,
17387,CXCL8,C0031069,Colchicine,DB01394,Familial Mediterranean Fever,Approved,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC},,Infectious disease,SCYB8,LUCT,LECT,MDNCF,TSG-1,IL-8,NAP-1,3-10C,MONAP,AMCF-I,LYNAP,NAF,b-ENAP,GCP-1,K60,GCP1,IL8,,,,,,,,,
24111,FCN2,C0036323,Praziquantel,DB01058,Schistosomiasis,Approved,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2},,Mental and behavioural disorder,P35,FCNL,EBP-37,ficolin-2,,,,,,,,,,,,,,,,,,,,,,
9789,THBS1,C0456107,Tobramycin,DB00684,Neonatal meningitis,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Infectious disease,TSP1,THBS,TSP,THBS-1,TSP-1,,,,,,,,,,,,,,,,,,,,,
8056,FADD,C1739363,Terazosin,DB01162,Prostatic Hypertrophy,Approved,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
3280,Hemin,DB03404,Acute intermittent porphyria,C0162565,Approved,CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1[N-]2)C)C=C)C)C=C)C)CCC(=O)O)CCC(=O)O.[Fe+2]},,Congenital disorder of metabolism,,,,,,,,,,,,,,,,,,,MAPK3,,,,,,,,
3144,RYR2,C0151636,Encainide,DB01228,Premature ventricular contractions,Approved,CN1CCCCC1CCC2=CC=CC=C2NC(=O)C3=CC=C(C=C3)OC},,Cardiovascular disease,ARVC2,VTSIP,ARVD2,,,,,,,,,,,,,,,EDA,,,,,,,,
34035,PDGFB,C0018681,Naratriptan,DB00952,Headache,Withdrawn,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C},Phase 3,,SSV,SIS,,,,,,,,,,,,,,,,,,,,,,,,
19124,IL4,C0002438,Sulfacetamide,DB00634,Amebiasis,Approved,CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N},,Infectious disease,BSF1,IL-4,BCGF1,BCGF-1,MGC79402,,,,,,,,,,,,,,,,,,,,,
15964,NRARP,C0153633,Carmustine,DB00262,Malignant neoplasm of brain,Approved,C(CCl)NC(=O)N(CCCl)N=O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29726,BCR,C0279627,Vorinostat,DB02546,adult acute myelomonocytic leukemia (M4),Terminated,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16864,FHL5,C0277528,Ofloxacin,DB01165,Traveler's diarrhea,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Digestive system disease,FLJ33049,dJ393D12.2,,,,,,,,,,,,,,,,,,,,,,,,
14324,TP53,C0936223,Nilutamide,DB00665,Metastatic Prostate Carcinoma,Approved,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
5099,Prazepam,DB01588,Anxiety,C0003467,Approved,C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,CYP2D7,,,,,,,,
34474,STAG2,C0023470,Mycophenolic acid,DB01024,Myeloid Leukemia,Terminated,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
34676,PIK3CD,C0220650,Temozolomide,DB00853,Metastatic malignant neoplasm to brain,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3821,Loteprednol,DB00873,Iridocyclitis,C0022073,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)OCCl)O)CCC4=CC(=O)C=C[C@]34C)O},,,,,,,,,,,,,,,,,,,,,HPSE,,,,,,,,
10818,MOG,C0027404,Sodium oxybate,DB09072,Narcolepsy,Approved,C(CC(=O)[O-])CO.[Na+]},,Nervous system disease,BTN6,BTNL11,,,,,,,,,,,,,,,,,,,,,,,,
36827,SPINT2,C0600139,Simvastatin,DB00641,Prostate carcinoma,Withdrawn,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
918,Carbamazepine,DB00564,Epilepsy characterized by intractable complex partial seizures,C2711653,Approved,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N},,Nervous system disease,,,,,,,,,,,,,,,,,,,Lubiprostone,,,,,,,,
27590,PLCD1,C0010073,Sildenafil,DB00203,Coronary Artery Vasospasm,Suspended,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C},Phase 3,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30246,PTPN11,C1292778,Prednisolone,DB00860,Chronic myeloproliferative disorder,Terminated,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},Phase 2,Cancer,BPTP3,SH-PTP2,SHP-2,PTP2C,SHP2,NS1,,,,,,,,,,,,,,,,,,,,
33829,HMOX1,C0011875,Heparin,DB01109,Diabetic Angiopathies,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 2/Phase 3,Vascular disease,bK286B10,HO-1,,,,,,,,,,,,,,,,,,,,,,,,
12738,LPA,C0149871,Warfarin,DB00682,Deep Vein Thrombosis,Approved,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4906,Phenylacetic acid,DB09269,Hyperammonemia,C0220994,Approved,C1=CC=C(C=C1)CC(=O)O},,Inherited metabolic disease,,,,,,,,,,,,,,,,,,,TUBA1B,,,,,,,,
23251,ZBTB16,C0025874,Progesterone,DB00396,Metrorrhagia,Approved,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,,PLZF,ZNF145,,,,,,,,,,,,,,,,,,,,,,,,
17427,DCTN4,C0854135,Colistin,DB00803,Pseudomonas aeruginosa infection,Approved,CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)[C@@H](C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11308,MYLK,C0032285,Simvastatin,DB00641,Pneumonia,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Infectious disease,smMLCK,MYLK1,MLCK1,,,,,,,,,,,,,,,,,,,,,,,
2774,Etizolam,DB09166,Anxiety,C0003467,Approved,CCC1=CC2=C(S1)N3C(=NN=C3CN=C2C4=CC=CC=C4Cl)C},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,LINC02831,,,,,,,,
12192,LIPC,C0020443,Vitamin E,DB00163,Hypercholesterolemia,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 3,Metabolic disease,HTGL,,,,,,,,,,,,,,,,,,,,,,,,,
22286,HLA-DRB1,C0035435,Indomethacin,DB00328,Rheumatism,Approved,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O},,Immune system disease,HLA-DR1B,,,,,,,,,,,,,,,,,,,,,,,,,
36718,DAP,C1153706,Norgestrel,DB09389,Endometrial adenocarcinoma,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
5883,Tetracycline,DB00759,Pneumonia,C0032285,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,ATXN7,,,,,,,,
1267,Cefradine,DB01333,Infective otitis media,C0729586,Approved,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CCC=CC3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,CFH,,,,,,,,
6171,Triamcinolone,DB00620,Status Asthmaticus,C0038218,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,,,,,,,,,,,,,,,,,,,TOB2,,,,,,,,
31131,SLC5A5,C0742558,Doxorubicin,DB00997,colon cancer liver metastasis,Terminated,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
31551,IL6,C3495917,Exemestane,DB00990,Advanced breast cancer,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C},Phase 2,Cancer,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
11301,CXCL5,C0032285,Simvastatin,DB00641,Pneumonia,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34647,EGFR,C1335703,Gefitinib,DB00317,Recurrent Head and Neck Carcinoma,Terminated,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4},Phase 3,Cancer,ERBB1,ERBB,,,,,,,,,,,,,,,,,,,,,,,,
29923,STAT3,C0856825,Pentostatin,DB00552,Acute GVH disease,Terminated,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O},Phase 1/Phase 2,Immune system disease,APRF,,,,,,,,,,,,,,,,,,,,,,,,,
37073,MIB1,C1168198,Propranolol,DB00571,Recurrent respiratory papillomatosis,Withdrawn,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},Phase 2/Phase 3,Infectious disease,DIP-1,MIB,KIAA1323,ZZANK2,ZZZ6,,,,,,,,,,,,,,,,,,,,,
27458,UROD,C0004903,Vincristine,DB00541,Beckwith-Wiedemann Syndrome,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Congenital malformation,,,,,,,,,,,,,,,,,,,,,,,,,,
3519,Ingenol Mebutate,DB05013,Actinic keratosis,C0022602,Approved,C/C=C(/C)\\C(=O)O[C@H]1C(=C[C@@]23[C@@]1([C@@H](C(=C[C@H](C2=O)[C@H]4[C@H](C4(C)C)C[C@H]3C)CO)O)O)C},,Skin disease,,,,,,,,,,,,,,,,,,,MGP,,,,,,,,
1977,Cyclacillin,DB01000,Urinary tract infection,C0042029,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C3(CCCCC3)N)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,TLR2,,,,,,,,
4515,Norfloxacin,DB01059,non-gonococcal urethritis (NGU),C1112709,Approved,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,HOXA9,,,,,,,,
28956,LCN2,C0024143,Tacrolimus,DB00864,Lupus Nephritis,Withdrawn,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC},Phase 3,Urinary system disease,NGAL,24p3,,,,,,,,,,,,,,,,,,,,,,,,
35153,CCL2,C0947751,Linagliptin,DB08882,Vascular inflammations,Terminated,CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C},Phase 3,Vascular disease,MCP1,MCP-1,MCAF,SMC-CF,GDCF-2,HC11,MGC9434,SCYA2,,,,,,,,,,,,,,,,,,
30450,SGK1,C0011882,Reboxetine,DB00234,Diabetic Neuropathies,Terminated,CCOC1=CC=CC=C1O[C@@H]([C@H]2CNCCO2)C3=CC=CC=C3},Phase 2,Urinary system disease,SGK,,,,,,,,,,,,,,,,,,,,,,,,,
31600,VSX1,C0035309,Finasteride,DB01216,Retinal Diseases,Terminated,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},Phase 2,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
27169,S100A1,C0206728,Sunitinib,DB01268,Plexiform Neurofibroma,Suspended,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
31637,CD44,C0338106,Oxaliplatin,DB00526,Adenocarcinoma of colon,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 3,Cancer,IN,MC56,Pgp1,CD44R,HCELL,CSPG8,MIC4,MDU2,MDU3,,,,,,,,,,,,,,,,,
33383,OPN1MW,C0878773,Lidocaine,DB00281,Overactive Bladder,Terminated,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1465,Celecoxib,DB00482,Ankylosing spondylitis,C0038013,Approved,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},,Musculoskeletal disease,,,,,,,,,,,,,,,,,,,Telmisartan,,,,,,,,
2371,Dimercaprol,DB06782,Accidental poisoning by lead and its compounds and fumes,C0261486,Approved,C(C(CS)S)O},,,,,,,,,,,,,,,,,,,,,STK11,,,,,,,,
2519,Doxycycline,DB00254,Yaws,C0043388,Approved,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,SLC2A9,,,,,,,,
25036,C9orf72,C0002736,Pioglitazone,DB01132,Amyotrophic Lateral Sclerosis,Terminated,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3},Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12319,TRAF6,C0003873,Thalidomide,DB01041,Rheumatoid Arthritis,Terminated,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O},Phase 2,Immune system disease,RNF85,,,,,,,,,,,,,,,,,,,,,,,,,
7783,ATM,C0079773,Belinostat,DB05015,"Lymphoma, T-Cell, Cutaneous",Terminated,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)/C=C/C(=O)NO},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,MIR185,,,,,,,,
12495,ALB,C0032290,Ticarcillin,DB01607,Aspiration Pneumonia,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
1151,Cefotaxime,DB00493,Meningitis due to Klebsiella mobilis,C1719906,Approved,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Oxyphencyclimine,,,,,,,,
16986,MMP9,C3875321,Pramocaine,DB09345,Inflammatory dermatosis,Approved,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2},,Skin and connective tissue disease,CLG4B,,,,,,,,,,,,,,,,,,,,,,,,,
17106,CYP17A1,C0021361,Clomifene,DB00882,Female infertility,Approved,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\Cl)/C3=CC=CC=C3},,Reproductive system disease,P450C17,CPT7,S17AH,CYP17,,,,,,,,,,,,,,,,,,,,,,
15891,IGF1R,C0020550,Sodium Iodide I-131,DB09293,Hyperthyroidism,Approved,[Na+].[131I-]},,Endocrine disease,JTK13,CD221,IGFIR,MGC18216,IGFR,,,,,,,,,,,,,,,,,,,,,
33204,COPD,C0948780,Simvastatin,DB00641,Rhinosinusitis,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21463,PAK3,C0022573,Tobramycin,DB00684,Keratoconjunctivitis,Approved,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
15678,ADGRG1,C0238111,Topiramate,DB00273,Lennox-Gastaut syndrome,Approved,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},,Nervous system disease,TM7LN4,TM7XN1,GPR56,,,,,,,,,,,,,,,,,,,,,,,
5909,Thiabendazole,DB00730,Ascariasis,C0003950,Approved,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3},,Infectious disease,,,,,,,,,,,,,,,,,,,HARS2,,,,,,,,
20294,CLCN5,C3536984,Ergocalciferol,DB00153,"Vitamin D-Resistant Rickets, X-Linked",Approved,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C},,Metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4140,Meticillin,DB01603,Staphylococcal Pneumonia,C0032308,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C3=C(C=CC=C3OC)OC)C(=O)O)C},,Infectious disease,,,,,,,,,,,,,,,,,,,RPS24,,,,,,,,
11880,DISC1,C0036341,Glycine,DB00145,Schizophrenia,Withdrawn,C(C(=O)O)N},Phase 3,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
25230,PAH,C0751434,Verapamil,DB00661,Classical phenylketonuria,Terminated,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC},Phase 2,Congenital disorder of metabolism,PH,,,,,,,,,,,,,,,,,,,,,,,,,
30377,HBB,C0018939,Melphalan,DB01042,Hematological Disease,Terminated,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl},Phase 2,Hematologic disease,CD113t-C,beta-globin,,,,,,,,,,,,,,,,,,,,,,,,
31565,NR1H4,C0400966,Ezetimibe,DB00973,Non-alcoholic Fatty Liver Disease,Terminated,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O},Phase 2,Endocrine disease,FXR,RIP14,HRR1,HRR-1,,,,,,,,,,,,,,,,,,,,,,
35033,CFP,C1609538,Ofloxacin,DB01165,Latent Tuberculosis,Terminated,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},Phase 3,Infectious disease,PFC,,,,,,,,,,,,,,,,,,,,,,,,,
35493,SELE,C0035126,Nitric Oxide,DB00435,Reperfusion Injury,Terminated,[N]=O},Phase 3,,ESEL,CD62E,ELAM1,ELAM,,,,,,,,,,,,,,,,,,,,,,
7275,CRLF2,C0037383,Tripelennamine,DB00792,Sneezing,Approved,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2},,,CRL2,TSLPR,,,,,,,,,,,,,,,,SNHG6,,,,,,,,
12480,PMM2,C0032290,Ticarcillin,DB01607,Aspiration Pneumonia,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
697,Betamethasone,DB00443,Humoral hypercalcemia of malignancy (disorder),C0149911,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Urinary system disease,,,,,,,,,,,,,,,,,,,CASQ2,,,,,,,,
22487,EPO,C0042373,Tolazoline,DB00797,Vascular Diseases,Approved,C1CN=C(N1)CC2=CC=CC=C2},,Vascular disease,EP,,,,,,,,,,,,,,,,,,,,,,,,,
1066,Cefdinir,DB00535,Acute Moraxella catarrhalis bronchitis,C0339932,Approved,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\O)/C3=CSC(=N3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Naloxegol,,,,,,,,
18935,PTGES,C0409959,Diclofenac,DB00586,"Osteoarthritis, Knee",Approved,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl},,Musculoskeletal disease,MGST-IV,PIG12,MGST1-L1,TP53I12,MGST1L1,,,,,,,,,,,,,,,,,,,,,
28657,FOLH1,C0153690,Ketoconazole,DB01026,Secondary malignant neoplasm of bone,Terminated,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2433,Dopamine,DB00988,Parkinsonian Disorders,C0242422,Approved,C1=CC(=C(C=C1CCN)O)O},,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,GNA11,,,,,,,,
22638,DPP4,C0036992,Glucagon recombinant,DB00040,Short Bowel Syndrome,Terminated,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CNC=N7)N)O},Phase 1/Phase 2,,CD26,ADCP2,,,,,,,,,,,,,,,,,,,,,,,,
7457,ACE,C1269683,Quetiapine,DB01224,Major Depressive Disorder,Terminated,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42},Phase 3,Mental and behavioural disorder,ACE1,CD143,DCP1,,,,,,,,,,,,,,,TAS2R13,,,,,,,,
24063,IL17D,C0341823,Olaparib,DB09074,Epithelial tumor of ovary,Approved,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
28052,GRIN2B,C0020429,Capsaicin,DB06774,Hyperalgesia,Terminated,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC},Phase 1,Nervous system,GluN2B,NMDAR2B,,,,,,,,,,,,,,,,,,,,,,,,
3310,Hydrocortisone,DB00741,Addison Disease,C0001403,Approved,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O},,Endocrine disease,,,,,,,,,,,,,,,,,,,DHDDS,,,,,,,,
6590,CD2AP,C0002351,Acetazolamide,DB00819,Altitude Sickness,Approved,CC(=O)NC1=NN=C(S1)S(=O)(=O)N},,,CMS,,,,,,,,,,,,,,,,,CYP26A1,,,,,,,,
25895,PKD3,C0085413,Tolvaptan,DB06212,"Polycystic Kidney, Autosomal Dominant",Approved,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C},,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
36691,RBP1,C0349579,Norgestrel,DB09389,Atypical Endometrial Hyperplasia,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Reproductive system disease,CRBP1,CRBP,RBPC,CRBPI,,,,,,,,,,,,,,,,,,,,,,
16820,CDKN2A,C0600041,Ofloxacin,DB01165,Infective cystitis,Approved,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O},,Infectious disease,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
7255,IL22,C1260880,Xylometazoline,DB06694,Rhinorrhea,Approved,CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C},,Nervous system disease,ILTIF,zcyto18,IL-TIF,IL-D110,TIFa,TIFIL-23,MGC79382,MGC79384,,,,,,,,,,ARHGAP31,,,,,,,,
22667,LTA,C0019151,Phenylacetic acid,DB09269,Hepatic Encephalopathy,Terminated,C1=CC=C(C=C1)CC(=O)O},Phase 2,Liver disease,TNFSF1,LT,TNFB,,,,,,,,,,,,,,,,,,,,,,,
5878,Tetracycline,DB00759,Infective otitis media,C0729586,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,LINC01478,,,,,,,,
6677,CAV1,C0017612,Unoprostone,DB06826,"Glaucoma, Open-Angle",Approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},,Nervous system disease,,,,,,,,,,,,,,,,,,TCL1B,,,,,,,,
24453,NGF,C0232849,Pentosan Polysulfate,DB00686,Bladder pain,Approved,C1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2CO[C@H]([C@@H]([C@H]2OS(=O)(=O)O)OS(=O)(=O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)O},,,NGFB,,,,,,,,,,,,,,,,,,,,,,,,,
26622,BAG3,C1335302,Paclitaxel,DB01229,Pancreatic Ductal Adenocarcinoma,Suspended,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C},Phase 1/Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
10871,CCL2,C0028754,Fenofibrate,DB01039,Obesity,Withdrawn,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl},Phase 1,Metabolic disease,MCP1,MCP-1,MCAF,SMC-CF,GDCF-2,HC11,MGC9434,SCYA2,,,,,,,,,,,,,,,,,,
20978,CFTR,C0025218,Tretinoin,DB00755,Chloasma,Approved,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},,Skin disease,ABC35,TNR-CFTR,CFTR/MRP,CF,ABCC7,,,,,,,,,,,,,,,,,,,,,
15179,CYP17A1,C0013390,Naproxen,DB00788,Dysmenorrhea,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,Reproductive system disease,P450C17,CPT7,S17AH,CYP17,,,,,,,,,,,,,,,,,,,,,,
5232,Prednisone,DB00635,Dermatitis Herpetiformis,C0011608,Approved,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},,Immune system disease,,,,,,,,,,,,,,,,,,,ADSS1,,,,,,,,
1107,Cefixime,DB00671,Upper Respiratory Infections,C0041912,Approved,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Nizatidine,,,,,,,,
13546,HBB,C0002875,Triamcinolone,DB00620,Cooley's anemia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Hematologic disease,CD113t-C,beta-globin,,,,,,,,,,,,,,,,,,,,,,,,
13734,SPINK5,C0011606,Triamcinolone,DB00620,Exfoliative dermatitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
16679,TMED7,C0027662,Erlotinib,DB00530,Multiple Endocrine Neoplasia,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
29377,CCK,C1699634,Letrozole,DB01006,HER-2 positive breast cancer,Withdrawn,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3},Phase 1/Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
19495,IFNL3,C0276535,Doxorubicin,DB00997,AIDS with Kaposi's sarcoma,Approved,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1304,Ceftazidime,DB00438,Haemophilus sepsis,C0854324,Approved,CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]},,Infectious disease,,,,,,,,,,,,,,,,,,,Quazepam,,,,,,,,
30248,EZH2,C0079731,Dexamethasone,DB01234,B-Cell Lymphomas,Terminated,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 2,Cancer,EZH1,ENX-1,KMT6,KMT6A,,,,,,,,,,,,,,,,,,,,,,
31911,GP9,C1696708,Losartan,DB00678,Prehypertension,Terminated,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl},Phase 2,Cardiovascular disease,CD42a,GPIX,,,,,,,,,,,,,,,,,,,,,,,,
5051,Potassium alum,DB09087,Gastroesophageal reflux disease,C0017168,Approved,[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Al+3].[K+]},,Digestive system disease,,,,,,,,,,,,,,,,,,,SLITRK5,,,,,,,,
6494,COMT,C0030193,Oxycodone,DB00497,Pain,Withdrawn,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O},Phase 3,,0,,,,,,,,,,,,,,,,,B3GNTL1,,,,,,,,
34336,CRP,C0085426,Vancomycin,DB00512,Gram-Positive Bacterial Infections,Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,
13104,PARP1,C0003175,Procaine benzylpenicillin,DB09320,Anthrax disease,Approved,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C},,Infectious disease,PARP,PPOL,ADPRT,,,,,,,,,,,,,,,,,,,,,,,
9076,GER,C0018834,Sodium Citrate,DB09154,Heartburn,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
136,Amantadine,DB00915,Parkinsonian Disorders,C0242422,Approved,C1C2CC3CC1CC(C2)(C3)N},,Neurodegenerative disease,,,,,,,,,,,,,,,,,,,Benzoic Acid,,,,,,,,
28707,FEN1,C0009404,Sorafenib,DB00398,Colorectal Neoplasms,Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
26956,KMT2A,C0280745,Decitabine,DB01262,secondary myelodysplastic syndromes,Terminated,C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O},Phase 1,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
16454,DNASE1L3,C0027498,Ondansetron,DB00904,Nausea and vomiting,Withdrawn,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C},Phase 3,Digestive system disease,DNAS1L3,LSD,,,,,,,,,,,,,,,,,,,,,,,,
718,Betamethasone,DB00443,Scalp Dermatoses,C0036271,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Immune system disease,,,,,,,,,,,,,,,,,,,Glycodiazine,,,,,,,,
18638,F5,C0019069,Desmopressin,DB00035,Hemophilia A,Approved,C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N},,Hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,
23759,TLR2,C0038160,Vancomycin,DB00512,Staphylococcal Infections,Approved,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},,Infectious disease,TIL4,CD282,,,,,,,,,,,,,,,,,,,,,,,,
17116,LIF,C0021361,Clomifene,DB00882,Female infertility,Approved,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\\Cl)/C3=CC=CC=C3},,Reproductive system disease,CDF,HILDA,,,,,,,,,,,,,,,,,,,,,,,,
30009,HLA-DQA1,C0024137,Tretinoin,DB00755,"Lupus Erythematosus, Cutaneous",Terminated,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C},Phase 2,Immune system disease,HLA-DQA,,,,,,,,,,,,,,,,,,,,,,,,,
24771,HMGB1,C0034069,Azathioprine,DB00993,Pulmonary Fibrosis,Terminated,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]},Phase 3,Lung disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31169,MMP3,C0877438,Doxycycline,DB00254,Non-ischemic cardiomyopathy,Terminated,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},Phase 2,Cardiovascular disease,STMY1,STMY,,,,,,,,,,,,,,,,,,,,,,,,
33229,MEIS1,C0280141,Sunitinib,DB01268,Acute Undifferentiated Leukemia,Terminated,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
4855,Pheniramine,DB01620,Headache Disorders,C0393735,Approved,CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2},,Nervous system disease,,,,,,,,,,,,,,,,,,,GNE,,,,,,,,
3712,Levomethadyl Acetate,DB01227,Opiate Addiction,C0524662,Approved,CC[C@@H](C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C},,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,IRF2BP2,,,,,,,,
29038,COMT,C0600427,Vigabatrin,DB01080,Cocaine Dependence,Terminated,C=CC(CCC(=O)O)N},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
19859,PRF1,C0002874,Heparin,DB01109,Aplastic Anemia,Terminated,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O},Phase 3,Hematologic disease,PFP,HPLH2,,,,,,,,,,,,,,,,,,,,,,,,
9509,IL6,C0242429,Pheniramine,DB01620,Sore Throat,Approved,CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2},,Infectious disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
20772,AR,C4083212,Finasteride,DB01216,"Alopecia, Male Pattern",Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C},,Skin disease,AIS,NR3C4,SMAX1,HUMARA,DHTR,SBMA,,,,,,,,,,,,,,,,,,,,
27057,CDKN2A,C0205824,Ifosfamide,DB01181,"Liposarcoma, Dedifferentiated",Suspended,C1CN(P(=O)(OC1)NCCCl)CCCl},Phase 2,Cancer,p16,INK4a,CMM2,ARF,INK4,p16INK4a,p19Arf,p14ARF,CDKN2,MLM,,,,,,,,,,,,,,,,
23259,SMUG1,C0153685,Progesterone,DB00396,Secondary malignant neoplasm of kidney,Approved,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
2489,Doxycycline,DB00254,Cutaneous anthrax,C0003177,Approved,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,ADA,,,,,,,,
10483,POMT1,C0010200,Sodium Citrate,DB09154,Coughing,Approved,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+]},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
5157,Prednisolone,DB00860,Exacerbation of asthma,C0349790,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Immune system disease,,,,,,,,,,,,,,,,,,,WDR45,,,,,,,,
23571,JAG1,C0020651,Midodrine,DB00211,"Hypotension, Orthostatic",Approved,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O},,Cardiovascular disease,AHD,AWS,HJ1,CD339,AGS,JAGL1,,,,,,,,,,,,,,,,,,,,
1467,Celecoxib,DB00482,Dysmenorrhea,C0013390,Approved,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F},,Reproductive system disease,,,,,,,,,,,,,,,,,,,IFIH1,,,,,,,,
13464,LRBA,C0002880,Triamcinolone,DB00620,Autoimmune hemolytic anemia,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31033,MLH3,C0280793,Temozolomide,DB00853,Mixed Oligodendroglioma-Astrocytoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
26647,NEU1,C0278486,Exemestane,DB00990,Breast cancer stage II,Withdrawn,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
1889,Cortisone acetate,DB01380,Cooley's anemia,C0002875,Approved,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O},,Hematologic disease,,,,,,,,,,,,,,,,,,,DNAAF2,,,,,,,,
23124,IL1B,C0010674,Amikacin,DB00479,Cystic Fibrosis,Withdrawn,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N},Phase 3,Congenital disorder of metabolism,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
13205,LEPR,C0041912,Phenoxymethylpenicillin,DB00417,Upper Respiratory Infections,Approved,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C},,Infectious disease,OBR,CD295,,,,,,,,,,,,,,,,,,,,,,,,
5575,Simvastatin,DB00641,Familial hypercholesterolemia - homozygous,C0342881,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Inherited metabolic disease,,,,,,,,,,,,,,,,,,,MSRB2,,,,,,,,
14513,FOXM1,C0007847,Topotecan,DB01030,Malignant tumor of cervix,Approved,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O},,Cancer,HFH-11,trident,HNF-3,INS-1,MPP2,MPHOSPH2,TGT3,FKHL16,,,,,,,,,,,,,,,,,,
28368,OTC,C0006111,Temozolomide,DB00853,Brain Diseases,Withdrawn,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 2,Nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
24855,TTN,C0007194,Propranolol,DB00571,Hypertrophic Cardiomyopathy,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,CMPD4,FLJ32040,TMD,CMH9,LGMD2J,MYLK5,CMD1G,,,,,,,,,,,,,,,,,,,
36239,UMOD,C0022658,Valsartan,DB00177,Kidney Diseases,Withdrawn,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O},Phase 3,Urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
31023,TP73-AS1,C0280793,Temozolomide,DB00853,Mixed Oligodendroglioma-Astrocytoma,Terminated,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
35222,IL6,C0012813,Mesalazine,DB00244,Diverticulitis,Terminated,C1=CC(=C(C=C1N)C(=O)O)O},Phase 3,Infectious disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
16405,IL33,C0162565,Promazine,DB00420,Acute intermittent porphyria,Approved,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31},,Congenital disorder of metabolism,DVS27,DKFZp586H0523,NF-HEV,IL1F11,C9orf26,,,,,,,,,,,,,,,,,,,,,
2319,Diethylcarbamazine,DB00711,Elephantiasis,C0013882,Approved,CCN(CC)C(=O)N1CCN(CC1)C},,Endocrine and metabolic disease,,,,,,,,,,,,,,,,,,,TRIM21,,,,,,,,
8784,LY6D,C0013295,Sucralfate,DB00364,Duodenal Ulcer,Approved,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al]},,Digestive system disease,E48,,,,,,,,,,,,,,,,,,,,,,,,,
33385,PSAT1,C0878773,Lidocaine,DB00281,Overactive Bladder,Terminated,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C},Phase 3,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
7273,MIR146A,C0037383,Tripelennamine,DB00792,Sneezing,Approved,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2},,,0,,,,,,,,,,,,,,,,,MAGEB6,,,,,,,,
14181,TG,C0040147,Triamcinolone,DB00620,Thyroiditis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Endocrine disease,TGN,AITD3,,,,,,,,,,,,,,,,,,,,,,,,
32515,ADIPOQ,C0279702,Sorafenib,DB00398,Conventional (Clear Cell) Renal Cell Carcinoma,Terminated,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F},Phase 2,Cancer,ACRP30,AdipoQ,apM1,GBP28,adiponectin,ACDC,,,,,,,,,,,,,,,,,,,,
11497,DDT,C0041471,Tetracycline,DB00759,TYPHUS,Approved,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11106,SOD1,C0010414,Amphotericin B,DB00681,Infection by Cryptococcus neoformans,Approved,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24768,HGF,C0034069,Azathioprine,DB00993,Pulmonary Fibrosis,Terminated,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]},Phase 3,Lung disease,F-TCF,HGFB,HPTA,DFNB39,,,,,,,,,,,,,,,,,,,,,,
12116,RELA,C0003850,Simvastatin,DB00641,Arteriosclerosis,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
1335,Ceftizoxime,DB01332,Acute gonococcal urethritis,C0275652,Approved,CO/N=C(/C1=CSC(=N1)N)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Rifaximin,,,,,,,,
14062,PAGR1,C0035439,Triamcinolone,DB00620,Rheumatic Heart Disease,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21000,PPARG,C0007102,Oxaliplatin,DB00526,Malignant tumor of colon,Withdrawn,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,PPARG1,PPARG2,NR1C3,PPARgamma,,,,,,,,,,,,,,,,,,,,,,
27361,AFP,C0334359,Trametinib,DB08911,Papillary serous cystadenocarcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2/Phase 3,Cancer,FETA,HPAFP,,,,,,,,,,,,,,,,,,,,,,,,
16064,ICOS,C0025289,Gemcitabine,DB00441,Meningitis,Terminated,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F},Phase 1,Infectious disease,AILIM,CD278,,,,,,,,,,,,,,,,,,,,,,,,
3874,Magnesium salicylate,DB01397,Pain,C0030193,Approved,C1=CC=C(C(=C1)C(=O)O)[O-].C1=CC=C(C(=C1)C(=O)O)[O-].[Mg+2]},,,,,,,,,,,,,,,,,,,,,TPP2,,,,,,,,
30772,FLT3,C0242596,Methotrexate,DB00563,"Neoplasm, Residual",Terminated,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,Cancer,FLK2,CD135,,,,,,,,,,,,,,,,,,,,,,,,
677,Betamethasone,DB00443,Autoimmune hemolytic anemia,C0002880,Approved,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},,Hematologic disease,,,,,,,,,,,,,,,,,,,Fomepizole,,,,,,,,
33425,ABCC4,C0013221,Triptorelin,DB06825,Drug toxicity,Terminated,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8},Phase 2,,MRP4,EST170205,MOAT-B,MOATB,,,,,,,,,,,,,,,,,,,,,,
29902,IL10,C0856825,Pentostatin,DB00552,Acute GVH disease,Terminated,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O},Phase 1/Phase 2,Immune system disease,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
14267,COL7A1,C0080274,Tamsulosin,DB00706,Urinary Retention,Terminated,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N},Phase 3,,EBDCT,EBD1,EBR1,,,,,,,,,,,,,,,,,,,,,,,
30214,LINC02401,C1861172,Atorvastatin,DB01076,Venous Thromboembolism,Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 2,Vascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
20699,ANGPTL3,C0473527,Simvastatin,DB00641,Hypoalphalipoproteinemias,Approved,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},,Endocrine and metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
21905,G6PD,C0002895,Hydroxyurea,DB01005,"Anemia, Sickle Cell",Approved,C(=O)(N)NO},,Hematologic disease,G6PD1,,,,,,,,,,,,,,,,,,,,,,,,,
7623,CXCL10,C0011615,Triamcinolone,DB00620,"Dermatitis, Atopic",Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,IFI10,IP-10,crg-2,mob-1,C7,gIP-10,INP10,SCYB10,,,,,,,,,,UNC5D,,,,,,,,
10304,KCNJ18,C0042510,Metoprolol,DB00264,Ventricular Fibrillation,Terminated,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O},Phase 2,,0,,,,,,,,,,,,,,,,,,,,,,,,,
3947,Menthol,DB00825,Arthritic pains,C0857177,Approved,CC1CCC(C(C1)O)C(C)C},,,,,,,,,,,,,,,,,,,,,FYN,,,,,,,,
1013,Cefamandole,DB01326,Escherichia coli urinary tract infection,C0577708,Approved,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)[C@@H](C4=CC=CC=C4)O)SC2)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Methyprylon,,,,,,,,
8014,CASR,C0342634,Alfacalcidol,DB01436,Neonatal hypocalcemia,Approved,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C},,Urinary system disease,FHH,NSHPT,GPRC2A,HHC,HHC1,,,,,,,,,,,,,,,,,,,,,
11448,CXCL13,C0153252,Voriconazole,DB00582,Systemic candidiasis,Approved,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4816,Pentobarbital,DB00312,Status Epilepticus,C0038220,Approved,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC},,Nervous system disease,,,,,,,,,,,,,,,,,,,FJX1,,,,,,,,
11660,CD34,C0040028,Anagrelide,DB00261,"Thrombocythemia, Essential",Approved,C1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
28874,CITED2,C0278493,Tamoxifen,DB00675,Breast cancer recurrent,Withdrawn,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},Phase 3,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
22153,B9D1,C0238198,Sunitinib,DB01268,Gastrointestinal Stromal Tumors,Approved,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\\2/C3=C(C=CC(=C3)F)NC2=O)C},,Cancer,EPPB9,MKS9,,,,,,,,,,,,,,,,,,,,,,,,
29573,HIF1A,C0007114,Fludarabine,DB01073,Malignant neoplasm of skin,Terminated,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N},Phase 1/Phase 2,Cancer,MOP1,HIF-1alpha,PASD8,HIF1,bHLHe78,,,,,,,,,,,,,,,,,,,,,
27934,CXADR,C0280100,Pegfilgrastim,DB00019,Solid tumour,Withdrawn,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO[C@@]2(C[C@@H]([C@H]([C@@H](O2)[C@@H]([C@@H](CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
20326,NF1,C0023827,Trabectedin,DB05109,liposarcoma,Approved,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O},,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
13940,LTB4R,C0026857,Triamcinolone,DB00620,Musculoskeletal Diseases,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,BLTR,P2Y7,LTB4R1,P2RY7,GPR16,CMKRL1,,,,,,,,,,,,,,,,,,,,
24180,MTOR,C0267963,Pancrelipase,DB00085,Exocrine pancreatic insufficiency,Approved,C1CC2C(C(C1O2)C(=O)[O-])C(=O)[O-].[Na+].[Na+]},,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
2324,Difenoxin,DB01501,Diarrhea,C0011991,Approved,C1CN(CCC1(C2=CC=CC=C2)C(=O)O)CCC(C#N)(C3=CC=CC=C3)C4=CC=CC=C4},,Digestive system disease,,,,,,,,,,,,,,,,,,,PLCG1,,,,,,,,
35266,EYA4,C0018784,Methotrexate,DB00563,Sensorineural Hearing Loss (disorder),Terminated,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 3,Cardiovascular disease,DFNA10,CMD1J,,,,,,,,,,,,,,,,,,,,,,,,
22099,COX2,C0346421,Imatinib,DB00619,Chronic eosinophilic leukemia,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
33872,TOP2A,C0751690,Imatinib,DB00619,Malignant Peripheral Nerve Sheath Tumor,Terminated,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},Phase 2/Phase 3,Cancer,TOP2,,,,,,,,,,,,,,,,,,,,,,,,,
22193,IL5RA,C0206141,Imatinib,DB00619,Idiopathic Hypereosinophilic Syndrome,Approved,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5},,Cancer,CDw125,CD125,IL5R,,,,,,,,,,,,,,,,,,,,,,,
18559,FXN,C0282193,Deferasirox,DB01609,Iron Overload,Withdrawn,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O},Phase 2,Mitochondrial disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
4961,Piperacillin,DB00319,Acute gonococcal cervicitis,C0153195,Approved,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,TMED7-TICAM2,,,,,,,,
17763,SOD2,C0042164,Triamcinolone,DB00620,Uveitis,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24363,MET,C0812413,Pemetrexed,DB00642,Malignant Pleural Mesothelioma,Approved,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O},,Cancer,HGFR,RCCP2,DFNB97,,,,,,,,,,,,,,,,,,,,,,,
5611,"Sodium phosphate, monobasic, monohydrate",DB09525,Incomplete passage of stool,C0426639,Approved,OP(=O)(O)[O-].[Na+]},,,,,,,,,,,,,,,,,,,,,INA,,,,,,,,
2418,ABCC8,C0011860,Atorvastatin,DB01076,"Diabetes Mellitus, Non-Insulin-Dependent",Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Endocrine disease,PHHI,SUR1,ABC36,HHF1,TNDM2,SUR,HRINS,,,,,,,,,,,DMD,,,,,,,,
11771,ITGB3,C0019080,Aprotinin,DB06692,Hemorrhage,Approved,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](CSSC[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N4CCC[C@@H]4C(=O)N5CCC[C@@H]5C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N6CCC[C@H]6C(=O)N[C@H](CSSC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CCC(=O)N)[C@@H](C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCNC(=N)N)C)CCCCN)[C@H](C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)[C@@H](C)CC},,,CD61,GPIIIa,GP3A,,,,,,,,,,,,,,,,,,,,,,,
23145,SERPINA3,C0033845,Thiopental,DB00599,Pseudotumor Cerebri,Approved,CCCC(C)C1(C(=O)NC(=S)NC1=O)CC},,Cancer,AACT,,,,,,,,,,,,,,,,,,,,,,,,,
34432,IL10,C0278601,Tamoxifen,DB00675,Inflammatory Breast Carcinoma,Terminated,CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3},Phase 3,Cancer,CSIF,IL10A,IL-10,,,,,,,,,,,,,,,,,,,,,,,
11608,CBLL2,C0013371,Trimethoprim,DB00440,Shigella Infections,Approved,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32082,GJB1,C0023903,Sirolimus,DB00877,Liver neoplasms,Withdrawn,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,CX32,CMTX1,CMTX,,,,,,,,,,,,,,,,,,,,,,,
30361,MAOA,C0019337,Buprenorphine,DB00921,Heroin Dependence,Terminated,C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)(C(C)(C)C)O},Phase 2,Mental and behavioural disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
33089,ATAD2B,C2076600,Rosuvastatin,DB01098,Influenza due to Influenza A virus subtype H1N1,Terminated,CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
31106,IL6,C0022661,Niacin,DB00627,"Kidney Failure, Chronic",Terminated,C1=CC(=CN=C1)C(=O)O},Phase 3,Urinary system disease,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
2150,HNF1B,C0011860,Atorvastatin,DB01076,"Diabetes Mellitus, Non-Insulin-Dependent",Terminated,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4},Phase 3,Endocrine disease,LFB3,VHNF1,HNF1beta,MODY5,TCF2,,,,,,,,,,,,,UROD,,,,,,,,
12560,CARD9,C0009324,Naltrexone,DB00704,Ulcerative Colitis,Withdrawn,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O},Phase 2,Immune system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32094,MLANA,C0031149,Oxaliplatin,DB00526,Peritoneal Neoplasms,Terminated,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]},Phase 2,Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,
14212,DEFB104A,C1384589,Zinc oxide,DB09321,Tinea cruris,Approved,O=[Zn]},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12962,SLC25A15,C0220994,Phenylacetic acid,DB09269,Hyperammonemia,Approved,C1=CC=C(C=C1)CC(=O)O},,Inherited metabolic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
30169,SRSF2,C3463824,Azacitidine,DB00928,MYELODYSPLASTIC SYNDROME,Terminated,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N},Phase 2,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
3433,Hydroxyzine,DB00557,Urticaria,C0042109,Approved,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl},,Skin and connective tissue disease,,,,,,,,,,,,,,,,,,,AK6,,,,,,,,
1739,Clindamycin,DB01190,Acne Vulgaris,C0001144,Approved,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl},,Infectious disease,,,,,,,,,,,,,,,,,,,GLIS3,,,,,,,,
12788,POT1,C0023434,Venetoclax,DB11581,Chronic Lymphocytic Leukemia,Approved,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C},,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
31846,CTNNB1,C3495949,Valproic Acid,DB00313,Locally advanced breast cancer,Terminated,CCCC(CCC)C(=O)O},Phase 2,Cancer,beta-catenin,armadillo,CTNNB,,,,,,,,,,,,,,,,,,,,,,,
21373,KLKB1,C0524702,Fondaparinux sodium,DB00569,Pulmonary Thromboembolisms,Approved,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]},,Hematologic disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36090,ZNRD2,C0004779,Verteporfin,DB00460,Basal Cell Nevus Syndrome,Terminated,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C.CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)O)C(=C3C)CCC(=O)OC)C=C},Phase 3,Skin and connective tissue disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
5130,Prednisolone,DB00860,Aspiration pneumonitis,C1761609,Approved,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,LLGL1,,,,,,,,
27256,CDH1,C0007097,Cisplatin,DB00515,Carcinoma,Withdrawn,N.N.Cl[Pt]Cl},Phase 3,Cancer,uvomorulin,CD324,UVO,,,,,,,,,,,,,,,,,,,,,,,
18206,MYCN,C0027708,Vincristine,DB00541,Nephroblastoma,Approved,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},,Cancer,bHLHe37,N-myc,MYCNOT,NMYC,,,,,,,,,,,,,,,,,,,,,,
34167,EGR1,C0853193,Risperidone,DB00734,Bipolar I disorder,Terminated,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F},Phase 3,Mental and behavioural disorder,TIS8,G0S30,NGFI-A,KROX-24,ZIF-268,AT225,ZNF225,,,,,,,,,,,,,,,,,,,
34269,ABCG5,C0242339,Simvastatin,DB00641,Dyslipidemias,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Metabolic disease,STSL,,,,,,,,,,,,,,,,,,,,,,,,,
21690,PRL,C0002453,Lisuride,DB00589,Amenorrhea,Approved,CCN(CC)C(=O)N[C@@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C},,Reproductive system disease,,,,,,,,,,,,,,,,,,,,,,,,,,
1641,Ciprofloxacin,DB00537,Cystitis escherichia,C0853852,Approved,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O},,Infectious disease,,,,,,,,,,,,,,,,,,,Ziconotide,,,,,,,,
35759,PF4,C0012359,Riboflavin,DB00140,Pathological Dilatation,Terminated,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)C[C@@H]([C@@H]([C@@H](CO)O)O)O},Phase 3,Congenital malformation,SCYB4,CXCL4,,,,,,,,,,,,,,,,,,,,,,,,
24236,MMP9,C0917798,Phentolamine,DB00692,Cerebral Ischemia,Approved,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O},,Cardiovascular disease,CLG4B,,,,,,,,,,,,,,,,,,,,,,,,,
15827,RAF1,C0032897,Somatropin recombinant,DB00052,Prader-Willi Syndrome,Approved,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N},,Chromosomal abnormality,0,,,,,,,,,,,,,,,,,,,,,,,,,
18678,CLCA1,C0042974,Desmopressin,DB00035,von Willebrand Disease,Approved,C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N},,Hematologic disease,CaCC,CLCRG1,,,,,,,,,,,,,,,,,,,,,,,,
15146,CALCA,C0009088,Sumatriptan,DB00669,Cluster Headache,Approved,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C},,,CALC1,,,,,,,,,,,,,,,,,,,,,,,,,
31510,ADCY1,C3898222,Sirolimus,DB00877,Mucosal Melanoma,Terminated,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC},Phase 2,Cancer,AC1,DFNB44,,,,,,,,,,,,,,,,,,,,,,,,
25758,PROKR2,C0020635,Testosterone,DB00624,Hypopituitarism,Approved,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C},,Endocrine disease,GPR73b,PKR2,GPRg2,dJ680N4.3,GPR73L1,KAL3,,,,,,,,,,,,,,,,,,,,
33728,BDNF,C0027609,Clonidine,DB00575,Neonatal Abstinence Syndrome,Terminated,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl},Phase 2/Phase 3,Vascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,
30306,MUC1,C0007120,Bortezomib,DB00188,Bronchioloalveolar Adenocarcinoma,Terminated,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O},Phase 2,Cancer,CD227,PEM,ADMCKD,ADMCKD1,MCKD,MCKD1,,,,,,,,,,,,,,,,,,,,
19658,SLIT2,C0149925,Cisplatin,DB00515,Small cell carcinoma of lung,Terminated,N.N.Cl[Pt]Cl},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
8795,IL1B,C0013295,Sucralfate,DB00364,Duodenal Ulcer,Approved,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al]},,Digestive system disease,IL1F2,IL-1B,IL1-BETA,,,,,,,,,,,,,,,,,,,,,,,
8896,SSTR3,C0013395,Omeprazole,DB00338,Dyspepsia,Suspended,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC},Phase 2,Digestive system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
19485,MIR126,C0270458,Doxepin,DB01142,Severe major depression with psychotic features,Approved,CN(C)CC/C=C/1\\C2=CC=CC=C2COC3=CC=CC=C31},,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
14362,KIT,C0009806,Oxycodone,DB00497,Constipation,Terminated,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O},Phase 3,Digestive system disease,CD117,SCFR,C-Kit,PBT,,,,,,,,,,,,,,,,,,,,,,
34650,DBH,C0342687,Norepinephrine,DB00368,dopamine beta hydroxylase deficiency,Terminated,C1=CC(=C(C=C1[C@H](CN)O)O)O},Phase 3,Nervous system disease,DBM,,,,,,,,,,,,,,,,,,,,,,,,,
36698,IRF1,C1153706,Norgestrel,DB09389,Endometrial adenocarcinoma,Withdrawn,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
25260,CYP1B1,C0152253,Scopolamine,DB00747,Posterior synechiae,Approved,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4},,,CP1B,GLC3A,,,,,,,,,,,,,,,,,,,,,,,,
18331,NALCN,C0024591,Dantrolene,DB01219,Malignant hyperpyrexia due to anesthesia,Approved,C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-]},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
14393,NEUROG3,C0011991,Zidovudine,DB00495,Diarrhea,Terminated,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]},Phase 3,Digestive system disease,Atoh5,Math4B,ngn3,bHLHa7,,,,,,,,,,,,,,,,,,,,,,
36098,CYP2D6,C0004779,Verteporfin,DB00460,Basal Cell Nevus Syndrome,Terminated,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C.CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)O)C(=C3C)CCC(=O)OC)C=C},Phase 3,Skin and connective tissue disease,CPD6,P450-DB1,P450C2D,CYP2DL1,CYP2D7P2,CYP2D7BP,CYP2D8P2,CYP2D7AP,,,,,,,,,,,,,,,,,,
27517,RNF125,C0332890,Vincristine,DB00541,Congenital hemihypertrophy,Suspended,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O},Phase 3,Congenital malformation,0,,,,,,,,,,,,,,,,,,,,,,,,,
31329,MLH1,C0014474,Erlotinib,DB00530,Ependymoma,Terminated,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC},Phase 2,Cancer,0,,,,,,,,,,,,,,,,,,,,,,,,,
3191,Gentamicin,DB00798,Proteus septicemia,C0577690,Approved,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC},,Infectious disease,,,,,,,,,,,,,,,,,,,DNAH9,,,,,,,,
20477,GPD1L,C0039240,Propranolol,DB00571,Supraventricular tachycardia,Approved,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O},,Cardiovascular disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
24390,SLC3A1,C0010691,Tiopronin,DB06823,Cystinuria,Approved,CC(C(=O)NCC(=O)O)S},,Congenital disorder of metabolism,CSNU1,D2H,RBAT,ATR1,NBAT,,,,,,,,,,,,,,,,,,,,,
2689,Ertapenem,DB00303,Streptococcal pneumonia,C0155862,Approved,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)[C@@H](C)O},,Infectious disease,,,,,,,,,,,,,,,,,,,GRIN3A,,,,,,,,
25991,ERBB3,C0002171,Triamcinolone,DB00620,Alopecia Areata,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Skin disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34264,BCL3,C0242339,Simvastatin,DB00641,Dyslipidemias,Terminated,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C},Phase 3,Metabolic disease,D19S37,BCL4,,,,,,,,,,,,,,,,,,,,,,,,
33420,FLII,C0687132,Topiramate,DB00273,heavy drinking,Terminated,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C},Phase 2,Mental and behavioural disorder,0,,,,,,,,,,,,,,,,,,,,,,,,,
32584,SUMF2,C0343401,Nitric Oxide,DB00435,MRSA - Methicillin resistant Staphylococcus aureus infection,Terminated,[N]=O},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
32585,MAVS,C0343401,Nitric Oxide,DB00435,MRSA - Methicillin resistant Staphylococcus aureus infection,Terminated,[N]=O},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
9817,COPD,C0949083,Vitamin E,DB00163,Nosocomial pneumonia,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
12445,CYP1A1,C0032302,Trovafloxacin,DB00685,Mycoplasma pneumonia,Approved,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F},,Infectious disease,P450DX,P1-450,P450-C,CP11,,,,,,,,,,,,,,,,,,,,,,
37035,EP300,C0520679,Dexmedetomidine,DB00633,"Sleep Apnea, Obstructive",Withdrawn,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C},Phase 2/Phase 3,,0,,,,,,,,,,,,,,,,,,,,,,,,,
24130,GBE1,C0005697,Oxybutynin,DB01062,Neurogenic Urinary Bladder,Approved,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O},,Urinary system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
11584,C6,C0025294,Sulfisoxazole,DB00263,Meningococcal meningitis,Approved,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N},,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
14258,FOXE3,C0028840,Unoprostone,DB06826,Ocular Hypertension,Approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\\CCCC(=O)O)O)O},,Nervous system disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
13939,ADAMTS5,C0026857,Triamcinolone,DB00620,Musculoskeletal Diseases,Approved,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O},,Musculoskeletal disease,ADMP-2,ADAMTS11,,,,,,,,,,,,,,,,,,,,,,,,
27185,AGER,C1266050,Trametinib,DB08911,Poorly Differentiated Thyroid Carcinoma,Suspended,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5},Phase 2,Cancer,SCARJ1,,,,,,,,,,,,,,,,,,,,,,,,,
23621,TP53,C0220756,Miglustat,DB00419,"Niemann-Pick Disease, Type C",Approved,CCCCN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O},,Congenital disorder of metabolism,0,,,,,,,,,,,,,,,,,,,,,,,,,
34567,LGALS3BP,C0023890,Dexamethasone,DB01234,Liver Cirrhosis,Terminated,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C},Phase 3,Liver disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
36752,NAT8L,C0206307,Lithium,DB01356,Canavan Disease,Withdrawn,[Li]},Phase 2,Neurodegenerative disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
34521,CABIN1,C0037278,Vancomycin,DB00512,"Skin Diseases, Infectious",Terminated,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O},Phase 3,Infectious disease,0,,,,,,,,,,,,,,,,,,,,,,,,,
967,Carteolol,DB00521,Ocular Hypertension,C0028840,Approved,CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O},,Nervous system disease,,,,,,,,,,,,,,,,,,,Mepyramine,,,,,,,,
10349,IL6,C0011581,Norepinephrine,DB00368,Depressive disorder,Terminated,C1=CC(=C(C=C1[C@H](CN)O)O)O},Phase 3,Mental and behavioural disorder,IL-6,BSF2,HSF,IFNB2,,,,,,,,,,,,,,,,,,,,,,
23806,ORAI1,C0231528,Naproxen,DB00788,Myalgia,Approved,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O},,,0,,,,,,,,,,,,,,,,,,,,,,,,,
33489,PTPN11,C0005779,Vitamin E,DB00163,Blood Coagulation Disorders,Terminated,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C},Phase 2,Hematologic disease,BPTP3,SH-PTP2,SHP-2,PTP2C,SHP2,NS1,,,,,,,,,,,,,,,,,,,,
5215,Prednisone,DB00635,Adrenal cortical hypofunction,C0405580,Approved,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C},,Endocrine disease,,,,,,,,,,,,,,,,,,,NUCB2,,,,,,,,
15534,CYP17A1,C0027796,Pregabalin,DB00230,Neuralgia,Terminated,CC(C)C[C@@H](CC(=O)O)CN},Phase 2,Nervous system disease,P450C17,CPT7,S17AH,CYP17,,,,,,,,,,,,,,,,,,,,,,
1733,Clemastine,DB00283,Sneezing,C0037383,Approved,C[C@@](C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCC[C@H]3CCCN3C},,,,,,,,,,,,,,,,,,,,,HSPA4,,,,,,,,
9756,Methotrexate,DB00563,Inflammation,C0021368,Withdrawn,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O},Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
20638,PLA2G1B,C0241961,Everolimus,DB01590,Angiomyolipoma of kidney,Approved,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC},,Cancer,PLA2,PPLA2,PLA2A,,,,,,,,,,,,,,,,,,,,,,,
